data_6uyi_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6uyi _Structure_validation_residue.Date_analyzed 2020-03-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.85 163.84 11.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.519 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.66 143.45 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -87.46 122.07 30.72 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.754 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.2 t -106.63 113.3 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.963 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -97.55 120.86 38.69 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.771 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 76.9 p -82.06 171.23 14.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 55.9 mt -64.85 -25.08 67.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.907 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -74.23 -9.27 58.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.86 -10.05 70.47 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -73.19 133.21 43.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 95.7 m -107.3 132.19 53.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.568 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.79 111.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.655 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -83.32 127.9 34.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.5 mt -120.41 132.43 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.21 117.52 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.72 163.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.714 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -103.93 152.04 38.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.86 -35.7 94.3 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.973 1.782 . . . . 0.0 112.148 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.28 -3.11 58.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -61.86 137.57 58.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.961 0.41 . . . . 0.0 110.704 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -78.29 162.87 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.53 -38.11 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.864 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.36 -42.11 90.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.032 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.06 -40.74 96.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.196 0.522 . . . . 0.0 110.519 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.31 -42.72 97.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.659 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.73 -40.09 91.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.5 90.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.254 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.89 -38.78 83.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 95.0 mt -66.74 -38.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.434 0.635 . . . . 0.0 110.359 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.39 -46.67 88.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.221 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.62 -31.24 68.13 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.481 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -89.8 -4.33 57.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -147.95 -41.64 0.17 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.45 11.77 28.37 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.309 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.79 121.09 84.39 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.42 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.42 154.54 63.42 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.496 1.464 . . . . 0.0 111.495 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.18 -31.19 94.9 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.937 1.758 . . . . 0.0 112.771 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.99 -40.22 94.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.905 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.32 -7.48 57.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.956 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -87.04 105.98 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.155 0.502 . . . . 0.0 111.536 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -116.51 99.11 6.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.175 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 75.6 mt -86.4 131.18 34.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.25 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 85.5 mt -131.36 127.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.695 0.283 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -149.17 150.87 33.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.127 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.82 16.41 9.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.46 -14.36 59.82 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.44 144.34 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.965 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.25 135.08 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.006 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 52.9 mt -71.64 105.44 3.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.781 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -75.22 139.03 42.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.41 138.55 57.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.41 55.84 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -82.04 172.55 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.4 p -118.26 161.69 19.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.579 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.69 -40.46 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.983 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -63.85 -23.46 67.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.3 -37.6 86.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.134 0.492 . . . . 0.0 110.184 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.39 13.19 28.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.201 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.77 40.26 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.78 114.63 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.942 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -100.2 -179.6 4.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.845 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.75 146.19 53.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 59.24 17.45 5.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -70.6 132.62 45.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -82.81 128.6 34.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.96 140.24 49.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.852 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.01 117.44 28.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.954 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -100.43 121.42 41.51 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.009 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -111.98 132.57 60.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.066 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.9 mt -109.36 145.66 35.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.093 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 . . . . . 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.623 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.76 163.51 13.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.299 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 pt -143.94 145.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.535 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -92.88 121.53 34.33 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.672 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -104.73 104.63 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.42 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -87.54 126.7 35.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.846 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 79.2 p -77.52 -171.86 2.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.09 -19.88 48.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.673 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 22.2 p -111.15 -176.37 2.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.95 -18.45 57.21 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.76 131.04 38.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.082 0.468 . . . . 0.0 110.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -125.08 136.91 54.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.499 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.39 104.99 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.837 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -83.26 129.07 34.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 77.0 mt -124.51 131.97 53.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.564 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -76.63 116.56 17.42 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.343 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.15 161.7 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.65 152.71 40.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.02 -29.62 83.59 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.614 1.543 . . . . 0.0 111.791 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.7 p -80.97 -12.6 59.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.839 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.03 144.72 57.09 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.909 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -85.71 165.35 17.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.21 0.528 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.79 -38.1 80.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.454 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.04 88.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.692 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.63 -41.07 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 110.345 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.4 -42.3 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.972 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -61.1 -40.55 94.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 110.202 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.87 89.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.905 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.75 -38.26 81.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.407 HG22 HD13 ' D' ' 30' ' ' ILE . 85.6 mt -64.24 -39.92 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' D' ' 35' ' ' GLY . 65.9 tt0 -60.35 -44.78 95.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.25 0.548 . . . . 0.0 110.134 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.48 -41.06 98.59 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.622 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -83.52 -14.53 52.08 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -136.36 -50.04 0.68 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 113.37 9.5 17.32 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 59.6 mt -78.08 125.69 84.82 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.59 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.99 159.95 50.87 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 120.917 1.078 . . . . 0.0 109.88 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.49 -40.41 78.82 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.165 1.91 . . . . 0.0 112.864 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.79 -44.37 96.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.65 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.65 -40.16 80.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.893 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -85.57 140.71 30.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.206 0.527 . . . . 0.0 111.383 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -130.25 118.96 22.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -96.22 118.14 32.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.134 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -124.22 127.52 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -123.67 128.59 49.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.259 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.81 26.75 12.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.502 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.48 13.2 83.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -121.72 127.44 50.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.23 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -62.43 135.37 57.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 0.0 110.476 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.57 103.87 10.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.154 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.66 143.99 49.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.401 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -67.49 167.07 13.48 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.424 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 18.37 79.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -128.87 148.83 50.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -90.9 165.31 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.79 -38.39 90.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.394 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -62.54 -25.55 68.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.243 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -36.55 81.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.095 0.474 . . . . 0.0 110.156 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.32 14.42 24.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 56.42 39.27 30.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.19 104.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.01 -175.03 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.344 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -67.53 150.16 49.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.101 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 58.06 30.09 18.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.813 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 31.1 m -81.2 128.01 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 30.8 m -85.76 122.47 29.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.7 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.17 145.82 36.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.45 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -89.91 115.85 27.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -100.85 118.54 37.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.498 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -116.02 130.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.872 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 48.8 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.674 -179.043 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.68 112.05 23.86 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.5 mt -65.97 -38.69 89.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.621 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.84 163.48 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.668 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.7 122.18 0.34 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.187 0.518 . . . . 0.0 110.855 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.07 156.61 37.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.378 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.29 125.04 26.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.081 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.13 143.26 15.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.549 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.68 163.11 12.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -96.57 171.9 8.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.239 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.0 mtp -136.95 174.94 10.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -124.33 128.85 49.73 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.3 tp -108.15 116.89 32.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.179 0.514 . . . . 0.0 110.193 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.65 111.34 18.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.397 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.22 0.37 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -142.41 20.34 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.856 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.3 m -120.25 129.27 53.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.769 0.319 . . . . 0.0 110.485 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.95 122.29 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.032 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.6 p -114.47 131.37 23.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.38 147.57 52.99 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.744 1.629 . . . . 0.0 112.996 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -100.78 133.92 44.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -70.73 -12.46 61.57 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.008 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -76.34 68.97 2.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -58.88 134.41 56.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.9 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.11 -150.57 7.15 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.223 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 tp -137.51 126.64 24.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.8 t -97.65 112.7 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.07 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -134.52 155.0 51.16 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.3 mt -118.61 136.62 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.698 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.75 129.61 32.83 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 123.495 0.497 . . . . 0.0 110.463 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -99.24 125.34 44.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 110.301 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 p -86.23 170.12 12.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.423 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -61.95 -10.56 9.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.296 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.77 0.83 56.13 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.472 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.76 19.93 7.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.255 0.55 . . . . 0.0 110.48 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -98.49 123.34 42.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.6 mm -80.85 123.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -99.38 114.76 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.978 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -93.16 107.69 19.44 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.4 m -120.65 148.22 44.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.717 0.77 . . . . 0.0 113.036 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -127.83 115.24 18.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.175 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.52 131.74 53.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.932 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -72.11 134.37 45.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.63 -17.42 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.942 0.401 . . . . 0.0 110.428 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -60.03 -45.65 92.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.694 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.0 p -116.37 -16.77 10.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.131 0.491 . . . . 0.0 109.871 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.67 22.15 75.57 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -100.46 152.26 20.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.08 104.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.851 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -82.13 -29.78 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.354 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -126.71 146.29 50.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.408 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -157.56 101.26 1.83 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.856 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' C' ' 47' ' ' GLY . 13.8 mt -130.95 128.88 41.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.427 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.23 124.83 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.0 122.23 67.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -88.44 162.92 38.17 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.586 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.87 138.54 86.29 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.202 1.934 . . . . 0.0 111.831 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.05 6.2 1.68 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.754 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -71.68 -37.64 70.72 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.683 0.277 . . . . 0.0 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.7 p -146.81 167.08 24.77 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.732 0.777 . . . . 0.0 111.019 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -128.52 128.94 45.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.324 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -99.04 118.53 36.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -143.64 165.55 27.3 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.913 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -79.53 160.29 26.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.62 90.36 12.45 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.109 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.59 59.75 7.54 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.812 1.675 . . . . 0.0 112.381 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.0 -39.76 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.321 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 p -127.82 75.45 78.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.478 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.04 130.01 30.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.981 1.788 . . . . 0.0 111.474 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.43 -44.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.662 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.38 -148.32 6.53 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.1 106.37 13.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.97 127.82 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -123.73 155.09 38.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.692 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.75 138.37 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.089 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.8 tp -104.78 121.24 43.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -117.79 121.64 41.33 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.172 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -80.68 112.3 17.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.52 -36.21 77.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.695 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.1 -17.71 14.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.397 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.89 -13.9 68.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.576 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 53.2 31.46 11.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.09 0.445 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -120.75 145.73 47.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.249 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -127.06 127.93 45.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.089 0.471 . . . . 0.0 111.532 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.9 mt -119.32 149.14 42.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.62 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.61 134.96 53.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.558 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.23 155.43 50.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.38 0.61 . . . . 0.0 111.322 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -129.01 136.23 50.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.183 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.5 mtp -81.29 138.4 35.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.227 0.537 . . . . 0.0 111.51 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.91 5.3 49.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.669 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.95 130.96 89.45 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.183 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.6 -24.83 41.29 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.692 1.595 . . . . 0.0 112.686 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.4 143.24 48.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.4 p -95.68 11.45 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.02 -20.62 58.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -122.81 9.28 9.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.067 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -62.85 -45.69 91.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.41 -32.82 73.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.415 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.48 -46.69 81.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.41 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -64.54 -40.81 96.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 109.626 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.1 t -63.1 -44.27 96.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.262 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -69.8 -41.33 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.241 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.54 -42.71 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.378 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.6 t -57.77 -48.26 84.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.917 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.824 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.12 -20.68 63.17 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.549 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -94.41 -18.2 21.77 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.746 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.3 mt -95.62 -24.64 16.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.096 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -118.72 -12.25 9.71 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.271 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.15 64.71 55.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.122 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.23 152.67 75.78 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.492 1.394 0 C-N-CA 122.245 1.963 . . . . 0.0 111.872 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -129.13 148.6 69.73 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.635 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.46 146.71 27.89 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.606 2.204 . . . . 0.0 112.194 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -73.41 153.03 90.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.45 154.0 65.34 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.938 1.759 . . . . 0.0 112.139 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.65 -170.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.336 2.024 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -126.43 159.02 65.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.197 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.41 139.9 87.79 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.457 2.105 . . . . 0.0 112.331 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.41 163.6 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.604 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -86.44 134.3 33.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -118.72 131.39 56.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -63.95 158.92 21.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.237 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.34 148.82 24.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.114 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -91.37 120.99 32.7 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.285 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.63 110.22 29.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -98.27 121.29 40.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.638 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -82.2 173.83 11.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 74.3 mt -61.65 -30.35 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.23 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -71.25 -12.15 61.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.13 -13.98 62.87 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.43 131.86 49.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 110.364 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 95.3 m -108.93 131.03 55.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.392 . . . . 0.0 110.374 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.03 114.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.474 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 29.1 m -81.32 129.98 34.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.347 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.61 127.32 48.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -71.3 115.26 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.37 163.49 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.634 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.34 152.86 40.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.98 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.35 -37.23 94.8 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.119 1.879 . . . . 0.0 112.229 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -83.84 -4.92 59.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.063 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -59.72 136.97 58.16 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.953 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -77.58 161.75 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.91 -38.99 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.236 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.13 -42.02 89.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.27 -41.04 98.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.145 0.498 . . . . 0.0 110.619 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.19 -43.45 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.77 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.63 -39.97 90.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.237 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.55 -39.68 88.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -66.28 -39.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.308 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.57 -40.99 93.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.32 -39.6 92.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.151 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -74.86 -64.39 1.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.712 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.17 170.93 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.219 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.26 21.12 26.31 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . 0.42 HG22 HD12 ' C' ' 36' ' ' ILE . 27.3 mm -77.03 117.49 65.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.851 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.77 156.27 57.26 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.299 1.999 . . . . 0.0 111.797 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.07 -39.3 70.6 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.071 1.847 . . . . 0.0 112.526 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.13 -39.59 93.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.681 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.39 -3.51 56.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.114 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -87.42 68.04 9.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.61 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -85.53 110.72 19.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 25.9 mt -98.78 132.58 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.64 129.62 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 110.525 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.66 151.65 40.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.984 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.88 15.56 6.11 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.34 -14.25 63.0 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.2 140.71 39.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.56 133.88 44.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.22 102.2 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.891 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -75.3 140.12 42.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.83 137.94 57.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.216 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.47 -17.78 52.58 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmp_? -83.49 177.7 8.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.337 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -125.24 163.21 23.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.109 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.54 -40.93 96.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.552 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.83 -24.41 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.78 -37.93 86.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.2 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.72 13.88 26.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.509 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.79 39.34 27.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.41 . . . . 0.0 110.264 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.54 118.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.069 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -106.87 -179.18 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.686 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -61.97 146.14 50.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.935 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.6 15.63 9.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.618 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.8 m -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -82.54 129.77 34.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.064 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -114.89 144.31 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.127 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -95.83 118.14 31.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.231 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.82 123.32 40.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.49 126.95 72.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.947 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 mt -98.45 -174.25 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.405 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.332 . . . . 0.0 110.527 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -63.21 154.83 30.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.078 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -133.9 160.72 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.321 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -101.59 125.71 48.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.615 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 78.5 t -111.56 107.15 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.898 0.38 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -85.2 129.23 34.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -90.18 176.6 6.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 110.961 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.65 -37.37 81.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -74.68 -8.22 55.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.75 67.37 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -63.29 126.59 27.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.059 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 92.3 m -96.21 136.88 36.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 0.0 110.611 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -122.3 118.18 54.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.278 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.41 125.14 31.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.061 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 90.5 mt -123.26 113.11 18.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.94 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -65.78 106.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.242 0.544 . . . . 0.0 110.853 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.61 163.2 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.639 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -105.76 155.09 38.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.58 -37.24 97.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.174 1.916 . . . . 0.0 111.981 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -83.42 -5.22 59.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.976 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -59.15 138.06 57.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.995 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -79.65 161.35 25.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.944 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -64.02 -38.37 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.755 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.77 -41.59 86.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.817 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.17 -41.4 98.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 110.714 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.19 -42.73 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.52 -39.8 89.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.406 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.63 92.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.511 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -59.82 -40.06 87.14 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.62 -39.62 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.338 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.17 -42.42 90.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.678 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -90.69 19.73 5.21 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -122.52 -39.56 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -126.11 -6.99 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.315 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 18.87 76.6 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 70.8 mt -77.05 120.56 82.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 147.84 92.36 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.341 2.027 . . . . 0.0 111.727 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 -41.76 62.97 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.943 1.762 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.11 -32.02 72.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.9 -10.24 58.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.466 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -88.88 112.97 23.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.601 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -115.74 101.42 8.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 mt -94.66 118.48 31.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.2 mt -125.99 123.08 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.116 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -113.42 122.83 48.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.15 30.11 19.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.473 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.46 89.99 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -103.41 119.11 38.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -64.11 138.64 58.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 mt -90.5 105.34 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.33 153.32 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.728 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -72.37 161.21 31.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.063 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.89 84.69 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.01 176.98 4.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.707 0.289 . . . . 0.0 110.45 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -126.16 164.42 20.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.24 -39.79 94.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.743 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -63.27 -29.52 70.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 0.0 110.923 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.78 -32.17 72.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.46 14.19 30.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.215 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 55.83 39.93 30.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.817 0.341 . . . . 0.0 110.542 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.35 105.01 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.817 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.26 -177.04 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.436 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -61.08 148.76 39.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.085 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 56.96 47.7 17.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -104.62 124.45 49.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.318 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 94.4 m -74.66 130.73 40.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -121.25 145.68 47.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -91.16 111.19 22.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.923 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 tp -98.28 118.03 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -115.84 135.61 55.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.071 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 mt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.528 -178.843 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -97.05 126.18 42.02 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.332 0.587 . . . . 0.0 109.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' ILE . 86.3 mt -68.24 -38.58 81.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.092 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.64 161.45 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.88 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.7 122.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.23 158.98 41.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.071 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.75 121.21 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.945 0.402 . . . . 0.0 111.004 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.77 145.0 22.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.27 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.86 153.15 17.28 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -88.2 173.95 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.977 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.5 mtp -136.93 175.47 9.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.9 m -124.23 124.56 42.71 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.8 tp -106.35 116.94 32.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.47 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -120.02 110.53 16.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.795 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -90.46 0.47 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 p -140.18 23.09 2.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.608 0.242 . . . . 0.0 110.745 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.0 m -125.06 129.82 51.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.655 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.99 122.72 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.139 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.3 m -118.74 129.08 25.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.05 146.48 64.75 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.692 1.594 . . . . 0.0 113.183 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.93 136.32 39.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.791 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -71.16 -8.73 55.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.639 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.87 77.32 0.89 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -58.08 134.23 56.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.96 -160.79 9.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.679 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tp -137.41 123.98 20.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -95.48 109.91 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.249 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -131.32 154.98 47.98 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.191 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -120.45 140.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.454 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.77 128.17 26.39 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.827 0.705 . . . . 0.0 110.35 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -99.5 124.4 44.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 p -84.63 172.14 11.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.551 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.65 -10.56 27.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.93 1.54 55.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.561 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t 70.24 21.05 6.01 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.309 0.576 . . . . 0.0 110.432 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.5 mt -98.76 121.56 40.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.1 mm -80.22 121.23 33.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.461 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -97.65 114.25 26.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.614 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -97.59 107.05 19.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.06 50.29 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.782 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -117.82 116.06 26.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.571 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -105.55 144.95 31.6 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.416 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.41 130.89 35.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.15 -18.69 62.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 110.755 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.1 m -59.41 -45.49 91.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.608 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.4 m -117.06 -11.85 10.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.972 0.415 . . . . 0.0 110.496 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 22.77 78.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.37 149.94 23.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.669 0.271 . . . . 0.0 110.448 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.58 102.19 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.07 -38.76 66.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.836 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -126.37 146.17 50.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.069 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -157.9 100.8 1.76 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.168 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.0 mt -126.86 135.93 51.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.976 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.2 mt -77.96 120.51 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.225 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 mm -110.5 121.48 63.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.236 0.541 . . . . 0.0 111.153 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -85.08 163.04 47.38 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.799 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.53 140.21 92.61 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.105 1.87 . . . . 0.0 111.567 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t0 60.08 11.86 2.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.45 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -84.23 -26.26 28.82 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.863 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.76 168.69 23.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.523 0.678 . . . . 0.0 110.603 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -135.06 131.72 37.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.382 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -103.38 117.34 34.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -142.13 167.52 21.93 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.823 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -82.69 160.25 22.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.945 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -112.64 90.12 14.32 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.014 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.9 60.05 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.904 1.736 . . . . 0.0 112.347 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.52 -39.72 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.514 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.3 t -127.44 85.99 59.6 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.647 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.39 130.62 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.679 1.586 . . . . 0.0 111.671 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 169.29 -40.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.13 -157.9 7.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -104.52 109.23 21.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.21 129.02 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -126.54 153.24 45.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.36 135.34 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.2 tp -103.61 119.92 39.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -116.29 131.13 57.03 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.302 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -84.47 114.37 21.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.038 0.447 . . . . 0.0 109.988 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.41 -36.49 82.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.46 -24.01 66.37 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.294 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -137.82 -148.98 5.46 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.7 p -121.08 7.2 10.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.637 0.256 . . . . 0.0 111.014 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.19 134.87 56.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -136.48 135.64 38.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.971 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 mt -119.55 145.01 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.517 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -116.36 131.66 56.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.724 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.6 154.84 51.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.237 0.542 . . . . 0.0 110.915 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -128.63 137.08 51.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.306 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.9 tpp -73.88 140.2 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.527 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.73 1.73 19.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -73.39 141.07 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.587 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -28.98 22.64 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.886 1.724 . . . . 0.0 112.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -119.1 143.63 47.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.477 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.2 p -97.73 6.01 48.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.021 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -58.2 -21.61 48.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -124.19 -14.18 7.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.046 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.32 -41.24 98.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.646 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.51 -40.35 96.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.75 -41.91 97.92 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.495 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -63.35 -40.61 97.77 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.49 0.662 . . . . 0.0 109.263 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.19 -46.8 88.97 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -65.5 -36.96 85.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.314 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -33.46 67.54 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.275 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.63 -46.71 95.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.146 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.51 -31.96 53.83 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -71.04 -30.56 66.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.349 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -83.75 -29.73 27.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.91 0.386 . . . . 0.0 110.304 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.9 mt -87.75 -23.68 24.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.913 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -108.91 -24.42 11.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.52 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -135.73 67.79 65.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.37 160.27 49.18 Favored 'Trans proline' 0 C--N 1.297 -2.137 0 C-N-CA 122.849 2.366 . . . . 0.0 112.242 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.187 . . . . 0.0 112.228 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.35 151.11 77.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.46 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.19 147.8 26.56 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.181 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.78 152.82 89.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.011 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.67 152.15 64.4 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.392 2.061 . . . . 0.0 112.221 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.85 -174.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.421 2.08 . . . . 0.0 111.964 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -122.44 157.64 58.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.205 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.19 139.49 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 122.457 2.105 . . . . 0.0 111.709 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 165.15 37.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -86.08 138.41 31.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -62.1 157.65 18.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.358 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -139.41 148.15 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.933 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.79 124.21 40.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.777 0.322 . . . . 0.0 110.986 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 99.4 t -108.18 114.57 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.646 -0.421 . . . . 0.0 109.99 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -97.31 119.86 36.61 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.342 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.6 p -79.56 171.83 14.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.51 -24.85 67.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.171 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -75.57 -10.5 59.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.051 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.56 -14.48 64.16 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.62 133.09 49.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 110.34 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -107.56 132.19 53.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.389 . . . . 0.0 110.759 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.1 112.67 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.466 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.01 132.99 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -130.96 122.24 26.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -66.81 115.17 6.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.1 163.45 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.589 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -107.3 152.7 41.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.634 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -37.16 87.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.922 1.748 . . . . 0.0 112.089 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -80.43 -9.57 59.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -58.51 136.0 57.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -77.61 158.97 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.134 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -66.43 -40.98 87.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -59.13 -42.7 91.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.36 -43.97 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.303 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.16 -44.01 97.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -38.63 79.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.061 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.04 94.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.532 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -61.68 -37.48 84.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.139 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.25 -39.2 84.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -59.02 -39.97 83.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.366 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -86.95 7.29 28.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -107.8 -47.62 3.56 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -116.54 -0.76 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.591 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 19.64 79.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 16.8 mm -81.43 119.96 76.96 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.133 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.26 149.3 65.24 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.065 1.843 . . . . 0.0 111.861 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -33.42 77.03 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.429 2.086 . . . . 0.0 112.65 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.05 7.68 39.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.395 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -108.33 -31.12 7.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.753 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -99.22 131.53 45.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.498 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -122.95 115.35 21.77 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.8 129.62 34.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.18 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt -131.87 129.16 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.326 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -145.96 150.08 35.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.019 0.438 . . . . 0.0 111.456 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.92 20.12 11.25 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.022 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 84.32 -8.72 66.65 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -107.9 137.22 46.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.972 0.415 . . . . 0.0 111.237 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -74.19 132.99 42.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.838 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 45.1 mt -74.95 98.66 3.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.53 141.23 43.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.819 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.68 142.86 52.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.99 -18.06 57.31 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -87.99 171.19 10.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.883 0.373 . . . . 0.0 110.476 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.8 p -115.46 163.52 15.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.131 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.41 -40.96 96.32 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.802 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 94.7 p -63.79 -22.64 67.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.448 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.78 -37.82 85.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.95 0.405 . . . . 0.0 110.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -98.37 15.47 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.245 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 58.98 41.8 20.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.586 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -88.39 109.99 20.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -95.51 178.37 5.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.453 0.644 . . . . 0.0 111.171 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -61.23 148.3 41.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.746 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 59.25 17.11 5.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.398 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -65.92 138.13 57.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 39.2 m -98.31 122.1 41.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mp -116.57 148.22 41.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.554 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -92.19 133.19 36.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tt -108.26 115.86 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.048 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.5 131.5 47.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.054 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 39.4 mt -106.1 132.92 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.536 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -63.06 160.69 14.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.162 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -138.41 156.42 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.258 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -96.29 125.37 40.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.709 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.45 107.35 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.913 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 122.78 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.093 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -82.3 172.1 13.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.22 -26.02 68.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.179 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -86.6 -1.34 57.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.828 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 -8.72 77.83 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -68.3 118.34 11.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.896 0.379 . . . . 0.0 110.107 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 74.6 m -90.99 137.38 32.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mt -122.48 119.0 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.116 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -86.47 117.8 25.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.702 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.89 123.39 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.94 113.06 7.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.05 160.52 42.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.276 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.45 152.98 40.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.926 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.1 -36.86 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 111.661 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -80.06 -9.7 59.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.303 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -57.93 138.43 55.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 47.0 p -81.03 163.11 23.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.174 0.511 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.54 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.207 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.18 -39.4 86.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.875 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.03 -43.48 99.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.698 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -61.34 -39.38 90.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.053 0.454 . . . . 0.0 109.994 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.38 89.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.125 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -59.92 -38.91 83.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 80.1 mt -64.89 -39.87 87.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.824 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.71 -44.57 96.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.057 0.456 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.83 -13.25 59.95 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.911 -0.493 . . . . 0.0 112.065 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -105.92 -4.01 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -148.48 -37.19 0.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 110.459 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.01 11.8 36.08 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 41.4 mt -82.38 121.02 78.1 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.898 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 155.07 42.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.038 1.825 . . . . 0.0 111.745 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.11 -25.27 73.06 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.626 2.217 . . . . 0.0 112.528 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -95.01 7.02 47.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -118.35 9.77 12.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.894 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -142.05 154.45 44.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -134.22 129.62 35.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.747 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -99.9 115.29 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.054 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 88.5 mt -121.47 117.07 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.326 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -64.71 -47.07 79.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.051 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -176.74 78.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.827 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.91 89.95 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -129.67 125.82 36.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.816 0.341 . . . . 0.0 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -82.71 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.476 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.36 106.24 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.65 143.81 48.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.037 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.06 156.96 20.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.2 16.58 69.02 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.91 165.8 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 110.49 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -113.15 165.49 12.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.26 -39.88 92.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.476 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.8 -26.41 68.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.53 -37.95 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.128 0.49 . . . . 0.0 110.186 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -95.03 13.62 24.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.056 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.16 40.81 27.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 87.0 mt -92.33 114.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -100.43 -169.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.395 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -68.86 151.54 46.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 56.72 37.57 28.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.625 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -86.87 123.58 32.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -80.15 124.3 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.55 132.78 54.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.149 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.71 123.79 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.918 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 65.9 tp -103.97 111.54 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.665 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.36 132.61 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.168 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 58.4 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 111.022 -178.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -99.62 126.98 45.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.391 0.615 . . . . 0.0 110.225 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 49' ' ' ILE . 85.6 mt -68.49 -37.34 80.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.072 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -147.31 161.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.756 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.53 122.68 0.36 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.183 0.515 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -153.72 158.32 40.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.084 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.77 120.92 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.619 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.51 145.32 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.112 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.42 152.48 17.83 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.46 171.4 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 28.6 mtp -132.63 174.47 10.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.0 m -122.7 123.22 40.61 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.9 tp -105.02 116.94 32.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.19 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -120.81 112.25 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.94 -92.45 0.46 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 p -138.35 23.28 2.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.678 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -125.32 131.73 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.3 t -111.01 123.73 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.204 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.4 p -119.02 135.12 23.66 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.141 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.5 150.38 57.57 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.98 1.787 . . . . 0.0 113.356 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -105.49 140.07 39.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.156 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -76.35 -7.08 54.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -72.76 75.13 1.13 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -55.48 127.96 32.12 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.78 -159.12 9.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tp -139.17 124.46 19.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.1 t -96.53 109.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.346 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -131.57 154.25 49.03 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.018 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.2 mt -118.42 139.14 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.712 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 128.53 30.76 Favored 'General case' 0 C--O 1.22 -0.478 0 O-C-N 123.89 0.744 . . . . 0.0 110.35 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -99.42 125.3 45.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.977 0.417 . . . . 0.0 109.956 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 p -85.56 170.39 12.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.384 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -62.79 -10.62 13.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.166 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.5 2.62 54.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.475 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t 69.63 20.62 6.94 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.208 0.528 . . . . 0.0 110.401 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.9 mt -97.32 121.97 39.82 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.1 mm -81.88 120.06 32.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -96.9 111.53 23.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.114 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -90.58 108.24 19.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.2 m -121.02 145.98 47.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.648 . . . . 0.0 112.627 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -124.39 112.84 17.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.435 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -104.86 135.23 46.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.028 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -74.79 136.69 41.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.874 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -78.9 -17.77 54.98 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.537 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -60.84 -46.64 89.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -117.02 -13.02 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.95 24.94 75.01 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -102.01 144.48 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 0.0 110.673 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.16 105.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.27 -28.11 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.008 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -127.69 144.05 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.196 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -159.49 95.9 1.25 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.87 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -123.13 138.01 54.77 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.821 0.343 . . . . 0.0 110.727 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.402 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 86.1 mt -83.21 116.8 27.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mp -105.52 116.65 49.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.957 0.408 . . . . 0.0 111.139 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -79.69 164.17 54.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.988 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.08 139.68 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.95 1.767 . . . . 0.0 111.041 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.59 11.82 3.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -85.91 -42.2 14.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.481 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.85 148.17 52.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.0 111.364 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -122.02 129.56 52.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.663 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -101.78 118.46 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -144.06 167.94 21.18 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.767 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -94.68 146.25 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.288 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.39 99.58 21.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.221 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.81 60.09 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.741 1.627 . . . . 0.0 112.223 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -114.35 -36.34 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.246 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 p -121.94 74.35 37.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.711 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.02 130.27 26.92 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.103 1.869 . . . . 0.0 111.745 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.98 -43.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.905 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.93 -139.61 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.47 106.38 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.3 127.31 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.82 156.21 35.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 p -131.7 137.52 54.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.3 tp -105.69 119.92 40.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -119.61 139.18 52.59 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.991 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -88.78 115.81 26.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.62 -37.19 83.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.526 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.98 -22.86 24.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.176 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.51 -169.28 21.9 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.1 m -124.0 17.96 9.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -89.64 138.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.27 0.557 . . . . 0.0 111.087 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.49 109.25 10.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.7 mt -96.0 150.4 20.51 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -123.94 136.48 54.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.258 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.06 155.7 49.33 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.316 0.579 . . . . 0.0 111.118 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -128.32 137.45 51.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.838 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.1 tpp -75.82 123.95 26.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.242 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -16.81 34.72 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.7 127.29 88.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.28 -20.05 43.33 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.94 1.76 . . . . 0.0 112.724 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.54 140.4 47.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.132 0.491 . . . . 0.0 110.317 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.9 p -99.12 10.88 40.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.09 -26.42 49.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.379 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -126.03 -0.69 7.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.805 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.73 -48.56 80.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.77 -40.91 97.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -64.07 -42.67 96.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.807 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -64.79 -39.65 93.94 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.511 0.672 . . . . 0.0 109.213 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.82 -45.72 92.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.558 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -64.37 -43.47 94.43 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.212 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.25 -38.1 87.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.89 -48.08 87.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.164 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -80.61 -32.51 36.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.04 -38.18 87.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.571 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -80.62 -37.78 30.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.005 0.431 . . . . 0.0 110.258 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 77.0 mt -71.53 -34.41 70.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.115 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -100.89 -24.13 14.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.677 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -139.99 69.04 35.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.746 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.83 160.49 49.23 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.916 2.411 . . . . 0.0 112.28 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.649 2.233 . . . . 0.0 112.248 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.67 81.99 68.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.724 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 138.88 83.81 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.808 2.339 . . . . 0.0 112.249 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.04 159.26 71.17 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.84 146.65 77.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.41 -173.96 1.29 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.541 2.161 . . . . 0.0 112.189 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -100.33 153.35 37.8 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.389 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.83 152.04 73.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.491 2.127 . . . . 0.0 112.084 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.43 168.74 25.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.35 132.14 34.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.82 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -113.37 136.04 53.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.079 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.447 -0.61 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.585 -179.23 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -62.45 160.34 13.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -139.31 149.97 22.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.614 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -91.86 119.82 31.99 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.263 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 69.4 t -104.36 108.64 25.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.07 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -92.75 122.31 35.03 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.889 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.0 p -81.56 171.5 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.593 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 mt -65.54 -21.34 66.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.047 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.25 -5.88 58.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.343 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.49 74.68 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -74.16 128.8 36.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.844 0.322 . . . . 0.0 110.236 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.48 132.16 47.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.07 111.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.438 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -81.44 126.99 32.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.71 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -120.03 129.82 54.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.66 116.58 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -136.13 165.63 28.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.706 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -110.32 154.14 43.06 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.42 -30.61 91.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.72 1.613 . . . . 0.0 111.965 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.3 m -88.86 -6.5 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.27 144.21 57.31 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.812 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.91 163.86 23.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.04 -38.56 82.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.786 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -58.96 -40.89 86.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.41 -46.37 90.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.566 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -60.71 -42.66 92.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.04 -37.04 78.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.33 95.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -39.31 82.81 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.228 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.15 -39.36 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.445 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.12 -43.05 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.43 19.31 6.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.47 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -123.72 -42.88 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.374 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -116.84 -18.95 10.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.575 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.26 10.81 65.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.515 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 52.0 mt -75.04 128.03 85.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.161 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.77 154.23 63.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.502 1.468 . . . . 0.0 111.02 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.64 -23.42 65.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.2 1.933 . . . . 0.0 111.968 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.85 -1.69 52.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.013 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -123.31 -31.49 3.55 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.52 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -78.8 132.84 37.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.318 0.58 . . . . 0.0 111.449 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -130.43 126.74 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.397 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 77.3 mt -103.39 124.71 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.961 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -129.38 129.08 67.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.293 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -144.39 149.41 36.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.899 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.6 16.72 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.396 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.26 -14.95 59.56 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -98.94 141.49 31.64 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.449 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -75.43 127.27 32.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.751 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 48.3 mt -76.09 89.49 3.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -74.97 171.37 14.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -75.81 169.0 18.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.079 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.42 19.49 77.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -124.53 167.2 14.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.687 0.279 . . . . 0.0 110.585 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -122.71 161.22 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.578 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -60.89 -40.51 93.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.8 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.62 -23.0 67.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.561 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.2 -38.06 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.017 0.437 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -97.18 13.2 30.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.151 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 59.05 41.08 21.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.257 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.35 118.4 33.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.912 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -107.07 178.38 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.002 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -59.53 146.59 40.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.807 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 61.49 18.6 9.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 27.5 t -71.6 131.09 42.71 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 93.6 m -83.91 127.89 34.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -116.5 144.1 44.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.201 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -92.33 123.64 35.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.056 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tt -102.8 115.25 30.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.127 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -108.96 132.82 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.095 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 33.3 mt -105.84 135.35 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.29 158.19 12.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.771 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -138.42 151.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.859 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -92.69 122.92 35.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.711 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.68 109.95 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.694 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -94.52 122.3 36.95 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.088 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 77.0 p -82.19 -179.08 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.321 0.581 . . . . 0.0 111.632 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.58 -37.06 82.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.825 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.14 -8.99 57.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.262 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.92 -9.12 70.6 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.81 128.0 34.13 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -102.05 130.54 48.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.118 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -124.37 113.86 38.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.743 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 10.6 m -80.03 125.78 30.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.757 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.25 118.25 30.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.281 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.19 110.29 2.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.299 0.571 . . . . 0.0 110.715 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.81 160.82 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -103.58 155.02 37.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.997 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 -38.37 95.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.124 1.883 . . . . 0.0 111.996 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.7 p -80.0 -8.78 59.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.026 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -58.7 135.74 57.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.979 0.418 . . . . 0.0 110.89 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.14 163.45 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 50.0 mm -64.23 -37.92 81.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.98 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.66 -43.81 89.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.99 -42.3 98.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 110.754 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.9 -42.38 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.923 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -60.64 -39.56 88.74 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.109 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.03 88.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -59.71 -38.98 83.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 87.3 mt -64.77 -40.58 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.931 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.69 -47.0 87.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.28 -15.94 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -103.57 -4.84 23.36 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.59 -37.65 0.2 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.78 10.42 32.82 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.82 127.45 82.01 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.17 155.98 42.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.168 1.245 . . . . 0.0 110.728 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.78 -36.69 83.23 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.063 1.842 . . . . 0.0 112.468 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.14 -39.01 88.43 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.311 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -96.65 23.26 7.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -118.29 112.32 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 111.712 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -118.64 110.61 17.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.7 117.12 31.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.1 mt -121.82 126.58 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -127.68 130.14 48.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.7 29.13 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 17.16 79.69 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -132.66 127.91 35.89 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.573 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -66.54 148.07 52.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.06 0.457 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 77.2 mt -90.21 115.36 27.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.882 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -70.01 136.7 50.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -61.31 136.94 58.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.198 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.62 55.72 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -82.25 172.58 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -118.27 163.21 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.89 -39.48 89.42 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.402 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.2 p -63.81 -24.35 67.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.3 . . . . 0.0 110.414 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.95 -37.75 85.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.327 0.584 . . . . 0.0 110.044 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -98.14 14.53 27.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.282 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 m120 56.83 39.94 29.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.829 0.347 . . . . 0.0 110.278 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -90.14 113.75 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.856 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -99.33 -172.25 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.531 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -68.79 150.75 47.49 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.273 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 56.85 41.77 27.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -98.5 127.45 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.559 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 90.3 m -78.22 127.53 32.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.57 138.4 52.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.921 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -89.07 113.96 25.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.46 120.53 39.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -112.97 132.75 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.252 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.455 -178.406 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -86.15 112.41 21.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.4 mt -68.32 -37.02 80.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.606 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.65 161.7 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.26 122.24 0.29 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 0.0 110.834 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.04 160.07 40.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.696 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -78.66 124.05 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.046 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.75 146.03 20.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.86 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.47 152.12 17.19 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -95.52 161.9 13.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.875 0.369 . . . . 0.0 111.13 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mtm -134.81 170.27 16.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -121.09 135.92 55.08 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.403 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.6 tp -110.97 119.36 38.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.947 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -120.75 112.38 18.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.85 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -106.54 1.81 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.6 p -124.06 20.86 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.292 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.0 m -124.61 130.32 52.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 110.798 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.71 121.28 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -108.77 131.55 21.71 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.95 145.4 45.08 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.062 1.842 . . . . 0.0 113.35 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.12 120.74 42.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -65.23 -11.32 39.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -72.31 78.84 1.0 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -58.83 140.13 55.55 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.98 -157.3 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.815 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -135.31 127.93 30.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.37 111.77 32.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.546 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -136.09 156.29 48.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.231 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.7 mt -122.24 137.7 54.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.873 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -135.06 130.56 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.632 0.583 . . . . 0.0 110.112 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -100.7 124.15 45.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.107 0.48 . . . . 0.0 110.085 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -85.34 171.59 11.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.49 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.02 -10.34 21.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.116 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.93 1.09 55.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.282 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t 69.12 21.74 7.14 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.312 0.577 . . . . 0.0 110.252 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.6 mt -98.28 122.72 41.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.1 mm -81.99 122.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -98.17 112.67 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.851 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -92.15 109.29 20.65 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 77.9 m -121.74 145.96 47.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -128.3 117.86 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.53 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -108.68 143.81 37.28 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.348 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -80.98 129.21 34.42 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -71.34 -16.64 62.44 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 m -59.4 -45.35 91.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.429 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.1 m -117.22 -13.27 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 110.182 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.79 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -101.72 152.04 21.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.04 103.86 6.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -77.97 -32.93 51.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -126.68 146.1 50.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.538 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -157.68 98.73 1.67 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.052 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 mt -127.64 133.85 49.65 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.501 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -79.09 123.92 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.23 129.5 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 111.103 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -94.14 162.51 26.33 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.436 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.76 140.67 91.56 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.172 1.915 . . . . 0.0 111.658 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 60.71 12.26 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -88.4 -35.24 17.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.977 0.418 . . . . 0.0 110.401 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.51 148.36 49.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.179 0.514 . . . . 0.0 111.561 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -122.61 127.68 49.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.455 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -100.57 120.63 40.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -145.37 167.13 23.63 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.792 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -92.14 159.27 15.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.889 0.376 . . . . 0.0 110.217 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 t -120.95 89.83 46.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.382 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.31 60.45 7.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.81 1.674 . . . . 0.0 112.169 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.69 -34.3 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.172 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.5 t -124.91 86.78 56.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.54 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.48 129.91 19.94 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.771 1.647 . . . . 0.0 111.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.98 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.33 -176.77 33.8 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 110.36 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.42 126.53 72.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -121.95 152.82 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.233 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.04 135.79 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.212 0.529 . . . . 0.0 109.904 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.5 tp -104.76 118.22 36.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -115.29 132.47 56.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 111.29 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -86.65 115.56 24.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.58 -37.14 82.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.318 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -108.68 -23.36 11.83 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.362 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.86 -33.7 87.94 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.76 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p 74.05 27.89 1.54 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.621 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -139.45 162.11 35.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.491 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.69 149.42 45.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.464 . . . . 0.0 111.2 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.24 150.82 46.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.304 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.3 135.92 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.501 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -137.34 156.38 48.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.191 0.519 . . . . 0.0 111.223 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -133.75 137.17 45.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.826 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttm -74.67 131.73 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.946 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.47 4.31 26.04 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.709 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -71.86 148.73 92.37 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.424 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.89 -27.6 14.29 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.099 1.866 . . . . 0.0 112.967 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -119.51 142.18 48.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.31 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.8 p -98.31 8.46 44.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.491 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.58 -22.47 13.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.351 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -123.73 8.11 8.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.579 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -61.16 -49.1 78.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.47 -40.5 95.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.209 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.77 -43.31 99.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.614 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -64.18 -40.13 95.46 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.92 94.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.792 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -65.65 -43.34 89.75 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.245 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.46 -39.33 93.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.887 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.14 -47.78 89.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.233 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.33 -27.88 38.25 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.82 -38.71 80.06 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.55 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -81.18 -33.23 33.16 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.64 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.5 mt -77.96 -28.63 49.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -104.83 -26.87 12.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.319 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.7 72.84 73.09 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.313 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.77 149.14 84.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.799 2.333 . . . . 0.0 111.573 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 122.175 1.916 . . . . 0.0 112.182 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 -72.08 154.35 92.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.449 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.16 153.88 66.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.829 2.352 . . . . 0.0 112.638 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.37 155.05 94.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.725 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.83 157.32 62.34 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.176 1.917 . . . . 0.0 112.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.74 176.94 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.224 . . . . 0.0 111.622 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.05 157.62 42.99 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.856 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 145.27 99.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.225 1.95 . . . . 0.0 111.788 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -158.07 169.3 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.09 137.86 32.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.185 0.517 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.9 121.49 38.18 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.471 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 63.4 mt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -62.08 156.09 22.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.019 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.97 148.83 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.27 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -90.21 123.86 34.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.443 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.55 114.73 47.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.195 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -103.02 123.07 45.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.644 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.3 p -84.1 172.5 11.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.069 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 73.4 mt -64.35 -25.47 68.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -74.28 -8.89 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.22 6.11 66.91 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.25 127.95 34.27 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.788 0.327 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -104.54 131.76 51.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.916 0.389 . . . . 0.0 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 117.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.295 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -83.72 130.14 34.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.447 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.24 122.95 39.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.775 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -66.13 110.77 3.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.744 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 22.4 m -134.23 163.44 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.447 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -106.09 154.35 39.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.98 -35.37 94.33 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.033 1.822 . . . . 0.0 112.17 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -84.78 -3.83 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.01 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -60.15 136.55 58.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 110.775 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.44 162.19 26.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.54 -38.32 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.12 -43.27 91.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.243 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.43 -41.63 98.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 110.909 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.7 -42.69 96.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.742 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -60.41 -39.32 86.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -40.26 93.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.379 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.22 -39.68 87.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.54 -39.8 84.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.211 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -59.49 -39.63 84.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 0.0 110.284 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.07 -44.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.701 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.82 -39.7 72.89 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -132.94 152.03 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.67 2.22 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.39 94.91 46.46 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.36 149.62 80.08 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.73 2.287 . . . . 0.0 112.232 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -52.62 -40.06 74.08 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.962 1.774 . . . . 0.0 112.387 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.57 -39.54 94.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.03 31.86 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -136.04 120.42 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.842 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -128.67 115.0 17.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.53 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 27.0 mt -92.89 132.31 37.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.151 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -129.46 128.61 66.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -144.27 151.39 39.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.869 0.366 . . . . 0.0 110.999 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 15.81 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.469 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.64 63.21 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.72 141.45 39.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.05 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -72.3 132.98 44.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.06 100.29 5.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.681 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.61 144.64 41.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.258 0.552 . . . . 0.0 110.765 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.0 141.01 57.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.338 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.19 54.56 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -84.26 178.53 7.75 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.333 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -126.54 165.59 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.71 -40.42 97.12 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.668 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.6 -26.67 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.99 -36.94 82.99 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 110.245 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -97.69 13.8 29.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.162 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.33 43.56 28.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.443 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.74 103.8 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.148 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.4 -179.39 5.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -63.28 148.98 46.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.007 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 59.51 44.33 14.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -102.83 127.93 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -77.58 127.76 33.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.29 145.69 42.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -98.19 123.16 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.374 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -100.27 126.0 46.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 93.9 t -108.75 131.03 60.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.444 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 33.1 mt -112.17 147.72 35.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.719 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.817 179.26 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -65.67 159.08 25.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.39 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.9 141.4 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.219 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.26 123.88 30.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.884 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -110.11 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.818 0.342 . . . . 0.0 110.505 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -92.9 122.28 35.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.807 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -82.86 179.13 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.74 -35.85 81.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.27 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 42.8 p -67.42 -11.41 57.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.727 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.1 -9.94 67.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.4 129.6 40.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.9 m -101.52 132.18 47.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 110.807 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -127.11 105.79 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.611 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -81.88 127.11 32.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.04 127.73 50.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.698 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.19 114.6 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.07 171.92 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.236 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.5 155.24 56.75 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.087 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.9 -39.41 84.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.128 1.886 . . . . 0.0 112.313 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -24.33 63.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.17 136.97 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.49 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -85.49 165.89 16.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.329 0.585 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.38 -37.66 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.846 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.76 -42.15 88.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.856 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.11 -41.11 97.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.96 -42.97 98.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.878 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.59 -40.41 91.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.162 0.506 . . . . 0.0 110.485 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.31 -38.67 80.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.5 -38.37 82.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.849 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -59.11 -38.99 80.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.23 -59.43 3.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.802 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -63.55 -41.49 98.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.03 142.52 50.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.095 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.97 60.28 3.04 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mt -115.26 122.01 33.93 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.231 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 159.29 49.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.476 1.451 . . . . 0.0 111.649 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.3 -37.32 70.8 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.149 1.899 . . . . 0.0 112.563 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.69 -39.88 93.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.555 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.39 -11.33 54.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.367 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -86.6 83.19 7.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.008 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -98.28 98.93 10.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 73.5 mt -86.81 122.64 30.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.443 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.26 126.79 71.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.006 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -128.61 130.26 47.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.0 28.35 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.95 79.01 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -131.01 129.53 42.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.5 139.16 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.96 118.68 23.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.11 137.32 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.315 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -66.73 147.54 53.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.179 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.58 -13.68 63.39 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -88.44 149.12 23.85 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -87.66 165.58 15.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.064 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.72 -36.13 81.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.722 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -62.01 -27.02 68.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.727 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.22 -37.55 85.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.125 0.488 . . . . 0.0 110.285 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -95.74 11.81 32.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 55.26 41.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.14 103.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -90.03 -176.8 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -63.32 152.16 38.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 55.5 40.1 31.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.4 t -90.31 120.44 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.444 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -75.42 127.09 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.163 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.76 145.97 45.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.271 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 67.9 m170 -92.97 117.76 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.098 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.84 99.46 10.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.371 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.78 135.57 26.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.382 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.442 -179.091 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.718 0.294 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -91.42 111.94 23.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.75 -37.79 87.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.597 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.62 162.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.363 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.16 122.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.0 111.127 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.68 158.28 36.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.919 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.53 121.3 22.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.411 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.13 140.9 20.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.026 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.65 151.98 17.14 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -88.6 170.93 10.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 0.0 111.248 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 mtp -135.65 174.21 10.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.757 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -124.71 121.62 35.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.8 tp -102.91 121.78 43.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.904 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -118.83 104.1 10.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.029 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 -82.54 0.8 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -144.8 18.03 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.492 0.187 . . . . 0.0 110.95 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.2 m -119.99 128.01 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.84 122.97 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.227 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.8 m -117.12 130.11 24.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.352 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.13 148.89 70.15 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.104 1.869 . . . . 0.0 113.229 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.77 136.04 45.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.91 -7.37 50.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.19 63.61 3.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -51.26 141.18 15.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.302 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.55 -153.37 6.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.369 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 tp -137.96 125.58 22.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.43 108.48 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.6 153.44 48.89 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.231 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 98.2 mt -119.17 138.55 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.469 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 129.87 31.78 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.806 0.691 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -99.94 123.79 44.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.51 . . . . 0.0 110.387 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 p -83.62 170.23 14.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.706 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.48 -10.09 10.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.169 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.95 3.06 55.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.64 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 69.53 20.12 7.23 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.325 0.583 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -96.35 121.66 38.39 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 mm -81.22 120.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -97.49 114.49 26.37 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.347 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -99.25 107.23 19.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.798 0.809 . . . . 0.0 112.827 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -118.72 113.53 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.827 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -101.57 126.87 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -73.58 133.26 43.49 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -76.54 -18.45 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.4 m -60.47 -45.36 94.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.033 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -116.47 -16.62 10.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.973 0.416 . . . . 0.0 109.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.34 78.91 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.21 145.02 30.57 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.5 104.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 0.0 109.9 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -80.93 -33.61 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -127.13 142.99 51.38 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.865 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -158.72 95.53 1.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.31 0.381 . . . . 0.0 110.162 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.2 mt -124.7 137.25 54.36 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.079 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -79.57 118.4 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.0 mm -108.06 121.27 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.801 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -84.66 160.5 55.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.153 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.02 144.91 99.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.004 1.803 . . . . 0.0 111.555 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 60.06 12.96 3.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.14 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.84 -25.77 17.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.536 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.7 p -149.12 166.22 29.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.321 0.582 . . . . 0.0 110.575 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -136.89 133.99 36.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.101 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -104.33 118.28 36.24 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -144.77 167.86 21.58 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.532 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -87.73 160.41 18.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.438 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.8 89.15 15.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.212 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.42 60.46 7.86 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.056 1.837 . . . . 0.0 112.111 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -114.02 -37.34 4.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.1 t -126.63 80.11 70.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.609 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.14 129.76 37.03 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.082 1.855 . . . . 0.0 111.186 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.52 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.858 0.724 . . . . 0.0 110.243 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.85 177.16 32.29 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -86.07 114.33 22.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.625 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.06 129.69 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.42 151.48 40.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.875 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.95 134.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.009 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.5 tp -100.45 120.07 39.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -115.96 131.97 56.79 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.28 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -82.73 111.99 19.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.267 0.556 . . . . 0.0 109.798 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -37.72 84.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.483 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 -20.54 23.14 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.261 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.82 177.42 27.92 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.2 p -114.14 23.36 12.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 153.72 46.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.855 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 157.09 46.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.7 mt -118.49 156.24 29.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.873 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -124.6 136.38 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -139.17 155.7 47.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.339 0.59 . . . . 0.0 111.247 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -128.99 137.45 51.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.4 tpp -67.8 132.45 47.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -2.89 15.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.0 146.6 97.44 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.231 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.27 -28.9 12.0 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.979 1.786 . . . . 0.0 113.155 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -118.59 144.73 45.92 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.633 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 p -100.49 12.27 37.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.734 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.28 -22.22 64.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.647 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -131.31 -6.63 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.837 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.81 -42.54 99.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.82 -39.8 91.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.0 111.305 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.86 -41.41 95.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.197 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -61.34 -40.05 92.84 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.552 0.692 . . . . 0.0 109.204 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.25 -44.91 94.87 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.644 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -62.65 -42.69 99.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.058 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -65.27 -35.64 81.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.018 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.0 t -57.21 -48.02 83.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.021 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.42 -31.08 48.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.561 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.65 -27.18 64.83 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.042 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -92.52 -23.81 18.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.4 mt -95.24 -17.58 21.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -18.72 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.366 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -134.48 63.1 58.67 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.038 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.52 159.11 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.834 2.356 . . . . 0.0 112.457 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 122.664 2.243 . . . . 0.0 112.139 -179.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -92.92 153.1 41.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.21 145.82 31.18 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.565 2.177 . . . . 0.0 112.006 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -80.37 159.69 69.39 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.71 134.76 59.95 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.162 1.908 . . . . 0.0 112.165 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.35 -162.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.269 1.979 . . . . 0.0 112.009 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -128.31 155.18 78.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.679 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.59 145.35 81.74 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.486 2.124 . . . . 0.0 111.704 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -155.55 164.34 38.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.677 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.62 138.55 32.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -124.81 121.71 35.35 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.79 158.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.61 150.47 20.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.118 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -98.43 127.12 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.87 116.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.675 -0.41 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -101.32 121.15 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.596 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -81.58 171.69 14.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.34 -25.65 68.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -75.11 -8.55 56.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 6.41 66.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.12 126.27 32.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -103.04 131.06 50.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.902 0.382 . . . . 0.0 110.035 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.23 113.17 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.485 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.85 134.75 35.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.766 0.317 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 68.8 mt -132.66 131.48 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.4 115.37 13.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 0.0 110.686 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -134.64 166.08 29.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.29 152.01 44.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.221 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.08 -25.51 78.18 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.953 1.769 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -91.05 -12.07 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.676 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.51 142.3 57.14 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.127 0.489 . . . . 0.0 110.928 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -80.46 166.67 21.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.972 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.03 -35.85 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.739 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -58.6 -41.64 86.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.011 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.26 -41.89 93.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.112 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.76 -48.19 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.998 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.28 -31.48 72.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.115 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.79 95.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.249 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.66 -39.77 89.56 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 93.9 mt -66.6 -39.57 84.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.326 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.39 -38.68 81.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.422 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -68.69 -47.95 65.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -64.19 -40.89 97.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.58 153.84 51.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.121 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.07 57.71 2.73 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . 0.401 HD13 HG23 ' C' ' 36' ' ' ILE . 39.1 mm -112.0 101.3 51.39 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.79 158.12 58.01 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.117 1.878 . . . . 0.0 112.219 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.15 -32.66 94.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.298 1.999 . . . . 0.0 112.349 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -66.94 -39.13 87.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.044 0.45 . . . . 0.0 109.898 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -103.67 23.37 12.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.686 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.42 116.36 18.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.809 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -127.21 124.77 39.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -102.09 127.15 49.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.194 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -125.89 126.05 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 0.0 110.222 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -148.76 147.9 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 19.73 11.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.426 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.14 -13.27 60.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 147.96 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.238 0.542 . . . . 0.0 111.34 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -97.57 111.33 23.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.558 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.29 97.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.794 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -76.98 -76.54 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.044 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -178.21 166.54 1.93 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.44 73.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -126.65 177.99 6.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -127.22 164.62 21.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.156 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.55 -39.93 92.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.412 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.32 -28.55 69.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.62 -26.58 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.99 0.424 . . . . 0.0 110.385 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -104.16 12.0 34.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.291 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.54 38.16 29.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.195 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.41 105.06 13.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.969 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.13 -175.96 5.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.347 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -68.65 148.2 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.965 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 57.84 37.96 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -89.66 133.2 34.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.839 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -91.15 120.75 32.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.145 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.59 146.21 40.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.536 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -91.26 131.31 36.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.17 119.13 38.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.299 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.4 t -104.07 131.42 52.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 26.4 mt -109.28 125.93 52.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.133 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 110.708 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -65.23 155.46 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.92 145.84 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -93.65 127.64 39.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.508 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -109.54 115.41 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.172 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -86.46 116.67 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -74.63 171.26 14.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.087 0.47 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -41.43 73.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.391 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -76.31 -6.56 52.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.41 -13.31 59.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -55.29 108.6 0.44 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -83.58 136.89 34.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.07 112.46 23.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.004 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.11 127.0 32.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.205 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -126.06 120.77 31.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.789 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -66.1 108.97 2.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.57 166.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.555 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.94 154.54 41.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.53 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.88 -36.47 95.61 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.029 1.82 . . . . 0.0 111.861 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.0 p -80.54 -7.94 59.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -58.17 135.27 57.03 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.006 0.432 . . . . 0.0 110.748 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.23 162.48 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.79 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.31 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.687 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.55 -41.6 90.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.937 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.15 -41.59 98.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.049 0.452 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.56 -43.17 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.615 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.99 -38.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.157 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.58 90.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.107 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.77 -39.41 88.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 mm -64.93 -40.96 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.524 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.42 -40.41 94.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.712 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -65.15 -44.42 88.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -74.16 -66.26 0.74 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.375 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -92.25 171.56 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.004 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -91.1 18.84 49.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mm -77.39 119.84 79.09 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.583 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.86 160.49 45.95 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.332 2.021 . . . . 0.0 111.478 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.58 -40.4 85.58 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.106 1.87 . . . . 0.0 112.993 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.08 -52.27 50.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.508 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.23 112.64 3.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.889 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -118.1 111.2 18.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.311 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 64.3 mt -90.43 120.57 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.472 . . . . 0.0 110.514 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.3 mt -124.96 127.0 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -128.24 128.46 44.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.124 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.38 28.52 9.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.21 79.69 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -128.08 128.66 45.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.0 0.429 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.62 137.96 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.499 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 mt -84.64 118.87 24.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.261 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.36 137.77 41.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -62.76 137.77 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.471 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -16.87 57.75 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -78.81 178.68 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 110.459 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 80.5 p -125.53 161.87 26.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.114 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.36 -39.95 92.52 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.106 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.03 -27.58 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.424 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.09 -37.02 81.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.189 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -98.25 15.02 25.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.084 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 54.74 40.45 31.92 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.859 0.361 . . . . 0.0 110.339 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -89.86 101.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -85.3 -175.83 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -64.09 166.67 7.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.032 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 45.72 36.49 2.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -89.61 122.86 33.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.19 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -83.46 125.48 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.135 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.81 162.75 15.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -109.99 120.73 43.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.381 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tt -99.31 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 81.6 t -103.83 132.69 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.227 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.231 -179.131 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.55 126.71 35.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.428 0.632 . . . . 0.0 110.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.05 -36.08 79.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.809 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.81 161.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.17 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -174.01 122.43 0.31 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.74 158.14 37.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.989 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.54 119.54 19.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.76 146.25 25.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.326 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.21 150.71 17.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.88 167.08 12.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 111.454 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.4 mtp -132.92 175.32 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.849 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.8 m -125.65 121.69 34.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.1 tp -104.46 118.08 35.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.393 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -122.74 113.42 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.977 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.12 -86.33 0.48 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 p -146.51 23.78 1.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.612 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.9 m -126.54 132.59 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.247 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -110.12 123.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.305 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.2 p -118.21 122.42 30.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.115 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.57 148.5 59.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.772 1.648 . . . . 0.0 113.365 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.88 133.06 44.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.845 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -7.63 48.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.33 78.58 1.85 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.11 132.66 33.34 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.634 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.05 -163.92 11.47 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.227 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tp -137.12 120.44 16.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.55 108.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.548 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -130.83 153.42 49.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.0 139.69 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.746 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.09 128.14 27.67 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 123.83 0.706 . . . . 0.0 110.847 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -99.0 125.15 44.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.416 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 p -83.51 171.47 13.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.682 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.88 -10.04 25.57 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.509 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.05 2.49 55.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.57 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 t 70.23 21.36 5.91 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 121.088 0.47 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.4 mt -99.45 120.65 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 57' ' ' ILE . 49.1 mm -79.33 122.43 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -98.56 115.44 28.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.58 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -96.09 107.98 20.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 96.9 m -121.38 146.15 47.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.728 0.775 . . . . 0.0 112.462 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -126.51 113.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.902 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -105.27 145.92 30.03 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.05 0.452 . . . . 0.0 110.572 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.13 132.19 34.71 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -71.64 -18.31 62.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.03 0.443 . . . . 0.0 110.852 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -59.55 -44.98 93.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.789 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.55 -10.36 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.66 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.68 22.85 78.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -102.46 147.16 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.8 106.41 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.67 -22.62 25.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -128.64 142.78 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.933 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -157.15 107.65 2.28 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.016 0.436 . . . . 0.0 110.193 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.86 130.72 22.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.355 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.67 124.26 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.6 119.6 60.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.602 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.38 161.03 68.99 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.332 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.89 142.12 97.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.063 1.842 . . . . 0.0 111.541 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 61.01 12.36 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.374 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -87.66 -37.39 16.79 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 120.584 0.231 . . . . 0.0 110.602 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.7 m -131.31 154.92 48.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.252 0.548 . . . . 0.0 111.745 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -126.72 128.21 46.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.113 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -100.39 117.2 34.1 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -143.64 167.34 22.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -83.56 160.53 21.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.551 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.05 89.21 13.43 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.333 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.3 60.23 7.76 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.124 1.882 . . . . 0.0 112.175 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -114.7 -40.52 3.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.409 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.3 t -128.89 79.65 74.16 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.578 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.29 130.32 39.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.301 2.001 . . . . 0.0 111.284 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.83 -36.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.17 -167.12 12.88 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.55 106.64 18.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.913 0.387 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.4 t -124.83 128.35 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.732 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -125.29 151.38 46.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.125 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.43 135.92 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.379 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.1 tp -102.07 112.71 25.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -112.2 143.1 43.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.505 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.87 116.52 28.01 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.25 -37.53 85.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.787 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.77 -22.33 18.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.397 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.03 174.97 26.98 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -111.94 21.44 15.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.661 0.267 . . . . 0.0 110.294 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.99 149.02 39.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.79 152.42 47.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 mt -120.16 154.63 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -124.46 134.74 52.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 0.0 110.287 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -138.85 155.31 48.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.106 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -129.97 137.27 50.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.7 mmm -72.23 138.0 47.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -1.19 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.292 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -74.1 132.25 79.93 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.09 -25.54 58.43 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.112 1.875 . . . . 0.0 112.585 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 139.59 50.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -94.17 0.89 56.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.056 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -54.28 -21.76 10.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -120.07 -15.65 8.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.71 -40.92 96.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.6 -42.15 98.27 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.166 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.15 -41.47 90.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -65.28 -39.84 93.09 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.01 -41.99 99.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.666 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -67.56 -40.96 84.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.243 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.64 -38.63 91.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.52 -48.14 86.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.266 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -80.54 -27.21 37.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.33 -38.25 78.08 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.47 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -82.01 -32.25 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.994 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.64 -25.16 41.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.304 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -110.83 -23.44 11.01 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.686 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -137.76 67.84 50.82 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.715 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.41 156.92 60.6 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.626 2.218 . . . . 0.0 112.569 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.127 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.69 89.3 52.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.29 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.33 139.32 73.61 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.475 2.116 . . . . 0.0 112.453 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -80.81 154.35 73.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.71 146.19 83.26 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.929 1.753 . . . . 0.0 112.278 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 163.55 36.91 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.791 2.327 . . . . 0.0 112.396 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.45 160.24 73.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.49 146.54 90.24 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.565 2.176 . . . . 0.0 111.864 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -150.29 162.71 39.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -85.96 140.12 30.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.983 0.421 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -121.91 133.46 54.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.86 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 9.1 mm . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.823 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.11 163.8 19.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.719 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 pt -143.65 145.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.261 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -93.59 113.05 25.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.392 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -97.27 115.63 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.628 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -100.67 127.72 46.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -82.03 175.73 10.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.76 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.61 -21.63 65.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -88.35 -4.33 58.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.75 74.9 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -59.36 120.78 9.94 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -101.93 132.2 47.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.5 107.05 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.328 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.06 120.66 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.55 130.99 54.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.606 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.9 115.94 15.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.466 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m -134.92 165.16 31.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.62 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -108.85 151.57 41.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.77 -25.31 75.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.106 1.871 . . . . 0.0 112.071 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 53.6 m -91.78 -10.27 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.527 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 143.25 57.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -80.76 164.42 22.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.609 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -63.27 -37.43 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.827 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.75 -41.59 86.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -61.49 -43.6 98.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 110.523 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.97 -42.47 96.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -60.4 -39.95 89.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.59 90.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.199 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.99 -39.32 85.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.71 -39.3 84.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.577 0.703 . . . . 0.0 110.32 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.79 -46.12 90.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -77.13 -14.64 59.76 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.665 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -102.09 -3.88 26.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -149.14 -42.48 0.14 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.224 0.535 . . . . 0.0 110.391 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.65 29.25 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.212 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 52.8 mt -72.08 128.43 89.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.777 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.65 153.27 48.89 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.828 1.685 . . . . 0.0 111.708 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.27 -38.17 61.27 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.066 1.844 . . . . 0.0 112.737 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.7 -39.77 92.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.842 0.353 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -89.44 -2.64 58.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.032 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -93.79 106.89 18.84 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.693 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 73.6 mt -79.54 133.9 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.837 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -135.04 129.39 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.345 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -151.47 151.72 32.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.843 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.36 16.54 10.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.731 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -10.63 67.19 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 145.14 40.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.312 0.577 . . . . 0.0 110.84 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -73.63 129.82 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.905 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.46 94.3 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.829 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.2 150.13 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 111.122 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -60.36 143.08 53.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.402 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.58 -19.35 48.02 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -88.14 169.1 12.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.522 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.9 p -118.17 164.5 15.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.954 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.01 -41.14 95.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.587 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -64.24 -22.72 67.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.388 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.96 -36.68 82.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.547 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -99.92 15.76 26.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.103 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 57.58 38.72 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.99 105.29 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.899 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -92.16 -178.89 5.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.409 0.623 . . . . 0.0 111.159 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.46 146.88 52.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.009 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 60.93 15.79 6.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.215 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 33.7 m -69.87 133.63 47.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -87.4 118.49 26.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.723 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.93 140.98 40.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.997 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -89.82 129.43 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -107.91 121.25 44.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.19 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.4 132.3 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.152 0.501 . . . . 0.0 110.128 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -106.16 152.14 23.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.559 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.454 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.82 157.04 22.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.351 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.84 148.12 25.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.419 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -89.11 121.97 31.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.1 105.97 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.554 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -89.12 129.95 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 110.893 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -89.16 175.98 7.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.73 -35.44 78.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.913 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -70.46 -11.65 61.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 -12.79 63.0 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.04 127.83 33.13 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -98.82 133.62 42.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.23 111.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -82.76 125.91 31.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.86 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.52 125.97 48.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.475 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -69.3 113.87 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -135.99 170.58 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.741 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -120.1 156.39 54.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.254 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.42 -26.64 82.62 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.163 1.909 . . . . 0.0 112.069 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -83.71 -14.26 52.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.563 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.17 144.05 57.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -87.68 166.33 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.41 -39.55 85.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.066 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.52 -42.25 91.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.183 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.29 -39.85 94.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.28 -43.34 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.996 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -61.3 -40.02 92.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.2 91.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.929 0.395 . . . . 0.0 109.998 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -59.86 -38.03 80.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mm -63.92 -39.93 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.156 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.78 -45.59 93.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.289 0.566 . . . . 0.0 110.635 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.2 -33.91 76.84 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.045 -0.409 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -89.95 -6.88 55.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -146.08 -53.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.0 110.456 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.28 20.68 4.68 Favored Glycine 0 CA--C 1.517 0.205 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -95.35 114.18 63.26 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.418 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.01 153.82 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.094 1.863 . . . . 0.0 112.215 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.99 -28.85 86.9 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.648 2.232 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -91.46 -4.34 55.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -92.6 -16.87 25.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -137.88 160.55 38.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.305 0.574 . . . . 0.0 111.444 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.18 130.93 53.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.561 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.79 119.54 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.823 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -121.23 128.07 75.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.981 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -122.61 128.48 50.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.455 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.15 25.05 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.534 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.67 90.29 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -110.29 126.23 53.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -65.05 135.55 55.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.66 107.69 17.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.112 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -74.79 154.15 38.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.337 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -72.97 162.99 28.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.342 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.43 20.73 77.18 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -122.94 150.79 42.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.66 0.267 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.6 p -96.87 160.44 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.467 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.37 -39.09 92.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.412 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.2 -39.06 93.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.055 0.455 . . . . 0.0 110.361 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -94.42 13.36 24.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 56.69 42.81 26.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 69.0 mt -90.97 104.24 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.097 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.04 179.31 5.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.438 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -60.74 150.65 31.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 58.49 45.42 16.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 85.5 p -101.21 128.89 47.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.988 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -81.15 126.05 31.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.582 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.03 148.27 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.38 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.67 116.32 28.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.441 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 5.2 tt -99.54 104.71 16.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.978 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 94.1 t -100.59 128.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.253 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 81.9 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.871 0.367 . . . . 0.0 110.755 -179.373 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 C--O 1.237 0.42 0 CA-C-O 120.827 0.346 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -90.06 120.54 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.327 0.584 . . . . 0.0 110.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.05 -35.28 76.38 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.154 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.22 161.14 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.984 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.63 122.66 0.35 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.229 0.537 . . . . 0.0 110.814 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.98 158.22 38.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.878 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -76.46 120.5 21.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.538 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.78 148.01 26.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.5 150.64 17.64 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -87.72 165.44 15.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.953 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.4 mtp -134.01 175.07 9.8 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.1 m -129.8 126.73 38.79 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.355 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.4 tt -102.16 125.52 48.88 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.472 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -116.13 103.29 10.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.903 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.16 -83.14 0.74 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -144.02 20.26 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.554 0.216 . . . . 0.0 110.879 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -122.22 129.18 52.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.74 125.47 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.061 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 p -118.72 128.28 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.328 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.99 145.97 51.37 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.779 1.653 . . . . 0.0 112.603 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -108.02 138.2 44.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.878 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -72.6 -5.42 37.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.993 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.2 73.67 0.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.64 134.83 41.46 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.408 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.76 -162.64 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -136.67 126.44 25.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 108.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.979 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -133.22 153.5 51.49 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.922 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.3 mt -119.45 139.48 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.285 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.63 132.49 40.83 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 123.923 0.765 . . . . 0.0 110.147 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -102.68 122.47 44.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 p -82.89 171.58 13.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.783 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.46 -10.06 22.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.705 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.6 8.17 40.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.47 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m 62.82 23.99 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 110.762 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.8 120.32 39.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.9 mm -80.1 121.15 32.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.552 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -97.67 112.55 24.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.899 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -92.9 107.2 19.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 93.3 m -119.38 143.9 47.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.929 0.871 . . . . 0.0 112.847 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.2 t90 -126.85 113.44 16.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.109 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -103.9 144.32 31.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.631 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -82.83 130.52 35.14 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -71.36 -16.65 62.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.75 0.31 . . . . 0.0 110.755 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.54 -45.87 90.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.442 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.69 -11.77 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.54 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.73 22.45 78.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -102.57 152.0 21.68 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.57 102.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.371 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.88 -38.25 67.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.888 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.48 147.18 49.86 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.392 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -158.78 97.74 1.45 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.314 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.8 mt -124.55 136.78 54.26 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.095 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.56 119.47 30.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 mm -109.29 120.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 111.05 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -85.13 163.03 47.28 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.452 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.51 141.48 95.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.171 1.914 . . . . 0.0 111.689 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 61.14 12.42 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -87.42 -25.99 23.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.3 p -149.98 167.02 27.89 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.452 0.644 . . . . 0.0 110.569 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -137.11 132.52 34.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.189 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -103.38 118.58 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.44 167.9 21.0 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.496 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -87.8 160.37 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.176 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.67 90.82 13.35 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.152 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.21 59.82 7.18 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -115.6 -36.72 4.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.526 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.9 t -127.89 81.72 69.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.288 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.29 130.4 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.898 1.732 . . . . 0.0 111.651 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t 169.1 -44.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.83 -147.83 5.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.13 105.73 12.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.188 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.3 t -122.71 126.59 74.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -123.57 152.93 41.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.718 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.97 135.36 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.2 tp -100.87 121.84 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -116.78 124.85 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.026 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -81.4 115.1 20.58 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.01 -37.54 82.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.497 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.72 -23.66 11.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.486 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.51 -24.5 72.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.192 -0.527 . . . . 0.0 111.894 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m 66.89 6.66 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -98.36 150.17 21.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.23 136.78 48.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.835 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.1 mt -123.29 151.16 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.045 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.67 137.52 54.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.41 155.22 47.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 111.4 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -129.82 136.75 49.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.127 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.82 141.26 58.35 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.341 0.591 . . . . 0.0 111.369 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -112.99 -8.2 13.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.169 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.2 135.15 89.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.704 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.94 -23.13 35.0 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.826 1.684 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -116.44 141.1 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.341 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.0 p -97.93 17.23 18.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.261 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.4 -21.14 59.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -135.64 17.76 3.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.841 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.63 -48.9 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.199 0.523 . . . . 0.0 111.059 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.63 -33.02 70.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.322 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.22 -44.78 90.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.489 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -62.01 -41.37 98.0 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.451 0.643 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.3 -44.83 95.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.847 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.5 -42.55 91.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.388 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.01 -37.61 88.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.918 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.78 -47.77 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.272 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -80.08 -28.41 39.14 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.843 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -68.91 -37.74 79.15 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.404 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.72 -33.16 35.45 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.731 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.5 mt -79.58 -26.89 41.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -108.25 -24.01 11.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.655 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -136.88 69.19 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.797 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.37 157.78 55.87 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.854 2.369 . . . . 0.0 112.55 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.654 2.236 . . . . 0.0 112.211 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -128.95 150.59 75.64 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.634 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.96 147.02 33.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.695 2.263 . . . . 0.0 112.031 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.25 153.64 92.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.21 151.36 76.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.106 1.871 . . . . 0.0 112.253 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.09 -171.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.466 2.11 . . . . 0.0 112.096 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -120.06 155.08 55.87 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.93 141.76 95.55 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.352 2.035 . . . . 0.0 112.115 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.73 165.2 37.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.834 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.64 136.69 32.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.849 0.357 . . . . 0.0 110.41 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -120.62 121.21 37.84 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.64 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -62.26 156.13 22.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.369 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -136.78 157.02 35.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.362 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -96.19 122.59 39.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.897 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.3 t -110.43 101.85 13.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.224 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -88.34 124.09 33.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.177 0.513 . . . . 0.0 110.82 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -86.47 172.09 10.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.07 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.5 -19.08 65.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -83.95 -5.0 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.057 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.32 80.5 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.17 126.37 30.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.87 0.366 . . . . 0.0 110.218 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -97.6 131.22 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -115.84 116.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.374 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 117.12 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.428 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.65 116.41 27.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.922 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.75 105.99 1.4 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -130.45 162.71 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.497 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -105.88 155.72 37.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -37.79 93.7 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.896 1.731 . . . . 0.0 112.109 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -80.32 -7.55 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.301 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -57.21 135.54 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -79.23 163.27 25.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 40.6 mm -64.54 -38.77 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.102 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.26 -41.48 88.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.995 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.05 -41.4 98.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.799 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.35 -42.98 98.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.795 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -60.83 -40.17 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.635 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.83 92.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.104 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.62 -38.75 82.15 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . 0.405 HG23 HD12 ' C' ' 30' ' ' ILE . 97.1 mt -66.37 -39.78 84.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.752 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -59.54 -46.93 87.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.365 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.21 -16.26 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.986 -0.446 . . . . 0.0 111.897 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -101.18 -5.81 25.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -148.31 -41.96 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.1 0.476 . . . . 0.0 110.476 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.8 8.16 28.43 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.352 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.08 128.78 82.27 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.899 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 160.44 43.66 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.564 1.509 . . . . 0.0 111.683 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.79 -39.16 93.4 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.274 1.982 . . . . 0.0 112.472 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.86 -39.88 93.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.761 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -89.17 -4.43 58.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.06 90.34 7.33 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -101.6 97.18 7.64 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 22.2 mt -88.27 129.47 35.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.594 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 83.7 mt -127.92 129.09 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.766 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -151.64 152.83 33.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.75 17.15 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.93 -13.59 60.8 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.99 146.5 42.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 110.599 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.19 132.18 42.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.045 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.26 101.47 0.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.35 140.69 44.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.91 143.0 55.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.299 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.56 -16.26 61.34 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -83.44 176.19 9.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.193 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -122.27 161.95 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.817 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.8 -40.39 95.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.823 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -63.69 -23.98 67.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -62.83 -37.63 87.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 110.149 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -96.46 13.48 27.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.252 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.05 42.42 22.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 64.9 mt -90.37 109.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.301 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -98.19 -177.99 3.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.213 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.26 146.89 52.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 59.34 42.28 18.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 45.7 m -97.55 127.28 43.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.98 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 87.1 m -76.86 126.57 31.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.113 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.33 149.03 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.084 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.26 117.34 32.44 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.21 99.05 10.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.642 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -87.06 130.67 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.8 mt -110.39 141.23 43.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.162 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.659 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.62 159.61 12.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.956 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.05 151.91 25.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.054 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -93.16 121.94 35.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.536 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.2 105.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -90.29 133.28 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.811 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -88.87 -174.9 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.34 -38.08 88.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.004 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -72.84 -9.04 58.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.615 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.45 -7.44 75.04 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.61 124.86 21.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -96.09 131.25 42.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mt -123.56 111.54 29.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.552 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -81.49 125.71 30.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.172 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.21 125.15 46.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.126 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.96 114.8 9.39 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.57 163.01 36.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.668 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -104.7 153.29 39.36 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.074 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.55 -36.17 97.58 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.948 1.766 . . . . 0.0 112.043 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.46 -0.65 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -62.28 136.63 58.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -76.96 161.81 28.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.26 0.552 . . . . 0.0 110.794 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.59 -38.54 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.27 -42.53 91.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.88 -41.3 97.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.64 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.4 -42.67 97.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -60.71 -39.38 88.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.133 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.26 93.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.411 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.06 -39.53 86.32 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.53 -39.66 84.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.297 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.34 -39.78 84.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.335 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.68 -50.3 52.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.711 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -66.18 -40.41 90.43 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -128.66 147.63 50.76 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.06 59.32 3.12 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . 0.412 HD13 HG22 ' D' ' 36' ' ' ILE . 31.0 mm -110.31 107.07 58.46 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.8 152.82 54.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.316 2.011 . . . . 0.0 111.747 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.61 -42.4 66.21 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.744 1.629 . . . . 0.0 112.884 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.6 -43.29 99.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -68.3 -38.55 81.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.05 118.03 4.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.013 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -121.21 106.31 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 19.8 mt -96.15 115.93 28.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.081 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -123.27 124.37 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.377 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -128.36 130.02 47.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.179 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.62 27.11 11.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.357 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.22 81.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -125.9 127.3 45.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.834 0.349 . . . . 0.0 110.725 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.47 137.0 55.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -78.68 122.06 25.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.083 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -76.15 136.28 39.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -65.06 130.92 45.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.5 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.67 -15.81 52.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -79.88 -176.99 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.8 p -125.66 163.47 22.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.22 -40.06 94.86 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.606 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.4 p -64.1 -27.46 69.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.13 -29.72 71.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.123 0.487 . . . . 0.0 110.178 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -101.66 12.41 37.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.403 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.48 40.41 29.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.036 0.446 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 90.0 mt -89.82 107.22 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.673 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.09 177.89 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -59.75 149.79 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 60.01 18.66 7.81 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.631 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.0 m -73.81 129.65 38.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.07 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -81.82 130.15 34.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.019 0.437 . . . . 0.0 110.58 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -120.63 140.11 52.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.127 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -86.49 113.44 22.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.72 115.49 30.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.431 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 78.1 t -114.53 139.38 40.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.74 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 37.9 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.161 -178.725 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt . . . . . 0 C--O 1.236 0.353 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -94.16 113.65 25.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.082 0.468 . . . . 0.0 109.792 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ILE . 95.7 mt -67.53 -36.94 81.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.76 162.3 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.868 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.15 122.5 0.39 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.251 0.548 . . . . 0.0 110.934 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.78 158.16 37.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.889 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.06 123.8 25.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.574 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.0 21.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.176 0.512 . . . . 0.0 110.35 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.51 16.94 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -92.11 158.4 16.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 0.0 110.78 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.33 163.32 25.99 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -115.69 129.92 56.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.741 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.5 tp -106.7 120.8 42.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.83 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -122.92 110.99 16.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.328 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.52 -93.61 0.55 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.3 p -137.45 21.27 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.604 0.24 . . . . 0.0 111.036 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.5 m -125.88 131.55 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.516 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.64 125.18 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.937 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.9 p -113.61 111.53 49.01 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.13 139.75 91.63 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.577 2.185 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -94.87 129.22 41.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -68.41 -10.17 53.42 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.864 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -72.19 82.85 1.01 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.19 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.27 133.59 52.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.193 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.8 -161.07 10.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.315 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 tp -138.77 126.98 22.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 t -100.2 110.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -133.13 155.0 50.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.26 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.4 mt -120.05 137.19 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.387 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.12 131.27 36.67 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.586 0.554 . . . . 0.0 110.231 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -100.84 125.98 47.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.044 0.45 . . . . 0.0 110.144 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.5 p -86.33 172.94 10.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.634 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.37 -10.83 27.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.657 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.34 5.65 46.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.442 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 m 63.55 24.81 14.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.0 mt -100.6 122.78 43.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.0 mm -80.9 122.28 35.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -98.36 114.9 27.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.693 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.46 108.39 20.32 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.9 m -121.44 146.92 46.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.753 0.787 . . . . 0.0 112.675 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -125.19 115.02 19.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.064 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -107.45 134.5 50.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.845 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.0 132.5 41.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.557 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -73.88 -18.55 60.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -59.94 -45.95 90.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.049 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -116.48 -16.26 10.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.102 0.477 . . . . 0.0 109.768 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.33 22.89 72.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -101.38 152.2 21.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.827 0.346 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -80.75 107.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.902 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.94 -27.5 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -127.94 144.15 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.183 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.59 99.76 1.6 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.46 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' C' ' 47' ' ' GLY . 40.5 mt -129.07 133.08 47.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.52 122.6 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.0 mm -112.39 121.31 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.366 0.603 . . . . 0.0 111.142 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -85.56 163.39 44.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.718 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.51 140.53 93.54 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.246 1.964 . . . . 0.0 111.536 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t0 60.07 12.08 3.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.344 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.48 -26.48 30.2 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.298 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.7 p -151.18 166.92 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.475 0.655 . . . . 0.0 110.677 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -133.58 132.06 40.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.259 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.4 119.45 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -143.86 168.87 18.94 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.742 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -85.7 157.06 20.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.58 89.37 7.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.319 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.18 61.03 7.64 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.965 1.776 . . . . 0.0 112.274 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.82 -39.22 4.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.398 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 p -129.69 73.61 81.38 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.45 130.06 36.75 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.213 1.942 . . . . 0.0 111.297 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.02 -45.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.146 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.88 -156.34 8.71 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.15 105.37 15.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.786 0.327 . . . . 0.0 110.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.63 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.08 152.22 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.405 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.86 134.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.281 0.562 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.3 tp -102.47 117.61 35.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -114.23 122.84 48.0 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.417 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -78.46 114.1 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.571 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.95 -37.95 84.15 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.14 -23.03 12.71 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.376 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.42 -20.29 78.19 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.133 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 m 59.75 34.33 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.945 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 162.02 36.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.484 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -134.9 143.31 46.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.911 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 mt -119.81 147.09 45.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.51 132.04 56.75 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.271 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.11 157.43 46.34 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.256 0.551 . . . . 0.0 110.938 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -134.25 141.64 47.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.387 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.0 mmm -74.68 139.09 43.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.062 0.458 . . . . 0.0 110.976 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.81 10.67 10.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.011 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.2 145.07 90.55 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.488 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.47 -39.1 79.08 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.994 1.796 . . . . 0.0 112.577 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -118.89 146.31 45.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.909 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.5 p -97.86 6.94 47.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.722 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -54.02 -20.98 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -126.94 14.77 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.155 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.59 -45.71 91.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.12 -33.06 67.52 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.521 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.6 -43.32 90.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.058 0.456 . . . . 0.0 110.641 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -65.31 -40.89 94.35 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.645 0.736 . . . . 0.0 109.383 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.6 t -62.32 -45.67 92.18 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.796 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -64.97 -43.34 92.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.322 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -62.48 -38.73 91.01 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.694 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.95 -47.65 89.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.36 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.23 -30.01 38.5 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.844 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.3 -38.94 85.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.567 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -80.33 -34.22 36.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.668 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.52 -26.96 51.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.435 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -108.53 -20.46 13.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.272 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -140.39 68.54 32.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.443 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.41 158.27 56.61 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 C-N-CA 122.949 2.432 . . . . 0.0 112.495 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--N 1.312 -1.356 0 C-N-CA 122.64 2.227 . . . . 0.0 112.321 -179.611 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.83 148.16 98.87 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.61 152.82 38.43 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.587 2.192 . . . . 0.0 111.959 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.91 151.03 90.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.118 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.21 158.75 48.44 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.278 1.985 . . . . 0.0 112.239 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 168.41 23.99 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.706 2.271 . . . . 0.0 111.918 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -105.68 159.86 28.08 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.78 145.97 87.87 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.237 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.87 166.56 33.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -85.15 138.01 32.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.32 125.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.84 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 46.5 mt . . . . . 0 C--N 1.313 -0.984 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -66.97 161.08 25.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.26 149.99 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.133 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.04 126.44 44.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.646 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.75 117.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -100.6 117.89 35.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.467 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 71.2 p -80.0 171.22 15.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.049 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 64.9 mt -63.42 -24.02 67.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.173 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.2 p -75.42 -8.73 57.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.24 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -72.41 132.89 44.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.792 0.33 . . . . 0.0 110.264 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -109.09 131.71 54.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.229 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.25 117.37 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.819 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 135.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -133.91 126.68 30.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.114 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -70.74 117.35 12.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.18 166.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -112.26 151.52 43.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.02 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.14 -26.37 81.48 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.981 1.788 . . . . 0.0 112.207 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -87.02 -11.51 50.18 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.743 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -62.99 143.49 57.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.615 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -81.67 165.95 20.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.315 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -62.44 -39.18 83.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.314 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.48 -41.99 91.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.83 -41.57 97.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.141 0.496 . . . . 0.0 110.876 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.7 t -63.13 -43.35 98.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.702 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.79 -39.71 89.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.43 91.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 0.0 110.519 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -60.15 -39.76 87.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.98 -38.4 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.257 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.28 -42.21 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -63.51 -43.79 96.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -65.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.225 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.41 155.9 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.854 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.8 57.82 4.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . 0.432 HD13 HG23 ' C' ' 36' ' ' ILE . 32.2 mm -110.78 104.69 56.44 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.37 157.57 35.28 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.53 2.154 . . . . 0.0 112.041 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.07 -30.55 90.59 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.249 1.966 . . . . 0.0 112.309 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.83 -40.73 88.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.056 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -87.22 -9.67 54.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.58 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -81.73 95.84 7.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.334 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -110.36 93.67 4.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -80.07 135.14 36.28 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.44 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -135.8 127.33 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -152.0 149.83 29.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.805 0.336 . . . . 0.0 111.211 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.03 15.27 9.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.14 -15.2 60.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -100.9 140.61 34.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.942 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -77.94 118.19 20.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mp -66.56 86.14 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.243 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -74.52 -175.89 2.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.4 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.7 156.5 30.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.15 -152.23 48.17 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 55.36 172.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.519 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -125.99 167.96 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.348 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 78.8 mt -60.7 -40.74 93.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.563 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -63.78 -24.32 67.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.91 -37.06 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.446 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -96.44 13.78 26.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.997 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.58 40.59 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 60.9 mt -87.88 108.68 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.754 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.71 179.99 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.82 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.65 145.97 53.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 59.18 17.64 5.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 137.23 57.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -98.07 120.21 38.08 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.685 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.6 142.27 46.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.324 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -88.91 130.32 35.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.194 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 59.9 tp -105.88 122.07 45.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.017 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.75 132.67 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 27.8 mt -108.49 143.25 37.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.345 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.686 179.806 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -62.88 155.64 26.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.552 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -134.85 154.61 36.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.547 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -94.87 125.08 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.83 99.06 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.383 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -85.18 130.05 34.68 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.73 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.51 -175.06 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.709 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.85 -26.01 63.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.291 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -78.97 -9.98 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.55 -13.55 64.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.71 132.08 48.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 68.5 m -102.72 130.75 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 110.608 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mm -113.47 117.9 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.489 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.58 118.75 28.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.44 116.95 28.17 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.67 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -65.46 105.69 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -129.13 166.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.205 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -115.18 155.91 46.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.03 -24.65 66.76 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.76 1.64 . . . . 0.0 111.707 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.7 p -88.18 -11.82 45.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.822 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.14 141.99 58.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.171 0.51 . . . . 0.0 111.103 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -81.52 164.18 22.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -62.86 -42.28 95.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.975 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -59.98 -34.56 73.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.353 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -64.76 -41.14 96.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.494 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 -42.38 95.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.456 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -60.56 -40.39 91.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.22 86.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.65 -39.5 84.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.607 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -67.84 -39.52 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.173 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -58.98 -42.52 90.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.917 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -89.77 17.99 6.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -123.16 -38.01 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -124.85 -8.28 7.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.297 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.71 77.0 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.449 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.04 121.58 79.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.512 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.55 153.61 60.01 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.956 1.771 . . . . 0.0 111.71 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.47 -39.52 73.97 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.112 1.874 . . . . 0.0 111.898 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.21 -39.66 93.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.683 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -83.54 -7.96 59.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.658 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.96 90.83 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.316 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -100.94 111.16 23.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 35.1 mt -96.67 114.83 26.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.384 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.45 125.14 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -144.12 151.29 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.334 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.13 22.91 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.62 16.01 80.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.54 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -149.29 152.96 36.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 110.794 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.26 139.9 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.38 127.57 33.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.2 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.75 135.54 40.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -67.09 132.16 47.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.211 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.17 -18.19 52.28 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.67 171.49 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.8 164.04 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.723 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.5 p -62.36 -29.15 70.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.4 -35.59 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.081 0.467 . . . . 0.0 110.164 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -96.56 12.58 31.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.304 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 55.18 41.79 31.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 110.14 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -90.39 104.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.638 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.39 -176.1 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -64.58 149.7 48.31 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.446 -0.501 . . . . 0.0 109.935 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 59.14 44.77 15.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 54.3 m -100.32 122.7 43.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.222 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -71.76 128.49 35.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.71 136.64 54.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.75 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -85.64 109.07 18.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.713 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 tp -96.76 113.4 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.01 134.49 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.035 0.445 . . . . 0.0 110.054 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 35.5 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.685 -178.485 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.233 0.191 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.12 110.96 19.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.223 0.535 . . . . 0.0 109.926 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.8 mt -65.89 -38.46 88.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.22 162.78 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.842 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.6 122.91 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.207 0.527 . . . . 0.0 110.686 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.47 155.4 34.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.765 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.39 121.35 18.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.824 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.25 22.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.106 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.48 152.64 17.34 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -87.13 159.24 18.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.823 0.344 . . . . 0.0 110.737 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.1 mtp -124.81 176.17 6.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -126.01 126.51 44.41 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.4 tp -107.27 122.32 46.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -117.42 106.24 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.923 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.04 -87.27 0.38 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -139.72 23.78 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.687 0.279 . . . . 0.0 111.054 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.4 m -125.08 125.69 44.18 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.236 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.16 124.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.916 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.6 m -123.09 134.26 25.01 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.78 146.89 79.97 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.947 1.765 . . . . 0.0 112.875 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.51 150.82 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -80.73 -6.87 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.808 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -72.79 73.3 1.1 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.86 129.99 43.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.76 -159.58 9.26 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.229 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -140.32 127.75 21.36 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -99.99 110.0 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.556 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -132.42 154.8 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.196 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.1 mt -119.01 138.12 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.397 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -134.66 130.55 36.53 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -101.1 124.38 46.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 0.0 109.954 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -85.15 172.5 11.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.816 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.48 -10.31 24.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.54 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.51 7.16 42.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.602 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m 63.37 23.86 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 110.603 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -98.63 122.48 41.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.8 mm -81.74 120.65 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -97.85 111.24 23.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.973 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -91.0 106.69 18.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 92.7 m -119.03 146.62 44.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.708 0.766 . . . . 0.0 112.752 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.7 t90 -124.94 113.4 17.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.262 -1.336 . . . . 0.0 108.331 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -105.85 135.3 47.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.959 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -76.82 132.7 39.34 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -73.58 -18.68 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -59.88 -46.1 90.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.829 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.1 m -116.46 -15.18 10.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.057 0.456 . . . . 0.0 110.072 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.37 21.51 77.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -101.88 152.74 20.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.242 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.0 t -78.16 107.84 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.54 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -86.59 -28.26 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -129.28 143.8 50.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.191 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -157.88 101.96 1.81 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.193 0.521 . . . . 0.0 110.523 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 mt -129.7 134.03 47.41 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.24 120.14 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mp -108.16 112.5 40.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -71.2 162.56 71.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.937 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.58 131.43 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.921 1.747 . . . . 0.0 111.668 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.7 t0 63.88 12.22 6.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.404 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -82.13 -35.92 28.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.315 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.74 150.62 50.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.301 0.572 . . . . 0.0 111.105 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -121.77 129.59 52.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.96 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -107.03 118.08 35.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.43 168.25 20.16 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.579 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -87.39 160.32 18.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.003 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.08 90.66 11.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.119 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.75 60.15 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.984 1.789 . . . . 0.0 112.359 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.84 -39.68 3.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.34 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.6 t -128.29 80.88 71.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.67 130.49 26.52 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.604 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.81 -41.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.02 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.98 -150.92 6.7 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.44 106.23 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.467 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.19 129.35 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.22 154.17 45.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.635 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.69 134.91 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.379 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.4 tp -104.08 123.19 46.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -122.02 130.98 53.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.129 0.49 . . . . 0.0 110.915 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -84.43 117.83 23.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.97 -31.52 71.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.462 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.73 -21.7 11.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.936 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.66 -25.68 55.84 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.961 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.31 8.93 6.0 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.309 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -93.97 143.88 25.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.811 0.339 . . . . 0.0 110.721 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -122.83 125.27 45.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.469 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.9 mt -114.27 141.88 47.01 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -115.07 134.74 54.91 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -138.01 153.55 49.39 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.276 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -129.03 136.44 50.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.532 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 29.9 tpp -72.34 134.08 45.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.078 0.466 . . . . 0.0 111.107 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.15 -0.9 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.913 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -73.16 133.08 81.62 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.278 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.96 -24.84 39.1 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.9 1.733 . . . . 0.0 112.88 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -111.25 140.8 45.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 p -99.0 12.32 36.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.371 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.92 -20.91 60.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.595 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -126.36 10.87 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.359 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.48 -47.02 83.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.534 . . . . 0.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.31 -31.04 65.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.122 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.64 -45.0 80.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.926 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -62.81 -41.15 99.17 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.704 0.764 . . . . 0.0 109.497 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.55 -44.34 96.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.506 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -65.68 -43.36 89.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.818 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.4 -42.19 99.24 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.59 -48.8 84.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.912 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.39 -39.16 88.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.298 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -74.39 -22.93 58.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.192 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.405 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 m-85 -89.42 -28.25 19.86 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.527 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.1 mt -92.91 -16.72 24.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.062 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -117.16 -17.61 10.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.316 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.52 63.98 18.17 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.798 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.82 153.67 68.39 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 122.522 2.148 . . . . 0.0 112.443 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.313 -1.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.22 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 48.69 70.74 1.9 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.643 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.73 145.73 70.34 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -73.73 159.15 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.298 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.14 154.36 46.31 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.762 2.308 . . . . 0.0 111.998 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.09 -155.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.615 2.21 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -125.39 155.34 71.85 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.01 143.44 90.95 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.473 2.115 . . . . 0.0 111.676 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -156.97 166.99 31.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.77 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.03 135.33 33.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 110.618 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -112.55 123.2 49.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.766 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.444 -0.748 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -67.67 161.15 26.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.503 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.66 143.11 31.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.5 123.74 32.73 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.42 114.68 47.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.413 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -100.74 121.94 42.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.901 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 79.7 p -83.39 172.49 12.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 67.2 mt -62.83 -25.09 68.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.289 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -73.9 -10.04 59.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -11.08 70.52 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.76 132.79 47.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.3 m -109.63 132.21 54.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.556 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.65 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.677 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -84.25 130.17 34.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.49 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.79 130.21 52.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.687 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.42 115.36 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.35 166.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.0 150.7 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.961 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.27 -36.57 86.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.94 1.76 . . . . 0.0 112.069 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -83.31 -9.98 58.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.85 138.52 57.24 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.663 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -79.5 163.81 24.42 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.772 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mm -65.39 -36.7 78.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.857 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.49 -44.15 89.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -62.9 -41.19 99.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 110.814 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.37 -42.86 97.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.48 -39.02 86.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.68 91.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.397 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -60.63 -39.19 87.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.63 -39.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.187 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.21 -38.51 80.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.241 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -67.32 -50.86 58.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.7 151.08 51.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.77 64.23 1.89 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 42.1 mm -117.98 93.11 43.72 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 149.59 70.68 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.744 2.296 . . . . 0.0 112.11 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -51.69 -42.59 55.86 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.112 1.874 . . . . 0.0 112.277 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.2 -38.66 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 110.347 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -95.7 25.39 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.507 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -131.61 119.87 22.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -127.23 106.64 9.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 63.4 mt -85.13 138.51 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.4 mt -134.39 130.23 53.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.599 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -156.37 155.88 32.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.55 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.54 14.13 9.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.59 -14.04 62.45 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.09 150.18 39.08 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.407 0.622 . . . . 0.0 110.551 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.04 137.66 45.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.509 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.13 101.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.18 139.43 42.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -61.48 138.81 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -17.68 55.66 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -83.03 175.68 9.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -119.23 162.21 19.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.279 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.31 -41.26 96.7 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.757 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -63.25 -24.07 67.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.839 0.352 . . . . 0.0 110.684 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.28 -36.92 83.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -98.3 14.47 27.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.272 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 57.69 38.68 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.894 0.378 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 53.1 mt -83.82 111.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.234 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -98.08 178.51 5.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -60.33 146.09 45.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.957 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 59.76 22.1 10.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 17.0 m -74.34 127.03 31.96 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.874 0.368 . . . . 0.0 110.185 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.1 m -80.33 126.43 31.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.41 152.86 33.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -103.0 126.18 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.152 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 tt -103.4 122.27 44.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.12 132.49 57.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.25 135.54 48.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.081 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 110.509 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -63.35 157.07 23.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.023 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 17.5 pt -138.17 145.17 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.163 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -86.5 126.96 34.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.841 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -112.38 101.18 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -90.67 127.63 36.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.696 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -89.73 -179.21 5.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.23 -34.59 78.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -68.21 -12.88 61.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.627 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.18 63.39 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.14 129.96 42.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -102.11 132.35 48.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.458 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.95 110.4 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.956 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -81.38 130.4 35.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 91.7 mt -125.73 123.73 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.471 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -66.11 112.43 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.073 0.463 . . . . 0.0 110.946 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.08 165.57 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.881 -0.512 . . . . 0.0 110.324 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.27 152.63 43.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.115 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -38.34 86.01 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.826 1.684 . . . . 0.0 112.222 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -66.27 -36.49 83.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.162 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -50.45 140.57 13.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.688 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 31.0 p -87.05 169.46 12.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.108 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.38 -34.73 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.279 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.63 -44.07 89.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.102 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.62 -42.4 99.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 68.0 t -63.21 -42.97 98.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -60.22 -40.42 90.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.58 94.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.704 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.81 -39.19 88.02 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.665 0.745 . . . . 0.0 109.089 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.53 -40.13 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.548 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -59.08 -42.17 89.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.732 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.74 -40.71 93.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.751 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -77.32 -62.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.327 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.16 156.4 18.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.375 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.92 55.48 4.26 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.8 99.06 36.7 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.136 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.31 153.13 71.47 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.775 1.65 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.62 -40.32 73.37 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.079 1.853 . . . . 0.0 111.952 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.36 -39.37 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 110.402 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -103.1 35.23 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.65 124.22 22.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.937 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -122.16 104.68 9.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mp -85.31 115.23 22.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.935 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -126.07 126.11 69.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.435 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -63.39 -46.21 87.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.658 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.71 -78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.776 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.26 2.56 57.82 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -145.02 136.81 25.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.126 0.489 . . . . 0.0 110.931 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -78.55 138.07 38.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.378 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 77.7 mt -74.47 122.96 23.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.96 132.56 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 133.63 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.619 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.41 55.61 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -82.3 147.21 29.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.735 0.302 . . . . 0.0 111.011 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 48.8 p -75.71 162.57 28.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.36 -38.27 84.52 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.632 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.09 -25.34 67.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.942 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.31 -37.63 83.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -98.06 15.15 25.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 54.37 39.89 31.31 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.75 91.32 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.779 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -82.11 177.99 8.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.974 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -58.7 151.37 21.16 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 60.09 44.51 12.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -97.29 120.9 38.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -75.06 127.27 32.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.21 126.83 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.194 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.01 120.76 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.95 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tt -100.12 112.22 24.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.978 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.92 132.16 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 60.9 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 -179.324 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.906 0.384 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.21 127.23 37.61 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.708 0.765 . . . . 0.0 110.206 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.12 -37.48 83.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.62 162.93 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.829 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -173.85 122.03 0.32 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.344 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.78 151.4 27.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.912 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.37 123.08 20.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 110.357 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.93 145.45 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.321 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.0 154.26 16.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -87.1 172.62 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 111.165 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.4 mtp -138.79 173.72 11.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -124.89 123.6 40.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.53 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.9 tp -107.61 117.24 33.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.363 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -120.97 114.46 21.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.953 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.78 -90.09 0.48 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.1 p -141.66 21.14 2.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.841 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.8 m -123.05 130.86 53.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -109.42 123.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.976 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.4 p -118.25 132.77 23.61 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.685 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.57 142.67 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.963 1.775 . . . . 0.0 113.05 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -97.74 145.62 26.17 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.733 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -81.21 -6.86 59.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.132 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -73.35 75.41 1.37 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.61 134.12 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.28 -156.53 7.88 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tp -138.72 123.01 18.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.1 t -95.77 108.42 21.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.711 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.4 p90 -131.25 153.88 49.06 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.665 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.5 mt -117.67 139.83 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.548 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.32 128.67 26.05 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 123.84 0.713 . . . . 0.0 110.854 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -98.29 124.22 42.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.308 0.575 . . . . 0.0 110.278 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.5 p -83.75 171.61 13.01 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.54 -10.05 23.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.549 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -89.22 1.97 54.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.5 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.66 19.18 7.4 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.4 mt -98.95 122.73 42.58 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 mm -79.21 125.06 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -101.11 114.87 29.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.108 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -93.31 106.67 18.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.89 145.46 45.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -126.96 111.98 14.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.837 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -102.59 145.24 29.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.627 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -81.7 133.55 35.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -73.96 -17.62 60.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.937 0.399 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.4 m -60.18 -45.3 93.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 m -117.79 -12.97 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.456 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.86 23.24 75.37 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -102.51 151.77 21.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.771 0.32 . . . . 0.0 110.813 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.01 109.03 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.309 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.06 -28.42 21.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.92 145.37 50.98 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.075 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -158.09 100.44 1.71 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.944 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 mt -131.7 129.24 40.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.441 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.29 125.97 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.105 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.2 mm -115.28 121.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.915 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -82.79 159.76 62.64 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.274 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.09 142.44 97.06 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.992 1.795 . . . . 0.0 111.324 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 61.27 12.64 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.876 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -93.09 -33.33 14.12 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.635 0.255 . . . . 0.0 110.889 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.48 148.42 42.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -120.89 132.24 54.86 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.403 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -105.82 115.83 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -140.81 168.97 18.53 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.098 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -85.61 162.38 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.316 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.54 88.56 9.42 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.317 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.47 60.95 8.02 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.507 2.138 . . . . 0.0 112.09 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 -41.99 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.451 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.3 t -129.23 80.01 73.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.474 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.23 130.11 38.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.189 1.926 . . . . 0.0 111.219 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t 168.02 -39.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.627 0.58 . . . . 0.0 110.123 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.54 -170.1 11.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -95.96 107.0 19.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.732 0.301 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.07 129.42 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -122.66 156.06 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.971 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.75 131.45 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.7 tp -102.34 123.23 45.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -118.98 137.54 53.44 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.74 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -92.8 112.75 24.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.309 0.576 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.88 -37.92 88.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.828 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.78 -21.63 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.514 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.62 -173.16 20.74 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.8 m -122.52 25.75 8.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.941 0.4 . . . . 0.0 110.299 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 149.43 33.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -134.81 144.86 47.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.463 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -120.2 152.08 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.768 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -124.03 135.0 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.812 0.339 . . . . 0.0 110.578 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.35 158.7 43.84 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -131.99 135.98 46.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.574 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.1 mmm -72.43 139.91 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.0 110.85 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -101.38 0.29 36.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.339 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -72.19 145.2 88.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.15 -28.35 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.095 1.863 . . . . 0.0 112.728 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.07 143.62 49.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.147 0.499 . . . . 0.0 110.321 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.9 p -89.52 -0.16 57.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.268 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.11 -19.22 42.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -117.76 -18.38 9.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.3 -41.03 98.17 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.335 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.23 -40.03 95.19 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.394 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.37 -42.92 95.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.535 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.87 -40.07 91.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.476 0.655 . . . . 0.0 109.303 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.91 -43.48 98.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.464 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -66.64 -41.44 88.26 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.524 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -64.59 -41.08 96.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.4 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.29 -46.98 85.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.72 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -62.21 -39.45 92.78 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.463 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.65 -25.59 61.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.019 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -87.62 -26.05 23.25 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.999 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.3 mt -95.44 -16.37 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.467 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -115.34 -22.44 9.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.09 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -135.22 71.76 67.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.935 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.42 147.57 77.15 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.254 1.97 . . . . 0.0 112.365 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.585 0 C-N-CA 122.463 2.109 . . . . 0.0 112.213 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.46 152.43 95.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.69 154.74 49.45 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.811 2.34 . . . . 0.0 112.385 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.72 156.58 35.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.382 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -53.18 138.08 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.839 1.693 . . . . 0.0 112.255 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 172.96 15.3 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -95.66 156.08 37.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.06 151.42 83.86 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.78 166.28 32.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.798 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.36 134.58 34.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -120.21 132.48 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -58.34 158.21 7.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.654 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 pt -139.05 142.27 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.911 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -81.94 127.21 32.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.157 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -114.67 115.84 50.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -96.91 118.6 33.68 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.17 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -75.23 173.73 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.86 -31.56 2.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.533 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 76.9 p -99.96 -179.87 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.56 -19.11 53.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -53.1 129.37 30.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.049 0.452 . . . . 0.0 110.728 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -127.58 134.6 49.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.454 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.7 122.39 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.517 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 85.7 m -88.8 131.87 34.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 65.7 mt -119.3 125.1 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -65.94 109.68 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 111.009 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -133.13 163.78 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.487 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -108.07 156.08 38.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.159 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.29 -37.85 96.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.136 1.891 . . . . 0.0 111.87 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -79.72 -7.2 58.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -57.6 137.57 56.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.008 0.432 . . . . 0.0 110.899 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -80.75 160.74 24.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.7 -41.41 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -57.95 -36.63 72.81 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.292 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.0 -41.51 95.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.556 . . . . 0.0 110.8 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.6 -42.63 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.773 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.76 -39.62 89.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.354 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.92 93.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.652 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.22 -38.86 84.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -65.05 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.962 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -59.01 -43.91 91.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.411 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.75 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.833 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -72.09 -75.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -93.71 151.49 19.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.366 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.46 56.02 4.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 42.6 mm -106.4 109.97 63.52 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.69 154.36 49.56 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.054 1.836 . . . . 0.0 112.195 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.98 -38.85 80.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.112 1.875 . . . . 0.0 112.235 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -61.52 -39.97 92.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -87.02 -3.18 59.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.476 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -88.16 67.15 8.76 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.565 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -84.27 109.89 18.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 23.4 mt -100.32 128.94 46.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.239 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -128.79 128.67 67.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.69 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -147.8 145.42 28.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.435 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 19.84 7.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.099 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.31 -13.15 65.91 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.66 145.99 24.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.27 0.557 . . . . 0.0 111.482 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -95.21 105.33 17.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.86 88.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.17 -74.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -177.05 169.02 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.46 20.84 77.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.32 171.28 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 110.025 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -126.33 163.69 22.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.8 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -57.87 -43.14 85.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.587 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -63.09 -22.35 66.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.951 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.77 -36.56 83.48 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.354 0.597 . . . . 0.0 109.784 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.28 11.29 39.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.454 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 57.7 46.41 17.39 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.298 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 80.9 mt -92.71 119.84 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.542 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.99 -178.9 3.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.83 147.84 52.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 58.79 45.21 15.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.215 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -98.45 126.36 43.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.075 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 82.3 m -75.62 126.97 32.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.1 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -112.52 145.44 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.12 114.62 26.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.387 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.17 126.43 41.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.261 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.45 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.822 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 27.4 mt -103.51 149.19 25.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.286 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.498 179.643 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.28 163.52 15.25 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.3 pt -141.84 142.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.044 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -87.01 126.56 34.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.75 105.36 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -88.57 125.86 34.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.71 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 73.7 p -78.01 -166.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.883 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.16 -28.47 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.793 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -102.91 -177.63 3.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.36 57.6 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -53.07 129.85 32.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 110.894 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.4 m -123.93 138.14 54.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.029 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.75 109.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.956 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -85.41 129.91 34.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.438 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -122.07 134.07 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.44 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.26 117.54 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.732 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -136.94 167.44 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.168 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.23 154.2 45.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.51 -29.6 85.42 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.609 1.539 . . . . 0.0 111.729 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -84.55 -11.87 55.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.609 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.66 142.16 58.14 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.786 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.0 p -83.27 166.91 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.078 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.57 -37.4 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.13 -42.73 91.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.98 -43.78 98.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.806 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -61.08 -38.39 86.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.317 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.1 94.35 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.105 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -59.96 -39.03 84.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.68 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.31 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.8 -39.5 89.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.175 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.79 -45.1 91.23 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.478 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -73.48 -40.51 64.06 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -128.16 151.19 49.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.27 62.06 2.23 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.1 103.25 54.71 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.07 154.43 66.52 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.346 1.364 . . . . 0.0 111.954 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -53.61 -25.97 35.39 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.629 2.22 . . . . 0.0 112.517 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.96 13.63 14.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.418 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -145.4 59.97 1.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.376 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.93 147.08 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.24 0.543 . . . . 0.0 111.774 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.8 124.29 31.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.466 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.8 mt -105.49 114.25 28.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.68 121.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.669 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.82 -46.99 79.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -179.04 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.021 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.34 -8.15 79.54 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -129.79 127.89 41.26 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.867 0.365 . . . . 0.0 110.499 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -81.13 153.47 27.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.572 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.57 102.71 14.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.062 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.84 155.62 35.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.56 154.37 41.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.41 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.13 12.67 63.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -127.33 150.78 49.43 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.198 0.523 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.37 163.36 13.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.999 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.91 -39.31 91.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.709 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.5 -22.51 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.322 . . . . 0.0 110.367 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.46 -38.33 83.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.261 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -99.83 16.86 22.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.86 40.93 28.64 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.337 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 78.8 mt -88.22 110.1 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -95.54 178.61 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -59.62 152.23 22.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.539 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 56.82 33.73 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -77.03 120.86 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.937 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 78.1 m -81.63 119.8 24.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.35 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.75 142.76 45.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.075 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -87.69 114.42 24.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.35 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -102.51 118.14 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.583 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -117.72 128.73 74.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.814 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.69 -178.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -95.87 113.19 24.79 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.6 mt -66.04 -39.01 89.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.603 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 p -147.5 163.04 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.05 122.38 0.31 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.756 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.31 158.7 40.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.815 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.08 124.21 25.85 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.097 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -157.0 145.28 19.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.336 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.47 154.72 16.47 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -90.26 174.7 7.45 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.17 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.4 mtp -138.76 172.77 12.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -123.12 123.9 41.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.0 tp -105.29 119.81 39.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.329 0.585 . . . . 0.0 110.618 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -121.42 107.62 12.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.571 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.56 -97.06 0.68 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 p -131.06 19.71 4.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.297 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.1 m -121.76 130.63 53.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.051 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.65 124.07 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.203 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.81 133.6 22.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.65 148.21 46.78 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.799 1.666 . . . . 0.0 112.959 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -103.63 130.69 51.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.68 -8.18 50.08 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.917 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.63 78.09 1.08 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -58.53 131.08 49.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.237 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.47 -158.56 9.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.84 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 tp -137.57 126.51 24.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 36.9 t -96.58 113.5 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.066 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -136.41 155.88 49.4 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.062 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' LEU . 90.8 mt -123.89 140.14 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.105 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -140.09 146.14 38.53 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -109.78 128.55 55.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.221 0.534 . . . . 0.0 110.335 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.5 p -89.68 172.64 8.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.756 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.56 -10.51 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.152 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.15 3.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m 63.12 26.55 15.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.336 0.589 . . . . 0.0 110.335 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.4 mt -103.97 125.47 50.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.11 122.92 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -100.59 116.03 31.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.713 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -93.25 110.37 21.89 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -124.64 146.99 48.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.162 0.982 . . . . 0.0 112.951 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -124.08 116.37 22.67 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.943 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -108.19 134.31 51.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.061 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.69 131.2 39.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.82 -17.27 61.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.888 0.375 . . . . 0.0 110.464 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -59.53 -46.4 88.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.863 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.6 m -116.49 -15.36 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 109.888 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.18 21.7 77.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -101.36 152.89 20.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.16 104.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.926 0.393 . . . . 0.0 110.424 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.73 -30.98 36.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -127.95 145.65 50.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.819 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -158.11 120.21 3.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.612 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.1 136.09 21.09 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.17 0.509 . . . . 0.0 110.381 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -81.62 122.88 37.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.574 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.6 mm -114.06 121.23 65.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.279 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -84.78 162.3 50.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.63 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.92 139.56 89.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.368 2.045 . . . . 0.0 111.54 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 59.64 12.02 2.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.229 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -87.17 -25.12 24.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.6 p -144.43 169.23 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.35 0.595 . . . . 0.0 110.324 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -137.54 125.25 22.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.809 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.23 118.74 37.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.57 164.71 30.84 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.415 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -79.4 159.84 26.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.018 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.6 t -111.36 90.62 12.28 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.18 60.25 7.72 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.829 1.686 . . . . 0.0 112.509 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -114.24 -38.82 4.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.991 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.06 82.35 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.585 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.16 130.33 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.702 1.602 . . . . 0.0 111.685 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.5 t 169.68 -45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.571 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.72 -154.98 8.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.85 106.81 16.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.505 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.65 128.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.08 154.37 41.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.681 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.01 136.12 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.196 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.7 tp -103.77 120.0 40.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -118.36 136.08 53.95 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.238 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -84.22 114.67 21.98 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.124 0.488 . . . . 0.0 109.833 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.9 -37.88 86.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.706 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.96 -21.92 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.23 -175.38 22.68 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -117.88 15.81 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.675 0.274 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -93.35 146.0 24.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.87 137.96 40.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.408 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.6 mt -119.23 148.21 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.44 133.59 55.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.961 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.72 157.99 45.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.293 0.568 . . . . 0.0 111.188 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -132.07 138.07 48.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.522 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.3 ttm -77.07 131.55 38.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.072 0.463 . . . . 0.0 111.475 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -1.7 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.702 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.25 144.91 98.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.06 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.32 -26.93 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.051 1.834 . . . . 0.0 112.786 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -121.85 144.57 48.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.054 0.454 . . . . 0.0 110.245 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.4 p -94.0 9.16 38.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.629 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.88 -22.1 61.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.84 -4.66 12.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.54 -46.95 87.77 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -41.44 99.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.71 -43.23 97.19 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -64.34 -40.7 96.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.577 0.703 . . . . 0.0 109.111 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.77 -45.07 94.38 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.901 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -68.01 -42.12 81.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.4 -41.88 98.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.513 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.2 t -59.13 -47.08 91.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.312 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.89 -39.59 93.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.271 0.558 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.87 -36.37 80.15 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.075 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -80.17 -30.43 38.83 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.955 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.02 -17.51 27.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.853 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -116.98 -19.0 9.98 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.372 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.81 69.78 36.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.339 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.21 157.6 59.01 Favored 'Trans proline' 0 C--N 1.296 -2.195 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.539 2.16 . . . . 0.0 112.319 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.69 154.69 81.84 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 145.1 29.19 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.402 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.35 156.47 68.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.018 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.17 137.39 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.017 1.811 . . . . 0.0 111.873 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.08 -170.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.033 1.822 . . . . 0.0 111.848 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -124.95 158.33 63.38 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.257 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.59 144.32 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.588 2.192 . . . . 0.0 112.377 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -155.53 164.43 38.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.72 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -86.16 135.74 33.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.905 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -121.06 122.95 41.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.429 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -69.37 161.84 28.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 pt -140.04 144.77 27.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.367 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.16 126.38 35.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -112.31 115.27 49.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -103.49 127.22 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.53 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -90.03 173.34 8.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 111.314 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.66 -25.92 68.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.174 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -73.41 -9.39 58.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.77 -7.41 73.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -71.87 130.83 41.99 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 110.198 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -109.84 132.22 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.255 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.7 116.55 27.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -87.07 131.45 34.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.072 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -123.38 133.64 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -73.5 115.49 12.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.532 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.37 168.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.458 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.19 153.35 45.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.193 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.22 -38.17 93.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.999 1.799 . . . . 0.0 112.345 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -81.73 -8.19 59.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -59.04 139.03 57.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.953 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -80.16 161.78 25.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 48.8 mm -63.67 -38.53 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.177 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.19 -41.93 89.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.284 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.12 -41.25 98.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.124 0.488 . . . . 0.0 110.548 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.91 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.614 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -60.96 -38.39 85.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.01 91.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.11 -39.28 85.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mm -64.59 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.471 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -59.69 -40.15 86.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.811 0.338 . . . . 0.0 110.377 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -67.55 -50.94 56.24 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -64.93 -40.98 95.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 112.038 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -132.18 146.41 52.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.199 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.04 63.98 2.01 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.71 112.32 32.39 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.16 157.35 57.65 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.777 1.651 . . . . 0.0 111.748 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.8 -38.07 96.6 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.168 1.912 . . . . 0.0 112.188 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.96 -40.92 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.915 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -88.64 -17.68 29.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.658 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -92.03 116.44 28.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.054 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -120.28 114.19 21.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -92.48 131.86 37.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.295 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -130.75 129.25 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -145.17 152.46 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.899 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.54 20.31 10.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 110.505 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.72 -5.09 76.44 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.11 139.31 50.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.087 0.47 . . . . 0.0 110.736 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.16 131.61 43.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 50.4 mt -69.68 103.7 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.778 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -75.31 138.94 42.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.97 137.04 58.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.69 -17.81 52.01 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -84.28 174.99 9.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -120.62 165.54 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.346 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.54 -39.88 94.99 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.567 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -64.11 -25.96 68.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.66 -33.55 75.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.437 . . . . 0.0 110.356 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -99.45 13.77 32.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.283 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 56.29 43.93 25.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -91.02 114.76 28.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.45 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -63.7 146.2 54.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.16 44.96 18.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.939 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 38.9 m -99.33 124.93 44.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 40.9 m -74.45 130.83 40.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.223 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.65 155.16 31.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.399 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -105.89 120.65 42.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.27 114.79 29.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.015 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.25 130.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.76 131.94 38.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.908 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -153.18 166.94 30.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.754 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 pt -144.1 150.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.019 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.0 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.43 111.95 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -95.43 122.04 37.73 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.639 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -79.77 173.3 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.985 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.1 -35.34 76.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.158 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -69.17 -12.03 61.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.892 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.4 60.3 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -61.56 130.96 48.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.71 0.291 . . . . 0.0 110.457 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -103.89 133.94 48.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -126.98 106.67 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.965 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 124.4 27.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.225 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -121.01 132.25 54.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.357 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.81 120.8 21.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.56 -177.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.744 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -132.04 152.08 79.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.119 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.75 -27.21 82.9 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.983 1.789 . . . . 0.0 111.977 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.3 p -86.21 -14.05 45.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.34 143.3 57.92 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.593 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -87.43 168.48 13.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.172 0.51 . . . . 0.0 110.854 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.89 -38.31 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.682 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.31 -39.71 87.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -62.29 -40.9 97.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.55 -42.47 96.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.784 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.81 -40.59 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.085 0.469 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.87 91.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.109 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.37 -38.69 81.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.37 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.167 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -61.13 -43.65 98.55 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.867 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.78 -23.18 61.54 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.079 -0.388 . . . . 0.0 111.904 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.46 3.54 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -149.22 -46.07 0.14 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 110.07 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.51 20.11 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -88.69 119.84 70.08 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.662 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.76 159.35 50.99 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.715 1.61 . . . . 0.0 111.888 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.37 -23.17 36.9 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.498 2.132 . . . . 0.0 112.537 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -93.24 18.17 9.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.886 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -146.14 23.96 1.32 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.728 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -150.12 144.77 25.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.978 0.418 . . . . 0.0 110.987 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -128.28 120.49 27.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.526 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -96.3 121.38 38.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.031 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.36 129.34 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.53 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -130.95 133.1 45.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.665 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.18 26.47 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.613 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.23 79.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -126.09 130.73 51.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -65.21 138.34 58.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.66 112.0 20.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.491 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.83 152.38 37.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -73.65 164.3 26.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.315 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.14 25.03 75.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -127.23 149.64 49.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -93.41 161.91 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.285 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.61 -39.55 94.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.733 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.0 p -63.3 -22.84 67.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.429 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.87 -37.97 86.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.036 0.446 . . . . 0.0 110.62 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -96.76 16.31 19.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.43 42.07 25.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -91.51 101.75 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.728 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -94.96 179.84 5.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.478 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -56.32 145.33 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.268 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 59.92 42.44 16.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.5 t -95.98 120.81 36.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.595 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -76.84 124.99 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.389 . . . . 0.0 110.396 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -115.69 136.02 53.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.154 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -84.0 124.02 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.404 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -104.9 118.37 36.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.701 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.43 132.04 65.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.238 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 49.9 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.488 -179.142 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.6 pttm . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.98 128.65 35.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' ILE . 81.7 mt -67.59 -37.26 82.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.853 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.67 160.98 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.84 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.47 122.56 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.12 155.17 34.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.08 118.03 16.57 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.358 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.15 26.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.94 150.72 17.12 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -89.32 157.84 18.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.73 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 29.6 mtp -124.24 175.56 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -126.16 122.64 36.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.246 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.5 tp -106.03 122.75 46.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.993 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -118.36 103.75 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.12 -85.18 0.69 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -141.3 18.11 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.534 0.206 . . . . 0.0 110.911 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.0 m -120.01 126.16 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.99 122.75 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.414 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.0 m -119.33 122.62 29.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.427 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 147.18 64.48 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.924 1.749 . . . . 0.0 112.905 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.15 139.99 39.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.969 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -72.93 -5.25 37.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -72.47 74.77 1.04 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -52.79 134.27 36.77 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.334 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.65 -165.06 11.3 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tp -135.92 122.55 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.63 108.36 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.831 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -133.14 153.59 51.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.576 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.8 mt -122.04 141.62 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.826 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -141.67 142.63 33.37 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 123.687 0.617 . . . . 0.0 110.18 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.29 127.6 53.36 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.9 p -87.3 172.79 9.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.754 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.11 -10.42 22.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.625 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.22 -0.16 56.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 70.04 19.77 6.72 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -101.72 126.02 48.5 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.4 mm -80.78 126.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -102.42 115.99 31.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.915 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -91.92 108.19 19.75 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 94.7 m -118.06 140.03 50.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.805 0.812 . . . . 0.0 112.902 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -125.46 113.25 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.189 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -106.18 144.7 32.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.817 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -80.62 131.65 35.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.82 -18.63 62.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.952 0.406 . . . . 0.0 110.529 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -59.65 -46.18 89.78 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.45 -11.3 10.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 0.0 110.646 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.08 22.78 78.7 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.51 146.88 27.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.722 0.296 . . . . 0.0 110.657 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.79 102.02 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.036 0.445 . . . . 0.0 110.304 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -73.08 -39.4 65.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.906 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.8 147.13 50.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.522 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.54 103.24 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.597 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.2 mt -126.98 135.7 51.23 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.775 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -77.43 122.22 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.5 mm -111.81 121.08 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.618 . . . . 0.0 111.183 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -82.76 160.98 59.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.391 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 142.35 98.64 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.797 1.664 . . . . 0.0 111.441 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 61.84 12.34 4.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.103 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -89.87 -35.79 15.44 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 120.628 0.251 . . . . 0.0 110.678 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.4 m -132.48 156.29 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.25 0.548 . . . . 0.0 111.399 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -129.31 130.63 46.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.126 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -101.96 117.95 35.89 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -143.49 161.27 38.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.538 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -83.19 160.34 21.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.131 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.5 89.39 15.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.192 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.6 60.21 7.55 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.091 1.86 . . . . 0.0 112.047 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -114.25 -44.27 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.9 t -116.36 99.06 52.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.78 129.73 15.9 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.38 1.386 . . . . 0.0 111.458 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 165.23 -38.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 O-C-N 124.02 0.825 . . . . 0.0 110.372 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.59 -179.69 25.64 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -91.83 113.55 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.88 128.26 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.176 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -119.18 155.75 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.719 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.63 137.74 52.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.4 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.9 tp -103.68 121.47 43.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -117.89 141.6 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -88.09 117.18 26.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.27 -37.47 85.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.949 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.83 -15.85 19.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.53 176.14 19.96 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.6 p -111.7 15.76 20.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.668 0.27 . . . . 0.0 110.465 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.28 144.56 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.969 0.414 . . . . 0.0 110.77 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.93 140.59 42.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.716 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.62 152.06 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -124.28 137.15 54.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.84 154.24 48.41 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.29 0.567 . . . . 0.0 111.216 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -132.43 136.04 46.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.07 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.95 131.68 51.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.121 0.486 . . . . 0.0 111.215 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 -1.67 12.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.483 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.09 149.23 94.56 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.664 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.14 -39.93 64.82 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.002 1.802 . . . . 0.0 112.224 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.57 145.91 48.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.3 p -98.45 18.72 15.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.5 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.49 -22.2 61.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.61 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -123.48 13.85 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.51 91.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.776 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.54 -41.21 84.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.066 0.46 . . . . 0.0 111.128 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.75 -43.35 96.71 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -63.54 -41.08 98.48 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.517 0.675 . . . . 0.0 109.322 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.23 -42.02 96.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -67.58 -40.14 84.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.2 -37.57 83.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.713 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.3 t -58.51 -47.83 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.412 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -80.05 -27.42 39.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.942 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.96 -38.22 82.5 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.53 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -81.62 -34.18 31.05 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.479 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.24 -26.69 56.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.917 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -107.45 -24.16 11.92 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.56 74.83 58.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.536 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.4 155.63 40.23 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.004 2.469 . . . . 0.0 112.362 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.081 -179.643 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 49.44 67.65 4.26 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.558 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.35 143.95 78.47 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.723 2.282 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.89 160.05 82.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.806 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.52 155.42 62.76 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.765 2.31 . . . . 0.0 112.187 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.35 -169.44 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.608 2.205 . . . . 0.0 111.608 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -110.1 160.4 28.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.14 142.68 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.538 2.159 . . . . 0.0 111.808 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.72 163.93 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.68 138.36 32.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.867 0.365 . . . . 0.0 110.434 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -124.57 119.87 30.32 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.784 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.716 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.14 162.93 18.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.461 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -144.35 147.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.962 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -96.43 119.5 35.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.571 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -103.5 103.8 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -87.67 118.54 27.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.803 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.9 p -82.36 171.13 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.89 -25.03 67.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.138 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.8 p -73.47 -11.5 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -13.74 63.59 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.56 132.53 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.257 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -101.56 132.02 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.144 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mm -116.3 103.55 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.95 120.31 25.53 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.098 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -122.34 132.76 54.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.32 114.45 16.16 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.91 171.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.989 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -116.51 156.33 47.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.237 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.98 -41.23 77.47 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.887 1.724 . . . . 0.0 112.322 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -72.94 -12.25 60.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -59.13 135.76 57.74 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.851 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -77.51 160.54 28.56 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -66.17 -37.65 80.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.071 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.44 -42.92 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -62.29 -42.03 99.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 110.074 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.21 -43.58 96.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.428 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -40.1 79.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.187 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.6 94.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.991 0.424 . . . . 0.0 110.339 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -59.8 -39.4 84.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.394 0.616 . . . . 0.0 109.386 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.56 -38.86 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.443 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -58.03 -42.36 85.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.447 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.11 -40.89 71.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.456 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -65.63 -40.96 93.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.959 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -138.07 157.27 46.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.45 57.44 3.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 32.6 mm -110.81 104.84 56.68 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 153.49 50.38 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.354 2.036 . . . . 0.0 112.204 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.81 -39.14 78.43 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.822 1.681 . . . . 0.0 112.302 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.83 -39.55 92.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.279 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.08 -9.24 59.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.913 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.55 93.87 7.93 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -108.82 95.81 5.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -84.55 130.21 34.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.274 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -132.17 127.51 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -141.76 148.82 39.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.948 0.404 . . . . 0.0 111.108 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.64 17.48 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.249 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 89.87 -17.11 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -95.48 133.27 39.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 111.056 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -75.73 130.92 39.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.69 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.89 129.8 38.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.58 -80.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.479 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.01 -68.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.611 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.12 94.49 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -49.07 162.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.514 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -109.54 178.46 4.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.308 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.79 -39.61 76.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.825 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.29 -24.96 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.56 -37.4 86.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -98.76 11.98 37.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.113 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 t30 59.33 40.08 21.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.852 0.358 . . . . 0.0 110.365 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -86.24 103.72 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -91.68 179.95 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.512 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -63.19 145.08 56.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.186 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 64.28 13.32 7.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.322 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.0 m -67.02 134.78 52.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 43.6 m -92.49 117.63 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.17 139.39 42.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.903 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.56 127.91 35.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.28 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 tp -105.85 121.17 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.819 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.87 132.61 56.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.736 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 22.4 mt -95.9 133.41 40.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.3 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -64.27 160.68 18.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.599 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -139.17 142.44 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.377 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -86.63 122.73 30.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -108.82 107.28 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.382 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -92.0 130.43 37.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.883 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -89.19 -179.32 5.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 111.086 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.36 -37.22 86.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.136 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.39 -12.18 61.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 -12.51 61.36 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.98 131.4 49.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 83.3 m -104.77 133.53 49.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 111.163 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.83 108.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.729 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.6 m -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.299 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 94.6 mt -122.91 126.57 47.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.627 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -68.85 116.39 9.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.849 0.357 . . . . 0.0 111.039 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 20.7 m -139.2 165.57 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -106.28 155.24 38.96 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.027 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.46 -32.77 90.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.102 1.868 . . . . 0.0 112.282 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -87.3 -3.31 59.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -60.06 136.24 57.96 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -80.18 163.41 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.234 0.54 . . . . 0.0 111.021 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -63.03 -37.26 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.39 -42.33 86.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.084 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -62.48 -41.27 98.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.443 . . . . 0.0 110.432 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.47 -43.61 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.67 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -61.08 -39.46 89.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.668 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.71 97.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -59.66 -38.92 82.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.571 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 59.2 mt -67.04 -38.48 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.842 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -59.12 -39.74 83.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.406 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -70.49 -53.76 14.99 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -63.14 -40.95 99.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.094 0.473 . . . . 0.0 111.753 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -128.2 143.45 51.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.793 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.36 61.96 2.69 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.02 110.11 49.01 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.54 155.07 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.16 1.907 . . . . 0.0 111.691 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.18 -34.49 98.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.216 1.944 . . . . 0.0 113.035 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.17 -47.42 77.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 110.101 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.2 -38.85 88.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -58.86 115.74 3.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.729 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -119.37 102.89 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.37 118.55 29.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.13 126.06 67.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -132.1 132.21 43.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.306 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.97 27.24 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.535 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.06 78.59 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -129.72 129.19 43.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -66.08 140.34 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.621 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.47 114.84 21.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.965 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.51 139.89 42.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.949 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.95 136.81 57.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.39 56.63 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -81.97 170.08 16.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.6 p -113.71 165.44 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.599 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.8 p -63.54 -26.72 68.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.067 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.27 -29.15 70.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.028 0.442 . . . . 0.0 110.389 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -103.08 15.65 28.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.87 38.81 30.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -89.88 115.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -104.93 -174.85 2.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.273 0.559 . . . . 0.0 110.804 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -61.57 144.26 54.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.324 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 60.98 19.78 10.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.826 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -70.1 126.41 29.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 59.4 m -79.06 129.89 34.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.212 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.94 144.45 46.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.074 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -91.67 110.0 21.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.117 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 tp -96.27 106.68 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t -99.83 140.14 19.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.124 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.122 -179.198 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.71 113.22 25.44 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.26 0.552 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 49' ' ' ILE . 92.0 mt -66.97 -38.86 86.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.479 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -149.34 162.75 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.955 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.83 122.81 0.33 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -155.32 158.17 38.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.869 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.2 122.01 23.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.05 0.452 . . . . 0.0 110.866 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.16 139.93 17.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.12 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.12 154.17 17.68 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -90.41 172.37 8.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.136 0.493 . . . . 0.0 111.435 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 22.9 mtp -134.74 172.23 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.639 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -122.68 121.88 37.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.4 tp -104.62 116.85 32.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.312 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.45 117.82 26.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.825 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -84.76 0.35 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 p -149.81 23.41 0.87 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.719 0.295 . . . . 0.0 110.689 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.1 m -125.85 131.34 52.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.431 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.4 t -108.9 122.44 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.02 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 p -114.71 131.25 23.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.223 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.79 148.59 46.62 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.195 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.51 142.61 27.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.817 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -82.46 -8.53 59.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.718 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.9 86.52 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -53.37 137.24 35.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.94 -162.98 10.83 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.047 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 tp -140.51 122.04 15.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -94.55 109.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -131.74 153.2 50.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.062 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.6 mt -122.36 140.83 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.365 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -141.57 144.99 34.55 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 123.499 0.5 . . . . 0.0 109.7 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -109.24 127.18 54.05 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.469 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.7 p -87.47 172.59 9.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.028 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.38 -10.72 18.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.698 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.49 4.7 48.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.586 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m 63.83 25.32 14.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.485 0.659 . . . . 0.0 110.566 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -103.24 125.51 49.94 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.437 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.6 mm -82.38 123.59 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.074 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -101.23 115.3 30.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.477 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -96.68 107.96 20.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.66 142.92 51.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.41 113.58 24.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.292 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -103.85 135.82 44.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.832 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.44 136.95 38.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.873 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -78.67 -18.65 54.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -60.65 -46.46 90.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.787 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -117.0 -13.3 10.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.22 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.14 75.5 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.8 144.47 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.702 0.287 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.45 102.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.879 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -75.31 -37.15 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.876 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -126.28 144.7 50.7 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -158.81 101.05 1.62 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.509 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -128.12 140.94 51.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.753 0.311 . . . . 0.0 110.451 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.425 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 97.0 mt -82.75 122.85 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.7 mm -112.91 122.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.067 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -85.16 162.95 47.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.587 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.36 140.25 93.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.138 1.892 . . . . 0.0 111.322 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.76 11.89 2.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.256 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -85.06 -26.24 27.11 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.719 0.295 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.8 p -147.19 167.2 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.319 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.04 127.74 32.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.222 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.51 117.06 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -142.37 168.17 20.37 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.699 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -87.36 160.27 18.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.194 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.42 89.76 13.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 60.83 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.015 1.81 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -52.16 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.5 t -114.52 98.11 48.32 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.66 130.46 17.08 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.483 1.455 . . . . 0.0 111.668 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.65 -32.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.8 0.688 . . . . 0.0 110.071 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.24 -171.9 20.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.351 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.42 110.1 22.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 110.466 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.97 154.48 38.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.31 133.62 62.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.7 tp -101.68 121.58 42.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -119.14 132.46 55.99 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.392 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -83.79 115.12 22.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.22 -37.41 87.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.795 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.24 -23.15 24.83 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.476 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.48 -169.71 19.56 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -120.55 13.79 11.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.554 0.216 . . . . 0.0 110.629 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -86.11 142.81 28.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -136.04 129.3 31.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.156 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 37.9 mt -115.18 150.58 35.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.812 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -124.22 137.86 54.47 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.124 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.47 156.81 47.21 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.29 0.567 . . . . 0.0 111.123 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -129.01 137.34 51.28 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.276 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.5 mmm -72.81 141.13 48.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -0.93 24.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.68 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.76 147.03 88.77 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.583 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.25 -27.16 13.88 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.163 1.908 . . . . 0.0 112.607 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.01 146.86 47.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.3 p -92.6 4.07 54.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.811 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.12 -21.17 45.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.51 -13.88 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -61.1 -45.58 94.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.296 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.91 -43.36 93.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.258 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -63.58 -40.62 97.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.62 0.724 . . . . 0.0 109.447 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -62.69 -45.04 94.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.855 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.96 -42.37 85.3 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.533 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.65 -42.87 99.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.484 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.57 -47.65 84.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.046 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -64.05 -39.41 94.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.76 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.22 -27.53 62.59 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.175 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -85.0 -29.03 25.35 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.735 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.53 -12.38 29.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -120.12 -16.65 8.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.794 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -144.23 72.68 16.21 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.81 148.97 90.44 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.931 2.421 . . . . 0.0 111.963 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 C-N-CA 122.308 2.005 . . . . 0.0 111.984 179.85 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -133.73 151.22 76.65 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.96 152.72 36.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.574 2.183 . . . . 0.0 111.661 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -95.13 156.28 38.0 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.186 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.84 140.01 68.36 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.447 2.098 . . . . 0.0 112.144 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.98 172.61 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.37 2.047 . . . . 0.0 112.097 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -93.03 154.33 41.73 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.88 150.29 85.86 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.467 2.112 . . . . 0.0 111.908 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.01 163.85 37.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -85.91 139.81 30.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.127 0.489 . . . . 0.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -124.89 128.82 49.25 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.355 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.366 179.74 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.48 162.4 15.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.462 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.43 151.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.285 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -92.34 114.5 27.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 80.1 t -104.37 98.85 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.135 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -77.79 116.45 18.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.805 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -73.21 -178.18 2.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.322 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.56 -29.21 4.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -101.06 -177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.045 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.38 -12.67 56.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.05 134.66 57.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -118.68 133.57 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.2 110.14 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -83.82 119.01 24.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 73.5 mt -118.31 125.9 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.563 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.5 113.35 9.44 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.35 164.56 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.091 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -107.49 155.56 39.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.741 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.48 -32.76 90.51 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.027 1.818 . . . . 0.0 112.302 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.52 -1.34 57.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.186 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -62.77 138.76 58.6 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -79.15 159.42 27.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.174 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -64.12 -40.96 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -58.02 -36.32 72.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.955 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.69 -43.13 94.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.197 0.522 . . . . 0.0 110.904 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.5 t -62.37 -43.08 97.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.802 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -60.75 -38.38 84.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.16 91.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.852 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -60.07 -38.74 83.75 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.343 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 mm -63.85 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.244 0.545 . . . . 0.0 110.14 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -59.88 -48.77 80.33 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.76 -11.55 59.85 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.082 -0.386 . . . . 0.0 112.026 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -104.87 -8.03 18.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -147.27 -35.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.433 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.81 15.54 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.465 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 mt -95.78 115.05 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.69 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.35 153.77 51.49 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.6 2.2 . . . . 0.0 111.294 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.31 -40.12 87.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.649 1.566 . . . . 0.0 111.855 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.95 -41.01 97.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.827 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -88.88 -2.57 58.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -111.88 120.83 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.798 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -122.77 120.54 33.88 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.12 131.47 45.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.199 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 78.5 mt -129.72 129.01 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.656 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.77 153.46 34.34 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.61 15.37 10.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.418 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.69 -12.0 66.85 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.42 146.85 43.18 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.624 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.18 137.14 44.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.014 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.79 103.17 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.741 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -74.6 135.98 42.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -59.95 136.67 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.67 -18.29 37.96 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -89.52 174.44 7.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.2 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -115.67 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.267 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.7 -40.19 96.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.801 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.05 -25.94 68.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.29 -30.63 71.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -100.82 12.82 36.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.42 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 56.7 39.66 29.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.378 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.93 117.77 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.225 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -101.98 175.09 5.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.015 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -59.81 145.46 45.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.753 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 59.13 20.81 8.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.405 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 7.9 m -67.93 133.92 49.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -86.75 120.3 27.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.358 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.19 147.98 38.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -100.27 129.03 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.55 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.91 121.26 43.34 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.07 135.41 45.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 31.1 mt -109.32 142.52 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.64 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 179.763 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.89 156.76 16.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.107 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -136.79 150.57 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.926 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -92.51 121.85 34.37 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.999 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.49 103.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.56 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -89.5 128.66 36.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.528 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -89.24 -177.36 5.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 111.228 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.97 -37.58 87.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.252 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -70.02 -10.35 58.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.907 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.59 -10.56 66.78 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.91 130.58 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.252 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 131.38 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -121.93 108.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -81.38 129.69 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.553 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 38.2 mt -127.06 123.19 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -65.73 111.79 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.409 0.623 . . . . 0.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -135.07 164.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.165 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.27 155.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.452 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.88 -33.69 95.4 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.084 1.856 . . . . 0.0 111.89 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -82.9 -5.6 59.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -60.96 133.29 55.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 110.717 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -76.34 161.53 28.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.532 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.44 -40.34 88.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.22 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.57 -40.04 86.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -61.89 -40.36 95.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.194 0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.24 -44.27 98.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.798 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -60.35 -40.79 91.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.3 93.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.502 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -60.0 -39.97 87.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.35 -40.67 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.581 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.99 -39.62 82.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.734 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.67 8.55 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.79 -58.12 2.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.865 0.364 . . . . 0.0 110.595 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.11 0.59 25.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.651 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.37 23.78 77.67 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 20.5 mm -84.07 117.78 69.57 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.901 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.08 150.8 76.87 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.244 1.963 . . . . 0.0 112.291 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.25 -19.74 51.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.301 2.001 . . . . 0.0 112.023 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.9 3.44 41.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -124.71 -54.8 1.64 Allowed 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.84 0.352 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.66 114.13 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.286 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -112.3 124.25 52.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.48 119.68 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.69 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 84.4 mt -126.88 126.04 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.731 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -125.44 131.53 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.07 26.23 12.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.447 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.73 16.03 80.47 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.28 130.16 53.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.516 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -67.53 131.99 46.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.72 97.59 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.04 163.36 27.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.868 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -73.45 163.77 27.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.91 71.2 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -131.24 165.53 23.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.104 0.478 . . . . 0.0 110.776 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -116.74 164.34 14.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mp -59.82 -38.65 82.58 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.97 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -62.09 -29.42 70.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.911 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.3 -30.12 71.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.159 0.504 . . . . 0.0 110.066 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -99.43 11.65 38.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 54.98 40.35 31.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.308 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.5 mt -89.81 115.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -103.87 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.443 0.64 . . . . 0.0 110.887 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -60.43 146.92 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.921 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 61.25 19.83 10.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.2 m -74.84 126.98 32.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.924 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 62.1 m -77.71 131.26 37.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.465 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.63 138.78 52.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.95 110.12 20.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.865 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 63.3 tp -98.15 117.56 32.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 95.5 t -110.28 132.77 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.517 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.968 -179.336 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.16 112.15 24.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.92 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.64 161.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.984 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 122.6 0.37 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.54 158.47 38.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -75.34 121.76 22.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.056 0.455 . . . . 0.0 110.713 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.85 146.02 22.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.52 152.24 17.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -91.66 164.46 13.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.952 0.406 . . . . 0.0 111.113 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.4 mtp -132.5 175.27 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.797 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.3 m -125.56 124.09 40.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.6 tp -107.27 119.62 39.9 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.323 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.7 113.78 19.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.952 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -87.78 0.57 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -145.1 21.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.566 0.222 . . . . 0.0 110.723 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.2 m -123.03 130.53 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.337 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.94 123.15 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.872 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.48 128.03 26.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.62 146.71 39.24 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.765 1.643 . . . . 0.0 112.552 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.55 134.56 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.11 -6.96 46.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -73.14 78.21 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -52.79 134.18 36.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.329 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.54 -165.9 11.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.068 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 tp -134.55 125.91 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.78 109.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -134.04 154.21 51.3 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.328 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 137.96 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.584 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.96 131.18 36.89 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.648 0.593 . . . . 0.0 110.399 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -100.87 124.97 47.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.22 0.534 . . . . 0.0 109.998 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 p -84.46 172.23 11.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.696 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.77 -10.0 24.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.653 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.75 7.49 41.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.482 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 m 63.42 24.41 14.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.434 0.635 . . . . 0.0 110.651 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.98 121.97 42.17 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.5 mm -81.14 121.23 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -97.59 113.69 25.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.999 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -93.1 108.35 19.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.3 m -120.86 145.83 47.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.747 0.784 . . . . 0.0 112.89 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -127.6 115.22 18.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.154 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -106.63 145.98 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.38 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -84.18 130.73 34.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -70.79 -17.51 62.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -59.21 -45.45 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.543 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.5 m -117.07 -11.54 10.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.44 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.15 21.47 79.2 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -102.56 148.33 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.1 t -76.27 106.01 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.13 -29.87 31.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.109 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -127.74 145.11 51.01 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.308 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -159.18 100.04 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.764 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' C' ' 47' ' ' GLY . 39.9 mt -128.27 133.59 48.8 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.65 119.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.126 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.3 mm -110.88 120.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.03 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -82.45 163.21 53.27 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.727 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 141.61 94.8 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.162 1.908 . . . . 0.0 111.728 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.95 12.28 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -85.1 -25.14 27.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.555 0.217 . . . . 0.0 110.875 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.7 p -149.26 167.17 26.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.529 0.68 . . . . 0.0 110.695 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.89 130.67 34.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.353 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.07 119.12 38.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.55 167.12 22.84 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.74 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -82.09 160.44 23.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.107 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.04 89.81 12.44 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 59.99 7.64 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.837 1.691 . . . . 0.0 112.246 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -114.65 -36.5 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.129 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 17.2 p -130.44 75.45 79.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.643 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 130.2 34.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.887 1.725 . . . . 0.0 111.558 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t 168.97 -43.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.919 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.05 -147.74 5.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.6 107.24 14.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 110.535 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.19 129.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 111.088 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.49 156.08 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.55 136.81 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 tp -103.31 122.36 44.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -118.76 130.9 56.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.073 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.28 115.81 21.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.289 0.566 . . . . 0.0 109.714 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.44 -37.54 87.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.579 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 -22.0 23.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.643 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.55 -171.84 19.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.4 m -117.8 12.67 13.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.622 0.248 . . . . 0.0 110.682 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -83.92 141.59 31.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.932 0.396 . . . . 0.0 110.787 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.19 125.97 25.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.0 mt -113.53 151.15 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.002 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.85 137.27 54.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.352 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.67 155.0 51.11 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.298 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -129.97 136.43 49.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.723 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 tpp -70.3 131.19 43.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.76 -4.86 17.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.022 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.15 149.13 94.66 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.559 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.43 -27.14 16.27 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.036 1.824 . . . . 0.0 112.922 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.03 142.72 49.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 110.266 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -98.22 13.95 29.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.57 -20.93 59.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -125.62 11.95 7.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.17 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -63.24 -46.57 86.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.698 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -71.84 -34.37 69.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.357 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.08 -46.21 82.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.407 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -63.23 -41.06 99.05 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.606 0.717 . . . . 0.0 109.727 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.99 -45.32 94.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.609 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -64.85 -43.77 91.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.214 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.15 -36.74 84.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.2 -48.26 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.092 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.7 -29.82 40.83 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.952 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -68.61 -36.58 78.86 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.316 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -81.3 -32.82 32.96 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.554 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.6 mt -80.32 -25.25 39.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.284 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -110.12 -20.37 12.71 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.641 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.36 69.13 39.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.487 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.98 159.99 50.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 123.038 2.492 . . . . 0.0 112.382 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -72.27 153.54 92.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.618 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.79 147.22 68.56 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.609 2.206 . . . . 0.0 112.179 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.96 157.5 87.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.0 139.23 84.53 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.551 2.167 . . . . 0.0 111.939 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.88 -172.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.043 1.828 . . . . 0.0 112.059 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -122.46 158.36 56.38 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.433 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.85 141.53 95.9 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.19 162.25 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.636 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -86.91 139.41 30.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.32 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -123.99 124.31 42.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.112 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.773 179.701 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.75 161.6 9.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.955 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 pt -139.73 146.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.092 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.57 124.85 33.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.79 116.02 51.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.84 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -94.92 118.31 31.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.138 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.29 173.08 10.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.251 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.49 -29.03 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.662 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -101.93 -179.1 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.119 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 -17.66 55.43 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -57.2 130.63 47.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.698 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 76.4 m -128.23 135.97 50.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.937 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.24 121.06 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -88.94 127.6 35.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.65 135.28 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.594 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -73.82 118.04 16.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.678 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.49 167.03 26.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.432 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.72 151.23 42.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.87 -35.87 94.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.818 1.679 . . . . 0.0 112.176 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -87.7 -0.99 57.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.115 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -62.81 137.92 58.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.725 0.298 . . . . 0.0 110.878 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -78.87 163.22 25.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.347 0.594 . . . . 0.0 111.342 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -62.75 -37.1 78.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.762 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.35 -41.25 84.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.157 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -64.33 -41.07 96.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 110.594 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.16 -47.36 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.9 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.02 -32.49 72.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.87 98.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.423 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.25 -38.72 84.35 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.42 -39.15 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -57.3 -43.97 83.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.23 -44.73 95.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.27 -78.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.745 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -89.1 149.14 23.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.911 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.72 56.09 4.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 mt -106.96 121.87 43.44 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.083 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.24 157.84 52.96 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.477 1.451 . . . . 0.0 111.19 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.8 -38.22 94.71 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.793 1.662 . . . . 0.0 112.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -61.59 -43.37 98.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -85.75 -5.95 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -87.27 74.91 9.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.151 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -88.58 97.51 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 25.7 mt -87.46 132.71 33.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.142 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.21 129.87 63.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.759 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -150.17 150.9 32.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.29 15.1 9.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.297 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.41 -13.6 64.85 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.9 143.27 43.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.181 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.06 132.3 43.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.684 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.08 98.45 2.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.79 140.43 43.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.523 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -58.81 140.04 55.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.335 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.12 -17.39 54.19 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -82.88 178.11 8.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.842 0.353 . . . . 0.0 110.427 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 58.9 p -125.66 161.56 26.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.948 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.27 -41.4 96.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.648 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -64.2 -22.74 67.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.803 0.335 . . . . 0.0 110.397 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -62.85 -36.8 84.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.398 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -98.16 13.94 29.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.196 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.86 39.81 23.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.181 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.56 117.35 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.962 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -104.43 178.36 4.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.17 143.95 47.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.127 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 60.78 21.08 11.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -70.05 127.84 34.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 81.4 m -78.81 128.34 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -113.18 151.22 31.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.59 116.76 33.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.444 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.32 114.34 26.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.259 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 96.0 t -108.78 127.21 65.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.73 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 26.4 mt -88.9 146.65 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.671 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.79 162.86 8.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.93 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.97 151.25 23.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -91.36 123.25 34.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 79.2 t -109.38 105.89 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.384 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -91.83 127.19 37.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.37 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -87.6 179.17 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.424 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.3 -36.22 81.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.817 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -68.79 -12.68 61.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.071 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.16 66.0 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.75 133.52 51.2 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -104.34 131.95 51.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.211 0.529 . . . . 0.0 110.507 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -121.02 113.44 39.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.625 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 14.0 m -83.98 124.7 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.118 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.05 128.73 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.309 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.15 116.98 12.08 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 110.585 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.4 m -135.39 166.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.012 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.06 153.29 47.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 -29.0 85.75 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.641 1.56 . . . . 0.0 111.912 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 60.3 m -87.47 -9.74 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.705 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -64.32 142.37 58.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 45.7 p -82.19 166.12 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.04 -36.58 76.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.773 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.04 90.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.989 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.36 -41.23 98.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.679 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 67.4 t -63.79 -43.35 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.838 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.536 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.54 90.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.286 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -60.39 -39.49 87.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 mm -64.83 -40.8 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.235 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.447 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.03 -40.81 98.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -76.8 -71.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.88 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.45 152.98 19.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 55.97 4.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . 0.435 HD12 HG21 ' D' ' 36' ' ' ILE . 32.7 mm -107.23 109.85 63.02 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.88 153.31 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.084 1.856 . . . . 0.0 111.51 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.85 -37.91 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.849 1.7 . . . . 0.0 112.233 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.15 -39.38 89.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -12.5 40.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -78.99 86.04 4.89 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.875 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -97.44 115.27 27.44 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.71 118.1 36.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.2 mt -125.09 127.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.474 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -119.1 127.24 53.19 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.46 26.35 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.15 2.71 90.6 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -112.86 121.84 45.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.013 0.407 . . . . 0.0 110.335 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -60.25 142.98 53.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.041 0.448 . . . . 0.0 110.388 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.09 123.85 27.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.063 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.92 138.67 50.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.69 129.96 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.093 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.91 -14.64 61.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.41 174.15 10.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -117.95 160.87 20.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.61 -39.87 92.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -63.88 -23.9 67.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.308 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -62.13 -37.6 85.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.295 0.569 . . . . 0.0 110.202 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -98.11 13.95 29.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.374 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 55.93 40.09 30.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.273 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -85.47 105.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.68 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -88.99 -172.82 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.434 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.55 149.58 49.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.316 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 57.5 42.39 24.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -89.87 121.43 31.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.965 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 67.3 m -71.33 127.57 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.98 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.41 139.53 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.173 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -88.22 105.35 17.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 67.3 tp -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 98.4 t -108.83 133.46 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.115 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.427 -178.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.4 pttp . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.895 0.378 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -94.88 128.77 41.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 109.897 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 49' ' ' ILE . 85.7 mt -69.78 -36.31 75.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.61 160.92 7.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.504 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -174.2 122.21 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.41 159.85 40.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.139 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.37 117.8 19.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.554 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.99 142.17 22.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.26 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.39 154.15 17.56 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -93.61 176.32 6.41 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.773 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.7 mtp -139.84 172.88 12.15 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.13 124.76 44.64 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.38 117.08 33.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.015 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -120.42 116.64 25.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.598 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 -85.76 0.36 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.56 22.04 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.576 0.227 . . . . 0.0 110.714 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.6 m -122.97 130.13 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.888 0.375 . . . . 0.0 110.559 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.4 122.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.667 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 p -112.55 120.85 40.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.37 141.34 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.029 1.819 . . . . 0.0 112.348 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -98.08 116.27 29.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.46 -15.05 14.94 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.142 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -74.57 73.63 1.97 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.541 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -54.15 140.94 30.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.754 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.26 -156.49 7.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.002 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.4 tp -135.22 125.66 26.67 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.95 109.14 23.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.314 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.23 154.55 49.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.273 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.0 mt -120.79 139.07 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.562 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.03 128.19 27.88 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.764 0.665 . . . . 0.0 110.485 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -98.63 124.93 43.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.072 0.463 . . . . 0.0 109.936 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 p -85.33 172.46 11.07 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.56 -10.17 24.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.766 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.18 7.92 40.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.296 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.7 m 62.3 25.95 15.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.261 0.553 . . . . 0.0 110.623 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -100.21 120.79 40.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.1 mm -81.46 120.25 32.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -96.58 113.89 25.49 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.531 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -97.43 107.09 19.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 143.32 50.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.889 0.852 . . . . 0.0 112.861 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -119.44 117.39 28.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.51 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -106.69 144.02 33.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.375 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -81.81 130.26 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -72.59 -17.59 61.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.05 0.452 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -59.21 -45.41 91.17 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -117.16 -12.42 10.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.307 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.94 23.58 77.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -102.07 152.31 21.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.81 101.97 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.215 0.531 . . . . 0.0 110.451 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.41 -38.1 65.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.125 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -126.4 145.52 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.285 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -158.26 98.18 1.55 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.143 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.5 mt -125.34 136.62 53.65 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 111.085 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.84 118.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 mm -109.15 120.41 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.196 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -82.59 163.24 52.81 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.598 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.02 141.08 96.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.498 2.132 . . . . 0.0 111.745 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t0 59.86 11.81 2.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.419 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.12 -29.38 28.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.727 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 p -148.03 168.7 21.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.411 0.624 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.17 130.94 36.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.354 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -100.96 118.83 37.75 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.92 168.03 20.71 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.645 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -83.24 157.68 22.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.45 88.88 9.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.56 60.17 7.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.831 1.687 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -114.28 -36.55 4.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.283 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -130.25 81.93 67.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.71 130.36 27.69 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.762 1.641 . . . . 0.0 111.817 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.0 -38.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.819 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.05 -153.25 6.08 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.14 106.59 15.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.1 t -125.8 129.57 72.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.02 154.43 39.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.434 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.83 136.75 59.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.943 0.402 . . . . 0.0 110.44 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.1 tp -102.98 121.37 42.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -118.51 132.24 56.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.048 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -82.96 115.21 21.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.302 0.572 . . . . 0.0 109.515 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.97 -37.64 87.94 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.36 -22.85 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.465 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.94 -171.74 20.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.9 m -119.52 13.95 12.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.566 0.222 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -86.55 141.14 29.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.004 0.431 . . . . 0.0 111.085 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -133.77 129.02 36.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.082 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.59 147.57 40.6 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.786 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -119.84 135.88 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.564 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.82 155.13 50.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -130.57 137.5 49.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.342 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.2 mmm -73.59 138.83 45.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.32 6.29 32.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.728 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.9 141.07 58.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.06 -26.3 26.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.945 1.763 . . . . 0.0 112.459 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.51 142.62 48.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.33 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.3 p -95.08 9.02 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.495 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.2 -20.36 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.21 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -126.38 -9.67 6.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.839 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.98 -40.64 98.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 110.719 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -69.93 -35.89 74.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.58 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.12 -42.99 88.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -63.96 -38.67 91.94 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.997 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.95 -46.03 92.36 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.031 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.46 -43.92 95.96 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.23 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.78 -38.23 87.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.1 t -58.38 -48.29 85.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.232 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.49 -28.84 41.46 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.934 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.38 -38.1 81.05 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.604 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.2 -32.42 33.52 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.02 -26.12 43.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -110.36 -21.03 12.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.82 67.7 42.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.371 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.11 158.42 56.56 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.984 2.456 . . . . 0.0 112.29 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.217 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.22 148.66 95.88 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.533 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.25 147.29 25.9 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.713 2.275 . . . . 0.0 112.089 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.91 155.87 90.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.74 151.11 69.12 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.059 1.839 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.74 -172.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.134 1.889 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -122.38 155.82 61.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.0 141.36 88.89 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.083 1.855 . . . . 0.0 112.073 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.82 163.45 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.739 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -86.58 138.73 31.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.379 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.78 127.64 46.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.073 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.635 179.71 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.85 163.84 11.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.519 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.66 143.45 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -87.46 122.07 30.72 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.754 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.2 t -106.63 113.3 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.963 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -97.55 120.86 38.69 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.771 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 76.9 p -82.06 171.23 14.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 55.9 mt -64.85 -25.08 67.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.907 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -74.23 -9.27 58.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.86 -10.05 70.47 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -73.19 133.21 43.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 95.7 m -107.3 132.19 53.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.568 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.79 111.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.655 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -83.32 127.9 34.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.5 mt -120.41 132.43 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.21 117.52 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.72 163.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.714 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -103.93 152.04 38.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.86 -35.7 94.3 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.973 1.782 . . . . 0.0 112.148 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.28 -3.11 58.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -61.86 137.57 58.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.961 0.41 . . . . 0.0 110.704 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -78.29 162.87 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.53 -38.11 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.864 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.36 -42.11 90.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.032 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.06 -40.74 96.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.196 0.522 . . . . 0.0 110.519 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.31 -42.72 97.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.659 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.73 -40.09 91.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.5 90.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.254 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.89 -38.78 83.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 95.0 mt -66.74 -38.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.434 0.635 . . . . 0.0 110.359 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.39 -46.67 88.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.221 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.62 -31.24 68.13 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.481 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -89.8 -4.33 57.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -147.95 -41.64 0.17 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.45 11.77 28.37 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.309 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.79 121.09 84.39 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.42 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.42 154.54 63.42 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.496 1.464 . . . . 0.0 111.495 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.18 -31.19 94.9 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.937 1.758 . . . . 0.0 112.771 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.99 -40.22 94.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.905 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.32 -7.48 57.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.956 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -87.04 105.98 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.155 0.502 . . . . 0.0 111.536 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -116.51 99.11 6.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.175 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 75.6 mt -86.4 131.18 34.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.25 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 85.5 mt -131.36 127.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.695 0.283 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -149.17 150.87 33.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.127 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.82 16.41 9.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.46 -14.36 59.82 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.44 144.34 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.965 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.25 135.08 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.006 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 52.9 mt -71.64 105.44 3.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.781 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -75.22 139.03 42.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.41 138.55 57.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.41 55.84 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -82.04 172.55 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.4 p -118.26 161.69 19.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.579 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.69 -40.46 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.983 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -63.85 -23.46 67.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.3 -37.6 86.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.134 0.492 . . . . 0.0 110.184 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.39 13.19 28.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.201 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.77 40.26 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.78 114.63 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.942 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -100.2 -179.6 4.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.845 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.75 146.19 53.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 59.24 17.45 5.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -70.6 132.62 45.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -82.81 128.6 34.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.96 140.24 49.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.852 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.01 117.44 28.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.954 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -100.43 121.42 41.51 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.009 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -111.98 132.57 60.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.066 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.9 mt -109.36 145.66 35.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.093 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -68.74 142.12 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.623 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.88 -39.55 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 53.85 42.25 31.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.28 179.29 46.61 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.66 -179.26 47.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 p30 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.73 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.76 163.51 13.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.299 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 pt -143.94 145.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.535 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -92.88 121.53 34.33 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.672 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -104.73 104.63 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.42 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -87.54 126.7 35.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.846 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 79.2 p -77.52 -171.86 2.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.09 -19.88 48.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.673 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 22.2 p -111.15 -176.37 2.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.95 -18.45 57.21 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.76 131.04 38.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.082 0.468 . . . . 0.0 110.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -125.08 136.91 54.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.499 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.39 104.99 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.837 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -83.26 129.07 34.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 77.0 mt -124.51 131.97 53.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.564 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -76.63 116.56 17.42 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.343 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.15 161.7 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.65 152.71 40.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.02 -29.62 83.59 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.614 1.543 . . . . 0.0 111.791 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.7 p -80.97 -12.6 59.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.839 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.03 144.72 57.09 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.909 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -85.71 165.35 17.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.21 0.528 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.79 -38.1 80.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.454 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.04 88.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.692 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.63 -41.07 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 110.345 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.4 -42.3 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.972 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -61.1 -40.55 94.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 110.202 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.87 89.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.905 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.75 -38.26 81.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.407 HG22 HD13 ' D' ' 30' ' ' ILE . 85.6 mt -64.24 -39.92 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' D' ' 35' ' ' GLY . 65.9 tt0 -60.35 -44.78 95.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.25 0.548 . . . . 0.0 110.134 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.48 -41.06 98.59 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.622 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -83.52 -14.53 52.08 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -136.36 -50.04 0.68 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 113.37 9.5 17.32 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 59.6 mt -78.08 125.69 84.82 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.59 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.99 159.95 50.87 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 120.917 1.078 . . . . 0.0 109.88 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.49 -40.41 78.82 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.165 1.91 . . . . 0.0 112.864 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.79 -44.37 96.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.65 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.65 -40.16 80.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.893 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -85.57 140.71 30.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.206 0.527 . . . . 0.0 111.383 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -130.25 118.96 22.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -96.22 118.14 32.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.134 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -124.22 127.52 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -123.67 128.59 49.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.259 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.81 26.75 12.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.502 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.48 13.2 83.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -121.72 127.44 50.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.23 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -62.43 135.37 57.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 0.0 110.476 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.57 103.87 10.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.154 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.66 143.99 49.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.401 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -67.49 167.07 13.48 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.424 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 18.37 79.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -128.87 148.83 50.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -90.9 165.31 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.79 -38.39 90.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.394 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -62.54 -25.55 68.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.243 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -36.55 81.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.095 0.474 . . . . 0.0 110.156 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.32 14.42 24.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 56.42 39.27 30.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.19 104.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.01 -175.03 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.344 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -67.53 150.16 49.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.101 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 58.06 30.09 18.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.813 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 31.1 m -81.2 128.01 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 30.8 m -85.76 122.47 29.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.7 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.17 145.82 36.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.45 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -89.91 115.85 27.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -100.85 118.54 37.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.498 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -116.02 130.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.872 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 48.8 mt -103.91 139.78 38.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.674 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -69.85 -174.55 0.77 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.3 120.13 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.12 0.486 . . . . 0.0 110.649 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -80.45 149.79 29.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.618 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.79 49.88 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.398 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.363 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -84.14 149.93 25.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.105 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.68 112.05 23.86 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.5 mt -65.97 -38.69 89.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.621 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.84 163.48 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.668 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.7 122.18 0.34 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.187 0.518 . . . . 0.0 110.855 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.07 156.61 37.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.378 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.29 125.04 26.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.081 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.13 143.26 15.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.549 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.68 163.11 12.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -96.57 171.9 8.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.239 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.0 mtp -136.95 174.94 10.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -124.33 128.85 49.73 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.3 tp -108.15 116.89 32.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.179 0.514 . . . . 0.0 110.193 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.65 111.34 18.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.397 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.22 0.37 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -142.41 20.34 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.856 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.3 m -120.25 129.27 53.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.769 0.319 . . . . 0.0 110.485 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.95 122.29 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.032 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.6 p -114.47 131.37 23.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.38 147.57 52.99 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.744 1.629 . . . . 0.0 112.996 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -100.78 133.92 44.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -70.73 -12.46 61.57 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.008 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -76.34 68.97 2.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -58.88 134.41 56.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.9 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.11 -150.57 7.15 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.223 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 tp -137.51 126.64 24.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.8 t -97.65 112.7 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.07 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -134.52 155.0 51.16 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.3 mt -118.61 136.62 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.698 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.75 129.61 32.83 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 123.495 0.497 . . . . 0.0 110.463 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -99.24 125.34 44.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 110.301 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 p -86.23 170.12 12.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.423 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -61.95 -10.56 9.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.296 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.77 0.83 56.13 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.472 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.76 19.93 7.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.255 0.55 . . . . 0.0 110.48 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -98.49 123.34 42.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.6 mm -80.85 123.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -99.38 114.76 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.978 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -93.16 107.69 19.44 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.4 m -120.65 148.22 44.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.717 0.77 . . . . 0.0 113.036 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -127.83 115.24 18.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.175 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.52 131.74 53.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.932 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -72.11 134.37 45.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.63 -17.42 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.942 0.401 . . . . 0.0 110.428 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -60.03 -45.65 92.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.694 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.0 p -116.37 -16.77 10.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.131 0.491 . . . . 0.0 109.871 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.67 22.15 75.57 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -100.46 152.26 20.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.08 104.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.851 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -82.13 -29.78 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.354 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -126.71 146.29 50.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.408 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -157.56 101.26 1.83 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.856 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' C' ' 47' ' ' GLY . 13.8 mt -130.95 128.88 41.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.427 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.23 124.83 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.0 122.23 67.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -88.44 162.92 38.17 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.586 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.87 138.54 86.29 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.202 1.934 . . . . 0.0 111.831 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.05 6.2 1.68 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.754 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -71.68 -37.64 70.72 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.683 0.277 . . . . 0.0 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.7 p -146.81 167.08 24.77 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.732 0.777 . . . . 0.0 111.019 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -128.52 128.94 45.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.324 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -99.04 118.53 36.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -143.64 165.55 27.3 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.913 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -79.53 160.29 26.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.62 90.36 12.45 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.109 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.59 59.75 7.54 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.812 1.675 . . . . 0.0 112.381 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.0 -39.76 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.321 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 p -127.82 75.45 78.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.478 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.04 130.01 30.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.981 1.788 . . . . 0.0 111.474 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.43 -44.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.662 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.38 -148.32 6.53 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.1 106.37 13.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.97 127.82 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -123.73 155.09 38.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.692 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.75 138.37 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.089 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.8 tp -104.78 121.24 43.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -117.79 121.64 41.33 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.172 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -80.68 112.3 17.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.52 -36.21 77.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.695 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.1 -17.71 14.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.397 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.89 -13.9 68.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.576 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 53.2 31.46 11.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.09 0.445 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -120.75 145.73 47.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.249 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -127.06 127.93 45.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.089 0.471 . . . . 0.0 111.532 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.9 mt -119.32 149.14 42.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.62 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.61 134.96 53.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.558 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.23 155.43 50.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.38 0.61 . . . . 0.0 111.322 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -129.01 136.23 50.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.183 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.5 mtp -81.29 138.4 35.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.227 0.537 . . . . 0.0 111.51 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.91 5.3 49.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.669 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.95 130.96 89.45 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.183 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.6 -24.83 41.29 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.692 1.595 . . . . 0.0 112.686 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.4 143.24 48.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.4 p -95.68 11.45 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.02 -20.62 58.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -122.81 9.28 9.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.067 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -62.85 -45.69 91.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.41 -32.82 73.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.415 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.48 -46.69 81.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.41 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -64.54 -40.81 96.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 109.626 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.1 t -63.1 -44.27 96.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.262 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -69.8 -41.33 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.241 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.54 -42.71 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.378 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.6 t -57.77 -48.26 84.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.917 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.824 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.12 -20.68 63.17 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.549 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -94.41 -18.2 21.77 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.746 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.3 mt -95.62 -24.64 16.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.096 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -118.72 -12.25 9.71 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.271 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.15 64.71 55.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.122 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.23 152.67 75.78 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.492 1.394 0 C-N-CA 122.245 1.963 . . . . 0.0 111.872 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -129.13 148.6 69.73 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.635 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.46 146.71 27.89 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.606 2.204 . . . . 0.0 112.194 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -73.41 153.03 90.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.45 154.0 65.34 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.938 1.759 . . . . 0.0 112.139 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.65 -170.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.336 2.024 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -126.43 159.02 65.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.197 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.41 139.9 87.79 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.457 2.105 . . . . 0.0 112.331 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.41 163.6 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.604 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -86.44 134.3 33.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -118.72 131.39 56.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.98 132.82 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -76.38 85.07 3.13 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.091 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.754 179.767 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -63.95 158.92 21.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.237 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.34 148.82 24.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.114 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -91.37 120.99 32.7 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.285 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.63 110.22 29.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -98.27 121.29 40.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.638 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -82.2 173.83 11.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 74.3 mt -61.65 -30.35 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.23 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -71.25 -12.15 61.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.13 -13.98 62.87 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.43 131.86 49.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 110.364 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 95.3 m -108.93 131.03 55.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.392 . . . . 0.0 110.374 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.03 114.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.474 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 29.1 m -81.32 129.98 34.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.347 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.61 127.32 48.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -71.3 115.26 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.37 163.49 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.634 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.34 152.86 40.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.98 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.35 -37.23 94.8 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.119 1.879 . . . . 0.0 112.229 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -83.84 -4.92 59.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.063 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -59.72 136.97 58.16 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.953 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -77.58 161.75 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.91 -38.99 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.236 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.13 -42.02 89.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.27 -41.04 98.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.145 0.498 . . . . 0.0 110.619 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.19 -43.45 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.77 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.63 -39.97 90.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.237 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.55 -39.68 88.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -66.28 -39.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.308 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.57 -40.99 93.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.32 -39.6 92.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.151 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -74.86 -64.39 1.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.712 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.17 170.93 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.219 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.26 21.12 26.31 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . 0.42 HG22 HD12 ' C' ' 36' ' ' ILE . 27.3 mm -77.03 117.49 65.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.851 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.77 156.27 57.26 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.299 1.999 . . . . 0.0 111.797 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.07 -39.3 70.6 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.071 1.847 . . . . 0.0 112.526 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.13 -39.59 93.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.681 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.39 -3.51 56.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.114 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -87.42 68.04 9.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.61 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -85.53 110.72 19.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 25.9 mt -98.78 132.58 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.64 129.62 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 110.525 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.66 151.65 40.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.984 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.88 15.56 6.11 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.34 -14.25 63.0 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.2 140.71 39.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.56 133.88 44.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.22 102.2 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.891 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -75.3 140.12 42.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.83 137.94 57.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.216 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.47 -17.78 52.58 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmp_? -83.49 177.7 8.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.337 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -125.24 163.21 23.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.109 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.54 -40.93 96.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.552 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.83 -24.41 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.78 -37.93 86.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.2 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.72 13.88 26.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.509 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.79 39.34 27.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.41 . . . . 0.0 110.264 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.54 118.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.069 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -106.87 -179.18 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.686 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -61.97 146.14 50.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.935 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.6 15.63 9.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.618 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.8 m -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -82.54 129.77 34.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.064 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -114.89 144.31 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.127 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -95.83 118.14 31.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.231 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.82 123.32 40.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.49 126.95 72.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.947 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 mt -98.45 -174.25 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.405 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -129.16 153.06 48.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.332 . . . . 0.0 110.527 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -109.1 142.96 39.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -100.63 125.71 47.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.55 -170.18 54.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -171.97 53.49 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.632 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -63.21 154.83 30.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.078 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -133.9 160.72 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.321 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -101.59 125.71 48.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.615 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 78.5 t -111.56 107.15 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.898 0.38 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -85.2 129.23 34.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -90.18 176.6 6.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 110.961 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.65 -37.37 81.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -74.68 -8.22 55.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.75 67.37 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -63.29 126.59 27.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.059 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 92.3 m -96.21 136.88 36.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 0.0 110.611 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -122.3 118.18 54.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.278 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.41 125.14 31.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.061 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 90.5 mt -123.26 113.11 18.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.94 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -65.78 106.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.242 0.544 . . . . 0.0 110.853 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.61 163.2 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.639 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -105.76 155.09 38.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.58 -37.24 97.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.174 1.916 . . . . 0.0 111.981 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -83.42 -5.22 59.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.976 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -59.15 138.06 57.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.995 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -79.65 161.35 25.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.944 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -64.02 -38.37 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.755 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.77 -41.59 86.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.817 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.17 -41.4 98.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 110.714 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.19 -42.73 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.52 -39.8 89.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.406 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.63 92.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.511 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -59.82 -40.06 87.14 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.62 -39.62 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.338 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.17 -42.42 90.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.678 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -90.69 19.73 5.21 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -122.52 -39.56 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -126.11 -6.99 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.315 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 18.87 76.6 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 70.8 mt -77.05 120.56 82.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 147.84 92.36 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.341 2.027 . . . . 0.0 111.727 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 -41.76 62.97 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.943 1.762 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.11 -32.02 72.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.9 -10.24 58.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.466 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -88.88 112.97 23.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.601 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -115.74 101.42 8.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 mt -94.66 118.48 31.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.2 mt -125.99 123.08 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.116 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -113.42 122.83 48.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.15 30.11 19.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.473 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.46 89.99 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -103.41 119.11 38.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -64.11 138.64 58.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 mt -90.5 105.34 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.33 153.32 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.728 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -72.37 161.21 31.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.063 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.89 84.69 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.01 176.98 4.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.707 0.289 . . . . 0.0 110.45 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -126.16 164.42 20.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.24 -39.79 94.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.743 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -63.27 -29.52 70.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 0.0 110.923 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.78 -32.17 72.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.46 14.19 30.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.215 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 55.83 39.93 30.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.817 0.341 . . . . 0.0 110.542 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.35 105.01 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.817 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.26 -177.04 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.436 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -61.08 148.76 39.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.085 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 56.96 47.7 17.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -104.62 124.45 49.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.318 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 94.4 m -74.66 130.73 40.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -121.25 145.68 47.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -91.16 111.19 22.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.923 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 tp -98.28 118.03 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -115.84 135.61 55.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.071 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 mt -101.77 150.42 23.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.528 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -111.1 140.05 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.249 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mp -98.05 142.32 29.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -107.87 107.14 17.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.31 -132.67 52.67 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.67 157.99 33.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.083 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -97.05 126.18 42.02 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.332 0.587 . . . . 0.0 109.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' ILE . 86.3 mt -68.24 -38.58 81.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.092 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.64 161.45 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.88 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.7 122.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.23 158.98 41.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.071 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.75 121.21 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.945 0.402 . . . . 0.0 111.004 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.77 145.0 22.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.27 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.86 153.15 17.28 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -88.2 173.95 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.977 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.5 mtp -136.93 175.47 9.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.9 m -124.23 124.56 42.71 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.8 tp -106.35 116.94 32.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.47 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -120.02 110.53 16.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.795 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -90.46 0.47 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 p -140.18 23.09 2.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.608 0.242 . . . . 0.0 110.745 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.0 m -125.06 129.82 51.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.655 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.99 122.72 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.139 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.3 m -118.74 129.08 25.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.05 146.48 64.75 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.692 1.594 . . . . 0.0 113.183 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.93 136.32 39.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.791 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -71.16 -8.73 55.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.639 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.87 77.32 0.89 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -58.08 134.23 56.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.96 -160.79 9.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.679 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tp -137.41 123.98 20.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -95.48 109.91 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.249 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -131.32 154.98 47.98 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.191 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -120.45 140.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.454 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.77 128.17 26.39 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.827 0.705 . . . . 0.0 110.35 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -99.5 124.4 44.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 p -84.63 172.14 11.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.551 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.65 -10.56 27.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.93 1.54 55.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.561 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t 70.24 21.05 6.01 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.309 0.576 . . . . 0.0 110.432 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.5 mt -98.76 121.56 40.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.1 mm -80.22 121.23 33.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.461 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -97.65 114.25 26.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.614 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -97.59 107.05 19.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.06 50.29 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.782 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -117.82 116.06 26.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.571 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -105.55 144.95 31.6 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.416 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.41 130.89 35.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.15 -18.69 62.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 110.755 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.1 m -59.41 -45.49 91.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.608 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.4 m -117.06 -11.85 10.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.972 0.415 . . . . 0.0 110.496 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 22.77 78.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.37 149.94 23.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.669 0.271 . . . . 0.0 110.448 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.58 102.19 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.07 -38.76 66.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.836 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -126.37 146.17 50.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.069 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -157.9 100.8 1.76 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.168 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.0 mt -126.86 135.93 51.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.976 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.2 mt -77.96 120.51 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.225 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 mm -110.5 121.48 63.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.236 0.541 . . . . 0.0 111.153 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -85.08 163.04 47.38 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.799 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.53 140.21 92.61 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.105 1.87 . . . . 0.0 111.567 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t0 60.08 11.86 2.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.45 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -84.23 -26.26 28.82 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.863 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.76 168.69 23.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.523 0.678 . . . . 0.0 110.603 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -135.06 131.72 37.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.382 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -103.38 117.34 34.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -142.13 167.52 21.93 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.823 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -82.69 160.25 22.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.945 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -112.64 90.12 14.32 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.014 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.9 60.05 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.904 1.736 . . . . 0.0 112.347 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.52 -39.72 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.514 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.3 t -127.44 85.99 59.6 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.647 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.39 130.62 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.679 1.586 . . . . 0.0 111.671 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 169.29 -40.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.13 -157.9 7.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -104.52 109.23 21.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.21 129.02 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -126.54 153.24 45.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.36 135.34 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.2 tp -103.61 119.92 39.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -116.29 131.13 57.03 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.302 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -84.47 114.37 21.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.038 0.447 . . . . 0.0 109.988 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.41 -36.49 82.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.46 -24.01 66.37 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.294 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -137.82 -148.98 5.46 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.7 p -121.08 7.2 10.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.637 0.256 . . . . 0.0 111.014 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.19 134.87 56.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -136.48 135.64 38.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.971 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 mt -119.55 145.01 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.517 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -116.36 131.66 56.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.724 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.6 154.84 51.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.237 0.542 . . . . 0.0 110.915 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -128.63 137.08 51.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.306 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.9 tpp -73.88 140.2 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.527 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.73 1.73 19.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -73.39 141.07 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.587 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -28.98 22.64 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.886 1.724 . . . . 0.0 112.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -119.1 143.63 47.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.477 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.2 p -97.73 6.01 48.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.021 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -58.2 -21.61 48.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -124.19 -14.18 7.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.046 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.32 -41.24 98.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.646 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.51 -40.35 96.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.75 -41.91 97.92 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.495 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -63.35 -40.61 97.77 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.49 0.662 . . . . 0.0 109.263 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.19 -46.8 88.97 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -65.5 -36.96 85.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.314 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -33.46 67.54 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.275 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.63 -46.71 95.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.146 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.51 -31.96 53.83 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -71.04 -30.56 66.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.349 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -83.75 -29.73 27.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.91 0.386 . . . . 0.0 110.304 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.9 mt -87.75 -23.68 24.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.913 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -108.91 -24.42 11.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.52 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -135.73 67.79 65.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.37 160.27 49.18 Favored 'Trans proline' 0 C--N 1.297 -2.137 0 C-N-CA 122.849 2.366 . . . . 0.0 112.242 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.187 . . . . 0.0 112.228 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.35 151.11 77.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.46 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.19 147.8 26.56 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.181 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.78 152.82 89.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.011 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.67 152.15 64.4 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.392 2.061 . . . . 0.0 112.221 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.85 -174.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.421 2.08 . . . . 0.0 111.964 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -122.44 157.64 58.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.205 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.19 139.49 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 122.457 2.105 . . . . 0.0 111.709 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 165.15 37.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -86.08 138.41 31.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.41 133.28 62.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -76.98 85.28 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.331 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.579 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -62.1 157.65 18.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.358 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -139.41 148.15 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.933 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.79 124.21 40.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.777 0.322 . . . . 0.0 110.986 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 99.4 t -108.18 114.57 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.646 -0.421 . . . . 0.0 109.99 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -97.31 119.86 36.61 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.342 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.6 p -79.56 171.83 14.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.51 -24.85 67.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.171 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -75.57 -10.5 59.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.051 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.56 -14.48 64.16 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.62 133.09 49.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 110.34 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -107.56 132.19 53.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.389 . . . . 0.0 110.759 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.1 112.67 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.466 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.01 132.99 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -130.96 122.24 26.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -66.81 115.17 6.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.1 163.45 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.589 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -107.3 152.7 41.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.634 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -37.16 87.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.922 1.748 . . . . 0.0 112.089 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -80.43 -9.57 59.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -58.51 136.0 57.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -77.61 158.97 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.134 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -66.43 -40.98 87.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -59.13 -42.7 91.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.36 -43.97 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.303 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.16 -44.01 97.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -38.63 79.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.061 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.04 94.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.532 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -61.68 -37.48 84.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.139 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.25 -39.2 84.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -59.02 -39.97 83.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.366 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -86.95 7.29 28.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -107.8 -47.62 3.56 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -116.54 -0.76 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.591 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 19.64 79.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 16.8 mm -81.43 119.96 76.96 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.133 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.26 149.3 65.24 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.065 1.843 . . . . 0.0 111.861 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -33.42 77.03 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.429 2.086 . . . . 0.0 112.65 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.05 7.68 39.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.395 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -108.33 -31.12 7.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.753 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -99.22 131.53 45.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.498 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -122.95 115.35 21.77 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.8 129.62 34.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.18 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt -131.87 129.16 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.326 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -145.96 150.08 35.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.019 0.438 . . . . 0.0 111.456 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.92 20.12 11.25 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.022 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 84.32 -8.72 66.65 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -107.9 137.22 46.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.972 0.415 . . . . 0.0 111.237 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -74.19 132.99 42.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.838 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 45.1 mt -74.95 98.66 3.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.53 141.23 43.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.819 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.68 142.86 52.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.99 -18.06 57.31 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -87.99 171.19 10.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.883 0.373 . . . . 0.0 110.476 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.8 p -115.46 163.52 15.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.131 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.41 -40.96 96.32 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.802 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 94.7 p -63.79 -22.64 67.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.448 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.78 -37.82 85.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.95 0.405 . . . . 0.0 110.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -98.37 15.47 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.245 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 58.98 41.8 20.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.586 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -88.39 109.99 20.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -95.51 178.37 5.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.453 0.644 . . . . 0.0 111.171 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -61.23 148.3 41.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.746 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 59.25 17.11 5.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.398 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -65.92 138.13 57.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 39.2 m -98.31 122.1 41.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mp -116.57 148.22 41.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.554 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -92.19 133.19 36.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tt -108.26 115.86 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.048 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.5 131.5 47.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.054 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 39.4 mt -106.1 132.92 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.536 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.0 145.21 46.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.24 148.87 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.551 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -62.46 -39.44 93.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.44 171.74 43.27 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.34 -40.29 98.42 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.2 p30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.719 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -63.06 160.69 14.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.162 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -138.41 156.42 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.258 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -96.29 125.37 40.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.709 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.45 107.35 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.913 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 122.78 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.093 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -82.3 172.1 13.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.22 -26.02 68.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.179 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -86.6 -1.34 57.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.828 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 -8.72 77.83 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -68.3 118.34 11.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.896 0.379 . . . . 0.0 110.107 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 74.6 m -90.99 137.38 32.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mt -122.48 119.0 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.116 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -86.47 117.8 25.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.702 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.89 123.39 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.94 113.06 7.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.05 160.52 42.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.276 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.45 152.98 40.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.926 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.1 -36.86 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 111.661 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -80.06 -9.7 59.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.303 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -57.93 138.43 55.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 47.0 p -81.03 163.11 23.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.174 0.511 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.54 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.207 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.18 -39.4 86.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.875 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.03 -43.48 99.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.698 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -61.34 -39.38 90.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.053 0.454 . . . . 0.0 109.994 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.38 89.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.125 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -59.92 -38.91 83.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 80.1 mt -64.89 -39.87 87.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.824 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.71 -44.57 96.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.057 0.456 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.83 -13.25 59.95 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.911 -0.493 . . . . 0.0 112.065 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -105.92 -4.01 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -148.48 -37.19 0.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 110.459 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.01 11.8 36.08 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 41.4 mt -82.38 121.02 78.1 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.898 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 155.07 42.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.038 1.825 . . . . 0.0 111.745 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.11 -25.27 73.06 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.626 2.217 . . . . 0.0 112.528 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -95.01 7.02 47.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -118.35 9.77 12.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.894 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -142.05 154.45 44.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -134.22 129.62 35.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.747 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -99.9 115.29 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.054 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 88.5 mt -121.47 117.07 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.326 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -64.71 -47.07 79.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.051 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -176.74 78.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.827 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.91 89.95 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -129.67 125.82 36.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.816 0.341 . . . . 0.0 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -82.71 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.476 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.36 106.24 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.65 143.81 48.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.037 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.06 156.96 20.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.2 16.58 69.02 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.91 165.8 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 110.49 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -113.15 165.49 12.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.26 -39.88 92.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.476 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.8 -26.41 68.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.53 -37.95 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.128 0.49 . . . . 0.0 110.186 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -95.03 13.62 24.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.056 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.16 40.81 27.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 87.0 mt -92.33 114.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -100.43 -169.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.395 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -68.86 151.54 46.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 56.72 37.57 28.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.625 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -86.87 123.58 32.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -80.15 124.3 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.55 132.78 54.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.149 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.71 123.79 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.918 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 65.9 tp -103.97 111.54 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.665 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.36 132.61 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.168 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 58.4 mt -104.67 136.4 44.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 111.022 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.05 146.61 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.578 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.23 14.59 21.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 120.53 9.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.928 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.71 15.56 79.39 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.528 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -66.91 151.74 47.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.425 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -99.62 126.98 45.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.391 0.615 . . . . 0.0 110.225 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 49' ' ' ILE . 85.6 mt -68.49 -37.34 80.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.072 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -147.31 161.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.756 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.53 122.68 0.36 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.183 0.515 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -153.72 158.32 40.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.084 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.77 120.92 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.619 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.51 145.32 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.112 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.42 152.48 17.83 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.46 171.4 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 28.6 mtp -132.63 174.47 10.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.0 m -122.7 123.22 40.61 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.9 tp -105.02 116.94 32.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.19 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -120.81 112.25 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.94 -92.45 0.46 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 p -138.35 23.28 2.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.678 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -125.32 131.73 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.3 t -111.01 123.73 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.204 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.4 p -119.02 135.12 23.66 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.141 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.5 150.38 57.57 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.98 1.787 . . . . 0.0 113.356 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -105.49 140.07 39.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.156 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -76.35 -7.08 54.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -72.76 75.13 1.13 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -55.48 127.96 32.12 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.78 -159.12 9.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tp -139.17 124.46 19.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.1 t -96.53 109.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.346 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -131.57 154.25 49.03 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.018 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.2 mt -118.42 139.14 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.712 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 128.53 30.76 Favored 'General case' 0 C--O 1.22 -0.478 0 O-C-N 123.89 0.744 . . . . 0.0 110.35 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -99.42 125.3 45.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.977 0.417 . . . . 0.0 109.956 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 p -85.56 170.39 12.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.384 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -62.79 -10.62 13.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.166 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.5 2.62 54.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.475 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t 69.63 20.62 6.94 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.208 0.528 . . . . 0.0 110.401 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.9 mt -97.32 121.97 39.82 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.1 mm -81.88 120.06 32.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -96.9 111.53 23.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.114 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -90.58 108.24 19.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.2 m -121.02 145.98 47.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.648 . . . . 0.0 112.627 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -124.39 112.84 17.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.435 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -104.86 135.23 46.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.028 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -74.79 136.69 41.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.874 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -78.9 -17.77 54.98 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.537 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -60.84 -46.64 89.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -117.02 -13.02 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.95 24.94 75.01 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -102.01 144.48 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 0.0 110.673 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.16 105.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.27 -28.11 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.008 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -127.69 144.05 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.196 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -159.49 95.9 1.25 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.87 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -123.13 138.01 54.77 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.821 0.343 . . . . 0.0 110.727 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.402 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 86.1 mt -83.21 116.8 27.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mp -105.52 116.65 49.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.957 0.408 . . . . 0.0 111.139 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -79.69 164.17 54.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.988 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.08 139.68 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.95 1.767 . . . . 0.0 111.041 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.59 11.82 3.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -85.91 -42.2 14.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.481 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.85 148.17 52.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.0 111.364 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -122.02 129.56 52.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.663 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -101.78 118.46 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -144.06 167.94 21.18 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.767 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -94.68 146.25 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.288 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.39 99.58 21.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.221 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.81 60.09 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.741 1.627 . . . . 0.0 112.223 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -114.35 -36.34 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.246 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 p -121.94 74.35 37.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.711 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.02 130.27 26.92 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.103 1.869 . . . . 0.0 111.745 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.98 -43.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.905 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.93 -139.61 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.47 106.38 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.3 127.31 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.82 156.21 35.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 p -131.7 137.52 54.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.3 tp -105.69 119.92 40.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -119.61 139.18 52.59 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.991 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -88.78 115.81 26.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.62 -37.19 83.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.526 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.98 -22.86 24.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.176 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.51 -169.28 21.9 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.1 m -124.0 17.96 9.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -89.64 138.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.27 0.557 . . . . 0.0 111.087 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.49 109.25 10.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.7 mt -96.0 150.4 20.51 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -123.94 136.48 54.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.258 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.06 155.7 49.33 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.316 0.579 . . . . 0.0 111.118 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -128.32 137.45 51.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.838 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.1 tpp -75.82 123.95 26.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.242 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -16.81 34.72 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.7 127.29 88.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.28 -20.05 43.33 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.94 1.76 . . . . 0.0 112.724 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.54 140.4 47.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.132 0.491 . . . . 0.0 110.317 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.9 p -99.12 10.88 40.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.09 -26.42 49.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.379 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -126.03 -0.69 7.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.805 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.73 -48.56 80.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.77 -40.91 97.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -64.07 -42.67 96.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.807 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -64.79 -39.65 93.94 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.511 0.672 . . . . 0.0 109.213 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.82 -45.72 92.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.558 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -64.37 -43.47 94.43 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.212 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.25 -38.1 87.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.89 -48.08 87.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.164 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -80.61 -32.51 36.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.04 -38.18 87.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.571 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -80.62 -37.78 30.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.005 0.431 . . . . 0.0 110.258 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 77.0 mt -71.53 -34.41 70.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.115 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -100.89 -24.13 14.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.677 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -139.99 69.04 35.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.746 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.83 160.49 49.23 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.916 2.411 . . . . 0.0 112.28 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.649 2.233 . . . . 0.0 112.248 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.67 81.99 68.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.724 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 138.88 83.81 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.808 2.339 . . . . 0.0 112.249 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.04 159.26 71.17 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.84 146.65 77.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.41 -173.96 1.29 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.541 2.161 . . . . 0.0 112.189 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -100.33 153.35 37.8 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.389 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.83 152.04 73.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.491 2.127 . . . . 0.0 112.084 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.43 168.74 25.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.35 132.14 34.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.82 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -113.37 136.04 53.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.079 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.44 129.93 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.585 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.24 85.89 0.26 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.338 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.054 -0.975 . . . . 0.0 110.49 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -62.45 160.34 13.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -139.31 149.97 22.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.614 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -91.86 119.82 31.99 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.263 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 69.4 t -104.36 108.64 25.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.07 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -92.75 122.31 35.03 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.889 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.0 p -81.56 171.5 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.593 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 mt -65.54 -21.34 66.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.047 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.25 -5.88 58.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.343 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.49 74.68 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -74.16 128.8 36.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.844 0.322 . . . . 0.0 110.236 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.48 132.16 47.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.07 111.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.438 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -81.44 126.99 32.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.71 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -120.03 129.82 54.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.66 116.58 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -136.13 165.63 28.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.706 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -110.32 154.14 43.06 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.42 -30.61 91.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.72 1.613 . . . . 0.0 111.965 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.3 m -88.86 -6.5 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.27 144.21 57.31 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.812 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.91 163.86 23.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.04 -38.56 82.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.786 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -58.96 -40.89 86.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.41 -46.37 90.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.566 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -60.71 -42.66 92.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.04 -37.04 78.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.33 95.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -39.31 82.81 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.228 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.15 -39.36 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.445 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.12 -43.05 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.43 19.31 6.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.47 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -123.72 -42.88 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.374 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -116.84 -18.95 10.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.575 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.26 10.81 65.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.515 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 52.0 mt -75.04 128.03 85.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.161 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.77 154.23 63.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.502 1.468 . . . . 0.0 111.02 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.64 -23.42 65.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.2 1.933 . . . . 0.0 111.968 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.85 -1.69 52.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.013 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -123.31 -31.49 3.55 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.52 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -78.8 132.84 37.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.318 0.58 . . . . 0.0 111.449 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -130.43 126.74 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.397 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 77.3 mt -103.39 124.71 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.961 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -129.38 129.08 67.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.293 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -144.39 149.41 36.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.899 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.6 16.72 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.396 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.26 -14.95 59.56 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -98.94 141.49 31.64 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.449 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -75.43 127.27 32.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.751 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 48.3 mt -76.09 89.49 3.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -74.97 171.37 14.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -75.81 169.0 18.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.079 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.42 19.49 77.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -124.53 167.2 14.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.687 0.279 . . . . 0.0 110.585 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -122.71 161.22 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.578 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -60.89 -40.51 93.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.8 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.62 -23.0 67.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.561 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.2 -38.06 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.017 0.437 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -97.18 13.2 30.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.151 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 59.05 41.08 21.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.257 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.35 118.4 33.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.912 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -107.07 178.38 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.002 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -59.53 146.59 40.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.807 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 61.49 18.6 9.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 27.5 t -71.6 131.09 42.71 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 93.6 m -83.91 127.89 34.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -116.5 144.1 44.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.201 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -92.33 123.64 35.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.056 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tt -102.8 115.25 30.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.127 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -108.96 132.82 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.095 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 33.3 mt -105.84 135.35 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -70.8 148.64 47.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.67 152.05 40.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.6 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.64 -39.11 90.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.321 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.1 141.01 42.61 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.07 89.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.343 179.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.29 158.19 12.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.771 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -138.42 151.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.859 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -92.69 122.92 35.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.711 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.68 109.95 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.694 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -94.52 122.3 36.95 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.088 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 77.0 p -82.19 -179.08 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.321 0.581 . . . . 0.0 111.632 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.58 -37.06 82.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.825 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.14 -8.99 57.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.262 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.92 -9.12 70.6 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.81 128.0 34.13 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -102.05 130.54 48.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.118 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -124.37 113.86 38.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.743 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 10.6 m -80.03 125.78 30.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.757 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.25 118.25 30.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.281 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.19 110.29 2.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.299 0.571 . . . . 0.0 110.715 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.81 160.82 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -103.58 155.02 37.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.997 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 -38.37 95.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.124 1.883 . . . . 0.0 111.996 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.7 p -80.0 -8.78 59.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.026 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -58.7 135.74 57.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.979 0.418 . . . . 0.0 110.89 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.14 163.45 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 50.0 mm -64.23 -37.92 81.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.98 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.66 -43.81 89.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.99 -42.3 98.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 110.754 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.9 -42.38 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.923 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -60.64 -39.56 88.74 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.109 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.03 88.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -59.71 -38.98 83.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 87.3 mt -64.77 -40.58 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.931 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.69 -47.0 87.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.28 -15.94 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -103.57 -4.84 23.36 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.59 -37.65 0.2 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.78 10.42 32.82 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.82 127.45 82.01 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.17 155.98 42.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.168 1.245 . . . . 0.0 110.728 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.78 -36.69 83.23 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.063 1.842 . . . . 0.0 112.468 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.14 -39.01 88.43 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.311 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -96.65 23.26 7.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -118.29 112.32 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 111.712 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -118.64 110.61 17.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.7 117.12 31.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.1 mt -121.82 126.58 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -127.68 130.14 48.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.7 29.13 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 17.16 79.69 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -132.66 127.91 35.89 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.573 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -66.54 148.07 52.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.06 0.457 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 77.2 mt -90.21 115.36 27.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.882 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -70.01 136.7 50.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -61.31 136.94 58.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.198 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.62 55.72 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -82.25 172.58 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -118.27 163.21 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.89 -39.48 89.42 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.402 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.2 p -63.81 -24.35 67.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.3 . . . . 0.0 110.414 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.95 -37.75 85.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.327 0.584 . . . . 0.0 110.044 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -98.14 14.53 27.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.282 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 m120 56.83 39.94 29.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.829 0.347 . . . . 0.0 110.278 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -90.14 113.75 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.856 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -99.33 -172.25 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.531 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -68.79 150.75 47.49 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.273 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 56.85 41.77 27.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -98.5 127.45 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.559 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 90.3 m -78.22 127.53 32.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.57 138.4 52.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.921 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -89.07 113.96 25.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.46 120.53 39.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -112.97 132.75 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.252 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 mt -105.0 128.94 53.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.455 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.74 141.2 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 110.947 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 33.0 mt -103.64 16.04 27.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.612 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -58.61 -45.05 90.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.881 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.18 9.67 22.68 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.617 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -84.05 146.65 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -86.15 112.41 21.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.4 mt -68.32 -37.02 80.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.606 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.65 161.7 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.26 122.24 0.29 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 0.0 110.834 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.04 160.07 40.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.696 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -78.66 124.05 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.046 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.75 146.03 20.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.86 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.47 152.12 17.19 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -95.52 161.9 13.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.875 0.369 . . . . 0.0 111.13 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mtm -134.81 170.27 16.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -121.09 135.92 55.08 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.403 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.6 tp -110.97 119.36 38.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.947 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -120.75 112.38 18.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.85 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -106.54 1.81 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.6 p -124.06 20.86 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.292 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.0 m -124.61 130.32 52.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 110.798 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.71 121.28 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -108.77 131.55 21.71 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.95 145.4 45.08 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.062 1.842 . . . . 0.0 113.35 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.12 120.74 42.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -65.23 -11.32 39.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -72.31 78.84 1.0 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -58.83 140.13 55.55 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.98 -157.3 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.815 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -135.31 127.93 30.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.37 111.77 32.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.546 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -136.09 156.29 48.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.231 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.7 mt -122.24 137.7 54.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.873 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -135.06 130.56 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.632 0.583 . . . . 0.0 110.112 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -100.7 124.15 45.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.107 0.48 . . . . 0.0 110.085 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -85.34 171.59 11.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.49 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.02 -10.34 21.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.116 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.93 1.09 55.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.282 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t 69.12 21.74 7.14 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.312 0.577 . . . . 0.0 110.252 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.6 mt -98.28 122.72 41.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.1 mm -81.99 122.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -98.17 112.67 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.851 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -92.15 109.29 20.65 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 77.9 m -121.74 145.96 47.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -128.3 117.86 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.53 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -108.68 143.81 37.28 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.348 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -80.98 129.21 34.42 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -71.34 -16.64 62.44 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 m -59.4 -45.35 91.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.429 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.1 m -117.22 -13.27 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 110.182 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.79 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -101.72 152.04 21.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.04 103.86 6.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -77.97 -32.93 51.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -126.68 146.1 50.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.538 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -157.68 98.73 1.67 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.052 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 mt -127.64 133.85 49.65 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.501 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -79.09 123.92 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.23 129.5 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 111.103 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -94.14 162.51 26.33 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.436 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.76 140.67 91.56 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.172 1.915 . . . . 0.0 111.658 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 60.71 12.26 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -88.4 -35.24 17.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.977 0.418 . . . . 0.0 110.401 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.51 148.36 49.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.179 0.514 . . . . 0.0 111.561 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -122.61 127.68 49.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.455 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -100.57 120.63 40.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -145.37 167.13 23.63 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.792 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -92.14 159.27 15.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.889 0.376 . . . . 0.0 110.217 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 t -120.95 89.83 46.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.382 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.31 60.45 7.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.81 1.674 . . . . 0.0 112.169 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.69 -34.3 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.172 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.5 t -124.91 86.78 56.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.54 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.48 129.91 19.94 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.771 1.647 . . . . 0.0 111.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.98 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.33 -176.77 33.8 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 110.36 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.42 126.53 72.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -121.95 152.82 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.233 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.04 135.79 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.212 0.529 . . . . 0.0 109.904 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.5 tp -104.76 118.22 36.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -115.29 132.47 56.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 111.29 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -86.65 115.56 24.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.58 -37.14 82.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.318 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -108.68 -23.36 11.83 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.362 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.86 -33.7 87.94 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.76 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p 74.05 27.89 1.54 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.621 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -139.45 162.11 35.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.491 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.69 149.42 45.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.464 . . . . 0.0 111.2 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.24 150.82 46.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.304 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.3 135.92 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.501 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -137.34 156.38 48.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.191 0.519 . . . . 0.0 111.223 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -133.75 137.17 45.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.826 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttm -74.67 131.73 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.946 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.47 4.31 26.04 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.709 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -71.86 148.73 92.37 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.424 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.89 -27.6 14.29 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.099 1.866 . . . . 0.0 112.967 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -119.51 142.18 48.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.31 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.8 p -98.31 8.46 44.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.491 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.58 -22.47 13.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.351 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -123.73 8.11 8.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.579 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -61.16 -49.1 78.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.47 -40.5 95.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.209 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.77 -43.31 99.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.614 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -64.18 -40.13 95.46 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.92 94.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.792 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -65.65 -43.34 89.75 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.245 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.46 -39.33 93.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.887 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.14 -47.78 89.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.233 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.33 -27.88 38.25 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.82 -38.71 80.06 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.55 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -81.18 -33.23 33.16 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.64 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.5 mt -77.96 -28.63 49.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -104.83 -26.87 12.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.319 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.7 72.84 73.09 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.313 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.77 149.14 84.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.799 2.333 . . . . 0.0 111.573 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 122.175 1.916 . . . . 0.0 112.182 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 -72.08 154.35 92.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.449 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.16 153.88 66.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.829 2.352 . . . . 0.0 112.638 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.37 155.05 94.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.725 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.83 157.32 62.34 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.176 1.917 . . . . 0.0 112.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.74 176.94 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.224 . . . . 0.0 111.622 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.05 157.62 42.99 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.856 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 145.27 99.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.225 1.95 . . . . 0.0 111.788 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -158.07 169.3 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.09 137.86 32.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.185 0.517 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.9 121.49 38.18 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.471 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 63.4 mt -130.49 125.61 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -75.46 83.76 2.54 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.053 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.608 179.67 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -62.08 156.09 22.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.019 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.97 148.83 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.27 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -90.21 123.86 34.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.443 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.55 114.73 47.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.195 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -103.02 123.07 45.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.644 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.3 p -84.1 172.5 11.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.069 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 73.4 mt -64.35 -25.47 68.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -74.28 -8.89 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.22 6.11 66.91 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.25 127.95 34.27 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.788 0.327 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -104.54 131.76 51.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.916 0.389 . . . . 0.0 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 117.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.295 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -83.72 130.14 34.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.447 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.24 122.95 39.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.775 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -66.13 110.77 3.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.744 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 22.4 m -134.23 163.44 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.447 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -106.09 154.35 39.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.98 -35.37 94.33 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.033 1.822 . . . . 0.0 112.17 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -84.78 -3.83 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.01 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -60.15 136.55 58.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 110.775 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.44 162.19 26.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.54 -38.32 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.12 -43.27 91.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.243 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.43 -41.63 98.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 110.909 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.7 -42.69 96.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.742 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -60.41 -39.32 86.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -40.26 93.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.379 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.22 -39.68 87.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.54 -39.8 84.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.211 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -59.49 -39.63 84.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 0.0 110.284 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.07 -44.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.701 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.82 -39.7 72.89 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -132.94 152.03 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.67 2.22 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.39 94.91 46.46 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.36 149.62 80.08 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.73 2.287 . . . . 0.0 112.232 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -52.62 -40.06 74.08 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.962 1.774 . . . . 0.0 112.387 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.57 -39.54 94.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.03 31.86 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -136.04 120.42 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.842 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -128.67 115.0 17.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.53 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 27.0 mt -92.89 132.31 37.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.151 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -129.46 128.61 66.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -144.27 151.39 39.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.869 0.366 . . . . 0.0 110.999 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 15.81 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.469 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.64 63.21 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.72 141.45 39.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.05 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -72.3 132.98 44.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.06 100.29 5.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.681 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.61 144.64 41.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.258 0.552 . . . . 0.0 110.765 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.0 141.01 57.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.338 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.19 54.56 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -84.26 178.53 7.75 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.333 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -126.54 165.59 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.71 -40.42 97.12 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.668 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.6 -26.67 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.99 -36.94 82.99 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 110.245 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -97.69 13.8 29.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.162 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.33 43.56 28.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.443 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.74 103.8 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.148 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.4 -179.39 5.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -63.28 148.98 46.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.007 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 59.51 44.33 14.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -102.83 127.93 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -77.58 127.76 33.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.29 145.69 42.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -98.19 123.16 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.374 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -100.27 126.0 46.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 93.9 t -108.75 131.03 60.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.444 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 33.1 mt -112.17 147.72 35.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.719 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.04 133.14 52.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.817 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -113.77 145.72 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.608 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -123.21 139.57 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.596 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.99 -173.65 54.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 19.03 79.91 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.522 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -65.67 159.08 25.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.39 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.9 141.4 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.219 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.26 123.88 30.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.884 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -110.11 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.818 0.342 . . . . 0.0 110.505 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -92.9 122.28 35.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.807 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -82.86 179.13 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.74 -35.85 81.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.27 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 42.8 p -67.42 -11.41 57.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.727 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.1 -9.94 67.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.4 129.6 40.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.9 m -101.52 132.18 47.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 110.807 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -127.11 105.79 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.611 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -81.88 127.11 32.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.04 127.73 50.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.698 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.19 114.6 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.07 171.92 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.236 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.5 155.24 56.75 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.087 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.9 -39.41 84.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.128 1.886 . . . . 0.0 112.313 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -24.33 63.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.17 136.97 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.49 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -85.49 165.89 16.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.329 0.585 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.38 -37.66 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.846 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.76 -42.15 88.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.856 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.11 -41.11 97.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.96 -42.97 98.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.878 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.59 -40.41 91.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.162 0.506 . . . . 0.0 110.485 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.31 -38.67 80.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.5 -38.37 82.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.849 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -59.11 -38.99 80.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.23 -59.43 3.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.802 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -63.55 -41.49 98.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.03 142.52 50.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.095 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.97 60.28 3.04 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mt -115.26 122.01 33.93 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.231 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 159.29 49.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.476 1.451 . . . . 0.0 111.649 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.3 -37.32 70.8 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.149 1.899 . . . . 0.0 112.563 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.69 -39.88 93.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.555 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.39 -11.33 54.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.367 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -86.6 83.19 7.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.008 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -98.28 98.93 10.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 73.5 mt -86.81 122.64 30.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.443 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.26 126.79 71.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.006 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -128.61 130.26 47.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.0 28.35 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.95 79.01 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -131.01 129.53 42.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.5 139.16 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.96 118.68 23.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.11 137.32 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.315 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -66.73 147.54 53.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.179 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.58 -13.68 63.39 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -88.44 149.12 23.85 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -87.66 165.58 15.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.064 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.72 -36.13 81.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.722 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -62.01 -27.02 68.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.727 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.22 -37.55 85.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.125 0.488 . . . . 0.0 110.285 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -95.74 11.81 32.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 55.26 41.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.14 103.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -90.03 -176.8 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -63.32 152.16 38.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 55.5 40.1 31.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.4 t -90.31 120.44 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.444 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -75.42 127.09 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.163 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.76 145.97 45.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.271 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 67.9 m170 -92.97 117.76 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.098 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.84 99.46 10.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.371 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.78 135.57 26.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.382 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 50.0 mt -111.82 161.71 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.442 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -76.33 -173.43 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.42 -13.4 58.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.639 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 11.6 mmm-85 -41.27 120.15 1.34 Allowed 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.148 0.499 . . . . 0.0 110.388 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.38 7.9 34.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 179.33 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.1 m120 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -82.41 152.15 26.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.461 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -91.42 111.94 23.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.75 -37.79 87.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.597 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.62 162.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.363 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.16 122.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.0 111.127 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.68 158.28 36.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.919 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.53 121.3 22.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.411 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.13 140.9 20.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.026 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.65 151.98 17.14 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -88.6 170.93 10.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 0.0 111.248 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 mtp -135.65 174.21 10.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.757 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -124.71 121.62 35.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.8 tp -102.91 121.78 43.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.904 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -118.83 104.1 10.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.029 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 -82.54 0.8 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -144.8 18.03 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.492 0.187 . . . . 0.0 110.95 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.2 m -119.99 128.01 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.84 122.97 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.227 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.8 m -117.12 130.11 24.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.352 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.13 148.89 70.15 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.104 1.869 . . . . 0.0 113.229 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.77 136.04 45.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.91 -7.37 50.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.19 63.61 3.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -51.26 141.18 15.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.302 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.55 -153.37 6.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.369 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 tp -137.96 125.58 22.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.43 108.48 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.6 153.44 48.89 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.231 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 98.2 mt -119.17 138.55 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.469 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 129.87 31.78 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.806 0.691 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -99.94 123.79 44.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.51 . . . . 0.0 110.387 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 p -83.62 170.23 14.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.706 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.48 -10.09 10.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.169 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.95 3.06 55.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.64 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 69.53 20.12 7.23 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.325 0.583 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -96.35 121.66 38.39 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 mm -81.22 120.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -97.49 114.49 26.37 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.347 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -99.25 107.23 19.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.798 0.809 . . . . 0.0 112.827 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -118.72 113.53 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.827 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -101.57 126.87 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -73.58 133.26 43.49 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -76.54 -18.45 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.4 m -60.47 -45.36 94.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.033 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -116.47 -16.62 10.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.973 0.416 . . . . 0.0 109.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.34 78.91 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.21 145.02 30.57 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.5 104.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 0.0 109.9 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -80.93 -33.61 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -127.13 142.99 51.38 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.865 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -158.72 95.53 1.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.31 0.381 . . . . 0.0 110.162 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.2 mt -124.7 137.25 54.36 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.079 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -79.57 118.4 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.0 mm -108.06 121.27 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.801 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -84.66 160.5 55.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.153 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.02 144.91 99.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.004 1.803 . . . . 0.0 111.555 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 60.06 12.96 3.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.14 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.84 -25.77 17.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.536 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.7 p -149.12 166.22 29.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.321 0.582 . . . . 0.0 110.575 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -136.89 133.99 36.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.101 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -104.33 118.28 36.24 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -144.77 167.86 21.58 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.532 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -87.73 160.41 18.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.438 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.8 89.15 15.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.212 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.42 60.46 7.86 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.056 1.837 . . . . 0.0 112.111 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -114.02 -37.34 4.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.1 t -126.63 80.11 70.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.609 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.14 129.76 37.03 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.082 1.855 . . . . 0.0 111.186 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.52 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.858 0.724 . . . . 0.0 110.243 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.85 177.16 32.29 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -86.07 114.33 22.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.625 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.06 129.69 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.42 151.48 40.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.875 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.95 134.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.009 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.5 tp -100.45 120.07 39.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -115.96 131.97 56.79 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.28 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -82.73 111.99 19.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.267 0.556 . . . . 0.0 109.798 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -37.72 84.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.483 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 -20.54 23.14 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.261 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.82 177.42 27.92 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.2 p -114.14 23.36 12.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 153.72 46.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.855 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 157.09 46.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.7 mt -118.49 156.24 29.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.873 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -124.6 136.38 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -139.17 155.7 47.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.339 0.59 . . . . 0.0 111.247 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -128.99 137.45 51.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.4 tpp -67.8 132.45 47.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -2.89 15.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.0 146.6 97.44 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.231 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.27 -28.9 12.0 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.979 1.786 . . . . 0.0 113.155 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -118.59 144.73 45.92 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.633 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 p -100.49 12.27 37.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.734 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.28 -22.22 64.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.647 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -131.31 -6.63 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.837 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.81 -42.54 99.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.82 -39.8 91.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.0 111.305 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.86 -41.41 95.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.197 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -61.34 -40.05 92.84 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.552 0.692 . . . . 0.0 109.204 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.25 -44.91 94.87 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.644 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -62.65 -42.69 99.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.058 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -65.27 -35.64 81.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.018 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.0 t -57.21 -48.02 83.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.021 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.42 -31.08 48.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.561 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.65 -27.18 64.83 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.042 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -92.52 -23.81 18.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.4 mt -95.24 -17.58 21.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -18.72 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.366 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -134.48 63.1 58.67 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.038 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.52 159.11 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.834 2.356 . . . . 0.0 112.457 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 122.664 2.243 . . . . 0.0 112.139 -179.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -92.92 153.1 41.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.21 145.82 31.18 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.565 2.177 . . . . 0.0 112.006 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -80.37 159.69 69.39 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.71 134.76 59.95 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.162 1.908 . . . . 0.0 112.165 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.35 -162.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.269 1.979 . . . . 0.0 112.009 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -128.31 155.18 78.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.679 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.59 145.35 81.74 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.486 2.124 . . . . 0.0 111.704 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -155.55 164.34 38.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.677 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.62 138.55 32.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -124.81 121.71 35.35 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 122.98 49.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -79.23 84.13 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.823 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 53.8 p30 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.773 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.79 158.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.61 150.47 20.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.118 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -98.43 127.12 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.87 116.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.675 -0.41 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -101.32 121.15 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.596 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -81.58 171.69 14.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.34 -25.65 68.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -75.11 -8.55 56.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 6.41 66.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.12 126.27 32.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -103.04 131.06 50.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.902 0.382 . . . . 0.0 110.035 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.23 113.17 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.485 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.85 134.75 35.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.766 0.317 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 68.8 mt -132.66 131.48 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.4 115.37 13.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 0.0 110.686 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -134.64 166.08 29.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.29 152.01 44.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.221 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.08 -25.51 78.18 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.953 1.769 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -91.05 -12.07 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.676 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.51 142.3 57.14 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.127 0.489 . . . . 0.0 110.928 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -80.46 166.67 21.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.972 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.03 -35.85 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.739 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -58.6 -41.64 86.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.011 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.26 -41.89 93.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.112 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.76 -48.19 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.998 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.28 -31.48 72.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.115 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.79 95.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.249 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.66 -39.77 89.56 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 93.9 mt -66.6 -39.57 84.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.326 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.39 -38.68 81.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.422 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -68.69 -47.95 65.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -64.19 -40.89 97.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.58 153.84 51.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.121 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.07 57.71 2.73 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . 0.401 HD13 HG23 ' C' ' 36' ' ' ILE . 39.1 mm -112.0 101.3 51.39 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.79 158.12 58.01 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.117 1.878 . . . . 0.0 112.219 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.15 -32.66 94.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.298 1.999 . . . . 0.0 112.349 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -66.94 -39.13 87.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.044 0.45 . . . . 0.0 109.898 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -103.67 23.37 12.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.686 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.42 116.36 18.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.809 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -127.21 124.77 39.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -102.09 127.15 49.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.194 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -125.89 126.05 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 0.0 110.222 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -148.76 147.9 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 19.73 11.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.426 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.14 -13.27 60.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 147.96 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.238 0.542 . . . . 0.0 111.34 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -97.57 111.33 23.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.558 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.29 97.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.794 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -76.98 -76.54 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.044 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -178.21 166.54 1.93 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.44 73.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -126.65 177.99 6.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -127.22 164.62 21.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.156 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.55 -39.93 92.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.412 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.32 -28.55 69.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.62 -26.58 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.99 0.424 . . . . 0.0 110.385 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -104.16 12.0 34.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.291 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.54 38.16 29.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.195 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.41 105.06 13.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.969 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.13 -175.96 5.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.347 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -68.65 148.2 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.965 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 57.84 37.96 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -89.66 133.2 34.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.839 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -91.15 120.75 32.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.145 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.59 146.21 40.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.536 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -91.26 131.31 36.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.17 119.13 38.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.299 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.4 t -104.07 131.42 52.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 26.4 mt -109.28 125.93 52.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.133 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -72.32 151.51 42.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.62 139.18 39.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -66.36 142.75 57.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.24 176.62 54.62 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.03 159.33 27.64 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 57.5 t0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.515 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -65.23 155.46 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.92 145.84 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -93.65 127.64 39.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.508 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -109.54 115.41 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.172 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -86.46 116.67 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -74.63 171.26 14.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.087 0.47 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -41.43 73.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.391 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -76.31 -6.56 52.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.41 -13.31 59.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -55.29 108.6 0.44 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -83.58 136.89 34.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.07 112.46 23.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.004 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.11 127.0 32.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.205 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -126.06 120.77 31.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.789 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -66.1 108.97 2.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.57 166.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.555 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.94 154.54 41.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.53 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.88 -36.47 95.61 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.029 1.82 . . . . 0.0 111.861 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.0 p -80.54 -7.94 59.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -58.17 135.27 57.03 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.006 0.432 . . . . 0.0 110.748 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.23 162.48 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.79 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.31 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.687 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.55 -41.6 90.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.937 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.15 -41.59 98.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.049 0.452 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.56 -43.17 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.615 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.99 -38.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.157 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.58 90.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.107 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.77 -39.41 88.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 mm -64.93 -40.96 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.524 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.42 -40.41 94.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.712 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -65.15 -44.42 88.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -74.16 -66.26 0.74 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.375 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -92.25 171.56 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.004 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -91.1 18.84 49.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mm -77.39 119.84 79.09 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.583 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.86 160.49 45.95 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.332 2.021 . . . . 0.0 111.478 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.58 -40.4 85.58 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.106 1.87 . . . . 0.0 112.993 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.08 -52.27 50.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.508 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.23 112.64 3.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.889 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -118.1 111.2 18.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.311 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 64.3 mt -90.43 120.57 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.472 . . . . 0.0 110.514 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.3 mt -124.96 127.0 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -128.24 128.46 44.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.124 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.38 28.52 9.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.21 79.69 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -128.08 128.66 45.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.0 0.429 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.62 137.96 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.499 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 mt -84.64 118.87 24.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.261 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.36 137.77 41.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -62.76 137.77 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.471 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -16.87 57.75 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -78.81 178.68 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 110.459 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 80.5 p -125.53 161.87 26.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.114 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.36 -39.95 92.52 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.106 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.03 -27.58 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.424 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.09 -37.02 81.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.189 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -98.25 15.02 25.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.084 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 54.74 40.45 31.92 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.859 0.361 . . . . 0.0 110.339 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -89.86 101.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -85.3 -175.83 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -64.09 166.67 7.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.032 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 45.72 36.49 2.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -89.61 122.86 33.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.19 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -83.46 125.48 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.135 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.81 162.75 15.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -109.99 120.73 43.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.381 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tt -99.31 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 81.6 t -103.83 132.69 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.227 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt -104.78 128.66 53.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.231 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -61.32 152.27 29.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.686 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tt -120.4 87.86 2.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.709 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 46.45 55.41 7.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.997 0.427 . . . . 0.0 110.682 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.76 -127.25 40.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.924 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.394 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.14 149.18 41.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.468 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.55 126.71 35.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.428 0.632 . . . . 0.0 110.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.05 -36.08 79.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.809 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.81 161.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.17 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -174.01 122.43 0.31 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.74 158.14 37.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.989 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.54 119.54 19.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.76 146.25 25.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.326 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.21 150.71 17.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.88 167.08 12.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 111.454 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.4 mtp -132.92 175.32 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.849 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.8 m -125.65 121.69 34.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.1 tp -104.46 118.08 35.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.393 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -122.74 113.42 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.977 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.12 -86.33 0.48 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 p -146.51 23.78 1.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.612 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.9 m -126.54 132.59 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.247 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -110.12 123.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.305 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.2 p -118.21 122.42 30.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.115 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.57 148.5 59.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.772 1.648 . . . . 0.0 113.365 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.88 133.06 44.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.845 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -7.63 48.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.33 78.58 1.85 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.11 132.66 33.34 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.634 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.05 -163.92 11.47 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.227 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tp -137.12 120.44 16.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.55 108.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.548 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -130.83 153.42 49.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.0 139.69 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.746 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.09 128.14 27.67 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 123.83 0.706 . . . . 0.0 110.847 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -99.0 125.15 44.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.416 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 p -83.51 171.47 13.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.682 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.88 -10.04 25.57 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.509 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.05 2.49 55.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.57 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 t 70.23 21.36 5.91 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 121.088 0.47 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.4 mt -99.45 120.65 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 57' ' ' ILE . 49.1 mm -79.33 122.43 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -98.56 115.44 28.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.58 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -96.09 107.98 20.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 96.9 m -121.38 146.15 47.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.728 0.775 . . . . 0.0 112.462 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -126.51 113.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.902 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -105.27 145.92 30.03 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.05 0.452 . . . . 0.0 110.572 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.13 132.19 34.71 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -71.64 -18.31 62.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.03 0.443 . . . . 0.0 110.852 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -59.55 -44.98 93.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.789 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.55 -10.36 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.66 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.68 22.85 78.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -102.46 147.16 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.8 106.41 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.67 -22.62 25.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -128.64 142.78 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.933 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -157.15 107.65 2.28 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.016 0.436 . . . . 0.0 110.193 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.86 130.72 22.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.355 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.67 124.26 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.6 119.6 60.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.602 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.38 161.03 68.99 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.332 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.89 142.12 97.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.063 1.842 . . . . 0.0 111.541 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 61.01 12.36 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.374 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -87.66 -37.39 16.79 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 120.584 0.231 . . . . 0.0 110.602 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.7 m -131.31 154.92 48.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.252 0.548 . . . . 0.0 111.745 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -126.72 128.21 46.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.113 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -100.39 117.2 34.1 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -143.64 167.34 22.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -83.56 160.53 21.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.551 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.05 89.21 13.43 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.333 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.3 60.23 7.76 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.124 1.882 . . . . 0.0 112.175 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -114.7 -40.52 3.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.409 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.3 t -128.89 79.65 74.16 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.578 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.29 130.32 39.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.301 2.001 . . . . 0.0 111.284 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.83 -36.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.17 -167.12 12.88 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.55 106.64 18.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.913 0.387 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.4 t -124.83 128.35 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.732 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -125.29 151.38 46.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.125 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.43 135.92 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.379 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.1 tp -102.07 112.71 25.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -112.2 143.1 43.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.505 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.87 116.52 28.01 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.25 -37.53 85.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.787 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.77 -22.33 18.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.397 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.03 174.97 26.98 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -111.94 21.44 15.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.661 0.267 . . . . 0.0 110.294 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.99 149.02 39.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.79 152.42 47.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 mt -120.16 154.63 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -124.46 134.74 52.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 0.0 110.287 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -138.85 155.31 48.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.106 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -129.97 137.27 50.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.7 mmm -72.23 138.0 47.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -1.19 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.292 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -74.1 132.25 79.93 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.09 -25.54 58.43 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.112 1.875 . . . . 0.0 112.585 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 139.59 50.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -94.17 0.89 56.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.056 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -54.28 -21.76 10.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -120.07 -15.65 8.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.71 -40.92 96.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.6 -42.15 98.27 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.166 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.15 -41.47 90.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -65.28 -39.84 93.09 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.01 -41.99 99.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.666 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -67.56 -40.96 84.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.243 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.64 -38.63 91.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.52 -48.14 86.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.266 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -80.54 -27.21 37.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.33 -38.25 78.08 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.47 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -82.01 -32.25 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.994 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.64 -25.16 41.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.304 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -110.83 -23.44 11.01 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.686 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -137.76 67.84 50.82 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.715 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.41 156.92 60.6 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.626 2.218 . . . . 0.0 112.569 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.127 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.69 89.3 52.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.29 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.33 139.32 73.61 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.475 2.116 . . . . 0.0 112.453 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -80.81 154.35 73.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.71 146.19 83.26 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.929 1.753 . . . . 0.0 112.278 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 163.55 36.91 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.791 2.327 . . . . 0.0 112.396 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.45 160.24 73.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.49 146.54 90.24 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.565 2.176 . . . . 0.0 111.864 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -150.29 162.71 39.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -85.96 140.12 30.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.983 0.421 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -121.91 133.46 54.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.86 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 9.1 mm -128.57 133.59 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -77.88 85.63 4.13 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.213 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.536 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.11 163.8 19.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.719 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 pt -143.65 145.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.261 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -93.59 113.05 25.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.392 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -97.27 115.63 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.628 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -100.67 127.72 46.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -82.03 175.73 10.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.76 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.61 -21.63 65.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -88.35 -4.33 58.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.75 74.9 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -59.36 120.78 9.94 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -101.93 132.2 47.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.5 107.05 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.328 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.06 120.66 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.55 130.99 54.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.606 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.9 115.94 15.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.466 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m -134.92 165.16 31.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.62 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -108.85 151.57 41.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.77 -25.31 75.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.106 1.871 . . . . 0.0 112.071 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 53.6 m -91.78 -10.27 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.527 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 143.25 57.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -80.76 164.42 22.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.609 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -63.27 -37.43 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.827 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.75 -41.59 86.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -61.49 -43.6 98.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 110.523 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.97 -42.47 96.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -60.4 -39.95 89.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.59 90.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.199 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.99 -39.32 85.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.71 -39.3 84.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.577 0.703 . . . . 0.0 110.32 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.79 -46.12 90.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -77.13 -14.64 59.76 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.665 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -102.09 -3.88 26.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -149.14 -42.48 0.14 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.224 0.535 . . . . 0.0 110.391 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.65 29.25 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.212 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 52.8 mt -72.08 128.43 89.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.777 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.65 153.27 48.89 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.828 1.685 . . . . 0.0 111.708 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.27 -38.17 61.27 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.066 1.844 . . . . 0.0 112.737 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.7 -39.77 92.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.842 0.353 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -89.44 -2.64 58.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.032 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -93.79 106.89 18.84 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.693 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 73.6 mt -79.54 133.9 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.837 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -135.04 129.39 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.345 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -151.47 151.72 32.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.843 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.36 16.54 10.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.731 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -10.63 67.19 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 145.14 40.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.312 0.577 . . . . 0.0 110.84 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -73.63 129.82 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.905 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.46 94.3 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.829 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.2 150.13 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 111.122 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -60.36 143.08 53.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.402 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.58 -19.35 48.02 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -88.14 169.1 12.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.522 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.9 p -118.17 164.5 15.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.954 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.01 -41.14 95.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.587 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -64.24 -22.72 67.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.388 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.96 -36.68 82.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.547 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -99.92 15.76 26.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.103 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 57.58 38.72 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.99 105.29 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.899 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -92.16 -178.89 5.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.409 0.623 . . . . 0.0 111.159 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.46 146.88 52.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.009 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 60.93 15.79 6.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.215 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 33.7 m -69.87 133.63 47.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -87.4 118.49 26.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.723 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.93 140.98 40.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.997 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -89.82 129.43 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -107.91 121.25 44.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.19 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.4 132.3 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.152 0.501 . . . . 0.0 110.128 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -106.16 152.14 23.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.559 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -100.86 126.08 47.44 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.454 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.86 140.04 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.719 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -71.7 134.02 46.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.162 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.66 0.87 88.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.54 -165.84 54.51 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.524 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.82 157.04 22.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.351 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.84 148.12 25.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.419 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -89.11 121.97 31.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.1 105.97 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.554 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -89.12 129.95 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 110.893 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -89.16 175.98 7.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.73 -35.44 78.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.913 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -70.46 -11.65 61.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 -12.79 63.0 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.04 127.83 33.13 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -98.82 133.62 42.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.23 111.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -82.76 125.91 31.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.86 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.52 125.97 48.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.475 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -69.3 113.87 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -135.99 170.58 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.741 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -120.1 156.39 54.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.254 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.42 -26.64 82.62 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.163 1.909 . . . . 0.0 112.069 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -83.71 -14.26 52.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.563 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.17 144.05 57.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -87.68 166.33 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.41 -39.55 85.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.066 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.52 -42.25 91.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.183 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.29 -39.85 94.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.28 -43.34 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.996 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -61.3 -40.02 92.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.2 91.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.929 0.395 . . . . 0.0 109.998 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -59.86 -38.03 80.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mm -63.92 -39.93 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.156 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.78 -45.59 93.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.289 0.566 . . . . 0.0 110.635 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.2 -33.91 76.84 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.045 -0.409 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -89.95 -6.88 55.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -146.08 -53.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.0 110.456 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.28 20.68 4.68 Favored Glycine 0 CA--C 1.517 0.205 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -95.35 114.18 63.26 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.418 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.01 153.82 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.094 1.863 . . . . 0.0 112.215 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.99 -28.85 86.9 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.648 2.232 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -91.46 -4.34 55.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -92.6 -16.87 25.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -137.88 160.55 38.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.305 0.574 . . . . 0.0 111.444 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.18 130.93 53.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.561 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.79 119.54 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.823 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -121.23 128.07 75.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.981 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -122.61 128.48 50.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.455 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.15 25.05 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.534 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.67 90.29 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -110.29 126.23 53.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -65.05 135.55 55.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.66 107.69 17.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.112 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -74.79 154.15 38.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.337 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -72.97 162.99 28.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.342 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.43 20.73 77.18 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -122.94 150.79 42.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.66 0.267 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.6 p -96.87 160.44 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.467 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.37 -39.09 92.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.412 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.2 -39.06 93.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.055 0.455 . . . . 0.0 110.361 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -94.42 13.36 24.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 56.69 42.81 26.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 69.0 mt -90.97 104.24 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.097 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.04 179.31 5.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.438 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -60.74 150.65 31.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 58.49 45.42 16.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 85.5 p -101.21 128.89 47.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.988 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -81.15 126.05 31.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.582 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.03 148.27 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.38 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.67 116.32 28.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.441 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 5.2 tt -99.54 104.71 16.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.978 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 94.1 t -100.59 128.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.253 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 81.9 mt -97.85 136.93 37.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.871 0.367 . . . . 0.0 110.755 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -79.09 154.33 29.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 57.1 mt -98.74 132.19 44.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.058 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -121.46 130.94 53.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.803 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.56 70.16 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -83.27 156.37 23.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.397 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -90.06 120.54 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.327 0.584 . . . . 0.0 110.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.05 -35.28 76.38 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.154 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.22 161.14 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.984 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.63 122.66 0.35 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.229 0.537 . . . . 0.0 110.814 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.98 158.22 38.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.878 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -76.46 120.5 21.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.538 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.78 148.01 26.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.5 150.64 17.64 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -87.72 165.44 15.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.953 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.4 mtp -134.01 175.07 9.8 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.1 m -129.8 126.73 38.79 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.355 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.4 tt -102.16 125.52 48.88 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.472 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -116.13 103.29 10.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.903 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.16 -83.14 0.74 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -144.02 20.26 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.554 0.216 . . . . 0.0 110.879 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -122.22 129.18 52.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.74 125.47 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.061 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 p -118.72 128.28 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.328 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.99 145.97 51.37 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.779 1.653 . . . . 0.0 112.603 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -108.02 138.2 44.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.878 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -72.6 -5.42 37.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.993 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.2 73.67 0.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.64 134.83 41.46 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.408 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.76 -162.64 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -136.67 126.44 25.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 108.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.979 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -133.22 153.5 51.49 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.922 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.3 mt -119.45 139.48 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.285 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.63 132.49 40.83 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 123.923 0.765 . . . . 0.0 110.147 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -102.68 122.47 44.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 p -82.89 171.58 13.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.783 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.46 -10.06 22.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.705 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.6 8.17 40.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.47 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m 62.82 23.99 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 110.762 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.8 120.32 39.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.9 mm -80.1 121.15 32.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.552 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -97.67 112.55 24.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.899 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -92.9 107.2 19.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 93.3 m -119.38 143.9 47.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.929 0.871 . . . . 0.0 112.847 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.2 t90 -126.85 113.44 16.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.109 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -103.9 144.32 31.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.631 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -82.83 130.52 35.14 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -71.36 -16.65 62.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.75 0.31 . . . . 0.0 110.755 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.54 -45.87 90.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.442 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.69 -11.77 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.54 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.73 22.45 78.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -102.57 152.0 21.68 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.57 102.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.371 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.88 -38.25 67.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.888 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.48 147.18 49.86 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.392 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -158.78 97.74 1.45 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.314 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.8 mt -124.55 136.78 54.26 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.095 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.56 119.47 30.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 mm -109.29 120.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 111.05 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -85.13 163.03 47.28 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.452 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.51 141.48 95.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.171 1.914 . . . . 0.0 111.689 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 61.14 12.42 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -87.42 -25.99 23.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.3 p -149.98 167.02 27.89 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.452 0.644 . . . . 0.0 110.569 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -137.11 132.52 34.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.189 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -103.38 118.58 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.44 167.9 21.0 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.496 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -87.8 160.37 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.176 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.67 90.82 13.35 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.152 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.21 59.82 7.18 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -115.6 -36.72 4.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.526 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.9 t -127.89 81.72 69.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.288 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.29 130.4 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.898 1.732 . . . . 0.0 111.651 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t 169.1 -44.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.83 -147.83 5.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.13 105.73 12.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.188 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.3 t -122.71 126.59 74.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -123.57 152.93 41.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.718 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.97 135.36 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.2 tp -100.87 121.84 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -116.78 124.85 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.026 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -81.4 115.1 20.58 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.01 -37.54 82.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.497 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.72 -23.66 11.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.486 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.51 -24.5 72.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.192 -0.527 . . . . 0.0 111.894 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m 66.89 6.66 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -98.36 150.17 21.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.23 136.78 48.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.835 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.1 mt -123.29 151.16 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.045 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.67 137.52 54.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.41 155.22 47.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 111.4 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -129.82 136.75 49.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.127 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.82 141.26 58.35 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.341 0.591 . . . . 0.0 111.369 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -112.99 -8.2 13.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.169 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.2 135.15 89.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.704 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.94 -23.13 35.0 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.826 1.684 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -116.44 141.1 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.341 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.0 p -97.93 17.23 18.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.261 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.4 -21.14 59.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -135.64 17.76 3.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.841 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.63 -48.9 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.199 0.523 . . . . 0.0 111.059 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.63 -33.02 70.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.322 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.22 -44.78 90.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.489 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -62.01 -41.37 98.0 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.451 0.643 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.3 -44.83 95.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.847 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.5 -42.55 91.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.388 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.01 -37.61 88.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.918 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.78 -47.77 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.272 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -80.08 -28.41 39.14 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.843 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -68.91 -37.74 79.15 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.404 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.72 -33.16 35.45 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.731 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.5 mt -79.58 -26.89 41.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -108.25 -24.01 11.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.655 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -136.88 69.19 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.797 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.37 157.78 55.87 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.854 2.369 . . . . 0.0 112.55 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.654 2.236 . . . . 0.0 112.211 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -128.95 150.59 75.64 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.634 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.96 147.02 33.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.695 2.263 . . . . 0.0 112.031 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.25 153.64 92.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.21 151.36 76.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.106 1.871 . . . . 0.0 112.253 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.09 -171.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.466 2.11 . . . . 0.0 112.096 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -120.06 155.08 55.87 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.93 141.76 95.55 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.352 2.035 . . . . 0.0 112.115 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.73 165.2 37.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.834 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.64 136.69 32.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.849 0.357 . . . . 0.0 110.41 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -120.62 121.21 37.84 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 55.5 mt -131.91 123.65 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -79.21 84.21 5.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.872 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.8 t0 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.452 179.552 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -62.26 156.13 22.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.369 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -136.78 157.02 35.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.362 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -96.19 122.59 39.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.897 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.3 t -110.43 101.85 13.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.224 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -88.34 124.09 33.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.177 0.513 . . . . 0.0 110.82 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -86.47 172.09 10.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.07 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.5 -19.08 65.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -83.95 -5.0 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.057 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.32 80.5 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.17 126.37 30.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.87 0.366 . . . . 0.0 110.218 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -97.6 131.22 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -115.84 116.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.374 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 117.12 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.428 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.65 116.41 27.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.922 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.75 105.99 1.4 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -130.45 162.71 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.497 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -105.88 155.72 37.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -37.79 93.7 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.896 1.731 . . . . 0.0 112.109 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -80.32 -7.55 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.301 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -57.21 135.54 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -79.23 163.27 25.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 40.6 mm -64.54 -38.77 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.102 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.26 -41.48 88.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.995 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.05 -41.4 98.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.799 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.35 -42.98 98.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.795 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -60.83 -40.17 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.635 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.83 92.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.104 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.62 -38.75 82.15 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . 0.405 HG23 HD12 ' C' ' 30' ' ' ILE . 97.1 mt -66.37 -39.78 84.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.752 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -59.54 -46.93 87.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.365 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.21 -16.26 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.986 -0.446 . . . . 0.0 111.897 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -101.18 -5.81 25.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -148.31 -41.96 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.1 0.476 . . . . 0.0 110.476 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.8 8.16 28.43 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.352 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.08 128.78 82.27 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.899 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 160.44 43.66 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.564 1.509 . . . . 0.0 111.683 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.79 -39.16 93.4 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.274 1.982 . . . . 0.0 112.472 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.86 -39.88 93.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.761 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -89.17 -4.43 58.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.06 90.34 7.33 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -101.6 97.18 7.64 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 22.2 mt -88.27 129.47 35.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.594 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 83.7 mt -127.92 129.09 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.766 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -151.64 152.83 33.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.75 17.15 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.93 -13.59 60.8 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.99 146.5 42.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 110.599 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.19 132.18 42.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.045 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.26 101.47 0.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.35 140.69 44.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.91 143.0 55.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.299 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.56 -16.26 61.34 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -83.44 176.19 9.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.193 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -122.27 161.95 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.817 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.8 -40.39 95.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.823 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -63.69 -23.98 67.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -62.83 -37.63 87.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 110.149 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -96.46 13.48 27.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.252 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.05 42.42 22.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 64.9 mt -90.37 109.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.301 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -98.19 -177.99 3.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.213 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.26 146.89 52.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 59.34 42.28 18.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 45.7 m -97.55 127.28 43.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.98 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 87.1 m -76.86 126.57 31.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.113 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.33 149.03 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.084 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.26 117.34 32.44 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.21 99.05 10.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.642 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -87.06 130.67 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.8 mt -110.39 141.23 43.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.162 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.71 142.43 57.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.0 131.19 38.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -62.68 -39.26 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.571 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.45 172.16 24.92 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.33 163.39 54.13 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.656 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.62 159.61 12.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.956 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.05 151.91 25.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.054 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -93.16 121.94 35.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.536 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.2 105.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -90.29 133.28 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.811 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -88.87 -174.9 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.34 -38.08 88.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.004 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -72.84 -9.04 58.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.615 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.45 -7.44 75.04 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.61 124.86 21.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -96.09 131.25 42.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mt -123.56 111.54 29.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.552 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -81.49 125.71 30.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.172 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.21 125.15 46.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.126 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.96 114.8 9.39 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.57 163.01 36.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.668 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -104.7 153.29 39.36 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.074 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.55 -36.17 97.58 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.948 1.766 . . . . 0.0 112.043 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.46 -0.65 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -62.28 136.63 58.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -76.96 161.81 28.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.26 0.552 . . . . 0.0 110.794 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.59 -38.54 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.27 -42.53 91.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.88 -41.3 97.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.64 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.4 -42.67 97.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -60.71 -39.38 88.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.133 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.26 93.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.411 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.06 -39.53 86.32 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.53 -39.66 84.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.297 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.34 -39.78 84.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.335 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.68 -50.3 52.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.711 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -66.18 -40.41 90.43 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -128.66 147.63 50.76 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.06 59.32 3.12 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . 0.412 HD13 HG22 ' D' ' 36' ' ' ILE . 31.0 mm -110.31 107.07 58.46 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.8 152.82 54.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.316 2.011 . . . . 0.0 111.747 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.61 -42.4 66.21 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.744 1.629 . . . . 0.0 112.884 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.6 -43.29 99.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -68.3 -38.55 81.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -58.05 118.03 4.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.013 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -121.21 106.31 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 19.8 mt -96.15 115.93 28.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.081 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -123.27 124.37 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.377 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -128.36 130.02 47.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.179 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.62 27.11 11.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.357 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.22 81.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -125.9 127.3 45.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.834 0.349 . . . . 0.0 110.725 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.47 137.0 55.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -78.68 122.06 25.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.083 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -76.15 136.28 39.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -65.06 130.92 45.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.5 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.67 -15.81 52.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -79.88 -176.99 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.8 p -125.66 163.47 22.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.22 -40.06 94.86 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.606 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.4 p -64.1 -27.46 69.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.13 -29.72 71.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.123 0.487 . . . . 0.0 110.178 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -101.66 12.41 37.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.403 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.48 40.41 29.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.036 0.446 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 90.0 mt -89.82 107.22 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.673 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.09 177.89 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -59.75 149.79 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 60.01 18.66 7.81 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.631 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.0 m -73.81 129.65 38.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.07 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -81.82 130.15 34.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.019 0.437 . . . . 0.0 110.58 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -120.63 140.11 52.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.127 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -86.49 113.44 22.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.72 115.49 30.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.431 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 78.1 t -114.53 139.38 40.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.74 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 37.9 mt -102.31 121.09 41.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.161 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.33 146.76 42.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 mt -69.65 139.12 53.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.263 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -118.42 127.65 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.254 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.89 -130.56 50.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.859 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.872 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -72.26 147.13 46.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.975 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -94.16 113.65 25.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.082 0.468 . . . . 0.0 109.792 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ILE . 95.7 mt -67.53 -36.94 81.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.76 162.3 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.868 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.15 122.5 0.39 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.251 0.548 . . . . 0.0 110.934 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.78 158.16 37.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.889 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.06 123.8 25.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.574 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.0 21.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.176 0.512 . . . . 0.0 110.35 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.51 16.94 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -92.11 158.4 16.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 0.0 110.78 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.33 163.32 25.99 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -115.69 129.92 56.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.741 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.5 tp -106.7 120.8 42.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.83 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -122.92 110.99 16.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.328 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.52 -93.61 0.55 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.3 p -137.45 21.27 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.604 0.24 . . . . 0.0 111.036 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.5 m -125.88 131.55 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.516 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.64 125.18 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.937 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.9 p -113.61 111.53 49.01 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.13 139.75 91.63 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.577 2.185 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -94.87 129.22 41.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -68.41 -10.17 53.42 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.864 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -72.19 82.85 1.01 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.19 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.27 133.59 52.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.193 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.8 -161.07 10.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.315 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 tp -138.77 126.98 22.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 t -100.2 110.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -133.13 155.0 50.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.26 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.4 mt -120.05 137.19 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.387 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.12 131.27 36.67 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.586 0.554 . . . . 0.0 110.231 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -100.84 125.98 47.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.044 0.45 . . . . 0.0 110.144 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.5 p -86.33 172.94 10.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.634 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.37 -10.83 27.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.657 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.34 5.65 46.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.442 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 m 63.55 24.81 14.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.0 mt -100.6 122.78 43.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.0 mm -80.9 122.28 35.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -98.36 114.9 27.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.693 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.46 108.39 20.32 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.9 m -121.44 146.92 46.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.753 0.787 . . . . 0.0 112.675 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -125.19 115.02 19.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.064 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -107.45 134.5 50.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.845 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.0 132.5 41.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.557 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -73.88 -18.55 60.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -59.94 -45.95 90.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.049 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -116.48 -16.26 10.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.102 0.477 . . . . 0.0 109.768 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.33 22.89 72.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -101.38 152.2 21.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.827 0.346 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -80.75 107.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.902 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.94 -27.5 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -127.94 144.15 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.183 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.59 99.76 1.6 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.46 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' C' ' 47' ' ' GLY . 40.5 mt -129.07 133.08 47.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.52 122.6 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.0 mm -112.39 121.31 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.366 0.603 . . . . 0.0 111.142 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -85.56 163.39 44.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.718 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.51 140.53 93.54 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.246 1.964 . . . . 0.0 111.536 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t0 60.07 12.08 3.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.344 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.48 -26.48 30.2 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.298 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.7 p -151.18 166.92 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.475 0.655 . . . . 0.0 110.677 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -133.58 132.06 40.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.259 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.4 119.45 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -143.86 168.87 18.94 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.742 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -85.7 157.06 20.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.58 89.37 7.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.319 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.18 61.03 7.64 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.965 1.776 . . . . 0.0 112.274 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.82 -39.22 4.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.398 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 p -129.69 73.61 81.38 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.45 130.06 36.75 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.213 1.942 . . . . 0.0 111.297 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.02 -45.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.146 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.88 -156.34 8.71 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.15 105.37 15.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.786 0.327 . . . . 0.0 110.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.63 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.08 152.22 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.405 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.86 134.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.281 0.562 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.3 tp -102.47 117.61 35.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -114.23 122.84 48.0 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.417 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -78.46 114.1 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.571 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.95 -37.95 84.15 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.14 -23.03 12.71 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.376 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.42 -20.29 78.19 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.133 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 m 59.75 34.33 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.945 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 162.02 36.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.484 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -134.9 143.31 46.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.911 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 mt -119.81 147.09 45.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.51 132.04 56.75 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.271 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.11 157.43 46.34 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.256 0.551 . . . . 0.0 110.938 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -134.25 141.64 47.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.387 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.0 mmm -74.68 139.09 43.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.062 0.458 . . . . 0.0 110.976 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.81 10.67 10.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.011 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.2 145.07 90.55 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.488 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.47 -39.1 79.08 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.994 1.796 . . . . 0.0 112.577 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -118.89 146.31 45.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.909 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.5 p -97.86 6.94 47.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.722 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -54.02 -20.98 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -126.94 14.77 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.155 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.59 -45.71 91.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.12 -33.06 67.52 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.521 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.6 -43.32 90.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.058 0.456 . . . . 0.0 110.641 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -65.31 -40.89 94.35 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.645 0.736 . . . . 0.0 109.383 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.6 t -62.32 -45.67 92.18 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.796 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -64.97 -43.34 92.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.322 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -62.48 -38.73 91.01 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.694 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.95 -47.65 89.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.36 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.23 -30.01 38.5 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.844 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.3 -38.94 85.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.567 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -80.33 -34.22 36.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.668 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.52 -26.96 51.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.435 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -108.53 -20.46 13.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.272 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -140.39 68.54 32.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.443 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.41 158.27 56.61 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 C-N-CA 122.949 2.432 . . . . 0.0 112.495 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--N 1.312 -1.356 0 C-N-CA 122.64 2.227 . . . . 0.0 112.321 -179.611 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.83 148.16 98.87 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.61 152.82 38.43 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.587 2.192 . . . . 0.0 111.959 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.91 151.03 90.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.118 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.21 158.75 48.44 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.278 1.985 . . . . 0.0 112.239 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 168.41 23.99 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.706 2.271 . . . . 0.0 111.918 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -105.68 159.86 28.08 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.78 145.97 87.87 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.237 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.87 166.56 33.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -85.15 138.01 32.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.32 125.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.84 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.51 127.28 56.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -74.18 84.31 1.85 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.811 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.569 179.672 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -66.97 161.08 25.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.26 149.99 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.133 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.04 126.44 44.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.646 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.75 117.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -100.6 117.89 35.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.467 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 71.2 p -80.0 171.22 15.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.049 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 64.9 mt -63.42 -24.02 67.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.173 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.2 p -75.42 -8.73 57.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.24 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -72.41 132.89 44.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.792 0.33 . . . . 0.0 110.264 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -109.09 131.71 54.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.229 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.25 117.37 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.819 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 135.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -133.91 126.68 30.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.114 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -70.74 117.35 12.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.18 166.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -112.26 151.52 43.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.02 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.14 -26.37 81.48 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.981 1.788 . . . . 0.0 112.207 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -87.02 -11.51 50.18 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.743 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -62.99 143.49 57.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.615 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -81.67 165.95 20.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.315 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -62.44 -39.18 83.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.314 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.48 -41.99 91.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.83 -41.57 97.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.141 0.496 . . . . 0.0 110.876 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.7 t -63.13 -43.35 98.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.702 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.79 -39.71 89.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.43 91.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 0.0 110.519 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -60.15 -39.76 87.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.98 -38.4 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.257 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.28 -42.21 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -63.51 -43.79 96.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -65.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.225 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.41 155.9 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.854 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.8 57.82 4.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . 0.432 HD13 HG23 ' C' ' 36' ' ' ILE . 32.2 mm -110.78 104.69 56.44 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.37 157.57 35.28 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.53 2.154 . . . . 0.0 112.041 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.07 -30.55 90.59 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.249 1.966 . . . . 0.0 112.309 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.83 -40.73 88.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.056 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -87.22 -9.67 54.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.58 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -81.73 95.84 7.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.334 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -110.36 93.67 4.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 74.3 mt -80.07 135.14 36.28 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.44 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -135.8 127.33 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -152.0 149.83 29.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.805 0.336 . . . . 0.0 111.211 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.03 15.27 9.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.14 -15.2 60.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -100.9 140.61 34.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.942 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -77.94 118.19 20.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mp -66.56 86.14 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.243 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -74.52 -175.89 2.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.4 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.7 156.5 30.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.15 -152.23 48.17 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 55.36 172.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.519 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -125.99 167.96 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.348 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 78.8 mt -60.7 -40.74 93.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.563 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -63.78 -24.32 67.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.91 -37.06 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.446 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -96.44 13.78 26.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.997 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.58 40.59 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 60.9 mt -87.88 108.68 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.754 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.71 179.99 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.82 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.65 145.97 53.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 59.18 17.64 5.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 137.23 57.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -98.07 120.21 38.08 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.685 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.6 142.27 46.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.324 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -88.91 130.32 35.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.194 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 59.9 tp -105.88 122.07 45.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.017 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.75 132.67 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 27.8 mt -108.49 143.25 37.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.345 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -62.82 -39.39 94.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.686 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.41 132.11 54.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.539 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -63.32 -39.32 94.24 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.59 174.79 55.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.44 -173.99 54.24 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.648 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -62.88 155.64 26.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.552 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -134.85 154.61 36.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.547 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -94.87 125.08 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.83 99.06 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.383 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -85.18 130.05 34.68 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.73 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.51 -175.06 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.709 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.85 -26.01 63.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.291 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -78.97 -9.98 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.55 -13.55 64.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.71 132.08 48.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 68.5 m -102.72 130.75 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 110.608 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mm -113.47 117.9 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.489 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.58 118.75 28.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.44 116.95 28.17 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.67 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -65.46 105.69 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -129.13 166.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.205 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -115.18 155.91 46.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.03 -24.65 66.76 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.76 1.64 . . . . 0.0 111.707 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.7 p -88.18 -11.82 45.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.822 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.14 141.99 58.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.171 0.51 . . . . 0.0 111.103 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -81.52 164.18 22.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -62.86 -42.28 95.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.975 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -59.98 -34.56 73.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.353 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -64.76 -41.14 96.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.494 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 -42.38 95.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.456 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -60.56 -40.39 91.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.22 86.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.65 -39.5 84.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.607 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -67.84 -39.52 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.173 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -58.98 -42.52 90.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.917 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -89.77 17.99 6.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -123.16 -38.01 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -124.85 -8.28 7.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.297 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.71 77.0 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.449 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.04 121.58 79.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.512 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.55 153.61 60.01 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.956 1.771 . . . . 0.0 111.71 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.47 -39.52 73.97 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.112 1.874 . . . . 0.0 111.898 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.21 -39.66 93.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.683 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -83.54 -7.96 59.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.658 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.96 90.83 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.316 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -100.94 111.16 23.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 35.1 mt -96.67 114.83 26.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.384 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.45 125.14 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -144.12 151.29 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.334 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.13 22.91 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.62 16.01 80.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.54 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -149.29 152.96 36.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 110.794 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.26 139.9 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.38 127.57 33.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.2 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.75 135.54 40.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -67.09 132.16 47.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.211 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.17 -18.19 52.28 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.67 171.49 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.8 164.04 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.723 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.5 p -62.36 -29.15 70.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.4 -35.59 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.081 0.467 . . . . 0.0 110.164 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -96.56 12.58 31.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.304 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 55.18 41.79 31.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 110.14 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -90.39 104.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.638 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.39 -176.1 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -64.58 149.7 48.31 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.446 -0.501 . . . . 0.0 109.935 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 59.14 44.77 15.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 54.3 m -100.32 122.7 43.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.222 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -71.76 128.49 35.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.71 136.64 54.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.75 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -85.64 109.07 18.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.713 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 tp -96.76 113.4 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.01 134.49 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.035 0.445 . . . . 0.0 110.054 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.15 143.39 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.685 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -84.42 161.31 20.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 21.7 mt -65.05 137.86 57.96 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.58 132.24 43.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.96 -129.68 47.81 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.669 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.23 151.2 28.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.12 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.12 110.96 19.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.223 0.535 . . . . 0.0 109.926 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.8 mt -65.89 -38.46 88.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.22 162.78 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.842 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.6 122.91 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.207 0.527 . . . . 0.0 110.686 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.47 155.4 34.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.765 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.39 121.35 18.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.824 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.25 22.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.106 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.48 152.64 17.34 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -87.13 159.24 18.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.823 0.344 . . . . 0.0 110.737 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.1 mtp -124.81 176.17 6.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -126.01 126.51 44.41 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.4 tp -107.27 122.32 46.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -117.42 106.24 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.923 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.04 -87.27 0.38 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -139.72 23.78 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.687 0.279 . . . . 0.0 111.054 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.4 m -125.08 125.69 44.18 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.236 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.16 124.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.916 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.6 m -123.09 134.26 25.01 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.78 146.89 79.97 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.947 1.765 . . . . 0.0 112.875 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.51 150.82 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -80.73 -6.87 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.808 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -72.79 73.3 1.1 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.86 129.99 43.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.76 -159.58 9.26 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.229 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -140.32 127.75 21.36 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -99.99 110.0 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.556 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -132.42 154.8 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.196 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.1 mt -119.01 138.12 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.397 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -134.66 130.55 36.53 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -101.1 124.38 46.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 0.0 109.954 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -85.15 172.5 11.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.816 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.48 -10.31 24.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.54 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.51 7.16 42.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.602 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m 63.37 23.86 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 110.603 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -98.63 122.48 41.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.8 mm -81.74 120.65 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -97.85 111.24 23.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.973 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -91.0 106.69 18.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 92.7 m -119.03 146.62 44.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.708 0.766 . . . . 0.0 112.752 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.7 t90 -124.94 113.4 17.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.262 -1.336 . . . . 0.0 108.331 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -105.85 135.3 47.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.959 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -76.82 132.7 39.34 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -73.58 -18.68 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -59.88 -46.1 90.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.829 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.1 m -116.46 -15.18 10.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.057 0.456 . . . . 0.0 110.072 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.37 21.51 77.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -101.88 152.74 20.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.242 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.0 t -78.16 107.84 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.54 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -86.59 -28.26 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -129.28 143.8 50.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.191 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -157.88 101.96 1.81 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.193 0.521 . . . . 0.0 110.523 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 mt -129.7 134.03 47.41 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.24 120.14 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mp -108.16 112.5 40.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -71.2 162.56 71.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.937 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.58 131.43 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.921 1.747 . . . . 0.0 111.668 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.7 t0 63.88 12.22 6.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.404 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -82.13 -35.92 28.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.315 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.74 150.62 50.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.301 0.572 . . . . 0.0 111.105 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -121.77 129.59 52.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.96 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -107.03 118.08 35.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.43 168.25 20.16 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.579 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -87.39 160.32 18.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.003 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.08 90.66 11.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.119 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.75 60.15 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.984 1.789 . . . . 0.0 112.359 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.84 -39.68 3.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.34 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.6 t -128.29 80.88 71.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.67 130.49 26.52 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.604 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.81 -41.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.02 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.98 -150.92 6.7 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.44 106.23 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.467 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.19 129.35 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.22 154.17 45.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.635 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.69 134.91 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.379 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.4 tp -104.08 123.19 46.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -122.02 130.98 53.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.129 0.49 . . . . 0.0 110.915 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -84.43 117.83 23.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.97 -31.52 71.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.462 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.73 -21.7 11.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.936 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.66 -25.68 55.84 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.961 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.31 8.93 6.0 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.309 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -93.97 143.88 25.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.811 0.339 . . . . 0.0 110.721 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -122.83 125.27 45.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.469 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.9 mt -114.27 141.88 47.01 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -115.07 134.74 54.91 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -138.01 153.55 49.39 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.276 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -129.03 136.44 50.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.532 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 29.9 tpp -72.34 134.08 45.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.078 0.466 . . . . 0.0 111.107 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.15 -0.9 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.913 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -73.16 133.08 81.62 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.278 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.96 -24.84 39.1 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.9 1.733 . . . . 0.0 112.88 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -111.25 140.8 45.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 p -99.0 12.32 36.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.371 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.92 -20.91 60.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.595 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -126.36 10.87 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.359 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.48 -47.02 83.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.534 . . . . 0.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.31 -31.04 65.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.122 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.64 -45.0 80.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.926 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -62.81 -41.15 99.17 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.704 0.764 . . . . 0.0 109.497 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.55 -44.34 96.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.506 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -65.68 -43.36 89.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.818 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.4 -42.19 99.24 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.59 -48.8 84.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.912 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.39 -39.16 88.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.298 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -74.39 -22.93 58.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.192 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.405 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 m-85 -89.42 -28.25 19.86 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.527 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.1 mt -92.91 -16.72 24.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.062 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -117.16 -17.61 10.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.316 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.52 63.98 18.17 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.798 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.82 153.67 68.39 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 122.522 2.148 . . . . 0.0 112.443 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.313 -1.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.22 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 48.69 70.74 1.9 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.643 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.73 145.73 70.34 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -73.73 159.15 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.298 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.14 154.36 46.31 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.762 2.308 . . . . 0.0 111.998 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.09 -155.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.615 2.21 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -125.39 155.34 71.85 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.01 143.44 90.95 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.473 2.115 . . . . 0.0 111.676 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -156.97 166.99 31.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.77 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.03 135.33 33.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 110.618 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -112.55 123.2 49.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.766 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.29 122.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.95 84.94 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.069 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 30.3 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.736 179.776 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -67.67 161.15 26.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.503 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.66 143.11 31.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.5 123.74 32.73 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.42 114.68 47.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.413 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -100.74 121.94 42.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.901 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 79.7 p -83.39 172.49 12.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 67.2 mt -62.83 -25.09 68.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.289 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -73.9 -10.04 59.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -11.08 70.52 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.76 132.79 47.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.3 m -109.63 132.21 54.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.556 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.65 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.677 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -84.25 130.17 34.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.49 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.79 130.21 52.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.687 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.42 115.36 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.35 166.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.0 150.7 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.961 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.27 -36.57 86.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.94 1.76 . . . . 0.0 112.069 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -83.31 -9.98 58.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.85 138.52 57.24 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.663 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -79.5 163.81 24.42 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.772 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mm -65.39 -36.7 78.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.857 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.49 -44.15 89.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -62.9 -41.19 99.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 110.814 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.37 -42.86 97.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.48 -39.02 86.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.68 91.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.397 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -60.63 -39.19 87.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.63 -39.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.187 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.21 -38.51 80.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.241 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -67.32 -50.86 58.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.7 151.08 51.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.77 64.23 1.89 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 42.1 mm -117.98 93.11 43.72 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 149.59 70.68 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.744 2.296 . . . . 0.0 112.11 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -51.69 -42.59 55.86 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.112 1.874 . . . . 0.0 112.277 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.2 -38.66 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 110.347 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -95.7 25.39 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.507 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -131.61 119.87 22.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -127.23 106.64 9.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 63.4 mt -85.13 138.51 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.4 mt -134.39 130.23 53.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.599 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -156.37 155.88 32.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.55 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.54 14.13 9.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.59 -14.04 62.45 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.09 150.18 39.08 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.407 0.622 . . . . 0.0 110.551 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.04 137.66 45.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.509 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.13 101.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.18 139.43 42.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -61.48 138.81 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -17.68 55.66 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -83.03 175.68 9.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -119.23 162.21 19.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.279 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.31 -41.26 96.7 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.757 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -63.25 -24.07 67.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.839 0.352 . . . . 0.0 110.684 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.28 -36.92 83.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -98.3 14.47 27.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.272 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 57.69 38.68 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.894 0.378 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 53.1 mt -83.82 111.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.234 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -98.08 178.51 5.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -60.33 146.09 45.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.957 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 59.76 22.1 10.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 17.0 m -74.34 127.03 31.96 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.874 0.368 . . . . 0.0 110.185 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.1 m -80.33 126.43 31.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.41 152.86 33.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -103.0 126.18 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.152 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 tt -103.4 122.27 44.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.12 132.49 57.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.25 135.54 48.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.081 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -62.18 -39.47 92.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 110.509 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -126.54 -77.18 0.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -153.62 -54.91 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.23 -172.06 55.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.72 90.27 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.69 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -63.35 157.07 23.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.023 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 17.5 pt -138.17 145.17 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.163 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -86.5 126.96 34.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.841 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -112.38 101.18 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -90.67 127.63 36.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.696 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -89.73 -179.21 5.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.23 -34.59 78.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -68.21 -12.88 61.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.627 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.18 63.39 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.14 129.96 42.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -102.11 132.35 48.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.458 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.95 110.4 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.956 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -81.38 130.4 35.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 91.7 mt -125.73 123.73 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.471 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -66.11 112.43 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.073 0.463 . . . . 0.0 110.946 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.08 165.57 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.881 -0.512 . . . . 0.0 110.324 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.27 152.63 43.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.115 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -38.34 86.01 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.826 1.684 . . . . 0.0 112.222 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -66.27 -36.49 83.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.162 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -50.45 140.57 13.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.688 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 31.0 p -87.05 169.46 12.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.108 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.38 -34.73 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.279 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.63 -44.07 89.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.102 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.62 -42.4 99.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 68.0 t -63.21 -42.97 98.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -60.22 -40.42 90.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.58 94.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.704 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.81 -39.19 88.02 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.665 0.745 . . . . 0.0 109.089 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.53 -40.13 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.548 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -59.08 -42.17 89.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.732 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.74 -40.71 93.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.751 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -77.32 -62.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.327 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.16 156.4 18.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.375 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.92 55.48 4.26 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.8 99.06 36.7 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.136 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.31 153.13 71.47 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.775 1.65 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.62 -40.32 73.37 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.079 1.853 . . . . 0.0 111.952 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.36 -39.37 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 110.402 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -103.1 35.23 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.65 124.22 22.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.937 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -122.16 104.68 9.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mp -85.31 115.23 22.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.935 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -126.07 126.11 69.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.435 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -63.39 -46.21 87.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.658 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.71 -78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.776 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.26 2.56 57.82 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -145.02 136.81 25.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.126 0.489 . . . . 0.0 110.931 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -78.55 138.07 38.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.378 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 77.7 mt -74.47 122.96 23.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.96 132.56 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 133.63 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.619 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.41 55.61 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -82.3 147.21 29.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.735 0.302 . . . . 0.0 111.011 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 48.8 p -75.71 162.57 28.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.36 -38.27 84.52 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.632 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.09 -25.34 67.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.942 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.31 -37.63 83.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -98.06 15.15 25.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 54.37 39.89 31.31 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.75 91.32 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.779 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -82.11 177.99 8.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.974 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -58.7 151.37 21.16 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 60.09 44.51 12.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -97.29 120.9 38.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -75.06 127.27 32.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.21 126.83 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.194 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.01 120.76 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.95 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tt -100.12 112.22 24.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.978 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.92 132.16 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 60.9 mt -102.4 135.77 43.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -72.4 136.05 45.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.63 6.49 47.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.824 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -54.59 134.15 46.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.06 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.57 -19.82 43.78 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.357 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.185 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.518 179.788 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.72 152.36 43.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.21 127.23 37.61 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.708 0.765 . . . . 0.0 110.206 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.12 -37.48 83.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.62 162.93 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.829 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -173.85 122.03 0.32 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.344 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.78 151.4 27.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.912 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.37 123.08 20.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 110.357 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.93 145.45 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.321 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.0 154.26 16.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -87.1 172.62 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 111.165 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.4 mtp -138.79 173.72 11.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -124.89 123.6 40.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.53 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.9 tp -107.61 117.24 33.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.363 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -120.97 114.46 21.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.953 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.78 -90.09 0.48 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.1 p -141.66 21.14 2.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.841 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.8 m -123.05 130.86 53.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -109.42 123.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.976 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.4 p -118.25 132.77 23.61 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.685 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.57 142.67 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.963 1.775 . . . . 0.0 113.05 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -97.74 145.62 26.17 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.733 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -81.21 -6.86 59.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.132 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -73.35 75.41 1.37 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.61 134.12 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.28 -156.53 7.88 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tp -138.72 123.01 18.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.1 t -95.77 108.42 21.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.711 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.4 p90 -131.25 153.88 49.06 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.665 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.5 mt -117.67 139.83 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.548 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.32 128.67 26.05 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 123.84 0.713 . . . . 0.0 110.854 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -98.29 124.22 42.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.308 0.575 . . . . 0.0 110.278 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.5 p -83.75 171.61 13.01 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.54 -10.05 23.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.549 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -89.22 1.97 54.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.5 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.66 19.18 7.4 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.4 mt -98.95 122.73 42.58 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 mm -79.21 125.06 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -101.11 114.87 29.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.108 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -93.31 106.67 18.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.89 145.46 45.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -126.96 111.98 14.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.837 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -102.59 145.24 29.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.627 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -81.7 133.55 35.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -73.96 -17.62 60.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.937 0.399 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.4 m -60.18 -45.3 93.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 m -117.79 -12.97 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.456 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.86 23.24 75.37 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -102.51 151.77 21.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.771 0.32 . . . . 0.0 110.813 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.01 109.03 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.309 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.06 -28.42 21.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.92 145.37 50.98 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.075 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -158.09 100.44 1.71 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.944 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 mt -131.7 129.24 40.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.441 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.29 125.97 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.105 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.2 mm -115.28 121.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.915 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -82.79 159.76 62.64 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.274 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.09 142.44 97.06 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.992 1.795 . . . . 0.0 111.324 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 61.27 12.64 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.876 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -93.09 -33.33 14.12 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.635 0.255 . . . . 0.0 110.889 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.48 148.42 42.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -120.89 132.24 54.86 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.403 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -105.82 115.83 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -140.81 168.97 18.53 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.098 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -85.61 162.38 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.316 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.54 88.56 9.42 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.317 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.47 60.95 8.02 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.507 2.138 . . . . 0.0 112.09 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 -41.99 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.451 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.3 t -129.23 80.01 73.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.474 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.23 130.11 38.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.189 1.926 . . . . 0.0 111.219 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t 168.02 -39.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.627 0.58 . . . . 0.0 110.123 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.54 -170.1 11.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -95.96 107.0 19.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.732 0.301 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.07 129.42 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -122.66 156.06 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.971 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.75 131.45 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.7 tp -102.34 123.23 45.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -118.98 137.54 53.44 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.74 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -92.8 112.75 24.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.309 0.576 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.88 -37.92 88.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.828 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.78 -21.63 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.514 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.62 -173.16 20.74 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.8 m -122.52 25.75 8.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.941 0.4 . . . . 0.0 110.299 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 149.43 33.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -134.81 144.86 47.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.463 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -120.2 152.08 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.768 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -124.03 135.0 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.812 0.339 . . . . 0.0 110.578 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.35 158.7 43.84 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -131.99 135.98 46.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.574 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.1 mmm -72.43 139.91 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.0 110.85 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -101.38 0.29 36.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.339 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -72.19 145.2 88.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.15 -28.35 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.095 1.863 . . . . 0.0 112.728 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.07 143.62 49.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.147 0.499 . . . . 0.0 110.321 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.9 p -89.52 -0.16 57.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.268 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.11 -19.22 42.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -117.76 -18.38 9.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.3 -41.03 98.17 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.335 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.23 -40.03 95.19 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.394 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.37 -42.92 95.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.535 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.87 -40.07 91.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.476 0.655 . . . . 0.0 109.303 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.91 -43.48 98.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.464 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -66.64 -41.44 88.26 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.524 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -64.59 -41.08 96.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.4 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.29 -46.98 85.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.72 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -62.21 -39.45 92.78 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.463 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.65 -25.59 61.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.019 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -87.62 -26.05 23.25 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.999 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.3 mt -95.44 -16.37 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.467 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -115.34 -22.44 9.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.09 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -135.22 71.76 67.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.935 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.42 147.57 77.15 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.254 1.97 . . . . 0.0 112.365 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.585 0 C-N-CA 122.463 2.109 . . . . 0.0 112.213 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.46 152.43 95.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.69 154.74 49.45 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.811 2.34 . . . . 0.0 112.385 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.72 156.58 35.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.382 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -53.18 138.08 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.839 1.693 . . . . 0.0 112.255 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 172.96 15.3 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -95.66 156.08 37.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.06 151.42 83.86 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.78 166.28 32.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.798 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.36 134.58 34.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -120.21 132.48 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.18 128.69 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -76.2 85.79 3.03 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.111 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.664 179.921 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -58.34 158.21 7.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.654 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 pt -139.05 142.27 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.911 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -81.94 127.21 32.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.157 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -114.67 115.84 50.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -96.91 118.6 33.68 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.17 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -75.23 173.73 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.86 -31.56 2.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.533 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 76.9 p -99.96 -179.87 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.56 -19.11 53.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -53.1 129.37 30.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.049 0.452 . . . . 0.0 110.728 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -127.58 134.6 49.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.454 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.7 122.39 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.517 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 85.7 m -88.8 131.87 34.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 65.7 mt -119.3 125.1 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -65.94 109.68 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 111.009 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -133.13 163.78 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.487 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -108.07 156.08 38.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.159 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.29 -37.85 96.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.136 1.891 . . . . 0.0 111.87 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -79.72 -7.2 58.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -57.6 137.57 56.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.008 0.432 . . . . 0.0 110.899 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -80.75 160.74 24.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.7 -41.41 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -57.95 -36.63 72.81 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.292 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.0 -41.51 95.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.556 . . . . 0.0 110.8 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.6 -42.63 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.773 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.76 -39.62 89.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.354 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.92 93.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.652 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.22 -38.86 84.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -65.05 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.962 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -59.01 -43.91 91.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.411 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.75 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.833 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -72.09 -75.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -93.71 151.49 19.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.366 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.46 56.02 4.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 42.6 mm -106.4 109.97 63.52 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.69 154.36 49.56 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.054 1.836 . . . . 0.0 112.195 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.98 -38.85 80.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.112 1.875 . . . . 0.0 112.235 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -61.52 -39.97 92.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -87.02 -3.18 59.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.476 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -88.16 67.15 8.76 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.565 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -84.27 109.89 18.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 23.4 mt -100.32 128.94 46.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.239 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -128.79 128.67 67.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.69 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -147.8 145.42 28.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.435 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 19.84 7.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.099 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.31 -13.15 65.91 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.66 145.99 24.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.27 0.557 . . . . 0.0 111.482 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -95.21 105.33 17.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.86 88.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.17 -74.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -177.05 169.02 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.46 20.84 77.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.32 171.28 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 110.025 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -126.33 163.69 22.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.8 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -57.87 -43.14 85.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.587 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -63.09 -22.35 66.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.951 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.77 -36.56 83.48 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.354 0.597 . . . . 0.0 109.784 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.28 11.29 39.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.454 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 57.7 46.41 17.39 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.298 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 80.9 mt -92.71 119.84 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.542 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.99 -178.9 3.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.83 147.84 52.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 58.79 45.21 15.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.215 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -98.45 126.36 43.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.075 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 82.3 m -75.62 126.97 32.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.1 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -112.52 145.44 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.12 114.62 26.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.387 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.17 126.43 41.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.261 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.45 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.822 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 27.4 mt -103.51 149.19 25.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.286 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -62.16 -39.9 94.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.498 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -113.69 147.45 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.613 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -60.66 -40.61 92.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.12 -158.52 53.38 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.68 179.08 47.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 64.2 t0 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.326 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.28 163.52 15.25 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.3 pt -141.84 142.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.044 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -87.01 126.56 34.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.75 105.36 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -88.57 125.86 34.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.71 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 73.7 p -78.01 -166.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.883 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.16 -28.47 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.793 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -102.91 -177.63 3.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.36 57.6 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -53.07 129.85 32.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 110.894 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.4 m -123.93 138.14 54.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.029 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.75 109.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.956 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -85.41 129.91 34.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.438 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -122.07 134.07 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.44 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.26 117.54 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.732 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -136.94 167.44 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.168 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.23 154.2 45.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.51 -29.6 85.42 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.609 1.539 . . . . 0.0 111.729 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -84.55 -11.87 55.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.609 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.66 142.16 58.14 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.786 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.0 p -83.27 166.91 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.078 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.57 -37.4 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.13 -42.73 91.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.98 -43.78 98.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.806 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -61.08 -38.39 86.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.317 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.1 94.35 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.105 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -59.96 -39.03 84.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.68 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.31 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.8 -39.5 89.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.175 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.79 -45.1 91.23 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.478 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -73.48 -40.51 64.06 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -128.16 151.19 49.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.27 62.06 2.23 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.1 103.25 54.71 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.07 154.43 66.52 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.346 1.364 . . . . 0.0 111.954 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -53.61 -25.97 35.39 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.629 2.22 . . . . 0.0 112.517 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.96 13.63 14.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.418 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -145.4 59.97 1.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.376 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.93 147.08 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.24 0.543 . . . . 0.0 111.774 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.8 124.29 31.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.466 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.8 mt -105.49 114.25 28.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.68 121.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.669 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.82 -46.99 79.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -179.04 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.021 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.34 -8.15 79.54 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -129.79 127.89 41.26 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.867 0.365 . . . . 0.0 110.499 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -81.13 153.47 27.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.572 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.57 102.71 14.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.062 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.84 155.62 35.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.56 154.37 41.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.41 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.13 12.67 63.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -127.33 150.78 49.43 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.198 0.523 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.37 163.36 13.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.999 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.91 -39.31 91.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.709 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.5 -22.51 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.322 . . . . 0.0 110.367 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.46 -38.33 83.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.261 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -99.83 16.86 22.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.86 40.93 28.64 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.337 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 78.8 mt -88.22 110.1 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -95.54 178.61 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -59.62 152.23 22.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.539 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 56.82 33.73 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -77.03 120.86 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.937 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 78.1 m -81.63 119.8 24.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.35 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.75 142.76 45.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.075 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -87.69 114.42 24.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.35 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -102.51 118.14 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.583 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -117.72 128.73 74.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.814 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.37 145.71 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.69 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -72.82 148.25 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.432 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 tp -70.06 127.49 33.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.516 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.2 143.44 52.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -14.47 62.61 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.498 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -71.68 139.76 49.34 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.054 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -95.87 113.19 24.79 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.6 mt -66.04 -39.01 89.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.603 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 p -147.5 163.04 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.05 122.38 0.31 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.756 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.31 158.7 40.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.815 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.08 124.21 25.85 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.097 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -157.0 145.28 19.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.336 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.47 154.72 16.47 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -90.26 174.7 7.45 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.17 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.4 mtp -138.76 172.77 12.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -123.12 123.9 41.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.0 tp -105.29 119.81 39.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.329 0.585 . . . . 0.0 110.618 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -121.42 107.62 12.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.571 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.56 -97.06 0.68 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 p -131.06 19.71 4.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.297 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.1 m -121.76 130.63 53.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.051 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.65 124.07 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.203 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.81 133.6 22.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.65 148.21 46.78 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.799 1.666 . . . . 0.0 112.959 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -103.63 130.69 51.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.68 -8.18 50.08 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.917 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.63 78.09 1.08 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -58.53 131.08 49.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.237 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.47 -158.56 9.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.84 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 tp -137.57 126.51 24.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 36.9 t -96.58 113.5 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.066 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -136.41 155.88 49.4 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.062 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' LEU . 90.8 mt -123.89 140.14 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.105 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -140.09 146.14 38.53 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -109.78 128.55 55.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.221 0.534 . . . . 0.0 110.335 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.5 p -89.68 172.64 8.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.756 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.56 -10.51 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.152 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.15 3.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m 63.12 26.55 15.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.336 0.589 . . . . 0.0 110.335 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.4 mt -103.97 125.47 50.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.11 122.92 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -100.59 116.03 31.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.713 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -93.25 110.37 21.89 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -124.64 146.99 48.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.162 0.982 . . . . 0.0 112.951 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -124.08 116.37 22.67 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.943 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -108.19 134.31 51.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.061 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.69 131.2 39.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.82 -17.27 61.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.888 0.375 . . . . 0.0 110.464 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -59.53 -46.4 88.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.863 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.6 m -116.49 -15.36 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 109.888 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.18 21.7 77.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -101.36 152.89 20.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.16 104.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.926 0.393 . . . . 0.0 110.424 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.73 -30.98 36.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -127.95 145.65 50.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.819 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -158.11 120.21 3.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.612 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.1 136.09 21.09 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.17 0.509 . . . . 0.0 110.381 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -81.62 122.88 37.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.574 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.6 mm -114.06 121.23 65.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.279 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -84.78 162.3 50.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.63 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.92 139.56 89.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.368 2.045 . . . . 0.0 111.54 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 59.64 12.02 2.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.229 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -87.17 -25.12 24.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.6 p -144.43 169.23 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.35 0.595 . . . . 0.0 110.324 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -137.54 125.25 22.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.809 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.23 118.74 37.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.57 164.71 30.84 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.415 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -79.4 159.84 26.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.018 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.6 t -111.36 90.62 12.28 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.18 60.25 7.72 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.829 1.686 . . . . 0.0 112.509 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -114.24 -38.82 4.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.991 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.06 82.35 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.585 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.16 130.33 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.702 1.602 . . . . 0.0 111.685 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.5 t 169.68 -45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.571 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.72 -154.98 8.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.85 106.81 16.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.505 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.65 128.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.08 154.37 41.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.681 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.01 136.12 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.196 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.7 tp -103.77 120.0 40.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -118.36 136.08 53.95 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.238 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -84.22 114.67 21.98 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.124 0.488 . . . . 0.0 109.833 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.9 -37.88 86.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.706 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.96 -21.92 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.23 -175.38 22.68 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -117.88 15.81 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.675 0.274 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -93.35 146.0 24.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.87 137.96 40.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.408 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.6 mt -119.23 148.21 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.44 133.59 55.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.961 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.72 157.99 45.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.293 0.568 . . . . 0.0 111.188 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -132.07 138.07 48.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.522 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.3 ttm -77.07 131.55 38.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.072 0.463 . . . . 0.0 111.475 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -1.7 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.702 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.25 144.91 98.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.06 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.32 -26.93 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.051 1.834 . . . . 0.0 112.786 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -121.85 144.57 48.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.054 0.454 . . . . 0.0 110.245 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.4 p -94.0 9.16 38.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.629 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.88 -22.1 61.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.84 -4.66 12.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.54 -46.95 87.77 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -41.44 99.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.71 -43.23 97.19 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -64.34 -40.7 96.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.577 0.703 . . . . 0.0 109.111 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.77 -45.07 94.38 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.901 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -68.01 -42.12 81.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.4 -41.88 98.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.513 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.2 t -59.13 -47.08 91.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.312 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.89 -39.59 93.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.271 0.558 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.87 -36.37 80.15 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.075 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -80.17 -30.43 38.83 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.955 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.02 -17.51 27.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.853 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -116.98 -19.0 9.98 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.372 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.81 69.78 36.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.339 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.21 157.6 59.01 Favored 'Trans proline' 0 C--N 1.296 -2.195 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.539 2.16 . . . . 0.0 112.319 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.69 154.69 81.84 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 145.1 29.19 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.402 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.35 156.47 68.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.018 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.17 137.39 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.017 1.811 . . . . 0.0 111.873 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.08 -170.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.033 1.822 . . . . 0.0 111.848 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -124.95 158.33 63.38 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.257 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.59 144.32 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.588 2.192 . . . . 0.0 112.377 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -155.53 164.43 38.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.72 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -86.16 135.74 33.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.905 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -121.06 122.95 41.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.429 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.33 124.1 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -68.92 83.4 0.31 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.807 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.515 179.506 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -69.37 161.84 28.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 pt -140.04 144.77 27.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.367 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.16 126.38 35.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -112.31 115.27 49.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -103.49 127.22 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.53 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -90.03 173.34 8.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 111.314 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.66 -25.92 68.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.174 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -73.41 -9.39 58.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.77 -7.41 73.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -71.87 130.83 41.99 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 110.198 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -109.84 132.22 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.255 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.7 116.55 27.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -87.07 131.45 34.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.072 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -123.38 133.64 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -73.5 115.49 12.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.532 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.37 168.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.458 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.19 153.35 45.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.193 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.22 -38.17 93.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.999 1.799 . . . . 0.0 112.345 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -81.73 -8.19 59.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -59.04 139.03 57.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.953 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -80.16 161.78 25.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 48.8 mm -63.67 -38.53 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.177 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.19 -41.93 89.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.284 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.12 -41.25 98.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.124 0.488 . . . . 0.0 110.548 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.91 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.614 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -60.96 -38.39 85.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.01 91.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.11 -39.28 85.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mm -64.59 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.471 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -59.69 -40.15 86.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.811 0.338 . . . . 0.0 110.377 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -67.55 -50.94 56.24 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -64.93 -40.98 95.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 112.038 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -132.18 146.41 52.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.199 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.04 63.98 2.01 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.71 112.32 32.39 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.16 157.35 57.65 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.777 1.651 . . . . 0.0 111.748 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.8 -38.07 96.6 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.168 1.912 . . . . 0.0 112.188 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.96 -40.92 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.915 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -88.64 -17.68 29.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.658 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -92.03 116.44 28.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.054 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -120.28 114.19 21.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -92.48 131.86 37.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.295 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -130.75 129.25 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -145.17 152.46 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.899 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.54 20.31 10.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 110.505 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.72 -5.09 76.44 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.11 139.31 50.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.087 0.47 . . . . 0.0 110.736 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.16 131.61 43.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 50.4 mt -69.68 103.7 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.778 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -75.31 138.94 42.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.97 137.04 58.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.69 -17.81 52.01 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -84.28 174.99 9.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -120.62 165.54 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.346 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.54 -39.88 94.99 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.567 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -64.11 -25.96 68.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.66 -33.55 75.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.437 . . . . 0.0 110.356 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -99.45 13.77 32.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.283 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 56.29 43.93 25.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -91.02 114.76 28.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.45 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -63.7 146.2 54.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.16 44.96 18.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.939 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 38.9 m -99.33 124.93 44.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 40.9 m -74.45 130.83 40.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.223 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.65 155.16 31.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.399 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -105.89 120.65 42.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.27 114.79 29.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.015 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.25 130.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.76 131.94 38.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -80.45 132.12 35.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.62 137.96 44.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -62.6 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.24 -166.56 52.72 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.9 -39.93 97.63 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.58 179.827 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -153.18 166.94 30.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.754 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 pt -144.1 150.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.019 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.0 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.43 111.95 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -95.43 122.04 37.73 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.639 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -79.77 173.3 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.985 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.1 -35.34 76.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.158 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -69.17 -12.03 61.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.892 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.4 60.3 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -61.56 130.96 48.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.71 0.291 . . . . 0.0 110.457 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -103.89 133.94 48.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -126.98 106.67 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.965 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 124.4 27.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.225 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -121.01 132.25 54.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.357 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.81 120.8 21.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.56 -177.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.744 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -132.04 152.08 79.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.119 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.75 -27.21 82.9 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.983 1.789 . . . . 0.0 111.977 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.3 p -86.21 -14.05 45.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.34 143.3 57.92 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.593 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -87.43 168.48 13.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.172 0.51 . . . . 0.0 110.854 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.89 -38.31 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.682 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.31 -39.71 87.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -62.29 -40.9 97.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.55 -42.47 96.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.784 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.81 -40.59 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.085 0.469 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.87 91.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.109 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.37 -38.69 81.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.37 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.167 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -61.13 -43.65 98.55 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.867 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.78 -23.18 61.54 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.079 -0.388 . . . . 0.0 111.904 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.46 3.54 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -149.22 -46.07 0.14 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 110.07 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.51 20.11 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -88.69 119.84 70.08 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.662 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.76 159.35 50.99 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.715 1.61 . . . . 0.0 111.888 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.37 -23.17 36.9 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.498 2.132 . . . . 0.0 112.537 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -93.24 18.17 9.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.886 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -146.14 23.96 1.32 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.728 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -150.12 144.77 25.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.978 0.418 . . . . 0.0 110.987 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -128.28 120.49 27.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.526 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -96.3 121.38 38.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.031 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.36 129.34 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.53 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -130.95 133.1 45.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.665 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.18 26.47 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.613 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.23 79.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -126.09 130.73 51.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -65.21 138.34 58.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.66 112.0 20.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.491 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.83 152.38 37.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -73.65 164.3 26.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.315 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.14 25.03 75.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -127.23 149.64 49.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -93.41 161.91 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.285 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.61 -39.55 94.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.733 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.0 p -63.3 -22.84 67.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.429 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.87 -37.97 86.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.036 0.446 . . . . 0.0 110.62 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -96.76 16.31 19.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.43 42.07 25.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -91.51 101.75 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.728 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -94.96 179.84 5.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.478 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -56.32 145.33 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.268 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 59.92 42.44 16.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.5 t -95.98 120.81 36.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.595 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -76.84 124.99 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.389 . . . . 0.0 110.396 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -115.69 136.02 53.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.154 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -84.0 124.02 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.404 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -104.9 118.37 36.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.701 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.43 132.04 65.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.238 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.55 152.84 21.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.488 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.88 -40.35 95.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt -121.62 144.64 48.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -97.38 -158.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.043 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.54 93.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.725 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -69.34 166.31 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.599 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.98 128.65 35.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' ILE . 81.7 mt -67.59 -37.26 82.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.853 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.67 160.98 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.84 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.47 122.56 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.12 155.17 34.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.08 118.03 16.57 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.358 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.15 26.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.94 150.72 17.12 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -89.32 157.84 18.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.73 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 29.6 mtp -124.24 175.56 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -126.16 122.64 36.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.246 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.5 tp -106.03 122.75 46.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.993 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -118.36 103.75 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.12 -85.18 0.69 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -141.3 18.11 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.534 0.206 . . . . 0.0 110.911 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.0 m -120.01 126.16 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.99 122.75 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.414 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.0 m -119.33 122.62 29.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.427 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 147.18 64.48 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.924 1.749 . . . . 0.0 112.905 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.15 139.99 39.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.969 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -72.93 -5.25 37.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -72.47 74.77 1.04 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -52.79 134.27 36.77 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.334 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.65 -165.06 11.3 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tp -135.92 122.55 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.63 108.36 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.831 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -133.14 153.59 51.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.576 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.8 mt -122.04 141.62 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.826 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -141.67 142.63 33.37 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 123.687 0.617 . . . . 0.0 110.18 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.29 127.6 53.36 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.9 p -87.3 172.79 9.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.754 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.11 -10.42 22.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.625 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.22 -0.16 56.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 70.04 19.77 6.72 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -101.72 126.02 48.5 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.4 mm -80.78 126.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -102.42 115.99 31.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.915 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -91.92 108.19 19.75 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 94.7 m -118.06 140.03 50.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.805 0.812 . . . . 0.0 112.902 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -125.46 113.25 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.189 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -106.18 144.7 32.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.817 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -80.62 131.65 35.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.82 -18.63 62.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.952 0.406 . . . . 0.0 110.529 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -59.65 -46.18 89.78 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.45 -11.3 10.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 0.0 110.646 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.08 22.78 78.7 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.51 146.88 27.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.722 0.296 . . . . 0.0 110.657 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.79 102.02 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.036 0.445 . . . . 0.0 110.304 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -73.08 -39.4 65.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.906 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.8 147.13 50.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.522 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.54 103.24 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.597 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.2 mt -126.98 135.7 51.23 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.775 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -77.43 122.22 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.5 mm -111.81 121.08 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.618 . . . . 0.0 111.183 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -82.76 160.98 59.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.391 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 142.35 98.64 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.797 1.664 . . . . 0.0 111.441 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 61.84 12.34 4.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.103 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -89.87 -35.79 15.44 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 120.628 0.251 . . . . 0.0 110.678 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.4 m -132.48 156.29 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.25 0.548 . . . . 0.0 111.399 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -129.31 130.63 46.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.126 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -101.96 117.95 35.89 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -143.49 161.27 38.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.538 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -83.19 160.34 21.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.131 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.5 89.39 15.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.192 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.6 60.21 7.55 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.091 1.86 . . . . 0.0 112.047 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -114.25 -44.27 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.9 t -116.36 99.06 52.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.78 129.73 15.9 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.38 1.386 . . . . 0.0 111.458 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 165.23 -38.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 O-C-N 124.02 0.825 . . . . 0.0 110.372 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.59 -179.69 25.64 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -91.83 113.55 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.88 128.26 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.176 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -119.18 155.75 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.719 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.63 137.74 52.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.4 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.9 tp -103.68 121.47 43.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -117.89 141.6 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -88.09 117.18 26.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.27 -37.47 85.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.949 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.83 -15.85 19.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.53 176.14 19.96 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.6 p -111.7 15.76 20.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.668 0.27 . . . . 0.0 110.465 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.28 144.56 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.969 0.414 . . . . 0.0 110.77 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.93 140.59 42.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.716 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.62 152.06 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -124.28 137.15 54.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.84 154.24 48.41 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.29 0.567 . . . . 0.0 111.216 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -132.43 136.04 46.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.07 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.95 131.68 51.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.121 0.486 . . . . 0.0 111.215 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 -1.67 12.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.483 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.09 149.23 94.56 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.664 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.14 -39.93 64.82 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.002 1.802 . . . . 0.0 112.224 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.57 145.91 48.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.3 p -98.45 18.72 15.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.5 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.49 -22.2 61.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.61 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -123.48 13.85 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.51 91.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.776 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.54 -41.21 84.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.066 0.46 . . . . 0.0 111.128 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.75 -43.35 96.71 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -63.54 -41.08 98.48 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.517 0.675 . . . . 0.0 109.322 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.23 -42.02 96.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -67.58 -40.14 84.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.2 -37.57 83.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.713 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.3 t -58.51 -47.83 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.412 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -80.05 -27.42 39.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.942 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.96 -38.22 82.5 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.53 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -81.62 -34.18 31.05 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.479 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.24 -26.69 56.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.917 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -107.45 -24.16 11.92 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.56 74.83 58.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.536 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.4 155.63 40.23 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.004 2.469 . . . . 0.0 112.362 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.081 -179.643 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 49.44 67.65 4.26 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.558 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.35 143.95 78.47 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.723 2.282 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.89 160.05 82.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.806 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.52 155.42 62.76 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.765 2.31 . . . . 0.0 112.187 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.35 -169.44 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.608 2.205 . . . . 0.0 111.608 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -110.1 160.4 28.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.14 142.68 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.538 2.159 . . . . 0.0 111.808 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.72 163.93 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.68 138.36 32.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.867 0.365 . . . . 0.0 110.434 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -124.57 119.87 30.32 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.784 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 49.8 mt -131.8 119.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -69.57 84.2 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.308 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 62.1 t0 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.537 179.685 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.14 162.93 18.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.461 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -144.35 147.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.962 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -96.43 119.5 35.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.571 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -103.5 103.8 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -87.67 118.54 27.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.803 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.9 p -82.36 171.13 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.89 -25.03 67.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.138 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.8 p -73.47 -11.5 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -13.74 63.59 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.56 132.53 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.257 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -101.56 132.02 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.144 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mm -116.3 103.55 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.95 120.31 25.53 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.098 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -122.34 132.76 54.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.32 114.45 16.16 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.91 171.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.989 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -116.51 156.33 47.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.237 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.98 -41.23 77.47 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.887 1.724 . . . . 0.0 112.322 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -72.94 -12.25 60.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -59.13 135.76 57.74 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.851 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -77.51 160.54 28.56 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -66.17 -37.65 80.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.071 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.44 -42.92 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -62.29 -42.03 99.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 110.074 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.21 -43.58 96.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.428 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -40.1 79.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.187 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.6 94.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.991 0.424 . . . . 0.0 110.339 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -59.8 -39.4 84.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.394 0.616 . . . . 0.0 109.386 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.56 -38.86 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.443 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -58.03 -42.36 85.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.447 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.11 -40.89 71.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.456 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -65.63 -40.96 93.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.959 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -138.07 157.27 46.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.45 57.44 3.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 32.6 mm -110.81 104.84 56.68 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 153.49 50.38 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.354 2.036 . . . . 0.0 112.204 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.81 -39.14 78.43 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.822 1.681 . . . . 0.0 112.302 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.83 -39.55 92.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.279 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.08 -9.24 59.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.913 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.55 93.87 7.93 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -108.82 95.81 5.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 81.5 mt -84.55 130.21 34.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.274 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -132.17 127.51 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -141.76 148.82 39.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.948 0.404 . . . . 0.0 111.108 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.64 17.48 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.249 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 89.87 -17.11 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -95.48 133.27 39.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 111.056 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -75.73 130.92 39.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.69 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.89 129.8 38.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.58 -80.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.479 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.01 -68.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.611 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.12 94.49 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -49.07 162.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.514 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -109.54 178.46 4.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.308 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.79 -39.61 76.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.825 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.29 -24.96 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.56 -37.4 86.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -98.76 11.98 37.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.113 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 t30 59.33 40.08 21.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.852 0.358 . . . . 0.0 110.365 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -86.24 103.72 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -91.68 179.95 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.512 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -63.19 145.08 56.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.186 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 64.28 13.32 7.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.322 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.0 m -67.02 134.78 52.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 43.6 m -92.49 117.63 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.17 139.39 42.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.903 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.56 127.91 35.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.28 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 tp -105.85 121.17 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.819 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.87 132.61 56.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.736 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 22.4 mt -95.9 133.41 40.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.3 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -86.98 130.49 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.2 mt -107.43 143.79 35.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.332 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -112.08 144.33 41.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.447 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.65 -170.67 52.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.58 18.57 79.73 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.623 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -64.27 160.68 18.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.599 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -139.17 142.44 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.377 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -86.63 122.73 30.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -108.82 107.28 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.382 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -92.0 130.43 37.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.883 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -89.19 -179.32 5.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 111.086 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.36 -37.22 86.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.136 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.39 -12.18 61.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 -12.51 61.36 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.98 131.4 49.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 83.3 m -104.77 133.53 49.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 111.163 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.83 108.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.729 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.6 m -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.299 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 94.6 mt -122.91 126.57 47.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.627 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -68.85 116.39 9.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.849 0.357 . . . . 0.0 111.039 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 20.7 m -139.2 165.57 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -106.28 155.24 38.96 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.027 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.46 -32.77 90.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.102 1.868 . . . . 0.0 112.282 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -87.3 -3.31 59.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -60.06 136.24 57.96 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -80.18 163.41 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.234 0.54 . . . . 0.0 111.021 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -63.03 -37.26 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.39 -42.33 86.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.084 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -62.48 -41.27 98.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.443 . . . . 0.0 110.432 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.47 -43.61 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.67 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -61.08 -39.46 89.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.668 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.71 97.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -59.66 -38.92 82.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.571 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 59.2 mt -67.04 -38.48 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.842 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -59.12 -39.74 83.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.406 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -70.49 -53.76 14.99 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -63.14 -40.95 99.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.094 0.473 . . . . 0.0 111.753 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -128.2 143.45 51.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.793 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.36 61.96 2.69 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.02 110.11 49.01 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.54 155.07 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.16 1.907 . . . . 0.0 111.691 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.18 -34.49 98.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.216 1.944 . . . . 0.0 113.035 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.17 -47.42 77.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 110.101 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.2 -38.85 88.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -58.86 115.74 3.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.729 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -119.37 102.89 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.37 118.55 29.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.13 126.06 67.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -132.1 132.21 43.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.306 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.97 27.24 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.535 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.06 78.59 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -129.72 129.19 43.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -66.08 140.34 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.621 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.47 114.84 21.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.965 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.51 139.89 42.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.949 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.95 136.81 57.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.39 56.63 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -81.97 170.08 16.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.6 p -113.71 165.44 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.599 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.8 p -63.54 -26.72 68.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.067 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.27 -29.15 70.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.028 0.442 . . . . 0.0 110.389 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -103.08 15.65 28.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.87 38.81 30.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -89.88 115.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -104.93 -174.85 2.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.273 0.559 . . . . 0.0 110.804 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -61.57 144.26 54.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.324 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 60.98 19.78 10.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.826 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -70.1 126.41 29.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 59.4 m -79.06 129.89 34.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.212 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.94 144.45 46.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.074 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -91.67 110.0 21.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.117 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 tp -96.27 106.68 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t -99.83 140.14 19.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.124 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 mt -115.04 140.48 49.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.122 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -63.23 143.74 57.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.33 107.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.301 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 53.08 35.25 19.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.139 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.77 79.81 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -70.45 146.87 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.178 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.71 113.22 25.44 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.26 0.552 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 49' ' ' ILE . 92.0 mt -66.97 -38.86 86.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.479 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -149.34 162.75 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.955 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.83 122.81 0.33 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -155.32 158.17 38.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.869 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.2 122.01 23.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.05 0.452 . . . . 0.0 110.866 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.16 139.93 17.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.12 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.12 154.17 17.68 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -90.41 172.37 8.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.136 0.493 . . . . 0.0 111.435 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 22.9 mtp -134.74 172.23 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.639 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -122.68 121.88 37.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.4 tp -104.62 116.85 32.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.312 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.45 117.82 26.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.825 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -84.76 0.35 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 p -149.81 23.41 0.87 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.719 0.295 . . . . 0.0 110.689 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.1 m -125.85 131.34 52.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.431 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.4 t -108.9 122.44 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.02 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 p -114.71 131.25 23.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.223 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.79 148.59 46.62 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.195 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.51 142.61 27.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.817 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -82.46 -8.53 59.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.718 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.9 86.52 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -53.37 137.24 35.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.94 -162.98 10.83 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.047 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 tp -140.51 122.04 15.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -94.55 109.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -131.74 153.2 50.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.062 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.6 mt -122.36 140.83 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.365 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -141.57 144.99 34.55 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 123.499 0.5 . . . . 0.0 109.7 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -109.24 127.18 54.05 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.469 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.7 p -87.47 172.59 9.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.028 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.38 -10.72 18.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.698 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.49 4.7 48.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.586 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m 63.83 25.32 14.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.485 0.659 . . . . 0.0 110.566 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -103.24 125.51 49.94 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.437 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.6 mm -82.38 123.59 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.074 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -101.23 115.3 30.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.477 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -96.68 107.96 20.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.66 142.92 51.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.41 113.58 24.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.292 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -103.85 135.82 44.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.832 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.44 136.95 38.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.873 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -78.67 -18.65 54.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -60.65 -46.46 90.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.787 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -117.0 -13.3 10.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.22 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.14 75.5 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.8 144.47 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.702 0.287 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.45 102.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.879 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -75.31 -37.15 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.876 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -126.28 144.7 50.7 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -158.81 101.05 1.62 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.509 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -128.12 140.94 51.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.753 0.311 . . . . 0.0 110.451 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.425 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 97.0 mt -82.75 122.85 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.7 mm -112.91 122.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.067 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -85.16 162.95 47.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.587 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.36 140.25 93.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.138 1.892 . . . . 0.0 111.322 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.76 11.89 2.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.256 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -85.06 -26.24 27.11 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.719 0.295 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.8 p -147.19 167.2 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.319 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.04 127.74 32.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.222 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.51 117.06 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -142.37 168.17 20.37 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.699 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -87.36 160.27 18.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.194 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.42 89.76 13.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 60.83 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.015 1.81 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -52.16 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.5 t -114.52 98.11 48.32 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.66 130.46 17.08 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.483 1.455 . . . . 0.0 111.668 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.65 -32.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.8 0.688 . . . . 0.0 110.071 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.24 -171.9 20.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.351 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.42 110.1 22.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 110.466 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.97 154.48 38.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.31 133.62 62.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.7 tp -101.68 121.58 42.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -119.14 132.46 55.99 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.392 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -83.79 115.12 22.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.22 -37.41 87.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.795 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.24 -23.15 24.83 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.476 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.48 -169.71 19.56 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -120.55 13.79 11.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.554 0.216 . . . . 0.0 110.629 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -86.11 142.81 28.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -136.04 129.3 31.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.156 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 37.9 mt -115.18 150.58 35.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.812 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -124.22 137.86 54.47 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.124 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.47 156.81 47.21 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.29 0.567 . . . . 0.0 111.123 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -129.01 137.34 51.28 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.276 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.5 mmm -72.81 141.13 48.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -0.93 24.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.68 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.76 147.03 88.77 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.583 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.25 -27.16 13.88 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.163 1.908 . . . . 0.0 112.607 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.01 146.86 47.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.3 p -92.6 4.07 54.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.811 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.12 -21.17 45.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.51 -13.88 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -61.1 -45.58 94.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.296 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.91 -43.36 93.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.258 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -63.58 -40.62 97.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.62 0.724 . . . . 0.0 109.447 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -62.69 -45.04 94.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.855 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.96 -42.37 85.3 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.533 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.65 -42.87 99.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.484 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.57 -47.65 84.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.046 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -64.05 -39.41 94.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.76 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.22 -27.53 62.59 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.175 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -85.0 -29.03 25.35 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.735 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.53 -12.38 29.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -120.12 -16.65 8.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.794 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -144.23 72.68 16.21 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.81 148.97 90.44 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.931 2.421 . . . . 0.0 111.963 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 C-N-CA 122.308 2.005 . . . . 0.0 111.984 179.85 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -133.73 151.22 76.65 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.96 152.72 36.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.574 2.183 . . . . 0.0 111.661 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -95.13 156.28 38.0 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.186 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.84 140.01 68.36 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.447 2.098 . . . . 0.0 112.144 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.98 172.61 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.37 2.047 . . . . 0.0 112.097 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -93.03 154.33 41.73 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.88 150.29 85.86 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.467 2.112 . . . . 0.0 111.908 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.01 163.85 37.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -85.91 139.81 30.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.127 0.489 . . . . 0.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -124.89 128.82 49.25 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.355 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.42 127.68 62.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.366 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -75.65 83.45 2.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.942 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.829 179.419 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.48 162.4 15.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.462 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.43 151.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.285 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -92.34 114.5 27.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 80.1 t -104.37 98.85 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.135 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -77.79 116.45 18.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.805 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -73.21 -178.18 2.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.322 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.56 -29.21 4.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -101.06 -177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.045 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.38 -12.67 56.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.05 134.66 57.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -118.68 133.57 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.2 110.14 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -83.82 119.01 24.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 73.5 mt -118.31 125.9 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.563 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.5 113.35 9.44 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.35 164.56 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.091 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -107.49 155.56 39.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.741 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.48 -32.76 90.51 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.027 1.818 . . . . 0.0 112.302 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.52 -1.34 57.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.186 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -62.77 138.76 58.6 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -79.15 159.42 27.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.174 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -64.12 -40.96 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -58.02 -36.32 72.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.955 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.69 -43.13 94.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.197 0.522 . . . . 0.0 110.904 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.5 t -62.37 -43.08 97.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.802 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -60.75 -38.38 84.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.16 91.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.852 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -60.07 -38.74 83.75 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.343 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 mm -63.85 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.244 0.545 . . . . 0.0 110.14 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -59.88 -48.77 80.33 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.76 -11.55 59.85 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.082 -0.386 . . . . 0.0 112.026 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -104.87 -8.03 18.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -147.27 -35.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.433 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.81 15.54 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.465 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 mt -95.78 115.05 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.69 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.35 153.77 51.49 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.6 2.2 . . . . 0.0 111.294 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.31 -40.12 87.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.649 1.566 . . . . 0.0 111.855 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.95 -41.01 97.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.827 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -88.88 -2.57 58.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -111.88 120.83 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.798 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -122.77 120.54 33.88 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.12 131.47 45.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.199 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 78.5 mt -129.72 129.01 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.656 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.77 153.46 34.34 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.61 15.37 10.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.418 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.69 -12.0 66.85 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.42 146.85 43.18 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.624 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.18 137.14 44.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.014 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.79 103.17 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.741 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -74.6 135.98 42.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -59.95 136.67 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.67 -18.29 37.96 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -89.52 174.44 7.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.2 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -115.67 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.267 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.7 -40.19 96.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.801 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.05 -25.94 68.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.29 -30.63 71.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -100.82 12.82 36.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.42 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 56.7 39.66 29.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.378 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.93 117.77 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.225 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -101.98 175.09 5.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.015 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -59.81 145.46 45.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.753 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 59.13 20.81 8.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.405 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 7.9 m -67.93 133.92 49.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -86.75 120.3 27.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.358 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.19 147.98 38.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -100.27 129.03 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.55 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.91 121.26 43.34 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.07 135.41 45.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 31.1 mt -109.32 142.52 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.64 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.17 -40.62 98.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 tp -124.34 128.99 49.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.76 144.31 49.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.23 147.52 18.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.46 -130.56 50.44 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.521 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.89 156.76 16.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.107 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -136.79 150.57 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.926 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -92.51 121.85 34.37 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.999 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.49 103.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.56 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -89.5 128.66 36.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.528 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -89.24 -177.36 5.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 111.228 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.97 -37.58 87.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.252 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -70.02 -10.35 58.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.907 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.59 -10.56 66.78 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.91 130.58 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.252 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 131.38 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -121.93 108.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -81.38 129.69 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.553 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 38.2 mt -127.06 123.19 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -65.73 111.79 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.409 0.623 . . . . 0.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -135.07 164.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.165 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.27 155.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.452 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.88 -33.69 95.4 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.084 1.856 . . . . 0.0 111.89 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -82.9 -5.6 59.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -60.96 133.29 55.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 110.717 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -76.34 161.53 28.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.532 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.44 -40.34 88.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.22 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.57 -40.04 86.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -61.89 -40.36 95.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.194 0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.24 -44.27 98.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.798 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -60.35 -40.79 91.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.3 93.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.502 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -60.0 -39.97 87.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.35 -40.67 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.581 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.99 -39.62 82.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.734 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.67 8.55 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.79 -58.12 2.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.865 0.364 . . . . 0.0 110.595 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.11 0.59 25.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.651 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.37 23.78 77.67 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 20.5 mm -84.07 117.78 69.57 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.901 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.08 150.8 76.87 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.244 1.963 . . . . 0.0 112.291 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.25 -19.74 51.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.301 2.001 . . . . 0.0 112.023 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.9 3.44 41.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -124.71 -54.8 1.64 Allowed 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.84 0.352 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.66 114.13 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.286 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -112.3 124.25 52.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.48 119.68 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.69 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 84.4 mt -126.88 126.04 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.731 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -125.44 131.53 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.07 26.23 12.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.447 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.73 16.03 80.47 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.28 130.16 53.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.516 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -67.53 131.99 46.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.72 97.59 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.04 163.36 27.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.868 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -73.45 163.77 27.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.91 71.2 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -131.24 165.53 23.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.104 0.478 . . . . 0.0 110.776 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -116.74 164.34 14.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mp -59.82 -38.65 82.58 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.97 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -62.09 -29.42 70.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.911 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.3 -30.12 71.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.159 0.504 . . . . 0.0 110.066 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -99.43 11.65 38.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 54.98 40.35 31.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.308 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.5 mt -89.81 115.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -103.87 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.443 0.64 . . . . 0.0 110.887 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -60.43 146.92 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.921 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 61.25 19.83 10.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.2 m -74.84 126.98 32.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.924 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 62.1 m -77.71 131.26 37.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.465 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.63 138.78 52.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.95 110.12 20.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.865 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 63.3 tp -98.15 117.56 32.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 95.5 t -110.28 132.77 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.517 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.48 136.07 46.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.968 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -62.92 -41.37 99.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.561 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 51.5 mt -132.87 144.28 50.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.232 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.4 117.48 8.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.028 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.98 79.21 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m120 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.28 155.33 22.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.158 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.16 112.15 24.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.92 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.64 161.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.984 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 122.6 0.37 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.54 158.47 38.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -75.34 121.76 22.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.056 0.455 . . . . 0.0 110.713 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.85 146.02 22.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.52 152.24 17.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -91.66 164.46 13.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.952 0.406 . . . . 0.0 111.113 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.4 mtp -132.5 175.27 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.797 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.3 m -125.56 124.09 40.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.6 tp -107.27 119.62 39.9 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.323 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.7 113.78 19.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.952 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -87.78 0.57 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -145.1 21.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.566 0.222 . . . . 0.0 110.723 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.2 m -123.03 130.53 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.337 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.94 123.15 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.872 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.48 128.03 26.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.62 146.71 39.24 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.765 1.643 . . . . 0.0 112.552 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.55 134.56 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.11 -6.96 46.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -73.14 78.21 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -52.79 134.18 36.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.329 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.54 -165.9 11.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.068 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 tp -134.55 125.91 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.78 109.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -134.04 154.21 51.3 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.328 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 137.96 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.584 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.96 131.18 36.89 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.648 0.593 . . . . 0.0 110.399 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -100.87 124.97 47.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.22 0.534 . . . . 0.0 109.998 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 p -84.46 172.23 11.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.696 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.77 -10.0 24.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.653 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.75 7.49 41.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.482 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 m 63.42 24.41 14.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.434 0.635 . . . . 0.0 110.651 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.98 121.97 42.17 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.5 mm -81.14 121.23 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -97.59 113.69 25.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.999 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -93.1 108.35 19.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.3 m -120.86 145.83 47.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.747 0.784 . . . . 0.0 112.89 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -127.6 115.22 18.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.154 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -106.63 145.98 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.38 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -84.18 130.73 34.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -70.79 -17.51 62.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -59.21 -45.45 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.543 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.5 m -117.07 -11.54 10.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.44 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.15 21.47 79.2 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -102.56 148.33 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.1 t -76.27 106.01 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.13 -29.87 31.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.109 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -127.74 145.11 51.01 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.308 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -159.18 100.04 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.764 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' C' ' 47' ' ' GLY . 39.9 mt -128.27 133.59 48.8 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.65 119.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.126 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.3 mm -110.88 120.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.03 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -82.45 163.21 53.27 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.727 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 141.61 94.8 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.162 1.908 . . . . 0.0 111.728 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.95 12.28 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -85.1 -25.14 27.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.555 0.217 . . . . 0.0 110.875 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.7 p -149.26 167.17 26.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.529 0.68 . . . . 0.0 110.695 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.89 130.67 34.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.353 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.07 119.12 38.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.55 167.12 22.84 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.74 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -82.09 160.44 23.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.107 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.04 89.81 12.44 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 59.99 7.64 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.837 1.691 . . . . 0.0 112.246 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -114.65 -36.5 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.129 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 17.2 p -130.44 75.45 79.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.643 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 130.2 34.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.887 1.725 . . . . 0.0 111.558 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t 168.97 -43.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.919 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.05 -147.74 5.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.6 107.24 14.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 110.535 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.19 129.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 111.088 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.49 156.08 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.55 136.81 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 tp -103.31 122.36 44.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -118.76 130.9 56.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.073 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.28 115.81 21.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.289 0.566 . . . . 0.0 109.714 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.44 -37.54 87.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.579 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 -22.0 23.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.643 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.55 -171.84 19.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.4 m -117.8 12.67 13.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.622 0.248 . . . . 0.0 110.682 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -83.92 141.59 31.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.932 0.396 . . . . 0.0 110.787 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.19 125.97 25.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.0 mt -113.53 151.15 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.002 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.85 137.27 54.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.352 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.67 155.0 51.11 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.298 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -129.97 136.43 49.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.723 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 tpp -70.3 131.19 43.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.76 -4.86 17.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.022 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.15 149.13 94.66 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.559 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.43 -27.14 16.27 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.036 1.824 . . . . 0.0 112.922 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.03 142.72 49.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 110.266 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -98.22 13.95 29.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.57 -20.93 59.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -125.62 11.95 7.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.17 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -63.24 -46.57 86.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.698 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -71.84 -34.37 69.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.357 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.08 -46.21 82.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.407 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -63.23 -41.06 99.05 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.606 0.717 . . . . 0.0 109.727 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.99 -45.32 94.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.609 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -64.85 -43.77 91.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.214 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.15 -36.74 84.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.2 -48.26 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.092 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.7 -29.82 40.83 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.952 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -68.61 -36.58 78.86 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.316 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -81.3 -32.82 32.96 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.554 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.6 mt -80.32 -25.25 39.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.284 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -110.12 -20.37 12.71 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.641 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.36 69.13 39.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.487 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.98 159.99 50.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 123.038 2.492 . . . . 0.0 112.382 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -72.27 153.54 92.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.618 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.79 147.22 68.56 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.609 2.206 . . . . 0.0 112.179 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.96 157.5 87.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.0 139.23 84.53 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.551 2.167 . . . . 0.0 111.939 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.88 -172.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.043 1.828 . . . . 0.0 112.059 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -122.46 158.36 56.38 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.433 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.85 141.53 95.9 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.19 162.25 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.636 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -86.91 139.41 30.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.32 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -123.99 124.31 42.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.112 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.06 123.94 51.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.773 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -82.02 84.05 7.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.61 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.4 t0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.776 179.723 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.75 161.6 9.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.955 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 pt -139.73 146.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.092 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.57 124.85 33.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.79 116.02 51.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.84 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -94.92 118.31 31.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.138 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.29 173.08 10.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.251 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.49 -29.03 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.662 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -101.93 -179.1 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.119 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 -17.66 55.43 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -57.2 130.63 47.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.698 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 76.4 m -128.23 135.97 50.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.937 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.24 121.06 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -88.94 127.6 35.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.65 135.28 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.594 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -73.82 118.04 16.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.678 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.49 167.03 26.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.432 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.72 151.23 42.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.87 -35.87 94.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.818 1.679 . . . . 0.0 112.176 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -87.7 -0.99 57.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.115 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -62.81 137.92 58.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.725 0.298 . . . . 0.0 110.878 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -78.87 163.22 25.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.347 0.594 . . . . 0.0 111.342 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -62.75 -37.1 78.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.762 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.35 -41.25 84.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.157 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -64.33 -41.07 96.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 110.594 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.16 -47.36 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.9 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.02 -32.49 72.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.87 98.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.423 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.25 -38.72 84.35 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.42 -39.15 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -57.3 -43.97 83.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.23 -44.73 95.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.27 -78.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.745 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -89.1 149.14 23.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.911 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.72 56.09 4.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 mt -106.96 121.87 43.44 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.083 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.24 157.84 52.96 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.477 1.451 . . . . 0.0 111.19 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.8 -38.22 94.71 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.793 1.662 . . . . 0.0 112.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -61.59 -43.37 98.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -85.75 -5.95 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -87.27 74.91 9.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.151 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -88.58 97.51 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 25.7 mt -87.46 132.71 33.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.142 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.21 129.87 63.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.759 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -150.17 150.9 32.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.29 15.1 9.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.297 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.41 -13.6 64.85 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.9 143.27 43.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.181 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.06 132.3 43.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.684 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.08 98.45 2.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.79 140.43 43.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.523 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -58.81 140.04 55.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.335 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.12 -17.39 54.19 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -82.88 178.11 8.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.842 0.353 . . . . 0.0 110.427 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 58.9 p -125.66 161.56 26.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.948 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.27 -41.4 96.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.648 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -64.2 -22.74 67.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.803 0.335 . . . . 0.0 110.397 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -62.85 -36.8 84.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.398 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -98.16 13.94 29.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.196 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.86 39.81 23.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.181 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.56 117.35 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.962 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -104.43 178.36 4.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.17 143.95 47.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.127 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 60.78 21.08 11.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -70.05 127.84 34.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 81.4 m -78.81 128.34 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -113.18 151.22 31.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.59 116.76 33.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.444 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.32 114.34 26.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.259 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 96.0 t -108.78 127.21 65.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.73 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 26.4 mt -88.9 146.65 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.671 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -104.91 125.93 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 66.0 tp -107.88 121.88 45.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -62.97 -38.93 93.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.602 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.34 -130.87 49.32 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.45 176.99 54.5 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.47 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.79 162.86 8.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.93 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.97 151.25 23.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -91.36 123.25 34.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 79.2 t -109.38 105.89 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.384 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -91.83 127.19 37.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.37 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -87.6 179.17 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.424 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.3 -36.22 81.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.817 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -68.79 -12.68 61.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.071 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.16 66.0 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.75 133.52 51.2 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -104.34 131.95 51.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.211 0.529 . . . . 0.0 110.507 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -121.02 113.44 39.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.625 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 14.0 m -83.98 124.7 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.118 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.05 128.73 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.309 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.15 116.98 12.08 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 110.585 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.4 m -135.39 166.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.012 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.06 153.29 47.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 -29.0 85.75 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.641 1.56 . . . . 0.0 111.912 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 60.3 m -87.47 -9.74 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.705 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -64.32 142.37 58.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 45.7 p -82.19 166.12 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.04 -36.58 76.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.773 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.04 90.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.989 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.36 -41.23 98.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.679 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 67.4 t -63.79 -43.35 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.838 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.536 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.54 90.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.286 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -60.39 -39.49 87.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 mm -64.83 -40.8 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.235 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.447 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.03 -40.81 98.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -76.8 -71.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.88 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.45 152.98 19.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 55.97 4.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . 0.435 HD12 HG21 ' D' ' 36' ' ' ILE . 32.7 mm -107.23 109.85 63.02 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.88 153.31 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.084 1.856 . . . . 0.0 111.51 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.85 -37.91 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.849 1.7 . . . . 0.0 112.233 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.15 -39.38 89.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -12.5 40.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -78.99 86.04 4.89 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.875 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -97.44 115.27 27.44 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.71 118.1 36.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.2 mt -125.09 127.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.474 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -119.1 127.24 53.19 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.46 26.35 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.15 2.71 90.6 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -112.86 121.84 45.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.013 0.407 . . . . 0.0 110.335 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -60.25 142.98 53.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.041 0.448 . . . . 0.0 110.388 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.09 123.85 27.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.063 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.92 138.67 50.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.69 129.96 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.093 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.91 -14.64 61.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.41 174.15 10.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -117.95 160.87 20.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.61 -39.87 92.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -63.88 -23.9 67.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.308 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -62.13 -37.6 85.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.295 0.569 . . . . 0.0 110.202 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -98.11 13.95 29.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.374 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 55.93 40.09 30.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.273 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -85.47 105.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.68 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -88.99 -172.82 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.434 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.55 149.58 49.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.316 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 57.5 42.39 24.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -89.87 121.43 31.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.965 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 67.3 m -71.33 127.57 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.98 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.41 139.53 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.173 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -88.22 105.35 17.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 67.3 tp -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 98.4 t -108.83 133.46 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.115 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 25.7 mt -96.13 129.58 43.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.427 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -74.18 142.51 45.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 mt -92.0 4.85 52.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.907 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 58.55 26.7 14.69 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.615 0.245 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.84 19.49 75.2 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.79 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -69.36 153.91 42.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -94.88 128.77 41.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 109.897 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 49' ' ' ILE . 85.7 mt -69.78 -36.31 75.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.61 160.92 7.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.504 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -174.2 122.21 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.41 159.85 40.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.139 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.37 117.8 19.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.554 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.99 142.17 22.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.26 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.39 154.15 17.56 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -93.61 176.32 6.41 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.773 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.7 mtp -139.84 172.88 12.15 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.13 124.76 44.64 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.38 117.08 33.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.015 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -120.42 116.64 25.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.598 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 -85.76 0.36 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.56 22.04 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.576 0.227 . . . . 0.0 110.714 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.6 m -122.97 130.13 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.888 0.375 . . . . 0.0 110.559 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.4 122.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.667 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 p -112.55 120.85 40.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.37 141.34 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.029 1.819 . . . . 0.0 112.348 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -98.08 116.27 29.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.46 -15.05 14.94 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.142 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -74.57 73.63 1.97 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.541 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -54.15 140.94 30.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.754 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.26 -156.49 7.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.002 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.4 tp -135.22 125.66 26.67 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.95 109.14 23.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.314 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.23 154.55 49.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.273 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.0 mt -120.79 139.07 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.562 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.03 128.19 27.88 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.764 0.665 . . . . 0.0 110.485 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -98.63 124.93 43.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.072 0.463 . . . . 0.0 109.936 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 p -85.33 172.46 11.07 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.56 -10.17 24.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.766 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.18 7.92 40.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.296 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.7 m 62.3 25.95 15.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.261 0.553 . . . . 0.0 110.623 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -100.21 120.79 40.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.1 mm -81.46 120.25 32.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -96.58 113.89 25.49 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.531 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -97.43 107.09 19.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 143.32 50.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.889 0.852 . . . . 0.0 112.861 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -119.44 117.39 28.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.51 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -106.69 144.02 33.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.375 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -81.81 130.26 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -72.59 -17.59 61.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.05 0.452 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -59.21 -45.41 91.17 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -117.16 -12.42 10.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.307 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.94 23.58 77.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -102.07 152.31 21.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.81 101.97 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.215 0.531 . . . . 0.0 110.451 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.41 -38.1 65.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.125 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -126.4 145.52 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.285 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -158.26 98.18 1.55 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.143 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.5 mt -125.34 136.62 53.65 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 111.085 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.84 118.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 mm -109.15 120.41 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.196 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -82.59 163.24 52.81 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.598 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.02 141.08 96.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.498 2.132 . . . . 0.0 111.745 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t0 59.86 11.81 2.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.419 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.12 -29.38 28.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.727 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 p -148.03 168.7 21.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.411 0.624 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.17 130.94 36.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.354 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -100.96 118.83 37.75 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.92 168.03 20.71 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.645 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -83.24 157.68 22.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.45 88.88 9.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.56 60.17 7.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.831 1.687 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -114.28 -36.55 4.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.283 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -130.25 81.93 67.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.71 130.36 27.69 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.762 1.641 . . . . 0.0 111.817 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.0 -38.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.819 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.05 -153.25 6.08 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.14 106.59 15.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.1 t -125.8 129.57 72.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.02 154.43 39.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.434 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.83 136.75 59.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.943 0.402 . . . . 0.0 110.44 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.1 tp -102.98 121.37 42.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -118.51 132.24 56.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.048 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -82.96 115.21 21.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.302 0.572 . . . . 0.0 109.515 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.97 -37.64 87.94 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.36 -22.85 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.465 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.94 -171.74 20.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.9 m -119.52 13.95 12.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.566 0.222 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -86.55 141.14 29.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.004 0.431 . . . . 0.0 111.085 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -133.77 129.02 36.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.082 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.59 147.57 40.6 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.786 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -119.84 135.88 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.564 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.82 155.13 50.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -130.57 137.5 49.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.342 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.2 mmm -73.59 138.83 45.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.32 6.29 32.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.728 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.9 141.07 58.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.06 -26.3 26.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.945 1.763 . . . . 0.0 112.459 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.51 142.62 48.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.33 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.3 p -95.08 9.02 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.495 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.2 -20.36 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.21 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -126.38 -9.67 6.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.839 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.98 -40.64 98.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 110.719 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -69.93 -35.89 74.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.58 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.12 -42.99 88.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -63.96 -38.67 91.94 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.997 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.95 -46.03 92.36 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.031 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.46 -43.92 95.96 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.23 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.78 -38.23 87.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.1 t -58.38 -48.29 85.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.232 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.49 -28.84 41.46 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.934 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.38 -38.1 81.05 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.604 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.2 -32.42 33.52 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.02 -26.12 43.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -110.36 -21.03 12.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.82 67.7 42.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.371 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.11 158.42 56.56 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.984 2.456 . . . . 0.0 112.29 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.217 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.22 148.66 95.88 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.533 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.25 147.29 25.9 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.713 2.275 . . . . 0.0 112.089 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.91 155.87 90.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.74 151.11 69.12 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.059 1.839 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.74 -172.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.134 1.889 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -122.38 155.82 61.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.0 141.36 88.89 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.083 1.855 . . . . 0.0 112.073 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.82 163.45 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.739 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -86.58 138.73 31.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.379 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.78 127.64 46.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.073 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.9 123.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.635 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.38 83.57 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.079 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 . . . . . 0 C--O 1.218 -0.578 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.522 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.85 163.84 11.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.519 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.66 143.45 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.519 ' HD2' HG21 ' C' ' 12' ' ' THR . 6.3 m-85 -87.46 122.07 30.72 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.754 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.2 t -106.63 113.3 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.963 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -97.55 120.86 38.69 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.771 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.828 HG22 HD23 ' C' ' 69' ' ' LEU . 76.9 p -82.06 171.23 14.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.595 HD11 ' H ' ' C' ' 71' ' ' LEU . 55.9 mt -64.85 -25.08 67.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.907 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -74.23 -9.27 58.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.86 -10.05 70.47 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -73.19 133.21 43.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' THR . . . . . 0.519 HG21 ' HD2' ' C' ' 4' ' ' PHE . 95.7 m -107.3 132.19 53.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.79 111.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.655 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -83.32 127.9 34.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.5 mt -120.41 132.43 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.21 117.52 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.484 HG12 ' HE3' ' C' ' 29' ' ' LYS . 27.5 m -135.72 163.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -103.93 152.04 38.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.86 -35.7 94.3 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.973 1.782 . . . . 0.0 112.148 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.28 -3.11 58.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -61.86 137.57 58.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.961 0.41 . . . . 0.0 110.704 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -78.29 162.87 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.483 HD12 HD13 ' C' ' 50' ' ' LEU . 47.9 mm -64.53 -38.11 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.864 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.36 -42.11 90.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.032 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.06 -40.74 96.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.196 0.522 . . . . 0.0 110.519 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.508 HG21 HD21 ' C' ' 56' ' ' LEU . 61.3 t -63.31 -42.72 97.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.659 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.73 -40.09 91.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.5 90.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.254 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.484 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.89 -38.78 83.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.764 ' CD1' HD21 ' C' ' 43' ' ' LEU . 95.0 mt -66.74 -38.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.434 0.635 . . . . 0.0 110.359 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.39 -46.67 88.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.221 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.62 -31.24 68.13 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.481 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -89.8 -4.33 57.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -147.95 -41.64 0.17 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.45 11.77 28.37 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.309 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.577 HG22 ' HG3' ' C' ' 41' ' ' GLN . 59.5 mt -75.79 121.09 84.39 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.42 154.54 63.42 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.496 1.464 . . . . 0.0 111.495 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.18 -31.19 94.9 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.937 1.758 . . . . 0.0 112.771 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.99 -40.22 94.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.905 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.32 -7.48 57.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.956 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.577 ' HG3' HG22 ' C' ' 36' ' ' ILE . 91.4 mt-30 -87.04 105.98 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.155 0.502 . . . . 0.0 111.536 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -116.51 99.11 6.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.175 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.764 HD21 ' CD1' ' C' ' 30' ' ' ILE . 75.6 mt -86.4 131.18 34.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.25 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.503 HG21 ' HE1' ' A' ' 76' ' ' PHE . 85.5 mt -131.36 127.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.695 0.283 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 67.7 t80 -149.17 150.87 33.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.127 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.82 16.41 9.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.46 -14.36 59.82 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.778 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -113.44 144.34 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.965 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -71.25 135.08 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.006 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' C' ' 43' ' ' LEU . 52.9 mt -71.64 105.44 3.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.781 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -75.22 139.03 42.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.41 138.55 57.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.41 55.84 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -82.04 172.55 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.4 p -118.26 161.69 19.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.579 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.508 HD21 HG21 ' C' ' 26' ' ' VAL . 84.1 mt -61.69 -40.46 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.983 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -63.85 -23.46 67.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.3 -37.6 86.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.134 0.492 . . . . 0.0 110.184 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.39 13.19 28.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.201 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.77 40.26 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.78 114.63 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.942 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -100.2 -179.6 4.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.845 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.75 146.19 53.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 59.24 17.45 5.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -70.6 132.62 45.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -82.81 128.6 34.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.96 140.24 49.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.852 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.01 117.44 28.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.954 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.828 HD23 HG22 ' C' ' 7' ' ' THR . 57.2 tp -100.43 121.42 41.51 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.009 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.712 HG11 HD11 ' A' ' 56' ' ' LEU . 62.5 t -111.98 132.57 60.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.066 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.595 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.9 mt -109.36 145.66 35.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.093 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 . . . . . 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.623 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.76 163.51 13.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.299 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 pt -143.94 145.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.535 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -92.88 121.53 34.33 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.672 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -104.73 104.63 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.42 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -87.54 126.7 35.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.846 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.807 HG22 HD23 ' D' ' 69' ' ' LEU . 79.2 p -77.52 -171.86 2.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.854 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' D' ' 70' ' ' VAL . 88.8 mt -59.09 -19.88 48.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.673 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 22.2 p -111.15 -176.37 2.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.95 -18.45 57.21 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.76 131.04 38.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.082 0.468 . . . . 0.0 110.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -125.08 136.91 54.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.499 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.39 104.99 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.837 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -83.26 129.07 34.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' D' ' 29' ' ' LYS . 77.0 mt -124.51 131.97 53.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -76.63 116.56 17.42 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.343 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.735 HG12 ' HE3' ' D' ' 29' ' ' LYS . 27.3 m -135.15 161.7 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.65 152.71 40.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.02 -29.62 83.59 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.614 1.543 . . . . 0.0 111.791 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.7 p -80.97 -12.6 59.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.839 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.03 144.72 57.09 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.909 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -85.71 165.35 17.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.21 0.528 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.434 HD12 HD13 ' D' ' 50' ' ' LEU . 47.1 mm -62.79 -38.1 80.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.04 88.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.692 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.63 -41.07 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 110.345 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.523 HG21 HD21 ' D' ' 56' ' ' LEU . 63.2 t -63.4 -42.3 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -61.1 -40.55 94.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 110.202 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.87 89.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.905 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.735 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.1 mttm -59.75 -38.26 81.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.788 ' CD1' HD21 ' D' ' 43' ' ' LEU . 85.6 mt -64.24 -39.92 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 31' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' D' ' 35' ' ' GLY . 65.9 tt0 -60.35 -44.78 95.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.25 0.548 . . . . 0.0 110.134 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.48 -41.06 98.59 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.622 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.45 ' HD2' HD21 ' D' ' 15' ' ' LEU . 18.0 mttm -83.52 -14.53 52.08 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -136.36 -50.04 0.68 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 113.37 9.5 17.32 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.565 HD13 ' CD2' ' D' ' 71' ' ' LEU . 59.6 mt -78.08 125.69 84.82 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.59 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.99 159.95 50.87 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 120.917 1.078 . . . . 0.0 109.88 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.49 -40.41 78.82 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.165 1.91 . . . . 0.0 112.864 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.79 -44.37 96.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.65 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.65 -40.16 80.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.893 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.577 ' OE1' HD12 ' D' ' 30' ' ' ILE . 24.1 pt20 -85.57 140.71 30.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.206 0.527 . . . . 0.0 111.383 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' ARG . . . . . 0.552 HH21 HG11 ' D' ' 70' ' ' VAL . 61.3 mtm180 -130.25 118.96 22.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.788 HD21 ' CD1' ' D' ' 30' ' ' ILE . 74.3 mt -96.22 118.14 32.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.134 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -124.22 127.52 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 68.6 t80 -123.67 128.59 49.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.259 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 64.81 26.75 12.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.502 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.48 13.2 83.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -121.72 127.44 50.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.23 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -62.43 135.37 57.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 0.0 110.476 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' D' ' 43' ' ' LEU . 84.5 mt -80.57 103.87 10.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.154 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.66 143.99 49.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.401 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -67.49 167.07 13.48 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.424 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 18.37 79.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -128.87 148.83 50.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -90.9 165.31 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.523 HD21 HG21 ' D' ' 26' ' ' VAL . 81.2 mt -62.79 -38.39 90.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.394 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -62.54 -25.55 68.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.243 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -36.55 81.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.095 0.474 . . . . 0.0 110.156 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.32 14.42 24.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 56.42 39.27 30.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.19 104.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.01 -175.03 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.344 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -67.53 150.16 49.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.101 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 58.06 30.09 18.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.813 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 31.1 m -81.2 128.01 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 30.8 m -85.76 122.47 29.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.7 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.17 145.82 36.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.45 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -89.91 115.85 27.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.807 HD23 HG22 ' D' ' 7' ' ' THR . 49.8 tp -100.85 118.54 37.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' D' ' 8' ' ' LEU . 96.9 t -116.02 130.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.872 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.565 ' CD2' HD13 ' D' ' 36' ' ' ILE . 48.8 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.674 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.68 112.05 23.86 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.5 mt -65.97 -38.69 89.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.621 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.4 p -148.84 163.48 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.668 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -173.7 122.18 0.34 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.187 0.518 . . . . 0.0 110.855 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.07 156.61 37.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.378 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -72.29 125.04 26.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.081 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -159.13 143.26 15.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.549 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.68 163.11 12.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -96.57 171.9 8.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.239 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.0 mtp -136.95 174.94 10.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -124.33 128.85 49.73 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.524 HD22 ' CE1' ' A' ' 106' ' ' PHE . 36.3 tp -108.15 116.89 32.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.179 0.514 . . . . 0.0 110.193 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.65 111.34 18.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.397 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.22 0.37 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -142.41 20.34 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.856 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.498 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.3 m -120.25 129.27 53.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.769 0.319 . . . . 0.0 110.485 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.0 t -107.95 122.29 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.032 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.6 p -114.47 131.37 23.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.38 147.57 52.99 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.744 1.629 . . . . 0.0 112.996 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -100.78 133.92 44.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -70.73 -12.46 61.57 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.008 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -76.34 68.97 2.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -58.88 134.41 56.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.9 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.11 -150.57 7.15 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.223 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 27' ' ' ARG . 2.7 tp -137.51 126.64 24.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 28' ' ' ALA . 48.8 t -97.65 112.7 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.07 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -134.52 155.0 51.16 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.3 mt -118.61 136.62 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.698 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.75 129.61 32.83 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 123.495 0.497 . . . . 0.0 110.463 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.486 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.4 tt0 -99.24 125.34 44.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 110.301 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.516 HG23 ' CD2' ' A' ' 58' ' ' HIS . 18.9 p -86.23 170.12 12.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.423 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -61.95 -10.56 9.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.296 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.77 0.83 56.13 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.472 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.76 19.93 7.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.255 0.55 . . . . 0.0 110.48 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.712 HD11 HG11 ' C' ' 70' ' ' VAL . 83.4 mt -98.49 123.34 42.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.6 mm -80.85 123.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.516 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.5 m-70 -99.38 114.76 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.978 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -93.16 107.69 19.44 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.4 m -120.65 148.22 44.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.717 0.77 . . . . 0.0 113.036 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -127.83 115.24 18.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.175 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.52 131.74 53.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.932 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -72.11 134.37 45.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.63 -17.42 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.942 0.401 . . . . 0.0 110.428 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -60.03 -45.65 92.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.694 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.0 p -116.37 -16.77 10.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.131 0.491 . . . . 0.0 109.871 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.67 22.15 75.57 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -100.46 152.26 20.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.08 104.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.851 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -82.13 -29.78 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.354 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -126.71 146.29 50.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.408 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.74 ' O ' HD23 ' A' ' 73' ' ' LEU . 68.5 t0 -157.56 101.26 1.83 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.856 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.778 HD22 ' HB3' ' C' ' 48' ' ' LYS . 13.8 mt -130.95 128.88 41.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.427 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.427 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -75.23 124.83 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.606 HG21 ' SG ' ' A' ' 80' ' ' CYS . 24.4 mm -114.0 122.23 67.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.631 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 65.5 m-85 -88.44 162.92 38.17 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.586 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.87 138.54 86.29 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.202 1.934 . . . . 0.0 111.831 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.05 6.2 1.68 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.754 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -71.68 -37.64 70.72 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.683 0.277 . . . . 0.0 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 96' ' ' LEU . 19.7 p -146.81 167.08 24.77 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.732 0.777 . . . . 0.0 111.019 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -128.52 128.94 45.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.324 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -99.04 118.53 36.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -143.64 165.55 27.3 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.913 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -79.53 160.29 26.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.62 90.36 12.45 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.109 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.59 59.75 7.54 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.812 1.675 . . . . 0.0 112.381 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.0 -39.76 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.321 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 p -127.82 75.45 78.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.478 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.04 130.01 30.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.981 1.788 . . . . 0.0 111.474 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.43 -44.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.662 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.38 -148.32 6.53 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -116.1 106.37 13.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.97 127.82 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -123.73 155.09 38.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.692 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 105' ' ' LEU . 13.1 p -129.75 138.37 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.089 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' A' ' 80' ' ' CYS . 67.8 tp -104.78 121.24 43.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -117.79 121.64 41.33 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.172 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.491 ' HE2' HD12 ' A' ' 75' ' ' ILE . 59.1 m-85 -80.68 112.3 17.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.52 -36.21 77.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.695 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.1 -17.71 14.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.397 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -85.89 -13.9 68.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.576 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 53.2 31.46 11.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.09 0.445 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 98' ' ' PHE . 12.1 ttmm -120.75 145.73 47.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.249 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -127.06 127.93 45.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.089 0.471 . . . . 0.0 111.532 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 95' ' ' VAL . 48.9 mt -119.32 149.14 42.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.62 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.524 ' CE1' HD22 ' A' ' 33' ' ' LEU . 91.2 m-85 -123.61 134.96 53.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.558 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.23 155.43 50.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.38 0.61 . . . . 0.0 111.322 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -129.01 136.23 50.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.183 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.5 mtp -81.29 138.4 35.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.227 0.537 . . . . 0.0 111.51 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.91 5.3 49.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.669 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.95 130.96 89.45 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.183 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.6 -24.83 41.29 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.692 1.595 . . . . 0.0 112.686 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.4 143.24 48.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.453 HG22 ' HG2' ' A' ' 92' ' ' ARG . 74.4 p -95.68 11.45 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.02 -20.62 58.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.431 ' NE2' ' OE1' ' A' ' 119' ' ' GLU . 23.4 mm100 -122.81 9.28 9.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.067 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -62.85 -45.69 91.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.41 -32.82 73.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.415 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.431 ' OE1' ' NE2' ' A' ' 116' ' ' GLN . 88.8 tt0 -64.48 -46.69 81.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.41 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.657 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.1 m170 -64.54 -40.81 96.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 109.626 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.1 t -63.1 -44.27 96.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.262 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -69.8 -41.33 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.241 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.54 -42.71 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.378 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.6 t -57.77 -48.26 84.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.917 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.824 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.12 -20.68 63.17 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.549 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 23.3 m-85 -94.41 -18.2 21.77 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.746 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 124' ' ' VAL . 86.3 mt -95.62 -24.64 16.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.096 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -118.72 -12.25 9.71 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.271 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.15 64.71 55.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.122 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.23 152.67 75.78 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.492 1.394 0 C-N-CA 122.245 1.963 . . . . 0.0 111.872 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -129.13 148.6 69.73 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.635 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.46 146.71 27.89 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.606 2.204 . . . . 0.0 112.194 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -73.41 153.03 90.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.45 154.0 65.34 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.938 1.759 . . . . 0.0 112.139 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.65 -170.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.336 2.024 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -126.43 159.02 65.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.197 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.41 139.9 87.79 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.457 2.105 . . . . 0.0 112.331 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.41 163.6 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.604 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -86.44 134.3 33.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -118.72 131.39 56.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -63.95 158.92 21.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.237 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.34 148.82 24.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.114 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -91.37 120.99 32.7 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.285 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.63 110.22 29.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -98.27 121.29 40.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.638 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -82.2 173.83 11.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.526 HD11 ' H ' ' C' ' 71' ' ' LEU . 74.3 mt -61.65 -30.35 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -71.25 -12.15 61.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.13 -13.98 62.87 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.43 131.86 49.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 110.364 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 95.3 m -108.93 131.03 55.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.392 . . . . 0.0 110.374 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.03 114.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.474 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 29.1 m -81.32 129.98 34.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.347 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.61 127.32 48.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -71.3 115.26 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.452 HG12 ' CD ' ' C' ' 29' ' ' LYS . 25.7 m -135.37 163.49 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.634 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.34 152.86 40.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.98 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.35 -37.23 94.8 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.119 1.879 . . . . 0.0 112.229 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -83.84 -4.92 59.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.063 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -59.72 136.97 58.16 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.953 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -77.58 161.75 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.2 mm -63.91 -38.99 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.236 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.13 -42.02 89.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.27 -41.04 98.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.145 0.498 . . . . 0.0 110.619 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 56' ' ' LEU . 54.1 t -63.19 -43.45 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.77 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.63 -39.97 90.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.237 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.452 ' CD ' HG12 ' C' ' 17' ' ' VAL . 67.5 mttm -60.55 -39.68 88.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.637 HG21 HD11 ' C' ' 69' ' ' LEU . 95.7 mt -66.28 -39.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.308 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.57 -40.99 93.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.32 -39.6 92.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.151 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -74.86 -64.39 1.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.712 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.17 170.93 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.219 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.26 21.12 26.31 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.679 HG22 ' HG3' ' C' ' 41' ' ' GLN . 27.3 mm -77.03 117.49 65.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.851 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.77 156.27 57.26 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.299 1.999 . . . . 0.0 111.797 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.07 -39.3 70.6 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.071 1.847 . . . . 0.0 112.526 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.13 -39.59 93.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.681 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.39 -3.51 56.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.114 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.679 ' HG3' HG22 ' C' ' 36' ' ' ILE . 17.7 mt-30 -87.42 68.04 9.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.61 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' C' ' 70' ' ' VAL . 94.0 mtt-85 -85.53 110.72 19.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.55 ' HB2' HD12 ' C' ' 50' ' ' LEU . 25.9 mt -98.78 132.58 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.64 129.62 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 110.525 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.66 151.65 40.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.984 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.88 15.56 6.11 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.34 -14.25 63.0 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.678 ' CG ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -107.2 140.71 39.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.56 133.88 44.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' C' ' 43' ' ' LEU . 48.6 mt -72.22 102.2 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.891 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -75.3 140.12 42.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.83 137.94 57.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.216 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.47 -17.78 52.58 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmp_? -83.49 177.7 8.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.337 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -125.24 163.21 23.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.109 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 26' ' ' VAL . 85.4 mt -61.54 -40.93 96.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.552 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.83 -24.41 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.78 -37.93 86.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.2 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.72 13.88 26.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.509 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.79 39.34 27.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.41 . . . . 0.0 110.264 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.414 HG21 HD22 ' C' ' 56' ' ' LEU . 63.2 mt -85.54 118.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.069 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -106.87 -179.18 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.686 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -61.97 146.14 50.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.935 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.6 15.63 9.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.618 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.8 m -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.545 ' C ' HD12 ' C' ' 67' ' ' LEU . 88.3 m -82.54 129.77 34.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.064 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.545 HD12 ' C ' ' C' ' 66' ' ' THR . 9.9 mp -114.89 144.31 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.127 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -95.83 118.14 31.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.231 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.637 HD11 HG21 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -96.82 123.32 40.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 56' ' ' LEU . 66.4 t -114.49 126.95 72.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.947 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.526 ' H ' HD11 ' C' ' 8' ' ' LEU . 15.7 mt -98.45 -174.25 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.405 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.332 . . . . 0.0 110.527 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -63.21 154.83 30.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.078 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -133.9 160.72 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.321 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.623 ' CD2' HG23 ' D' ' 14' ' ' THR . 12.9 m-30 -101.59 125.71 48.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.615 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.47 HG21 HD12 ' D' ' 15' ' ' LEU . 78.5 t -111.56 107.15 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.898 0.38 . . . . 0.0 111.008 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -85.2 129.23 34.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.679 HG22 HD23 ' D' ' 69' ' ' LEU . 68.5 p -90.18 176.6 6.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 110.961 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.648 HD11 ' H ' ' D' ' 71' ' ' LEU . 90.1 mt -60.65 -37.37 81.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -74.68 -8.22 55.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.75 67.37 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -63.29 126.59 27.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.059 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 92.3 m -96.21 136.88 36.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 0.0 110.611 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -122.3 118.18 54.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.278 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.623 HG23 ' CD2' ' D' ' 4' ' ' PHE . 0.2 OUTLIER -83.41 125.14 31.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.061 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 29' ' ' LYS . 90.5 mt -123.26 113.11 18.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.94 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -65.78 106.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.242 0.544 . . . . 0.0 110.853 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.658 HG12 ' HE3' ' D' ' 29' ' ' LYS . 32.7 m -130.61 163.2 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.639 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -105.76 155.09 38.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.58 -37.24 97.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.174 1.916 . . . . 0.0 111.981 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -83.42 -5.22 59.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.976 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -59.15 138.06 57.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.995 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -79.65 161.35 25.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.944 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -64.02 -38.37 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.755 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.77 -41.59 86.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.817 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.17 -41.4 98.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 110.714 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.406 HG22 HG11 ' D' ' 17' ' ' VAL . 65.9 t -64.19 -42.73 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.1 mtmt -60.52 -39.8 89.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.406 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.63 92.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.511 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.681 ' HB3' HD22 ' D' ' 15' ' ' LEU . 66.8 mttm -59.82 -40.06 87.14 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.62 -39.62 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.338 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.17 -42.42 90.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.678 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -90.69 19.73 5.21 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -122.52 -39.56 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -126.11 -6.99 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.315 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 18.87 76.6 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.675 ' CD1' HD21 ' D' ' 69' ' ' LEU . 70.8 mt -77.05 120.56 82.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 147.84 92.36 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.341 2.027 . . . . 0.0 111.727 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 -41.76 62.97 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.943 1.762 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.11 -32.02 72.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.9 -10.24 58.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.466 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.625 ' HG3' HG22 ' D' ' 36' ' ' ILE . 89.2 mt-30 -88.88 112.97 23.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.601 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -115.74 101.42 8.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' D' ' 27' ' ' LYS . 10.0 mt -94.66 118.48 31.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.2 mt -125.99 123.08 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.116 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -113.42 122.83 48.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.15 30.11 19.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.473 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.46 89.99 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -103.41 119.11 38.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -64.11 138.64 58.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' D' ' 43' ' ' LEU . 49.3 mt -90.5 105.34 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.33 153.32 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.728 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -72.37 161.21 31.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.063 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.89 84.69 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.01 176.98 4.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.707 0.289 . . . . 0.0 110.45 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -126.16 164.42 20.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.406 HD21 HG21 ' D' ' 26' ' ' VAL . 91.1 mt -62.24 -39.79 94.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.743 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -63.27 -29.52 70.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 0.0 110.923 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.78 -32.17 72.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.46 14.19 30.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.215 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 55.83 39.93 30.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.817 0.341 . . . . 0.0 110.542 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.35 105.01 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.817 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.26 -177.04 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.436 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -61.08 148.76 39.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.085 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 56.96 47.7 17.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -104.62 124.45 49.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.318 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.537 ' C ' HD12 ' D' ' 67' ' ' LEU . 94.4 m -74.66 130.73 40.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.537 HD12 ' C ' ' D' ' 66' ' ' THR . 7.9 mp -121.25 145.68 47.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -91.16 111.19 22.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.923 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.679 HD23 HG22 ' D' ' 7' ' ' THR . 64.4 tp -98.28 118.03 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.531 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.3 t -115.84 135.61 55.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.071 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.648 ' H ' HD11 ' D' ' 8' ' ' LEU . 49.0 mt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.528 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -97.05 126.18 42.02 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.332 0.587 . . . . 0.0 109.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 51' ' ' GLN . 86.3 mt -68.24 -38.58 81.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.092 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -145.64 161.45 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.88 179.136 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.7 122.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.23 158.98 41.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.071 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.75 121.21 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.945 0.402 . . . . 0.0 111.004 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.77 145.0 22.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.27 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.86 153.15 17.28 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -88.2 173.95 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.977 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.5 mtp -136.93 175.47 9.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.9 m -124.23 124.56 42.71 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.473 HD13 ' CG2' ' A' ' 38' ' ' VAL . 25.8 tp -106.35 116.94 32.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.47 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -120.02 110.53 16.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.795 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -90.46 0.47 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 p -140.18 23.09 2.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.608 0.242 . . . . 0.0 110.745 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.0 m -125.06 129.82 51.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.655 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.473 ' CG2' HD13 ' A' ' 33' ' ' LEU . 61.2 t -110.99 122.72 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.3 m -118.74 129.08 25.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.05 146.48 64.75 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.692 1.594 . . . . 0.0 113.183 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.93 136.32 39.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.791 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -71.16 -8.73 55.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.639 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.87 77.32 0.89 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -58.08 134.23 56.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.96 -160.79 9.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.679 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.7 tp -137.41 123.98 20.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -95.48 109.91 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.249 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -131.32 154.98 47.98 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.191 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -120.45 140.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.454 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.77 128.17 26.39 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.827 0.705 . . . . 0.0 110.35 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.75 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.7 tt0 -99.5 124.4 44.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 58' ' ' HIS . 10.7 p -84.63 172.14 11.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.65 -10.56 27.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.93 1.54 55.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.561 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t 70.24 21.05 6.01 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.309 0.576 . . . . 0.0 110.432 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.672 HD11 HG11 ' C' ' 70' ' ' VAL . 75.5 mt -98.76 121.56 40.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.622 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -80.22 121.23 33.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.461 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 52' ' ' THR . 70.2 m-70 -97.65 114.25 26.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.614 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -97.59 107.05 19.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.06 50.29 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.782 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -117.82 116.06 26.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.571 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -105.55 144.95 31.6 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.416 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.41 130.89 35.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.15 -18.69 62.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 110.755 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.1 m -59.41 -45.49 91.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.608 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.4 m -117.06 -11.85 10.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.972 0.415 . . . . 0.0 110.496 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 22.77 78.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.37 149.94 23.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.669 0.271 . . . . 0.0 110.448 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.58 102.19 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.07 -38.76 66.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.836 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -126.37 146.17 50.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.069 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.8 t0 -157.9 100.8 1.76 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.678 HD22 ' CG ' ' C' ' 48' ' ' LYS . 35.0 mt -126.86 135.93 51.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.976 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.2 mt -77.96 120.51 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.225 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.699 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.4 mm -110.5 121.48 63.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.236 0.541 . . . . 0.0 111.153 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.639 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 59.6 m-85 -85.08 163.04 47.38 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.799 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.53 140.21 92.61 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.105 1.87 . . . . 0.0 111.567 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t0 60.08 11.86 2.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.45 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -84.23 -26.26 28.82 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.863 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.699 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.7 p -150.76 168.69 23.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.523 0.678 . . . . 0.0 110.603 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -135.06 131.72 37.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.382 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -103.38 117.34 34.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -142.13 167.52 21.93 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.823 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -82.69 160.25 22.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.945 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -112.64 90.12 14.32 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.014 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.9 60.05 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.904 1.736 . . . . 0.0 112.347 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.52 -39.72 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.514 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.3 t -127.44 85.99 59.6 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.647 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.39 130.62 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.679 1.586 . . . . 0.0 111.671 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 169.29 -40.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.13 -157.9 7.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -104.52 109.23 21.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.21 129.02 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -126.54 153.24 45.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.36 135.34 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.589 HD11 ' SG ' ' A' ' 80' ' ' CYS . 66.2 tp -103.61 119.92 39.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -116.29 131.13 57.03 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.302 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -84.47 114.37 21.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.038 0.447 . . . . 0.0 109.988 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.41 -36.49 82.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.46 -24.01 66.37 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.294 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -137.82 -148.98 5.46 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.7 p -121.08 7.2 10.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.637 0.256 . . . . 0.0 111.014 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HE2' HD21 ' A' ' 105' ' ' LEU . 87.6 tttt -63.19 134.87 56.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -136.48 135.64 38.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.971 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.466 HD21 ' HE2' ' A' ' 103' ' ' LYS . 60.9 mt -119.55 145.01 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.517 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 33' ' ' LEU . 95.7 m-85 -116.36 131.66 56.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.724 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.6 154.84 51.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.237 0.542 . . . . 0.0 110.915 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -128.63 137.08 51.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.306 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.45 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 26.9 tpp -73.88 140.2 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.527 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.73 1.73 19.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 109' ' ' MET . 76.5 mm-40 -73.39 141.07 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.587 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -28.98 22.64 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.886 1.724 . . . . 0.0 112.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -119.1 143.63 47.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.477 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.2 p -97.73 6.01 48.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.021 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -58.2 -21.61 48.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -124.19 -14.18 7.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.046 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.32 -41.24 98.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.646 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.51 -40.35 96.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.75 -41.91 97.92 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.495 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.8 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.2 m170 -63.35 -40.61 97.77 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.49 0.662 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.19 -46.8 88.97 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -65.5 -36.96 85.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.314 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -33.46 67.54 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.275 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.3 t -60.63 -46.71 95.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.146 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.51 -31.96 53.83 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -71.04 -30.56 66.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.349 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -83.75 -29.73 27.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.91 0.386 . . . . 0.0 110.304 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.622 HD23 HG21 ' A' ' 57' ' ' ILE . 67.9 mt -87.75 -23.68 24.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.913 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -108.91 -24.42 11.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.52 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -135.73 67.79 65.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.37 160.27 49.18 Favored 'Trans proline' 0 C--N 1.297 -2.137 0 C-N-CA 122.849 2.366 . . . . 0.0 112.242 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.187 . . . . 0.0 112.228 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.35 151.11 77.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.46 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.19 147.8 26.56 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.181 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.78 152.82 89.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.011 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.67 152.15 64.4 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.392 2.061 . . . . 0.0 112.221 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.85 -174.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.421 2.08 . . . . 0.0 111.964 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -122.44 157.64 58.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.205 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.19 139.49 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 122.457 2.105 . . . . 0.0 111.709 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 165.15 37.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -86.08 138.41 31.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.419 HD13 HG21 ' B' ' 951' ' ' ILE . 3.8 mt . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' C' ' 16' ' ' GLU . 9.6 pt20 -62.1 157.65 18.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -139.41 148.15 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.933 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.79 124.21 40.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.777 0.322 . . . . 0.0 110.986 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.722 HG11 HD12 ' C' ' 69' ' ' LEU . 99.4 t -108.18 114.57 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.646 -0.421 . . . . 0.0 109.99 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -97.31 119.86 36.61 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.342 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.6 p -79.56 171.83 14.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.535 HD11 ' H ' ' C' ' 71' ' ' LEU . 56.9 mt -62.51 -24.85 67.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.171 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -75.57 -10.5 59.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.051 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.56 -14.48 64.16 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.62 133.09 49.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 110.34 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -107.56 132.19 53.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.389 . . . . 0.0 110.759 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.1 112.67 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.466 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.01 132.99 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.666 HD21 ' HG3' ' C' ' 33' ' ' LYS . 29.6 mt -130.96 122.24 26.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' C' ' 2' ' ' GLN . 8.7 pt-20 -66.81 115.17 6.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.1 163.45 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.589 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -107.3 152.7 41.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.634 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -37.16 87.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.922 1.748 . . . . 0.0 112.089 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -80.43 -9.57 59.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -58.51 136.0 57.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -77.61 158.97 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.134 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.497 HD12 HD13 ' C' ' 50' ' ' LEU . 46.8 mm -66.43 -40.98 87.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -59.13 -42.7 91.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.36 -43.97 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.303 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.16 -44.01 97.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -38.63 79.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.061 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.04 94.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.532 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.444 ' HE2' HD22 ' C' ' 15' ' ' LEU . 9.4 mtmm -61.68 -37.48 84.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.139 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.821 ' CD1' HD21 ' C' ' 43' ' ' LEU . 80.8 mt -64.25 -39.2 84.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -59.02 -39.97 83.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.366 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -86.95 7.29 28.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.666 ' HG3' HD21 ' C' ' 15' ' ' LEU . 2.0 mmtt -107.8 -47.62 3.56 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -116.54 -0.76 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.591 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 19.64 79.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.551 HG21 ' HB3' ' C' ' 41' ' ' GLN . 16.8 mm -81.43 119.96 76.96 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.133 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.26 149.3 65.24 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.065 1.843 . . . . 0.0 111.861 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -33.42 77.03 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.429 2.086 . . . . 0.0 112.65 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.05 7.68 39.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.395 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -108.33 -31.12 7.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.753 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.605 ' CB ' HD21 ' C' ' 69' ' ' LEU . 7.8 pt20 -99.22 131.53 45.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.498 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -122.95 115.35 21.77 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.821 HD21 ' CD1' ' C' ' 30' ' ' ILE . 70.0 mt -85.8 129.62 34.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.18 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt -131.87 129.16 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.326 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' PHE . . . . . 0.566 ' HB2' HD23 ' C' ' 67' ' ' LEU . 92.6 t80 -145.96 150.08 35.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.019 0.438 . . . . 0.0 111.456 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.92 20.12 11.25 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.022 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 84.32 -8.72 66.65 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.673 ' HG2' HD22 ' A' ' 73' ' ' LEU . 8.8 mtpt -107.9 137.22 46.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.972 0.415 . . . . 0.0 111.237 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -74.19 132.99 42.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.838 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.721 HD12 ' CB ' ' C' ' 43' ' ' LEU . 45.1 mt -74.95 98.66 3.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.53 141.23 43.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.819 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.68 142.86 52.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.99 -18.06 57.31 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -87.99 171.19 10.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.883 0.373 . . . . 0.0 110.476 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.8 p -115.46 163.52 15.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.131 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' C' ' 56' ' ' LEU . 77.9 mt -61.41 -40.96 96.32 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 94.7 p -63.79 -22.64 67.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.448 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.78 -37.82 85.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.95 0.405 . . . . 0.0 110.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -98.37 15.47 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.245 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 58.98 41.8 20.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.586 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -88.39 109.99 20.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -95.51 178.37 5.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.453 0.644 . . . . 0.0 111.171 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -61.23 148.3 41.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.746 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 59.25 17.11 5.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.398 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -65.92 138.13 57.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 39.2 m -98.31 122.1 41.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' C' ' 45' ' ' PHE . 3.3 mp -116.57 148.22 41.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.554 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -92.19 133.19 36.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.722 HD12 HG11 ' C' ' 5' ' ' VAL . 1.9 tt -108.26 115.86 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.048 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.5 131.5 47.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.054 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.658 HD21 HD22 ' C' ' 69' ' ' LEU . 39.4 mt -106.1 132.92 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.536 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 2' ' ' GLN . . . . . 0.513 ' OE1' HG21 ' D' ' 14' ' ' THR . 5.4 pt20 -63.06 160.69 14.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.162 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -138.41 156.42 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.258 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.6 m-30 -96.29 125.37 40.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.709 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.45 107.35 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.913 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 122.78 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.093 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.424 HG23 ' O ' ' D' ' 11' ' ' LYS . 80.4 p -82.3 172.1 13.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.776 HD11 ' H ' ' D' ' 71' ' ' LEU . 88.1 mt -63.22 -26.02 68.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.179 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -86.6 -1.34 57.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.828 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 -8.72 77.83 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' LYS . . . . . 0.424 ' O ' HG23 ' D' ' 7' ' ' THR . 7.5 tmtm? -68.3 118.34 11.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.896 0.379 . . . . 0.0 110.107 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 74.6 m -90.99 137.38 32.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mt -122.48 119.0 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.116 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.573 HG23 ' CD2' ' D' ' 4' ' ' PHE . 1.1 m -86.47 117.8 25.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.702 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.89 123.39 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.94 113.06 7.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.707 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.6 m -133.05 160.52 42.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.276 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.45 152.98 40.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.926 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.1 -36.86 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 111.661 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -80.06 -9.7 59.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.303 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -57.93 138.43 55.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 47.0 p -81.03 163.11 23.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.174 0.511 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.861 HD12 HD23 ' D' ' 50' ' ' LEU . 43.5 mm -63.54 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.207 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.18 -39.4 86.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.875 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.529 HG21 HD21 ' D' ' 56' ' ' LEU . 52.9 t -63.03 -43.48 99.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.698 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -61.34 -39.38 90.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.053 0.454 . . . . 0.0 109.994 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.38 89.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.125 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.707 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.7 mttm -59.92 -38.91 83.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.6 ' CD1' HD21 ' D' ' 43' ' ' LEU . 80.1 mt -64.89 -39.87 87.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.71 -44.57 96.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.057 0.456 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.83 -13.25 59.95 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.911 -0.493 . . . . 0.0 112.065 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -105.92 -4.01 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -148.48 -37.19 0.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 110.459 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.01 11.8 36.08 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.535 HD13 ' CD2' ' D' ' 71' ' ' LEU . 41.4 mt -82.38 121.02 78.1 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 155.07 42.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.038 1.825 . . . . 0.0 111.745 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.11 -25.27 73.06 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.626 2.217 . . . . 0.0 112.528 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -95.01 7.02 47.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -118.35 9.77 12.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.894 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' D' ' 69' ' ' LEU . 26.8 pt20 -142.05 154.45 44.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 42' ' ' ARG . . . . . 0.475 ' NE ' HD11 ' D' ' 44' ' ' ILE . 58.0 ttp180 -134.22 129.62 35.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.747 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' D' ' 30' ' ' ILE . 67.0 mt -99.9 115.29 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.054 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.475 HD11 ' NE ' ' D' ' 42' ' ' ARG . 88.5 mt -121.47 117.07 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.326 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -64.71 -47.07 79.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.051 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -176.74 78.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.827 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.91 89.95 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -129.67 125.82 36.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.816 0.341 . . . . 0.0 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -82.71 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.476 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.861 HD23 HD12 ' D' ' 23' ' ' ILE . 7.9 mp -75.36 106.24 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.65 143.81 48.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.037 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.06 156.96 20.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.2 16.58 69.02 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.91 165.8 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 110.49 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -113.15 165.49 12.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.529 HD21 HG21 ' D' ' 26' ' ' VAL . 89.6 mt -61.26 -39.88 92.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.476 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.8 -26.41 68.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.53 -37.95 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.128 0.49 . . . . 0.0 110.186 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -95.03 13.62 24.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.056 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.16 40.81 27.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ILE . . . . . 0.833 HD11 HD21 ' D' ' 50' ' ' LEU . 87.0 mt -92.33 114.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -100.43 -169.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.395 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -68.86 151.54 46.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 56.72 37.57 28.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.625 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -86.87 123.58 32.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -80.15 124.3 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.55 132.78 54.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.149 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.71 123.79 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.918 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' D' ' 41' ' ' GLN . 65.9 tp -103.97 111.54 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.666 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.6 t -107.36 132.61 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.776 ' H ' HD11 ' D' ' 8' ' ' LEU . 58.4 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 111.022 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -99.62 126.98 45.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.391 0.615 . . . . 0.0 110.225 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 51' ' ' GLN . 85.6 mt -68.49 -37.34 80.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.072 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.1 p -147.31 161.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.756 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.53 122.68 0.36 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.183 0.515 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -153.72 158.32 40.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.084 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.535 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -74.77 120.92 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.619 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -152.51 145.32 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.112 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.42 152.48 17.83 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.46 171.4 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.413 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 28.6 mtp -132.63 174.47 10.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.0 m -122.7 123.22 40.61 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 37' ' ' THR . 26.9 tp -105.02 116.94 32.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.19 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -120.81 112.25 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.94 -92.45 0.46 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 p -138.35 23.28 2.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.678 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' HD12 ' A' ' 33' ' ' LEU . 88.3 m -125.32 131.73 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 33' ' ' LEU . 74.3 t -111.01 123.73 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.204 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.799 HG22 ' HB3' ' B' ' 947' ' ' PRO . 58.4 p -119.02 135.12 23.66 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.141 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.5 150.38 57.57 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.98 1.787 . . . . 0.0 113.356 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -105.49 140.07 39.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.156 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -76.35 -7.08 54.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -72.76 75.13 1.13 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -55.48 127.96 32.12 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.78 -159.12 9.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.2 tp -139.17 124.46 19.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 28' ' ' ALA . 41.1 t -96.53 109.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.346 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.0 p90 -131.57 154.25 49.03 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.018 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.2 mt -118.42 139.14 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.712 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 128.53 30.76 Favored 'General case' 0 C--O 1.22 -0.478 0 O-C-N 123.89 0.744 . . . . 0.0 110.35 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.757 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.8 tt0 -99.42 125.3 45.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.977 0.417 . . . . 0.0 109.956 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.6 p -85.56 170.39 12.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.384 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -62.79 -10.62 13.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.166 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.5 2.62 54.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.475 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t 69.63 20.62 6.94 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.208 0.528 . . . . 0.0 110.401 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 74.9 mt -97.32 121.97 39.82 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.476 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -81.88 120.06 32.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.7 m-70 -96.9 111.53 23.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.114 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -90.58 108.24 19.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 74.2 m -121.02 145.98 47.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.648 . . . . 0.0 112.627 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -124.39 112.84 17.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.435 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -104.86 135.23 46.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.028 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -74.79 136.69 41.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.874 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -78.9 -17.77 54.98 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.537 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -60.84 -46.64 89.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -117.02 -13.02 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.95 24.94 75.01 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -102.01 144.48 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 0.0 110.673 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.16 105.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.27 -28.11 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.008 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -127.69 144.05 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.196 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.6 p30 -159.49 95.9 1.25 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.87 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.673 HD22 ' HG2' ' C' ' 48' ' ' LYS . 41.3 mt -123.13 138.01 54.77 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.821 0.343 . . . . 0.0 110.727 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 86.1 mt -83.21 116.8 27.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.496 ' HB ' HD22 ' A' ' 128' ' ' LEU . 1.2 mp -105.52 116.65 49.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.957 0.408 . . . . 0.0 111.139 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.585 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 44.7 m-85 -79.69 164.17 54.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.988 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.08 139.68 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.95 1.767 . . . . 0.0 111.041 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.59 11.82 3.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -85.91 -42.2 14.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.481 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.473 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -130.85 148.17 52.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.0 111.364 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -122.02 129.56 52.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.663 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -101.78 118.46 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -144.06 167.94 21.18 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.767 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -94.68 146.25 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.288 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.39 99.58 21.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.221 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.81 60.09 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.741 1.627 . . . . 0.0 112.223 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -114.35 -36.34 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.246 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 p -121.94 74.35 37.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.711 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.02 130.27 26.92 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.103 1.869 . . . . 0.0 111.745 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.98 -43.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.905 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.93 -139.61 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.47 106.38 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.3 127.31 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.82 156.21 35.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 105' ' ' LEU . 10.5 p -131.7 137.52 54.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.473 HD11 ' SG ' ' A' ' 80' ' ' CYS . 60.3 tp -105.69 119.92 40.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -119.61 139.18 52.59 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.991 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -88.78 115.81 26.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.62 -37.19 83.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.526 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.98 -22.86 24.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.176 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.51 -169.28 21.9 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.1 m -124.0 17.96 9.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.771 ' HD3' HD21 ' A' ' 105' ' ' LEU . 30.5 ttmt -89.64 138.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.27 0.557 . . . . 0.0 111.087 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.49 109.25 10.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.771 HD21 ' HD3' ' A' ' 103' ' ' LYS . 50.7 mt -96.0 150.4 20.51 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.45 ' CE1' HD22 ' A' ' 33' ' ' LEU . 88.3 m-85 -123.94 136.48 54.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.258 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.06 155.7 49.33 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.316 0.579 . . . . 0.0 111.118 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -128.32 137.45 51.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.838 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.1 tpp -75.82 123.95 26.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.242 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -16.81 34.72 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.7 127.29 88.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.28 -20.05 43.33 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.94 1.76 . . . . 0.0 112.724 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.54 140.4 47.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.132 0.491 . . . . 0.0 110.317 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.9 p -99.12 10.88 40.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.09 -26.42 49.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.379 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.444 ' NE2' ' OE1' ' A' ' 119' ' ' GLU . 29.9 mm100 -126.03 -0.69 7.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.805 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.73 -48.56 80.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.77 -40.91 97.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.444 ' OE1' ' NE2' ' A' ' 116' ' ' GLN . 88.4 tt0 -64.07 -42.67 96.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.807 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.784 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.4 m170 -64.79 -39.65 93.94 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.511 0.672 . . . . 0.0 109.213 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.82 -45.72 92.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.558 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -64.37 -43.47 94.43 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.212 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.25 -38.1 87.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.1 t -58.89 -48.08 87.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.164 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -80.61 -32.51 36.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.04 -38.18 87.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.571 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -80.62 -37.78 30.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.005 0.431 . . . . 0.0 110.258 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 75' ' ' ILE . 77.0 mt -71.53 -34.41 70.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.115 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -100.89 -24.13 14.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.677 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -139.99 69.04 35.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.746 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.83 160.49 49.23 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.916 2.411 . . . . 0.0 112.28 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.649 2.233 . . . . 0.0 112.248 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.67 81.99 68.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.724 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 138.88 83.81 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.808 2.339 . . . . 0.0 112.249 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.04 159.26 71.17 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.84 146.65 77.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.41 -173.96 1.29 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.541 2.161 . . . . 0.0 112.189 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -100.33 153.35 37.8 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.389 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.799 ' HB3' HG22 ' A' ' 39' ' ' THR . 43.2 Cg_endo -68.83 152.04 73.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.491 2.127 . . . . 0.0 112.084 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.43 168.74 25.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.35 132.14 34.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.82 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -113.37 136.04 53.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.079 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.447 -0.61 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.585 -179.23 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -62.45 160.34 13.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -139.31 149.97 22.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.614 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -91.86 119.82 31.99 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.263 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.422 ' CG1' HD12 ' C' ' 69' ' ' LEU . 69.4 t -104.36 108.64 25.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.07 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -92.75 122.31 35.03 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.889 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.0 p -81.56 171.5 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.593 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.645 HD11 ' H ' ' C' ' 71' ' ' LEU . 62.3 mt -65.54 -21.34 66.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.047 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.25 -5.88 58.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.343 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.49 74.68 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -74.16 128.8 36.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.844 0.322 . . . . 0.0 110.236 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.48 132.16 47.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.07 111.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.438 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -81.44 126.99 32.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.71 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' C' ' 29' ' ' LYS . 79.0 mt -120.03 129.82 54.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.66 116.58 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.441 HG12 ' HE2' ' C' ' 29' ' ' LYS . 21.0 m -136.13 165.63 28.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.706 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.405 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.2 mt-10 -110.32 154.14 43.06 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.42 -30.61 91.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.72 1.613 . . . . 0.0 111.965 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.3 m -88.86 -6.5 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.27 144.21 57.31 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.812 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.91 163.86 23.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.3 mm -63.04 -38.56 82.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.786 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -58.96 -40.89 86.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.41 -46.37 90.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.566 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.449 HG21 HD21 ' C' ' 56' ' ' LEU . 74.7 t -60.71 -42.66 92.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.04 -37.04 78.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.33 95.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' C' ' 15' ' ' LEU . 0.9 OUTLIER -59.35 -39.31 82.81 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.228 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' C' ' 43' ' ' LEU . 80.8 mt -65.15 -39.36 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.445 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -60.12 -43.05 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.43 19.31 6.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.47 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -123.72 -42.88 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.374 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -116.84 -18.95 10.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.575 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.26 10.81 65.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.515 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.402 HD13 ' CD2' ' C' ' 71' ' ' LEU . 52.0 mt -75.04 128.03 85.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.77 154.23 63.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.502 1.468 . . . . 0.0 111.02 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.64 -23.42 65.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.2 1.933 . . . . 0.0 111.968 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.85 -1.69 52.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.013 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -123.31 -31.49 3.55 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.52 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -78.8 132.84 37.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.318 0.58 . . . . 0.0 111.449 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -130.43 126.74 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.397 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' C' ' 30' ' ' ILE . 77.3 mt -103.39 124.71 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.961 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.508 HG21 ' HE1' ' A' ' 76' ' ' PHE . 80.5 mt -129.38 129.08 67.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.293 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -144.39 149.41 36.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.899 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.6 16.72 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.396 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.26 -14.95 59.56 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.702 ' HG2' HD22 ' A' ' 73' ' ' LEU . 9.7 mttt -98.94 141.49 31.64 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.449 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -75.43 127.27 32.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.751 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' C' ' 43' ' ' LEU . 48.3 mt -76.09 89.49 3.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -74.97 171.37 14.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -75.81 169.0 18.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.079 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.42 19.49 77.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -124.53 167.2 14.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.687 0.279 . . . . 0.0 110.585 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -122.71 161.22 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.578 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.449 HD21 HG21 ' C' ' 26' ' ' VAL . 80.6 mt -60.89 -40.51 93.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.8 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.62 -23.0 67.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.561 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.2 -38.06 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.017 0.437 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.438 ' CE2' HD23 ' C' ' 50' ' ' LEU . 71.1 m-85 -97.18 13.2 30.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.151 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 59.05 41.08 21.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.257 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.35 118.4 33.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.912 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -107.07 178.38 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.002 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -59.53 146.59 40.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.807 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 61.49 18.6 9.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 27.5 t -71.6 131.09 42.71 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 93.6 m -83.91 127.89 34.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -116.5 144.1 44.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.201 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -92.33 123.64 35.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.056 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.612 HD22 HD21 ' C' ' 71' ' ' LEU . 1.8 tt -102.8 115.25 30.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.127 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 56' ' ' LEU . 68.4 t -108.96 132.82 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.645 ' H ' HD11 ' C' ' 8' ' ' LEU . 33.3 mt -105.84 135.35 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.29 158.19 12.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.771 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -138.42 151.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.859 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.447 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.0 m-30 -92.69 122.92 35.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.711 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.68 109.95 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.694 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -94.52 122.3 36.95 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.088 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.649 HG22 HD23 ' D' ' 69' ' ' LEU . 77.0 p -82.19 -179.08 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.321 0.581 . . . . 0.0 111.632 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.747 HD11 ' H ' ' D' ' 71' ' ' LEU . 85.0 mt -61.58 -37.06 82.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.825 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.14 -8.99 57.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.262 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.92 -9.12 70.6 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.81 128.0 34.13 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -102.05 130.54 48.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.118 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.41 HG21 HD13 ' D' ' 13' ' ' ILE . 1.3 mt -124.37 113.86 38.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.743 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.447 HG23 ' CD2' ' D' ' 4' ' ' PHE . 10.6 m -80.03 125.78 30.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.757 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.25 118.25 30.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.281 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.19 110.29 2.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.299 0.571 . . . . 0.0 110.715 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.673 HG12 ' HE2' ' D' ' 29' ' ' LYS . 29.3 m -133.81 160.82 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -103.58 155.02 37.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.997 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 -38.37 95.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.124 1.883 . . . . 0.0 111.996 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.7 p -80.0 -8.78 59.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.026 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -58.7 135.74 57.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.979 0.418 . . . . 0.0 110.89 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.14 163.45 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.547 HD12 HD13 ' D' ' 50' ' ' LEU . 50.0 mm -64.23 -37.92 81.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.98 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.66 -43.81 89.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.99 -42.3 98.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 110.754 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.465 HG22 HG11 ' D' ' 17' ' ' VAL . 61.2 t -62.9 -42.38 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.923 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -60.64 -39.56 88.74 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.109 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.03 88.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.673 ' HE2' HG12 ' D' ' 17' ' ' VAL . 62.9 mttp -59.71 -38.98 83.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.813 ' CD1' HD21 ' D' ' 43' ' ' LEU . 87.3 mt -64.77 -40.58 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.931 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.69 -47.0 87.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.28 -15.94 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -103.57 -4.84 23.36 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.59 -37.65 0.2 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.78 10.42 32.82 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.618 HD13 ' CD2' ' D' ' 71' ' ' LEU . 49.9 mt -77.82 127.45 82.01 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.17 155.98 42.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.168 1.245 . . . . 0.0 110.728 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.78 -36.69 83.23 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.063 1.842 . . . . 0.0 112.468 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.14 -39.01 88.43 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.311 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -96.65 23.26 7.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.551 ' HG3' HG22 ' D' ' 36' ' ' ILE . 36.9 mt-30 -118.29 112.32 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 111.712 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -118.64 110.61 17.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.813 HD21 ' CD1' ' D' ' 30' ' ' ILE . 78.0 mt -97.7 117.12 31.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.417 HG23 ' C ' ' D' ' 48' ' ' ARG . 85.1 mt -121.82 126.58 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 85.5 t80 -127.68 130.14 48.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.7 29.13 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 17.16 79.69 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.417 ' C ' HG23 ' D' ' 44' ' ' ILE . 44.2 ttm180 -132.66 127.91 35.89 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.573 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -66.54 148.07 52.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.06 0.457 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.547 HD13 HD12 ' D' ' 23' ' ' ILE . 77.2 mt -90.21 115.36 27.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.882 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -70.01 136.7 50.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -61.31 136.94 58.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.198 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.62 55.72 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -82.25 172.58 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -118.27 163.21 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.89 -39.48 89.42 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.402 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.2 p -63.81 -24.35 67.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.3 . . . . 0.0 110.414 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.95 -37.75 85.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.327 0.584 . . . . 0.0 110.044 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -98.14 14.53 27.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.282 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 m120 56.83 39.94 29.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.829 0.347 . . . . 0.0 110.278 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -90.14 113.75 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.856 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -99.33 -172.25 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.531 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -68.79 150.75 47.49 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.273 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 56.85 41.77 27.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -98.5 127.45 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.559 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.51 ' C ' HD12 ' D' ' 67' ' ' LEU . 90.3 m -78.22 127.53 32.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.51 HD12 ' C ' ' D' ' 66' ' ' THR . 8.5 mp -118.57 138.4 52.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.921 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -89.07 113.96 25.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.649 HD23 HG22 ' D' ' 7' ' ' THR . 48.5 tp -99.46 120.53 39.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.695 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.5 t -112.97 132.75 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.747 ' H ' HD11 ' D' ' 8' ' ' LEU . 24.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.455 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -86.15 112.41 21.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.4 mt -68.32 -37.02 80.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.606 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -147.65 161.7 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.26 122.24 0.29 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 0.0 110.834 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.04 160.07 40.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.696 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.8 mtm-85 -78.66 124.05 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.046 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.75 146.03 20.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.86 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.47 152.12 17.19 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -95.52 161.9 13.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.875 0.369 . . . . 0.0 111.13 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mtm -134.81 170.27 16.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -121.09 135.92 55.08 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.403 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 37' ' ' THR . 29.6 tp -110.97 119.36 38.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.947 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -120.75 112.38 18.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.85 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -106.54 1.81 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.6 p -124.06 20.86 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.292 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.563 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.0 m -124.61 130.32 52.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 110.798 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.561 HG22 HD13 ' A' ' 33' ' ' LEU . 62.1 t -107.71 121.28 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -108.77 131.55 21.71 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.95 145.4 45.08 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.062 1.842 . . . . 0.0 113.35 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.12 120.74 42.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -65.23 -11.32 39.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -72.31 78.84 1.0 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -58.83 140.13 55.55 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.98 -157.3 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.815 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.0 tp -135.31 127.93 30.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.37 111.77 32.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.546 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -136.09 156.29 48.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.231 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.7 mt -122.24 137.7 54.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.873 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -135.06 130.56 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.632 0.583 . . . . 0.0 110.112 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.668 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.4 tt0 -100.7 124.15 45.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.107 0.48 . . . . 0.0 110.085 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.507 HG23 ' CD2' ' A' ' 58' ' ' HIS . 17.7 p -85.34 171.59 11.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.49 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.02 -10.34 21.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.116 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.93 1.09 55.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.282 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t 69.12 21.74 7.14 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.312 0.577 . . . . 0.0 110.252 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.844 HD11 HG11 ' C' ' 70' ' ' VAL . 83.6 mt -98.28 122.72 41.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.439 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.1 mm -81.99 122.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.507 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.0 m-70 -98.17 112.67 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.851 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -92.15 109.29 20.65 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 77.9 m -121.74 145.96 47.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -128.3 117.86 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.53 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -108.68 143.81 37.28 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.348 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -80.98 129.21 34.42 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -71.34 -16.64 62.44 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 m -59.4 -45.35 91.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.429 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.1 m -117.22 -13.27 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 110.182 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.79 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -101.72 152.04 21.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.04 103.86 6.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -77.97 -32.93 51.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -126.68 146.1 50.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.538 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 73' ' ' LEU . 68.2 t0 -157.68 98.73 1.67 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.052 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.702 HD22 ' HG2' ' C' ' 48' ' ' LYS . 28.3 mt -127.64 133.85 49.65 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.501 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -79.09 123.92 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.421 ' HB ' HD22 ' A' ' 128' ' ' LEU . 29.0 mm -112.23 129.5 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 111.103 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.508 ' HE1' HG21 ' C' ' 44' ' ' ILE . 59.3 m-85 -94.14 162.51 26.33 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.436 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.76 140.67 91.56 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.172 1.915 . . . . 0.0 111.658 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 60.71 12.26 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -88.4 -35.24 17.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.977 0.418 . . . . 0.0 110.401 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -135.51 148.36 49.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.179 0.514 . . . . 0.0 111.561 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -122.61 127.68 49.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.455 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -100.57 120.63 40.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -145.37 167.13 23.63 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.792 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -92.14 159.27 15.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.889 0.376 . . . . 0.0 110.217 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 t -120.95 89.83 46.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.382 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.31 60.45 7.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.81 1.674 . . . . 0.0 112.169 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.69 -34.3 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.172 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.5 t -124.91 86.78 56.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.54 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.48 129.91 19.94 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.771 1.647 . . . . 0.0 111.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.98 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.33 -176.77 33.8 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.521 ' NE ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -86.03 110.36 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.42 126.53 72.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -121.95 152.82 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.233 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.9 p -128.04 135.79 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.212 0.529 . . . . 0.0 109.904 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.453 HD11 ' SG ' ' A' ' 80' ' ' CYS . 61.5 tp -104.76 118.22 36.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -115.29 132.47 56.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 111.29 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 54.5 m-85 -86.65 115.56 24.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.58 -37.14 82.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.318 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -108.68 -23.36 11.83 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.362 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -63.86 -33.7 87.94 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.76 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p 74.05 27.89 1.54 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.621 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -139.45 162.11 35.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.491 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -138.69 149.42 45.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.464 . . . . 0.0 111.2 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 95' ' ' VAL . 46.1 mt -125.24 150.82 46.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' A' ' 33' ' ' LEU . 94.1 m-85 -120.3 135.92 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.501 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -137.34 156.38 48.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.191 0.519 . . . . 0.0 111.223 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -133.75 137.17 45.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.826 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttm -74.67 131.73 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.946 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.47 4.31 26.04 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.709 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -71.86 148.73 92.37 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.424 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.89 -27.6 14.29 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.099 1.866 . . . . 0.0 112.967 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -119.51 142.18 48.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.31 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.521 HG22 ' NE ' ' A' ' 92' ' ' ARG . 79.8 p -98.31 8.46 44.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.491 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.58 -22.47 13.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.351 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -123.73 8.11 8.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.579 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -61.16 -49.1 78.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.47 -40.5 95.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.209 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.77 -43.31 99.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.614 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.5 m170 -64.18 -40.13 95.46 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.92 94.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.792 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -65.65 -43.34 89.75 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.245 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.46 -39.33 93.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.887 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.3 t -59.14 -47.78 89.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.233 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.33 -27.88 38.25 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.82 -38.71 80.06 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.55 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -81.18 -33.23 33.16 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.64 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 75' ' ' ILE . 67.5 mt -77.96 -28.63 49.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -104.83 -26.87 12.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.319 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.7 72.84 73.09 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.313 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.411 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.1 Cg_exo -59.77 149.14 84.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.799 2.333 . . . . 0.0 111.573 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 122.175 1.916 . . . . 0.0 112.182 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 -72.08 154.35 92.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.449 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.16 153.88 66.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.829 2.352 . . . . 0.0 112.638 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.37 155.05 94.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.725 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.83 157.32 62.34 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.176 1.917 . . . . 0.0 112.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.74 176.94 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.224 . . . . 0.0 111.622 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.05 157.62 42.99 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.856 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 145.27 99.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.225 1.95 . . . . 0.0 111.788 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -158.07 169.3 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.09 137.86 32.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.185 0.517 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.9 121.49 38.18 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.471 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 63.4 mt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -62.08 156.09 22.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.019 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.97 148.83 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.27 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -90.21 123.86 34.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.443 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.55 114.73 47.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.195 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -103.02 123.07 45.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.644 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.3 p -84.1 172.5 11.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.069 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.54 HD11 ' H ' ' C' ' 71' ' ' LEU . 73.4 mt -64.35 -25.47 68.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -74.28 -8.89 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.22 6.11 66.91 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.25 127.95 34.27 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.788 0.327 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -104.54 131.76 51.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.916 0.389 . . . . 0.0 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 117.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.295 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -83.72 130.14 34.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.447 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' C' ' 33' ' ' LYS . 90.7 mt -123.24 122.95 39.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.775 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -66.13 110.77 3.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.744 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.503 HG12 ' HE3' ' C' ' 29' ' ' LYS . 22.4 m -134.23 163.44 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.447 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -106.09 154.35 39.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.98 -35.37 94.33 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.033 1.822 . . . . 0.0 112.17 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -84.78 -3.83 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.01 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -60.15 136.55 58.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 110.775 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.44 162.19 26.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.54 -38.32 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.12 -43.27 91.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.243 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.43 -41.63 98.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 110.909 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.7 -42.69 96.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.742 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' C' ' 43' ' ' LEU . 58.2 mtmt -60.41 -39.32 86.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -40.26 93.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.379 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.519 ' HB3' HD22 ' C' ' 15' ' ' LEU . 66.6 mttm -60.22 -39.68 87.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.543 HG21 HD11 ' C' ' 69' ' ' LEU . 96.8 mt -66.54 -39.8 84.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.211 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -59.49 -39.63 84.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 0.0 110.284 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.07 -44.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.701 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.617 ' HG3' HD21 ' C' ' 15' ' ' LEU . 19.7 mttt -70.82 -39.7 72.89 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -132.94 152.03 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.67 2.22 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.553 HG22 ' HB2' ' C' ' 41' ' ' GLN . 41.3 mm -117.39 94.91 46.46 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.36 149.62 80.08 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.73 2.287 . . . . 0.0 112.232 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -52.62 -40.06 74.08 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.962 1.774 . . . . 0.0 112.387 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.57 -39.54 94.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -99.03 31.86 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.706 ' HG3' HD21 ' C' ' 69' ' ' LEU . 12.9 tt0 -136.04 120.42 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.842 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -128.67 115.0 17.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.53 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.501 ' CB ' HD12 ' C' ' 50' ' ' LEU . 27.0 mt -92.89 132.31 37.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.151 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -129.46 128.61 66.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -144.27 151.39 39.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.869 0.366 . . . . 0.0 110.999 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 15.81 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.469 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.64 63.21 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.658 ' CG ' HD22 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -107.72 141.45 39.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.05 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -72.3 132.98 44.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.501 HD12 ' CB ' ' C' ' 43' ' ' LEU . 51.0 mt -77.06 100.29 5.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.681 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.61 144.64 41.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.258 0.552 . . . . 0.0 110.765 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.0 141.01 57.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.338 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.19 54.56 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -84.26 178.53 7.75 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.333 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -126.54 165.59 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.45 HD22 HG21 ' C' ' 61' ' ' ILE . 84.8 mt -62.71 -40.42 97.12 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.668 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.6 -26.67 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.99 -36.94 82.99 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 110.245 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.474 ' CE2' HD23 ' C' ' 50' ' ' LEU . 76.0 m-85 -97.69 13.8 29.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.162 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.33 43.56 28.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.443 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.45 HG21 HD22 ' C' ' 56' ' ' LEU . 57.6 mt -89.74 103.8 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.4 -179.39 5.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -63.28 148.98 46.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.007 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 59.51 44.33 14.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -102.83 127.93 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.432 ' C ' HD12 ' C' ' 67' ' ' LEU . 86.0 m -77.58 127.76 33.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.432 HD12 ' C ' ' C' ' 66' ' ' THR . 7.2 mp -116.29 145.69 42.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -98.19 123.16 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.374 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.747 HD22 HD21 ' C' ' 71' ' ' LEU . 1.7 tt -100.27 126.0 46.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.61 ' N ' HD23 ' C' ' 69' ' ' LEU . 93.9 t -108.75 131.03 60.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.444 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.747 HD21 HD22 ' C' ' 69' ' ' LEU . 33.1 mt -112.17 147.72 35.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.719 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.817 179.26 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -65.67 159.08 25.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.39 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.561 HD13 HD21 ' D' ' 56' ' ' LEU . 15.0 pt -137.9 141.4 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.219 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.594 ' HD2' HG21 ' D' ' 12' ' ' THR . 4.2 m-85 -84.26 123.88 30.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.884 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -110.11 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.818 0.342 . . . . 0.0 110.505 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -92.9 122.28 35.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.807 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -82.86 179.13 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.762 HD11 ' H ' ' D' ' 71' ' ' LEU . 85.0 mt -62.74 -35.85 81.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.27 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 42.8 p -67.42 -11.41 57.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.727 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.1 -9.94 67.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.4 129.6 40.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.594 HG21 ' HD2' ' D' ' 4' ' ' PHE . 98.9 m -101.52 132.18 47.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 110.807 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -127.11 105.79 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.611 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -81.88 127.11 32.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' D' ' 29' ' ' LYS . 86.5 mt -122.04 127.73 50.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.698 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.19 114.6 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.713 HG12 ' HE3' ' D' ' 29' ' ' LYS . 16.4 m -137.07 171.92 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.5 155.24 56.75 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.087 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.9 -39.41 84.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.128 1.886 . . . . 0.0 112.313 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -24.33 63.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.17 136.97 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.49 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -85.49 165.89 16.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.329 0.585 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.51 HD12 HD13 ' D' ' 50' ' ' LEU . 43.8 mm -63.38 -37.66 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.846 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.76 -42.15 88.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.856 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.11 -41.11 97.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.506 HG21 HD11 ' D' ' 56' ' ' LEU . 53.4 t -62.96 -42.97 98.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.878 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.59 -40.41 91.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.162 0.506 . . . . 0.0 110.485 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.713 ' HE3' HG12 ' D' ' 17' ' ' VAL . 64.8 mttm -59.31 -38.67 80.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.825 ' CD1' HD21 ' D' ' 43' ' ' LEU . 96.9 mt -64.5 -38.37 82.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.849 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -59.11 -38.99 80.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.23 -59.43 3.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.802 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.552 ' HD2' HD21 ' D' ' 15' ' ' LEU . 69.4 mttt -63.55 -41.49 98.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.03 142.52 50.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.095 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.97 60.28 3.04 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' D' ' 41' ' ' GLN . 2.9 mt -115.26 122.01 33.93 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.231 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 159.29 49.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.476 1.451 . . . . 0.0 111.649 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.3 -37.32 70.8 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.149 1.899 . . . . 0.0 112.563 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.69 -39.88 93.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.555 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.39 -11.33 54.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.367 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' D' ' 36' ' ' ILE . 91.4 mt-30 -86.6 83.19 7.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.008 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -98.28 98.93 10.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.825 HD21 ' CD1' ' D' ' 30' ' ' ILE . 73.5 mt -86.81 122.64 30.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.443 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.26 126.79 71.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.006 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.444 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.3 t80 -128.61 130.26 47.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.0 28.35 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.95 79.01 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -131.01 129.53 42.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.5 139.16 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.51 HD13 HD12 ' D' ' 23' ' ' ILE . 85.8 mt -82.96 118.68 23.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.11 137.32 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.315 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -66.73 147.54 53.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.179 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.58 -13.68 63.39 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -88.44 149.12 23.85 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -87.66 165.58 15.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.064 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.561 HD21 HD13 ' D' ' 3' ' ' ILE . 5.4 mp -66.72 -36.13 81.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.722 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -62.01 -27.02 68.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.727 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.22 -37.55 85.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.125 0.488 . . . . 0.0 110.285 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -95.74 11.81 32.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 55.26 41.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.14 103.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -90.03 -176.8 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -63.32 152.16 38.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 55.5 40.1 31.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.4 t -90.31 120.44 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.444 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.434 ' C ' HD12 ' D' ' 67' ' ' LEU . 61.6 m -75.42 127.09 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.163 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.434 HD12 ' C ' ' D' ' 66' ' ' THR . 7.1 mp -118.76 145.97 45.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 67.9 m170 -92.97 117.76 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.098 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.703 HD11 HD13 ' D' ' 30' ' ' ILE . 0.4 OUTLIER -97.84 99.46 10.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.371 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' D' ' 8' ' ' LEU . 73.3 t -90.78 135.57 26.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.382 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.762 ' H ' HD11 ' D' ' 8' ' ' LEU . 50.0 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.442 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.718 0.294 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -91.42 111.94 23.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.0 mt -65.75 -37.79 87.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.597 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -150.62 162.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.363 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.16 122.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.0 111.127 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.68 158.28 36.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.919 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -75.53 121.3 22.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.411 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.13 140.9 20.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.026 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.65 151.98 17.14 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -88.6 170.93 10.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 0.0 111.248 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 mtp -135.65 174.21 10.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.757 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -124.71 121.62 35.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 37' ' ' THR . 32.8 tp -102.91 121.78 43.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.904 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -118.83 104.1 10.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.029 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 -82.54 0.8 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -144.8 18.03 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.492 0.187 . . . . 0.0 110.95 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.656 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.2 m -119.99 128.01 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 33' ' ' LEU . 58.1 t -107.84 122.97 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.227 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.8 m -117.12 130.11 24.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.352 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.13 148.89 70.15 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.104 1.869 . . . . 0.0 113.229 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.77 136.04 45.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.91 -7.37 50.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.19 63.61 3.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -51.26 141.18 15.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.302 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.55 -153.37 6.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.369 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.1 tp -137.96 125.58 22.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.43 108.48 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.6 153.44 48.89 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.231 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' CG1' HG12 ' A' ' 24' ' ' VAL . 98.2 mt -119.17 138.55 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.469 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 129.87 31.78 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.806 0.691 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.546 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.9 tt0 -99.94 123.79 44.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.51 . . . . 0.0 110.387 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.0 p -83.62 170.23 14.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.706 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.48 -10.09 10.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.169 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.95 3.06 55.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.64 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 69.53 20.12 7.23 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.325 0.583 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 73.8 mt -96.35 121.66 38.39 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.521 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.3 mm -81.22 120.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.487 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.2 m-70 -97.49 114.49 26.37 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.347 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -99.25 107.23 19.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.798 0.809 . . . . 0.0 112.827 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -118.72 113.53 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.827 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -101.57 126.87 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -73.58 133.26 43.49 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -76.54 -18.45 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.4 m -60.47 -45.36 94.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.033 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -116.47 -16.62 10.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.973 0.416 . . . . 0.0 109.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.34 78.91 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.21 145.02 30.57 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.5 104.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 0.0 109.9 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -80.93 -33.61 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -127.13 142.99 51.38 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.865 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.3 t0 -158.72 95.53 1.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.31 0.381 . . . . 0.0 110.162 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.658 HD22 ' CG ' ' C' ' 48' ' ' LYS . 40.2 mt -124.7 137.25 54.36 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.079 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -79.57 118.4 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.725 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.0 mm -108.06 121.27 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.801 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 49.5 m-85 -84.66 160.5 55.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.153 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.02 144.91 99.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.004 1.803 . . . . 0.0 111.555 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 60.06 12.96 3.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.14 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.84 -25.77 17.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.536 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 75' ' ' ILE . 11.7 p -149.12 166.22 29.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.321 0.582 . . . . 0.0 110.575 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.411 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.9 tt0 -136.89 133.99 36.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.101 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -104.33 118.28 36.24 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -144.77 167.86 21.58 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.532 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -87.73 160.41 18.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.438 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.8 89.15 15.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.212 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.42 60.46 7.86 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.056 1.837 . . . . 0.0 112.111 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -114.02 -37.34 4.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.1 t -126.63 80.11 70.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.609 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.14 129.76 37.03 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.082 1.855 . . . . 0.0 111.186 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.52 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.858 0.724 . . . . 0.0 110.243 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.85 177.16 32.29 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -86.07 114.33 22.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.625 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.06 129.69 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.42 151.48 40.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.875 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.5 p -130.95 134.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.635 HD11 ' SG ' ' A' ' 80' ' ' CYS . 65.5 tp -100.45 120.07 39.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -115.96 131.97 56.79 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.28 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -82.73 111.99 19.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.267 0.556 . . . . 0.0 109.798 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -37.72 84.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.483 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 -20.54 23.14 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.261 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.82 177.42 27.92 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.2 p -114.14 23.36 12.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 153.72 46.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.855 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 157.09 46.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 95' ' ' VAL . 36.7 mt -118.49 156.24 29.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.873 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 91.1 m-85 -124.6 136.38 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -139.17 155.7 47.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.339 0.59 . . . . 0.0 111.247 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -128.99 137.45 51.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.4 tpp -67.8 132.45 47.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -2.89 15.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.0 146.6 97.44 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.231 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.27 -28.9 12.0 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.979 1.786 . . . . 0.0 113.155 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -118.59 144.73 45.92 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.633 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 p -100.49 12.27 37.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.734 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.28 -22.22 64.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.647 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -131.31 -6.63 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.837 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.81 -42.54 99.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.82 -39.8 91.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.0 111.305 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.86 -41.41 95.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.197 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.785 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.0 m170 -61.34 -40.05 92.84 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.552 0.692 . . . . 0.0 109.204 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.25 -44.91 94.87 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.644 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -62.65 -42.69 99.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.058 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -65.27 -35.64 81.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.018 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 120' ' ' HIS . 71.0 t -57.21 -48.02 83.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.021 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.42 -31.08 48.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.561 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.65 -27.18 64.83 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.042 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -92.52 -23.81 18.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.473 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.4 mt -95.24 -17.58 21.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -18.72 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.366 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -134.48 63.1 58.67 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.038 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.52 159.11 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.834 2.356 . . . . 0.0 112.457 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 122.664 2.243 . . . . 0.0 112.139 -179.427 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -92.92 153.1 41.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.21 145.82 31.18 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.565 2.177 . . . . 0.0 112.006 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -80.37 159.69 69.39 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.71 134.76 59.95 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.162 1.908 . . . . 0.0 112.165 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.35 -162.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.269 1.979 . . . . 0.0 112.009 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -128.31 155.18 78.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.679 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.59 145.35 81.74 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.486 2.124 . . . . 0.0 111.704 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -155.55 164.34 38.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.677 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.62 138.55 32.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -124.81 121.71 35.35 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.79 158.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.61 150.47 20.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.118 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -98.43 127.12 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.87 116.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.675 -0.41 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -101.32 121.15 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.596 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -81.58 171.69 14.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.494 HD11 ' H ' ' C' ' 71' ' ' LEU . 71.4 mt -63.34 -25.65 68.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -75.11 -8.55 56.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 6.41 66.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.12 126.27 32.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -103.04 131.06 50.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.902 0.382 . . . . 0.0 110.035 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.23 113.17 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.485 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.85 134.75 35.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.766 0.317 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.798 HD21 ' HG3' ' C' ' 33' ' ' LYS . 68.8 mt -132.66 131.48 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.4 115.37 13.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 0.0 110.686 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.447 HG12 ' CD ' ' C' ' 29' ' ' LYS . 21.3 m -134.64 166.08 29.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.558 ' O ' HD12 ' C' ' 56' ' ' LEU . 95.6 mt-10 -113.29 152.01 44.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.221 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.08 -25.51 78.18 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.953 1.769 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -91.05 -12.07 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.676 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.51 142.3 57.14 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.127 0.489 . . . . 0.0 110.928 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -80.46 166.67 21.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.972 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 1.001 HD12 HD23 ' C' ' 50' ' ' LEU . 33.2 mm -64.03 -35.85 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.739 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -58.6 -41.64 86.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.011 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.26 -41.89 93.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.112 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.575 HG21 HD21 ' C' ' 56' ' ' LEU . 64.3 t -63.76 -48.19 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.998 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.28 -31.48 72.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.115 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.79 95.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.249 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.507 ' HB3' HD22 ' C' ' 15' ' ' LEU . 67.6 mttm -60.66 -39.77 89.56 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.541 HG21 HD11 ' C' ' 69' ' ' LEU . 93.9 mt -66.6 -39.57 84.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.326 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.39 -38.68 81.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.422 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -68.69 -47.95 65.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.798 ' HG3' HD21 ' C' ' 15' ' ' LEU . 3.4 mttm -64.19 -40.89 97.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.58 153.84 51.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.121 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.07 57.71 2.73 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' C' ' 41' ' ' GLN . 39.1 mm -112.0 101.3 51.39 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.79 158.12 58.01 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.117 1.878 . . . . 0.0 112.219 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.15 -32.66 94.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.298 1.999 . . . . 0.0 112.349 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -66.94 -39.13 87.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.044 0.45 . . . . 0.0 109.898 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -103.67 23.37 12.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.686 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.728 ' HB2' HG22 ' C' ' 36' ' ' ILE . 0.8 OUTLIER -130.42 116.36 18.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.809 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -127.21 124.77 39.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -102.09 127.15 49.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.194 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -125.89 126.05 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 0.0 110.222 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -148.76 147.9 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 19.73 11.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.426 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.14 -13.27 60.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 147.96 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.238 0.542 . . . . 0.0 111.34 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -97.57 111.33 23.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.558 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 1.001 HD23 HD12 ' C' ' 23' ' ' ILE . 10.6 mp -64.29 97.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.794 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -76.98 -76.54 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.044 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -178.21 166.54 1.93 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.44 73.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -126.65 177.99 6.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -127.22 164.62 21.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.156 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.575 HD21 HG21 ' C' ' 26' ' ' VAL . 78.6 mt -61.55 -39.93 92.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.412 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.32 -28.55 69.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.62 -26.58 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.99 0.424 . . . . 0.0 110.385 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -104.16 12.0 34.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.291 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.54 38.16 29.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.195 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.41 105.06 13.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.969 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.13 -175.96 5.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.347 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -68.65 148.2 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.965 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 57.84 37.96 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -89.66 133.2 34.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.839 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -91.15 120.75 32.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.145 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.463 HD12 ' N ' ' C' ' 67' ' ' LEU . 5.2 mp -113.59 146.21 40.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -91.26 131.31 36.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.591 HD21 ' HG2' ' C' ' 41' ' ' GLN . 0.7 OUTLIER -106.17 119.13 38.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.299 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.477 ' N ' HD23 ' C' ' 69' ' ' LEU . 95.4 t -104.07 131.42 52.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.494 ' H ' HD11 ' C' ' 8' ' ' LEU . 26.4 mt -109.28 125.93 52.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.133 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 110.708 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.23 155.46 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.92 145.84 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -93.65 127.64 39.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.508 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.56 HG11 HD11 ' D' ' 30' ' ' ILE . 85.6 t -109.54 115.41 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.172 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -86.46 116.67 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.583 HG23 ' O ' ' D' ' 11' ' ' LYS . 82.0 p -74.63 171.26 14.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.087 0.47 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -41.43 73.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.391 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -76.31 -6.56 52.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.41 -13.31 59.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' LYS . . . . . 0.583 ' O ' HG23 ' D' ' 7' ' ' THR . 11.9 tmtt? -55.29 108.6 0.44 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -83.58 136.89 34.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.07 112.46 23.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.004 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.11 127.0 32.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.205 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.431 HD13 ' CB ' ' D' ' 29' ' ' LYS . 85.1 mt -126.06 120.77 31.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.789 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -66.1 108.97 2.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.719 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.4 m -131.57 166.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.94 154.54 41.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.53 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.88 -36.47 95.61 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.029 1.82 . . . . 0.0 111.861 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.0 p -80.54 -7.94 59.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -58.17 135.27 57.03 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.006 0.432 . . . . 0.0 110.748 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.23 162.48 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.79 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.31 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.687 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.55 -41.6 90.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.937 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.15 -41.59 98.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.049 0.452 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.56 -43.17 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.615 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.99 -38.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.157 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.58 90.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.107 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.719 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.8 mttm -60.77 -39.41 88.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.56 HD11 HG11 ' D' ' 5' ' ' VAL . 7.4 mm -64.93 -40.96 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.524 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.42 -40.41 94.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.712 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -65.15 -44.42 88.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.41 ' HD2' HD21 ' D' ' 15' ' ' LEU . 52.6 mttt -74.16 -66.26 0.74 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.375 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -92.25 171.56 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.004 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -91.1 18.84 49.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.552 HG22 ' HB2' ' D' ' 41' ' ' GLN . 30.2 mm -77.39 119.84 79.09 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.583 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.86 160.49 45.95 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.332 2.021 . . . . 0.0 111.478 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.58 -40.4 85.58 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.106 1.87 . . . . 0.0 112.993 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.08 -52.27 50.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.508 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.58 ' OE1' HD21 ' D' ' 43' ' ' LEU . 4.5 tt0 -65.23 112.64 3.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.889 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -118.1 111.2 18.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.311 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.58 HD21 ' OE1' ' D' ' 41' ' ' GLN . 64.3 mt -90.43 120.57 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.472 . . . . 0.0 110.514 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.3 mt -124.96 127.0 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 78.6 t80 -128.24 128.46 44.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.124 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.38 28.52 9.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.21 79.69 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -128.08 128.66 45.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.0 0.429 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.62 137.96 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.499 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' D' ' 59' ' ' TYR . 66.3 mt -84.64 118.87 24.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.261 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.36 137.77 41.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -62.76 137.77 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.471 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -16.87 57.75 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -78.81 178.68 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 110.459 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 80.5 p -125.53 161.87 26.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.114 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.36 -39.95 92.52 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.106 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.03 -27.58 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.424 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.09 -37.02 81.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.189 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.2 m-85 -98.25 15.02 25.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.084 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 54.74 40.45 31.92 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.859 0.361 . . . . 0.0 110.339 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -89.86 101.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -85.3 -175.83 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -64.09 166.67 7.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.032 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 45.72 36.49 2.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -89.61 122.86 33.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.19 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -83.46 125.48 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.135 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.81 162.75 15.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -109.99 120.73 43.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.381 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.493 HD11 HG21 ' D' ' 30' ' ' ILE . 1.3 tt -99.31 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 81.6 t -103.83 132.69 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.227 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.45 HD21 HD22 ' D' ' 69' ' ' LEU . 48.6 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.231 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.55 126.71 35.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.428 0.632 . . . . 0.0 110.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 51' ' ' GLN . 88.7 mt -68.05 -36.08 79.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.809 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 ' CG1' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -148.81 161.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.17 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -174.01 122.43 0.31 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.74 158.14 37.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.989 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.5 mtt180 -75.54 119.54 19.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.76 146.25 25.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.326 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.21 150.71 17.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.88 167.08 12.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 111.454 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.4 mtp -132.92 175.32 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.849 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.8 m -125.65 121.69 34.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 37' ' ' THR . 29.1 tp -104.46 118.08 35.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.393 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -122.74 113.42 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.977 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.12 -86.33 0.48 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 p -146.51 23.78 1.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.612 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.522 ' O ' HD12 ' A' ' 33' ' ' LEU . 87.9 m -126.54 132.59 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 33' ' ' LEU . 63.4 t -110.12 123.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.305 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.499 HG22 ' HB3' ' B' ' 947' ' ' PRO . 42.2 p -118.21 122.42 30.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.115 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.57 148.5 59.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.772 1.648 . . . . 0.0 113.365 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.88 133.06 44.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.845 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -7.63 48.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.33 78.58 1.85 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.11 132.66 33.34 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.634 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.05 -163.92 11.47 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.227 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.4 tp -137.12 120.44 16.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.55 108.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.548 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.0 p90 -130.83 153.42 49.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' CG1' HG12 ' A' ' 24' ' ' VAL . 96.7 mt -119.0 139.69 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.09 128.14 27.67 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 123.83 0.706 . . . . 0.0 110.847 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.648 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.8 tt0 -99.0 125.15 44.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.416 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.495 HG23 ' CD2' ' A' ' 58' ' ' HIS . 10.7 p -83.51 171.47 13.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.682 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.88 -10.04 25.57 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.509 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.05 2.49 55.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.57 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 t 70.23 21.36 5.91 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 121.088 0.47 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.4 mt -99.45 120.65 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.57 HG21 HD23 ' A' ' 128' ' ' LEU . 49.1 mm -79.33 122.43 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.495 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.6 m-70 -98.56 115.44 28.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.58 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -96.09 107.98 20.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 96.9 m -121.38 146.15 47.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.728 0.775 . . . . 0.0 112.462 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -126.51 113.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.902 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -105.27 145.92 30.03 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.05 0.452 . . . . 0.0 110.572 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.13 132.19 34.71 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -71.64 -18.31 62.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.03 0.443 . . . . 0.0 110.852 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -59.55 -44.98 93.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.789 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.55 -10.36 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.66 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.68 22.85 78.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -102.46 147.16 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.8 106.41 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.67 -22.62 25.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.799 ' OD2' HD21 ' A' ' 73' ' ' LEU . 7.3 t0 -128.64 142.78 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.933 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' HD23 ' A' ' 73' ' ' LEU . 66.6 t0 -157.15 107.65 2.28 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.016 0.436 . . . . 0.0 110.193 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.799 HD21 ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -141.86 130.72 22.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.355 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.67 124.26 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.571 ' HB ' HD22 ' A' ' 128' ' ' LEU . 23.6 mm -111.6 119.6 60.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.602 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.38 161.03 68.99 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.332 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.89 142.12 97.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.063 1.842 . . . . 0.0 111.541 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 61.01 12.36 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.374 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -87.66 -37.39 16.79 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 120.584 0.231 . . . . 0.0 110.602 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.516 ' HB3' HD11 ' A' ' 96' ' ' LEU . 72.7 m -131.31 154.92 48.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.252 0.548 . . . . 0.0 111.745 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -126.72 128.21 46.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.113 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -100.39 117.2 34.1 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -143.64 167.34 22.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -83.56 160.53 21.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.551 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.05 89.21 13.43 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.333 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.3 60.23 7.76 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.124 1.882 . . . . 0.0 112.175 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -114.7 -40.52 3.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.409 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.3 t -128.89 79.65 74.16 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.578 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.29 130.32 39.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.301 2.001 . . . . 0.0 111.284 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.83 -36.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.17 -167.12 12.88 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.55 106.64 18.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.913 0.387 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.4 t -124.83 128.35 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.732 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -125.29 151.38 46.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.125 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -125.43 135.92 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.379 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 80' ' ' CYS . 60.1 tp -102.07 112.71 25.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -112.2 143.1 43.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.505 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.87 116.52 28.01 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.25 -37.53 85.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.787 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.77 -22.33 18.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.397 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.03 174.97 26.98 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -111.94 21.44 15.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.661 0.267 . . . . 0.0 110.294 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.99 149.02 39.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.79 152.42 47.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 95' ' ' VAL . 43.5 mt -120.16 154.63 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CE1' HD22 ' A' ' 33' ' ' LEU . 90.8 m-85 -124.46 134.74 52.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 0.0 110.287 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -138.85 155.31 48.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.106 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -129.97 137.27 50.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.7 mmm -72.23 138.0 47.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -103.76 -1.19 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.292 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -74.1 132.25 79.93 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.09 -25.54 58.43 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.112 1.875 . . . . 0.0 112.585 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 139.59 50.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -94.17 0.89 56.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.056 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -54.28 -21.76 10.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -120.07 -15.65 8.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.71 -40.92 96.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.6 -42.15 98.27 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.166 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.15 -41.47 90.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.727 ' O ' HG23 ' A' ' 124' ' ' VAL . 59.9 m170 -65.28 -39.84 93.09 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.01 -41.99 99.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.666 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -67.56 -40.96 84.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.243 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.64 -38.63 91.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.8 t -58.52 -48.14 86.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.266 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -80.54 -27.21 37.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.33 -38.25 78.08 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.47 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -82.01 -32.25 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.994 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.571 HD22 ' HB ' ' A' ' 75' ' ' ILE . 73.5 mt -79.64 -25.16 41.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.304 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -110.83 -23.44 11.01 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.686 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -137.76 67.84 50.82 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.715 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.41 156.92 60.6 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.626 2.218 . . . . 0.0 112.569 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.127 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.69 89.3 52.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.29 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.33 139.32 73.61 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.475 2.116 . . . . 0.0 112.453 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -80.81 154.35 73.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.71 146.19 83.26 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.929 1.753 . . . . 0.0 112.278 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 163.55 36.91 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.791 2.327 . . . . 0.0 112.396 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.45 160.24 73.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 39' ' ' THR . 41.9 Cg_exo -58.49 146.54 90.24 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.565 2.176 . . . . 0.0 111.864 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -150.29 162.71 39.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -85.96 140.12 30.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.983 0.421 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 950' ' ' TYR . . . . . 0.782 ' O ' HD13 ' B' ' 951' ' ' ILE . 56.7 t80 -121.91 133.46 54.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.86 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.782 HD13 ' O ' ' B' ' 950' ' ' TYR . 9.1 mm . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.11 163.8 19.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.719 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.531 ' HB ' HD13 ' C' ' 67' ' ' LEU . 14.9 pt -143.65 145.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.261 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -93.59 113.05 25.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.392 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -97.27 115.63 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.628 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -100.67 127.72 46.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.673 HG22 HD23 ' C' ' 69' ' ' LEU . 81.4 p -82.03 175.73 10.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.76 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.576 HD11 ' H ' ' C' ' 71' ' ' LEU . 60.4 mt -62.61 -21.63 65.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -88.35 -4.33 58.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.75 74.9 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -59.36 120.78 9.94 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -101.93 132.2 47.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.5 107.05 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.328 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.06 120.66 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.55 130.99 54.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.606 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.9 115.94 15.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.466 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.479 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.2 m -134.92 165.16 31.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.62 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.489 ' O ' HD12 ' C' ' 56' ' ' LEU . 98.0 mt-10 -108.85 151.57 41.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.77 -25.31 75.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.106 1.871 . . . . 0.0 112.071 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 53.6 m -91.78 -10.27 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.527 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 143.25 57.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -80.76 164.42 22.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.609 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.907 HD12 HD23 ' C' ' 50' ' ' LEU . 41.1 mm -63.27 -37.43 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.827 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.75 -41.59 86.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -61.49 -43.6 98.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 110.523 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.533 HG21 HD21 ' C' ' 56' ' ' LEU . 63.2 t -62.97 -42.47 96.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -60.4 -39.95 89.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.59 90.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.199 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.479 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.99 -39.32 85.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.76 ' CD1' HD21 ' C' ' 43' ' ' LEU . 95.3 mt -65.71 -39.3 84.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.577 0.703 . . . . 0.0 110.32 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.79 -46.12 90.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -77.13 -14.64 59.76 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.665 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -102.09 -3.88 26.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -149.14 -42.48 0.14 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.224 0.535 . . . . 0.0 110.391 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.65 29.25 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.212 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' C' ' 41' ' ' GLN . 52.8 mt -72.08 128.43 89.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.777 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.65 153.27 48.89 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.828 1.685 . . . . 0.0 111.708 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.27 -38.17 61.27 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.066 1.844 . . . . 0.0 112.737 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.7 -39.77 92.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.842 0.353 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -89.44 -2.64 58.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.032 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.624 ' HG3' HG22 ' C' ' 36' ' ' ILE . 92.2 mt-30 -93.79 106.89 18.84 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.693 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.76 HD21 ' CD1' ' C' ' 30' ' ' ILE . 73.6 mt -79.54 133.9 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.837 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.539 HG21 ' HE1' ' A' ' 76' ' ' PHE . 80.5 mt -135.04 129.39 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.345 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 71.1 t80 -151.47 151.72 32.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.36 16.54 10.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.731 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -10.63 67.19 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.649 ' HG2' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -112.68 145.14 40.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.312 0.577 . . . . 0.0 110.84 -178.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -73.63 129.82 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.905 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.907 HD23 HD12 ' C' ' 23' ' ' ILE . 9.2 mp -76.46 94.3 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.829 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.2 150.13 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 111.122 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -60.36 143.08 53.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.402 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.58 -19.35 48.02 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -88.14 169.1 12.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.522 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.9 p -118.17 164.5 15.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.954 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.533 HD21 HG21 ' C' ' 26' ' ' VAL . 80.0 mt -61.01 -41.14 95.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.587 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -64.24 -22.72 67.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.388 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.96 -36.68 82.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.547 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -99.92 15.76 26.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.103 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 57.58 38.72 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.694 HD11 HD21 ' C' ' 50' ' ' LEU . 61.7 mt -83.99 105.29 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.899 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -92.16 -178.89 5.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.409 0.623 . . . . 0.0 111.159 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.46 146.88 52.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.009 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 60.93 15.79 6.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.215 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 33.7 m -69.87 133.63 47.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -87.4 118.49 26.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.723 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' C' ' 3' ' ' ILE . 6.8 mp -107.93 140.98 40.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.997 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -89.82 129.43 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.673 HD23 HG22 ' C' ' 7' ' ' THR . 50.2 tp -107.91 121.25 44.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.19 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 56' ' ' LEU . 90.5 t -108.4 132.3 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.152 0.501 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.576 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.7 mt -106.16 152.14 23.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.559 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.454 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.82 157.04 22.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.351 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.84 148.12 25.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.419 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.0 m-30 -89.11 121.97 31.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.788 HG11 HD11 ' D' ' 30' ' ' ILE . 58.9 t -110.1 105.97 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.554 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -89.12 129.95 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 110.893 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -89.16 175.98 7.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.812 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.7 mt -61.73 -35.44 78.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.913 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -70.46 -11.65 61.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 -12.79 63.0 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.04 127.83 33.13 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -98.82 133.62 42.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 13' ' ' ILE . 1.4 mt -124.23 111.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.429 HG23 ' CD2' ' D' ' 4' ' ' PHE . 17.5 m -82.76 125.91 31.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.86 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.52 125.97 48.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.475 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -69.3 113.87 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.619 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 13.1 m -135.99 170.58 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -120.1 156.39 54.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.254 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.42 -26.64 82.62 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.163 1.909 . . . . 0.0 112.069 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -83.71 -14.26 52.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.563 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.17 144.05 57.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -87.68 166.33 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.41 -39.55 85.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.066 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.52 -42.25 91.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.183 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.29 -39.85 94.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.28 -43.34 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.996 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -61.3 -40.02 92.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.2 91.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.929 0.395 . . . . 0.0 109.998 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.619 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 87.9 mttt -59.86 -38.03 80.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.788 HD11 HG11 ' D' ' 5' ' ' VAL . 5.3 mm -63.92 -39.93 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.156 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.78 -45.59 93.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.289 0.566 . . . . 0.0 110.635 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.2 -33.91 76.84 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.045 -0.409 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -89.95 -6.88 55.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -146.08 -53.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.0 110.456 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.28 20.68 4.68 Favored Glycine 0 CA--C 1.517 0.205 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.567 HD13 HD21 ' D' ' 71' ' ' LEU . 60.4 mt -95.35 114.18 63.26 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.418 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.01 153.82 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.094 1.863 . . . . 0.0 112.215 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.99 -28.85 86.9 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.648 2.232 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -91.46 -4.34 55.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -92.6 -16.87 25.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.551 ' OE1' HD11 ' D' ' 69' ' ' LEU . 15.6 pt20 -137.88 160.55 38.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.305 0.574 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.18 130.93 53.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.561 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.79 119.54 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.823 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -121.23 128.07 75.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.981 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 89.6 t80 -122.61 128.48 50.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.455 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 64.15 25.05 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.67 90.29 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -110.29 126.23 53.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -65.05 135.55 55.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.66 107.69 17.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.112 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -74.79 154.15 38.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.337 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -72.97 162.99 28.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.342 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.43 20.73 77.18 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -122.94 150.79 42.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.66 0.267 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.6 p -96.87 160.44 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.467 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.37 -39.09 92.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.412 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.2 -39.06 93.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.055 0.455 . . . . 0.0 110.361 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -94.42 13.36 24.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 56.69 42.81 26.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 69.0 mt -90.97 104.24 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.097 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.04 179.31 5.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.438 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -60.74 150.65 31.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 58.49 45.42 16.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 85.5 p -101.21 128.89 47.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.988 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.426 ' C ' HD12 ' D' ' 67' ' ' LEU . 87.2 m -81.15 126.05 31.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.582 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.426 HD12 ' C ' ' D' ' 66' ' ' THR . 7.4 mp -117.03 148.27 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.38 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.67 116.32 28.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.441 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.551 HD11 ' OE1' ' D' ' 41' ' ' GLN . 5.2 tt -99.54 104.71 16.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.978 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.621 ' HA ' HD21 ' D' ' 8' ' ' LEU . 94.1 t -100.59 128.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.253 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.812 ' H ' HD11 ' D' ' 8' ' ' LEU . 81.9 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.871 0.367 . . . . 0.0 110.755 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 C--O 1.237 0.42 0 CA-C-O 120.827 0.346 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -90.06 120.54 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.327 0.584 . . . . 0.0 110.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 51' ' ' GLN . 95.1 mt -69.05 -35.28 76.38 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -149.22 161.14 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.984 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.63 122.66 0.35 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.229 0.537 . . . . 0.0 110.814 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.98 158.22 38.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.878 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HA ' HD12 ' A' ' 46' ' ' LEU . 90.7 mtt-85 -76.46 120.5 21.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.538 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.78 148.01 26.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.5 150.64 17.64 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -87.72 165.44 15.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.953 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 26.4 mtp -134.01 175.07 9.8 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.1 m -129.8 126.73 38.79 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.355 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 33' ' ' LEU . 8.4 tt -102.16 125.52 48.88 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.472 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -116.13 103.29 10.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.903 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.16 -83.14 0.74 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -144.02 20.26 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.554 0.216 . . . . 0.0 110.879 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -122.22 129.18 52.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 HD12 ' A' ' 33' ' ' LEU . 57.8 t -100.74 125.47 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.626 HG22 ' HB3' ' B' ' 947' ' ' PRO . 27.3 p -118.72 128.28 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.328 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.99 145.97 51.37 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.779 1.653 . . . . 0.0 112.603 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -108.02 138.2 44.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.878 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -72.6 -5.42 37.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.993 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.2 73.67 0.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.64 134.83 41.46 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.408 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.76 -162.64 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.0 tp -136.67 126.44 25.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 108.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.979 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.6 p90 -133.22 153.5 51.49 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.922 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.414 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.3 mt -119.45 139.48 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.285 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.63 132.49 40.83 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 123.923 0.765 . . . . 0.0 110.147 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.665 ' HB2' HD11 ' A' ' 23' ' ' LEU . 49.5 tt0 -102.68 122.47 44.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.133 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.456 HG23 ' CD2' ' A' ' 58' ' ' HIS . 8.2 p -82.89 171.58 13.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.46 -10.06 22.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.705 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.6 8.17 40.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.47 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m 62.82 23.99 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 110.762 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.598 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 69.7 mt -98.8 120.32 39.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.527 HG21 HD23 ' A' ' 128' ' ' LEU . 51.9 mm -80.1 121.15 32.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.552 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.456 ' CD2' HG23 ' A' ' 52' ' ' THR . 75.3 m-70 -97.67 112.55 24.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.899 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -92.9 107.2 19.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 93.3 m -119.38 143.9 47.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.929 0.871 . . . . 0.0 112.847 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.2 t90 -126.85 113.44 16.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.109 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -103.9 144.32 31.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.631 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -82.83 130.52 35.14 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -71.36 -16.65 62.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.75 0.31 . . . . 0.0 110.755 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.54 -45.87 90.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.442 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.69 -11.77 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.54 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.73 22.45 78.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -102.57 152.0 21.68 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.57 102.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.371 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.88 -38.25 67.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.888 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.48 147.18 49.86 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.392 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.497 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p-10 -158.78 97.74 1.45 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.314 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD22 ' HG2' ' C' ' 48' ' ' LYS . 31.8 mt -124.55 136.78 54.26 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.095 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.56 119.47 30.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.705 HG21 ' SG ' ' A' ' 80' ' ' CYS . 22.5 mm -109.29 120.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 111.05 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.598 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.0 m-85 -85.13 163.03 47.28 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.51 141.48 95.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.171 1.914 . . . . 0.0 111.689 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 61.14 12.42 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -87.42 -25.99 23.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.705 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.3 p -149.98 167.02 27.89 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.452 0.644 . . . . 0.0 110.569 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -137.11 132.52 34.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.189 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -103.38 118.58 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.44 167.9 21.0 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.496 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -87.8 160.37 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.176 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.67 90.82 13.35 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.152 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.21 59.82 7.18 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -115.6 -36.72 4.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.526 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.9 t -127.89 81.72 69.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.288 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.29 130.4 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.898 1.732 . . . . 0.0 111.651 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t 169.1 -44.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.83 -147.83 5.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' HD3' HG22 ' A' ' 114' ' ' THR . 0.1 OUTLIER -118.13 105.73 12.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.188 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.3 t -122.71 126.59 74.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -123.57 152.93 41.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.718 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -130.97 135.36 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.516 HD11 ' SG ' ' A' ' 80' ' ' CYS . 61.2 tp -100.87 121.84 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -116.78 124.85 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.026 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' HE2' HD12 ' A' ' 75' ' ' ILE . 32.3 m-85 -81.4 115.1 20.58 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.01 -37.54 82.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.497 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.72 -23.66 11.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.486 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.51 -24.5 72.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.192 -0.527 . . . . 0.0 111.894 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m 66.89 6.66 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.576 ' HD3' HD21 ' A' ' 105' ' ' LEU . 5.5 ttmm -98.36 150.17 21.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.498 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.6 mtt180 -131.23 136.78 48.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.835 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.576 HD21 ' HD3' ' A' ' 103' ' ' LYS . 40.1 mt -123.29 151.16 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.045 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 97.6 m-85 -123.67 137.52 54.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.41 155.22 47.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 111.4 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -129.82 136.75 49.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.127 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.82 141.26 58.35 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.341 0.591 . . . . 0.0 111.369 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -112.99 -8.2 13.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.169 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.2 135.15 89.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.704 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.94 -23.13 35.0 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.826 1.684 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -116.44 141.1 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.341 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.49 HG22 ' HD3' ' A' ' 92' ' ' ARG . 77.0 p -97.93 17.23 18.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.261 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.4 -21.14 59.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -135.64 17.76 3.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.841 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.63 -48.9 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.199 0.523 . . . . 0.0 111.059 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.63 -33.02 70.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.322 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.22 -44.78 90.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.489 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.748 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.2 m170 -62.01 -41.37 98.0 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.451 0.643 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.3 -44.83 95.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.847 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.5 -42.55 91.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.388 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.01 -37.61 88.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.918 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.0 t -58.78 -47.77 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.272 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -80.08 -28.41 39.14 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.843 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -68.91 -37.74 79.15 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.404 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.72 -33.16 35.45 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.731 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 75' ' ' ILE . 69.5 mt -79.58 -26.89 41.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -108.25 -24.01 11.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.655 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -136.88 69.19 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.797 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.37 157.78 55.87 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.854 2.369 . . . . 0.0 112.55 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.654 2.236 . . . . 0.0 112.211 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -128.95 150.59 75.64 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.634 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.96 147.02 33.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.695 2.263 . . . . 0.0 112.031 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.25 153.64 92.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.21 151.36 76.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.106 1.871 . . . . 0.0 112.253 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.09 -171.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.466 2.11 . . . . 0.0 112.096 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -120.06 155.08 55.87 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.626 ' HB3' HG22 ' A' ' 39' ' ' THR . 22.2 Cg_endo -60.93 141.76 95.55 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.352 2.035 . . . . 0.0 112.115 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.73 165.2 37.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.834 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.64 136.69 32.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.849 0.357 . . . . 0.0 110.41 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -120.62 121.21 37.84 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.64 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -62.26 156.13 22.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.369 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -136.78 157.02 35.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.362 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.619 ' CD2' HG23 ' C' ' 14' ' ' THR . 15.5 m-30 -96.19 122.59 39.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.897 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.3 t -110.43 101.85 13.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.224 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -88.34 124.09 33.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.177 0.513 . . . . 0.0 110.82 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.519 HG21 ' OE2' ' C' ' 34' ' ' GLU . 82.1 p -86.47 172.09 10.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.07 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.524 HD11 ' H ' ' C' ' 71' ' ' LEU . 70.5 mt -65.5 -19.08 65.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -83.95 -5.0 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.057 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.32 80.5 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.17 126.37 30.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.87 0.366 . . . . 0.0 110.218 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -97.6 131.22 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -115.84 116.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.374 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' THR . . . . . 0.619 HG23 ' CD2' ' C' ' 4' ' ' PHE . 0.2 OUTLIER -85.15 117.12 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.428 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.65 116.41 27.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.922 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.75 105.99 1.4 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.731 HG12 ' HE3' ' C' ' 29' ' ' LYS . 28.4 m -130.45 162.71 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.497 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -105.88 155.72 37.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -37.79 93.7 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.896 1.731 . . . . 0.0 112.109 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -80.32 -7.55 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.301 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ASP . . . . . 0.418 ' HB3' HD12 ' C' ' 56' ' ' LEU . 31.8 t0 -57.21 135.54 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -79.23 163.27 25.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.767 HD12 HD23 ' C' ' 50' ' ' LEU . 40.6 mm -64.54 -38.77 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.102 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.26 -41.48 88.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.995 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.05 -41.4 98.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.799 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.455 HG21 HD21 ' C' ' 56' ' ' LEU . 57.5 t -63.35 -42.98 98.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.417 ' HG2' HD11 ' C' ' 43' ' ' LEU . 55.0 mtmt -60.83 -40.17 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.635 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.83 92.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.104 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.731 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.62 -38.75 82.15 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.752 HD13 HD11 ' C' ' 69' ' ' LEU . 97.1 mt -66.37 -39.78 84.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.752 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -59.54 -46.93 87.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.365 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.21 -16.26 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.986 -0.446 . . . . 0.0 111.897 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -101.18 -5.81 25.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLU . . . . . 0.519 ' OE2' HG21 ' C' ' 7' ' ' THR . 81.5 mt-10 -148.31 -41.96 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.1 0.476 . . . . 0.0 110.476 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.8 8.16 28.43 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.352 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.08 128.78 82.27 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.899 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 160.44 43.66 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.564 1.509 . . . . 0.0 111.683 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.79 -39.16 93.4 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.274 1.982 . . . . 0.0 112.472 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.86 -39.88 93.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.761 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -89.17 -4.43 58.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.06 90.34 7.33 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -101.6 97.18 7.64 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.417 HD11 ' HG2' ' C' ' 27' ' ' LYS . 22.2 mt -88.27 129.47 35.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.594 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.415 HG21 ' HE1' ' A' ' 76' ' ' PHE . 83.7 mt -127.92 129.09 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -151.64 152.83 33.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.75 17.15 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.93 -13.59 60.8 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.675 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.99 146.5 42.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 110.599 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.19 132.18 42.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.045 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.767 HD23 HD12 ' C' ' 23' ' ' ILE . 6.8 mp -67.26 101.47 0.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.35 140.69 44.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.91 143.0 55.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.299 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.56 -16.26 61.34 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -83.44 176.19 9.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.193 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -122.27 161.95 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.817 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.455 HD21 HG21 ' C' ' 26' ' ' VAL . 84.5 mt -61.8 -40.39 95.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.823 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -63.69 -23.98 67.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -62.83 -37.63 87.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 110.149 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -96.46 13.48 27.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.252 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.05 42.42 22.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.41 HG21 HD22 ' C' ' 56' ' ' LEU . 64.9 mt -90.37 109.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.301 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -98.19 -177.99 3.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.213 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.26 146.89 52.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 59.34 42.28 18.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' SER . . . . . 0.479 ' O ' HD12 ' C' ' 67' ' ' LEU . 45.7 m -97.55 127.28 43.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.98 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 87.1 m -76.86 126.57 31.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.113 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.479 HD12 ' O ' ' C' ' 65' ' ' SER . 5.7 mp -116.33 149.03 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.084 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.26 117.34 32.44 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.752 HD11 HD13 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -97.21 99.05 10.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.642 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -87.06 130.67 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.524 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.8 mt -110.39 141.23 43.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.162 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.659 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.62 159.61 12.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.956 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.05 151.91 25.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.054 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.432 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.5 m-30 -93.16 121.94 35.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.536 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.2 105.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 6' ' ' LYS . . . . . 0.458 ' HG3' HG23 ' D' ' 66' ' ' THR . 32.2 mtmt -90.29 133.28 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.717 HG22 HD23 ' D' ' 69' ' ' LEU . 82.0 p -88.87 -174.9 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.592 HD21 ' HA ' ' D' ' 70' ' ' VAL . 88.7 mt -62.34 -38.08 88.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.004 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -72.84 -9.04 58.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.615 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.45 -7.44 75.04 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.61 124.86 21.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -96.09 131.25 42.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mt -123.56 111.54 29.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.552 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.432 HG23 ' CD2' ' D' ' 4' ' ' PHE . 8.3 m -81.49 125.71 30.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.425 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.8 mt -121.21 125.15 46.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.126 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.96 114.8 9.39 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.441 HG12 ' CD ' ' D' ' 29' ' ' LYS . 26.7 m -135.57 163.01 36.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -104.7 153.29 39.36 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.074 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.55 -36.17 97.58 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.948 1.766 . . . . 0.0 112.043 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.46 -0.65 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -62.28 136.63 58.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -76.96 161.81 28.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.26 0.552 . . . . 0.0 110.794 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.59 -38.54 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.27 -42.53 91.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.88 -41.3 97.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.64 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.4 -42.67 97.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.597 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.2 mtmt -60.71 -39.38 88.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.133 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.26 93.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.411 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.441 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.4 mttm -60.06 -39.53 86.32 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.53 -39.66 84.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.297 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.34 -39.78 84.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.335 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.68 -50.3 52.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.711 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.425 ' HD2' HD21 ' D' ' 15' ' ' LEU . 24.6 mttp -66.18 -40.41 90.43 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -128.66 147.63 50.76 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.06 59.32 3.12 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.563 HG23 HD22 ' D' ' 71' ' ' LEU . 31.0 mm -110.31 107.07 58.46 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.8 152.82 54.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.316 2.011 . . . . 0.0 111.747 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.61 -42.4 66.21 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.744 1.629 . . . . 0.0 112.884 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.6 -43.29 99.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -68.3 -38.55 81.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.444 ' HG3' HG22 ' D' ' 36' ' ' ILE . 68.2 mt-30 -58.05 118.03 4.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.013 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' ARG . . . . . 0.731 ' NE ' HD11 ' D' ' 44' ' ' ILE . 77.9 ttt180 -121.21 106.31 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' D' ' 27' ' ' LYS . 19.8 mt -96.15 115.93 28.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.081 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.731 HD11 ' NE ' ' D' ' 42' ' ' ARG . 83.9 mt -123.27 124.37 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.377 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 85.1 t80 -128.36 130.02 47.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.179 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.62 27.11 11.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.357 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.22 81.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -125.9 127.3 45.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.834 0.349 . . . . 0.0 110.725 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.47 137.0 55.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.47 HD12 ' CB ' ' D' ' 43' ' ' LEU . 77.9 mt -78.68 122.06 25.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.083 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -76.15 136.28 39.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -65.06 130.92 45.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.5 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.67 -15.81 52.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -79.88 -176.99 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.8 p -125.66 163.47 22.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' D' ' 56' ' ' LEU . 85.7 mt -62.22 -40.06 94.86 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.606 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.4 p -64.1 -27.46 69.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.13 -29.72 71.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.123 0.487 . . . . 0.0 110.178 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -101.66 12.41 37.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.403 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.48 40.41 29.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.036 0.446 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 90.0 mt -89.82 107.22 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.673 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.09 177.89 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -59.75 149.79 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 60.01 18.66 7.81 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.631 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.0 m -73.81 129.65 38.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.07 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.647 ' C ' HD12 ' D' ' 67' ' ' LEU . 86.7 m -81.82 130.15 34.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.019 0.437 . . . . 0.0 110.58 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.647 HD12 ' C ' ' D' ' 66' ' ' THR . 9.4 mp -120.63 140.11 52.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -86.49 113.44 22.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.717 HD23 HG22 ' D' ' 7' ' ' THR . 62.8 tp -100.72 115.49 30.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.431 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.592 ' HA ' HD21 ' D' ' 8' ' ' LEU . 78.1 t -114.53 139.38 40.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.74 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.563 HD22 HG23 ' D' ' 36' ' ' ILE . 37.9 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.161 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt . . . . . 0 C--O 1.236 0.353 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -94.16 113.65 25.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.082 0.468 . . . . 0.0 109.792 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' A' ' 57' ' ' ILE . 95.7 mt -67.53 -36.94 81.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' HE3' ' A' ' 123' ' ' LYS . 1.2 p -149.76 162.3 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.868 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.15 122.5 0.39 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.251 0.548 . . . . 0.0 110.934 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.78 158.16 37.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.889 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.06 123.8 25.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.574 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.0 21.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.176 0.512 . . . . 0.0 110.35 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.51 16.94 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -92.11 158.4 16.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 0.0 110.78 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.33 163.32 25.99 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -115.69 129.92 56.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.741 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 37' ' ' THR . 31.5 tp -106.7 120.8 42.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.83 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -122.92 110.99 16.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.328 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.52 -93.61 0.55 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.3 p -137.45 21.27 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.604 0.24 . . . . 0.0 111.036 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.516 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.5 m -125.88 131.55 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.516 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' CG2' HD13 ' A' ' 33' ' ' LEU . 60.3 t -107.64 125.18 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.9 p -113.61 111.53 49.01 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.13 139.75 91.63 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.577 2.185 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -94.87 129.22 41.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -68.41 -10.17 53.42 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.864 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -72.19 82.85 1.01 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.19 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.27 133.59 52.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.193 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.8 -161.07 10.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.315 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.1 tp -138.77 126.98 22.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 t -100.2 110.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -133.13 155.0 50.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.26 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.4 mt -120.05 137.19 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.387 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.12 131.27 36.67 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.586 0.554 . . . . 0.0 110.231 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.471 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.4 tt0 -100.84 125.98 47.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.044 0.45 . . . . 0.0 110.144 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.504 HG23 ' CD2' ' A' ' 58' ' ' HIS . 16.5 p -86.33 172.94 10.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.634 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.37 -10.83 27.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.657 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.34 5.65 46.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.442 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 m 63.55 24.81 14.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.587 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 75.0 mt -100.6 122.78 43.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.511 HG21 HD23 ' A' ' 128' ' ' LEU . 51.0 mm -80.9 122.28 35.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.504 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.8 m-70 -98.36 114.9 27.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.693 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.46 108.39 20.32 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.9 m -121.44 146.92 46.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.753 0.787 . . . . 0.0 112.675 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -125.19 115.02 19.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.064 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -107.45 134.5 50.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.845 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.0 132.5 41.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.557 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -73.88 -18.55 60.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -59.94 -45.95 90.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.049 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -116.48 -16.26 10.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.102 0.477 . . . . 0.0 109.768 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.33 22.89 72.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -101.38 152.2 21.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.827 0.346 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -80.75 107.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.902 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.94 -27.5 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -127.94 144.15 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.183 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.571 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -158.59 99.76 1.6 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.46 179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' C' ' 48' ' ' LYS . 40.5 mt -129.07 133.08 47.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.52 122.6 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.632 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.0 mm -112.39 121.31 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.366 0.603 . . . . 0.0 111.142 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 38.6 m-85 -85.56 163.39 44.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.718 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.51 140.53 93.54 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.246 1.964 . . . . 0.0 111.536 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t0 60.07 12.08 3.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.344 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.48 -26.48 30.2 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.298 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 96' ' ' LEU . 17.7 p -151.18 166.92 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.475 0.655 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -133.58 132.06 40.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.259 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.4 119.45 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -143.86 168.87 18.94 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.742 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -85.7 157.06 20.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.58 89.37 7.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.319 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.18 61.03 7.64 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.965 1.776 . . . . 0.0 112.274 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.82 -39.22 4.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.398 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 p -129.69 73.61 81.38 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.45 130.06 36.75 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.213 1.942 . . . . 0.0 111.297 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.02 -45.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.146 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.88 -156.34 8.71 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.15 105.37 15.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.786 0.327 . . . . 0.0 110.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.63 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.08 152.22 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.405 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.86 134.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.281 0.562 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.3 tp -102.47 117.61 35.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -114.23 122.84 48.0 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.417 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.469 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 37.9 m-85 -78.46 114.1 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.95 -37.95 84.15 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.14 -23.03 12.71 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.376 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -71.42 -20.29 78.19 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.133 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 m 59.75 34.33 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.945 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 162.02 36.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.484 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -134.9 143.31 46.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.911 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 mt -119.81 147.09 45.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.5 m-85 -115.51 132.04 56.75 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.271 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.11 157.43 46.34 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.256 0.551 . . . . 0.0 110.938 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -134.25 141.64 47.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.387 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.0 mmm -74.68 139.09 43.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.062 0.458 . . . . 0.0 110.976 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.81 10.67 10.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.011 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.2 145.07 90.55 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.488 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.47 -39.1 79.08 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.994 1.796 . . . . 0.0 112.577 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -118.89 146.31 45.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.909 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.5 p -97.86 6.94 47.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.722 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -54.02 -20.98 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.421 ' NE2' ' OE1' ' A' ' 119' ' ' GLU . 30.7 mm100 -126.94 14.77 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.155 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.59 -45.71 91.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.12 -33.06 67.52 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.521 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.421 ' OE1' ' NE2' ' A' ' 116' ' ' GLN . 36.0 tt0 -65.6 -43.32 90.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.058 0.456 . . . . 0.0 110.641 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.772 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.3 m170 -65.31 -40.89 94.35 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.645 0.736 . . . . 0.0 109.383 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.6 t -62.32 -45.67 92.18 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.796 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -64.97 -43.34 92.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.322 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HE3' HG23 ' A' ' 24' ' ' VAL . 27.2 mtpp -62.48 -38.73 91.01 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.694 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.8 t -58.95 -47.65 89.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.36 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.23 -30.01 38.5 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.844 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.3 -38.94 85.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.567 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -80.33 -34.22 36.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.668 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.574 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.5 mt -77.52 -26.96 51.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.435 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -108.53 -20.46 13.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.272 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -140.39 68.54 32.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.443 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.41 158.27 56.61 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 C-N-CA 122.949 2.432 . . . . 0.0 112.495 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--N 1.312 -1.356 0 C-N-CA 122.64 2.227 . . . . 0.0 112.321 -179.611 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.83 148.16 98.87 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.61 152.82 38.43 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.587 2.192 . . . . 0.0 111.959 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.91 151.03 90.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.118 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.21 158.75 48.44 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.278 1.985 . . . . 0.0 112.239 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 168.41 23.99 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.706 2.271 . . . . 0.0 111.918 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -105.68 159.86 28.08 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.78 145.97 87.87 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.237 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.87 166.56 33.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -85.15 138.01 32.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.32 125.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.84 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 46.5 mt . . . . . 0 C--N 1.313 -0.984 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -66.97 161.08 25.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.26 149.99 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.133 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.04 126.44 44.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.646 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.75 117.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -100.6 117.89 35.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.467 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.674 HG22 HD23 ' C' ' 69' ' ' LEU . 71.2 p -80.0 171.22 15.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.049 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.525 HD11 ' H ' ' C' ' 71' ' ' LEU . 64.9 mt -63.42 -24.02 67.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.173 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.2 p -75.42 -8.73 57.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.24 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -72.41 132.89 44.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.792 0.33 . . . . 0.0 110.264 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -109.09 131.71 54.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.229 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.25 117.37 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.819 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 135.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.665 HD21 ' CD ' ' C' ' 33' ' ' LYS . 16.0 mt -133.91 126.68 30.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.114 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -70.74 117.35 12.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.653 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 21.3 m -137.18 166.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.538 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.6 mt-10 -112.26 151.52 43.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.02 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.14 -26.37 81.48 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.981 1.788 . . . . 0.0 112.207 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -87.02 -11.51 50.18 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.743 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -62.99 143.49 57.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.615 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -81.67 165.95 20.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.315 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.634 HD12 HD23 ' C' ' 50' ' ' LEU . 42.4 mm -62.44 -39.18 83.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.314 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.48 -41.99 91.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.83 -41.57 97.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.141 0.496 . . . . 0.0 110.876 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.677 HG21 HD21 ' C' ' 56' ' ' LEU . 56.7 t -63.13 -43.35 98.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.702 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.79 -39.71 89.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.43 91.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 0.0 110.519 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.664 ' HB3' HD22 ' C' ' 15' ' ' LEU . 71.9 mttt -60.15 -39.76 87.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.373 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.8 ' CD1' HD21 ' C' ' 43' ' ' LEU . 96.8 mt -66.98 -38.4 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.257 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.28 -42.21 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -63.51 -43.79 96.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.665 ' CD ' HD21 ' C' ' 15' ' ' LEU . 0.0 OUTLIER -69.49 -65.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.225 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.41 155.9 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.854 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.8 57.82 4.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.674 HG22 ' HG3' ' C' ' 41' ' ' GLN . 32.2 mm -110.78 104.69 56.44 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.37 157.57 35.28 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.53 2.154 . . . . 0.0 112.041 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.07 -30.55 90.59 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.249 1.966 . . . . 0.0 112.309 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.83 -40.73 88.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.056 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -87.22 -9.67 54.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.58 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.674 ' HG3' HG22 ' C' ' 36' ' ' ILE . 86.1 mt-30 -81.73 95.84 7.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.334 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -110.36 93.67 4.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' C' ' 30' ' ' ILE . 74.3 mt -80.07 135.14 36.28 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.44 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -135.8 127.33 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -152.0 149.83 29.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.805 0.336 . . . . 0.0 111.211 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.03 15.27 9.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.14 -15.2 60.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.457 ' HE3' HD22 ' A' ' 73' ' ' LEU . 12.1 mtpt -100.9 140.61 34.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.942 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -77.94 118.19 20.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.886 HD21 HD11 ' C' ' 61' ' ' ILE . 8.6 mp -66.56 86.14 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.243 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' GLU . . . . . 0.437 ' O ' HG21 ' C' ' 23' ' ' ILE . 24.5 pt-20 -74.52 -175.89 2.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.4 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.7 156.5 30.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.15 -152.23 48.17 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 55.36 172.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.519 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -125.99 167.96 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.348 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.677 HD21 HG21 ' C' ' 26' ' ' VAL . 78.8 mt -60.7 -40.74 93.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.563 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -63.78 -24.32 67.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.91 -37.06 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.446 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -96.44 13.78 26.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.997 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 58.58 40.59 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.886 HD11 HD21 ' C' ' 50' ' ' LEU . 60.9 mt -87.88 108.68 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.754 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.71 179.99 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.82 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.65 145.97 53.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 59.18 17.64 5.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 137.23 57.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -98.07 120.21 38.08 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.685 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.497 HD12 ' N ' ' C' ' 67' ' ' LEU . 4.8 mp -113.6 142.27 46.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.324 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -88.91 130.32 35.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.194 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.674 HD23 HG22 ' C' ' 7' ' ' THR . 59.9 tp -105.88 122.07 45.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.017 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.75 132.67 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.525 ' H ' HD11 ' C' ' 8' ' ' LEU . 27.8 mt -108.49 143.25 37.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.345 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.686 179.806 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' GLN . . . . . 0.458 HE21 HG21 ' D' ' 14' ' ' THR . 9.8 pt20 -62.88 155.64 26.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.552 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -134.85 154.61 36.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.547 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.578 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.1 m-30 -94.87 125.08 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.397 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.83 99.06 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.383 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -85.18 130.05 34.68 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.73 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.838 HG23 HD23 ' D' ' 69' ' ' LEU . 0.2 OUTLIER -90.51 -175.06 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.709 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.656 HD11 ' H ' ' D' ' 71' ' ' LEU . 73.2 mt -70.85 -26.01 63.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.291 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -78.97 -9.98 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.55 -13.55 64.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.71 132.08 48.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 68.5 m -102.72 130.75 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 110.608 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mm -113.47 117.9 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.489 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.578 HG23 ' CD2' ' D' ' 4' ' ' PHE . 0.5 OUTLIER -88.58 118.75 28.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.598 HD11 HG12 ' D' ' 30' ' ' ILE . 81.1 mt -117.44 116.95 28.17 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.67 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -65.46 105.69 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.674 HG12 ' HE3' ' D' ' 29' ' ' LYS . 17.8 m -129.13 166.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.205 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -115.18 155.91 46.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.03 -24.65 66.76 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.76 1.64 . . . . 0.0 111.707 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.7 p -88.18 -11.82 45.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.822 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.14 141.99 58.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.171 0.51 . . . . 0.0 111.103 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -81.52 164.18 22.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.505 HD12 HD13 ' D' ' 50' ' ' LEU . 48.7 mm -62.86 -42.28 95.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -59.98 -34.56 73.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.353 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -64.76 -41.14 96.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.494 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 -42.38 95.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.456 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.434 ' HG2' HD11 ' D' ' 43' ' ' LEU . 55.6 mtmt -60.56 -40.39 91.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.286 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.22 86.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.674 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.65 -39.5 84.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.607 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.598 HG12 HD11 ' D' ' 15' ' ' LEU . 60.7 mt -67.84 -39.52 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.173 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -58.98 -42.52 90.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.917 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -89.77 17.99 6.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -123.16 -38.01 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -124.85 -8.28 7.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.297 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.71 77.0 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.449 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.549 HD13 ' CD2' ' D' ' 71' ' ' LEU . 44.1 mt -82.04 121.58 79.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.512 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.55 153.61 60.01 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.956 1.771 . . . . 0.0 111.71 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.47 -39.52 73.97 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.112 1.874 . . . . 0.0 111.898 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.21 -39.66 93.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.683 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -83.54 -7.96 59.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.658 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.96 90.83 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.316 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -100.94 111.16 23.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.437 HD21 HD12 ' D' ' 30' ' ' ILE . 35.1 mt -96.67 114.83 26.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.384 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.45 125.14 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 71.0 t80 -144.12 151.29 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.334 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.13 22.91 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.62 16.01 80.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.54 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.4 ' NH1' ' HB1' ' D' ' 46' ' ' ALA . 32.1 ptt-85 -149.29 152.96 36.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 110.794 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.26 139.9 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.505 HD13 HD12 ' D' ' 23' ' ' ILE . 84.8 mt -76.38 127.57 33.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.75 135.54 40.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -67.09 132.16 47.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.211 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.17 -18.19 52.28 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.67 171.49 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.8 164.04 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.723 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.5 p -62.36 -29.15 70.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.4 -35.59 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.081 0.467 . . . . 0.0 110.164 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -96.56 12.58 31.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.304 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 55.18 41.79 31.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 110.14 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -90.39 104.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.638 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.39 -176.1 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -64.58 149.7 48.31 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.446 -0.501 . . . . 0.0 109.935 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 59.14 44.77 15.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 54.3 m -100.32 122.7 43.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.222 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -71.76 128.49 35.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.71 136.64 54.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.75 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -85.64 109.07 18.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.713 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.838 HD23 HG23 ' D' ' 7' ' ' THR . 63.0 tp -96.76 113.4 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.01 134.49 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.035 0.445 . . . . 0.0 110.054 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.656 ' H ' HD11 ' D' ' 8' ' ' LEU . 35.5 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.685 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.233 0.191 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.12 110.96 19.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.223 0.535 . . . . 0.0 109.926 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.8 mt -65.89 -38.46 88.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.22 162.78 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.842 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.6 122.91 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.207 0.527 . . . . 0.0 110.686 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.47 155.4 34.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.765 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.732 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -71.39 121.35 18.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.824 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.25 22.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.106 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.48 152.64 17.34 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -87.13 159.24 18.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.823 0.344 . . . . 0.0 110.737 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.1 mtp -124.81 176.17 6.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -126.01 126.51 44.41 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 37' ' ' THR . 33.4 tp -107.27 122.32 46.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -117.42 106.24 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.923 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.04 -87.27 0.38 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -139.72 23.78 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.687 0.279 . . . . 0.0 111.054 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.704 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.4 m -125.08 125.69 44.18 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.236 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.569 ' CG2' HD13 ' A' ' 33' ' ' LEU . 58.0 t -105.16 124.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.916 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.6 m -123.09 134.26 25.01 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.78 146.89 79.97 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.947 1.765 . . . . 0.0 112.875 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.51 150.82 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -80.73 -6.87 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.808 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -72.79 73.3 1.1 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.86 129.99 43.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.76 -159.58 9.26 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.229 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 27' ' ' ARG . 2.2 tp -140.32 127.75 21.36 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -99.99 110.0 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.556 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.0 p90 -132.42 154.8 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.196 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.1 mt -119.01 138.12 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.397 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -134.66 130.55 36.53 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.666 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.6 tt0 -101.1 124.38 46.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 0.0 109.954 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.481 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.0 p -85.15 172.5 11.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.816 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.48 -10.31 24.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.54 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.51 7.16 42.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.602 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m 63.37 23.86 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 110.603 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -98.63 122.48 41.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.516 HG21 HD23 ' A' ' 128' ' ' LEU . 51.8 mm -81.74 120.65 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.481 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.0 m-70 -97.85 111.24 23.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.973 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -91.0 106.69 18.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 92.7 m -119.03 146.62 44.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.708 0.766 . . . . 0.0 112.752 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.7 t90 -124.94 113.4 17.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.262 -1.336 . . . . 0.0 108.331 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -105.85 135.3 47.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.959 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -76.82 132.7 39.34 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -73.58 -18.68 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -59.88 -46.1 90.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.829 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.1 m -116.46 -15.18 10.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.057 0.456 . . . . 0.0 110.072 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.37 21.51 77.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -101.88 152.74 20.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.242 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.0 t -78.16 107.84 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.54 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -86.59 -28.26 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -129.28 143.8 50.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.191 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.767 ' O ' HD23 ' A' ' 73' ' ' LEU . 43.5 p-10 -157.88 101.96 1.81 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.193 0.521 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 72' ' ' ASP . 5.5 mt -129.7 134.03 47.41 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.24 120.14 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.2 mp -108.16 112.5 40.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -71.2 162.56 71.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.937 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.58 131.43 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.921 1.747 . . . . 0.0 111.668 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.7 t0 63.88 12.22 6.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.404 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -82.13 -35.92 28.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.315 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -128.74 150.62 50.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.301 0.572 . . . . 0.0 111.105 -178.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.567 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.2 tp10 -121.77 129.59 52.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.96 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -107.03 118.08 35.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.43 168.25 20.16 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.579 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -87.39 160.32 18.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.003 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.08 90.66 11.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.119 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.75 60.15 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.984 1.789 . . . . 0.0 112.359 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.84 -39.68 3.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.34 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.6 t -128.29 80.88 71.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.67 130.49 26.52 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.604 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.81 -41.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.02 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.98 -150.92 6.7 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.44 106.23 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.467 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.19 129.35 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.22 154.17 45.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.635 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.69 134.91 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.379 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 81' ' ' GLU . 61.4 tp -104.08 123.19 46.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -122.02 130.98 53.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.129 0.49 . . . . 0.0 110.915 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 61.3 m-85 -84.43 117.83 23.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.97 -31.52 71.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.462 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.73 -21.7 11.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.936 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -80.66 -25.68 55.84 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.961 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.31 8.93 6.0 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.309 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.618 ' HD3' HD21 ' A' ' 105' ' ' LEU . 22.8 ttmt -93.97 143.88 25.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.811 0.339 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -122.83 125.27 45.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.469 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.618 HD21 ' HD3' ' A' ' 103' ' ' LYS . 52.9 mt -114.27 141.88 47.01 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.52 ' CE1' HD22 ' A' ' 33' ' ' LEU . 99.6 m-85 -115.07 134.74 54.91 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -138.01 153.55 49.39 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.276 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -129.03 136.44 50.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.532 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.445 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 29.9 tpp -72.34 134.08 45.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.078 0.466 . . . . 0.0 111.107 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.15 -0.9 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.913 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 109' ' ' MET . 99.3 mt-10 -73.16 133.08 81.62 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.278 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.96 -24.84 39.1 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.9 1.733 . . . . 0.0 112.88 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -111.25 140.8 45.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 p -99.0 12.32 36.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.371 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.92 -20.91 60.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.595 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -126.36 10.87 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.359 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.48 -47.02 83.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.534 . . . . 0.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.31 -31.04 65.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.122 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.64 -45.0 80.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.926 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.671 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.8 m170 -62.81 -41.15 99.17 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.704 0.764 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.55 -44.34 96.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.506 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -65.68 -43.36 89.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.818 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.4 -42.19 99.24 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 120' ' ' HIS . 59.9 t -58.59 -48.8 84.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.912 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.39 -39.16 88.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.298 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -74.39 -22.93 58.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.192 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 m-85 -89.42 -28.25 19.86 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.527 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.516 HD23 HG21 ' A' ' 57' ' ' ILE . 63.1 mt -92.91 -16.72 24.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.062 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -117.16 -17.61 10.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.316 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.52 63.98 18.17 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.798 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.82 153.67 68.39 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 122.522 2.148 . . . . 0.0 112.443 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.313 -1.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.22 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 48.69 70.74 1.9 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.643 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.73 145.73 70.34 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -73.73 159.15 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.298 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.14 154.36 46.31 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.762 2.308 . . . . 0.0 111.998 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.09 -155.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.615 2.21 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -125.39 155.34 71.85 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.01 143.44 90.95 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.473 2.115 . . . . 0.0 111.676 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -156.97 166.99 31.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.77 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.03 135.33 33.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 110.618 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -112.55 123.2 49.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.766 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.444 -0.748 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -67.67 161.15 26.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.503 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.66 143.11 31.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.417 ' HD2' HG21 ' C' ' 12' ' ' THR . 6.4 m-85 -87.5 123.74 32.73 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.42 114.68 47.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.413 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -100.74 121.94 42.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.901 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 79.7 p -83.39 172.49 12.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.597 HD11 ' H ' ' C' ' 71' ' ' LEU . 67.2 mt -62.83 -25.09 68.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.289 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -73.9 -10.04 59.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -11.08 70.52 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.76 132.79 47.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' THR . . . . . 0.417 HG21 ' HD2' ' C' ' 4' ' ' PHE . 93.3 m -109.63 132.21 54.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.556 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.65 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.677 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -84.25 130.17 34.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.49 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.6 mt -123.79 130.21 52.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.687 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.42 115.36 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' C' ' 29' ' ' LYS . 22.4 m -135.35 166.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.0 150.7 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.961 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.27 -36.57 86.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.94 1.76 . . . . 0.0 112.069 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -83.31 -9.98 58.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.85 138.52 57.24 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.663 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -79.5 163.81 24.42 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.772 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.974 HD12 HD23 ' C' ' 50' ' ' LEU . 42.0 mm -65.39 -36.7 78.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.857 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.49 -44.15 89.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -62.9 -41.19 99.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 110.814 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.411 HG21 HD21 ' C' ' 56' ' ' LEU . 62.0 t -63.37 -42.86 97.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.48 -39.02 86.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.68 91.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.397 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.515 ' CB ' HD13 ' C' ' 15' ' ' LEU . 67.2 mttm -60.63 -39.19 87.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.71 ' CD1' HD21 ' C' ' 43' ' ' LEU . 96.8 mt -67.63 -39.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.187 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.21 -38.51 80.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.241 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -67.32 -50.86 58.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.649 ' HG3' HD21 ' C' ' 15' ' ' LEU . 22.1 mttt -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.7 151.08 51.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.77 64.23 1.89 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.648 HG22 ' HB2' ' C' ' 41' ' ' GLN . 42.1 mm -117.98 93.11 43.72 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 149.59 70.68 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.744 2.296 . . . . 0.0 112.11 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -51.69 -42.59 55.86 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.112 1.874 . . . . 0.0 112.277 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.2 -38.66 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 110.347 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -95.7 25.39 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.507 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.648 ' HB2' HG22 ' C' ' 36' ' ' ILE . 12.7 tt0 -131.61 119.87 22.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -127.23 106.64 9.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.71 HD21 ' CD1' ' C' ' 30' ' ' ILE . 63.4 mt -85.13 138.51 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.4 mt -134.39 130.23 53.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.599 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 69.0 t80 -156.37 155.88 32.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.55 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.54 14.13 9.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 89.59 -14.04 62.45 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.09 150.18 39.08 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.407 0.622 . . . . 0.0 110.551 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.04 137.66 45.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.509 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.974 HD23 HD12 ' C' ' 23' ' ' ILE . 6.6 mp -74.13 101.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.18 139.43 42.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -61.48 138.81 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -17.68 55.66 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -83.03 175.68 9.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -119.23 162.21 19.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.279 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.411 HD21 HG21 ' C' ' 26' ' ' VAL . 80.9 mt -61.31 -41.26 96.7 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.757 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -63.25 -24.07 67.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.839 0.352 . . . . 0.0 110.684 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.28 -36.92 83.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -98.3 14.47 27.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.272 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 57.69 38.68 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.894 0.378 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.41 HG21 HD22 ' C' ' 56' ' ' LEU . 53.1 mt -83.82 111.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.234 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -98.08 178.51 5.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -60.33 146.09 45.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.957 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 59.76 22.1 10.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' SER . . . . . 0.532 ' O ' HD12 ' C' ' 67' ' ' LEU . 17.0 m -74.34 127.03 31.96 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.874 0.368 . . . . 0.0 110.185 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.1 m -80.33 126.43 31.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.532 HD12 ' O ' ' C' ' 65' ' ' SER . 4.5 mp -116.41 152.86 33.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -103.0 126.18 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.152 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.656 HD22 HD21 ' C' ' 71' ' ' LEU . 2.3 tt -103.4 122.27 44.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 56' ' ' LEU . 47.6 t -109.12 132.49 57.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.656 HD21 HD22 ' C' ' 69' ' ' LEU . 29.1 mt -107.25 135.54 48.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.081 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 110.509 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -63.35 157.07 23.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.023 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 17.5 pt -138.17 145.17 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.163 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -86.5 126.96 34.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.841 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -112.38 101.18 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -90.67 127.63 36.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.696 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -89.73 -179.21 5.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.688 HD11 ' H ' ' D' ' 71' ' ' LEU . 79.3 mt -64.23 -34.59 78.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -68.21 -12.88 61.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.627 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.18 63.39 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.14 129.96 42.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -102.11 132.35 48.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.458 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.419 HD13 HG21 ' D' ' 13' ' ' ILE . 1.4 mt -126.95 110.4 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.956 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -81.38 130.4 35.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.571 HD21 ' HD2' ' D' ' 33' ' ' LYS . 91.7 mt -125.73 123.73 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.471 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -66.11 112.43 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.073 0.463 . . . . 0.0 110.946 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.517 HG12 ' CD ' ' D' ' 29' ' ' LYS . 20.0 m -136.08 165.57 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.881 -0.512 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' GLU . . . . . 0.602 ' O ' HD12 ' D' ' 56' ' ' LEU . 96.1 mt-10 -111.27 152.63 43.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.115 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -38.34 86.01 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.826 1.684 . . . . 0.0 112.222 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -66.27 -36.49 83.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.162 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -50.45 140.57 13.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.688 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 31.0 p -87.05 169.46 12.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.108 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.38 -34.73 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.279 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.63 -44.07 89.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.102 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.62 -42.4 99.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.466 HG21 HD21 ' D' ' 56' ' ' LEU . 68.0 t -63.21 -42.97 98.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.462 ' CG ' HD22 ' D' ' 43' ' ' LEU . 56.5 mtmt -60.22 -40.42 90.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.58 94.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.704 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.517 ' CD ' HG12 ' D' ' 17' ' ' VAL . 68.4 mttm -60.81 -39.19 88.02 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.665 0.745 . . . . 0.0 109.089 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' D' ' 43' ' ' LEU . 97.4 mt -63.53 -40.13 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.548 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -59.08 -42.17 89.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.732 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.74 -40.71 93.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.751 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.571 ' HD2' HD21 ' D' ' 15' ' ' LEU . 28.0 mttm -77.32 -62.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.327 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.16 156.4 18.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.375 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.92 55.48 4.26 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.656 HG22 ' HB2' ' D' ' 41' ' ' GLN . 41.9 mm -109.8 99.06 36.7 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.136 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.31 153.13 71.47 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.775 1.65 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.62 -40.32 73.37 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.079 1.853 . . . . 0.0 111.952 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.36 -39.37 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 110.402 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -103.1 35.23 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.656 ' HB2' HG22 ' D' ' 36' ' ' ILE . 12.0 tt0 -136.65 124.22 22.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.937 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -122.16 104.68 9.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.53 HD11 ' CD1' ' D' ' 30' ' ' ILE . 3.5 mp -85.31 115.23 22.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.935 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -126.07 126.11 69.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.435 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.569 ' HB2' HD21 ' D' ' 50' ' ' LEU . 52.1 t80 -63.39 -46.21 87.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.658 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.71 -78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.776 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.26 2.56 57.82 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -145.02 136.81 25.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.126 0.489 . . . . 0.0 110.931 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -78.55 138.07 38.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.378 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' D' ' 45' ' ' PHE . 77.7 mt -74.47 122.96 23.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.96 132.56 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 133.63 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.619 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.41 55.61 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -82.3 147.21 29.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.735 0.302 . . . . 0.0 111.011 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 48.8 p -75.71 162.57 28.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.602 HD12 ' O ' ' D' ' 18' ' ' GLU . 80.5 mt -67.36 -38.27 84.52 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.632 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.09 -25.34 67.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.942 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.31 -37.63 83.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -98.06 15.15 25.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 54.37 39.89 31.31 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.75 91.32 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.779 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -82.11 177.99 8.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.974 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -58.7 151.37 21.16 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 60.09 44.51 12.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -97.29 120.9 38.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.526 ' C ' HD12 ' D' ' 67' ' ' LEU . 84.9 m -75.06 127.27 32.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.526 HD12 ' C ' ' D' ' 66' ' ' THR . 8.2 mp -121.21 126.83 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.194 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.01 120.76 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.95 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.458 HD22 HD21 ' D' ' 71' ' ' LEU . 3.5 tt -100.12 112.22 24.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.978 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' D' ' 8' ' ' LEU . 92.1 t -99.92 132.16 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.688 ' H ' HD11 ' D' ' 8' ' ' LEU . 60.9 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.906 0.384 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.21 127.23 37.61 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.708 0.765 . . . . 0.0 110.206 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 51' ' ' GLN . 84.3 mt -67.12 -37.48 83.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.53 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.495 HG11 HG22 ' A' ' 124' ' ' VAL . 1.4 p -148.62 162.93 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.829 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -173.85 122.03 0.32 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.344 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.78 151.4 27.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.912 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -70.37 123.08 20.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 110.357 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -154.93 145.45 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.0 154.26 16.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -87.1 172.62 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 111.165 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 23.4 mtp -138.79 173.72 11.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -124.89 123.6 40.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.53 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 37' ' ' THR . 25.9 tp -107.61 117.24 33.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -120.97 114.46 21.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.953 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.78 -90.09 0.48 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.1 p -141.66 21.14 2.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.841 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.581 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.8 m -123.05 130.86 53.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 33' ' ' LEU . 96.3 t -109.42 123.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.976 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.821 HG22 ' HB3' ' B' ' 947' ' ' PRO . 59.4 p -118.25 132.77 23.61 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.685 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.57 142.67 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.963 1.775 . . . . 0.0 113.05 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -97.74 145.62 26.17 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.733 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -81.21 -6.86 59.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.132 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -73.35 75.41 1.37 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.61 134.12 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.28 -156.53 7.88 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -138.72 123.01 18.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 28' ' ' ALA . 56.1 t -95.77 108.42 21.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.711 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.4 p90 -131.25 153.88 49.06 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.665 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 24' ' ' VAL . 95.5 mt -117.67 139.83 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.548 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.32 128.67 26.05 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 123.84 0.713 . . . . 0.0 110.854 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.537 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.0 tt0 -98.29 124.22 42.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.308 0.575 . . . . 0.0 110.278 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 58' ' ' HIS . 14.5 p -83.75 171.61 13.01 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.54 -10.05 23.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.549 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -89.22 1.97 54.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.5 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.66 19.18 7.4 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.672 HD11 HG11 ' C' ' 70' ' ' VAL . 72.4 mt -98.95 122.73 42.58 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 mm -79.21 125.06 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.506 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.7 m-70 -101.11 114.87 29.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.108 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -93.31 106.67 18.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.89 145.46 45.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -126.96 111.98 14.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.837 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -102.59 145.24 29.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.627 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -81.7 133.55 35.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -73.96 -17.62 60.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.937 0.399 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.4 m -60.18 -45.3 93.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 m -117.79 -12.97 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.456 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.86 23.24 75.37 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -102.51 151.77 21.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.771 0.32 . . . . 0.0 110.813 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.01 109.03 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.309 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.06 -28.42 21.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.92 145.37 50.98 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.075 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.778 ' O ' HD23 ' A' ' 73' ' ' LEU . 64.4 t0 -158.09 100.44 1.71 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.944 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.778 HD23 ' O ' ' A' ' 72' ' ' ASP . 4.7 mt -131.7 129.24 40.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.441 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -75.29 125.97 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.105 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 74' ' ' ILE . 26.2 mm -115.28 121.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.915 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.474 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 39.3 m-85 -82.79 159.76 62.64 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.274 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.09 142.44 97.06 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.992 1.795 . . . . 0.0 111.324 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 61.27 12.64 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.876 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -93.09 -33.33 14.12 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.635 0.255 . . . . 0.0 110.889 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -139.48 148.42 42.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.5 tp10 -120.89 132.24 54.86 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.403 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -105.82 115.83 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -140.81 168.97 18.53 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.098 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -85.61 162.38 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.316 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.54 88.56 9.42 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.317 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.47 60.95 8.02 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.507 2.138 . . . . 0.0 112.09 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 -41.99 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.451 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.3 t -129.23 80.01 73.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.474 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.23 130.11 38.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.189 1.926 . . . . 0.0 111.219 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t 168.02 -39.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.627 0.58 . . . . 0.0 110.123 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.54 -170.1 11.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.605 ' HG3' HG22 ' A' ' 114' ' ' THR . 1.4 mmt-85 -95.96 107.0 19.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.732 0.301 . . . . 0.0 111.002 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.07 129.42 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -122.66 156.06 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.971 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.75 131.45 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 81' ' ' GLU . 60.7 tp -102.34 123.23 45.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -118.98 137.54 53.44 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.74 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -92.8 112.75 24.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.309 0.576 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.88 -37.92 88.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.828 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.78 -21.63 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.514 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.62 -173.16 20.74 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.8 m -122.52 25.75 8.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.941 0.4 . . . . 0.0 110.299 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 149.43 33.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -134.81 144.86 47.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.463 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -120.2 152.08 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.768 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 31' ' ' MET . 98.1 m-85 -124.03 135.0 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.812 0.339 . . . . 0.0 110.578 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.35 158.7 43.84 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -131.99 135.98 46.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.574 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.1 mmm -72.43 139.91 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.0 110.85 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -101.38 0.29 36.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.339 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -72.19 145.2 88.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.15 -28.35 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.095 1.863 . . . . 0.0 112.728 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.07 143.62 49.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.147 0.499 . . . . 0.0 110.321 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.605 HG22 ' HG3' ' A' ' 92' ' ' ARG . 76.9 p -89.52 -0.16 57.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.268 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.11 -19.22 42.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -117.76 -18.38 9.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.3 -41.03 98.17 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.335 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.23 -40.03 95.19 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.394 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.37 -42.92 95.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.535 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.724 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.5 m170 -65.87 -40.07 91.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.476 0.655 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.91 -43.48 98.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.464 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -66.64 -41.44 88.26 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.524 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -64.59 -41.08 96.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.4 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.2 t -57.29 -46.98 85.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.72 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -62.21 -39.45 92.78 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.463 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.65 -25.59 61.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.019 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -87.62 -26.05 23.25 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.999 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 HG12 ' A' ' 124' ' ' VAL . 88.3 mt -95.44 -16.37 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.467 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -115.34 -22.44 9.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.09 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -135.22 71.76 67.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.935 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.42 147.57 77.15 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.254 1.97 . . . . 0.0 112.365 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.585 0 C-N-CA 122.463 2.109 . . . . 0.0 112.213 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.46 152.43 95.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.69 154.74 49.45 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.811 2.34 . . . . 0.0 112.385 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.72 156.58 35.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.382 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -53.18 138.08 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.839 1.693 . . . . 0.0 112.255 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 172.96 15.3 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -95.66 156.08 37.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.821 ' HB3' HG22 ' A' ' 39' ' ' THR . 34.8 Cg_endo -66.06 151.42 83.86 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.78 166.28 32.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.798 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.36 134.58 34.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -120.21 132.48 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.415 HD13 HG21 ' B' ' 951' ' ' ILE . 2.9 mt . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 2' ' ' GLN . . . . . 0.466 ' HB2' HG22 ' C' ' 14' ' ' THR . 4.2 pt20 -58.34 158.21 7.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.654 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.681 HD13 HD21 ' C' ' 56' ' ' LEU . 20.9 pt -139.05 142.27 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.911 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -81.94 127.21 32.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.157 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -114.67 115.84 50.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -96.91 118.6 33.68 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.17 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -75.23 173.73 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.429 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -45.86 -31.56 2.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.533 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 76.9 p -99.96 -179.87 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.56 -19.11 53.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -53.1 129.37 30.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.049 0.452 . . . . 0.0 110.728 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -127.58 134.6 49.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.454 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.533 HD13 ' HG2' ' C' ' 34' ' ' GLU . 0.0 OUTLIER -130.7 122.39 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.517 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 14' ' ' THR . . . . . 0.466 HG22 ' HB2' ' C' ' 2' ' ' GLN . 85.7 m -88.8 131.87 34.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.595 HD13 ' CB ' ' C' ' 29' ' ' LYS . 65.7 mt -119.3 125.1 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' C' ' 2' ' ' GLN . 8.0 pm0 -65.94 109.68 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 111.009 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.652 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.3 m -133.13 163.78 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.487 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -108.07 156.08 38.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.159 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.29 -37.85 96.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.136 1.891 . . . . 0.0 111.87 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -79.72 -7.2 58.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ASP . . . . . 0.54 ' HB3' HD13 ' C' ' 56' ' ' LEU . 34.6 t0 -57.6 137.57 56.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.008 0.432 . . . . 0.0 110.899 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -80.75 160.74 24.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.835 HD12 HD23 ' C' ' 50' ' ' LEU . 43.1 mm -63.7 -41.41 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -57.95 -36.63 72.81 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.292 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.0 -41.51 95.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.556 . . . . 0.0 110.8 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.814 HG21 HD11 ' C' ' 56' ' ' LEU . 61.5 t -63.6 -42.63 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.773 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.469 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.8 mtmt -60.76 -39.62 89.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.354 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.92 93.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.652 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.652 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.1 mttm -60.22 -38.86 84.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.77 HD13 HD11 ' C' ' 69' ' ' LEU . 97.2 mt -65.05 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.962 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -59.01 -43.91 91.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.411 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.75 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.833 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -72.09 -75.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' GLU . . . . . 0.533 ' HG2' HD13 ' C' ' 13' ' ' ILE . 77.1 mm-40 -93.71 151.49 19.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.366 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.46 56.02 4.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.464 HG23 HD22 ' C' ' 71' ' ' LEU . 42.6 mm -106.4 109.97 63.52 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.69 154.36 49.56 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.054 1.836 . . . . 0.0 112.195 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.98 -38.85 80.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.112 1.875 . . . . 0.0 112.235 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -61.52 -39.97 92.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -87.02 -3.18 59.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.476 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.401 ' HG3' HG22 ' C' ' 36' ' ' ILE . 81.2 mt-30 -88.16 67.15 8.76 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.565 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -84.27 109.89 18.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' C' ' 27' ' ' LYS . 23.4 mt -100.32 128.94 46.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.239 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -128.79 128.67 67.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.69 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -147.8 145.42 28.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.435 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 19.84 7.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.099 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 75' ' ' ILE . . . 90.31 -13.15 65.91 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.66 145.99 24.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.27 0.557 . . . . 0.0 111.482 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -95.21 105.33 17.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.835 HD23 HD12 ' C' ' 23' ' ' ILE . 10.2 mp -65.86 88.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.17 -74.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -177.05 169.02 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.46 20.84 77.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.32 171.28 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 110.025 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -126.33 163.69 22.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.8 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.814 HD11 HG21 ' C' ' 26' ' ' VAL . 3.1 mp -57.87 -43.14 85.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.587 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -63.09 -22.35 66.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.951 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.77 -36.56 83.48 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.354 0.597 . . . . 0.0 109.784 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.28 11.29 39.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.454 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 57.7 46.41 17.39 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.298 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' C' ' 56' ' ' LEU . 80.9 mt -92.71 119.84 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.542 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.99 -178.9 3.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.83 147.84 52.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 58.79 45.21 15.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.215 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -98.45 126.36 43.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.075 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 82.3 m -75.62 126.97 32.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.1 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -112.52 145.44 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.12 114.62 26.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.387 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.77 HD11 HD13 ' C' ' 30' ' ' ILE . 1.2 mt -96.17 126.43 41.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.261 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.648 HG11 HD11 ' A' ' 56' ' ' LEU . 58.3 t -116.45 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.464 HD22 HG23 ' C' ' 36' ' ' ILE . 27.4 mt -103.51 149.19 25.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.286 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.498 179.643 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.28 163.52 15.25 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' D' ' 65' ' ' SER . 16.3 pt -141.84 142.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.044 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.64 ' HD2' HG21 ' D' ' 12' ' ' THR . 5.5 m-85 -87.01 126.56 34.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.75 105.36 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -88.57 125.86 34.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.71 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.581 HG22 HD23 ' D' ' 69' ' ' LEU . 73.7 p -78.01 -166.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.883 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' D' ' 70' ' ' VAL . 92.4 mt -59.16 -28.47 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.793 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -102.91 -177.63 3.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.36 57.6 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -53.07 129.85 32.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 110.894 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.64 HG21 ' HD2' ' D' ' 4' ' ' PHE . 98.4 m -123.93 138.14 54.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.029 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.51 HG22 ' HD2' ' D' ' 33' ' ' LYS . 0.9 OUTLIER -122.75 109.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.956 -178.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -85.41 129.91 34.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.438 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.539 HD21 ' HD2' ' D' ' 33' ' ' LYS . 96.1 mt -122.07 134.07 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.44 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.26 117.54 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.732 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.439 HG12 ' HE2' ' D' ' 29' ' ' LYS . 21.7 m -136.94 167.44 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.168 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.23 154.2 45.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.51 -29.6 85.42 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.609 1.539 . . . . 0.0 111.729 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -84.55 -11.87 55.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.609 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.66 142.16 58.14 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.786 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.0 p -83.27 166.91 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.078 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.57 -37.4 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.13 -42.73 91.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.507 HG21 HD21 ' D' ' 56' ' ' LEU . 69.7 t -61.98 -43.78 98.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.806 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.529 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.7 mtmt -61.08 -38.39 86.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.1 94.35 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.105 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.475 ' CB ' HD13 ' D' ' 15' ' ' LEU . 15.3 mttp -59.96 -39.03 84.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.68 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.31 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.8 -39.5 89.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.175 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.79 -45.1 91.23 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.478 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.539 ' HD2' HD21 ' D' ' 15' ' ' LEU . 71.2 mttt -73.48 -40.51 64.06 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -128.16 151.19 49.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.27 62.06 2.23 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.1 103.25 54.71 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.07 154.43 66.52 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.346 1.364 . . . . 0.0 111.954 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -53.61 -25.97 35.39 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.629 2.22 . . . . 0.0 112.517 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.96 13.63 14.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.418 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -145.4 59.97 1.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.376 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.93 147.08 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.24 0.543 . . . . 0.0 111.774 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.8 124.29 31.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.466 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.529 HD11 ' HG2' ' D' ' 27' ' ' LYS . 53.8 mt -105.49 114.25 28.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.57 HG23 ' C ' ' D' ' 48' ' ' ARG . 82.3 mt -121.68 121.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.82 -46.99 79.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -179.04 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.021 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.34 -8.15 79.54 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.57 ' C ' HG23 ' D' ' 44' ' ' ILE . 44.0 ttm180 -129.79 127.89 41.26 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.867 0.365 . . . . 0.0 110.499 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -81.13 153.47 27.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.572 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.57 102.71 14.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.062 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.84 155.62 35.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.56 154.37 41.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.41 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.13 12.67 63.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -127.33 150.78 49.43 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.198 0.523 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.37 163.36 13.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.999 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.507 HD21 HG21 ' D' ' 26' ' ' VAL . 81.3 mt -61.91 -39.31 91.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.709 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.5 -22.51 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.322 . . . . 0.0 110.367 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.46 -38.33 83.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.261 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -99.83 16.86 22.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.86 40.93 28.64 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.337 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ILE . . . . . 0.463 HG23 ' OG ' ' D' ' 65' ' ' SER . 78.8 mt -88.22 110.1 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -95.54 178.61 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -59.62 152.23 22.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.539 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 56.82 33.73 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 65' ' ' SER . . . . . 0.463 ' OG ' HG23 ' D' ' 61' ' ' ILE . 4.2 t -77.03 120.86 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.937 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 78.1 m -81.63 119.8 24.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.35 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.75 142.76 45.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.075 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -87.69 114.42 24.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.35 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.581 HD23 HG22 ' D' ' 7' ' ' THR . 36.1 tp -102.51 118.14 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.583 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.438 ' HA ' HD21 ' D' ' 8' ' ' LEU . 87.0 t -117.72 128.73 74.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.814 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.69 -178.976 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -95.87 113.19 24.79 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.479 ' CD1' HD12 ' A' ' 57' ' ' ILE . 96.6 mt -66.04 -39.01 89.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.603 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.3 p -147.5 163.04 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.05 122.38 0.31 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.756 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.31 158.7 40.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.815 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -74.08 124.21 25.85 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.097 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.416 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -157.0 145.28 19.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.336 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.47 154.72 16.47 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -90.26 174.7 7.45 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.17 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.4 mtp -138.76 172.77 12.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -123.12 123.9 41.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 37' ' ' THR . 27.0 tp -105.29 119.81 39.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.329 0.585 . . . . 0.0 110.618 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -121.42 107.62 12.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.571 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.56 -97.06 0.68 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 p -131.06 19.71 4.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.297 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.563 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.1 m -121.76 130.63 53.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.7 t -110.65 124.07 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.81 133.6 22.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.65 148.21 46.78 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.799 1.666 . . . . 0.0 112.959 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -103.63 130.69 51.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.68 -8.18 50.08 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.917 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.63 78.09 1.08 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -58.53 131.08 49.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.237 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.47 -158.56 9.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.84 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.7 tp -137.57 126.51 24.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 28' ' ' ALA . 36.9 t -96.58 113.5 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.066 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -136.41 155.88 49.4 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.062 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' LEU . 90.8 mt -123.89 140.14 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.105 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -140.09 146.14 38.53 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -109.78 128.55 55.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.221 0.534 . . . . 0.0 110.335 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 58' ' ' HIS . 28.5 p -89.68 172.64 8.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.756 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.56 -10.51 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.152 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.15 3.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m 63.12 26.55 15.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.336 0.589 . . . . 0.0 110.335 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.648 HD11 HG11 ' C' ' 70' ' ' VAL . 71.4 mt -103.97 125.47 50.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.479 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.2 mm -83.11 122.92 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.518 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.8 m-70 -100.59 116.03 31.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.713 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -93.25 110.37 21.89 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -124.64 146.99 48.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.162 0.982 . . . . 0.0 112.951 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -124.08 116.37 22.67 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.943 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -108.19 134.31 51.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.061 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.69 131.2 39.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.82 -17.27 61.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.888 0.375 . . . . 0.0 110.464 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -59.53 -46.4 88.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.863 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.6 m -116.49 -15.36 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 109.888 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.18 21.7 77.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -101.36 152.89 20.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.16 104.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.926 0.393 . . . . 0.0 110.424 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.73 -30.98 36.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -127.95 145.65 50.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.819 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.576 ' C ' HD23 ' A' ' 73' ' ' LEU . 42.9 p-10 -158.11 120.21 3.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.612 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.817 HD12 HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -148.1 136.09 21.09 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.17 0.509 . . . . 0.0 110.381 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -81.62 122.88 37.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.574 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.817 HD11 HD12 ' A' ' 73' ' ' LEU . 24.6 mm -114.06 121.23 65.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.279 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 61.9 m-85 -84.78 162.3 50.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.63 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.92 139.56 89.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.368 2.045 . . . . 0.0 111.54 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 59.64 12.02 2.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.229 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -87.17 -25.12 24.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.716 ' SG ' HG21 ' A' ' 75' ' ' ILE . 14.6 p -144.43 169.23 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.35 0.595 . . . . 0.0 110.324 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -137.54 125.25 22.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.809 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.23 118.74 37.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.57 164.71 30.84 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.415 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -79.4 159.84 26.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.018 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.6 t -111.36 90.62 12.28 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.18 60.25 7.72 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.829 1.686 . . . . 0.0 112.509 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -114.24 -38.82 4.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.991 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.06 82.35 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.585 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.16 130.33 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.702 1.602 . . . . 0.0 111.685 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.5 t 169.68 -45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.571 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.72 -154.98 8.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.7 OUTLIER -109.85 106.81 16.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.505 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.65 128.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.08 154.37 41.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.681 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.01 136.12 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.196 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.442 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.7 tp -103.77 120.0 40.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -118.36 136.08 53.95 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.238 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -84.22 114.67 21.98 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.124 0.488 . . . . 0.0 109.833 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.9 -37.88 86.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.706 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.96 -21.92 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.23 -175.38 22.68 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -117.88 15.81 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.675 0.274 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HD3' HD21 ' A' ' 105' ' ' LEU . 10.2 ttmt -93.35 146.0 24.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.87 137.96 40.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.408 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.673 HD21 ' HD3' ' A' ' 103' ' ' LYS . 43.6 mt -119.23 148.21 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.44 133.59 55.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.961 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.72 157.99 45.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.293 0.568 . . . . 0.0 111.188 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -132.07 138.07 48.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.522 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.3 ttm -77.07 131.55 38.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.072 0.463 . . . . 0.0 111.475 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -1.7 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.702 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.25 144.91 98.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.06 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.32 -26.93 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.051 1.834 . . . . 0.0 112.786 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -121.85 144.57 48.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.054 0.454 . . . . 0.0 110.245 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.46 HG22 ' HG2' ' A' ' 92' ' ' ARG . 72.4 p -94.0 9.16 38.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.629 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.88 -22.1 61.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.84 -4.66 12.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.54 -46.95 87.77 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -41.44 99.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.71 -43.23 97.19 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.716 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.9 m170 -64.34 -40.7 96.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.577 0.703 . . . . 0.0 109.111 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.77 -45.07 94.38 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.901 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -68.01 -42.12 81.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.4 -41.88 98.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.513 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 120' ' ' HIS . 56.2 t -59.13 -47.08 91.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.312 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.89 -39.59 93.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.271 0.558 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.87 -36.37 80.15 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.075 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.441 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 23.7 m-85 -80.17 -30.43 38.83 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.955 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 75' ' ' ILE . 80.4 mt -90.02 -17.51 27.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.853 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -116.98 -19.0 9.98 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.372 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.81 69.78 36.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.339 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.21 157.6 59.01 Favored 'Trans proline' 0 C--N 1.296 -2.195 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.539 2.16 . . . . 0.0 112.319 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.69 154.69 81.84 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 145.1 29.19 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.402 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.35 156.47 68.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.018 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.17 137.39 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.017 1.811 . . . . 0.0 111.873 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.08 -170.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.033 1.822 . . . . 0.0 111.848 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -124.95 158.33 63.38 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.257 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.59 144.32 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.588 2.192 . . . . 0.0 112.377 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -155.53 164.43 38.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.72 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -86.16 135.74 33.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.905 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -121.06 122.95 41.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.429 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -69.37 161.84 28.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 pt -140.04 144.77 27.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.367 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.16 126.38 35.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.774 HG11 HD11 ' C' ' 30' ' ' ILE . 96.5 t -112.31 115.27 49.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -103.49 127.22 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.53 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -90.03 173.34 8.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 111.314 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.66 -25.92 68.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.174 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -73.41 -9.39 58.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.77 -7.41 73.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -71.87 130.83 41.99 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 110.198 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -109.84 132.22 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.255 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.4 HD13 HG21 ' C' ' 13' ' ' ILE . 0.0 OUTLIER -132.7 116.55 27.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 -179.15 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -87.07 131.45 34.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.072 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.626 HD21 ' HG3' ' C' ' 33' ' ' LYS . 92.5 mt -123.38 133.64 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -73.5 115.49 12.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.532 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.463 HG12 ' HE3' ' C' ' 29' ' ' LYS . 22.9 m -135.37 168.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.458 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.19 153.35 45.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.193 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.22 -38.17 93.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.999 1.799 . . . . 0.0 112.345 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -81.73 -8.19 59.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -59.04 139.03 57.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.953 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -80.16 161.78 25.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.491 HD12 HD13 ' C' ' 50' ' ' LEU . 48.8 mm -63.67 -38.53 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.177 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.19 -41.93 89.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.284 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.12 -41.25 98.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.124 0.488 . . . . 0.0 110.548 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.414 HG22 HG11 ' C' ' 17' ' ' VAL . 56.1 t -62.91 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.614 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -60.96 -38.39 85.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.01 91.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.585 ' CB ' HD13 ' C' ' 15' ' ' LEU . 67.3 mttm -60.11 -39.28 85.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.774 HD11 HG11 ' C' ' 5' ' ' VAL . 5.8 mm -64.59 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.471 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -59.69 -40.15 86.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.811 0.338 . . . . 0.0 110.377 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -67.55 -50.94 56.24 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.626 ' HG3' HD21 ' C' ' 15' ' ' LEU . 19.6 mttt -64.93 -40.98 95.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 112.038 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -132.18 146.41 52.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.199 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.04 63.98 2.01 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.589 HG22 ' HB2' ' C' ' 41' ' ' GLN . 3.5 mt -121.71 112.32 32.39 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.16 157.35 57.65 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.777 1.651 . . . . 0.0 111.748 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.8 -38.07 96.6 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.168 1.912 . . . . 0.0 112.188 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.96 -40.92 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.915 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -88.64 -17.68 29.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.658 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.589 ' HB2' HG22 ' C' ' 36' ' ' ILE . 4.8 tt0 -92.03 116.44 28.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.054 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -120.28 114.19 21.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.667 ' CB ' HD12 ' C' ' 50' ' ' LEU . 79.4 mt -92.48 131.86 37.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.295 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -130.75 129.25 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -145.17 152.46 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.899 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.54 20.31 10.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 110.505 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.72 -5.09 76.44 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.668 ' HG2' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -115.11 139.31 50.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.087 0.47 . . . . 0.0 110.736 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.16 131.61 43.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.667 HD12 ' CB ' ' C' ' 43' ' ' LEU . 50.4 mt -69.68 103.7 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.778 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -75.31 138.94 42.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.97 137.04 58.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.69 -17.81 52.01 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -84.28 174.99 9.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -120.62 165.54 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.346 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' C' ' 56' ' ' LEU . 79.3 mt -62.54 -39.88 94.99 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.567 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -64.11 -25.96 68.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.66 -33.55 75.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.437 . . . . 0.0 110.356 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -99.45 13.77 32.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.283 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 56.29 43.93 25.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -91.02 114.76 28.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.45 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -63.7 146.2 54.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.16 44.96 18.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.939 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 38.9 m -99.33 124.93 44.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.47 ' C ' HD12 ' C' ' 67' ' ' LEU . 40.9 m -74.45 130.83 40.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.223 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.47 HD12 ' C ' ' C' ' 66' ' ' THR . 7.5 mp -118.65 155.16 31.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.399 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -105.89 120.65 42.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.503 HD11 HG21 ' C' ' 30' ' ' ILE . 1.8 tt -101.27 114.79 29.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.015 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.574 HG11 HD11 ' A' ' 56' ' ' LEU . 58.8 t -104.25 130.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.76 131.94 38.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.908 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -153.18 166.94 30.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.754 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.611 HG22 ' HB3' ' D' ' 65' ' ' SER . 3.1 pt -144.1 150.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.019 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.0 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.43 111.95 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -95.43 122.04 37.73 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.639 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.713 HG22 HD23 ' D' ' 69' ' ' LEU . 75.3 p -79.77 173.3 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.778 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.4 mt -61.1 -35.34 76.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.158 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -69.17 -12.03 61.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.892 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.4 60.3 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -61.56 130.96 48.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.71 0.291 . . . . 0.0 110.457 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -103.89 133.94 48.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.561 HD12 ' OE2' ' D' ' 34' ' ' GLU . 1.3 mt -126.98 106.67 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.965 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 124.4 27.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.225 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -121.01 132.25 54.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.357 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.81 120.8 21.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.632 HG12 ' CD ' ' D' ' 29' ' ' LYS . 31.4 m -134.56 -177.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.744 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 18' ' ' GLU . . . . . 0.533 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.6 mt-10 -132.04 152.08 79.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.119 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.75 -27.21 82.9 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.983 1.789 . . . . 0.0 111.977 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.3 p -86.21 -14.05 45.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.34 143.3 57.92 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.593 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -87.43 168.48 13.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.172 0.51 . . . . 0.0 110.854 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.89 -38.31 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.682 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.31 -39.71 87.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -62.29 -40.9 97.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.687 HG21 HD21 ' D' ' 56' ' ' LEU . 58.7 t -63.55 -42.47 96.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.784 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.81 -40.59 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.085 0.469 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.87 91.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.109 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.632 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.37 -38.69 81.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.779 ' CD1' HD21 ' D' ' 43' ' ' LEU . 81.1 mt -64.37 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.167 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -61.13 -43.65 98.55 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.867 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.78 -23.18 61.54 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.079 -0.388 . . . . 0.0 111.904 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.46 3.54 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' GLU . . . . . 0.679 ' OE2' HG23 ' D' ' 30' ' ' ILE . 43.0 mt-10 -149.22 -46.07 0.14 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.51 20.11 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' D' ' 71' ' ' LEU . 30.2 mt -88.69 119.84 70.08 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.662 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.76 159.35 50.99 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.715 1.61 . . . . 0.0 111.888 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.37 -23.17 36.9 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.498 2.132 . . . . 0.0 112.537 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -93.24 18.17 9.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.886 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -146.14 23.96 1.32 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.728 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.423 ' HB2' HD11 ' D' ' 69' ' ' LEU . 27.5 pt20 -150.12 144.77 25.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.978 0.418 . . . . 0.0 110.987 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -128.28 120.49 27.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.526 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.779 HD21 ' CD1' ' D' ' 30' ' ' ILE . 74.9 mt -96.3 121.38 38.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.36 129.34 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.53 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 74.0 t80 -130.95 133.1 45.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.18 26.47 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.23 79.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -126.09 130.73 51.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -65.21 138.34 58.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' D' ' 43' ' ' LEU . 84.0 mt -84.66 112.0 20.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.491 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.83 152.38 37.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -73.65 164.3 26.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.315 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.14 25.03 75.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -127.23 149.64 49.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -93.41 161.91 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.285 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.687 HD21 HG21 ' D' ' 26' ' ' VAL . 76.9 mt -62.61 -39.55 94.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.733 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.0 p -63.3 -22.84 67.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.429 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.87 -37.97 86.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.036 0.446 . . . . 0.0 110.62 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -96.76 16.31 19.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.43 42.07 25.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -91.51 101.75 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.728 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -94.96 179.84 5.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.478 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -56.32 145.33 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.268 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 59.92 42.44 16.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 65' ' ' SER . . . . . 0.611 ' HB3' HG22 ' D' ' 3' ' ' ILE . 28.5 t -95.98 120.81 36.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.595 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.432 ' C ' HD12 ' D' ' 67' ' ' LEU . 25.1 m -76.84 124.99 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.389 . . . . 0.0 110.396 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.432 HD12 ' C ' ' D' ' 66' ' ' THR . 7.9 mp -115.69 136.02 53.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.154 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -84.0 124.02 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.404 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.713 HD23 HG22 ' D' ' 7' ' ' THR . 55.4 tp -104.9 118.37 36.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.701 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.665 ' HA ' HD21 ' D' ' 8' ' ' LEU . 98.0 t -115.43 132.04 65.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.238 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.778 ' H ' HD11 ' D' ' 8' ' ' LEU . 49.9 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.488 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.6 pttm . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.98 128.65 35.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 51' ' ' GLN . 81.7 mt -67.59 -37.26 82.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.853 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -148.67 160.98 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.84 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.47 122.56 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.12 155.17 34.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.649 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -74.08 118.03 16.57 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.358 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.15 26.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.94 150.72 17.12 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -89.32 157.84 18.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.73 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 29.6 mtp -124.24 175.56 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -126.16 122.64 36.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.246 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 37' ' ' THR . 30.5 tp -106.03 122.75 46.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.993 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -118.36 103.75 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.12 -85.18 0.69 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -141.3 18.11 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.534 0.206 . . . . 0.0 110.911 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.674 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.0 m -120.01 126.16 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG2' HD13 ' A' ' 33' ' ' LEU . 61.2 t -105.99 122.75 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.414 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.596 HG23 ' HG3' ' B' ' 947' ' ' PRO . 53.0 m -119.33 122.62 29.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.427 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 147.18 64.48 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.924 1.749 . . . . 0.0 112.905 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.15 139.99 39.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.969 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -72.93 -5.25 37.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -72.47 74.77 1.04 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -52.79 134.27 36.77 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.334 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.65 -165.06 11.3 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.9 tp -135.92 122.55 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG22 ' HD1' ' A' ' 61' ' ' TRP . 53.7 t -97.63 108.36 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.831 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 39.0 p90 -133.14 153.59 51.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.576 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.8 mt -122.04 141.62 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.826 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -141.67 142.63 33.37 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 123.687 0.617 . . . . 0.0 110.18 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.478 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.8 tt0 -106.29 127.6 53.36 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 58' ' ' HIS . 20.9 p -87.3 172.79 9.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.754 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.11 -10.42 22.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.625 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.22 -0.16 56.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 70.04 19.77 6.72 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.574 HD11 HG11 ' C' ' 70' ' ' VAL . 70.4 mt -101.72 126.02 48.5 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 131' ' ' PRO . 49.4 mm -80.78 126.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.501 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -102.42 115.99 31.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.915 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -91.92 108.19 19.75 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.06 140.03 50.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.805 0.812 . . . . 0.0 112.902 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.417 ' HD1' HG22 ' A' ' 47' ' ' VAL . 92.4 t90 -125.46 113.25 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.189 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -106.18 144.7 32.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.817 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -80.62 131.65 35.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.82 -18.63 62.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.952 0.406 . . . . 0.0 110.529 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -59.65 -46.18 89.78 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.45 -11.3 10.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 0.0 110.646 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.08 22.78 78.7 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.51 146.88 27.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.722 0.296 . . . . 0.0 110.657 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.79 102.02 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.036 0.445 . . . . 0.0 110.304 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -73.08 -39.4 65.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.906 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.8 147.13 50.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.522 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p30 -158.54 103.24 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.597 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD22 ' HG2' ' C' ' 48' ' ' LYS . 35.2 mt -126.98 135.7 51.23 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.775 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -77.43 122.22 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' A' ' 80' ' ' CYS . 31.5 mm -111.81 121.08 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.618 . . . . 0.0 111.183 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 42.9 m-85 -82.76 160.98 59.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 142.35 98.64 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.797 1.664 . . . . 0.0 111.441 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 61.84 12.34 4.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.103 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -89.87 -35.79 15.44 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 120.628 0.251 . . . . 0.0 110.678 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.609 ' HB3' HD11 ' A' ' 96' ' ' LEU . 71.4 m -132.48 156.29 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.25 0.548 . . . . 0.0 111.399 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.516 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.4 tt0 -129.31 130.63 46.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.126 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -101.96 117.95 35.89 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.412 ' NZ ' HG11 ' A' ' 95' ' ' VAL . 22.8 pttp -143.49 161.27 38.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.538 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -83.19 160.34 21.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.131 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.5 89.39 15.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.192 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.6 60.21 7.55 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.091 1.86 . . . . 0.0 112.047 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -114.25 -44.27 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.9 t -116.36 99.06 52.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.78 129.73 15.9 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.38 1.386 . . . . 0.0 111.458 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 165.23 -38.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 O-C-N 124.02 0.825 . . . . 0.0 110.372 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.59 -179.69 25.64 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -91.83 113.55 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.88 128.26 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.176 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -119.18 155.75 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.719 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.2 p -133.63 137.74 52.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.4 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 80' ' ' CYS . 63.9 tp -103.68 121.47 43.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -117.89 141.6 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -88.09 117.18 26.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.27 -37.47 85.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.949 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.83 -15.85 19.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.53 176.14 19.96 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.6 p -111.7 15.76 20.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.668 0.27 . . . . 0.0 110.465 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' CE ' HD21 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -95.28 144.56 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.969 0.414 . . . . 0.0 110.77 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.93 140.59 42.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.716 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . 57.9 mt -119.62 152.06 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.5 m-85 -124.28 137.15 54.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.84 154.24 48.41 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.29 0.567 . . . . 0.0 111.216 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -132.43 136.04 46.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.07 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.95 131.68 51.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.121 0.486 . . . . 0.0 111.215 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 -1.67 12.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.483 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.09 149.23 94.56 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.664 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.14 -39.93 64.82 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.002 1.802 . . . . 0.0 112.224 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.57 145.91 48.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.3 p -98.45 18.72 15.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.5 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.49 -22.2 61.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.61 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -123.48 13.85 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.51 91.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.776 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.54 -41.21 84.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.066 0.46 . . . . 0.0 111.128 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.75 -43.35 96.71 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.757 ' O ' HG23 ' A' ' 124' ' ' VAL . 60.8 m170 -63.54 -41.08 98.48 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.517 0.675 . . . . 0.0 109.322 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.23 -42.02 96.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -67.58 -40.14 84.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.2 -37.57 83.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.713 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.3 t -58.51 -47.83 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -80.05 -27.42 39.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.942 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.96 -38.22 82.5 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.53 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -81.62 -34.18 31.05 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.479 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 124' ' ' VAL . 67.3 mt -76.24 -26.69 56.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.917 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -107.45 -24.16 11.92 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.56 74.83 58.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.536 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.8 Cg_exo -59.4 155.63 40.23 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.004 2.469 . . . . 0.0 112.362 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.081 -179.643 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 49.44 67.65 4.26 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.558 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.35 143.95 78.47 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.723 2.282 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.89 160.05 82.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.806 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.52 155.42 62.76 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.765 2.31 . . . . 0.0 112.187 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.35 -169.44 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.608 2.205 . . . . 0.0 111.608 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -110.1 160.4 28.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.596 ' HG3' HG23 ' A' ' 39' ' ' THR . 50.8 Cg_exo -57.14 142.68 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.538 2.159 . . . . 0.0 111.808 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.72 163.93 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.68 138.36 32.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.867 0.365 . . . . 0.0 110.434 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -124.57 119.87 30.32 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.784 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.716 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.14 162.93 18.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.461 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.499 HD13 HD21 ' C' ' 56' ' ' LEU . 16.6 pt -144.35 147.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.962 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -96.43 119.5 35.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.571 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -103.5 103.8 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -87.67 118.54 27.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.803 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.786 HG22 HD23 ' C' ' 69' ' ' LEU . 80.9 p -82.36 171.13 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.431 HD11 ' H ' ' C' ' 71' ' ' LEU . 67.9 mt -64.89 -25.03 67.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.138 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.8 p -73.47 -11.5 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -13.74 63.59 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.56 132.53 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.257 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -101.56 132.02 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.144 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mm -116.3 103.55 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.95 120.31 25.53 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.098 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.771 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.9 mt -122.34 132.76 54.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.32 114.45 16.16 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.574 HG12 ' HE3' ' C' ' 29' ' ' LYS . 26.7 m -136.91 171.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.989 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -116.51 156.33 47.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.237 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.98 -41.23 77.47 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.887 1.724 . . . . 0.0 112.322 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -72.94 -12.25 60.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -59.13 135.76 57.74 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.851 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -77.51 160.54 28.56 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.869 HD12 HD13 ' C' ' 50' ' ' LEU . 47.9 mm -66.17 -37.65 80.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.071 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.44 -42.92 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -62.29 -42.03 99.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 110.074 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.678 HG21 HD11 ' C' ' 56' ' ' LEU . 53.0 t -61.21 -43.58 96.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.428 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -40.1 79.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.187 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.6 94.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.991 0.424 . . . . 0.0 110.339 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.63 ' HB3' HD13 ' C' ' 15' ' ' LEU . 67.0 mttm -59.8 -39.4 84.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.394 0.616 . . . . 0.0 109.386 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.798 ' CD1' HD21 ' C' ' 43' ' ' LEU . 97.3 mt -66.56 -38.86 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.443 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -58.03 -42.36 85.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.447 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.11 -40.89 71.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.456 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.771 ' HG3' HD21 ' C' ' 15' ' ' LEU . 7.0 mmtm -65.63 -40.96 93.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.959 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -138.07 157.27 46.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.45 57.44 3.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 32.6 mm -110.81 104.84 56.68 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 153.49 50.38 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.354 2.036 . . . . 0.0 112.204 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.81 -39.14 78.43 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.822 1.681 . . . . 0.0 112.302 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.83 -39.55 92.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.279 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.08 -9.24 59.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.913 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.55 93.87 7.93 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' ARG . . . . . 0.428 ' HB2' ' HB ' ' C' ' 70' ' ' VAL . 76.5 mtp85 -108.82 95.81 5.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.798 HD21 ' CD1' ' C' ' 30' ' ' ILE . 81.5 mt -84.55 130.21 34.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.274 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -132.17 127.51 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -141.76 148.82 39.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.948 0.404 . . . . 0.0 111.108 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.64 17.48 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.249 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 89.87 -17.11 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -95.48 133.27 39.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 111.056 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -75.73 130.92 39.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.69 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.869 HD13 HD12 ' C' ' 23' ' ' ILE . 35.5 mt -72.89 129.8 38.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.58 -80.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.479 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.01 -68.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.611 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.12 94.49 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -49.07 162.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.514 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -109.54 178.46 4.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.308 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.678 HD11 HG21 ' C' ' 26' ' ' VAL . 6.6 mp -69.79 -39.61 76.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.825 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.29 -24.96 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.56 -37.4 86.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.451 ' CE2' HD23 ' C' ' 50' ' ' LEU . 85.1 m-85 -98.76 11.98 37.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.113 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 t30 59.33 40.08 21.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.852 0.358 . . . . 0.0 110.365 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -86.24 103.72 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -91.68 179.95 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.512 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -63.19 145.08 56.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.186 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 64.28 13.32 7.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.322 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.0 m -67.02 134.78 52.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 43.6 m -92.49 117.63 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.518 HD12 ' N ' ' C' ' 67' ' ' LEU . 5.8 mp -108.17 139.39 42.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.56 127.91 35.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.28 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.786 HD23 HG22 ' C' ' 7' ' ' THR . 55.7 tp -105.85 121.17 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.722 HG11 HD11 ' A' ' 56' ' ' LEU . 57.6 t -108.87 132.61 56.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.736 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.431 ' H ' HD11 ' C' ' 8' ' ' LEU . 22.4 mt -95.9 133.41 40.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.3 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -64.27 160.68 18.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.599 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -139.17 142.44 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.377 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.633 ' HD2' HG21 ' D' ' 12' ' ' THR . 4.0 m-85 -86.63 122.73 30.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -108.82 107.28 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.382 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -92.0 130.43 37.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.883 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.802 HG22 HD23 ' D' ' 69' ' ' LEU . 61.6 p -89.19 -179.32 5.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.662 HD11 ' H ' ' D' ' 71' ' ' LEU . 80.8 mt -64.36 -37.22 86.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.136 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.39 -12.18 61.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 -12.51 61.36 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.98 131.4 49.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.633 HG21 ' HD2' ' D' ' 4' ' ' PHE . 83.3 m -104.77 133.53 49.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 111.163 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.405 HD13 HG21 ' D' ' 13' ' ' ILE . 0.9 OUTLIER -125.83 108.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.729 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.6 m -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.299 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' D' ' 29' ' ' LYS . 94.6 mt -122.91 126.57 47.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.627 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -68.85 116.39 9.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.849 0.357 . . . . 0.0 111.039 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.564 HG12 ' HE2' ' D' ' 29' ' ' LYS . 20.7 m -139.2 165.57 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -106.28 155.24 38.96 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.027 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.46 -32.77 90.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.102 1.868 . . . . 0.0 112.282 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -87.3 -3.31 59.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -60.06 136.24 57.96 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -80.18 163.41 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.234 0.54 . . . . 0.0 111.021 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.412 HD12 HD13 ' D' ' 50' ' ' LEU . 49.9 mm -63.03 -37.26 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.426 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.39 -42.33 86.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.084 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -62.48 -41.27 98.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.443 . . . . 0.0 110.432 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.572 HG21 HD21 ' D' ' 56' ' ' LEU . 53.2 t -61.47 -43.61 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.67 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.404 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.8 mtmt -61.08 -39.46 89.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.71 97.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.564 ' HE2' HG12 ' D' ' 17' ' ' VAL . 16.2 mttp -59.66 -38.92 82.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.571 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.426 HD12 HD21 ' D' ' 43' ' ' LEU . 59.2 mt -67.04 -38.48 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.842 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -59.12 -39.74 83.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.406 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -70.49 -53.76 14.99 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.485 ' HD2' HD21 ' D' ' 15' ' ' LEU . 28.7 mttp -63.14 -40.95 99.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.094 0.473 . . . . 0.0 111.753 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -128.2 143.45 51.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.793 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.36 61.96 2.69 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' D' ' 41' ' ' GLN . 2.8 mt -114.02 110.11 49.01 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.54 155.07 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.16 1.907 . . . . 0.0 111.691 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.18 -34.49 98.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.216 1.944 . . . . 0.0 113.035 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.17 -47.42 77.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 110.101 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.2 -38.85 88.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.624 ' HG3' HG22 ' D' ' 36' ' ' ILE . 89.3 mt-30 -58.86 115.74 3.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.729 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -119.37 102.89 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.583 ' CB ' HD12 ' D' ' 50' ' ' LEU . 30.9 mt -90.37 118.55 29.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.13 126.06 67.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 86.8 t80 -132.1 132.21 43.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.306 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.97 27.24 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.535 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.06 78.59 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -129.72 129.19 43.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -66.08 140.34 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.621 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.583 HD12 ' CB ' ' D' ' 43' ' ' LEU . 70.8 mt -82.47 114.84 21.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.965 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.51 139.89 42.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.949 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.95 136.81 57.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.39 56.63 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -81.97 170.08 16.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.6 p -113.71 165.44 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.572 HD21 HG21 ' D' ' 26' ' ' VAL . 88.4 mt -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.599 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.8 p -63.54 -26.72 68.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.067 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.27 -29.15 70.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.028 0.442 . . . . 0.0 110.389 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' TYR . . . . . 0.405 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.0 m-85 -103.08 15.65 28.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.87 38.81 30.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -89.88 115.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -104.93 -174.85 2.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.273 0.559 . . . . 0.0 110.804 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -61.57 144.26 54.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.324 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 60.98 19.78 10.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.826 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -70.1 126.41 29.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 59.4 m -79.06 129.89 34.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.212 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.94 144.45 46.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.074 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -91.67 110.0 21.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.117 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.802 HD23 HG22 ' D' ' 7' ' ' THR . 61.0 tp -96.27 106.68 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.498 ' HA ' HD21 ' D' ' 8' ' ' LEU . 80.1 t -99.83 140.14 19.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.124 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.662 ' H ' HD11 ' D' ' 8' ' ' LEU . 46.1 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.122 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.71 113.22 25.44 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.26 0.552 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 57' ' ' ILE . 92.0 mt -66.97 -38.86 86.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.479 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.1 p -149.34 162.75 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.955 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.83 122.81 0.33 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -155.32 158.17 38.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.869 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.564 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.2 122.01 23.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.05 0.452 . . . . 0.0 110.866 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.16 139.93 17.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.12 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.12 154.17 17.68 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -90.41 172.37 8.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.136 0.493 . . . . 0.0 111.435 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.403 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 22.9 mtp -134.74 172.23 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.639 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -122.68 121.88 37.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD13 ' CG2' ' A' ' 38' ' ' VAL . 29.4 tp -104.62 116.85 32.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.312 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.45 117.82 26.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.825 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -84.76 0.35 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 p -149.81 23.41 0.87 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.719 0.295 . . . . 0.0 110.689 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.1 m -125.85 131.34 52.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.431 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.4 t -108.9 122.44 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.639 HG22 ' HB3' ' B' ' 947' ' ' PRO . 67.3 p -114.71 131.25 23.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.223 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.79 148.59 46.62 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.195 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.51 142.61 27.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.817 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -82.46 -8.53 59.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.718 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.9 86.52 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -53.37 137.24 35.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.94 -162.98 10.83 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.047 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.7 tp -140.51 122.04 15.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -94.55 109.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -131.74 153.2 50.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.062 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.6 mt -122.36 140.83 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.365 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -141.57 144.99 34.55 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 123.499 0.5 . . . . 0.0 109.7 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -109.24 127.18 54.05 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.469 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.503 HG23 ' CD2' ' A' ' 58' ' ' HIS . 20.7 p -87.47 172.59 9.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.028 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.38 -10.72 18.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.698 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.49 4.7 48.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.586 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m 63.83 25.32 14.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.485 0.659 . . . . 0.0 110.566 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.722 HD11 HG11 ' C' ' 70' ' ' VAL . 63.4 mt -103.24 125.51 49.94 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.437 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.6 mm -82.38 123.59 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.074 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.9 m-70 -101.23 115.3 30.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.477 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -96.68 107.96 20.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.66 142.92 51.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.41 113.58 24.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.292 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -103.85 135.82 44.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.832 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.44 136.95 38.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.873 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -78.67 -18.65 54.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -60.65 -46.46 90.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.787 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -117.0 -13.3 10.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.22 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.14 75.5 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.8 144.47 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.702 0.287 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.45 102.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.879 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -75.31 -37.15 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.876 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -126.28 144.7 50.7 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.2 t0 -158.81 101.05 1.62 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.509 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 72' ' ' ASP . 47.4 mt -128.12 140.94 51.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.753 0.311 . . . . 0.0 110.451 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.448 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 97.0 mt -82.75 122.85 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.712 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.7 mm -112.91 122.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.067 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -85.16 162.95 47.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.587 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.36 140.25 93.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.138 1.892 . . . . 0.0 111.322 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.76 11.89 2.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.256 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -85.06 -26.24 27.11 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.719 0.295 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 75' ' ' ILE . 15.8 p -147.19 167.2 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.319 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.04 127.74 32.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.222 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.51 117.06 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -142.37 168.17 20.37 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.699 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -87.36 160.27 18.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.194 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.42 89.76 13.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 60.83 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.015 1.81 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -52.16 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.5 t -114.52 98.11 48.32 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.66 130.46 17.08 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.483 1.455 . . . . 0.0 111.668 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.65 -32.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.8 0.688 . . . . 0.0 110.071 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.24 -171.9 20.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.351 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.42 110.1 22.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 110.466 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.97 154.48 38.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.31 133.62 62.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 ' SG ' ' A' ' 80' ' ' CYS . 66.7 tp -101.68 121.58 42.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -119.14 132.46 55.99 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.392 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -83.79 115.12 22.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.22 -37.41 87.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.795 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.24 -23.15 24.83 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.476 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.48 -169.71 19.56 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -120.55 13.79 11.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.554 0.216 . . . . 0.0 110.629 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.725 ' HD3' HD21 ' A' ' 105' ' ' LEU . 19.9 ttmt -86.11 142.81 28.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -136.04 129.3 31.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.156 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.725 HD21 ' HD3' ' A' ' 103' ' ' LYS . 37.9 mt -115.18 150.58 35.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.812 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' A' ' 33' ' ' LEU . 89.6 m-85 -124.22 137.86 54.47 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.124 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.47 156.81 47.21 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.29 0.567 . . . . 0.0 111.123 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -129.01 137.34 51.28 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.276 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.5 mmm -72.81 141.13 48.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -0.93 24.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.68 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.76 147.03 88.77 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.583 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.25 -27.16 13.88 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.163 1.908 . . . . 0.0 112.607 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.01 146.86 47.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.3 p -92.6 4.07 54.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.811 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.12 -21.17 45.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.51 -13.88 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -61.1 -45.58 94.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.296 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.91 -43.36 93.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.258 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.713 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.7 m170 -63.58 -40.62 97.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.62 0.724 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -62.69 -45.04 94.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.855 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.96 -42.37 85.3 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.533 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.65 -42.87 99.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.484 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.2 t -57.57 -47.65 84.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.046 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -64.05 -39.41 94.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.76 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.22 -27.53 62.59 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.175 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.1 m-85 -85.0 -29.03 25.35 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.735 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.53 -12.38 29.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -120.12 -16.65 8.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.794 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -144.23 72.68 16.21 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 57' ' ' ILE . 34.9 Cg_exo -60.81 148.97 90.44 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.931 2.421 . . . . 0.0 111.963 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 C-N-CA 122.308 2.005 . . . . 0.0 111.984 179.85 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -133.73 151.22 76.65 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.96 152.72 36.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.574 2.183 . . . . 0.0 111.661 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -95.13 156.28 38.0 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.186 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.84 140.01 68.36 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.447 2.098 . . . . 0.0 112.144 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.98 172.61 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.37 2.047 . . . . 0.0 112.097 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -93.03 154.33 41.73 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 39' ' ' THR . 36.2 Cg_endo -65.88 150.29 85.86 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.467 2.112 . . . . 0.0 111.908 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.01 163.85 37.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -85.91 139.81 30.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.127 0.489 . . . . 0.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -124.89 128.82 49.25 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.355 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.417 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.8 mp . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.366 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 2' ' ' GLN . . . . . 0.445 ' OE1' HG21 ' C' ' 14' ' ' THR . 6.5 pt20 -64.48 162.4 15.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.462 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.43 151.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.285 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.546 ' CD1' HG23 ' C' ' 14' ' ' THR . 10.9 m-30 -92.34 114.5 27.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.893 HG11 HD11 ' C' ' 30' ' ' ILE . 80.1 t -104.37 98.85 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.135 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -77.79 116.45 18.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.805 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -73.21 -178.18 2.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.322 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -48.56 -29.21 4.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -101.06 -177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.045 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.38 -12.67 56.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.05 134.66 57.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' THR . . . . . 0.432 ' C ' HD13 ' C' ' 13' ' ' ILE . 93.6 m -118.68 133.57 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.432 HD13 ' C ' ' C' ' 12' ' ' THR . 12.8 mm -113.2 110.14 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' THR . . . . . 0.546 HG23 ' CD1' ' C' ' 4' ' ' PHE . 3.8 m -83.82 119.01 24.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.603 HD13 ' CB ' ' C' ' 29' ' ' LYS . 73.5 mt -118.31 125.9 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.563 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.5 113.35 9.44 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.487 HG11 HG22 ' C' ' 26' ' ' VAL . 31.1 m -135.35 164.56 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.091 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -107.49 155.56 39.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.741 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.48 -32.76 90.51 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.027 1.818 . . . . 0.0 112.302 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.52 -1.34 57.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.186 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -62.77 138.76 58.6 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -79.15 159.42 27.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.174 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.52 HD12 HD13 ' C' ' 50' ' ' LEU . 43.9 mm -64.12 -40.96 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -58.02 -36.32 72.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.955 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.69 -43.13 94.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.197 0.522 . . . . 0.0 110.904 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.499 HG21 HD21 ' C' ' 56' ' ' LEU . 62.5 t -62.37 -43.08 97.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.802 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -60.75 -38.38 84.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.16 91.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.852 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.603 ' CB ' HD13 ' C' ' 15' ' ' LEU . 5.8 mptt -60.07 -38.74 83.75 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.343 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.893 HD11 HG11 ' C' ' 5' ' ' VAL . 6.9 mm -63.85 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.244 0.545 . . . . 0.0 110.14 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -59.88 -48.77 80.33 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.76 -11.55 59.85 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.082 -0.386 . . . . 0.0 112.026 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -104.87 -8.03 18.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -147.27 -35.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.433 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.81 15.54 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.465 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' C' ' 41' ' ' GLN . 28.5 mt -95.78 115.05 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.69 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.35 153.77 51.49 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.6 2.2 . . . . 0.0 111.294 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.31 -40.12 87.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.649 1.566 . . . . 0.0 111.855 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.95 -41.01 97.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.827 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -88.88 -2.57 58.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.585 ' HG3' HD21 ' C' ' 69' ' ' LEU . 4.7 tt0 -111.88 120.83 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.798 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -122.77 120.54 33.88 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.546 ' CB ' HD12 ' C' ' 50' ' ' LEU . 78.2 mt -99.12 131.47 45.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.199 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.425 HG21 ' HE1' ' A' ' 76' ' ' PHE . 78.5 mt -129.72 129.01 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 45' ' ' PHE . . . . . 0.541 ' HB2' HD23 ' C' ' 67' ' ' LEU . 75.1 t80 -151.77 153.46 34.34 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.61 15.37 10.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.418 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 47' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.69 -12.0 66.85 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.736 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -117.42 146.85 43.18 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.624 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.18 137.14 44.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.014 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.546 HD12 ' CB ' ' C' ' 43' ' ' LEU . 44.1 mt -72.79 103.17 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.741 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -74.6 135.98 42.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -59.95 136.67 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.67 -18.29 37.96 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -89.52 174.44 7.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.2 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -115.67 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.267 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.499 HD21 HG21 ' C' ' 26' ' ' VAL . 82.0 mt -62.7 -40.19 96.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.801 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.05 -25.94 68.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.29 -30.63 71.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' C' ' 50' ' ' LEU . 59.3 m-85 -100.82 12.82 36.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.42 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 56.7 39.66 29.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.378 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.422 HG21 HD22 ' C' ' 56' ' ' LEU . 48.2 mt -83.93 117.77 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -101.98 175.09 5.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.015 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -59.81 145.46 45.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.753 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 59.13 20.81 8.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.405 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 7.9 m -67.93 133.92 49.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -86.75 120.3 27.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.358 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' C' ' 45' ' ' PHE . 3.7 mp -114.19 147.98 38.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -100.27 129.03 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.55 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.585 HD21 ' HG3' ' C' ' 41' ' ' GLN . 0.6 OUTLIER -104.91 121.26 43.34 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 56' ' ' LEU . 57.7 t -107.07 135.41 45.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.545 ' HG ' HD23 ' C' ' 8' ' ' LEU . 31.1 mt -109.32 142.52 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.64 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 179.763 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.89 156.76 16.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.107 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.619 HD13 HD21 ' D' ' 56' ' ' LEU . 16.8 pt -136.79 150.57 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.415 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.8 m-30 -92.51 121.85 34.37 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.999 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.49 103.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.56 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -89.5 128.66 36.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.528 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.763 HG22 HD23 ' D' ' 69' ' ' LEU . 81.6 p -89.24 -177.36 5.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 111.228 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.692 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.1 mt -63.97 -37.58 87.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -70.02 -10.35 58.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.907 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.59 -10.56 66.78 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.91 130.58 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.252 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 131.38 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -121.93 108.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.415 HG23 ' CD2' ' D' ' 4' ' ' PHE . 19.6 m -81.38 129.69 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.553 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.77 HD21 ' HG3' ' D' ' 33' ' ' LYS . 38.2 mt -127.06 123.19 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -65.73 111.79 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.409 0.623 . . . . 0.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.691 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 18.1 m -135.07 164.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.165 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.27 155.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.452 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.88 -33.69 95.4 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.084 1.856 . . . . 0.0 111.89 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -82.9 -5.6 59.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.529 ' OD2' HG23 ' D' ' 26' ' ' VAL . 35.2 t70 -60.96 133.29 55.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 110.717 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -76.34 161.53 28.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.532 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.916 HD12 HD23 ' D' ' 50' ' ' LEU . 44.0 mm -64.44 -40.34 88.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.22 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.57 -40.04 86.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -61.89 -40.36 95.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.194 0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.878 HG21 HD11 ' D' ' 56' ' ' LEU . 54.6 t -62.24 -44.27 98.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.546 ' HG2' HD23 ' D' ' 43' ' ' LEU . 30.8 mtmt -60.35 -40.79 91.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.814 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.3 93.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.502 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.691 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 90.7 mttt -60.0 -39.97 87.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.637 HD11 HD11 ' D' ' 43' ' ' LEU . 96.4 mt -67.35 -40.67 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.581 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.99 -39.62 82.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.734 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.67 8.55 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.77 ' HG3' HD21 ' D' ' 15' ' ' LEU . 0.0 OUTLIER -109.79 -58.12 2.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.865 0.364 . . . . 0.0 110.595 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.11 0.59 25.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.651 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.37 23.78 77.67 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 20.5 mm -84.07 117.78 69.57 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.901 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.08 150.8 76.87 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.244 1.963 . . . . 0.0 112.291 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.25 -19.74 51.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.301 2.001 . . . . 0.0 112.023 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.9 3.44 41.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -124.71 -54.8 1.64 Allowed 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.84 0.352 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.66 114.13 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.286 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -112.3 124.25 52.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.637 HD11 HD11 ' D' ' 30' ' ' ILE . 4.4 mm? -100.48 119.68 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.69 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 84.4 mt -126.88 126.04 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.731 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 84.4 t80 -125.44 131.53 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.085 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.07 26.23 12.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.447 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.73 16.03 80.47 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.28 130.16 53.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.516 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -67.53 131.99 46.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.916 HD23 HD12 ' D' ' 23' ' ' ILE . 8.0 mp -88.72 97.59 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.04 163.36 27.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.868 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -73.45 163.77 27.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.91 71.2 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -131.24 165.53 23.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.104 0.478 . . . . 0.0 110.776 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -116.74 164.34 14.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.878 HD11 HG21 ' D' ' 26' ' ' VAL . 4.6 mp -59.82 -38.65 82.58 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.97 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -62.09 -29.42 70.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.911 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.3 -30.12 71.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.159 0.504 . . . . 0.0 110.066 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -99.43 11.65 38.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 54.98 40.35 31.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.308 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ILE . . . . . 0.62 HD11 HD21 ' D' ' 50' ' ' LEU . 81.5 mt -89.81 115.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -103.87 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.443 0.64 . . . . 0.0 110.887 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -60.43 146.92 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.921 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 61.25 19.83 10.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.2 m -74.84 126.98 32.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.924 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.475 ' C ' HD12 ' D' ' 67' ' ' LEU . 62.1 m -77.71 131.26 37.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.465 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.475 HD12 ' C ' ' D' ' 66' ' ' THR . 7.5 mp -118.63 138.78 52.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.95 110.12 20.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.865 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.763 HD23 HG22 ' D' ' 7' ' ' THR . 63.3 tp -98.15 117.56 32.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' D' ' 8' ' ' LEU . 95.5 t -110.28 132.77 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.517 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.692 ' H ' HD11 ' D' ' 8' ' ' LEU . 41.2 mt . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.968 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.16 112.15 24.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.5 mt -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.92 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.64 161.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.984 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 122.6 0.37 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.54 158.47 38.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.2 mtm-85 -75.34 121.76 22.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.056 0.455 . . . . 0.0 110.713 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.85 146.02 22.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.52 152.24 17.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -91.66 164.46 13.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.952 0.406 . . . . 0.0 111.113 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.4 mtp -132.5 175.27 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.797 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.3 m -125.56 124.09 40.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 37' ' ' THR . 36.6 tp -107.27 119.62 39.9 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.323 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.7 113.78 19.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.952 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -87.78 0.57 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -145.1 21.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.566 0.222 . . . . 0.0 110.723 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.663 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.2 m -123.03 130.53 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.536 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.1 t -106.94 123.15 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.872 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.48 128.03 26.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.62 146.71 39.24 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.765 1.643 . . . . 0.0 112.552 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.55 134.56 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.11 -6.96 46.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -73.14 78.21 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -52.79 134.18 36.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.329 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.54 -165.9 11.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.068 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 27' ' ' ARG . 8.6 tp -134.55 125.91 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.78 109.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.3 p90 -134.04 154.21 51.3 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 137.96 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.584 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.96 131.18 36.89 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.648 0.593 . . . . 0.0 110.399 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.569 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.3 tt0 -100.87 124.97 47.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.22 0.534 . . . . 0.0 109.998 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.4 p -84.46 172.23 11.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.696 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.77 -10.0 24.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.653 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.75 7.49 41.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.482 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 m 63.42 24.41 14.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.434 0.635 . . . . 0.0 110.651 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.569 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 73.8 mt -99.98 121.97 42.17 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.542 HG21 HD23 ' A' ' 128' ' ' LEU . 51.5 mm -81.14 121.23 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.6 m-70 -97.59 113.69 25.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.999 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -93.1 108.35 19.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 82.3 m -120.86 145.83 47.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.747 0.784 . . . . 0.0 112.89 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -127.6 115.22 18.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.154 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -106.63 145.98 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.38 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -84.18 130.73 34.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -70.79 -17.51 62.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -59.21 -45.45 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.543 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.5 m -117.07 -11.54 10.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.44 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.15 21.47 79.2 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -102.56 148.33 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.1 t -76.27 106.01 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.13 -29.87 31.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.109 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -127.74 145.11 51.01 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.308 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.7 p-10 -159.18 100.04 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.764 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.736 HD22 ' HB3' ' C' ' 48' ' ' LYS . 39.9 mt -128.27 133.59 48.8 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.65 119.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.126 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.712 HG21 ' SG ' ' A' ' 80' ' ' CYS . 26.3 mm -110.88 120.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.03 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 47.2 m-85 -82.45 163.21 53.27 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.727 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 141.61 94.8 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.162 1.908 . . . . 0.0 111.728 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.95 12.28 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -85.1 -25.14 27.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.555 0.217 . . . . 0.0 110.875 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.7 p -149.26 167.17 26.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.529 0.68 . . . . 0.0 110.695 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.89 130.67 34.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.353 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.07 119.12 38.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.55 167.12 22.84 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.74 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -82.09 160.44 23.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.107 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.04 89.81 12.44 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 59.99 7.64 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.837 1.691 . . . . 0.0 112.246 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -114.65 -36.5 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.129 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 17.2 p -130.44 75.45 79.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.643 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 130.2 34.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.887 1.725 . . . . 0.0 111.558 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t 168.97 -43.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.919 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.05 -147.74 5.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.6 107.24 14.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 110.535 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.19 129.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 111.088 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.49 156.08 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.55 136.81 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.499 HD11 ' SG ' ' A' ' 80' ' ' CYS . 64.7 tp -103.31 122.36 44.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -118.76 130.9 56.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.073 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.28 115.81 21.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.289 0.566 . . . . 0.0 109.714 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.44 -37.54 87.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.579 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 -22.0 23.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.643 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.55 -171.84 19.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.4 m -117.8 12.67 13.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.622 0.248 . . . . 0.0 110.682 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.652 ' HD3' HD21 ' A' ' 105' ' ' LEU . 26.5 ttmt -83.92 141.59 31.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.932 0.396 . . . . 0.0 110.787 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.19 125.97 25.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.652 HD21 ' HD3' ' A' ' 103' ' ' LYS . 38.0 mt -113.53 151.15 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.002 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 33' ' ' LEU . 96.6 m-85 -124.85 137.27 54.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.352 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.67 155.0 51.11 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.298 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -129.97 136.43 49.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.723 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 tpp -70.3 131.19 43.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.76 -4.86 17.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.022 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.15 149.13 94.66 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.559 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' B' ' 942' ' ' PRO . 58.3 Cg_endo -72.43 -27.14 16.27 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.036 1.824 . . . . 0.0 112.922 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.03 142.72 49.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 110.266 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -98.22 13.95 29.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.57 -20.93 59.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -125.62 11.95 7.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.17 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -63.24 -46.57 86.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.698 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -71.84 -34.37 69.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.357 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.08 -46.21 82.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.407 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.6 m170 -63.23 -41.06 99.05 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.606 0.717 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.99 -45.32 94.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.609 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -64.85 -43.77 91.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.214 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.15 -36.74 84.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 120' ' ' HIS . 58.2 t -59.2 -48.26 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.092 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.7 -29.82 40.83 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.952 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -68.61 -36.58 78.86 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.316 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -81.3 -32.82 32.96 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.554 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.632 HD22 ' HB ' ' A' ' 75' ' ' ILE . 80.6 mt -80.32 -25.25 39.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.284 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -110.12 -20.37 12.71 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.641 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.36 69.13 39.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.487 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.98 159.99 50.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 123.038 2.492 . . . . 0.0 112.382 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -72.27 153.54 92.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.618 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 942' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 55.5 Cg_endo -68.79 147.22 68.56 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.609 2.206 . . . . 0.0 112.179 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.96 157.5 87.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.0 139.23 84.53 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.551 2.167 . . . . 0.0 111.939 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.88 -172.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.043 1.828 . . . . 0.0 112.059 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -122.46 158.36 56.38 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.433 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.85 141.53 95.9 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.19 162.25 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.636 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -86.91 139.41 30.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.32 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -123.99 124.31 42.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.112 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.773 179.701 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.75 161.6 9.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.955 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 pt -139.73 146.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.092 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.57 124.85 33.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.79 116.02 51.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.84 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -94.92 118.31 31.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.138 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.29 173.08 10.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.251 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.564 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -46.49 -29.03 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.662 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -101.93 -179.1 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.119 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 -17.66 55.43 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -57.2 130.63 47.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.698 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 76.4 m -128.23 135.97 50.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.937 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.541 HD13 ' HG2' ' C' ' 34' ' ' GLU . 0.0 OUTLIER -126.24 121.06 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -88.94 127.6 35.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' C' ' 29' ' ' LYS . 67.4 mt -119.65 135.28 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.594 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -73.82 118.04 16.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.678 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.577 HG12 ' HE3' ' C' ' 29' ' ' LYS . 30.4 m -135.49 167.03 26.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.72 151.23 42.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.87 -35.87 94.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.818 1.679 . . . . 0.0 112.176 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -87.7 -0.99 57.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.115 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -62.81 137.92 58.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.725 0.298 . . . . 0.0 110.878 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -78.87 163.22 25.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.347 0.594 . . . . 0.0 111.342 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' C' ' 50' ' ' LEU . 48.3 mm -62.75 -37.1 78.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.762 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.35 -41.25 84.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.157 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -64.33 -41.07 96.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 110.594 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.586 HG21 HD21 ' C' ' 56' ' ' LEU . 57.7 t -64.16 -47.36 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.02 -32.49 72.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.87 98.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.423 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.633 ' HB3' HD13 ' C' ' 15' ' ' LEU . 66.8 mttm -60.25 -38.72 84.35 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.742 HD13 HD11 ' C' ' 69' ' ' LEU . 90.1 mt -64.42 -39.15 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -57.3 -43.97 83.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.23 -44.73 95.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.27 -78.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.745 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' GLU . . . . . 0.541 ' HG2' HD13 ' C' ' 13' ' ' ILE . 79.4 mm-40 -89.1 149.14 23.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.72 56.09 4.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.542 HG22 ' HG3' ' C' ' 41' ' ' GLN . 30.9 mt -106.96 121.87 43.44 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.083 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.24 157.84 52.96 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.477 1.451 . . . . 0.0 111.19 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.8 -38.22 94.71 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.793 1.662 . . . . 0.0 112.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -61.59 -43.37 98.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -85.75 -5.95 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.542 ' HG3' HG22 ' C' ' 36' ' ' ILE . 31.4 mt-30 -87.27 74.91 9.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.151 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -88.58 97.51 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.425 ' CB ' HD12 ' C' ' 50' ' ' LEU . 25.7 mt -87.46 132.71 33.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.142 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.21 129.87 63.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.759 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 85.8 t80 -150.17 150.9 32.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.29 15.1 9.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.297 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.41 -13.6 64.85 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.606 ' CG ' HD22 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -111.9 143.27 43.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.181 -178.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -73.06 132.3 43.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.684 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' C' ' 59' ' ' TYR . 54.6 mt -72.08 98.45 2.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.79 140.43 43.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.523 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -58.81 140.04 55.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.335 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.12 -17.39 54.19 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -82.88 178.11 8.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.842 0.353 . . . . 0.0 110.427 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 58.9 p -125.66 161.56 26.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.948 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.586 HD21 HG21 ' C' ' 26' ' ' VAL . 83.9 mt -61.27 -41.4 96.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.648 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -64.2 -22.74 67.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.803 0.335 . . . . 0.0 110.397 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -62.85 -36.8 84.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.398 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.433 ' CE2' HD23 ' C' ' 50' ' ' LEU . 73.1 m-85 -98.16 13.94 29.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.196 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.86 39.81 23.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.181 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.428 HG21 HD22 ' C' ' 56' ' ' LEU . 65.5 mt -84.56 117.35 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.962 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -104.43 178.36 4.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.17 143.95 47.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.127 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 60.78 21.08 11.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -70.05 127.84 34.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.436 ' C ' HD12 ' C' ' 67' ' ' LEU . 81.4 m -78.81 128.34 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.436 HD12 ' C ' ' C' ' 66' ' ' THR . 9.1 mp -113.18 151.22 31.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.59 116.76 33.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.444 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.742 HD11 HD13 ' C' ' 30' ' ' ILE . 0.9 OUTLIER -96.32 114.34 26.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.259 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 56' ' ' LEU . 96.0 t -108.78 127.21 65.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.73 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.564 ' HG ' HD23 ' C' ' 8' ' ' LEU . 26.4 mt -88.9 146.65 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.671 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.79 162.86 8.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.93 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.97 151.25 23.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.407 ' CD1' HG23 ' D' ' 14' ' ' THR . 11.7 m-30 -91.36 123.25 34.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.756 HG11 HD11 ' D' ' 30' ' ' ILE . 79.2 t -109.38 105.89 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.384 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -91.83 127.19 37.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.37 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.865 HG22 HD23 ' D' ' 69' ' ' LEU . 73.6 p -87.6 179.17 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.424 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.641 HD11 ' H ' ' D' ' 71' ' ' LEU . 80.8 mt -62.3 -36.22 81.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.817 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -68.79 -12.68 61.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.071 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.16 66.0 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.75 133.52 51.2 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -104.34 131.95 51.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.211 0.529 . . . . 0.0 110.507 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -121.02 113.44 39.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.625 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.407 HG23 ' CD1' ' D' ' 4' ' ' PHE . 14.0 m -83.98 124.7 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.118 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.583 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.9 mt -120.05 128.73 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.309 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.15 116.98 12.08 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 110.585 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.435 HG12 ' HD2' ' D' ' 29' ' ' LYS . 24.4 m -135.39 166.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.012 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.06 153.29 47.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 -29.0 85.75 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.641 1.56 . . . . 0.0 111.912 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 60.3 m -87.47 -9.74 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.705 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -64.32 142.37 58.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 45.7 p -82.19 166.12 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.742 ' CD1' HD12 ' D' ' 50' ' ' LEU . 37.0 mm -63.04 -36.58 76.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.773 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.04 90.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.989 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.36 -41.23 98.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.679 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 67.4 t -63.79 -43.35 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.838 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.536 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.54 90.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.286 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.435 ' HD2' HG12 ' D' ' 17' ' ' VAL . 67.2 mttm -60.39 -39.49 87.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.756 HD11 HG11 ' D' ' 5' ' ' VAL . 8.8 mm -64.83 -40.8 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.235 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.447 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.03 -40.81 98.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.583 ' HD2' HD21 ' D' ' 15' ' ' LEU . 45.1 mttt -76.8 -71.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.88 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.45 152.98 19.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 55.97 4.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.643 HG22 ' HG3' ' D' ' 41' ' ' GLN . 32.7 mm -107.23 109.85 63.02 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.88 153.31 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.084 1.856 . . . . 0.0 111.51 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.85 -37.91 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.849 1.7 . . . . 0.0 112.233 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.15 -39.38 89.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -89.18 -12.5 40.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.643 ' HG3' HG22 ' D' ' 36' ' ' ILE . 20.0 mt-30 -78.99 86.04 4.89 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.875 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' ARG . . . . . 0.482 ' HD3' HD11 ' D' ' 44' ' ' ILE . 61.4 ttm-85 -97.44 115.27 27.44 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.71 118.1 36.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.482 HD11 ' HD3' ' D' ' 42' ' ' ARG . 83.2 mt -125.09 127.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.474 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' D' ' 67' ' ' LEU . 40.8 t80 -119.1 127.24 53.19 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.46 26.35 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.15 2.71 90.6 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.411 ' C ' HG23 ' D' ' 44' ' ' ILE . 43.3 ttm180 -112.86 121.84 45.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.013 0.407 . . . . 0.0 110.335 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -60.25 142.98 53.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.041 0.448 . . . . 0.0 110.388 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.742 HD12 ' CD1' ' D' ' 23' ' ' ILE . 4.0 mm? -78.09 123.85 27.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.063 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.92 138.67 50.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.69 129.96 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.093 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.91 -14.64 61.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.41 174.15 10.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -117.95 160.87 20.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.61 -39.87 92.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -63.88 -23.9 67.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.308 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -62.13 -37.6 85.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.295 0.569 . . . . 0.0 110.202 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -98.11 13.95 29.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.374 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 55.93 40.09 30.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.273 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -85.47 105.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.68 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -88.99 -172.82 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.434 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.55 149.58 49.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.316 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 57.5 42.39 24.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -89.87 121.43 31.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.965 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.455 ' O ' HD22 ' D' ' 67' ' ' LEU . 67.3 m -71.33 127.57 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.455 HD22 ' O ' ' D' ' 66' ' ' THR . 3.0 mm? -117.41 139.53 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.173 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -88.22 105.35 17.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.865 HD23 HG22 ' D' ' 7' ' ' THR . 67.3 tp -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.475 ' HA ' HD21 ' D' ' 8' ' ' LEU . 98.4 t -108.83 133.46 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.115 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.641 ' H ' HD11 ' D' ' 8' ' ' LEU . 25.7 mt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.427 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.4 pttp . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.895 0.378 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -94.88 128.77 41.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 109.897 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 51' ' ' GLN . 85.7 mt -69.78 -36.31 75.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.435 HG12 ' CG1' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -147.61 160.92 7.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.504 178.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -174.2 122.21 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.41 159.85 40.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.139 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -77.37 117.8 19.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.554 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.99 142.17 22.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.26 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.39 154.15 17.56 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -93.61 176.32 6.41 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.773 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.7 mtp -139.84 172.88 12.15 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.13 124.76 44.64 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 37' ' ' THR . 48.5 tp -105.38 117.08 33.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.015 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -120.42 116.64 25.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.598 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 -85.76 0.36 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.56 22.04 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.576 0.227 . . . . 0.0 110.714 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.583 ' O ' HD12 ' A' ' 33' ' ' LEU . 93.6 m -122.97 130.13 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.888 0.375 . . . . 0.0 110.559 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 33' ' ' LEU . 59.3 t -103.4 122.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.667 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 p -112.55 120.85 40.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.37 141.34 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.029 1.819 . . . . 0.0 112.348 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -98.08 116.27 29.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.46 -15.05 14.94 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.142 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -74.57 73.63 1.97 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.541 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -54.15 140.94 30.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.754 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.26 -156.49 7.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.002 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 27' ' ' ARG . 7.4 tp -135.22 125.66 26.67 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.95 109.14 23.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.314 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.23 154.55 49.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.273 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.0 mt -120.79 139.07 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.562 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.03 128.19 27.88 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.764 0.665 . . . . 0.0 110.485 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.67 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.6 tt0 -98.63 124.93 43.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.072 0.463 . . . . 0.0 109.936 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.7 p -85.33 172.46 11.07 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.56 -10.17 24.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.766 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.18 7.92 40.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.296 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.7 m 62.3 25.95 15.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.261 0.553 . . . . 0.0 110.623 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.639 HD11 HG11 ' C' ' 70' ' ' VAL . 73.3 mt -100.21 120.79 40.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.53 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -81.46 120.25 32.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -96.58 113.89 25.49 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.531 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -97.43 107.09 19.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 143.32 50.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.889 0.852 . . . . 0.0 112.861 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -119.44 117.39 28.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.51 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -106.69 144.02 33.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.375 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -81.81 130.26 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -72.59 -17.59 61.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.05 0.452 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -59.21 -45.41 91.17 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -117.16 -12.42 10.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.307 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.94 23.58 77.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -102.07 152.31 21.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.81 101.97 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.215 0.531 . . . . 0.0 110.451 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.41 -38.1 65.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.125 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -126.4 145.52 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.285 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.445 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.6 t0 -158.26 98.18 1.55 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.143 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.606 HD22 ' CG ' ' C' ' 48' ' ' LYS . 42.5 mt -125.34 136.62 53.65 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.84 118.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.696 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.4 mm -109.15 120.41 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.196 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.557 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 40.8 m-85 -82.59 163.24 52.81 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.598 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.02 141.08 96.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.498 2.132 . . . . 0.0 111.745 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t0 59.86 11.81 2.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.419 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.12 -29.38 28.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.727 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 75' ' ' ILE . 18.6 p -148.03 168.7 21.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.411 0.624 . . . . 0.0 110.783 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.17 130.94 36.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.354 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -100.96 118.83 37.75 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.92 168.03 20.71 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.645 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -83.24 157.68 22.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.45 88.88 9.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.56 60.17 7.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.831 1.687 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -114.28 -36.55 4.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.283 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -130.25 81.93 67.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.71 130.36 27.69 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.762 1.641 . . . . 0.0 111.817 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.0 -38.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.819 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.05 -153.25 6.08 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.14 106.59 15.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.1 t -125.8 129.57 72.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.02 154.43 39.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.434 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.83 136.75 59.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.943 0.402 . . . . 0.0 110.44 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.561 HD11 ' SG ' ' A' ' 80' ' ' CYS . 68.1 tp -102.98 121.37 42.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -118.51 132.24 56.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.048 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -82.96 115.21 21.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.302 0.572 . . . . 0.0 109.515 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.97 -37.64 87.94 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.36 -22.85 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.465 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.94 -171.74 20.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.9 m -119.52 13.95 12.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.566 0.222 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.72 ' HD3' HD21 ' A' ' 105' ' ' LEU . 24.0 ttmt -86.55 141.14 29.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.004 0.431 . . . . 0.0 111.085 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -133.77 129.02 36.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.082 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.72 HD21 ' HD3' ' A' ' 103' ' ' LYS . 42.5 mt -115.59 147.57 40.6 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.786 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' CE1' HD22 ' A' ' 33' ' ' LEU . 92.2 m-85 -119.84 135.88 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.564 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.82 155.13 50.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -130.57 137.5 49.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.342 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.2 mmm -73.59 138.83 45.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.32 6.29 32.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.728 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.9 141.07 58.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.06 -26.3 26.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.945 1.763 . . . . 0.0 112.459 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.51 142.62 48.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.33 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.3 p -95.08 9.02 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.495 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.2 -20.36 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.21 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -126.38 -9.67 6.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.839 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.98 -40.64 98.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 110.719 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -69.93 -35.89 74.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.58 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.12 -42.99 88.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.756 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.4 m170 -63.96 -38.67 91.94 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.997 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.95 -46.03 92.36 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.031 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.46 -43.92 95.96 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.23 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.78 -38.23 87.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 120' ' ' HIS . 57.1 t -58.38 -48.29 85.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.232 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.49 -28.84 41.46 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.934 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.38 -38.1 81.05 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.604 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.2 -32.42 33.52 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.2 mt -79.02 -26.12 43.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -110.36 -21.03 12.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.82 67.7 42.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.371 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.11 158.42 56.56 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.984 2.456 . . . . 0.0 112.29 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.217 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.22 148.66 95.88 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.533 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.25 147.29 25.9 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.713 2.275 . . . . 0.0 112.089 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.91 155.87 90.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.74 151.11 69.12 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.059 1.839 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.74 -172.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.134 1.889 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -122.38 155.82 61.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.0 141.36 88.89 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.083 1.855 . . . . 0.0 112.073 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.82 163.45 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.739 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -86.58 138.73 31.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.379 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.78 127.64 46.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.073 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.403 ' N ' HD12 ' B' ' 951' ' ' ILE . 3.0 mp . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.635 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.85 163.84 11.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.519 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.66 143.45 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.519 ' HD2' HG21 ' C' ' 12' ' ' THR . 6.3 m-85 -87.46 122.07 30.72 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.754 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.2 t -106.63 113.3 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.963 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -97.55 120.86 38.69 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.771 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.828 HG22 HD23 ' C' ' 69' ' ' LEU . 76.9 p -82.06 171.23 14.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.595 HD11 ' H ' ' C' ' 71' ' ' LEU . 55.9 mt -64.85 -25.08 67.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.907 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -74.23 -9.27 58.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.86 -10.05 70.47 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -73.19 133.21 43.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' THR . . . . . 0.519 HG21 ' HD2' ' C' ' 4' ' ' PHE . 95.7 m -107.3 132.19 53.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.79 111.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.655 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -83.32 127.9 34.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.5 mt -120.41 132.43 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.21 117.52 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.484 HG12 ' HE3' ' C' ' 29' ' ' LYS . 27.5 m -135.72 163.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -103.93 152.04 38.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.86 -35.7 94.3 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.973 1.782 . . . . 0.0 112.148 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.28 -3.11 58.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -61.86 137.57 58.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.961 0.41 . . . . 0.0 110.704 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -78.29 162.87 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.483 HD12 HD13 ' C' ' 50' ' ' LEU . 47.9 mm -64.53 -38.11 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.864 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.36 -42.11 90.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.032 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.06 -40.74 96.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.196 0.522 . . . . 0.0 110.519 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.508 HG21 HD21 ' C' ' 56' ' ' LEU . 61.3 t -63.31 -42.72 97.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.659 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.73 -40.09 91.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.5 90.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.254 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.484 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.89 -38.78 83.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.764 ' CD1' HD21 ' C' ' 43' ' ' LEU . 95.0 mt -66.74 -38.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.434 0.635 . . . . 0.0 110.359 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.39 -46.67 88.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.221 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.62 -31.24 68.13 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.481 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -89.8 -4.33 57.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -147.95 -41.64 0.17 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.45 11.77 28.37 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.309 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.577 HG22 ' HG3' ' C' ' 41' ' ' GLN . 59.5 mt -75.79 121.09 84.39 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.42 154.54 63.42 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.496 1.464 . . . . 0.0 111.495 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.18 -31.19 94.9 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.937 1.758 . . . . 0.0 112.771 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.99 -40.22 94.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.905 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.32 -7.48 57.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.956 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.577 ' HG3' HG22 ' C' ' 36' ' ' ILE . 91.4 mt-30 -87.04 105.98 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.155 0.502 . . . . 0.0 111.536 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -116.51 99.11 6.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.175 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.764 HD21 ' CD1' ' C' ' 30' ' ' ILE . 75.6 mt -86.4 131.18 34.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.25 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.503 HG21 ' HE1' ' A' ' 76' ' ' PHE . 85.5 mt -131.36 127.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.695 0.283 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 67.7 t80 -149.17 150.87 33.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.127 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.82 16.41 9.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.46 -14.36 59.82 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.778 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -113.44 144.34 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.965 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -71.25 135.08 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.006 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' C' ' 43' ' ' LEU . 52.9 mt -71.64 105.44 3.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.781 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -75.22 139.03 42.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.41 138.55 57.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.41 55.84 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -82.04 172.55 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.4 p -118.26 161.69 19.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.579 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.508 HD21 HG21 ' C' ' 26' ' ' VAL . 84.1 mt -61.69 -40.46 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.983 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -63.85 -23.46 67.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.3 -37.6 86.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.134 0.492 . . . . 0.0 110.184 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.39 13.19 28.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.201 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.77 40.26 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.78 114.63 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.942 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -100.2 -179.6 4.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.845 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.75 146.19 53.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 59.24 17.45 5.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -70.6 132.62 45.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -82.81 128.6 34.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.96 140.24 49.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.852 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.01 117.44 28.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.954 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.828 HD23 HG22 ' C' ' 7' ' ' THR . 57.2 tp -100.43 121.42 41.51 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.009 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.712 HG11 HD11 ' A' ' 56' ' ' LEU . 62.5 t -111.98 132.57 60.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.066 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.595 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.9 mt -109.36 145.66 35.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.093 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -68.74 142.12 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.623 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.88 -39.55 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 53.85 42.25 31.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.28 179.29 46.61 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.66 -179.26 47.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 p30 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.73 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.76 163.51 13.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.299 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 pt -143.94 145.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.535 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -92.88 121.53 34.33 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.672 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -104.73 104.63 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.42 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -87.54 126.7 35.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.846 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.807 HG22 HD23 ' D' ' 69' ' ' LEU . 79.2 p -77.52 -171.86 2.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.854 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' D' ' 70' ' ' VAL . 88.8 mt -59.09 -19.88 48.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.673 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 22.2 p -111.15 -176.37 2.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.95 -18.45 57.21 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.76 131.04 38.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.082 0.468 . . . . 0.0 110.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -125.08 136.91 54.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.499 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.39 104.99 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.837 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -83.26 129.07 34.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' D' ' 29' ' ' LYS . 77.0 mt -124.51 131.97 53.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -76.63 116.56 17.42 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.343 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.735 HG12 ' HE3' ' D' ' 29' ' ' LYS . 27.3 m -135.15 161.7 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.65 152.71 40.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.02 -29.62 83.59 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.614 1.543 . . . . 0.0 111.791 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.7 p -80.97 -12.6 59.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.839 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.03 144.72 57.09 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.909 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -85.71 165.35 17.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.21 0.528 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.434 HD12 HD13 ' D' ' 50' ' ' LEU . 47.1 mm -62.79 -38.1 80.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.04 88.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.692 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.63 -41.07 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 110.345 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.523 HG21 HD21 ' D' ' 56' ' ' LEU . 63.2 t -63.4 -42.3 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -61.1 -40.55 94.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 110.202 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.87 89.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.905 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.735 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.1 mttm -59.75 -38.26 81.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.788 ' CD1' HD21 ' D' ' 43' ' ' LEU . 85.6 mt -64.24 -39.92 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 31' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' D' ' 35' ' ' GLY . 65.9 tt0 -60.35 -44.78 95.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.25 0.548 . . . . 0.0 110.134 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.48 -41.06 98.59 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.622 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.45 ' HD2' HD21 ' D' ' 15' ' ' LEU . 18.0 mttm -83.52 -14.53 52.08 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -136.36 -50.04 0.68 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 113.37 9.5 17.32 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.565 HD13 ' CD2' ' D' ' 71' ' ' LEU . 59.6 mt -78.08 125.69 84.82 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.59 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.99 159.95 50.87 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 120.917 1.078 . . . . 0.0 109.88 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.49 -40.41 78.82 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.165 1.91 . . . . 0.0 112.864 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.79 -44.37 96.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.65 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.65 -40.16 80.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.893 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.577 ' OE1' HD12 ' D' ' 30' ' ' ILE . 24.1 pt20 -85.57 140.71 30.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.206 0.527 . . . . 0.0 111.383 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ARG . . . . . 0.552 HH21 HG11 ' D' ' 70' ' ' VAL . 61.3 mtm180 -130.25 118.96 22.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.788 HD21 ' CD1' ' D' ' 30' ' ' ILE . 74.3 mt -96.22 118.14 32.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.134 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -124.22 127.52 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 68.6 t80 -123.67 128.59 49.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.259 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 64.81 26.75 12.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.502 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.48 13.2 83.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -121.72 127.44 50.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.23 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -62.43 135.37 57.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 0.0 110.476 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' D' ' 43' ' ' LEU . 84.5 mt -80.57 103.87 10.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.154 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.66 143.99 49.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.401 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -67.49 167.07 13.48 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.424 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 18.37 79.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -128.87 148.83 50.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -90.9 165.31 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.523 HD21 HG21 ' D' ' 26' ' ' VAL . 81.2 mt -62.79 -38.39 90.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.394 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -62.54 -25.55 68.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.243 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -36.55 81.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.095 0.474 . . . . 0.0 110.156 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.32 14.42 24.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 56.42 39.27 30.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.19 104.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.01 -175.03 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.344 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -67.53 150.16 49.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.101 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 58.06 30.09 18.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.813 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 31.1 m -81.2 128.01 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 30.8 m -85.76 122.47 29.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.7 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.17 145.82 36.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.45 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -89.91 115.85 27.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.807 HD23 HG22 ' D' ' 7' ' ' THR . 49.8 tp -100.85 118.54 37.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' D' ' 8' ' ' LEU . 96.9 t -116.02 130.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.872 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.565 ' CD2' HD13 ' D' ' 36' ' ' ILE . 48.8 mt -103.91 139.78 38.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.674 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -69.85 -174.55 0.77 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.557 HD23 ' CE ' ' C' ' 48' ' ' LYS . 1.1 mp -64.3 120.13 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.12 0.486 . . . . 0.0 110.649 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -80.45 149.79 29.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.618 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.79 49.88 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.398 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.363 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -84.14 149.93 25.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.105 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.68 112.05 23.86 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.5 mt -65.97 -38.69 89.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.621 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.4 p -148.84 163.48 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.668 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -173.7 122.18 0.34 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.187 0.518 . . . . 0.0 110.855 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.07 156.61 37.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.378 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -72.29 125.04 26.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.081 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -159.13 143.26 15.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.549 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.68 163.11 12.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -96.57 171.9 8.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.239 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.0 mtp -136.95 174.94 10.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -124.33 128.85 49.73 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.524 HD22 ' CE1' ' A' ' 106' ' ' PHE . 36.3 tp -108.15 116.89 32.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.179 0.514 . . . . 0.0 110.193 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.65 111.34 18.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.397 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.22 0.37 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -142.41 20.34 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.856 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.498 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.3 m -120.25 129.27 53.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.769 0.319 . . . . 0.0 110.485 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.0 t -107.95 122.29 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.032 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.6 p -114.47 131.37 23.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.38 147.57 52.99 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.744 1.629 . . . . 0.0 112.996 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -100.78 133.92 44.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -70.73 -12.46 61.57 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.008 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -76.34 68.97 2.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -58.88 134.41 56.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.9 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.11 -150.57 7.15 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.223 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 27' ' ' ARG . 2.7 tp -137.51 126.64 24.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 28' ' ' ALA . 48.8 t -97.65 112.7 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.07 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -134.52 155.0 51.16 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.3 mt -118.61 136.62 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.698 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.75 129.61 32.83 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 123.495 0.497 . . . . 0.0 110.463 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.486 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.4 tt0 -99.24 125.34 44.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 110.301 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.516 HG23 ' CD2' ' A' ' 58' ' ' HIS . 18.9 p -86.23 170.12 12.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.423 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -61.95 -10.56 9.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.296 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.77 0.83 56.13 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.472 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.76 19.93 7.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.255 0.55 . . . . 0.0 110.48 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.712 HD11 HG11 ' C' ' 70' ' ' VAL . 83.4 mt -98.49 123.34 42.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.6 mm -80.85 123.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.516 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.5 m-70 -99.38 114.76 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.978 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -93.16 107.69 19.44 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.4 m -120.65 148.22 44.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.717 0.77 . . . . 0.0 113.036 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -127.83 115.24 18.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.175 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.52 131.74 53.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.932 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -72.11 134.37 45.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.63 -17.42 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.942 0.401 . . . . 0.0 110.428 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -60.03 -45.65 92.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.694 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.0 p -116.37 -16.77 10.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.131 0.491 . . . . 0.0 109.871 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.67 22.15 75.57 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -100.46 152.26 20.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.08 104.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.851 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -82.13 -29.78 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.354 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -126.71 146.29 50.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.408 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.74 ' O ' HD23 ' A' ' 73' ' ' LEU . 68.5 t0 -157.56 101.26 1.83 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.856 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.778 HD22 ' HB3' ' C' ' 48' ' ' LYS . 13.8 mt -130.95 128.88 41.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.427 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.427 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -75.23 124.83 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.606 HG21 ' SG ' ' A' ' 80' ' ' CYS . 24.4 mm -114.0 122.23 67.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.631 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 65.5 m-85 -88.44 162.92 38.17 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.586 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.87 138.54 86.29 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.202 1.934 . . . . 0.0 111.831 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.05 6.2 1.68 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.754 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -71.68 -37.64 70.72 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.683 0.277 . . . . 0.0 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 96' ' ' LEU . 19.7 p -146.81 167.08 24.77 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.732 0.777 . . . . 0.0 111.019 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -128.52 128.94 45.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.324 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -99.04 118.53 36.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -143.64 165.55 27.3 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.913 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -79.53 160.29 26.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.62 90.36 12.45 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.109 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.59 59.75 7.54 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.812 1.675 . . . . 0.0 112.381 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.0 -39.76 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.321 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 p -127.82 75.45 78.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.478 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.04 130.01 30.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.981 1.788 . . . . 0.0 111.474 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.43 -44.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.662 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.38 -148.32 6.53 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -116.1 106.37 13.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.97 127.82 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -123.73 155.09 38.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.692 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 105' ' ' LEU . 13.1 p -129.75 138.37 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.089 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' A' ' 80' ' ' CYS . 67.8 tp -104.78 121.24 43.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -117.79 121.64 41.33 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.172 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.491 ' HE2' HD12 ' A' ' 75' ' ' ILE . 59.1 m-85 -80.68 112.3 17.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.52 -36.21 77.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.695 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.1 -17.71 14.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.397 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -85.89 -13.9 68.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.576 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 53.2 31.46 11.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.09 0.445 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 98' ' ' PHE . 12.1 ttmm -120.75 145.73 47.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.249 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -127.06 127.93 45.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.089 0.471 . . . . 0.0 111.532 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 95' ' ' VAL . 48.9 mt -119.32 149.14 42.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.62 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.524 ' CE1' HD22 ' A' ' 33' ' ' LEU . 91.2 m-85 -123.61 134.96 53.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.558 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.23 155.43 50.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.38 0.61 . . . . 0.0 111.322 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -129.01 136.23 50.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.183 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.5 mtp -81.29 138.4 35.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.227 0.537 . . . . 0.0 111.51 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.91 5.3 49.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.669 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.95 130.96 89.45 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.183 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.6 -24.83 41.29 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.692 1.595 . . . . 0.0 112.686 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.4 143.24 48.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.453 HG22 ' HG2' ' A' ' 92' ' ' ARG . 74.4 p -95.68 11.45 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.02 -20.62 58.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.431 ' NE2' ' OE1' ' A' ' 119' ' ' GLU . 23.4 mm100 -122.81 9.28 9.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.067 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -62.85 -45.69 91.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.41 -32.82 73.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.415 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.431 ' OE1' ' NE2' ' A' ' 116' ' ' GLN . 88.8 tt0 -64.48 -46.69 81.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.41 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.657 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.1 m170 -64.54 -40.81 96.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 109.626 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.1 t -63.1 -44.27 96.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.262 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -69.8 -41.33 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.241 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.54 -42.71 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.378 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.6 t -57.77 -48.26 84.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.917 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.824 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.12 -20.68 63.17 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.549 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 23.3 m-85 -94.41 -18.2 21.77 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.746 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 124' ' ' VAL . 86.3 mt -95.62 -24.64 16.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.096 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -118.72 -12.25 9.71 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.271 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.15 64.71 55.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.122 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.23 152.67 75.78 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.492 1.394 0 C-N-CA 122.245 1.963 . . . . 0.0 111.872 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -129.13 148.6 69.73 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.635 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.46 146.71 27.89 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.606 2.204 . . . . 0.0 112.194 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -73.41 153.03 90.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.45 154.0 65.34 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.938 1.759 . . . . 0.0 112.139 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.65 -170.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.336 2.024 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -126.43 159.02 65.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.197 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.41 139.9 87.79 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.457 2.105 . . . . 0.0 112.331 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.41 163.6 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.604 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -86.44 134.3 33.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -118.72 131.39 56.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.98 132.82 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -76.38 85.07 3.13 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.091 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.754 179.767 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -63.95 158.92 21.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.237 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.34 148.82 24.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.114 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -91.37 120.99 32.7 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.285 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.63 110.22 29.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -98.27 121.29 40.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.638 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -82.2 173.83 11.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.526 HD11 ' H ' ' C' ' 71' ' ' LEU . 74.3 mt -61.65 -30.35 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -71.25 -12.15 61.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.13 -13.98 62.87 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.43 131.86 49.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 110.364 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 95.3 m -108.93 131.03 55.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.392 . . . . 0.0 110.374 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.03 114.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.474 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 29.1 m -81.32 129.98 34.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.347 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.61 127.32 48.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -71.3 115.26 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.452 HG12 ' CD ' ' C' ' 29' ' ' LYS . 25.7 m -135.37 163.49 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.634 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.34 152.86 40.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.98 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.35 -37.23 94.8 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.119 1.879 . . . . 0.0 112.229 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -83.84 -4.92 59.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.063 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -59.72 136.97 58.16 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.953 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -77.58 161.75 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.2 mm -63.91 -38.99 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.236 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.13 -42.02 89.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.27 -41.04 98.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.145 0.498 . . . . 0.0 110.619 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 56' ' ' LEU . 54.1 t -63.19 -43.45 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.77 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.63 -39.97 90.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.237 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.452 ' CD ' HG12 ' C' ' 17' ' ' VAL . 67.5 mttm -60.55 -39.68 88.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.637 HG21 HD11 ' C' ' 69' ' ' LEU . 95.7 mt -66.28 -39.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.308 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.57 -40.99 93.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.32 -39.6 92.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.151 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -74.86 -64.39 1.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.712 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.17 170.93 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.219 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.26 21.12 26.31 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.679 HG22 ' HG3' ' C' ' 41' ' ' GLN . 27.3 mm -77.03 117.49 65.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.851 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.77 156.27 57.26 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.299 1.999 . . . . 0.0 111.797 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.07 -39.3 70.6 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.071 1.847 . . . . 0.0 112.526 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.13 -39.59 93.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.681 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.39 -3.51 56.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.114 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.679 ' HG3' HG22 ' C' ' 36' ' ' ILE . 17.7 mt-30 -87.42 68.04 9.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.61 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' C' ' 70' ' ' VAL . 94.0 mtt-85 -85.53 110.72 19.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.55 ' HB2' HD12 ' C' ' 50' ' ' LEU . 25.9 mt -98.78 132.58 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.64 129.62 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 110.525 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.66 151.65 40.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.984 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.88 15.56 6.11 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.34 -14.25 63.0 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.678 ' CG ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -107.2 140.71 39.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.56 133.88 44.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' C' ' 43' ' ' LEU . 48.6 mt -72.22 102.2 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.891 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -75.3 140.12 42.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.83 137.94 57.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.216 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.47 -17.78 52.58 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmp_? -83.49 177.7 8.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.337 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -125.24 163.21 23.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.109 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 26' ' ' VAL . 85.4 mt -61.54 -40.93 96.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.552 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.83 -24.41 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.78 -37.93 86.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.2 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.72 13.88 26.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.509 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.79 39.34 27.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.41 . . . . 0.0 110.264 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.414 HG21 HD22 ' C' ' 56' ' ' LEU . 63.2 mt -85.54 118.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.069 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -106.87 -179.18 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.686 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -61.97 146.14 50.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.935 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.6 15.63 9.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.618 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.8 m -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.545 ' C ' HD12 ' C' ' 67' ' ' LEU . 88.3 m -82.54 129.77 34.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.064 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.545 HD12 ' C ' ' C' ' 66' ' ' THR . 9.9 mp -114.89 144.31 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.127 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -95.83 118.14 31.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.231 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.637 HD11 HG21 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -96.82 123.32 40.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 56' ' ' LEU . 66.4 t -114.49 126.95 72.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.947 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.526 ' H ' HD11 ' C' ' 8' ' ' LEU . 15.7 mt -98.45 -174.25 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.405 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -129.16 153.06 48.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.332 . . . . 0.0 110.527 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -109.1 142.96 39.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -100.63 125.71 47.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.55 -170.18 54.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -171.97 53.49 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.632 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -63.21 154.83 30.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.078 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -133.9 160.72 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.321 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.623 ' CD2' HG23 ' D' ' 14' ' ' THR . 12.9 m-30 -101.59 125.71 48.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.615 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.47 HG21 HD12 ' D' ' 15' ' ' LEU . 78.5 t -111.56 107.15 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.898 0.38 . . . . 0.0 111.008 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -85.2 129.23 34.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.679 HG22 HD23 ' D' ' 69' ' ' LEU . 68.5 p -90.18 176.6 6.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 110.961 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.648 HD11 ' H ' ' D' ' 71' ' ' LEU . 90.1 mt -60.65 -37.37 81.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -74.68 -8.22 55.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.75 67.37 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -63.29 126.59 27.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.059 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 92.3 m -96.21 136.88 36.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 0.0 110.611 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -122.3 118.18 54.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.278 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.623 HG23 ' CD2' ' D' ' 4' ' ' PHE . 0.2 OUTLIER -83.41 125.14 31.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.061 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 29' ' ' LYS . 90.5 mt -123.26 113.11 18.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.94 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -65.78 106.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.242 0.544 . . . . 0.0 110.853 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.658 HG12 ' HE3' ' D' ' 29' ' ' LYS . 32.7 m -130.61 163.2 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.639 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -105.76 155.09 38.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.58 -37.24 97.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.174 1.916 . . . . 0.0 111.981 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -83.42 -5.22 59.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.976 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -59.15 138.06 57.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.995 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -79.65 161.35 25.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.944 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -64.02 -38.37 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.755 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.77 -41.59 86.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.817 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.17 -41.4 98.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 110.714 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.406 HG22 HG11 ' D' ' 17' ' ' VAL . 65.9 t -64.19 -42.73 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.1 mtmt -60.52 -39.8 89.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.406 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.63 92.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.511 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.681 ' HB3' HD22 ' D' ' 15' ' ' LEU . 66.8 mttm -59.82 -40.06 87.14 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.62 -39.62 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.338 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.17 -42.42 90.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.678 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -90.69 19.73 5.21 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -122.52 -39.56 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -126.11 -6.99 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.315 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 18.87 76.6 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.675 ' CD1' HD21 ' D' ' 69' ' ' LEU . 70.8 mt -77.05 120.56 82.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 147.84 92.36 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.341 2.027 . . . . 0.0 111.727 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 -41.76 62.97 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.943 1.762 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.11 -32.02 72.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.9 -10.24 58.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.466 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.625 ' HG3' HG22 ' D' ' 36' ' ' ILE . 89.2 mt-30 -88.88 112.97 23.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.601 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -115.74 101.42 8.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' D' ' 27' ' ' LYS . 10.0 mt -94.66 118.48 31.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.2 mt -125.99 123.08 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.116 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -113.42 122.83 48.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.15 30.11 19.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.473 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.46 89.99 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -103.41 119.11 38.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -64.11 138.64 58.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' D' ' 43' ' ' LEU . 49.3 mt -90.5 105.34 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.33 153.32 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.728 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -72.37 161.21 31.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.063 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.89 84.69 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.01 176.98 4.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.707 0.289 . . . . 0.0 110.45 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -126.16 164.42 20.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.406 HD21 HG21 ' D' ' 26' ' ' VAL . 91.1 mt -62.24 -39.79 94.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.743 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -63.27 -29.52 70.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 0.0 110.923 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.78 -32.17 72.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.46 14.19 30.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.215 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 55.83 39.93 30.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.817 0.341 . . . . 0.0 110.542 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.35 105.01 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.817 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.26 -177.04 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.436 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -61.08 148.76 39.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.085 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 56.96 47.7 17.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -104.62 124.45 49.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.318 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.537 ' C ' HD12 ' D' ' 67' ' ' LEU . 94.4 m -74.66 130.73 40.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.537 HD12 ' C ' ' D' ' 66' ' ' THR . 7.9 mp -121.25 145.68 47.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -91.16 111.19 22.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.923 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.679 HD23 HG22 ' D' ' 7' ' ' THR . 64.4 tp -98.28 118.03 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.531 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.3 t -115.84 135.61 55.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.071 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.648 ' H ' HD11 ' D' ' 8' ' ' LEU . 49.0 mt -101.77 150.42 23.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.528 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -111.1 140.05 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.249 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mp -98.05 142.32 29.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -107.87 107.14 17.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.31 -132.67 52.67 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.67 157.99 33.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.083 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -97.05 126.18 42.02 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.332 0.587 . . . . 0.0 109.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 51' ' ' GLN . 86.3 mt -68.24 -38.58 81.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.092 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -145.64 161.45 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.88 179.136 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.7 122.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.23 158.98 41.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.071 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.75 121.21 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.945 0.402 . . . . 0.0 111.004 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.77 145.0 22.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.27 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.86 153.15 17.28 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -88.2 173.95 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.977 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.5 mtp -136.93 175.47 9.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.9 m -124.23 124.56 42.71 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.473 HD13 ' CG2' ' A' ' 38' ' ' VAL . 25.8 tp -106.35 116.94 32.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.47 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -120.02 110.53 16.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.795 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -90.46 0.47 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 p -140.18 23.09 2.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.608 0.242 . . . . 0.0 110.745 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.0 m -125.06 129.82 51.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.655 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.473 ' CG2' HD13 ' A' ' 33' ' ' LEU . 61.2 t -110.99 122.72 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.3 m -118.74 129.08 25.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.05 146.48 64.75 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.692 1.594 . . . . 0.0 113.183 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.93 136.32 39.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.791 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -71.16 -8.73 55.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.639 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.87 77.32 0.89 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -58.08 134.23 56.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.96 -160.79 9.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.679 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.7 tp -137.41 123.98 20.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -95.48 109.91 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.249 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -131.32 154.98 47.98 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.191 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -120.45 140.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.454 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.77 128.17 26.39 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.827 0.705 . . . . 0.0 110.35 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.75 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.7 tt0 -99.5 124.4 44.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 58' ' ' HIS . 10.7 p -84.63 172.14 11.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.65 -10.56 27.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.93 1.54 55.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.561 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t 70.24 21.05 6.01 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.309 0.576 . . . . 0.0 110.432 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.672 HD11 HG11 ' C' ' 70' ' ' VAL . 75.5 mt -98.76 121.56 40.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.622 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -80.22 121.23 33.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.461 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 52' ' ' THR . 70.2 m-70 -97.65 114.25 26.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.614 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -97.59 107.05 19.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.06 50.29 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.782 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -117.82 116.06 26.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.571 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -105.55 144.95 31.6 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.416 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.41 130.89 35.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.15 -18.69 62.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 110.755 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.1 m -59.41 -45.49 91.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.608 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.4 m -117.06 -11.85 10.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.972 0.415 . . . . 0.0 110.496 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 22.77 78.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.37 149.94 23.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.669 0.271 . . . . 0.0 110.448 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.58 102.19 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.07 -38.76 66.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.836 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -126.37 146.17 50.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.069 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.8 t0 -157.9 100.8 1.76 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.678 HD22 ' CG ' ' C' ' 48' ' ' LYS . 35.0 mt -126.86 135.93 51.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.976 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.2 mt -77.96 120.51 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.225 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.699 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.4 mm -110.5 121.48 63.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.236 0.541 . . . . 0.0 111.153 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.639 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 59.6 m-85 -85.08 163.04 47.38 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.799 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.53 140.21 92.61 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.105 1.87 . . . . 0.0 111.567 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t0 60.08 11.86 2.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.45 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -84.23 -26.26 28.82 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.863 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.699 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.7 p -150.76 168.69 23.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.523 0.678 . . . . 0.0 110.603 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -135.06 131.72 37.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.382 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -103.38 117.34 34.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -142.13 167.52 21.93 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.823 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -82.69 160.25 22.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.945 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -112.64 90.12 14.32 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.014 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.9 60.05 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.904 1.736 . . . . 0.0 112.347 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.52 -39.72 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.514 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.3 t -127.44 85.99 59.6 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.647 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.39 130.62 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.679 1.586 . . . . 0.0 111.671 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 169.29 -40.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.13 -157.9 7.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -104.52 109.23 21.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.21 129.02 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -126.54 153.24 45.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.36 135.34 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.589 HD11 ' SG ' ' A' ' 80' ' ' CYS . 66.2 tp -103.61 119.92 39.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -116.29 131.13 57.03 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.302 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -84.47 114.37 21.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.038 0.447 . . . . 0.0 109.988 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.41 -36.49 82.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.46 -24.01 66.37 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.294 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -137.82 -148.98 5.46 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.7 p -121.08 7.2 10.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.637 0.256 . . . . 0.0 111.014 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HE2' HD21 ' A' ' 105' ' ' LEU . 87.6 tttt -63.19 134.87 56.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -136.48 135.64 38.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.971 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.466 HD21 ' HE2' ' A' ' 103' ' ' LYS . 60.9 mt -119.55 145.01 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.517 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 33' ' ' LEU . 95.7 m-85 -116.36 131.66 56.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.724 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.6 154.84 51.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.237 0.542 . . . . 0.0 110.915 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -128.63 137.08 51.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.306 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.45 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 26.9 tpp -73.88 140.2 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.527 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.73 1.73 19.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 109' ' ' MET . 76.5 mm-40 -73.39 141.07 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.587 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -28.98 22.64 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.886 1.724 . . . . 0.0 112.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -119.1 143.63 47.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.477 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.2 p -97.73 6.01 48.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.021 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -58.2 -21.61 48.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -124.19 -14.18 7.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.046 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.32 -41.24 98.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.646 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.51 -40.35 96.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.75 -41.91 97.92 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.495 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.8 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.2 m170 -63.35 -40.61 97.77 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.49 0.662 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.19 -46.8 88.97 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -65.5 -36.96 85.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.314 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -33.46 67.54 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.275 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.3 t -60.63 -46.71 95.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.146 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.51 -31.96 53.83 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -71.04 -30.56 66.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.349 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -83.75 -29.73 27.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.91 0.386 . . . . 0.0 110.304 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.622 HD23 HG21 ' A' ' 57' ' ' ILE . 67.9 mt -87.75 -23.68 24.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.913 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -108.91 -24.42 11.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.52 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -135.73 67.79 65.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.37 160.27 49.18 Favored 'Trans proline' 0 C--N 1.297 -2.137 0 C-N-CA 122.849 2.366 . . . . 0.0 112.242 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.187 . . . . 0.0 112.228 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.35 151.11 77.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.46 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.19 147.8 26.56 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.181 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.78 152.82 89.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.011 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.67 152.15 64.4 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.392 2.061 . . . . 0.0 112.221 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.85 -174.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.421 2.08 . . . . 0.0 111.964 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -122.44 157.64 58.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.205 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.19 139.49 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 122.457 2.105 . . . . 0.0 111.709 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 165.15 37.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -86.08 138.41 31.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.419 HD13 HG21 ' B' ' 951' ' ' ILE . 3.8 mt -131.41 133.28 62.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -76.98 85.28 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.331 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.579 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' C' ' 16' ' ' GLU . 9.6 pt20 -62.1 157.65 18.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -139.41 148.15 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.933 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.79 124.21 40.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.777 0.322 . . . . 0.0 110.986 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.722 HG11 HD12 ' C' ' 69' ' ' LEU . 99.4 t -108.18 114.57 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.646 -0.421 . . . . 0.0 109.99 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -97.31 119.86 36.61 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.342 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.6 p -79.56 171.83 14.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.535 HD11 ' H ' ' C' ' 71' ' ' LEU . 56.9 mt -62.51 -24.85 67.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.171 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -75.57 -10.5 59.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.051 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.56 -14.48 64.16 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.62 133.09 49.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 110.34 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -107.56 132.19 53.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.389 . . . . 0.0 110.759 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.1 112.67 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.466 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.01 132.99 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.666 HD21 ' HG3' ' C' ' 33' ' ' LYS . 29.6 mt -130.96 122.24 26.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' C' ' 2' ' ' GLN . 8.7 pt-20 -66.81 115.17 6.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.1 163.45 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.589 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -107.3 152.7 41.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.634 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -37.16 87.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.922 1.748 . . . . 0.0 112.089 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -80.43 -9.57 59.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -58.51 136.0 57.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -77.61 158.97 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.134 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.497 HD12 HD13 ' C' ' 50' ' ' LEU . 46.8 mm -66.43 -40.98 87.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -59.13 -42.7 91.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.36 -43.97 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.303 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.16 -44.01 97.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -38.63 79.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.061 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.04 94.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.532 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.444 ' HE2' HD22 ' C' ' 15' ' ' LEU . 9.4 mtmm -61.68 -37.48 84.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.139 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.821 ' CD1' HD21 ' C' ' 43' ' ' LEU . 80.8 mt -64.25 -39.2 84.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -59.02 -39.97 83.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.366 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -86.95 7.29 28.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.666 ' HG3' HD21 ' C' ' 15' ' ' LEU . 2.0 mmtt -107.8 -47.62 3.56 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -116.54 -0.76 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.591 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 19.64 79.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.551 HG21 ' HB3' ' C' ' 41' ' ' GLN . 16.8 mm -81.43 119.96 76.96 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.133 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.26 149.3 65.24 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.065 1.843 . . . . 0.0 111.861 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -33.42 77.03 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.429 2.086 . . . . 0.0 112.65 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.05 7.68 39.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.395 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -108.33 -31.12 7.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.753 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.605 ' CB ' HD21 ' C' ' 69' ' ' LEU . 7.8 pt20 -99.22 131.53 45.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.498 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -122.95 115.35 21.77 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.821 HD21 ' CD1' ' C' ' 30' ' ' ILE . 70.0 mt -85.8 129.62 34.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.18 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt -131.87 129.16 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.326 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' PHE . . . . . 0.566 ' HB2' HD23 ' C' ' 67' ' ' LEU . 92.6 t80 -145.96 150.08 35.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.019 0.438 . . . . 0.0 111.456 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.92 20.12 11.25 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.022 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 84.32 -8.72 66.65 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.778 ' HE2' HD22 ' D' ' 73' ' ' LEU . 8.8 mtpt -107.9 137.22 46.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.972 0.415 . . . . 0.0 111.237 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -74.19 132.99 42.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.838 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.721 HD12 ' CB ' ' C' ' 43' ' ' LEU . 45.1 mt -74.95 98.66 3.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.53 141.23 43.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.819 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.68 142.86 52.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.99 -18.06 57.31 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -87.99 171.19 10.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.883 0.373 . . . . 0.0 110.476 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.8 p -115.46 163.52 15.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.131 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' C' ' 56' ' ' LEU . 77.9 mt -61.41 -40.96 96.32 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 94.7 p -63.79 -22.64 67.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.448 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.78 -37.82 85.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.95 0.405 . . . . 0.0 110.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' D' ' 73' ' ' LEU . 74.2 m-85 -98.37 15.47 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.245 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 58.98 41.8 20.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.586 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -88.39 109.99 20.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -95.51 178.37 5.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.453 0.644 . . . . 0.0 111.171 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -61.23 148.3 41.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.746 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 59.25 17.11 5.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.398 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -65.92 138.13 57.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 39.2 m -98.31 122.1 41.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' C' ' 45' ' ' PHE . 3.3 mp -116.57 148.22 41.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.554 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -92.19 133.19 36.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.722 HD12 HG11 ' C' ' 5' ' ' VAL . 1.9 tt -108.26 115.86 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.048 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.5 131.5 47.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.054 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.658 HD21 HD22 ' C' ' 69' ' ' LEU . 39.4 mt -106.1 132.92 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.536 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.0 145.21 46.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.24 148.87 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.551 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -62.46 -39.44 93.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.44 171.74 43.27 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.34 -40.29 98.42 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.2 p30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.719 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' GLN . . . . . 0.513 ' OE1' HG21 ' D' ' 14' ' ' THR . 5.4 pt20 -63.06 160.69 14.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.162 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -138.41 156.42 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.258 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.6 m-30 -96.29 125.37 40.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.709 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.45 107.35 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.913 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 122.78 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.093 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.424 HG23 ' O ' ' D' ' 11' ' ' LYS . 80.4 p -82.3 172.1 13.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.776 HD11 ' H ' ' D' ' 71' ' ' LEU . 88.1 mt -63.22 -26.02 68.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.179 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -86.6 -1.34 57.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.828 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 -8.72 77.83 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' LYS . . . . . 0.424 ' O ' HG23 ' D' ' 7' ' ' THR . 7.5 tmtm? -68.3 118.34 11.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.896 0.379 . . . . 0.0 110.107 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 74.6 m -90.99 137.38 32.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mt -122.48 119.0 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.116 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.573 HG23 ' CD2' ' D' ' 4' ' ' PHE . 1.1 m -86.47 117.8 25.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.702 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.89 123.39 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.94 113.06 7.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.707 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.6 m -133.05 160.52 42.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.276 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.45 152.98 40.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.926 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.1 -36.86 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 111.661 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -80.06 -9.7 59.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.303 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -57.93 138.43 55.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 47.0 p -81.03 163.11 23.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.174 0.511 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.861 HD12 HD23 ' D' ' 50' ' ' LEU . 43.5 mm -63.54 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.207 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.18 -39.4 86.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.875 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.529 HG21 HD21 ' D' ' 56' ' ' LEU . 52.9 t -63.03 -43.48 99.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.698 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -61.34 -39.38 90.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.053 0.454 . . . . 0.0 109.994 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.38 89.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.125 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.707 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.7 mttm -59.92 -38.91 83.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.6 ' CD1' HD21 ' D' ' 43' ' ' LEU . 80.1 mt -64.89 -39.87 87.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.71 -44.57 96.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.057 0.456 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.83 -13.25 59.95 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.911 -0.493 . . . . 0.0 112.065 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -105.92 -4.01 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -148.48 -37.19 0.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 110.459 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.01 11.8 36.08 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.535 HD13 ' CD2' ' D' ' 71' ' ' LEU . 41.4 mt -82.38 121.02 78.1 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 155.07 42.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.038 1.825 . . . . 0.0 111.745 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.11 -25.27 73.06 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.626 2.217 . . . . 0.0 112.528 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -95.01 7.02 47.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -118.35 9.77 12.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.894 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' D' ' 69' ' ' LEU . 26.8 pt20 -142.05 154.45 44.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 42' ' ' ARG . . . . . 0.475 ' NE ' HD11 ' D' ' 44' ' ' ILE . 58.0 ttp180 -134.22 129.62 35.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.747 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' D' ' 30' ' ' ILE . 67.0 mt -99.9 115.29 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.054 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.475 HD11 ' NE ' ' D' ' 42' ' ' ARG . 88.5 mt -121.47 117.07 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.326 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -64.71 -47.07 79.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.051 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -176.74 78.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.827 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.91 89.95 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -129.67 125.82 36.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.816 0.341 . . . . 0.0 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -82.71 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.476 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.861 HD23 HD12 ' D' ' 23' ' ' ILE . 7.9 mp -75.36 106.24 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.65 143.81 48.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.037 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.06 156.96 20.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.2 16.58 69.02 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.91 165.8 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 110.49 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -113.15 165.49 12.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.529 HD21 HG21 ' D' ' 26' ' ' VAL . 89.6 mt -61.26 -39.88 92.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.476 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.8 -26.41 68.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.53 -37.95 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.128 0.49 . . . . 0.0 110.186 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -95.03 13.62 24.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.056 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.16 40.81 27.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ILE . . . . . 0.833 HD11 HD21 ' D' ' 50' ' ' LEU . 87.0 mt -92.33 114.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -100.43 -169.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.395 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -68.86 151.54 46.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 56.72 37.57 28.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.625 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -86.87 123.58 32.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -80.15 124.3 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.55 132.78 54.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.149 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.71 123.79 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.918 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' D' ' 41' ' ' GLN . 65.9 tp -103.97 111.54 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.666 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.6 t -107.36 132.61 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.776 ' H ' HD11 ' D' ' 8' ' ' LEU . 58.4 mt -104.67 136.4 44.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 111.022 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.05 146.61 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.578 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.778 HD22 ' HE2' ' C' ' 48' ' ' LYS . 78.7 mt -95.23 14.59 21.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 120.53 9.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.928 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.71 15.56 79.39 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.528 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -66.91 151.74 47.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.425 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -99.62 126.98 45.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.391 0.615 . . . . 0.0 110.225 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 51' ' ' GLN . 85.6 mt -68.49 -37.34 80.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.072 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.1 p -147.31 161.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.756 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.53 122.68 0.36 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.183 0.515 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -153.72 158.32 40.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.084 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -74.77 120.92 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.619 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -152.51 145.32 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.112 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.42 152.48 17.83 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.46 171.4 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.413 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 28.6 mtp -132.63 174.47 10.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.0 m -122.7 123.22 40.61 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 37' ' ' THR . 26.9 tp -105.02 116.94 32.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.19 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -120.81 112.25 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.94 -92.45 0.46 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 p -138.35 23.28 2.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.678 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' HD12 ' A' ' 33' ' ' LEU . 88.3 m -125.32 131.73 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 33' ' ' LEU . 74.3 t -111.01 123.73 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.204 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.799 HG22 ' HB3' ' B' ' 947' ' ' PRO . 58.4 p -119.02 135.12 23.66 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.141 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.5 150.38 57.57 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.98 1.787 . . . . 0.0 113.356 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -105.49 140.07 39.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.156 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -76.35 -7.08 54.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -72.76 75.13 1.13 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -55.48 127.96 32.12 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.78 -159.12 9.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.2 tp -139.17 124.46 19.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 28' ' ' ALA . 41.1 t -96.53 109.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.346 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.0 p90 -131.57 154.25 49.03 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.018 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.2 mt -118.42 139.14 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.712 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 128.53 30.76 Favored 'General case' 0 C--O 1.22 -0.478 0 O-C-N 123.89 0.744 . . . . 0.0 110.35 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.757 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.8 tt0 -99.42 125.3 45.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.977 0.417 . . . . 0.0 109.956 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.6 p -85.56 170.39 12.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.384 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -62.79 -10.62 13.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.166 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.5 2.62 54.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.475 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t 69.63 20.62 6.94 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.208 0.528 . . . . 0.0 110.401 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 74.9 mt -97.32 121.97 39.82 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.476 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -81.88 120.06 32.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.7 m-70 -96.9 111.53 23.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.114 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -90.58 108.24 19.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 74.2 m -121.02 145.98 47.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.648 . . . . 0.0 112.627 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -124.39 112.84 17.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.435 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -104.86 135.23 46.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.028 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -74.79 136.69 41.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.874 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -78.9 -17.77 54.98 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.537 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -60.84 -46.64 89.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -117.02 -13.02 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.95 24.94 75.01 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -102.01 144.48 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 0.0 110.673 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.16 105.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.27 -28.11 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.008 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -127.69 144.05 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.196 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.6 p30 -159.49 95.9 1.25 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.87 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.673 HD22 ' HG2' ' C' ' 48' ' ' LYS . 41.3 mt -123.13 138.01 54.77 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.821 0.343 . . . . 0.0 110.727 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 86.1 mt -83.21 116.8 27.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.496 ' HB ' HD22 ' A' ' 128' ' ' LEU . 1.2 mp -105.52 116.65 49.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.957 0.408 . . . . 0.0 111.139 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.585 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 44.7 m-85 -79.69 164.17 54.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.988 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.08 139.68 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.95 1.767 . . . . 0.0 111.041 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.59 11.82 3.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -85.91 -42.2 14.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.481 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.473 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -130.85 148.17 52.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.0 111.364 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -122.02 129.56 52.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.663 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -101.78 118.46 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -144.06 167.94 21.18 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.767 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -94.68 146.25 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.288 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.39 99.58 21.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.221 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.81 60.09 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.741 1.627 . . . . 0.0 112.223 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -114.35 -36.34 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.246 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 p -121.94 74.35 37.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.711 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.02 130.27 26.92 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.103 1.869 . . . . 0.0 111.745 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.98 -43.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.905 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.93 -139.61 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.47 106.38 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.3 127.31 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.82 156.21 35.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 105' ' ' LEU . 10.5 p -131.7 137.52 54.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.473 HD11 ' SG ' ' A' ' 80' ' ' CYS . 60.3 tp -105.69 119.92 40.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -119.61 139.18 52.59 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.991 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -88.78 115.81 26.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.62 -37.19 83.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.526 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.98 -22.86 24.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.176 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.51 -169.28 21.9 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.1 m -124.0 17.96 9.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.771 ' HD3' HD21 ' A' ' 105' ' ' LEU . 30.5 ttmt -89.64 138.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.27 0.557 . . . . 0.0 111.087 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.49 109.25 10.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.771 HD21 ' HD3' ' A' ' 103' ' ' LYS . 50.7 mt -96.0 150.4 20.51 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.45 ' CE1' HD22 ' A' ' 33' ' ' LEU . 88.3 m-85 -123.94 136.48 54.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.258 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.06 155.7 49.33 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.316 0.579 . . . . 0.0 111.118 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -128.32 137.45 51.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.838 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.1 tpp -75.82 123.95 26.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.242 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -16.81 34.72 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.7 127.29 88.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.28 -20.05 43.33 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.94 1.76 . . . . 0.0 112.724 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.54 140.4 47.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.132 0.491 . . . . 0.0 110.317 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.9 p -99.12 10.88 40.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.09 -26.42 49.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.379 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.444 ' NE2' ' OE1' ' A' ' 119' ' ' GLU . 29.9 mm100 -126.03 -0.69 7.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.805 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.73 -48.56 80.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.77 -40.91 97.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.444 ' OE1' ' NE2' ' A' ' 116' ' ' GLN . 88.4 tt0 -64.07 -42.67 96.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.807 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.784 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.4 m170 -64.79 -39.65 93.94 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.511 0.672 . . . . 0.0 109.213 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.82 -45.72 92.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.558 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -64.37 -43.47 94.43 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.212 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.25 -38.1 87.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.1 t -58.89 -48.08 87.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.164 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -80.61 -32.51 36.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.04 -38.18 87.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.571 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -80.62 -37.78 30.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.005 0.431 . . . . 0.0 110.258 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 75' ' ' ILE . 77.0 mt -71.53 -34.41 70.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.115 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -100.89 -24.13 14.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.677 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -139.99 69.04 35.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.746 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.83 160.49 49.23 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.916 2.411 . . . . 0.0 112.28 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.649 2.233 . . . . 0.0 112.248 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.67 81.99 68.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.724 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 138.88 83.81 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.808 2.339 . . . . 0.0 112.249 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.04 159.26 71.17 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.84 146.65 77.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.41 -173.96 1.29 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.541 2.161 . . . . 0.0 112.189 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -100.33 153.35 37.8 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.389 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.799 ' HB3' HG22 ' A' ' 39' ' ' THR . 43.2 Cg_endo -68.83 152.04 73.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.491 2.127 . . . . 0.0 112.084 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.43 168.74 25.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.35 132.14 34.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.82 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -113.37 136.04 53.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.079 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.44 129.93 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.585 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.24 85.89 0.26 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.338 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.054 -0.975 . . . . 0.0 110.49 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -62.45 160.34 13.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -139.31 149.97 22.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.614 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -91.86 119.82 31.99 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.263 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.422 ' CG1' HD12 ' C' ' 69' ' ' LEU . 69.4 t -104.36 108.64 25.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.07 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -92.75 122.31 35.03 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.889 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.0 p -81.56 171.5 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.593 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.645 HD11 ' H ' ' C' ' 71' ' ' LEU . 62.3 mt -65.54 -21.34 66.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.047 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.25 -5.88 58.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.343 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.49 74.68 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -74.16 128.8 36.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.844 0.322 . . . . 0.0 110.236 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.48 132.16 47.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.07 111.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.438 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -81.44 126.99 32.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.71 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' C' ' 29' ' ' LYS . 79.0 mt -120.03 129.82 54.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.66 116.58 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.441 HG12 ' HE2' ' C' ' 29' ' ' LYS . 21.0 m -136.13 165.63 28.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.706 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.405 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.2 mt-10 -110.32 154.14 43.06 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.42 -30.61 91.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.72 1.613 . . . . 0.0 111.965 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.3 m -88.86 -6.5 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.27 144.21 57.31 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.812 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.91 163.86 23.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.3 mm -63.04 -38.56 82.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.786 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -58.96 -40.89 86.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.41 -46.37 90.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.566 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.449 HG21 HD21 ' C' ' 56' ' ' LEU . 74.7 t -60.71 -42.66 92.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.04 -37.04 78.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.33 95.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' C' ' 15' ' ' LEU . 0.9 OUTLIER -59.35 -39.31 82.81 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.228 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' C' ' 43' ' ' LEU . 80.8 mt -65.15 -39.36 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.445 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -60.12 -43.05 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.43 19.31 6.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.47 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -123.72 -42.88 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.374 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -116.84 -18.95 10.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.575 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.26 10.81 65.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.515 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.402 HD13 ' CD2' ' C' ' 71' ' ' LEU . 52.0 mt -75.04 128.03 85.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.77 154.23 63.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.502 1.468 . . . . 0.0 111.02 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.64 -23.42 65.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.2 1.933 . . . . 0.0 111.968 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.85 -1.69 52.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.013 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -123.31 -31.49 3.55 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.52 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -78.8 132.84 37.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.318 0.58 . . . . 0.0 111.449 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -130.43 126.74 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.397 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' C' ' 30' ' ' ILE . 77.3 mt -103.39 124.71 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.961 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.508 HG21 ' HE1' ' A' ' 76' ' ' PHE . 80.5 mt -129.38 129.08 67.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.293 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -144.39 149.41 36.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.899 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.6 16.72 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.396 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.26 -14.95 59.56 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.771 ' HD2' HD22 ' D' ' 73' ' ' LEU . 9.7 mttt -98.94 141.49 31.64 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.449 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -75.43 127.27 32.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.751 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' C' ' 43' ' ' LEU . 48.3 mt -76.09 89.49 3.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -74.97 171.37 14.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -75.81 169.0 18.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.079 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.42 19.49 77.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -124.53 167.2 14.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.687 0.279 . . . . 0.0 110.585 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -122.71 161.22 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.578 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.449 HD21 HG21 ' C' ' 26' ' ' VAL . 80.6 mt -60.89 -40.51 93.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.8 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.62 -23.0 67.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.561 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.2 -38.06 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.017 0.437 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.505 ' CE2' HD13 ' D' ' 73' ' ' LEU . 71.1 m-85 -97.18 13.2 30.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.151 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 59.05 41.08 21.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.257 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.35 118.4 33.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.912 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -107.07 178.38 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.002 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -59.53 146.59 40.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.807 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 61.49 18.6 9.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 27.5 t -71.6 131.09 42.71 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 93.6 m -83.91 127.89 34.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -116.5 144.1 44.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.201 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -92.33 123.64 35.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.056 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.612 HD22 HD21 ' C' ' 71' ' ' LEU . 1.8 tt -102.8 115.25 30.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.127 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 56' ' ' LEU . 68.4 t -108.96 132.82 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.645 ' H ' HD11 ' C' ' 8' ' ' LEU . 33.3 mt -105.84 135.35 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -70.8 148.64 47.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.67 152.05 40.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.6 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.64 -39.11 90.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.321 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.1 141.01 42.61 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.07 89.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.343 179.699 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.29 158.19 12.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.771 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -138.42 151.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.859 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.447 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.0 m-30 -92.69 122.92 35.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.711 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.68 109.95 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.694 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -94.52 122.3 36.95 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.088 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.649 HG22 HD23 ' D' ' 69' ' ' LEU . 77.0 p -82.19 -179.08 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.321 0.581 . . . . 0.0 111.632 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.747 HD11 ' H ' ' D' ' 71' ' ' LEU . 85.0 mt -61.58 -37.06 82.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.825 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.14 -8.99 57.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.262 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.92 -9.12 70.6 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.81 128.0 34.13 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -102.05 130.54 48.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.118 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.41 HG21 HD13 ' D' ' 13' ' ' ILE . 1.3 mt -124.37 113.86 38.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.743 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.447 HG23 ' CD2' ' D' ' 4' ' ' PHE . 10.6 m -80.03 125.78 30.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.757 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.25 118.25 30.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.281 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.19 110.29 2.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.299 0.571 . . . . 0.0 110.715 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.673 HG12 ' HE2' ' D' ' 29' ' ' LYS . 29.3 m -133.81 160.82 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -103.58 155.02 37.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.997 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 -38.37 95.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.124 1.883 . . . . 0.0 111.996 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.7 p -80.0 -8.78 59.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.026 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -58.7 135.74 57.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.979 0.418 . . . . 0.0 110.89 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.14 163.45 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.547 HD12 HD13 ' D' ' 50' ' ' LEU . 50.0 mm -64.23 -37.92 81.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.98 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.66 -43.81 89.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.99 -42.3 98.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 110.754 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.465 HG22 HG11 ' D' ' 17' ' ' VAL . 61.2 t -62.9 -42.38 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.923 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -60.64 -39.56 88.74 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.109 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.03 88.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.673 ' HE2' HG12 ' D' ' 17' ' ' VAL . 62.9 mttp -59.71 -38.98 83.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.813 ' CD1' HD21 ' D' ' 43' ' ' LEU . 87.3 mt -64.77 -40.58 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.931 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.69 -47.0 87.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.28 -15.94 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -103.57 -4.84 23.36 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.59 -37.65 0.2 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.78 10.42 32.82 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.618 HD13 ' CD2' ' D' ' 71' ' ' LEU . 49.9 mt -77.82 127.45 82.01 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.17 155.98 42.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.168 1.245 . . . . 0.0 110.728 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.78 -36.69 83.23 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.063 1.842 . . . . 0.0 112.468 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.14 -39.01 88.43 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.311 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -96.65 23.26 7.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.551 ' HG3' HG22 ' D' ' 36' ' ' ILE . 36.9 mt-30 -118.29 112.32 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 111.712 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -118.64 110.61 17.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.813 HD21 ' CD1' ' D' ' 30' ' ' ILE . 78.0 mt -97.7 117.12 31.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.417 HG23 ' C ' ' D' ' 48' ' ' ARG . 85.1 mt -121.82 126.58 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 85.5 t80 -127.68 130.14 48.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.7 29.13 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 17.16 79.69 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.417 ' C ' HG23 ' D' ' 44' ' ' ILE . 44.2 ttm180 -132.66 127.91 35.89 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.573 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -66.54 148.07 52.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.06 0.457 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.547 HD13 HD12 ' D' ' 23' ' ' ILE . 77.2 mt -90.21 115.36 27.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.882 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -70.01 136.7 50.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -61.31 136.94 58.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.198 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.62 55.72 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -82.25 172.58 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -118.27 163.21 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.89 -39.48 89.42 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.402 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.2 p -63.81 -24.35 67.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.3 . . . . 0.0 110.414 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.95 -37.75 85.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.327 0.584 . . . . 0.0 110.044 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -98.14 14.53 27.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.282 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 m120 56.83 39.94 29.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.829 0.347 . . . . 0.0 110.278 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -90.14 113.75 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.856 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -99.33 -172.25 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.531 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -68.79 150.75 47.49 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.273 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 56.85 41.77 27.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -98.5 127.45 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.559 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.51 ' C ' HD12 ' D' ' 67' ' ' LEU . 90.3 m -78.22 127.53 32.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.51 HD12 ' C ' ' D' ' 66' ' ' THR . 8.5 mp -118.57 138.4 52.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.921 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -89.07 113.96 25.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.649 HD23 HG22 ' D' ' 7' ' ' THR . 48.5 tp -99.46 120.53 39.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.695 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.5 t -112.97 132.75 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.747 ' H ' HD11 ' D' ' 8' ' ' LEU . 24.4 mt -105.0 128.94 53.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.455 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.74 141.2 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 110.947 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.771 HD22 ' HD2' ' C' ' 48' ' ' LYS . 33.0 mt -103.64 16.04 27.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.612 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -58.61 -45.05 90.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.881 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.18 9.67 22.68 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.617 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -84.05 146.65 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -86.15 112.41 21.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.4 mt -68.32 -37.02 80.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.606 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -147.65 161.7 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.26 122.24 0.29 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 0.0 110.834 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.04 160.07 40.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.696 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.8 mtm-85 -78.66 124.05 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.046 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.75 146.03 20.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.86 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.47 152.12 17.19 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -95.52 161.9 13.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.875 0.369 . . . . 0.0 111.13 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mtm -134.81 170.27 16.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -121.09 135.92 55.08 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.403 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 37' ' ' THR . 29.6 tp -110.97 119.36 38.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.947 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -120.75 112.38 18.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.85 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -106.54 1.81 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.6 p -124.06 20.86 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.292 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.563 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.0 m -124.61 130.32 52.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 110.798 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.561 HG22 HD13 ' A' ' 33' ' ' LEU . 62.1 t -107.71 121.28 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -108.77 131.55 21.71 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.95 145.4 45.08 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.062 1.842 . . . . 0.0 113.35 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.12 120.74 42.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -65.23 -11.32 39.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -72.31 78.84 1.0 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -58.83 140.13 55.55 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.98 -157.3 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.815 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.0 tp -135.31 127.93 30.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.37 111.77 32.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.546 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -136.09 156.29 48.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.231 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.7 mt -122.24 137.7 54.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.873 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -135.06 130.56 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.632 0.583 . . . . 0.0 110.112 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.668 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.4 tt0 -100.7 124.15 45.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.107 0.48 . . . . 0.0 110.085 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.507 HG23 ' CD2' ' A' ' 58' ' ' HIS . 17.7 p -85.34 171.59 11.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.49 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.02 -10.34 21.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.116 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.93 1.09 55.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.282 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t 69.12 21.74 7.14 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.312 0.577 . . . . 0.0 110.252 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.844 HD11 HG11 ' C' ' 70' ' ' VAL . 83.6 mt -98.28 122.72 41.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.439 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.1 mm -81.99 122.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.507 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.0 m-70 -98.17 112.67 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.851 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -92.15 109.29 20.65 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 77.9 m -121.74 145.96 47.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -128.3 117.86 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.53 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -108.68 143.81 37.28 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.348 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -80.98 129.21 34.42 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -71.34 -16.64 62.44 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 m -59.4 -45.35 91.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.429 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.1 m -117.22 -13.27 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 110.182 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.79 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -101.72 152.04 21.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.04 103.86 6.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -77.97 -32.93 51.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -126.68 146.1 50.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.538 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 73' ' ' LEU . 68.2 t0 -157.68 98.73 1.67 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.052 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.702 HD22 ' HG2' ' C' ' 48' ' ' LYS . 28.3 mt -127.64 133.85 49.65 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.501 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -79.09 123.92 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.421 ' HB ' HD22 ' A' ' 128' ' ' LEU . 29.0 mm -112.23 129.5 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 111.103 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.508 ' HE1' HG21 ' C' ' 44' ' ' ILE . 59.3 m-85 -94.14 162.51 26.33 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.436 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.76 140.67 91.56 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.172 1.915 . . . . 0.0 111.658 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 60.71 12.26 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -88.4 -35.24 17.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.977 0.418 . . . . 0.0 110.401 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -135.51 148.36 49.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.179 0.514 . . . . 0.0 111.561 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -122.61 127.68 49.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.455 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -100.57 120.63 40.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -145.37 167.13 23.63 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.792 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -92.14 159.27 15.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.889 0.376 . . . . 0.0 110.217 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 t -120.95 89.83 46.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.382 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.31 60.45 7.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.81 1.674 . . . . 0.0 112.169 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.69 -34.3 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.172 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.5 t -124.91 86.78 56.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.54 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.48 129.91 19.94 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.771 1.647 . . . . 0.0 111.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.98 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.33 -176.77 33.8 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.521 ' NE ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -86.03 110.36 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.42 126.53 72.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -121.95 152.82 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.233 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.9 p -128.04 135.79 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.212 0.529 . . . . 0.0 109.904 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.453 HD11 ' SG ' ' A' ' 80' ' ' CYS . 61.5 tp -104.76 118.22 36.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -115.29 132.47 56.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 111.29 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 54.5 m-85 -86.65 115.56 24.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.58 -37.14 82.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.318 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -108.68 -23.36 11.83 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.362 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -63.86 -33.7 87.94 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.76 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p 74.05 27.89 1.54 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.621 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -139.45 162.11 35.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.491 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -138.69 149.42 45.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.464 . . . . 0.0 111.2 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 95' ' ' VAL . 46.1 mt -125.24 150.82 46.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' A' ' 33' ' ' LEU . 94.1 m-85 -120.3 135.92 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.501 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -137.34 156.38 48.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.191 0.519 . . . . 0.0 111.223 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -133.75 137.17 45.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.826 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttm -74.67 131.73 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.946 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.47 4.31 26.04 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.709 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -71.86 148.73 92.37 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.424 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.89 -27.6 14.29 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.099 1.866 . . . . 0.0 112.967 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -119.51 142.18 48.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.31 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.521 HG22 ' NE ' ' A' ' 92' ' ' ARG . 79.8 p -98.31 8.46 44.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.491 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.58 -22.47 13.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.351 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -123.73 8.11 8.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.579 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -61.16 -49.1 78.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.47 -40.5 95.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.209 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.77 -43.31 99.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.614 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.5 m170 -64.18 -40.13 95.46 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.92 94.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.792 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -65.65 -43.34 89.75 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.245 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.46 -39.33 93.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.887 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.3 t -59.14 -47.78 89.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.233 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.33 -27.88 38.25 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.82 -38.71 80.06 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.55 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -81.18 -33.23 33.16 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.64 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 75' ' ' ILE . 67.5 mt -77.96 -28.63 49.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -104.83 -26.87 12.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.319 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.7 72.84 73.09 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.313 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.411 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.1 Cg_exo -59.77 149.14 84.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.799 2.333 . . . . 0.0 111.573 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 122.175 1.916 . . . . 0.0 112.182 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 -72.08 154.35 92.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.449 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.16 153.88 66.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.829 2.352 . . . . 0.0 112.638 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.37 155.05 94.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.725 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.83 157.32 62.34 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.176 1.917 . . . . 0.0 112.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.74 176.94 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.224 . . . . 0.0 111.622 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.05 157.62 42.99 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.856 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 145.27 99.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.225 1.95 . . . . 0.0 111.788 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -158.07 169.3 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.09 137.86 32.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.185 0.517 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.9 121.49 38.18 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.471 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 63.4 mt -130.49 125.61 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -75.46 83.76 2.54 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.053 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.608 179.67 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -62.08 156.09 22.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.019 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.97 148.83 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.27 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -90.21 123.86 34.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.443 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.55 114.73 47.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.195 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -103.02 123.07 45.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.644 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.3 p -84.1 172.5 11.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.069 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.54 HD11 ' H ' ' C' ' 71' ' ' LEU . 73.4 mt -64.35 -25.47 68.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -74.28 -8.89 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.22 6.11 66.91 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.25 127.95 34.27 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.788 0.327 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -104.54 131.76 51.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.916 0.389 . . . . 0.0 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 117.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.295 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -83.72 130.14 34.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.447 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' C' ' 33' ' ' LYS . 90.7 mt -123.24 122.95 39.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.775 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -66.13 110.77 3.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.744 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.503 HG12 ' HE3' ' C' ' 29' ' ' LYS . 22.4 m -134.23 163.44 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.447 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -106.09 154.35 39.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.98 -35.37 94.33 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.033 1.822 . . . . 0.0 112.17 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -84.78 -3.83 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.01 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -60.15 136.55 58.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 110.775 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.44 162.19 26.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.54 -38.32 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.12 -43.27 91.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.243 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.43 -41.63 98.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 110.909 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.7 -42.69 96.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.742 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' C' ' 43' ' ' LEU . 58.2 mtmt -60.41 -39.32 86.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -40.26 93.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.379 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.519 ' HB3' HD22 ' C' ' 15' ' ' LEU . 66.6 mttm -60.22 -39.68 87.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.543 HG21 HD11 ' C' ' 69' ' ' LEU . 96.8 mt -66.54 -39.8 84.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.211 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -59.49 -39.63 84.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 0.0 110.284 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.07 -44.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.701 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.617 ' HG3' HD21 ' C' ' 15' ' ' LEU . 19.7 mttt -70.82 -39.7 72.89 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -132.94 152.03 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.67 2.22 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.553 HG22 ' HB2' ' C' ' 41' ' ' GLN . 41.3 mm -117.39 94.91 46.46 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.36 149.62 80.08 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.73 2.287 . . . . 0.0 112.232 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -52.62 -40.06 74.08 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.962 1.774 . . . . 0.0 112.387 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.57 -39.54 94.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -99.03 31.86 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.706 ' HG3' HD21 ' C' ' 69' ' ' LEU . 12.9 tt0 -136.04 120.42 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.842 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -128.67 115.0 17.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.53 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.501 ' CB ' HD12 ' C' ' 50' ' ' LEU . 27.0 mt -92.89 132.31 37.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.151 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -129.46 128.61 66.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -144.27 151.39 39.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.869 0.366 . . . . 0.0 110.999 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 15.81 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.469 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.64 63.21 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.727 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.1 OUTLIER -107.72 141.45 39.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.05 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -72.3 132.98 44.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.501 HD12 ' CB ' ' C' ' 43' ' ' LEU . 51.0 mt -77.06 100.29 5.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.681 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.61 144.64 41.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.258 0.552 . . . . 0.0 110.765 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.0 141.01 57.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.338 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.19 54.56 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -84.26 178.53 7.75 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.333 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -126.54 165.59 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.45 HD22 HG21 ' C' ' 61' ' ' ILE . 84.8 mt -62.71 -40.42 97.12 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.668 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.6 -26.67 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.99 -36.94 82.99 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 110.245 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.5 ' CE2' HD13 ' D' ' 73' ' ' LEU . 76.0 m-85 -97.69 13.8 29.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.162 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.33 43.56 28.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.443 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.45 HG21 HD22 ' C' ' 56' ' ' LEU . 57.6 mt -89.74 103.8 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.4 -179.39 5.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -63.28 148.98 46.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.007 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 59.51 44.33 14.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -102.83 127.93 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.432 ' C ' HD12 ' C' ' 67' ' ' LEU . 86.0 m -77.58 127.76 33.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.432 HD12 ' C ' ' C' ' 66' ' ' THR . 7.2 mp -116.29 145.69 42.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -98.19 123.16 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.374 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.747 HD22 HD21 ' C' ' 71' ' ' LEU . 1.7 tt -100.27 126.0 46.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.61 ' N ' HD23 ' C' ' 69' ' ' LEU . 93.9 t -108.75 131.03 60.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.444 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.747 HD21 HD22 ' C' ' 69' ' ' LEU . 33.1 mt -112.17 147.72 35.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.719 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.04 133.14 52.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.817 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -113.77 145.72 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.608 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -123.21 139.57 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.596 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.99 -173.65 54.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 19.03 79.91 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.522 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -65.67 159.08 25.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.39 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.561 HD13 HD21 ' D' ' 56' ' ' LEU . 15.0 pt -137.9 141.4 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.219 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.594 ' HD2' HG21 ' D' ' 12' ' ' THR . 4.2 m-85 -84.26 123.88 30.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.884 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -110.11 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.818 0.342 . . . . 0.0 110.505 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -92.9 122.28 35.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.807 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -82.86 179.13 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.762 HD11 ' H ' ' D' ' 71' ' ' LEU . 85.0 mt -62.74 -35.85 81.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.27 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 42.8 p -67.42 -11.41 57.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.727 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.1 -9.94 67.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.4 129.6 40.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.594 HG21 ' HD2' ' D' ' 4' ' ' PHE . 98.9 m -101.52 132.18 47.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 110.807 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -127.11 105.79 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.611 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -81.88 127.11 32.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' D' ' 29' ' ' LYS . 86.5 mt -122.04 127.73 50.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.698 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.19 114.6 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.713 HG12 ' HE3' ' D' ' 29' ' ' LYS . 16.4 m -137.07 171.92 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.5 155.24 56.75 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.087 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.9 -39.41 84.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.128 1.886 . . . . 0.0 112.313 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -24.33 63.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.17 136.97 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.49 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -85.49 165.89 16.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.329 0.585 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.51 HD12 HD13 ' D' ' 50' ' ' LEU . 43.8 mm -63.38 -37.66 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.846 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.76 -42.15 88.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.856 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.11 -41.11 97.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.506 HG21 HD11 ' D' ' 56' ' ' LEU . 53.4 t -62.96 -42.97 98.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.878 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.59 -40.41 91.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.162 0.506 . . . . 0.0 110.485 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.713 ' HE3' HG12 ' D' ' 17' ' ' VAL . 64.8 mttm -59.31 -38.67 80.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.825 ' CD1' HD21 ' D' ' 43' ' ' LEU . 96.9 mt -64.5 -38.37 82.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.849 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -59.11 -38.99 80.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.23 -59.43 3.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.802 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.552 ' HD2' HD21 ' D' ' 15' ' ' LEU . 69.4 mttt -63.55 -41.49 98.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.03 142.52 50.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.095 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.97 60.28 3.04 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' D' ' 41' ' ' GLN . 2.9 mt -115.26 122.01 33.93 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.231 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 159.29 49.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.476 1.451 . . . . 0.0 111.649 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.3 -37.32 70.8 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.149 1.899 . . . . 0.0 112.563 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.69 -39.88 93.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.555 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -85.39 -11.33 54.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.367 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' D' ' 36' ' ' ILE . 91.4 mt-30 -86.6 83.19 7.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.008 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -98.28 98.93 10.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.825 HD21 ' CD1' ' D' ' 30' ' ' ILE . 73.5 mt -86.81 122.64 30.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.443 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.26 126.79 71.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.006 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.444 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.3 t80 -128.61 130.26 47.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.0 28.35 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.95 79.01 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -131.01 129.53 42.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.5 139.16 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.51 HD13 HD12 ' D' ' 23' ' ' ILE . 85.8 mt -82.96 118.68 23.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.11 137.32 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.315 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -66.73 147.54 53.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.179 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.58 -13.68 63.39 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -88.44 149.12 23.85 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -87.66 165.58 15.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.064 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.561 HD21 HD13 ' D' ' 3' ' ' ILE . 5.4 mp -66.72 -36.13 81.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.722 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -62.01 -27.02 68.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.727 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.22 -37.55 85.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.125 0.488 . . . . 0.0 110.285 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -95.74 11.81 32.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 55.26 41.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.14 103.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -90.03 -176.8 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -63.32 152.16 38.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 55.5 40.1 31.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.4 t -90.31 120.44 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.444 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.434 ' C ' HD12 ' D' ' 67' ' ' LEU . 61.6 m -75.42 127.09 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.163 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.434 HD12 ' C ' ' D' ' 66' ' ' THR . 7.1 mp -118.76 145.97 45.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 67.9 m170 -92.97 117.76 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.098 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.703 HD11 HD13 ' D' ' 30' ' ' ILE . 0.4 OUTLIER -97.84 99.46 10.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.371 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' D' ' 8' ' ' LEU . 73.3 t -90.78 135.57 26.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.382 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.762 ' H ' HD11 ' D' ' 8' ' ' LEU . 50.0 mt -111.82 161.71 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.442 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -76.33 -173.43 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.727 HD22 ' HE2' ' C' ' 48' ' ' LYS . 83.6 mt -65.42 -13.4 58.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.639 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 11.6 mmm-85 -41.27 120.15 1.34 Allowed 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.148 0.499 . . . . 0.0 110.388 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.38 7.9 34.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 179.33 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.1 m120 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -82.41 152.15 26.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.461 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -91.42 111.94 23.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.0 mt -65.75 -37.79 87.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.597 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -150.62 162.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.363 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.16 122.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.0 111.127 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.68 158.28 36.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.919 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -75.53 121.3 22.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.411 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.13 140.9 20.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.026 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.65 151.98 17.14 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -88.6 170.93 10.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 0.0 111.248 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 mtp -135.65 174.21 10.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.757 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -124.71 121.62 35.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 37' ' ' THR . 32.8 tp -102.91 121.78 43.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.904 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -118.83 104.1 10.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.029 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 -82.54 0.8 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -144.8 18.03 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.492 0.187 . . . . 0.0 110.95 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.656 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.2 m -119.99 128.01 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 33' ' ' LEU . 58.1 t -107.84 122.97 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.227 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.8 m -117.12 130.11 24.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.352 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.13 148.89 70.15 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.104 1.869 . . . . 0.0 113.229 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.77 136.04 45.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.91 -7.37 50.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.19 63.61 3.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -51.26 141.18 15.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.302 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.55 -153.37 6.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.369 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.1 tp -137.96 125.58 22.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.43 108.48 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.6 153.44 48.89 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.231 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' CG1' HG12 ' A' ' 24' ' ' VAL . 98.2 mt -119.17 138.55 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.469 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 129.87 31.78 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.806 0.691 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.546 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.9 tt0 -99.94 123.79 44.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.51 . . . . 0.0 110.387 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.0 p -83.62 170.23 14.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.706 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.48 -10.09 10.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.169 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.95 3.06 55.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.64 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 69.53 20.12 7.23 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.325 0.583 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 73.8 mt -96.35 121.66 38.39 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.521 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.3 mm -81.22 120.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.487 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.2 m-70 -97.49 114.49 26.37 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.347 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -99.25 107.23 19.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.798 0.809 . . . . 0.0 112.827 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -118.72 113.53 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.827 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -101.57 126.87 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -73.58 133.26 43.49 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -76.54 -18.45 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.4 m -60.47 -45.36 94.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.033 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -116.47 -16.62 10.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.973 0.416 . . . . 0.0 109.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.34 78.91 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.21 145.02 30.57 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.5 104.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 0.0 109.9 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -80.93 -33.61 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -127.13 142.99 51.38 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.865 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.3 t0 -158.72 95.53 1.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.31 0.381 . . . . 0.0 110.162 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.658 HD22 ' CG ' ' C' ' 48' ' ' LYS . 40.2 mt -124.7 137.25 54.36 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.079 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -79.57 118.4 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.725 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.0 mm -108.06 121.27 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.801 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 49.5 m-85 -84.66 160.5 55.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.153 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.02 144.91 99.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.004 1.803 . . . . 0.0 111.555 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 60.06 12.96 3.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.14 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.84 -25.77 17.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.536 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 75' ' ' ILE . 11.7 p -149.12 166.22 29.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.321 0.582 . . . . 0.0 110.575 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.411 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.9 tt0 -136.89 133.99 36.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.101 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -104.33 118.28 36.24 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -144.77 167.86 21.58 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.532 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -87.73 160.41 18.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.438 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.8 89.15 15.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.212 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.42 60.46 7.86 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.056 1.837 . . . . 0.0 112.111 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -114.02 -37.34 4.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.1 t -126.63 80.11 70.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.609 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.14 129.76 37.03 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.082 1.855 . . . . 0.0 111.186 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.52 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.858 0.724 . . . . 0.0 110.243 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.85 177.16 32.29 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -86.07 114.33 22.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.625 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.06 129.69 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.42 151.48 40.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.875 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.5 p -130.95 134.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.635 HD11 ' SG ' ' A' ' 80' ' ' CYS . 65.5 tp -100.45 120.07 39.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -115.96 131.97 56.79 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.28 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -82.73 111.99 19.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.267 0.556 . . . . 0.0 109.798 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -37.72 84.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.483 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 -20.54 23.14 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.261 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.82 177.42 27.92 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.2 p -114.14 23.36 12.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 153.72 46.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.855 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 157.09 46.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 95' ' ' VAL . 36.7 mt -118.49 156.24 29.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.873 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 91.1 m-85 -124.6 136.38 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -139.17 155.7 47.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.339 0.59 . . . . 0.0 111.247 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -128.99 137.45 51.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.4 tpp -67.8 132.45 47.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -2.89 15.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.0 146.6 97.44 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.231 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.27 -28.9 12.0 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.979 1.786 . . . . 0.0 113.155 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -118.59 144.73 45.92 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.633 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 p -100.49 12.27 37.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.734 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.28 -22.22 64.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.647 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -131.31 -6.63 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.837 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.81 -42.54 99.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.82 -39.8 91.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.0 111.305 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.86 -41.41 95.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.197 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.785 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.0 m170 -61.34 -40.05 92.84 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.552 0.692 . . . . 0.0 109.204 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.25 -44.91 94.87 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.644 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -62.65 -42.69 99.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.058 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -65.27 -35.64 81.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.018 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 120' ' ' HIS . 71.0 t -57.21 -48.02 83.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.021 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.42 -31.08 48.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.561 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.65 -27.18 64.83 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.042 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -92.52 -23.81 18.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.473 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.4 mt -95.24 -17.58 21.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -18.72 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.366 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -134.48 63.1 58.67 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.038 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.52 159.11 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.834 2.356 . . . . 0.0 112.457 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 122.664 2.243 . . . . 0.0 112.139 -179.427 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -92.92 153.1 41.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.21 145.82 31.18 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.565 2.177 . . . . 0.0 112.006 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -80.37 159.69 69.39 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.71 134.76 59.95 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.162 1.908 . . . . 0.0 112.165 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.35 -162.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.269 1.979 . . . . 0.0 112.009 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -128.31 155.18 78.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.679 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.59 145.35 81.74 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.486 2.124 . . . . 0.0 111.704 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -155.55 164.34 38.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.677 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.62 138.55 32.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -124.81 121.71 35.35 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 122.98 49.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -79.23 84.13 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.823 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 53.8 p30 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.773 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.79 158.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.61 150.47 20.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.118 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -98.43 127.12 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.87 116.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.675 -0.41 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -101.32 121.15 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.596 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -81.58 171.69 14.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.494 HD11 ' H ' ' C' ' 71' ' ' LEU . 71.4 mt -63.34 -25.65 68.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -75.11 -8.55 56.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 6.41 66.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.12 126.27 32.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -103.04 131.06 50.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.902 0.382 . . . . 0.0 110.035 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.23 113.17 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.485 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.85 134.75 35.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.766 0.317 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.798 HD21 ' HG3' ' C' ' 33' ' ' LYS . 68.8 mt -132.66 131.48 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.4 115.37 13.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 0.0 110.686 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.447 HG12 ' CD ' ' C' ' 29' ' ' LYS . 21.3 m -134.64 166.08 29.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.558 ' O ' HD12 ' C' ' 56' ' ' LEU . 95.6 mt-10 -113.29 152.01 44.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.221 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.08 -25.51 78.18 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.953 1.769 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -91.05 -12.07 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.676 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.51 142.3 57.14 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.127 0.489 . . . . 0.0 110.928 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -80.46 166.67 21.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.972 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 1.001 HD12 HD23 ' C' ' 50' ' ' LEU . 33.2 mm -64.03 -35.85 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.739 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -58.6 -41.64 86.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.011 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.26 -41.89 93.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.112 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.575 HG21 HD21 ' C' ' 56' ' ' LEU . 64.3 t -63.76 -48.19 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.998 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.28 -31.48 72.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.115 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.79 95.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.249 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.507 ' HB3' HD22 ' C' ' 15' ' ' LEU . 67.6 mttm -60.66 -39.77 89.56 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.541 HG21 HD11 ' C' ' 69' ' ' LEU . 93.9 mt -66.6 -39.57 84.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.326 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.39 -38.68 81.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.422 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -68.69 -47.95 65.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.798 ' HG3' HD21 ' C' ' 15' ' ' LEU . 3.4 mttm -64.19 -40.89 97.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.58 153.84 51.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.121 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.07 57.71 2.73 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' C' ' 41' ' ' GLN . 39.1 mm -112.0 101.3 51.39 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.79 158.12 58.01 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.117 1.878 . . . . 0.0 112.219 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.15 -32.66 94.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.298 1.999 . . . . 0.0 112.349 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -66.94 -39.13 87.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.044 0.45 . . . . 0.0 109.898 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -103.67 23.37 12.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.686 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.728 ' HB2' HG22 ' C' ' 36' ' ' ILE . 0.8 OUTLIER -130.42 116.36 18.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.809 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -127.21 124.77 39.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -102.09 127.15 49.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.194 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -125.89 126.05 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 0.0 110.222 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -148.76 147.9 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 19.73 11.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.426 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.14 -13.27 60.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 147.96 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.238 0.542 . . . . 0.0 111.34 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -97.57 111.33 23.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.558 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 1.001 HD23 HD12 ' C' ' 23' ' ' ILE . 10.6 mp -64.29 97.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.794 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -76.98 -76.54 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.044 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -178.21 166.54 1.93 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.44 73.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -126.65 177.99 6.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -127.22 164.62 21.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.156 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.575 HD21 HG21 ' C' ' 26' ' ' VAL . 78.6 mt -61.55 -39.93 92.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.412 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.32 -28.55 69.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.62 -26.58 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.99 0.424 . . . . 0.0 110.385 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.403 ' CZ ' HD13 ' D' ' 73' ' ' LEU . 67.2 m-85 -104.16 12.0 34.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.291 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.54 38.16 29.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.195 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.41 105.06 13.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.969 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.13 -175.96 5.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.347 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -68.65 148.2 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.965 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 57.84 37.96 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -89.66 133.2 34.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.839 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -91.15 120.75 32.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.145 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.463 HD12 ' N ' ' C' ' 67' ' ' LEU . 5.2 mp -113.59 146.21 40.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -91.26 131.31 36.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.591 HD21 ' HG2' ' C' ' 41' ' ' GLN . 0.7 OUTLIER -106.17 119.13 38.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.299 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.477 ' N ' HD23 ' C' ' 69' ' ' LEU . 95.4 t -104.07 131.42 52.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.494 ' H ' HD11 ' C' ' 8' ' ' LEU . 26.4 mt -109.28 125.93 52.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.133 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -72.32 151.51 42.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.62 139.18 39.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -66.36 142.75 57.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.24 176.62 54.62 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.03 159.33 27.64 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 57.5 t0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.515 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.23 155.46 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.92 145.84 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -93.65 127.64 39.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.508 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.56 HG11 HD11 ' D' ' 30' ' ' ILE . 85.6 t -109.54 115.41 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.172 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -86.46 116.67 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.583 HG23 ' O ' ' D' ' 11' ' ' LYS . 82.0 p -74.63 171.26 14.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.087 0.47 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -41.43 73.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.391 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -76.31 -6.56 52.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.41 -13.31 59.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' LYS . . . . . 0.583 ' O ' HG23 ' D' ' 7' ' ' THR . 11.9 tmtt? -55.29 108.6 0.44 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -83.58 136.89 34.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.07 112.46 23.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.004 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.11 127.0 32.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.205 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.431 HD13 ' CB ' ' D' ' 29' ' ' LYS . 85.1 mt -126.06 120.77 31.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.789 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -66.1 108.97 2.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.719 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.4 m -131.57 166.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.94 154.54 41.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.53 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.88 -36.47 95.61 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.029 1.82 . . . . 0.0 111.861 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.0 p -80.54 -7.94 59.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -58.17 135.27 57.03 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.006 0.432 . . . . 0.0 110.748 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.23 162.48 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.79 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.31 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.687 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.55 -41.6 90.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.937 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.15 -41.59 98.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.049 0.452 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.56 -43.17 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.615 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.99 -38.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.157 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.58 90.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.107 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.719 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.8 mttm -60.77 -39.41 88.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.56 HD11 HG11 ' D' ' 5' ' ' VAL . 7.4 mm -64.93 -40.96 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.524 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.42 -40.41 94.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.712 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -65.15 -44.42 88.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.41 ' HD2' HD21 ' D' ' 15' ' ' LEU . 52.6 mttt -74.16 -66.26 0.74 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.375 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -92.25 171.56 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.004 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -91.1 18.84 49.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.552 HG22 ' HB2' ' D' ' 41' ' ' GLN . 30.2 mm -77.39 119.84 79.09 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.583 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.86 160.49 45.95 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.332 2.021 . . . . 0.0 111.478 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.58 -40.4 85.58 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.106 1.87 . . . . 0.0 112.993 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.08 -52.27 50.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.508 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.58 ' OE1' HD21 ' D' ' 43' ' ' LEU . 4.5 tt0 -65.23 112.64 3.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.889 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -118.1 111.2 18.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.311 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.58 HD21 ' OE1' ' D' ' 41' ' ' GLN . 64.3 mt -90.43 120.57 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.472 . . . . 0.0 110.514 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.3 mt -124.96 127.0 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 78.6 t80 -128.24 128.46 44.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.124 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.38 28.52 9.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.21 79.69 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -128.08 128.66 45.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.0 0.429 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.62 137.96 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.499 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' D' ' 59' ' ' TYR . 66.3 mt -84.64 118.87 24.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.261 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.36 137.77 41.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -62.76 137.77 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.471 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -16.87 57.75 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -78.81 178.68 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 110.459 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 80.5 p -125.53 161.87 26.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.114 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.36 -39.95 92.52 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.106 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.03 -27.58 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.424 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.09 -37.02 81.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.189 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.2 m-85 -98.25 15.02 25.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.084 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 54.74 40.45 31.92 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.859 0.361 . . . . 0.0 110.339 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -89.86 101.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -85.3 -175.83 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -64.09 166.67 7.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.032 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 45.72 36.49 2.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -89.61 122.86 33.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.19 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -83.46 125.48 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.135 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.81 162.75 15.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -109.99 120.73 43.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.381 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.493 HD11 HG21 ' D' ' 30' ' ' ILE . 1.3 tt -99.31 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 81.6 t -103.83 132.69 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.227 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.45 HD21 HD22 ' D' ' 69' ' ' LEU . 48.6 mt -104.78 128.66 53.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.231 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -61.32 152.27 29.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.686 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.456 ' O ' HD23 ' D' ' 73' ' ' LEU . 6.3 tt -120.4 87.86 2.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.709 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 46.45 55.41 7.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.997 0.427 . . . . 0.0 110.682 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.76 -127.25 40.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.924 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.394 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.14 149.18 41.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.468 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.55 126.71 35.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.428 0.632 . . . . 0.0 110.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 51' ' ' GLN . 88.7 mt -68.05 -36.08 79.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.809 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 ' CG1' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -148.81 161.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.17 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -174.01 122.43 0.31 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.74 158.14 37.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.989 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.5 mtt180 -75.54 119.54 19.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.76 146.25 25.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.326 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.21 150.71 17.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.88 167.08 12.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 111.454 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.4 mtp -132.92 175.32 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.849 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.8 m -125.65 121.69 34.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 37' ' ' THR . 29.1 tp -104.46 118.08 35.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.393 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -122.74 113.42 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.977 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.12 -86.33 0.48 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 p -146.51 23.78 1.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.612 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.522 ' O ' HD12 ' A' ' 33' ' ' LEU . 87.9 m -126.54 132.59 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 33' ' ' LEU . 63.4 t -110.12 123.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.305 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.499 HG22 ' HB3' ' B' ' 947' ' ' PRO . 42.2 p -118.21 122.42 30.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.115 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.57 148.5 59.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.772 1.648 . . . . 0.0 113.365 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.88 133.06 44.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.845 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -7.63 48.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.33 78.58 1.85 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.11 132.66 33.34 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.634 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.05 -163.92 11.47 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.227 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.4 tp -137.12 120.44 16.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.55 108.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.548 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.0 p90 -130.83 153.42 49.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' CG1' HG12 ' A' ' 24' ' ' VAL . 96.7 mt -119.0 139.69 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.09 128.14 27.67 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 123.83 0.706 . . . . 0.0 110.847 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.648 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.8 tt0 -99.0 125.15 44.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.416 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.495 HG23 ' CD2' ' A' ' 58' ' ' HIS . 10.7 p -83.51 171.47 13.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.682 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.88 -10.04 25.57 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.509 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.05 2.49 55.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.57 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 t 70.23 21.36 5.91 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 121.088 0.47 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.4 mt -99.45 120.65 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.57 HG21 HD23 ' A' ' 128' ' ' LEU . 49.1 mm -79.33 122.43 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.495 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.6 m-70 -98.56 115.44 28.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.58 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -96.09 107.98 20.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 96.9 m -121.38 146.15 47.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.728 0.775 . . . . 0.0 112.462 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -126.51 113.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.902 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -105.27 145.92 30.03 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.05 0.452 . . . . 0.0 110.572 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.13 132.19 34.71 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -71.64 -18.31 62.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.03 0.443 . . . . 0.0 110.852 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -59.55 -44.98 93.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.789 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.55 -10.36 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.66 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.68 22.85 78.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -102.46 147.16 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.8 106.41 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.67 -22.62 25.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.799 ' OD2' HD21 ' A' ' 73' ' ' LEU . 7.3 t0 -128.64 142.78 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.933 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' HD23 ' A' ' 73' ' ' LEU . 66.6 t0 -157.15 107.65 2.28 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.016 0.436 . . . . 0.0 110.193 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.799 HD21 ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -141.86 130.72 22.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.355 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.67 124.26 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.571 ' HB ' HD22 ' A' ' 128' ' ' LEU . 23.6 mm -111.6 119.6 60.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.602 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.38 161.03 68.99 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.332 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.89 142.12 97.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.063 1.842 . . . . 0.0 111.541 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 61.01 12.36 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.374 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -87.66 -37.39 16.79 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 120.584 0.231 . . . . 0.0 110.602 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.516 ' HB3' HD11 ' A' ' 96' ' ' LEU . 72.7 m -131.31 154.92 48.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.252 0.548 . . . . 0.0 111.745 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -126.72 128.21 46.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.113 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -100.39 117.2 34.1 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -143.64 167.34 22.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -83.56 160.53 21.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.551 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.05 89.21 13.43 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.333 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.3 60.23 7.76 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.124 1.882 . . . . 0.0 112.175 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -114.7 -40.52 3.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.409 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.3 t -128.89 79.65 74.16 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.578 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.29 130.32 39.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.301 2.001 . . . . 0.0 111.284 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.83 -36.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.17 -167.12 12.88 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.55 106.64 18.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.913 0.387 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.4 t -124.83 128.35 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.732 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -125.29 151.38 46.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.125 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -125.43 135.92 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.379 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 80' ' ' CYS . 60.1 tp -102.07 112.71 25.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -112.2 143.1 43.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.505 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.87 116.52 28.01 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.25 -37.53 85.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.787 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.77 -22.33 18.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.397 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.03 174.97 26.98 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -111.94 21.44 15.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.661 0.267 . . . . 0.0 110.294 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.99 149.02 39.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.79 152.42 47.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 95' ' ' VAL . 43.5 mt -120.16 154.63 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CE1' HD22 ' A' ' 33' ' ' LEU . 90.8 m-85 -124.46 134.74 52.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 0.0 110.287 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -138.85 155.31 48.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.106 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -129.97 137.27 50.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.7 mmm -72.23 138.0 47.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -103.76 -1.19 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.292 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -74.1 132.25 79.93 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.09 -25.54 58.43 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.112 1.875 . . . . 0.0 112.585 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 139.59 50.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -94.17 0.89 56.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.056 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -54.28 -21.76 10.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -120.07 -15.65 8.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.71 -40.92 96.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.6 -42.15 98.27 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.166 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.15 -41.47 90.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.727 ' O ' HG23 ' A' ' 124' ' ' VAL . 59.9 m170 -65.28 -39.84 93.09 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.01 -41.99 99.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.666 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -67.56 -40.96 84.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.243 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.64 -38.63 91.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.8 t -58.52 -48.14 86.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.266 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -80.54 -27.21 37.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.33 -38.25 78.08 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.47 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -82.01 -32.25 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.994 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.571 HD22 ' HB ' ' A' ' 75' ' ' ILE . 73.5 mt -79.64 -25.16 41.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.304 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -110.83 -23.44 11.01 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.686 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -137.76 67.84 50.82 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.715 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.41 156.92 60.6 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.626 2.218 . . . . 0.0 112.569 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.127 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.69 89.3 52.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.29 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.33 139.32 73.61 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.475 2.116 . . . . 0.0 112.453 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -80.81 154.35 73.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.71 146.19 83.26 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.929 1.753 . . . . 0.0 112.278 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 163.55 36.91 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.791 2.327 . . . . 0.0 112.396 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.45 160.24 73.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 39' ' ' THR . 41.9 Cg_exo -58.49 146.54 90.24 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.565 2.176 . . . . 0.0 111.864 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -150.29 162.71 39.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -85.96 140.12 30.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.983 0.421 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 950' ' ' TYR . . . . . 0.782 ' O ' HD13 ' B' ' 951' ' ' ILE . 56.7 t80 -121.91 133.46 54.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.86 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.782 HD13 ' O ' ' B' ' 950' ' ' TYR . 9.1 mm -128.57 133.59 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -77.88 85.63 4.13 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.213 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.536 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.11 163.8 19.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.719 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.531 ' HB ' HD13 ' C' ' 67' ' ' LEU . 14.9 pt -143.65 145.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.261 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -93.59 113.05 25.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.392 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -97.27 115.63 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.628 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -100.67 127.72 46.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.673 HG22 HD23 ' C' ' 69' ' ' LEU . 81.4 p -82.03 175.73 10.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.76 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.576 HD11 ' H ' ' C' ' 71' ' ' LEU . 60.4 mt -62.61 -21.63 65.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -88.35 -4.33 58.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.75 74.9 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -59.36 120.78 9.94 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -101.93 132.2 47.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.5 107.05 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.328 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.06 120.66 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.55 130.99 54.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.606 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.9 115.94 15.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.466 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.479 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.2 m -134.92 165.16 31.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.62 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.489 ' O ' HD12 ' C' ' 56' ' ' LEU . 98.0 mt-10 -108.85 151.57 41.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.77 -25.31 75.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.106 1.871 . . . . 0.0 112.071 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 53.6 m -91.78 -10.27 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.527 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 143.25 57.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -80.76 164.42 22.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.609 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.907 HD12 HD23 ' C' ' 50' ' ' LEU . 41.1 mm -63.27 -37.43 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.827 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.75 -41.59 86.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -61.49 -43.6 98.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 110.523 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.533 HG21 HD21 ' C' ' 56' ' ' LEU . 63.2 t -62.97 -42.47 96.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -60.4 -39.95 89.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.59 90.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.199 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.479 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.99 -39.32 85.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.76 ' CD1' HD21 ' C' ' 43' ' ' LEU . 95.3 mt -65.71 -39.3 84.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.577 0.703 . . . . 0.0 110.32 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.79 -46.12 90.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -77.13 -14.64 59.76 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.665 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -102.09 -3.88 26.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -149.14 -42.48 0.14 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.224 0.535 . . . . 0.0 110.391 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.65 29.25 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.212 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' C' ' 41' ' ' GLN . 52.8 mt -72.08 128.43 89.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.777 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.65 153.27 48.89 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.828 1.685 . . . . 0.0 111.708 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.27 -38.17 61.27 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.066 1.844 . . . . 0.0 112.737 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.7 -39.77 92.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.842 0.353 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -89.44 -2.64 58.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.032 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.624 ' HG3' HG22 ' C' ' 36' ' ' ILE . 92.2 mt-30 -93.79 106.89 18.84 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.693 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.76 HD21 ' CD1' ' C' ' 30' ' ' ILE . 73.6 mt -79.54 133.9 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.837 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.539 HG21 ' HE1' ' A' ' 76' ' ' PHE . 80.5 mt -135.04 129.39 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.345 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 71.1 t80 -151.47 151.72 32.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.36 16.54 10.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.731 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -10.63 67.19 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.83 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.0 OUTLIER -112.68 145.14 40.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.312 0.577 . . . . 0.0 110.84 -178.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -73.63 129.82 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.905 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.907 HD23 HD12 ' C' ' 23' ' ' ILE . 9.2 mp -76.46 94.3 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.829 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.2 150.13 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 111.122 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -60.36 143.08 53.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.402 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.58 -19.35 48.02 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -88.14 169.1 12.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.522 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.9 p -118.17 164.5 15.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.954 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.533 HD21 HG21 ' C' ' 26' ' ' VAL . 80.0 mt -61.01 -41.14 95.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.587 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -64.24 -22.72 67.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.388 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.96 -36.68 82.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.547 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.521 ' CE2' HD13 ' D' ' 73' ' ' LEU . 82.5 m-85 -99.92 15.76 26.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.103 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 57.58 38.72 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.694 HD11 HD21 ' C' ' 50' ' ' LEU . 61.7 mt -83.99 105.29 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.899 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -92.16 -178.89 5.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.409 0.623 . . . . 0.0 111.159 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.46 146.88 52.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.009 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 60.93 15.79 6.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.215 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 33.7 m -69.87 133.63 47.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -87.4 118.49 26.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.723 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' C' ' 3' ' ' ILE . 6.8 mp -107.93 140.98 40.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.997 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -89.82 129.43 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.673 HD23 HG22 ' C' ' 7' ' ' THR . 50.2 tp -107.91 121.25 44.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.19 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 56' ' ' LEU . 90.5 t -108.4 132.3 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.152 0.501 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.576 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.7 mt -106.16 152.14 23.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.559 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -100.86 126.08 47.44 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.454 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.86 140.04 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.719 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -71.7 134.02 46.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.162 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.66 0.87 88.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.54 -165.84 54.51 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.524 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.82 157.04 22.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.351 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.84 148.12 25.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.419 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.0 m-30 -89.11 121.97 31.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.788 HG11 HD11 ' D' ' 30' ' ' ILE . 58.9 t -110.1 105.97 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.554 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -89.12 129.95 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 110.893 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -89.16 175.98 7.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.812 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.7 mt -61.73 -35.44 78.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.913 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -70.46 -11.65 61.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 -12.79 63.0 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.04 127.83 33.13 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -98.82 133.62 42.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 13' ' ' ILE . 1.4 mt -124.23 111.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.429 HG23 ' CD2' ' D' ' 4' ' ' PHE . 17.5 m -82.76 125.91 31.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.86 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.52 125.97 48.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.475 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -69.3 113.87 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.619 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 13.1 m -135.99 170.58 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -120.1 156.39 54.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.254 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.42 -26.64 82.62 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.163 1.909 . . . . 0.0 112.069 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -83.71 -14.26 52.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.563 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.17 144.05 57.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -87.68 166.33 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.41 -39.55 85.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.066 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.52 -42.25 91.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.183 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.29 -39.85 94.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.28 -43.34 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.996 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -61.3 -40.02 92.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.2 91.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.929 0.395 . . . . 0.0 109.998 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.619 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 87.9 mttt -59.86 -38.03 80.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.788 HD11 HG11 ' D' ' 5' ' ' VAL . 5.3 mm -63.92 -39.93 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.156 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.78 -45.59 93.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.289 0.566 . . . . 0.0 110.635 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.2 -33.91 76.84 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.045 -0.409 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -89.95 -6.88 55.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -146.08 -53.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.0 110.456 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.28 20.68 4.68 Favored Glycine 0 CA--C 1.517 0.205 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.567 HD13 HD21 ' D' ' 71' ' ' LEU . 60.4 mt -95.35 114.18 63.26 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.418 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.01 153.82 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.094 1.863 . . . . 0.0 112.215 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.99 -28.85 86.9 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.648 2.232 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -91.46 -4.34 55.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -92.6 -16.87 25.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.551 ' OE1' HD11 ' D' ' 69' ' ' LEU . 15.6 pt20 -137.88 160.55 38.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.305 0.574 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.18 130.93 53.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.561 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.79 119.54 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.823 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -121.23 128.07 75.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.981 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 89.6 t80 -122.61 128.48 50.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.455 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 64.15 25.05 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.67 90.29 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -110.29 126.23 53.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -65.05 135.55 55.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.66 107.69 17.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.112 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -74.79 154.15 38.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.337 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -72.97 162.99 28.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.342 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.43 20.73 77.18 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -122.94 150.79 42.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.66 0.267 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.6 p -96.87 160.44 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.467 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.37 -39.09 92.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.412 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.2 -39.06 93.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.055 0.455 . . . . 0.0 110.361 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -94.42 13.36 24.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 56.69 42.81 26.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 69.0 mt -90.97 104.24 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.097 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.04 179.31 5.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.438 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -60.74 150.65 31.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 58.49 45.42 16.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 85.5 p -101.21 128.89 47.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.988 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.426 ' C ' HD12 ' D' ' 67' ' ' LEU . 87.2 m -81.15 126.05 31.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.582 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.426 HD12 ' C ' ' D' ' 66' ' ' THR . 7.4 mp -117.03 148.27 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.38 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.67 116.32 28.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.441 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.551 HD11 ' OE1' ' D' ' 41' ' ' GLN . 5.2 tt -99.54 104.71 16.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.978 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.621 ' HA ' HD21 ' D' ' 8' ' ' LEU . 94.1 t -100.59 128.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.253 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.812 ' H ' HD11 ' D' ' 8' ' ' LEU . 81.9 mt -97.85 136.93 37.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.871 0.367 . . . . 0.0 110.755 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -79.09 154.33 29.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.83 HD22 ' HE2' ' C' ' 48' ' ' LYS . 57.1 mt -98.74 132.19 44.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.058 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -121.46 130.94 53.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.803 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.56 70.16 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -83.27 156.37 23.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.397 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -90.06 120.54 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.327 0.584 . . . . 0.0 110.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 51' ' ' GLN . 95.1 mt -69.05 -35.28 76.38 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -149.22 161.14 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.984 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.63 122.66 0.35 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.229 0.537 . . . . 0.0 110.814 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.98 158.22 38.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.878 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HA ' HD12 ' A' ' 46' ' ' LEU . 90.7 mtt-85 -76.46 120.5 21.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.538 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.78 148.01 26.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.5 150.64 17.64 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -87.72 165.44 15.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.953 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 26.4 mtp -134.01 175.07 9.8 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.1 m -129.8 126.73 38.79 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.355 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 33' ' ' LEU . 8.4 tt -102.16 125.52 48.88 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.472 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -116.13 103.29 10.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.903 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.16 -83.14 0.74 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -144.02 20.26 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.554 0.216 . . . . 0.0 110.879 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -122.22 129.18 52.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 HD12 ' A' ' 33' ' ' LEU . 57.8 t -100.74 125.47 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.626 HG22 ' HB3' ' B' ' 947' ' ' PRO . 27.3 p -118.72 128.28 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.328 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.99 145.97 51.37 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.779 1.653 . . . . 0.0 112.603 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -108.02 138.2 44.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.878 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -72.6 -5.42 37.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.993 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.2 73.67 0.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.64 134.83 41.46 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.408 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.76 -162.64 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.0 tp -136.67 126.44 25.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 108.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.979 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.6 p90 -133.22 153.5 51.49 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.922 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.414 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.3 mt -119.45 139.48 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.285 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.63 132.49 40.83 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 123.923 0.765 . . . . 0.0 110.147 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.665 ' HB2' HD11 ' A' ' 23' ' ' LEU . 49.5 tt0 -102.68 122.47 44.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.133 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.456 HG23 ' CD2' ' A' ' 58' ' ' HIS . 8.2 p -82.89 171.58 13.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.46 -10.06 22.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.705 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.6 8.17 40.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.47 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m 62.82 23.99 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 110.762 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.598 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 69.7 mt -98.8 120.32 39.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.527 HG21 HD23 ' A' ' 128' ' ' LEU . 51.9 mm -80.1 121.15 32.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.552 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.456 ' CD2' HG23 ' A' ' 52' ' ' THR . 75.3 m-70 -97.67 112.55 24.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.899 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -92.9 107.2 19.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 93.3 m -119.38 143.9 47.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.929 0.871 . . . . 0.0 112.847 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.2 t90 -126.85 113.44 16.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.109 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -103.9 144.32 31.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.631 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -82.83 130.52 35.14 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -71.36 -16.65 62.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.75 0.31 . . . . 0.0 110.755 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.54 -45.87 90.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.442 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.69 -11.77 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.54 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.73 22.45 78.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -102.57 152.0 21.68 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.57 102.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.371 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.88 -38.25 67.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.888 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.48 147.18 49.86 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.392 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.497 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p-10 -158.78 97.74 1.45 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.314 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD22 ' HG2' ' C' ' 48' ' ' LYS . 31.8 mt -124.55 136.78 54.26 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.095 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.56 119.47 30.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.705 HG21 ' SG ' ' A' ' 80' ' ' CYS . 22.5 mm -109.29 120.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 111.05 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.598 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.0 m-85 -85.13 163.03 47.28 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.51 141.48 95.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.171 1.914 . . . . 0.0 111.689 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 61.14 12.42 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -87.42 -25.99 23.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.705 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.3 p -149.98 167.02 27.89 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.452 0.644 . . . . 0.0 110.569 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -137.11 132.52 34.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.189 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -103.38 118.58 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.44 167.9 21.0 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.496 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -87.8 160.37 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.176 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.67 90.82 13.35 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.152 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.21 59.82 7.18 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -115.6 -36.72 4.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.526 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.9 t -127.89 81.72 69.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.288 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.29 130.4 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.898 1.732 . . . . 0.0 111.651 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t 169.1 -44.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.83 -147.83 5.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' HD3' HG22 ' A' ' 114' ' ' THR . 0.1 OUTLIER -118.13 105.73 12.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.188 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.3 t -122.71 126.59 74.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -123.57 152.93 41.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.718 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -130.97 135.36 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.516 HD11 ' SG ' ' A' ' 80' ' ' CYS . 61.2 tp -100.87 121.84 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -116.78 124.85 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.026 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' HE2' HD12 ' A' ' 75' ' ' ILE . 32.3 m-85 -81.4 115.1 20.58 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.01 -37.54 82.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.497 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.72 -23.66 11.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.486 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.51 -24.5 72.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.192 -0.527 . . . . 0.0 111.894 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m 66.89 6.66 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.576 ' HD3' HD21 ' A' ' 105' ' ' LEU . 5.5 ttmm -98.36 150.17 21.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.498 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.6 mtt180 -131.23 136.78 48.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.835 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.576 HD21 ' HD3' ' A' ' 103' ' ' LYS . 40.1 mt -123.29 151.16 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.045 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 97.6 m-85 -123.67 137.52 54.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.41 155.22 47.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 111.4 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -129.82 136.75 49.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.127 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.82 141.26 58.35 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.341 0.591 . . . . 0.0 111.369 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -112.99 -8.2 13.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.169 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.2 135.15 89.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.704 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.94 -23.13 35.0 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.826 1.684 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -116.44 141.1 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.341 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.49 HG22 ' HD3' ' A' ' 92' ' ' ARG . 77.0 p -97.93 17.23 18.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.261 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.4 -21.14 59.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -135.64 17.76 3.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.841 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.63 -48.9 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.199 0.523 . . . . 0.0 111.059 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.63 -33.02 70.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.322 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.22 -44.78 90.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.489 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.748 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.2 m170 -62.01 -41.37 98.0 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.451 0.643 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.3 -44.83 95.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.847 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.5 -42.55 91.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.388 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.01 -37.61 88.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.918 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.0 t -58.78 -47.77 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.272 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -80.08 -28.41 39.14 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.843 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -68.91 -37.74 79.15 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.404 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.72 -33.16 35.45 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.731 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 75' ' ' ILE . 69.5 mt -79.58 -26.89 41.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -108.25 -24.01 11.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.655 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -136.88 69.19 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.797 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.37 157.78 55.87 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.854 2.369 . . . . 0.0 112.55 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.654 2.236 . . . . 0.0 112.211 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -128.95 150.59 75.64 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.634 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.96 147.02 33.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.695 2.263 . . . . 0.0 112.031 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.25 153.64 92.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.21 151.36 76.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.106 1.871 . . . . 0.0 112.253 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.09 -171.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.466 2.11 . . . . 0.0 112.096 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -120.06 155.08 55.87 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.626 ' HB3' HG22 ' A' ' 39' ' ' THR . 22.2 Cg_endo -60.93 141.76 95.55 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.352 2.035 . . . . 0.0 112.115 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.73 165.2 37.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.834 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.64 136.69 32.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.849 0.357 . . . . 0.0 110.41 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -120.62 121.21 37.84 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 55.5 mt -131.91 123.65 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -79.21 84.21 5.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.872 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.8 t0 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.452 179.552 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -62.26 156.13 22.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.369 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -136.78 157.02 35.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.362 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.619 ' CD2' HG23 ' C' ' 14' ' ' THR . 15.5 m-30 -96.19 122.59 39.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.897 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.3 t -110.43 101.85 13.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.224 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -88.34 124.09 33.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.177 0.513 . . . . 0.0 110.82 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.519 HG21 ' OE2' ' C' ' 34' ' ' GLU . 82.1 p -86.47 172.09 10.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.07 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.524 HD11 ' H ' ' C' ' 71' ' ' LEU . 70.5 mt -65.5 -19.08 65.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -83.95 -5.0 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.057 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.32 80.5 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.17 126.37 30.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.87 0.366 . . . . 0.0 110.218 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -97.6 131.22 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -115.84 116.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.374 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' THR . . . . . 0.619 HG23 ' CD2' ' C' ' 4' ' ' PHE . 0.2 OUTLIER -85.15 117.12 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.428 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.65 116.41 27.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.922 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.75 105.99 1.4 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.731 HG12 ' HE3' ' C' ' 29' ' ' LYS . 28.4 m -130.45 162.71 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.497 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -105.88 155.72 37.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -37.79 93.7 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.896 1.731 . . . . 0.0 112.109 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -80.32 -7.55 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.301 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ASP . . . . . 0.418 ' HB3' HD12 ' C' ' 56' ' ' LEU . 31.8 t0 -57.21 135.54 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -79.23 163.27 25.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.767 HD12 HD23 ' C' ' 50' ' ' LEU . 40.6 mm -64.54 -38.77 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.102 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.26 -41.48 88.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.995 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.05 -41.4 98.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.799 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.455 HG21 HD21 ' C' ' 56' ' ' LEU . 57.5 t -63.35 -42.98 98.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.417 ' HG2' HD11 ' C' ' 43' ' ' LEU . 55.0 mtmt -60.83 -40.17 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.635 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.83 92.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.104 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.731 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.62 -38.75 82.15 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.752 HD13 HD11 ' C' ' 69' ' ' LEU . 97.1 mt -66.37 -39.78 84.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.752 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -59.54 -46.93 87.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.365 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.21 -16.26 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.986 -0.446 . . . . 0.0 111.897 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -101.18 -5.81 25.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLU . . . . . 0.519 ' OE2' HG21 ' C' ' 7' ' ' THR . 81.5 mt-10 -148.31 -41.96 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.1 0.476 . . . . 0.0 110.476 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.8 8.16 28.43 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.352 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.08 128.78 82.27 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.899 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 160.44 43.66 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.564 1.509 . . . . 0.0 111.683 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.79 -39.16 93.4 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.274 1.982 . . . . 0.0 112.472 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.86 -39.88 93.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.761 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -89.17 -4.43 58.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.06 90.34 7.33 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -101.6 97.18 7.64 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.417 HD11 ' HG2' ' C' ' 27' ' ' LYS . 22.2 mt -88.27 129.47 35.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.594 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.415 HG21 ' HE1' ' A' ' 76' ' ' PHE . 83.7 mt -127.92 129.09 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -151.64 152.83 33.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.75 17.15 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.93 -13.59 60.8 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.675 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.99 146.5 42.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 110.599 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.19 132.18 42.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.045 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.767 HD23 HD12 ' C' ' 23' ' ' ILE . 6.8 mp -67.26 101.47 0.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.35 140.69 44.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.91 143.0 55.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.299 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.56 -16.26 61.34 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -83.44 176.19 9.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.193 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -122.27 161.95 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.817 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.455 HD21 HG21 ' C' ' 26' ' ' VAL . 84.5 mt -61.8 -40.39 95.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.823 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -63.69 -23.98 67.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -62.83 -37.63 87.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 110.149 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -96.46 13.48 27.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.252 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.05 42.42 22.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.41 HG21 HD22 ' C' ' 56' ' ' LEU . 64.9 mt -90.37 109.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.301 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -98.19 -177.99 3.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.213 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.26 146.89 52.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 59.34 42.28 18.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' SER . . . . . 0.479 ' O ' HD12 ' C' ' 67' ' ' LEU . 45.7 m -97.55 127.28 43.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.98 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 87.1 m -76.86 126.57 31.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.113 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.479 HD12 ' O ' ' C' ' 65' ' ' SER . 5.7 mp -116.33 149.03 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.084 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.26 117.34 32.44 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.752 HD11 HD13 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -97.21 99.05 10.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.642 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -87.06 130.67 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.524 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.8 mt -110.39 141.23 43.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.162 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.71 142.43 57.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.0 131.19 38.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -62.68 -39.26 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.571 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.45 172.16 24.92 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.33 163.39 54.13 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.656 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.62 159.61 12.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.956 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.05 151.91 25.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.054 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.432 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.5 m-30 -93.16 121.94 35.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.536 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.2 105.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' LYS . . . . . 0.458 ' HG3' HG23 ' D' ' 66' ' ' THR . 32.2 mtmt -90.29 133.28 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.717 HG22 HD23 ' D' ' 69' ' ' LEU . 82.0 p -88.87 -174.9 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.592 HD21 ' HA ' ' D' ' 70' ' ' VAL . 88.7 mt -62.34 -38.08 88.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.004 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -72.84 -9.04 58.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.615 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.45 -7.44 75.04 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.61 124.86 21.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -96.09 131.25 42.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mt -123.56 111.54 29.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.552 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.432 HG23 ' CD2' ' D' ' 4' ' ' PHE . 8.3 m -81.49 125.71 30.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.425 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.8 mt -121.21 125.15 46.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.126 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.96 114.8 9.39 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.441 HG12 ' CD ' ' D' ' 29' ' ' LYS . 26.7 m -135.57 163.01 36.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -104.7 153.29 39.36 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.074 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.55 -36.17 97.58 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.948 1.766 . . . . 0.0 112.043 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.46 -0.65 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -62.28 136.63 58.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -76.96 161.81 28.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.26 0.552 . . . . 0.0 110.794 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.59 -38.54 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.27 -42.53 91.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.88 -41.3 97.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.64 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.4 -42.67 97.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.597 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.2 mtmt -60.71 -39.38 88.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.133 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.26 93.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.411 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.441 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.4 mttm -60.06 -39.53 86.32 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.53 -39.66 84.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.297 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.34 -39.78 84.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.335 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.68 -50.3 52.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.711 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.425 ' HD2' HD21 ' D' ' 15' ' ' LEU . 24.6 mttp -66.18 -40.41 90.43 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -128.66 147.63 50.76 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.06 59.32 3.12 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.563 HG23 HD22 ' D' ' 71' ' ' LEU . 31.0 mm -110.31 107.07 58.46 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.8 152.82 54.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.316 2.011 . . . . 0.0 111.747 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.61 -42.4 66.21 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.744 1.629 . . . . 0.0 112.884 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.6 -43.29 99.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -68.3 -38.55 81.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.444 ' HG3' HG22 ' D' ' 36' ' ' ILE . 68.2 mt-30 -58.05 118.03 4.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.013 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' ARG . . . . . 0.731 ' NE ' HD11 ' D' ' 44' ' ' ILE . 77.9 ttt180 -121.21 106.31 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' D' ' 27' ' ' LYS . 19.8 mt -96.15 115.93 28.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.081 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.731 HD11 ' NE ' ' D' ' 42' ' ' ARG . 83.9 mt -123.27 124.37 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.377 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 85.1 t80 -128.36 130.02 47.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.179 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.62 27.11 11.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.357 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.22 81.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -125.9 127.3 45.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.834 0.349 . . . . 0.0 110.725 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.47 137.0 55.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.47 HD12 ' CB ' ' D' ' 43' ' ' LEU . 77.9 mt -78.68 122.06 25.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.083 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -76.15 136.28 39.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -65.06 130.92 45.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.5 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.67 -15.81 52.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -79.88 -176.99 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.8 p -125.66 163.47 22.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' D' ' 56' ' ' LEU . 85.7 mt -62.22 -40.06 94.86 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.606 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.4 p -64.1 -27.46 69.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.13 -29.72 71.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.123 0.487 . . . . 0.0 110.178 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -101.66 12.41 37.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.403 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.48 40.41 29.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.036 0.446 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 90.0 mt -89.82 107.22 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.673 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.09 177.89 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -59.75 149.79 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 60.01 18.66 7.81 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.631 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.0 m -73.81 129.65 38.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.07 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.647 ' C ' HD12 ' D' ' 67' ' ' LEU . 86.7 m -81.82 130.15 34.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.019 0.437 . . . . 0.0 110.58 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.647 HD12 ' C ' ' D' ' 66' ' ' THR . 9.4 mp -120.63 140.11 52.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -86.49 113.44 22.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.717 HD23 HG22 ' D' ' 7' ' ' THR . 62.8 tp -100.72 115.49 30.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.431 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.592 ' HA ' HD21 ' D' ' 8' ' ' LEU . 78.1 t -114.53 139.38 40.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.74 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.563 HD22 HG23 ' D' ' 36' ' ' ILE . 37.9 mt -102.31 121.09 41.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.161 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.33 146.76 42.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 mt -69.65 139.12 53.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.263 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -118.42 127.65 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.254 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.89 -130.56 50.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.859 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.872 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -72.26 147.13 46.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.975 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -94.16 113.65 25.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.082 0.468 . . . . 0.0 109.792 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' A' ' 57' ' ' ILE . 95.7 mt -67.53 -36.94 81.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' HE3' ' A' ' 123' ' ' LYS . 1.2 p -149.76 162.3 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.868 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.15 122.5 0.39 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.251 0.548 . . . . 0.0 110.934 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.78 158.16 37.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.889 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.06 123.8 25.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.574 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.0 21.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.176 0.512 . . . . 0.0 110.35 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.51 16.94 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -92.11 158.4 16.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 0.0 110.78 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.33 163.32 25.99 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -115.69 129.92 56.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.741 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 37' ' ' THR . 31.5 tp -106.7 120.8 42.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.83 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -122.92 110.99 16.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.328 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.52 -93.61 0.55 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.3 p -137.45 21.27 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.604 0.24 . . . . 0.0 111.036 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.516 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.5 m -125.88 131.55 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.516 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' CG2' HD13 ' A' ' 33' ' ' LEU . 60.3 t -107.64 125.18 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.9 p -113.61 111.53 49.01 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.13 139.75 91.63 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.577 2.185 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -94.87 129.22 41.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -68.41 -10.17 53.42 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.864 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -72.19 82.85 1.01 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.19 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.27 133.59 52.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.193 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.8 -161.07 10.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.315 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.1 tp -138.77 126.98 22.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 t -100.2 110.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -133.13 155.0 50.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.26 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.4 mt -120.05 137.19 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.387 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.12 131.27 36.67 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.586 0.554 . . . . 0.0 110.231 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.471 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.4 tt0 -100.84 125.98 47.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.044 0.45 . . . . 0.0 110.144 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.504 HG23 ' CD2' ' A' ' 58' ' ' HIS . 16.5 p -86.33 172.94 10.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.634 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.37 -10.83 27.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.657 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.34 5.65 46.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.442 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 m 63.55 24.81 14.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.587 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 75.0 mt -100.6 122.78 43.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.511 HG21 HD23 ' A' ' 128' ' ' LEU . 51.0 mm -80.9 122.28 35.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.504 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.8 m-70 -98.36 114.9 27.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.693 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.46 108.39 20.32 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.9 m -121.44 146.92 46.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.753 0.787 . . . . 0.0 112.675 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -125.19 115.02 19.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.064 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -107.45 134.5 50.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.845 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.0 132.5 41.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.557 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -73.88 -18.55 60.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -59.94 -45.95 90.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.049 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -116.48 -16.26 10.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.102 0.477 . . . . 0.0 109.768 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.33 22.89 72.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -101.38 152.2 21.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.827 0.346 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -80.75 107.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.902 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.94 -27.5 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -127.94 144.15 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.183 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.571 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -158.59 99.76 1.6 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.46 179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' C' ' 48' ' ' LYS . 40.5 mt -129.07 133.08 47.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.52 122.6 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.632 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.0 mm -112.39 121.31 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.366 0.603 . . . . 0.0 111.142 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 38.6 m-85 -85.56 163.39 44.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.718 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.51 140.53 93.54 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.246 1.964 . . . . 0.0 111.536 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t0 60.07 12.08 3.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.344 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.48 -26.48 30.2 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.298 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 96' ' ' LEU . 17.7 p -151.18 166.92 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.475 0.655 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -133.58 132.06 40.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.259 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.4 119.45 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -143.86 168.87 18.94 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.742 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -85.7 157.06 20.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.58 89.37 7.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.319 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.18 61.03 7.64 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.965 1.776 . . . . 0.0 112.274 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.82 -39.22 4.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.398 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 p -129.69 73.61 81.38 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.45 130.06 36.75 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.213 1.942 . . . . 0.0 111.297 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.02 -45.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.146 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.88 -156.34 8.71 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.15 105.37 15.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.786 0.327 . . . . 0.0 110.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.63 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.08 152.22 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.405 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.86 134.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.281 0.562 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.3 tp -102.47 117.61 35.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -114.23 122.84 48.0 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.417 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.469 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 37.9 m-85 -78.46 114.1 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.95 -37.95 84.15 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.14 -23.03 12.71 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.376 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -71.42 -20.29 78.19 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.133 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 m 59.75 34.33 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.945 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 162.02 36.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.484 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -134.9 143.31 46.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.911 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 mt -119.81 147.09 45.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.5 m-85 -115.51 132.04 56.75 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.271 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.11 157.43 46.34 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.256 0.551 . . . . 0.0 110.938 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -134.25 141.64 47.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.387 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.0 mmm -74.68 139.09 43.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.062 0.458 . . . . 0.0 110.976 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.81 10.67 10.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.011 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.2 145.07 90.55 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.488 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.47 -39.1 79.08 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.994 1.796 . . . . 0.0 112.577 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -118.89 146.31 45.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.909 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.5 p -97.86 6.94 47.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.722 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -54.02 -20.98 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.421 ' NE2' ' OE1' ' A' ' 119' ' ' GLU . 30.7 mm100 -126.94 14.77 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.155 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.59 -45.71 91.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.12 -33.06 67.52 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.521 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.421 ' OE1' ' NE2' ' A' ' 116' ' ' GLN . 36.0 tt0 -65.6 -43.32 90.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.058 0.456 . . . . 0.0 110.641 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.772 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.3 m170 -65.31 -40.89 94.35 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.645 0.736 . . . . 0.0 109.383 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.6 t -62.32 -45.67 92.18 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.796 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -64.97 -43.34 92.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.322 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HE3' HG23 ' A' ' 24' ' ' VAL . 27.2 mtpp -62.48 -38.73 91.01 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.694 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.8 t -58.95 -47.65 89.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.36 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.23 -30.01 38.5 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.844 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.3 -38.94 85.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.567 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -80.33 -34.22 36.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.668 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.574 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.5 mt -77.52 -26.96 51.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.435 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -108.53 -20.46 13.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.272 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -140.39 68.54 32.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.443 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.41 158.27 56.61 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 C-N-CA 122.949 2.432 . . . . 0.0 112.495 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--N 1.312 -1.356 0 C-N-CA 122.64 2.227 . . . . 0.0 112.321 -179.611 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.83 148.16 98.87 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.61 152.82 38.43 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.587 2.192 . . . . 0.0 111.959 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.91 151.03 90.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.118 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.21 158.75 48.44 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.278 1.985 . . . . 0.0 112.239 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 168.41 23.99 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.706 2.271 . . . . 0.0 111.918 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -105.68 159.86 28.08 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.78 145.97 87.87 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.237 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.87 166.56 33.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -85.15 138.01 32.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.32 125.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.84 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.51 127.28 56.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -74.18 84.31 1.85 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.811 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.569 179.672 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -66.97 161.08 25.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.26 149.99 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.133 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.04 126.44 44.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.646 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.75 117.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -100.6 117.89 35.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.467 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.674 HG22 HD23 ' C' ' 69' ' ' LEU . 71.2 p -80.0 171.22 15.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.049 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.525 HD11 ' H ' ' C' ' 71' ' ' LEU . 64.9 mt -63.42 -24.02 67.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.173 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.2 p -75.42 -8.73 57.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.24 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -72.41 132.89 44.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.792 0.33 . . . . 0.0 110.264 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -109.09 131.71 54.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.229 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.25 117.37 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.819 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 135.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.665 HD21 ' CD ' ' C' ' 33' ' ' LYS . 16.0 mt -133.91 126.68 30.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.114 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -70.74 117.35 12.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.653 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 21.3 m -137.18 166.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.538 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.6 mt-10 -112.26 151.52 43.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.02 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.14 -26.37 81.48 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.981 1.788 . . . . 0.0 112.207 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -87.02 -11.51 50.18 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.743 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -62.99 143.49 57.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.615 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -81.67 165.95 20.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.315 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.634 HD12 HD23 ' C' ' 50' ' ' LEU . 42.4 mm -62.44 -39.18 83.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.314 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.48 -41.99 91.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.83 -41.57 97.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.141 0.496 . . . . 0.0 110.876 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.677 HG21 HD21 ' C' ' 56' ' ' LEU . 56.7 t -63.13 -43.35 98.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.702 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.79 -39.71 89.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.43 91.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 0.0 110.519 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.664 ' HB3' HD22 ' C' ' 15' ' ' LEU . 71.9 mttt -60.15 -39.76 87.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.373 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.8 ' CD1' HD21 ' C' ' 43' ' ' LEU . 96.8 mt -66.98 -38.4 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.257 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.28 -42.21 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -63.51 -43.79 96.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.665 ' CD ' HD21 ' C' ' 15' ' ' LEU . 0.0 OUTLIER -69.49 -65.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.225 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.41 155.9 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.854 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.8 57.82 4.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.674 HG22 ' HG3' ' C' ' 41' ' ' GLN . 32.2 mm -110.78 104.69 56.44 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.37 157.57 35.28 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.53 2.154 . . . . 0.0 112.041 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.07 -30.55 90.59 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.249 1.966 . . . . 0.0 112.309 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.83 -40.73 88.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.056 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -87.22 -9.67 54.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.58 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.674 ' HG3' HG22 ' C' ' 36' ' ' ILE . 86.1 mt-30 -81.73 95.84 7.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.334 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -110.36 93.67 4.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' C' ' 30' ' ' ILE . 74.3 mt -80.07 135.14 36.28 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.44 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -135.8 127.33 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -152.0 149.83 29.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.805 0.336 . . . . 0.0 111.211 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.03 15.27 9.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.14 -15.2 60.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.457 ' HE3' HD22 ' A' ' 73' ' ' LEU . 12.1 mtpt -100.9 140.61 34.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.942 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -77.94 118.19 20.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.886 HD21 HD11 ' C' ' 61' ' ' ILE . 8.6 mp -66.56 86.14 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.243 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' GLU . . . . . 0.437 ' O ' HG21 ' C' ' 23' ' ' ILE . 24.5 pt-20 -74.52 -175.89 2.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.4 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.7 156.5 30.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.15 -152.23 48.17 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 55.36 172.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.519 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -125.99 167.96 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.348 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.677 HD21 HG21 ' C' ' 26' ' ' VAL . 78.8 mt -60.7 -40.74 93.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.563 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -63.78 -24.32 67.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.91 -37.06 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.446 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.793 ' CZ ' HD11 ' D' ' 73' ' ' LEU . 67.0 m-85 -96.44 13.78 26.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.997 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 58.58 40.59 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.886 HD11 HD21 ' C' ' 50' ' ' LEU . 60.9 mt -87.88 108.68 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.754 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.71 179.99 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.82 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.65 145.97 53.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 59.18 17.64 5.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 137.23 57.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -98.07 120.21 38.08 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.685 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.497 HD12 ' N ' ' C' ' 67' ' ' LEU . 4.8 mp -113.6 142.27 46.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.324 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -88.91 130.32 35.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.194 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.674 HD23 HG22 ' C' ' 7' ' ' THR . 59.9 tp -105.88 122.07 45.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.017 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.75 132.67 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.525 ' H ' HD11 ' C' ' 8' ' ' LEU . 27.8 mt -108.49 143.25 37.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.345 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -62.82 -39.39 94.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.686 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.41 132.11 54.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.539 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -63.32 -39.32 94.24 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.59 174.79 55.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.44 -173.99 54.24 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.648 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' GLN . . . . . 0.458 HE21 HG21 ' D' ' 14' ' ' THR . 9.8 pt20 -62.88 155.64 26.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.552 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -134.85 154.61 36.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.547 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.578 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.1 m-30 -94.87 125.08 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.397 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.83 99.06 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.383 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -85.18 130.05 34.68 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.73 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.838 HG23 HD23 ' D' ' 69' ' ' LEU . 0.2 OUTLIER -90.51 -175.06 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.709 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.656 HD11 ' H ' ' D' ' 71' ' ' LEU . 73.2 mt -70.85 -26.01 63.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.291 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -78.97 -9.98 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.55 -13.55 64.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.71 132.08 48.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 68.5 m -102.72 130.75 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 110.608 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mm -113.47 117.9 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.489 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.578 HG23 ' CD2' ' D' ' 4' ' ' PHE . 0.5 OUTLIER -88.58 118.75 28.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.598 HD11 HG12 ' D' ' 30' ' ' ILE . 81.1 mt -117.44 116.95 28.17 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.67 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -65.46 105.69 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.674 HG12 ' HE3' ' D' ' 29' ' ' LYS . 17.8 m -129.13 166.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.205 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -115.18 155.91 46.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.03 -24.65 66.76 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.76 1.64 . . . . 0.0 111.707 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.7 p -88.18 -11.82 45.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.822 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.14 141.99 58.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.171 0.51 . . . . 0.0 111.103 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -81.52 164.18 22.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.505 HD12 HD13 ' D' ' 50' ' ' LEU . 48.7 mm -62.86 -42.28 95.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -59.98 -34.56 73.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.353 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -64.76 -41.14 96.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.494 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 -42.38 95.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.456 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.434 ' HG2' HD11 ' D' ' 43' ' ' LEU . 55.6 mtmt -60.56 -40.39 91.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.286 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.22 86.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.674 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.65 -39.5 84.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.607 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.598 HG12 HD11 ' D' ' 15' ' ' LEU . 60.7 mt -67.84 -39.52 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.173 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -58.98 -42.52 90.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.917 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -89.77 17.99 6.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -123.16 -38.01 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -124.85 -8.28 7.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.297 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.71 77.0 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.449 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.549 HD13 ' CD2' ' D' ' 71' ' ' LEU . 44.1 mt -82.04 121.58 79.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.512 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.55 153.61 60.01 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.956 1.771 . . . . 0.0 111.71 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.47 -39.52 73.97 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.112 1.874 . . . . 0.0 111.898 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.21 -39.66 93.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.683 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -83.54 -7.96 59.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.658 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.96 90.83 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.316 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -100.94 111.16 23.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.437 HD21 HD12 ' D' ' 30' ' ' ILE . 35.1 mt -96.67 114.83 26.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.384 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.45 125.14 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 71.0 t80 -144.12 151.29 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.334 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.13 22.91 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.62 16.01 80.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.54 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.4 ' NH1' ' HB1' ' D' ' 46' ' ' ALA . 32.1 ptt-85 -149.29 152.96 36.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 110.794 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.26 139.9 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.505 HD13 HD12 ' D' ' 23' ' ' ILE . 84.8 mt -76.38 127.57 33.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.75 135.54 40.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -67.09 132.16 47.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.211 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.17 -18.19 52.28 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.67 171.49 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.8 164.04 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.723 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.5 p -62.36 -29.15 70.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.4 -35.59 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.081 0.467 . . . . 0.0 110.164 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -96.56 12.58 31.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.304 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 55.18 41.79 31.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 110.14 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -90.39 104.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.638 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.39 -176.1 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -64.58 149.7 48.31 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.446 -0.501 . . . . 0.0 109.935 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 59.14 44.77 15.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 54.3 m -100.32 122.7 43.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.222 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -71.76 128.49 35.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.71 136.64 54.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.75 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -85.64 109.07 18.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.713 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.838 HD23 HG23 ' D' ' 7' ' ' THR . 63.0 tp -96.76 113.4 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.01 134.49 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.035 0.445 . . . . 0.0 110.054 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.656 ' H ' HD11 ' D' ' 8' ' ' LEU . 35.5 mt -105.15 143.39 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.685 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -84.42 161.31 20.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.793 HD11 ' CZ ' ' C' ' 59' ' ' TYR . 21.7 mt -65.05 137.86 57.96 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.58 132.24 43.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.96 -129.68 47.81 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.669 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.23 151.2 28.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.12 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.12 110.96 19.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.223 0.535 . . . . 0.0 109.926 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.8 mt -65.89 -38.46 88.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.22 162.78 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.842 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.6 122.91 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.207 0.527 . . . . 0.0 110.686 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.47 155.4 34.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.765 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.732 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -71.39 121.35 18.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.824 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.25 22.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.106 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.48 152.64 17.34 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -87.13 159.24 18.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.823 0.344 . . . . 0.0 110.737 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.1 mtp -124.81 176.17 6.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -126.01 126.51 44.41 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 37' ' ' THR . 33.4 tp -107.27 122.32 46.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -117.42 106.24 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.923 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.04 -87.27 0.38 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -139.72 23.78 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.687 0.279 . . . . 0.0 111.054 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.704 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.4 m -125.08 125.69 44.18 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.236 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.569 ' CG2' HD13 ' A' ' 33' ' ' LEU . 58.0 t -105.16 124.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.916 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.6 m -123.09 134.26 25.01 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.78 146.89 79.97 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.947 1.765 . . . . 0.0 112.875 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.51 150.82 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -80.73 -6.87 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.808 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -72.79 73.3 1.1 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.86 129.99 43.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.76 -159.58 9.26 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.229 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 27' ' ' ARG . 2.2 tp -140.32 127.75 21.36 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -99.99 110.0 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.556 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.0 p90 -132.42 154.8 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.196 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.1 mt -119.01 138.12 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.397 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -134.66 130.55 36.53 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.666 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.6 tt0 -101.1 124.38 46.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 0.0 109.954 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.481 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.0 p -85.15 172.5 11.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.816 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.48 -10.31 24.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.54 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.51 7.16 42.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.602 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m 63.37 23.86 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 110.603 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -98.63 122.48 41.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.516 HG21 HD23 ' A' ' 128' ' ' LEU . 51.8 mm -81.74 120.65 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.481 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.0 m-70 -97.85 111.24 23.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.973 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -91.0 106.69 18.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 92.7 m -119.03 146.62 44.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.708 0.766 . . . . 0.0 112.752 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.7 t90 -124.94 113.4 17.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.262 -1.336 . . . . 0.0 108.331 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -105.85 135.3 47.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.959 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -76.82 132.7 39.34 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -73.58 -18.68 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -59.88 -46.1 90.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.829 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.1 m -116.46 -15.18 10.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.057 0.456 . . . . 0.0 110.072 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.37 21.51 77.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -101.88 152.74 20.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.242 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.0 t -78.16 107.84 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.54 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -86.59 -28.26 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -129.28 143.8 50.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.191 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.767 ' O ' HD23 ' A' ' 73' ' ' LEU . 43.5 p-10 -157.88 101.96 1.81 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.193 0.521 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 72' ' ' ASP . 5.5 mt -129.7 134.03 47.41 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.24 120.14 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.2 mp -108.16 112.5 40.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -71.2 162.56 71.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.937 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.58 131.43 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.921 1.747 . . . . 0.0 111.668 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.7 t0 63.88 12.22 6.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.404 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -82.13 -35.92 28.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.315 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -128.74 150.62 50.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.301 0.572 . . . . 0.0 111.105 -178.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.567 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.2 tp10 -121.77 129.59 52.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.96 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -107.03 118.08 35.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.43 168.25 20.16 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.579 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -87.39 160.32 18.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.003 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.08 90.66 11.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.119 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.75 60.15 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.984 1.789 . . . . 0.0 112.359 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.84 -39.68 3.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.34 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.6 t -128.29 80.88 71.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.67 130.49 26.52 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.604 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.81 -41.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.02 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.98 -150.92 6.7 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.44 106.23 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.467 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.19 129.35 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.22 154.17 45.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.635 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.69 134.91 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.379 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 81' ' ' GLU . 61.4 tp -104.08 123.19 46.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -122.02 130.98 53.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.129 0.49 . . . . 0.0 110.915 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 61.3 m-85 -84.43 117.83 23.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.97 -31.52 71.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.462 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.73 -21.7 11.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.936 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -80.66 -25.68 55.84 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.961 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.31 8.93 6.0 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.309 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.618 ' HD3' HD21 ' A' ' 105' ' ' LEU . 22.8 ttmt -93.97 143.88 25.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.811 0.339 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -122.83 125.27 45.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.469 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.618 HD21 ' HD3' ' A' ' 103' ' ' LYS . 52.9 mt -114.27 141.88 47.01 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.52 ' CE1' HD22 ' A' ' 33' ' ' LEU . 99.6 m-85 -115.07 134.74 54.91 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -138.01 153.55 49.39 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.276 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -129.03 136.44 50.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.532 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.445 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 29.9 tpp -72.34 134.08 45.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.078 0.466 . . . . 0.0 111.107 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.15 -0.9 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.913 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 109' ' ' MET . 99.3 mt-10 -73.16 133.08 81.62 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.278 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.96 -24.84 39.1 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.9 1.733 . . . . 0.0 112.88 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -111.25 140.8 45.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 p -99.0 12.32 36.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.371 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.92 -20.91 60.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.595 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -126.36 10.87 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.359 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.48 -47.02 83.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.534 . . . . 0.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.31 -31.04 65.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.122 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.64 -45.0 80.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.926 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.671 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.8 m170 -62.81 -41.15 99.17 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.704 0.764 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.55 -44.34 96.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.506 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -65.68 -43.36 89.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.818 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.4 -42.19 99.24 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 120' ' ' HIS . 59.9 t -58.59 -48.8 84.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.912 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.39 -39.16 88.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.298 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -74.39 -22.93 58.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.192 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 m-85 -89.42 -28.25 19.86 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.527 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.516 HD23 HG21 ' A' ' 57' ' ' ILE . 63.1 mt -92.91 -16.72 24.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.062 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -117.16 -17.61 10.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.316 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.52 63.98 18.17 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.798 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.82 153.67 68.39 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 122.522 2.148 . . . . 0.0 112.443 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.313 -1.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.22 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 48.69 70.74 1.9 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.643 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.73 145.73 70.34 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -73.73 159.15 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.298 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.14 154.36 46.31 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.762 2.308 . . . . 0.0 111.998 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.09 -155.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.615 2.21 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -125.39 155.34 71.85 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.01 143.44 90.95 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.473 2.115 . . . . 0.0 111.676 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -156.97 166.99 31.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.77 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.03 135.33 33.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 110.618 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -112.55 123.2 49.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.766 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.29 122.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.95 84.94 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.069 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 30.3 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.736 179.776 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -67.67 161.15 26.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.503 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.66 143.11 31.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.417 ' HD2' HG21 ' C' ' 12' ' ' THR . 6.4 m-85 -87.5 123.74 32.73 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.42 114.68 47.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.413 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -100.74 121.94 42.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.901 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 79.7 p -83.39 172.49 12.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.597 HD11 ' H ' ' C' ' 71' ' ' LEU . 67.2 mt -62.83 -25.09 68.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.289 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -73.9 -10.04 59.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -11.08 70.52 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.76 132.79 47.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' THR . . . . . 0.417 HG21 ' HD2' ' C' ' 4' ' ' PHE . 93.3 m -109.63 132.21 54.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.556 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.65 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.677 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -84.25 130.17 34.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.49 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.6 mt -123.79 130.21 52.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.687 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.42 115.36 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' C' ' 29' ' ' LYS . 22.4 m -135.35 166.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.0 150.7 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.961 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.27 -36.57 86.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.94 1.76 . . . . 0.0 112.069 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -83.31 -9.98 58.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.85 138.52 57.24 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.663 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -79.5 163.81 24.42 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.772 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.974 HD12 HD23 ' C' ' 50' ' ' LEU . 42.0 mm -65.39 -36.7 78.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.857 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.49 -44.15 89.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -62.9 -41.19 99.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 110.814 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.411 HG21 HD21 ' C' ' 56' ' ' LEU . 62.0 t -63.37 -42.86 97.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.48 -39.02 86.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.68 91.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.397 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.515 ' CB ' HD13 ' C' ' 15' ' ' LEU . 67.2 mttm -60.63 -39.19 87.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.71 ' CD1' HD21 ' C' ' 43' ' ' LEU . 96.8 mt -67.63 -39.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.187 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.21 -38.51 80.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.241 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -67.32 -50.86 58.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.649 ' HG3' HD21 ' C' ' 15' ' ' LEU . 22.1 mttt -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.7 151.08 51.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.77 64.23 1.89 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.648 HG22 ' HB2' ' C' ' 41' ' ' GLN . 42.1 mm -117.98 93.11 43.72 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 149.59 70.68 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.744 2.296 . . . . 0.0 112.11 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -51.69 -42.59 55.86 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.112 1.874 . . . . 0.0 112.277 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.2 -38.66 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 110.347 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -95.7 25.39 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.507 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.648 ' HB2' HG22 ' C' ' 36' ' ' ILE . 12.7 tt0 -131.61 119.87 22.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -127.23 106.64 9.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.71 HD21 ' CD1' ' C' ' 30' ' ' ILE . 63.4 mt -85.13 138.51 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.4 mt -134.39 130.23 53.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.599 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 69.0 t80 -156.37 155.88 32.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.55 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.54 14.13 9.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 89.59 -14.04 62.45 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.613 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.0 OUTLIER -117.09 150.18 39.08 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.407 0.622 . . . . 0.0 110.551 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.04 137.66 45.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.509 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.974 HD23 HD12 ' C' ' 23' ' ' ILE . 6.6 mp -74.13 101.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.18 139.43 42.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -61.48 138.81 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -17.68 55.66 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -83.03 175.68 9.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -119.23 162.21 19.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.279 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.411 HD21 HG21 ' C' ' 26' ' ' VAL . 80.9 mt -61.31 -41.26 96.7 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.757 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -63.25 -24.07 67.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.839 0.352 . . . . 0.0 110.684 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.28 -36.92 83.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.548 ' CE2' HD13 ' D' ' 73' ' ' LEU . 66.2 m-85 -98.3 14.47 27.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.272 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 57.69 38.68 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.894 0.378 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.41 HG21 HD22 ' C' ' 56' ' ' LEU . 53.1 mt -83.82 111.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.234 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -98.08 178.51 5.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -60.33 146.09 45.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.957 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 59.76 22.1 10.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' SER . . . . . 0.532 ' O ' HD12 ' C' ' 67' ' ' LEU . 17.0 m -74.34 127.03 31.96 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.874 0.368 . . . . 0.0 110.185 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.1 m -80.33 126.43 31.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.532 HD12 ' O ' ' C' ' 65' ' ' SER . 4.5 mp -116.41 152.86 33.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -103.0 126.18 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.152 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.656 HD22 HD21 ' C' ' 71' ' ' LEU . 2.3 tt -103.4 122.27 44.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 56' ' ' LEU . 47.6 t -109.12 132.49 57.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.656 HD21 HD22 ' C' ' 69' ' ' LEU . 29.1 mt -107.25 135.54 48.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.081 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.631 ' O ' HD22 ' C' ' 73' ' ' LEU . 94.1 mtt-85 -62.18 -39.47 92.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 110.509 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' LEU . . . . . 0.631 HD22 ' O ' ' C' ' 72' ' ' ARG . 1.5 mm? -126.54 -77.18 0.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.328 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ARG . . . . . 0.569 ' O ' HD13 ' C' ' 71' ' ' LEU . 12.8 tpt180 -153.62 -54.91 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.23 -172.06 55.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.72 90.27 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.69 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -63.35 157.07 23.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.023 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 17.5 pt -138.17 145.17 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.163 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -86.5 126.96 34.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.841 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -112.38 101.18 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -90.67 127.63 36.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.696 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -89.73 -179.21 5.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.688 HD11 ' H ' ' D' ' 71' ' ' LEU . 79.3 mt -64.23 -34.59 78.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -68.21 -12.88 61.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.627 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.18 63.39 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.14 129.96 42.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -102.11 132.35 48.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.458 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.419 HD13 HG21 ' D' ' 13' ' ' ILE . 1.4 mt -126.95 110.4 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.956 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -81.38 130.4 35.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.571 HD21 ' HD2' ' D' ' 33' ' ' LYS . 91.7 mt -125.73 123.73 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.471 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -66.11 112.43 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.073 0.463 . . . . 0.0 110.946 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.517 HG12 ' CD ' ' D' ' 29' ' ' LYS . 20.0 m -136.08 165.57 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.881 -0.512 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' GLU . . . . . 0.602 ' O ' HD12 ' D' ' 56' ' ' LEU . 96.1 mt-10 -111.27 152.63 43.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.115 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -38.34 86.01 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.826 1.684 . . . . 0.0 112.222 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -66.27 -36.49 83.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.162 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -50.45 140.57 13.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.688 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 31.0 p -87.05 169.46 12.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.108 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.38 -34.73 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.279 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.63 -44.07 89.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.102 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.62 -42.4 99.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.466 HG21 HD21 ' D' ' 56' ' ' LEU . 68.0 t -63.21 -42.97 98.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.462 ' CG ' HD22 ' D' ' 43' ' ' LEU . 56.5 mtmt -60.22 -40.42 90.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.58 94.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.704 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.517 ' CD ' HG12 ' D' ' 17' ' ' VAL . 68.4 mttm -60.81 -39.19 88.02 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.665 0.745 . . . . 0.0 109.089 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' D' ' 43' ' ' LEU . 97.4 mt -63.53 -40.13 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.548 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -59.08 -42.17 89.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.732 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.74 -40.71 93.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.751 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.571 ' HD2' HD21 ' D' ' 15' ' ' LEU . 28.0 mttm -77.32 -62.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.327 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.16 156.4 18.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.375 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.92 55.48 4.26 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.656 HG22 ' HB2' ' D' ' 41' ' ' GLN . 41.9 mm -109.8 99.06 36.7 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.136 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.31 153.13 71.47 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.775 1.65 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.62 -40.32 73.37 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.079 1.853 . . . . 0.0 111.952 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.36 -39.37 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 110.402 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -103.1 35.23 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.656 ' HB2' HG22 ' D' ' 36' ' ' ILE . 12.0 tt0 -136.65 124.22 22.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.937 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -122.16 104.68 9.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.53 HD11 ' CD1' ' D' ' 30' ' ' ILE . 3.5 mp -85.31 115.23 22.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.935 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -126.07 126.11 69.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.435 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.569 ' HB2' HD21 ' D' ' 50' ' ' LEU . 52.1 t80 -63.39 -46.21 87.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.658 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.71 -78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.776 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.26 2.56 57.82 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -145.02 136.81 25.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.126 0.489 . . . . 0.0 110.931 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -78.55 138.07 38.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.378 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' D' ' 45' ' ' PHE . 77.7 mt -74.47 122.96 23.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.96 132.56 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 133.63 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.619 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.41 55.61 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -82.3 147.21 29.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.735 0.302 . . . . 0.0 111.011 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 48.8 p -75.71 162.57 28.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.602 HD12 ' O ' ' D' ' 18' ' ' GLU . 80.5 mt -67.36 -38.27 84.52 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.632 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.09 -25.34 67.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.942 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.31 -37.63 83.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -98.06 15.15 25.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 54.37 39.89 31.31 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.75 91.32 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.779 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -82.11 177.99 8.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.974 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -58.7 151.37 21.16 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 60.09 44.51 12.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -97.29 120.9 38.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.526 ' C ' HD12 ' D' ' 67' ' ' LEU . 84.9 m -75.06 127.27 32.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.526 HD12 ' C ' ' D' ' 66' ' ' THR . 8.2 mp -121.21 126.83 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.194 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.01 120.76 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.95 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.458 HD22 HD21 ' D' ' 71' ' ' LEU . 3.5 tt -100.12 112.22 24.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.978 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' D' ' 8' ' ' LEU . 92.1 t -99.92 132.16 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.688 ' H ' HD11 ' D' ' 8' ' ' LEU . 60.9 mt -102.4 135.77 43.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -72.4 136.05 45.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.613 HD22 ' HE2' ' C' ' 48' ' ' LYS . 53.3 mt -98.63 6.49 47.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.824 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -54.59 134.15 46.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.06 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.57 -19.82 43.78 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.357 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.185 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.518 179.788 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.72 152.36 43.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.21 127.23 37.61 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.708 0.765 . . . . 0.0 110.206 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 51' ' ' GLN . 84.3 mt -67.12 -37.48 83.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.53 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.495 HG11 HG22 ' A' ' 124' ' ' VAL . 1.4 p -148.62 162.93 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.829 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -173.85 122.03 0.32 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.344 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.78 151.4 27.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.912 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -70.37 123.08 20.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 110.357 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -154.93 145.45 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.0 154.26 16.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -87.1 172.62 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 111.165 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 23.4 mtp -138.79 173.72 11.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -124.89 123.6 40.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.53 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 37' ' ' THR . 25.9 tp -107.61 117.24 33.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -120.97 114.46 21.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.953 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.78 -90.09 0.48 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.1 p -141.66 21.14 2.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.841 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.581 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.8 m -123.05 130.86 53.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 33' ' ' LEU . 96.3 t -109.42 123.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.976 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.821 HG22 ' HB3' ' B' ' 947' ' ' PRO . 59.4 p -118.25 132.77 23.61 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.685 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.57 142.67 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.963 1.775 . . . . 0.0 113.05 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -97.74 145.62 26.17 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.733 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -81.21 -6.86 59.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.132 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -73.35 75.41 1.37 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.61 134.12 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.28 -156.53 7.88 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -138.72 123.01 18.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 28' ' ' ALA . 56.1 t -95.77 108.42 21.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.711 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.4 p90 -131.25 153.88 49.06 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.665 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 24' ' ' VAL . 95.5 mt -117.67 139.83 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.548 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.32 128.67 26.05 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 123.84 0.713 . . . . 0.0 110.854 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.537 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.0 tt0 -98.29 124.22 42.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.308 0.575 . . . . 0.0 110.278 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 58' ' ' HIS . 14.5 p -83.75 171.61 13.01 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.54 -10.05 23.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.549 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -89.22 1.97 54.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.5 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.66 19.18 7.4 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.672 HD11 HG11 ' C' ' 70' ' ' VAL . 72.4 mt -98.95 122.73 42.58 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 mm -79.21 125.06 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.506 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.7 m-70 -101.11 114.87 29.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.108 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -93.31 106.67 18.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.89 145.46 45.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -126.96 111.98 14.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.837 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -102.59 145.24 29.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.627 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -81.7 133.55 35.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -73.96 -17.62 60.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.937 0.399 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.4 m -60.18 -45.3 93.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 m -117.79 -12.97 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.456 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.86 23.24 75.37 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -102.51 151.77 21.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.771 0.32 . . . . 0.0 110.813 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.01 109.03 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.309 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.06 -28.42 21.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.92 145.37 50.98 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.075 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.778 ' O ' HD23 ' A' ' 73' ' ' LEU . 64.4 t0 -158.09 100.44 1.71 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.944 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.778 HD23 ' O ' ' A' ' 72' ' ' ASP . 4.7 mt -131.7 129.24 40.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.441 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -75.29 125.97 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.105 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 74' ' ' ILE . 26.2 mm -115.28 121.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.915 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.474 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 39.3 m-85 -82.79 159.76 62.64 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.274 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.09 142.44 97.06 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.992 1.795 . . . . 0.0 111.324 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 61.27 12.64 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.876 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -93.09 -33.33 14.12 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.635 0.255 . . . . 0.0 110.889 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -139.48 148.42 42.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.5 tp10 -120.89 132.24 54.86 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.403 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -105.82 115.83 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -140.81 168.97 18.53 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.098 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -85.61 162.38 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.316 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.54 88.56 9.42 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.317 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.47 60.95 8.02 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.507 2.138 . . . . 0.0 112.09 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 -41.99 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.451 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.3 t -129.23 80.01 73.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.474 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.23 130.11 38.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.189 1.926 . . . . 0.0 111.219 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t 168.02 -39.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.627 0.58 . . . . 0.0 110.123 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.54 -170.1 11.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.605 ' HG3' HG22 ' A' ' 114' ' ' THR . 1.4 mmt-85 -95.96 107.0 19.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.732 0.301 . . . . 0.0 111.002 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.07 129.42 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -122.66 156.06 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.971 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.75 131.45 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 81' ' ' GLU . 60.7 tp -102.34 123.23 45.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -118.98 137.54 53.44 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.74 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -92.8 112.75 24.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.309 0.576 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.88 -37.92 88.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.828 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.78 -21.63 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.514 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.62 -173.16 20.74 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.8 m -122.52 25.75 8.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.941 0.4 . . . . 0.0 110.299 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 149.43 33.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -134.81 144.86 47.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.463 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -120.2 152.08 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.768 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 31' ' ' MET . 98.1 m-85 -124.03 135.0 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.812 0.339 . . . . 0.0 110.578 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.35 158.7 43.84 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -131.99 135.98 46.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.574 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.1 mmm -72.43 139.91 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.0 110.85 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -101.38 0.29 36.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.339 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -72.19 145.2 88.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.15 -28.35 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.095 1.863 . . . . 0.0 112.728 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.07 143.62 49.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.147 0.499 . . . . 0.0 110.321 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.605 HG22 ' HG3' ' A' ' 92' ' ' ARG . 76.9 p -89.52 -0.16 57.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.268 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.11 -19.22 42.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -117.76 -18.38 9.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.3 -41.03 98.17 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.335 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.23 -40.03 95.19 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.394 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.37 -42.92 95.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.535 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.724 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.5 m170 -65.87 -40.07 91.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.476 0.655 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.91 -43.48 98.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.464 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -66.64 -41.44 88.26 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.524 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -64.59 -41.08 96.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.4 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.2 t -57.29 -46.98 85.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.72 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -62.21 -39.45 92.78 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.463 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.65 -25.59 61.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.019 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -87.62 -26.05 23.25 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.999 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 HG12 ' A' ' 124' ' ' VAL . 88.3 mt -95.44 -16.37 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.467 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -115.34 -22.44 9.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.09 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -135.22 71.76 67.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.935 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.42 147.57 77.15 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.254 1.97 . . . . 0.0 112.365 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.585 0 C-N-CA 122.463 2.109 . . . . 0.0 112.213 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.46 152.43 95.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.69 154.74 49.45 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.811 2.34 . . . . 0.0 112.385 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.72 156.58 35.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.382 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -53.18 138.08 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.839 1.693 . . . . 0.0 112.255 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 172.96 15.3 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -95.66 156.08 37.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.821 ' HB3' HG22 ' A' ' 39' ' ' THR . 34.8 Cg_endo -66.06 151.42 83.86 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.78 166.28 32.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.798 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.36 134.58 34.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -120.21 132.48 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.415 HD13 HG21 ' B' ' 951' ' ' ILE . 2.9 mt -130.18 128.69 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -76.2 85.79 3.03 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.111 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.664 179.921 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' GLN . . . . . 0.466 ' HB2' HG22 ' C' ' 14' ' ' THR . 4.2 pt20 -58.34 158.21 7.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.654 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.681 HD13 HD21 ' C' ' 56' ' ' LEU . 20.9 pt -139.05 142.27 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.911 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -81.94 127.21 32.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.157 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -114.67 115.84 50.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -96.91 118.6 33.68 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.17 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -75.23 173.73 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.429 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -45.86 -31.56 2.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.533 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 76.9 p -99.96 -179.87 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.56 -19.11 53.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -53.1 129.37 30.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.049 0.452 . . . . 0.0 110.728 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -127.58 134.6 49.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.454 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.533 HD13 ' HG2' ' C' ' 34' ' ' GLU . 0.0 OUTLIER -130.7 122.39 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.517 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 14' ' ' THR . . . . . 0.466 HG22 ' HB2' ' C' ' 2' ' ' GLN . 85.7 m -88.8 131.87 34.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.595 HD13 ' CB ' ' C' ' 29' ' ' LYS . 65.7 mt -119.3 125.1 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' C' ' 2' ' ' GLN . 8.0 pm0 -65.94 109.68 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 111.009 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.652 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.3 m -133.13 163.78 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.487 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -108.07 156.08 38.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.159 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.29 -37.85 96.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.136 1.891 . . . . 0.0 111.87 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -79.72 -7.2 58.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ASP . . . . . 0.54 ' HB3' HD13 ' C' ' 56' ' ' LEU . 34.6 t0 -57.6 137.57 56.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.008 0.432 . . . . 0.0 110.899 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -80.75 160.74 24.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.835 HD12 HD23 ' C' ' 50' ' ' LEU . 43.1 mm -63.7 -41.41 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -57.95 -36.63 72.81 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.292 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.0 -41.51 95.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.556 . . . . 0.0 110.8 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.814 HG21 HD11 ' C' ' 56' ' ' LEU . 61.5 t -63.6 -42.63 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.773 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.469 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.8 mtmt -60.76 -39.62 89.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.354 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.92 93.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.652 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.652 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.1 mttm -60.22 -38.86 84.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.77 HD13 HD11 ' C' ' 69' ' ' LEU . 97.2 mt -65.05 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.962 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -59.01 -43.91 91.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.411 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.75 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.833 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -72.09 -75.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' GLU . . . . . 0.533 ' HG2' HD13 ' C' ' 13' ' ' ILE . 77.1 mm-40 -93.71 151.49 19.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.366 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.46 56.02 4.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.464 HG23 HD22 ' C' ' 71' ' ' LEU . 42.6 mm -106.4 109.97 63.52 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.69 154.36 49.56 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.054 1.836 . . . . 0.0 112.195 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.98 -38.85 80.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.112 1.875 . . . . 0.0 112.235 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -61.52 -39.97 92.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -87.02 -3.18 59.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.476 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.401 ' HG3' HG22 ' C' ' 36' ' ' ILE . 81.2 mt-30 -88.16 67.15 8.76 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.565 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -84.27 109.89 18.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' C' ' 27' ' ' LYS . 23.4 mt -100.32 128.94 46.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.239 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -128.79 128.67 67.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.69 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -147.8 145.42 28.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.435 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 19.84 7.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.099 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 75' ' ' ILE . . . 90.31 -13.15 65.91 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.758 ' HD2' HD23 ' D' ' 73' ' ' LEU . 72.8 mmtt -91.66 145.99 24.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.27 0.557 . . . . 0.0 111.482 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -95.21 105.33 17.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.835 HD23 HD12 ' C' ' 23' ' ' ILE . 10.2 mp -65.86 88.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.17 -74.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -177.05 169.02 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.46 20.84 77.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.32 171.28 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 110.025 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -126.33 163.69 22.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.8 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.814 HD11 HG21 ' C' ' 26' ' ' VAL . 3.1 mp -57.87 -43.14 85.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.587 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -63.09 -22.35 66.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.951 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.77 -36.56 83.48 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.354 0.597 . . . . 0.0 109.784 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.64 ' CE2' HD22 ' D' ' 73' ' ' LEU . 97.2 m-85 -100.28 11.29 39.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.454 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 57.7 46.41 17.39 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.298 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' C' ' 56' ' ' LEU . 80.9 mt -92.71 119.84 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.542 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.99 -178.9 3.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.83 147.84 52.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 58.79 45.21 15.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.215 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -98.45 126.36 43.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.075 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 82.3 m -75.62 126.97 32.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.1 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -112.52 145.44 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.12 114.62 26.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.387 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.77 HD11 HD13 ' C' ' 30' ' ' ILE . 1.2 mt -96.17 126.43 41.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.261 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.648 HG11 HD11 ' A' ' 56' ' ' LEU . 58.3 t -116.45 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.464 HD22 HG23 ' C' ' 36' ' ' ILE . 27.4 mt -103.51 149.19 25.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.286 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -62.16 -39.9 94.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.498 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -113.69 147.45 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.613 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -60.66 -40.61 92.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.12 -158.52 53.38 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.68 179.08 47.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 64.2 t0 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.326 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.28 163.52 15.25 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' D' ' 65' ' ' SER . 16.3 pt -141.84 142.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.044 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.64 ' HD2' HG21 ' D' ' 12' ' ' THR . 5.5 m-85 -87.01 126.56 34.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.75 105.36 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -88.57 125.86 34.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.71 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.581 HG22 HD23 ' D' ' 69' ' ' LEU . 73.7 p -78.01 -166.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.883 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' D' ' 70' ' ' VAL . 92.4 mt -59.16 -28.47 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.793 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -102.91 -177.63 3.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.36 57.6 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -53.07 129.85 32.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 110.894 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.64 HG21 ' HD2' ' D' ' 4' ' ' PHE . 98.4 m -123.93 138.14 54.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.029 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.51 HG22 ' HD2' ' D' ' 33' ' ' LYS . 0.9 OUTLIER -122.75 109.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.956 -178.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -85.41 129.91 34.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.438 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.539 HD21 ' HD2' ' D' ' 33' ' ' LYS . 96.1 mt -122.07 134.07 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.44 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.26 117.54 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.732 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.439 HG12 ' HE2' ' D' ' 29' ' ' LYS . 21.7 m -136.94 167.44 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.168 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.23 154.2 45.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.51 -29.6 85.42 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.609 1.539 . . . . 0.0 111.729 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -84.55 -11.87 55.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.609 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.66 142.16 58.14 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.786 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.0 p -83.27 166.91 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.078 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.57 -37.4 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.13 -42.73 91.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.507 HG21 HD21 ' D' ' 56' ' ' LEU . 69.7 t -61.98 -43.78 98.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.806 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.529 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.7 mtmt -61.08 -38.39 86.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.1 94.35 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.105 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.475 ' CB ' HD13 ' D' ' 15' ' ' LEU . 15.3 mttp -59.96 -39.03 84.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.68 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.31 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.8 -39.5 89.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.175 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.79 -45.1 91.23 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.478 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.539 ' HD2' HD21 ' D' ' 15' ' ' LEU . 71.2 mttt -73.48 -40.51 64.06 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -128.16 151.19 49.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.27 62.06 2.23 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.1 103.25 54.71 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.07 154.43 66.52 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.346 1.364 . . . . 0.0 111.954 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -53.61 -25.97 35.39 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.629 2.22 . . . . 0.0 112.517 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.96 13.63 14.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.418 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -145.4 59.97 1.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.376 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.93 147.08 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.24 0.543 . . . . 0.0 111.774 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.8 124.29 31.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.466 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.529 HD11 ' HG2' ' D' ' 27' ' ' LYS . 53.8 mt -105.49 114.25 28.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.57 HG23 ' C ' ' D' ' 48' ' ' ARG . 82.3 mt -121.68 121.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.82 -46.99 79.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -179.04 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.021 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.34 -8.15 79.54 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.57 ' C ' HG23 ' D' ' 44' ' ' ILE . 44.0 ttm180 -129.79 127.89 41.26 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.867 0.365 . . . . 0.0 110.499 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -81.13 153.47 27.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.572 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.57 102.71 14.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.062 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.84 155.62 35.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.56 154.37 41.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.41 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.13 12.67 63.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -127.33 150.78 49.43 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.198 0.523 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.37 163.36 13.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.999 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.507 HD21 HG21 ' D' ' 26' ' ' VAL . 81.3 mt -61.91 -39.31 91.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.709 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.5 -22.51 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.322 . . . . 0.0 110.367 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.46 -38.33 83.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.261 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -99.83 16.86 22.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.86 40.93 28.64 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.337 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ILE . . . . . 0.463 HG23 ' OG ' ' D' ' 65' ' ' SER . 78.8 mt -88.22 110.1 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -95.54 178.61 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -59.62 152.23 22.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.539 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 56.82 33.73 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 65' ' ' SER . . . . . 0.463 ' OG ' HG23 ' D' ' 61' ' ' ILE . 4.2 t -77.03 120.86 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.937 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 78.1 m -81.63 119.8 24.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.35 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.75 142.76 45.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.075 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -87.69 114.42 24.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.35 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.581 HD23 HG22 ' D' ' 7' ' ' THR . 36.1 tp -102.51 118.14 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.583 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.438 ' HA ' HD21 ' D' ' 8' ' ' LEU . 87.0 t -117.72 128.73 74.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.814 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.37 145.71 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.69 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -72.82 148.25 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.432 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.758 HD23 ' HD2' ' C' ' 48' ' ' LYS . 63.0 tp -70.06 127.49 33.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.516 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.2 143.44 52.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -14.47 62.61 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.498 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -71.68 139.76 49.34 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.054 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -95.87 113.19 24.79 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.479 ' CD1' HD12 ' A' ' 57' ' ' ILE . 96.6 mt -66.04 -39.01 89.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.603 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.3 p -147.5 163.04 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.05 122.38 0.31 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.756 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.31 158.7 40.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.815 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -74.08 124.21 25.85 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.097 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.416 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -157.0 145.28 19.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.336 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.47 154.72 16.47 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -90.26 174.7 7.45 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.17 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.4 mtp -138.76 172.77 12.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -123.12 123.9 41.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 37' ' ' THR . 27.0 tp -105.29 119.81 39.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.329 0.585 . . . . 0.0 110.618 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -121.42 107.62 12.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.571 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.56 -97.06 0.68 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 p -131.06 19.71 4.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.297 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.563 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.1 m -121.76 130.63 53.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.7 t -110.65 124.07 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.81 133.6 22.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.65 148.21 46.78 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.799 1.666 . . . . 0.0 112.959 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -103.63 130.69 51.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.68 -8.18 50.08 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.917 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.63 78.09 1.08 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -58.53 131.08 49.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.237 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.47 -158.56 9.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.84 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.7 tp -137.57 126.51 24.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 28' ' ' ALA . 36.9 t -96.58 113.5 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.066 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -136.41 155.88 49.4 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.062 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' LEU . 90.8 mt -123.89 140.14 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.105 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -140.09 146.14 38.53 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -109.78 128.55 55.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.221 0.534 . . . . 0.0 110.335 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 58' ' ' HIS . 28.5 p -89.68 172.64 8.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.756 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.56 -10.51 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.152 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.15 3.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m 63.12 26.55 15.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.336 0.589 . . . . 0.0 110.335 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.648 HD11 HG11 ' C' ' 70' ' ' VAL . 71.4 mt -103.97 125.47 50.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.479 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.2 mm -83.11 122.92 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.518 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.8 m-70 -100.59 116.03 31.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.713 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -93.25 110.37 21.89 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -124.64 146.99 48.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.162 0.982 . . . . 0.0 112.951 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -124.08 116.37 22.67 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.943 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -108.19 134.31 51.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.061 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.69 131.2 39.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.82 -17.27 61.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.888 0.375 . . . . 0.0 110.464 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -59.53 -46.4 88.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.863 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.6 m -116.49 -15.36 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 109.888 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.18 21.7 77.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -101.36 152.89 20.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.16 104.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.926 0.393 . . . . 0.0 110.424 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.73 -30.98 36.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -127.95 145.65 50.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.819 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.576 ' C ' HD23 ' A' ' 73' ' ' LEU . 42.9 p-10 -158.11 120.21 3.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.612 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.817 HD12 HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -148.1 136.09 21.09 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.17 0.509 . . . . 0.0 110.381 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -81.62 122.88 37.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.574 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.817 HD11 HD12 ' A' ' 73' ' ' LEU . 24.6 mm -114.06 121.23 65.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.279 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 61.9 m-85 -84.78 162.3 50.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.63 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.92 139.56 89.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.368 2.045 . . . . 0.0 111.54 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 59.64 12.02 2.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.229 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -87.17 -25.12 24.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.716 ' SG ' HG21 ' A' ' 75' ' ' ILE . 14.6 p -144.43 169.23 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.35 0.595 . . . . 0.0 110.324 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -137.54 125.25 22.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.809 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.23 118.74 37.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.57 164.71 30.84 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.415 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -79.4 159.84 26.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.018 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.6 t -111.36 90.62 12.28 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.18 60.25 7.72 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.829 1.686 . . . . 0.0 112.509 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -114.24 -38.82 4.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.991 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.06 82.35 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.585 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.16 130.33 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.702 1.602 . . . . 0.0 111.685 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.5 t 169.68 -45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.571 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.72 -154.98 8.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.7 OUTLIER -109.85 106.81 16.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.505 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.65 128.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.08 154.37 41.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.681 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.01 136.12 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.196 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.442 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.7 tp -103.77 120.0 40.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -118.36 136.08 53.95 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.238 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -84.22 114.67 21.98 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.124 0.488 . . . . 0.0 109.833 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.9 -37.88 86.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.706 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.96 -21.92 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.23 -175.38 22.68 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -117.88 15.81 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.675 0.274 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HD3' HD21 ' A' ' 105' ' ' LEU . 10.2 ttmt -93.35 146.0 24.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.87 137.96 40.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.408 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.673 HD21 ' HD3' ' A' ' 103' ' ' LYS . 43.6 mt -119.23 148.21 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.44 133.59 55.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.961 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.72 157.99 45.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.293 0.568 . . . . 0.0 111.188 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -132.07 138.07 48.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.522 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.3 ttm -77.07 131.55 38.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.072 0.463 . . . . 0.0 111.475 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -1.7 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.702 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.25 144.91 98.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.06 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.32 -26.93 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.051 1.834 . . . . 0.0 112.786 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -121.85 144.57 48.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.054 0.454 . . . . 0.0 110.245 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.46 HG22 ' HG2' ' A' ' 92' ' ' ARG . 72.4 p -94.0 9.16 38.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.629 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.88 -22.1 61.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.84 -4.66 12.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.54 -46.95 87.77 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -41.44 99.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.71 -43.23 97.19 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.716 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.9 m170 -64.34 -40.7 96.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.577 0.703 . . . . 0.0 109.111 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.77 -45.07 94.38 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.901 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -68.01 -42.12 81.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.4 -41.88 98.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.513 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 120' ' ' HIS . 56.2 t -59.13 -47.08 91.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.312 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.89 -39.59 93.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.271 0.558 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.87 -36.37 80.15 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.075 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.441 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 23.7 m-85 -80.17 -30.43 38.83 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.955 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 75' ' ' ILE . 80.4 mt -90.02 -17.51 27.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.853 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -116.98 -19.0 9.98 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.372 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.81 69.78 36.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.339 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.21 157.6 59.01 Favored 'Trans proline' 0 C--N 1.296 -2.195 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.539 2.16 . . . . 0.0 112.319 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.69 154.69 81.84 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 145.1 29.19 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.402 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.35 156.47 68.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.018 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.17 137.39 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.017 1.811 . . . . 0.0 111.873 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.08 -170.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.033 1.822 . . . . 0.0 111.848 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -124.95 158.33 63.38 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.257 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.59 144.32 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.588 2.192 . . . . 0.0 112.377 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -155.53 164.43 38.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.72 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -86.16 135.74 33.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.905 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -121.06 122.95 41.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.429 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.33 124.1 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -68.92 83.4 0.31 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.807 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.515 179.506 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -69.37 161.84 28.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 pt -140.04 144.77 27.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.367 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.16 126.38 35.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.774 HG11 HD11 ' C' ' 30' ' ' ILE . 96.5 t -112.31 115.27 49.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -103.49 127.22 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.53 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -90.03 173.34 8.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 111.314 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.66 -25.92 68.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.174 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -73.41 -9.39 58.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.77 -7.41 73.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -71.87 130.83 41.99 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 110.198 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -109.84 132.22 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.255 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.4 HD13 HG21 ' C' ' 13' ' ' ILE . 0.0 OUTLIER -132.7 116.55 27.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 -179.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -87.07 131.45 34.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.072 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.626 HD21 ' HG3' ' C' ' 33' ' ' LYS . 92.5 mt -123.38 133.64 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -73.5 115.49 12.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.532 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.463 HG12 ' HE3' ' C' ' 29' ' ' LYS . 22.9 m -135.37 168.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.458 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.19 153.35 45.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.193 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.22 -38.17 93.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.999 1.799 . . . . 0.0 112.345 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -81.73 -8.19 59.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -59.04 139.03 57.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.953 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -80.16 161.78 25.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.491 HD12 HD13 ' C' ' 50' ' ' LEU . 48.8 mm -63.67 -38.53 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.177 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.19 -41.93 89.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.284 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.12 -41.25 98.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.124 0.488 . . . . 0.0 110.548 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.414 HG22 HG11 ' C' ' 17' ' ' VAL . 56.1 t -62.91 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.614 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -60.96 -38.39 85.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.01 91.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.585 ' CB ' HD13 ' C' ' 15' ' ' LEU . 67.3 mttm -60.11 -39.28 85.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.774 HD11 HG11 ' C' ' 5' ' ' VAL . 5.8 mm -64.59 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.471 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -59.69 -40.15 86.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.811 0.338 . . . . 0.0 110.377 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -67.55 -50.94 56.24 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.626 ' HG3' HD21 ' C' ' 15' ' ' LEU . 19.6 mttt -64.93 -40.98 95.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 112.038 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -132.18 146.41 52.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.199 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.04 63.98 2.01 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.589 HG22 ' HB2' ' C' ' 41' ' ' GLN . 3.5 mt -121.71 112.32 32.39 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.16 157.35 57.65 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.777 1.651 . . . . 0.0 111.748 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.8 -38.07 96.6 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.168 1.912 . . . . 0.0 112.188 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.96 -40.92 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.915 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -88.64 -17.68 29.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.658 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.589 ' HB2' HG22 ' C' ' 36' ' ' ILE . 4.8 tt0 -92.03 116.44 28.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.054 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -120.28 114.19 21.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.667 ' CB ' HD12 ' C' ' 50' ' ' LEU . 79.4 mt -92.48 131.86 37.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.295 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -130.75 129.25 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -145.17 152.46 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.899 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.54 20.31 10.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 110.505 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.72 -5.09 76.44 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.668 ' HG2' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -115.11 139.31 50.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.087 0.47 . . . . 0.0 110.736 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.16 131.61 43.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.667 HD12 ' CB ' ' C' ' 43' ' ' LEU . 50.4 mt -69.68 103.7 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.778 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -75.31 138.94 42.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.97 137.04 58.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.69 -17.81 52.01 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -84.28 174.99 9.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -120.62 165.54 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.346 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' C' ' 56' ' ' LEU . 79.3 mt -62.54 -39.88 94.99 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.567 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -64.11 -25.96 68.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.66 -33.55 75.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.437 . . . . 0.0 110.356 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' D' ' 73' ' ' LEU . 65.1 m-85 -99.45 13.77 32.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.283 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 56.29 43.93 25.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -91.02 114.76 28.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.45 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -63.7 146.2 54.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.16 44.96 18.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.939 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 38.9 m -99.33 124.93 44.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.47 ' C ' HD12 ' C' ' 67' ' ' LEU . 40.9 m -74.45 130.83 40.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.223 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.47 HD12 ' C ' ' C' ' 66' ' ' THR . 7.5 mp -118.65 155.16 31.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.399 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -105.89 120.65 42.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.503 HD11 HG21 ' C' ' 30' ' ' ILE . 1.8 tt -101.27 114.79 29.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.015 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.574 HG11 HD11 ' A' ' 56' ' ' LEU . 58.8 t -104.25 130.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.76 131.94 38.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -80.45 132.12 35.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.62 137.96 44.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -62.6 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.24 -166.56 52.72 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.9 -39.93 97.63 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.58 179.827 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -153.18 166.94 30.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.754 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.611 HG22 ' HB3' ' D' ' 65' ' ' SER . 3.1 pt -144.1 150.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.019 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.0 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.43 111.95 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -95.43 122.04 37.73 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.639 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.713 HG22 HD23 ' D' ' 69' ' ' LEU . 75.3 p -79.77 173.3 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.778 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.4 mt -61.1 -35.34 76.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.158 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -69.17 -12.03 61.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.892 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.4 60.3 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -61.56 130.96 48.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.71 0.291 . . . . 0.0 110.457 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -103.89 133.94 48.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.561 HD12 ' OE2' ' D' ' 34' ' ' GLU . 1.3 mt -126.98 106.67 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.965 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 124.4 27.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.225 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -121.01 132.25 54.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.357 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.81 120.8 21.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.632 HG12 ' CD ' ' D' ' 29' ' ' LYS . 31.4 m -134.56 -177.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.744 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 18' ' ' GLU . . . . . 0.533 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.6 mt-10 -132.04 152.08 79.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.119 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.75 -27.21 82.9 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.983 1.789 . . . . 0.0 111.977 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.3 p -86.21 -14.05 45.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.34 143.3 57.92 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.593 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -87.43 168.48 13.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.172 0.51 . . . . 0.0 110.854 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.89 -38.31 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.682 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.31 -39.71 87.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -62.29 -40.9 97.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.687 HG21 HD21 ' D' ' 56' ' ' LEU . 58.7 t -63.55 -42.47 96.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.784 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.81 -40.59 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.085 0.469 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.87 91.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.109 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.632 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.37 -38.69 81.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.779 ' CD1' HD21 ' D' ' 43' ' ' LEU . 81.1 mt -64.37 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.167 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -61.13 -43.65 98.55 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.867 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.78 -23.18 61.54 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.079 -0.388 . . . . 0.0 111.904 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.46 3.54 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' GLU . . . . . 0.679 ' OE2' HG23 ' D' ' 30' ' ' ILE . 43.0 mt-10 -149.22 -46.07 0.14 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.51 20.11 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' D' ' 71' ' ' LEU . 30.2 mt -88.69 119.84 70.08 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.662 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.76 159.35 50.99 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.715 1.61 . . . . 0.0 111.888 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.37 -23.17 36.9 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.498 2.132 . . . . 0.0 112.537 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -93.24 18.17 9.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.886 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -146.14 23.96 1.32 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.728 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.423 ' HB2' HD11 ' D' ' 69' ' ' LEU . 27.5 pt20 -150.12 144.77 25.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.978 0.418 . . . . 0.0 110.987 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -128.28 120.49 27.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.526 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.779 HD21 ' CD1' ' D' ' 30' ' ' ILE . 74.9 mt -96.3 121.38 38.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.36 129.34 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.53 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 74.0 t80 -130.95 133.1 45.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.18 26.47 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.23 79.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -126.09 130.73 51.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -65.21 138.34 58.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' D' ' 43' ' ' LEU . 84.0 mt -84.66 112.0 20.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.491 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.83 152.38 37.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -73.65 164.3 26.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.315 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.14 25.03 75.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -127.23 149.64 49.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -93.41 161.91 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.285 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.687 HD21 HG21 ' D' ' 26' ' ' VAL . 76.9 mt -62.61 -39.55 94.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.733 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.0 p -63.3 -22.84 67.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.429 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.87 -37.97 86.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.036 0.446 . . . . 0.0 110.62 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -96.76 16.31 19.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.43 42.07 25.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -91.51 101.75 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.728 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -94.96 179.84 5.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.478 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -56.32 145.33 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.268 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 59.92 42.44 16.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' SER . . . . . 0.611 ' HB3' HG22 ' D' ' 3' ' ' ILE . 28.5 t -95.98 120.81 36.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.595 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.432 ' C ' HD12 ' D' ' 67' ' ' LEU . 25.1 m -76.84 124.99 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.389 . . . . 0.0 110.396 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.432 HD12 ' C ' ' D' ' 66' ' ' THR . 7.9 mp -115.69 136.02 53.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.154 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -84.0 124.02 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.404 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.713 HD23 HG22 ' D' ' 7' ' ' THR . 55.4 tp -104.9 118.37 36.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.701 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.665 ' HA ' HD21 ' D' ' 8' ' ' LEU . 98.0 t -115.43 132.04 65.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.238 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.778 ' H ' HD11 ' D' ' 8' ' ' LEU . 49.9 mt -104.55 152.84 21.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.488 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.88 -40.35 95.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' C' ' 59' ' ' TYR . 88.0 mt -121.62 144.64 48.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -97.38 -158.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.043 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.54 93.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.725 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -69.34 166.31 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.599 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.98 128.65 35.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 51' ' ' GLN . 81.7 mt -67.59 -37.26 82.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.853 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -148.67 160.98 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.84 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.47 122.56 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.12 155.17 34.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.649 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -74.08 118.03 16.57 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.358 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.15 26.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.94 150.72 17.12 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -89.32 157.84 18.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.73 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 29.6 mtp -124.24 175.56 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -126.16 122.64 36.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.246 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 37' ' ' THR . 30.5 tp -106.03 122.75 46.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.993 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -118.36 103.75 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.12 -85.18 0.69 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -141.3 18.11 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.534 0.206 . . . . 0.0 110.911 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.674 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.0 m -120.01 126.16 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG2' HD13 ' A' ' 33' ' ' LEU . 61.2 t -105.99 122.75 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.414 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.596 HG23 ' HG3' ' B' ' 947' ' ' PRO . 53.0 m -119.33 122.62 29.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.427 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 147.18 64.48 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.924 1.749 . . . . 0.0 112.905 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.15 139.99 39.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.969 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -72.93 -5.25 37.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -72.47 74.77 1.04 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -52.79 134.27 36.77 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.334 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.65 -165.06 11.3 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.9 tp -135.92 122.55 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG22 ' HD1' ' A' ' 61' ' ' TRP . 53.7 t -97.63 108.36 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.831 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 39.0 p90 -133.14 153.59 51.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.576 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.8 mt -122.04 141.62 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.826 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -141.67 142.63 33.37 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 123.687 0.617 . . . . 0.0 110.18 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.478 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.8 tt0 -106.29 127.6 53.36 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 58' ' ' HIS . 20.9 p -87.3 172.79 9.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.754 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.11 -10.42 22.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.625 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.22 -0.16 56.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 70.04 19.77 6.72 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.574 HD11 HG11 ' C' ' 70' ' ' VAL . 70.4 mt -101.72 126.02 48.5 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 131' ' ' PRO . 49.4 mm -80.78 126.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.501 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -102.42 115.99 31.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.915 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -91.92 108.19 19.75 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.06 140.03 50.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.805 0.812 . . . . 0.0 112.902 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.417 ' HD1' HG22 ' A' ' 47' ' ' VAL . 92.4 t90 -125.46 113.25 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.189 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -106.18 144.7 32.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.817 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -80.62 131.65 35.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.82 -18.63 62.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.952 0.406 . . . . 0.0 110.529 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -59.65 -46.18 89.78 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.45 -11.3 10.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 0.0 110.646 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.08 22.78 78.7 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.51 146.88 27.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.722 0.296 . . . . 0.0 110.657 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.79 102.02 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.036 0.445 . . . . 0.0 110.304 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -73.08 -39.4 65.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.906 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.8 147.13 50.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.522 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p30 -158.54 103.24 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.597 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD22 ' HG2' ' C' ' 48' ' ' LYS . 35.2 mt -126.98 135.7 51.23 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.775 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -77.43 122.22 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' A' ' 80' ' ' CYS . 31.5 mm -111.81 121.08 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.618 . . . . 0.0 111.183 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 42.9 m-85 -82.76 160.98 59.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 142.35 98.64 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.797 1.664 . . . . 0.0 111.441 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 61.84 12.34 4.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.103 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -89.87 -35.79 15.44 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 120.628 0.251 . . . . 0.0 110.678 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.609 ' HB3' HD11 ' A' ' 96' ' ' LEU . 71.4 m -132.48 156.29 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.25 0.548 . . . . 0.0 111.399 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.516 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.4 tt0 -129.31 130.63 46.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.126 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -101.96 117.95 35.89 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.412 ' NZ ' HG11 ' A' ' 95' ' ' VAL . 22.8 pttp -143.49 161.27 38.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.538 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -83.19 160.34 21.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.131 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.5 89.39 15.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.192 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.6 60.21 7.55 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.091 1.86 . . . . 0.0 112.047 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -114.25 -44.27 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.9 t -116.36 99.06 52.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.78 129.73 15.9 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.38 1.386 . . . . 0.0 111.458 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 165.23 -38.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 O-C-N 124.02 0.825 . . . . 0.0 110.372 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.59 -179.69 25.64 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -91.83 113.55 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.88 128.26 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.176 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -119.18 155.75 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.719 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.2 p -133.63 137.74 52.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.4 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 80' ' ' CYS . 63.9 tp -103.68 121.47 43.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -117.89 141.6 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -88.09 117.18 26.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.27 -37.47 85.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.949 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.83 -15.85 19.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.53 176.14 19.96 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.6 p -111.7 15.76 20.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.668 0.27 . . . . 0.0 110.465 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' CE ' HD21 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -95.28 144.56 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.969 0.414 . . . . 0.0 110.77 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.93 140.59 42.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.716 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . 57.9 mt -119.62 152.06 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.5 m-85 -124.28 137.15 54.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.84 154.24 48.41 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.29 0.567 . . . . 0.0 111.216 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -132.43 136.04 46.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.07 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.95 131.68 51.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.121 0.486 . . . . 0.0 111.215 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 -1.67 12.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.483 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.09 149.23 94.56 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.664 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.14 -39.93 64.82 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.002 1.802 . . . . 0.0 112.224 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.57 145.91 48.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.3 p -98.45 18.72 15.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.5 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.49 -22.2 61.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.61 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -123.48 13.85 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.51 91.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.776 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.54 -41.21 84.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.066 0.46 . . . . 0.0 111.128 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.75 -43.35 96.71 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.757 ' O ' HG23 ' A' ' 124' ' ' VAL . 60.8 m170 -63.54 -41.08 98.48 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.517 0.675 . . . . 0.0 109.322 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.23 -42.02 96.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -67.58 -40.14 84.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.2 -37.57 83.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.713 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.3 t -58.51 -47.83 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -80.05 -27.42 39.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.942 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.96 -38.22 82.5 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.53 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -81.62 -34.18 31.05 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.479 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 124' ' ' VAL . 67.3 mt -76.24 -26.69 56.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.917 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -107.45 -24.16 11.92 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.56 74.83 58.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.536 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.8 Cg_exo -59.4 155.63 40.23 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.004 2.469 . . . . 0.0 112.362 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.081 -179.643 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 49.44 67.65 4.26 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.558 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.35 143.95 78.47 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.723 2.282 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.89 160.05 82.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.806 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.52 155.42 62.76 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.765 2.31 . . . . 0.0 112.187 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.35 -169.44 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.608 2.205 . . . . 0.0 111.608 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -110.1 160.4 28.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.596 ' HG3' HG23 ' A' ' 39' ' ' THR . 50.8 Cg_exo -57.14 142.68 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.538 2.159 . . . . 0.0 111.808 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.72 163.93 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.68 138.36 32.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.867 0.365 . . . . 0.0 110.434 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -124.57 119.87 30.32 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.784 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 49.8 mt -131.8 119.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -69.57 84.2 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.308 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 62.1 t0 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.537 179.685 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.14 162.93 18.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.461 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.499 HD13 HD21 ' C' ' 56' ' ' LEU . 16.6 pt -144.35 147.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.962 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -96.43 119.5 35.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.571 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -103.5 103.8 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -87.67 118.54 27.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.803 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.786 HG22 HD23 ' C' ' 69' ' ' LEU . 80.9 p -82.36 171.13 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.431 HD11 ' H ' ' C' ' 71' ' ' LEU . 67.9 mt -64.89 -25.03 67.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.138 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.8 p -73.47 -11.5 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -13.74 63.59 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.56 132.53 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.257 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -101.56 132.02 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.144 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mm -116.3 103.55 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.95 120.31 25.53 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.098 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.771 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.9 mt -122.34 132.76 54.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.32 114.45 16.16 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.574 HG12 ' HE3' ' C' ' 29' ' ' LYS . 26.7 m -136.91 171.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.989 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -116.51 156.33 47.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.237 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.98 -41.23 77.47 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.887 1.724 . . . . 0.0 112.322 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -72.94 -12.25 60.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -59.13 135.76 57.74 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.851 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -77.51 160.54 28.56 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.869 HD12 HD13 ' C' ' 50' ' ' LEU . 47.9 mm -66.17 -37.65 80.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.071 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.44 -42.92 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -62.29 -42.03 99.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 110.074 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.678 HG21 HD11 ' C' ' 56' ' ' LEU . 53.0 t -61.21 -43.58 96.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.428 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -40.1 79.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.187 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.6 94.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.991 0.424 . . . . 0.0 110.339 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.63 ' HB3' HD13 ' C' ' 15' ' ' LEU . 67.0 mttm -59.8 -39.4 84.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.394 0.616 . . . . 0.0 109.386 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.798 ' CD1' HD21 ' C' ' 43' ' ' LEU . 97.3 mt -66.56 -38.86 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.443 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -58.03 -42.36 85.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.447 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.11 -40.89 71.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.456 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.771 ' HG3' HD21 ' C' ' 15' ' ' LEU . 7.0 mmtm -65.63 -40.96 93.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.959 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -138.07 157.27 46.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.45 57.44 3.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 32.6 mm -110.81 104.84 56.68 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 153.49 50.38 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.354 2.036 . . . . 0.0 112.204 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.81 -39.14 78.43 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.822 1.681 . . . . 0.0 112.302 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.83 -39.55 92.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.279 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.08 -9.24 59.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.913 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.55 93.87 7.93 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' ARG . . . . . 0.428 ' HB2' ' HB ' ' C' ' 70' ' ' VAL . 76.5 mtp85 -108.82 95.81 5.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.798 HD21 ' CD1' ' C' ' 30' ' ' ILE . 81.5 mt -84.55 130.21 34.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.274 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -132.17 127.51 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -141.76 148.82 39.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.948 0.404 . . . . 0.0 111.108 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.64 17.48 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.249 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 89.87 -17.11 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.552 ' HE2' HD22 ' D' ' 73' ' ' LEU . 17.8 mtpt -95.48 133.27 39.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 111.056 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -75.73 130.92 39.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.69 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.869 HD13 HD12 ' C' ' 23' ' ' ILE . 35.5 mt -72.89 129.8 38.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.58 -80.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.479 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.01 -68.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.611 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.12 94.49 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -49.07 162.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.514 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -109.54 178.46 4.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.308 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.678 HD11 HG21 ' C' ' 26' ' ' VAL . 6.6 mp -69.79 -39.61 76.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.825 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.29 -24.96 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.56 -37.4 86.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.469 ' CE2' HD13 ' D' ' 73' ' ' LEU . 85.1 m-85 -98.76 11.98 37.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.113 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 t30 59.33 40.08 21.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.852 0.358 . . . . 0.0 110.365 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -86.24 103.72 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -91.68 179.95 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.512 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -63.19 145.08 56.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.186 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 64.28 13.32 7.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.322 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.0 m -67.02 134.78 52.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 43.6 m -92.49 117.63 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.518 HD12 ' N ' ' C' ' 67' ' ' LEU . 5.8 mp -108.17 139.39 42.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.56 127.91 35.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.28 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.786 HD23 HG22 ' C' ' 7' ' ' THR . 55.7 tp -105.85 121.17 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.722 HG11 HD11 ' A' ' 56' ' ' LEU . 57.6 t -108.87 132.61 56.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.736 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.431 ' H ' HD11 ' C' ' 8' ' ' LEU . 22.4 mt -95.9 133.41 40.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.3 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -86.98 130.49 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.2 mt -107.43 143.79 35.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.332 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -112.08 144.33 41.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.447 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.65 -170.67 52.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.58 18.57 79.73 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.623 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -64.27 160.68 18.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.599 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -139.17 142.44 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.377 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.633 ' HD2' HG21 ' D' ' 12' ' ' THR . 4.0 m-85 -86.63 122.73 30.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -108.82 107.28 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.382 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -92.0 130.43 37.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.883 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.802 HG22 HD23 ' D' ' 69' ' ' LEU . 61.6 p -89.19 -179.32 5.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.662 HD11 ' H ' ' D' ' 71' ' ' LEU . 80.8 mt -64.36 -37.22 86.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.136 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.39 -12.18 61.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 -12.51 61.36 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.98 131.4 49.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.633 HG21 ' HD2' ' D' ' 4' ' ' PHE . 83.3 m -104.77 133.53 49.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 111.163 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.405 HD13 HG21 ' D' ' 13' ' ' ILE . 0.9 OUTLIER -125.83 108.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.729 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.6 m -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.299 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' D' ' 29' ' ' LYS . 94.6 mt -122.91 126.57 47.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.627 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -68.85 116.39 9.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.849 0.357 . . . . 0.0 111.039 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.564 HG12 ' HE2' ' D' ' 29' ' ' LYS . 20.7 m -139.2 165.57 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -106.28 155.24 38.96 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.027 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.46 -32.77 90.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.102 1.868 . . . . 0.0 112.282 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -87.3 -3.31 59.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -60.06 136.24 57.96 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -80.18 163.41 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.234 0.54 . . . . 0.0 111.021 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.412 HD12 HD13 ' D' ' 50' ' ' LEU . 49.9 mm -63.03 -37.26 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.426 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.39 -42.33 86.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.084 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -62.48 -41.27 98.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.443 . . . . 0.0 110.432 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.572 HG21 HD21 ' D' ' 56' ' ' LEU . 53.2 t -61.47 -43.61 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.67 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.404 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.8 mtmt -61.08 -39.46 89.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.71 97.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.564 ' HE2' HG12 ' D' ' 17' ' ' VAL . 16.2 mttp -59.66 -38.92 82.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.571 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.426 HD12 HD21 ' D' ' 43' ' ' LEU . 59.2 mt -67.04 -38.48 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.842 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -59.12 -39.74 83.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.406 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -70.49 -53.76 14.99 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.485 ' HD2' HD21 ' D' ' 15' ' ' LEU . 28.7 mttp -63.14 -40.95 99.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.094 0.473 . . . . 0.0 111.753 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -128.2 143.45 51.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.793 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.36 61.96 2.69 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' D' ' 41' ' ' GLN . 2.8 mt -114.02 110.11 49.01 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.54 155.07 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.16 1.907 . . . . 0.0 111.691 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.18 -34.49 98.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.216 1.944 . . . . 0.0 113.035 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.17 -47.42 77.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 110.101 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.2 -38.85 88.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.624 ' HG3' HG22 ' D' ' 36' ' ' ILE . 89.3 mt-30 -58.86 115.74 3.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.729 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -119.37 102.89 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.583 ' CB ' HD12 ' D' ' 50' ' ' LEU . 30.9 mt -90.37 118.55 29.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.13 126.06 67.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 86.8 t80 -132.1 132.21 43.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.306 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.97 27.24 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.535 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.06 78.59 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -129.72 129.19 43.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -66.08 140.34 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.621 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.583 HD12 ' CB ' ' D' ' 43' ' ' LEU . 70.8 mt -82.47 114.84 21.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.965 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.51 139.89 42.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.949 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.95 136.81 57.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.39 56.63 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -81.97 170.08 16.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.6 p -113.71 165.44 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.572 HD21 HG21 ' D' ' 26' ' ' VAL . 88.4 mt -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.599 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.8 p -63.54 -26.72 68.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.067 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.27 -29.15 70.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.028 0.442 . . . . 0.0 110.389 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' TYR . . . . . 0.405 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.0 m-85 -103.08 15.65 28.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.87 38.81 30.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -89.88 115.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -104.93 -174.85 2.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.273 0.559 . . . . 0.0 110.804 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -61.57 144.26 54.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.324 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 60.98 19.78 10.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.826 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -70.1 126.41 29.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 59.4 m -79.06 129.89 34.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.212 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.94 144.45 46.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.074 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -91.67 110.0 21.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.117 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.802 HD23 HG22 ' D' ' 7' ' ' THR . 61.0 tp -96.27 106.68 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.498 ' HA ' HD21 ' D' ' 8' ' ' LEU . 80.1 t -99.83 140.14 19.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.124 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.662 ' H ' HD11 ' D' ' 8' ' ' LEU . 46.1 mt -115.04 140.48 49.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.122 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -63.23 143.74 57.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.552 HD22 ' HE2' ' C' ' 48' ' ' LYS . 3.1 tt -65.33 107.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.301 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 53.08 35.25 19.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.139 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.77 79.81 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -70.45 146.87 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.178 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.71 113.22 25.44 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.26 0.552 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 57' ' ' ILE . 92.0 mt -66.97 -38.86 86.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.479 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.1 p -149.34 162.75 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.955 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.83 122.81 0.33 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -155.32 158.17 38.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.869 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.564 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.2 122.01 23.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.05 0.452 . . . . 0.0 110.866 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.16 139.93 17.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.12 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.12 154.17 17.68 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -90.41 172.37 8.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.136 0.493 . . . . 0.0 111.435 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.403 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 22.9 mtp -134.74 172.23 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.639 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -122.68 121.88 37.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD13 ' CG2' ' A' ' 38' ' ' VAL . 29.4 tp -104.62 116.85 32.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.312 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.45 117.82 26.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.825 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -84.76 0.35 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 p -149.81 23.41 0.87 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.719 0.295 . . . . 0.0 110.689 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.1 m -125.85 131.34 52.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.431 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.4 t -108.9 122.44 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.639 HG22 ' HB3' ' B' ' 947' ' ' PRO . 67.3 p -114.71 131.25 23.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.223 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.79 148.59 46.62 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.195 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.51 142.61 27.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.817 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -82.46 -8.53 59.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.718 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.9 86.52 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -53.37 137.24 35.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.94 -162.98 10.83 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.047 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.7 tp -140.51 122.04 15.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -94.55 109.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -131.74 153.2 50.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.062 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.6 mt -122.36 140.83 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.365 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -141.57 144.99 34.55 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 123.499 0.5 . . . . 0.0 109.7 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -109.24 127.18 54.05 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.469 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.503 HG23 ' CD2' ' A' ' 58' ' ' HIS . 20.7 p -87.47 172.59 9.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.028 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.38 -10.72 18.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.698 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.49 4.7 48.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.586 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m 63.83 25.32 14.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.485 0.659 . . . . 0.0 110.566 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.722 HD11 HG11 ' C' ' 70' ' ' VAL . 63.4 mt -103.24 125.51 49.94 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.437 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.6 mm -82.38 123.59 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.074 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.9 m-70 -101.23 115.3 30.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.477 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -96.68 107.96 20.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.66 142.92 51.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.41 113.58 24.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.292 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -103.85 135.82 44.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.832 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.44 136.95 38.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.873 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -78.67 -18.65 54.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -60.65 -46.46 90.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.787 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -117.0 -13.3 10.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.22 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.14 75.5 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.8 144.47 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.702 0.287 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.45 102.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.879 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -75.31 -37.15 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.876 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -126.28 144.7 50.7 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.2 t0 -158.81 101.05 1.62 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.509 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 72' ' ' ASP . 47.4 mt -128.12 140.94 51.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.753 0.311 . . . . 0.0 110.451 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.448 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 97.0 mt -82.75 122.85 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.712 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.7 mm -112.91 122.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.067 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -85.16 162.95 47.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.587 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.36 140.25 93.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.138 1.892 . . . . 0.0 111.322 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.76 11.89 2.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.256 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -85.06 -26.24 27.11 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.719 0.295 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 75' ' ' ILE . 15.8 p -147.19 167.2 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.319 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.04 127.74 32.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.222 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.51 117.06 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -142.37 168.17 20.37 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.699 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -87.36 160.27 18.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.194 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.42 89.76 13.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 60.83 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.015 1.81 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -52.16 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.5 t -114.52 98.11 48.32 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.66 130.46 17.08 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.483 1.455 . . . . 0.0 111.668 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.65 -32.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.8 0.688 . . . . 0.0 110.071 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.24 -171.9 20.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.351 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.42 110.1 22.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 110.466 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.97 154.48 38.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.31 133.62 62.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 ' SG ' ' A' ' 80' ' ' CYS . 66.7 tp -101.68 121.58 42.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -119.14 132.46 55.99 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.392 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -83.79 115.12 22.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.22 -37.41 87.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.795 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.24 -23.15 24.83 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.476 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.48 -169.71 19.56 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -120.55 13.79 11.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.554 0.216 . . . . 0.0 110.629 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.725 ' HD3' HD21 ' A' ' 105' ' ' LEU . 19.9 ttmt -86.11 142.81 28.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -136.04 129.3 31.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.156 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.725 HD21 ' HD3' ' A' ' 103' ' ' LYS . 37.9 mt -115.18 150.58 35.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.812 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' A' ' 33' ' ' LEU . 89.6 m-85 -124.22 137.86 54.47 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.124 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.47 156.81 47.21 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.29 0.567 . . . . 0.0 111.123 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -129.01 137.34 51.28 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.276 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.5 mmm -72.81 141.13 48.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -0.93 24.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.68 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.76 147.03 88.77 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.583 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.25 -27.16 13.88 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.163 1.908 . . . . 0.0 112.607 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.01 146.86 47.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.3 p -92.6 4.07 54.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.811 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.12 -21.17 45.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.51 -13.88 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -61.1 -45.58 94.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.296 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.91 -43.36 93.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.258 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.713 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.7 m170 -63.58 -40.62 97.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.62 0.724 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -62.69 -45.04 94.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.855 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.96 -42.37 85.3 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.533 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.65 -42.87 99.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.484 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.2 t -57.57 -47.65 84.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.046 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -64.05 -39.41 94.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.76 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.22 -27.53 62.59 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.175 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.1 m-85 -85.0 -29.03 25.35 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.735 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.53 -12.38 29.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -120.12 -16.65 8.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.794 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -144.23 72.68 16.21 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 57' ' ' ILE . 34.9 Cg_exo -60.81 148.97 90.44 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.931 2.421 . . . . 0.0 111.963 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 C-N-CA 122.308 2.005 . . . . 0.0 111.984 179.85 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -133.73 151.22 76.65 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.96 152.72 36.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.574 2.183 . . . . 0.0 111.661 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -95.13 156.28 38.0 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.186 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.84 140.01 68.36 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.447 2.098 . . . . 0.0 112.144 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.98 172.61 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.37 2.047 . . . . 0.0 112.097 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -93.03 154.33 41.73 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 39' ' ' THR . 36.2 Cg_endo -65.88 150.29 85.86 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.467 2.112 . . . . 0.0 111.908 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.01 163.85 37.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -85.91 139.81 30.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.127 0.489 . . . . 0.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -124.89 128.82 49.25 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.355 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.417 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.8 mp -130.42 127.68 62.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.366 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -75.65 83.45 2.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.942 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.829 179.419 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' GLN . . . . . 0.445 ' OE1' HG21 ' C' ' 14' ' ' THR . 6.5 pt20 -64.48 162.4 15.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.462 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.43 151.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.285 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.546 ' CD1' HG23 ' C' ' 14' ' ' THR . 10.9 m-30 -92.34 114.5 27.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.893 HG11 HD11 ' C' ' 30' ' ' ILE . 80.1 t -104.37 98.85 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.135 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -77.79 116.45 18.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.805 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -73.21 -178.18 2.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.322 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -48.56 -29.21 4.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -101.06 -177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.045 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.38 -12.67 56.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.05 134.66 57.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' THR . . . . . 0.432 ' C ' HD13 ' C' ' 13' ' ' ILE . 93.6 m -118.68 133.57 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.432 HD13 ' C ' ' C' ' 12' ' ' THR . 12.8 mm -113.2 110.14 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' THR . . . . . 0.546 HG23 ' CD1' ' C' ' 4' ' ' PHE . 3.8 m -83.82 119.01 24.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.603 HD13 ' CB ' ' C' ' 29' ' ' LYS . 73.5 mt -118.31 125.9 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.563 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.5 113.35 9.44 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.487 HG11 HG22 ' C' ' 26' ' ' VAL . 31.1 m -135.35 164.56 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.091 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -107.49 155.56 39.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.741 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.48 -32.76 90.51 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.027 1.818 . . . . 0.0 112.302 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.52 -1.34 57.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.186 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -62.77 138.76 58.6 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -79.15 159.42 27.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.174 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.52 HD12 HD13 ' C' ' 50' ' ' LEU . 43.9 mm -64.12 -40.96 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -58.02 -36.32 72.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.955 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.69 -43.13 94.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.197 0.522 . . . . 0.0 110.904 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.499 HG21 HD21 ' C' ' 56' ' ' LEU . 62.5 t -62.37 -43.08 97.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.802 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -60.75 -38.38 84.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.16 91.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.852 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.603 ' CB ' HD13 ' C' ' 15' ' ' LEU . 5.8 mptt -60.07 -38.74 83.75 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.343 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.893 HD11 HG11 ' C' ' 5' ' ' VAL . 6.9 mm -63.85 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.244 0.545 . . . . 0.0 110.14 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -59.88 -48.77 80.33 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.76 -11.55 59.85 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.082 -0.386 . . . . 0.0 112.026 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -104.87 -8.03 18.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -147.27 -35.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.433 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.81 15.54 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.465 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' C' ' 41' ' ' GLN . 28.5 mt -95.78 115.05 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.69 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.35 153.77 51.49 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.6 2.2 . . . . 0.0 111.294 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.31 -40.12 87.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.649 1.566 . . . . 0.0 111.855 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.95 -41.01 97.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.827 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -88.88 -2.57 58.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.585 ' HG3' HD21 ' C' ' 69' ' ' LEU . 4.7 tt0 -111.88 120.83 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.798 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -122.77 120.54 33.88 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.546 ' CB ' HD12 ' C' ' 50' ' ' LEU . 78.2 mt -99.12 131.47 45.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.199 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.425 HG21 ' HE1' ' A' ' 76' ' ' PHE . 78.5 mt -129.72 129.01 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 45' ' ' PHE . . . . . 0.541 ' HB2' HD23 ' C' ' 67' ' ' LEU . 75.1 t80 -151.77 153.46 34.34 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.61 15.37 10.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.418 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.69 -12.0 66.85 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.802 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.0 OUTLIER -117.42 146.85 43.18 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.624 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.18 137.14 44.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.014 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.546 HD12 ' CB ' ' C' ' 43' ' ' LEU . 44.1 mt -72.79 103.17 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.741 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -74.6 135.98 42.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -59.95 136.67 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.67 -18.29 37.96 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -89.52 174.44 7.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.2 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -115.67 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.267 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.499 HD21 HG21 ' C' ' 26' ' ' VAL . 82.0 mt -62.7 -40.19 96.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.801 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.05 -25.94 68.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.29 -30.63 71.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' C' ' 50' ' ' LEU . 59.3 m-85 -100.82 12.82 36.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.42 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 56.7 39.66 29.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.378 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.422 HG21 HD22 ' C' ' 56' ' ' LEU . 48.2 mt -83.93 117.77 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -101.98 175.09 5.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.015 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -59.81 145.46 45.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.753 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 59.13 20.81 8.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.405 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 7.9 m -67.93 133.92 49.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -86.75 120.3 27.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.358 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' C' ' 45' ' ' PHE . 3.7 mp -114.19 147.98 38.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -100.27 129.03 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.55 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.585 HD21 ' HG3' ' C' ' 41' ' ' GLN . 0.6 OUTLIER -104.91 121.26 43.34 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 56' ' ' LEU . 57.7 t -107.07 135.41 45.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.545 ' HG ' HD23 ' C' ' 8' ' ' LEU . 31.1 mt -109.32 142.52 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.64 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.17 -40.62 98.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 tp -124.34 128.99 49.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.76 144.31 49.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.23 147.52 18.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.46 -130.56 50.44 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.521 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.89 156.76 16.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.107 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.619 HD13 HD21 ' D' ' 56' ' ' LEU . 16.8 pt -136.79 150.57 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.415 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.8 m-30 -92.51 121.85 34.37 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.999 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.49 103.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.56 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -89.5 128.66 36.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.528 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.763 HG22 HD23 ' D' ' 69' ' ' LEU . 81.6 p -89.24 -177.36 5.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 111.228 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.692 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.1 mt -63.97 -37.58 87.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -70.02 -10.35 58.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.907 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.59 -10.56 66.78 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.91 130.58 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.252 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 131.38 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -121.93 108.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.415 HG23 ' CD2' ' D' ' 4' ' ' PHE . 19.6 m -81.38 129.69 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.553 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.77 HD21 ' HG3' ' D' ' 33' ' ' LYS . 38.2 mt -127.06 123.19 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -65.73 111.79 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.409 0.623 . . . . 0.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.691 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 18.1 m -135.07 164.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.165 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.27 155.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.452 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.88 -33.69 95.4 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.084 1.856 . . . . 0.0 111.89 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -82.9 -5.6 59.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.529 ' OD2' HG23 ' D' ' 26' ' ' VAL . 35.2 t70 -60.96 133.29 55.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 110.717 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -76.34 161.53 28.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.532 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.916 HD12 HD23 ' D' ' 50' ' ' LEU . 44.0 mm -64.44 -40.34 88.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.22 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.57 -40.04 86.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -61.89 -40.36 95.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.194 0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.878 HG21 HD11 ' D' ' 56' ' ' LEU . 54.6 t -62.24 -44.27 98.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.546 ' HG2' HD23 ' D' ' 43' ' ' LEU . 30.8 mtmt -60.35 -40.79 91.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.814 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.3 93.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.502 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.691 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 90.7 mttt -60.0 -39.97 87.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.637 HD11 HD11 ' D' ' 43' ' ' LEU . 96.4 mt -67.35 -40.67 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.581 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.99 -39.62 82.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.734 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.67 8.55 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.77 ' HG3' HD21 ' D' ' 15' ' ' LEU . 0.0 OUTLIER -109.79 -58.12 2.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.865 0.364 . . . . 0.0 110.595 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.11 0.59 25.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.651 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.37 23.78 77.67 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 20.5 mm -84.07 117.78 69.57 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.901 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.08 150.8 76.87 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.244 1.963 . . . . 0.0 112.291 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.25 -19.74 51.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.301 2.001 . . . . 0.0 112.023 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.9 3.44 41.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -124.71 -54.8 1.64 Allowed 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.84 0.352 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.66 114.13 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.286 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -112.3 124.25 52.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.637 HD11 HD11 ' D' ' 30' ' ' ILE . 4.4 mm? -100.48 119.68 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.69 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 84.4 mt -126.88 126.04 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.731 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 84.4 t80 -125.44 131.53 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.085 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.07 26.23 12.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.447 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.73 16.03 80.47 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.28 130.16 53.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.516 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -67.53 131.99 46.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.916 HD23 HD12 ' D' ' 23' ' ' ILE . 8.0 mp -88.72 97.59 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.04 163.36 27.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.868 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -73.45 163.77 27.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.91 71.2 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -131.24 165.53 23.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.104 0.478 . . . . 0.0 110.776 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -116.74 164.34 14.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.878 HD11 HG21 ' D' ' 26' ' ' VAL . 4.6 mp -59.82 -38.65 82.58 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.97 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -62.09 -29.42 70.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.911 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.3 -30.12 71.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.159 0.504 . . . . 0.0 110.066 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -99.43 11.65 38.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 54.98 40.35 31.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.308 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ILE . . . . . 0.62 HD11 HD21 ' D' ' 50' ' ' LEU . 81.5 mt -89.81 115.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -103.87 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.443 0.64 . . . . 0.0 110.887 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -60.43 146.92 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.921 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 61.25 19.83 10.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.2 m -74.84 126.98 32.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.924 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.475 ' C ' HD12 ' D' ' 67' ' ' LEU . 62.1 m -77.71 131.26 37.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.465 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.475 HD12 ' C ' ' D' ' 66' ' ' THR . 7.5 mp -118.63 138.78 52.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.95 110.12 20.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.865 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.763 HD23 HG22 ' D' ' 7' ' ' THR . 63.3 tp -98.15 117.56 32.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' D' ' 8' ' ' LEU . 95.5 t -110.28 132.77 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.517 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.692 ' H ' HD11 ' D' ' 8' ' ' LEU . 41.2 mt -106.48 136.07 46.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.968 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 72' ' ' ARG . . . . . 0.619 ' O ' HD23 ' D' ' 73' ' ' LEU . 81.0 mtp180 -62.92 -41.37 99.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.561 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.802 HD22 ' HE2' ' C' ' 48' ' ' LYS . 51.5 mt -132.87 144.28 50.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.232 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.4 117.48 8.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.028 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.98 79.21 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m120 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.28 155.33 22.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.158 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.16 112.15 24.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.5 mt -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.92 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.64 161.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.984 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 122.6 0.37 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.54 158.47 38.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.2 mtm-85 -75.34 121.76 22.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.056 0.455 . . . . 0.0 110.713 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.85 146.02 22.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.52 152.24 17.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -91.66 164.46 13.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.952 0.406 . . . . 0.0 111.113 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.4 mtp -132.5 175.27 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.797 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.3 m -125.56 124.09 40.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 37' ' ' THR . 36.6 tp -107.27 119.62 39.9 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.323 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.7 113.78 19.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.952 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -87.78 0.57 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -145.1 21.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.566 0.222 . . . . 0.0 110.723 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.663 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.2 m -123.03 130.53 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.536 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.1 t -106.94 123.15 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.872 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.48 128.03 26.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.62 146.71 39.24 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.765 1.643 . . . . 0.0 112.552 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.55 134.56 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.11 -6.96 46.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -73.14 78.21 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -52.79 134.18 36.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.329 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.54 -165.9 11.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.068 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 27' ' ' ARG . 8.6 tp -134.55 125.91 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.78 109.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.3 p90 -134.04 154.21 51.3 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 137.96 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.584 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.96 131.18 36.89 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.648 0.593 . . . . 0.0 110.399 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.569 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.3 tt0 -100.87 124.97 47.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.22 0.534 . . . . 0.0 109.998 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.4 p -84.46 172.23 11.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.696 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.77 -10.0 24.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.653 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.75 7.49 41.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.482 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 m 63.42 24.41 14.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.434 0.635 . . . . 0.0 110.651 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.569 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 73.8 mt -99.98 121.97 42.17 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.542 HG21 HD23 ' A' ' 128' ' ' LEU . 51.5 mm -81.14 121.23 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.6 m-70 -97.59 113.69 25.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.999 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -93.1 108.35 19.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 82.3 m -120.86 145.83 47.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.747 0.784 . . . . 0.0 112.89 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -127.6 115.22 18.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.154 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -106.63 145.98 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.38 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -84.18 130.73 34.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -70.79 -17.51 62.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -59.21 -45.45 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.543 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.5 m -117.07 -11.54 10.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.44 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.15 21.47 79.2 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -102.56 148.33 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.1 t -76.27 106.01 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.13 -29.87 31.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.109 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -127.74 145.11 51.01 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.308 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.7 p-10 -159.18 100.04 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.764 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.736 HD22 ' HB3' ' C' ' 48' ' ' LYS . 39.9 mt -128.27 133.59 48.8 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.65 119.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.126 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.712 HG21 ' SG ' ' A' ' 80' ' ' CYS . 26.3 mm -110.88 120.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.03 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 47.2 m-85 -82.45 163.21 53.27 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.727 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 141.61 94.8 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.162 1.908 . . . . 0.0 111.728 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.95 12.28 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -85.1 -25.14 27.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.555 0.217 . . . . 0.0 110.875 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.7 p -149.26 167.17 26.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.529 0.68 . . . . 0.0 110.695 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.89 130.67 34.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.353 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.07 119.12 38.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.55 167.12 22.84 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.74 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -82.09 160.44 23.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.107 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.04 89.81 12.44 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 59.99 7.64 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.837 1.691 . . . . 0.0 112.246 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -114.65 -36.5 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.129 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 17.2 p -130.44 75.45 79.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.643 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 130.2 34.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.887 1.725 . . . . 0.0 111.558 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t 168.97 -43.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.919 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.05 -147.74 5.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.6 107.24 14.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 110.535 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.19 129.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 111.088 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.49 156.08 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.55 136.81 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.499 HD11 ' SG ' ' A' ' 80' ' ' CYS . 64.7 tp -103.31 122.36 44.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -118.76 130.9 56.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.073 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.28 115.81 21.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.289 0.566 . . . . 0.0 109.714 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.44 -37.54 87.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.579 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 -22.0 23.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.643 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.55 -171.84 19.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.4 m -117.8 12.67 13.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.622 0.248 . . . . 0.0 110.682 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.652 ' HD3' HD21 ' A' ' 105' ' ' LEU . 26.5 ttmt -83.92 141.59 31.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.932 0.396 . . . . 0.0 110.787 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.19 125.97 25.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.652 HD21 ' HD3' ' A' ' 103' ' ' LYS . 38.0 mt -113.53 151.15 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.002 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 33' ' ' LEU . 96.6 m-85 -124.85 137.27 54.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.352 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.67 155.0 51.11 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.298 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -129.97 136.43 49.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.723 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 tpp -70.3 131.19 43.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.76 -4.86 17.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.022 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.15 149.13 94.66 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.559 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' B' ' 942' ' ' PRO . 58.3 Cg_endo -72.43 -27.14 16.27 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.036 1.824 . . . . 0.0 112.922 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.03 142.72 49.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 110.266 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -98.22 13.95 29.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.57 -20.93 59.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -125.62 11.95 7.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.17 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -63.24 -46.57 86.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.698 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -71.84 -34.37 69.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.357 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.08 -46.21 82.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.407 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.6 m170 -63.23 -41.06 99.05 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.606 0.717 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.99 -45.32 94.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.609 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -64.85 -43.77 91.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.214 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.15 -36.74 84.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 120' ' ' HIS . 58.2 t -59.2 -48.26 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.092 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.7 -29.82 40.83 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.952 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -68.61 -36.58 78.86 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.316 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -81.3 -32.82 32.96 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.554 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.632 HD22 ' HB ' ' A' ' 75' ' ' ILE . 80.6 mt -80.32 -25.25 39.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.284 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -110.12 -20.37 12.71 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.641 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.36 69.13 39.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.487 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.98 159.99 50.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 123.038 2.492 . . . . 0.0 112.382 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -72.27 153.54 92.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.618 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 942' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 55.5 Cg_endo -68.79 147.22 68.56 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.609 2.206 . . . . 0.0 112.179 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.96 157.5 87.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.0 139.23 84.53 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.551 2.167 . . . . 0.0 111.939 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.88 -172.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.043 1.828 . . . . 0.0 112.059 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -122.46 158.36 56.38 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.433 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.85 141.53 95.9 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.19 162.25 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.636 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -86.91 139.41 30.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.32 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -123.99 124.31 42.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.112 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.06 123.94 51.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.773 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -82.02 84.05 7.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.61 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.4 t0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.776 179.723 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.75 161.6 9.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.955 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 pt -139.73 146.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.092 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.57 124.85 33.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.79 116.02 51.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.84 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -94.92 118.31 31.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.138 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.29 173.08 10.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.251 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.564 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -46.49 -29.03 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.662 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -101.93 -179.1 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.119 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 -17.66 55.43 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -57.2 130.63 47.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.698 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 76.4 m -128.23 135.97 50.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.937 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.541 HD13 ' HG2' ' C' ' 34' ' ' GLU . 0.0 OUTLIER -126.24 121.06 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -88.94 127.6 35.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' C' ' 29' ' ' LYS . 67.4 mt -119.65 135.28 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.594 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -73.82 118.04 16.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.678 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.577 HG12 ' HE3' ' C' ' 29' ' ' LYS . 30.4 m -135.49 167.03 26.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.72 151.23 42.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.87 -35.87 94.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.818 1.679 . . . . 0.0 112.176 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -87.7 -0.99 57.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.115 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -62.81 137.92 58.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.725 0.298 . . . . 0.0 110.878 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -78.87 163.22 25.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.347 0.594 . . . . 0.0 111.342 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' C' ' 50' ' ' LEU . 48.3 mm -62.75 -37.1 78.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.762 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.35 -41.25 84.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.157 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -64.33 -41.07 96.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 110.594 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.586 HG21 HD21 ' C' ' 56' ' ' LEU . 57.7 t -64.16 -47.36 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.02 -32.49 72.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.87 98.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.423 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.633 ' HB3' HD13 ' C' ' 15' ' ' LEU . 66.8 mttm -60.25 -38.72 84.35 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.742 HD13 HD11 ' C' ' 69' ' ' LEU . 90.1 mt -64.42 -39.15 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -57.3 -43.97 83.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.23 -44.73 95.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.27 -78.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.745 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' GLU . . . . . 0.541 ' HG2' HD13 ' C' ' 13' ' ' ILE . 79.4 mm-40 -89.1 149.14 23.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.72 56.09 4.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.542 HG22 ' HG3' ' C' ' 41' ' ' GLN . 30.9 mt -106.96 121.87 43.44 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.083 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.24 157.84 52.96 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.477 1.451 . . . . 0.0 111.19 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.8 -38.22 94.71 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.793 1.662 . . . . 0.0 112.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -61.59 -43.37 98.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -85.75 -5.95 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.542 ' HG3' HG22 ' C' ' 36' ' ' ILE . 31.4 mt-30 -87.27 74.91 9.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.151 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -88.58 97.51 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.425 ' CB ' HD12 ' C' ' 50' ' ' LEU . 25.7 mt -87.46 132.71 33.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.142 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.21 129.87 63.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.759 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 85.8 t80 -150.17 150.9 32.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.29 15.1 9.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.297 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.41 -13.6 64.85 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.797 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.1 OUTLIER -111.9 143.27 43.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.181 -178.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -73.06 132.3 43.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.684 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' C' ' 59' ' ' TYR . 54.6 mt -72.08 98.45 2.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.79 140.43 43.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.523 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -58.81 140.04 55.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.335 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.12 -17.39 54.19 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -82.88 178.11 8.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.842 0.353 . . . . 0.0 110.427 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 58.9 p -125.66 161.56 26.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.948 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.586 HD21 HG21 ' C' ' 26' ' ' VAL . 83.9 mt -61.27 -41.4 96.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.648 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -64.2 -22.74 67.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.803 0.335 . . . . 0.0 110.397 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -62.85 -36.8 84.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.398 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.433 ' CE2' HD23 ' C' ' 50' ' ' LEU . 73.1 m-85 -98.16 13.94 29.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.196 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.86 39.81 23.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.181 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.428 HG21 HD22 ' C' ' 56' ' ' LEU . 65.5 mt -84.56 117.35 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.962 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -104.43 178.36 4.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.17 143.95 47.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.127 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 60.78 21.08 11.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -70.05 127.84 34.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.436 ' C ' HD12 ' C' ' 67' ' ' LEU . 81.4 m -78.81 128.34 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.436 HD12 ' C ' ' C' ' 66' ' ' THR . 9.1 mp -113.18 151.22 31.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.59 116.76 33.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.444 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.742 HD11 HD13 ' C' ' 30' ' ' ILE . 0.9 OUTLIER -96.32 114.34 26.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.259 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 56' ' ' LEU . 96.0 t -108.78 127.21 65.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.73 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.564 ' HG ' HD23 ' C' ' 8' ' ' LEU . 26.4 mt -88.9 146.65 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.671 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -104.91 125.93 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 66.0 tp -107.88 121.88 45.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -62.97 -38.93 93.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.602 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.34 -130.87 49.32 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.45 176.99 54.5 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.47 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.79 162.86 8.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.93 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.97 151.25 23.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.407 ' CD1' HG23 ' D' ' 14' ' ' THR . 11.7 m-30 -91.36 123.25 34.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.756 HG11 HD11 ' D' ' 30' ' ' ILE . 79.2 t -109.38 105.89 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.384 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -91.83 127.19 37.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.37 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.865 HG22 HD23 ' D' ' 69' ' ' LEU . 73.6 p -87.6 179.17 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.424 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.641 HD11 ' H ' ' D' ' 71' ' ' LEU . 80.8 mt -62.3 -36.22 81.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.817 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -68.79 -12.68 61.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.071 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.16 66.0 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.75 133.52 51.2 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -104.34 131.95 51.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.211 0.529 . . . . 0.0 110.507 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -121.02 113.44 39.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.625 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.407 HG23 ' CD1' ' D' ' 4' ' ' PHE . 14.0 m -83.98 124.7 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.118 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.583 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.9 mt -120.05 128.73 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.309 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.15 116.98 12.08 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 110.585 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.435 HG12 ' HD2' ' D' ' 29' ' ' LYS . 24.4 m -135.39 166.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.012 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.06 153.29 47.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 -29.0 85.75 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.641 1.56 . . . . 0.0 111.912 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 60.3 m -87.47 -9.74 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.705 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -64.32 142.37 58.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 45.7 p -82.19 166.12 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.742 ' CD1' HD12 ' D' ' 50' ' ' LEU . 37.0 mm -63.04 -36.58 76.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.773 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.04 90.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.989 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.36 -41.23 98.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.679 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 67.4 t -63.79 -43.35 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.838 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.536 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.54 90.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.286 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.435 ' HD2' HG12 ' D' ' 17' ' ' VAL . 67.2 mttm -60.39 -39.49 87.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.756 HD11 HG11 ' D' ' 5' ' ' VAL . 8.8 mm -64.83 -40.8 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.235 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.447 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.03 -40.81 98.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.583 ' HD2' HD21 ' D' ' 15' ' ' LEU . 45.1 mttt -76.8 -71.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.88 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.45 152.98 19.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 55.97 4.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.643 HG22 ' HG3' ' D' ' 41' ' ' GLN . 32.7 mm -107.23 109.85 63.02 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.88 153.31 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.084 1.856 . . . . 0.0 111.51 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.85 -37.91 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.849 1.7 . . . . 0.0 112.233 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.15 -39.38 89.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -89.18 -12.5 40.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.643 ' HG3' HG22 ' D' ' 36' ' ' ILE . 20.0 mt-30 -78.99 86.04 4.89 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.875 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' ARG . . . . . 0.482 ' HD3' HD11 ' D' ' 44' ' ' ILE . 61.4 ttm-85 -97.44 115.27 27.44 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.71 118.1 36.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.482 HD11 ' HD3' ' D' ' 42' ' ' ARG . 83.2 mt -125.09 127.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.474 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' D' ' 67' ' ' LEU . 40.8 t80 -119.1 127.24 53.19 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.46 26.35 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.15 2.71 90.6 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.411 ' C ' HG23 ' D' ' 44' ' ' ILE . 43.3 ttm180 -112.86 121.84 45.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.013 0.407 . . . . 0.0 110.335 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -60.25 142.98 53.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.041 0.448 . . . . 0.0 110.388 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.742 HD12 ' CD1' ' D' ' 23' ' ' ILE . 4.0 mm? -78.09 123.85 27.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.063 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.92 138.67 50.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.69 129.96 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.093 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.91 -14.64 61.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.41 174.15 10.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -117.95 160.87 20.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.61 -39.87 92.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -63.88 -23.9 67.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.308 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -62.13 -37.6 85.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.295 0.569 . . . . 0.0 110.202 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -98.11 13.95 29.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.374 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 55.93 40.09 30.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.273 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -85.47 105.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.68 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -88.99 -172.82 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.434 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.55 149.58 49.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.316 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 57.5 42.39 24.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -89.87 121.43 31.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.965 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.455 ' O ' HD22 ' D' ' 67' ' ' LEU . 67.3 m -71.33 127.57 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.455 HD22 ' O ' ' D' ' 66' ' ' THR . 3.0 mm? -117.41 139.53 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.173 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -88.22 105.35 17.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.865 HD23 HG22 ' D' ' 7' ' ' THR . 67.3 tp -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.475 ' HA ' HD21 ' D' ' 8' ' ' LEU . 98.4 t -108.83 133.46 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.115 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.641 ' H ' HD11 ' D' ' 8' ' ' LEU . 25.7 mt -96.13 129.58 43.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.427 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -74.18 142.51 45.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.797 HD22 ' HE2' ' C' ' 48' ' ' LYS . 47.2 mt -92.0 4.85 52.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.907 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 58.55 26.7 14.69 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.615 0.245 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.84 19.49 75.2 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.79 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -69.36 153.91 42.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -94.88 128.77 41.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 109.897 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 51' ' ' GLN . 85.7 mt -69.78 -36.31 75.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.435 HG12 ' CG1' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -147.61 160.92 7.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.504 178.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -174.2 122.21 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.41 159.85 40.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.139 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -77.37 117.8 19.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.554 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.99 142.17 22.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.26 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.39 154.15 17.56 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -93.61 176.32 6.41 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.773 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.7 mtp -139.84 172.88 12.15 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.13 124.76 44.64 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 37' ' ' THR . 48.5 tp -105.38 117.08 33.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.015 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -120.42 116.64 25.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.598 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 -85.76 0.36 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.56 22.04 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.576 0.227 . . . . 0.0 110.714 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.583 ' O ' HD12 ' A' ' 33' ' ' LEU . 93.6 m -122.97 130.13 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.888 0.375 . . . . 0.0 110.559 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 33' ' ' LEU . 59.3 t -103.4 122.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.667 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 p -112.55 120.85 40.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.37 141.34 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.029 1.819 . . . . 0.0 112.348 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -98.08 116.27 29.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.46 -15.05 14.94 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.142 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -74.57 73.63 1.97 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.541 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -54.15 140.94 30.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.754 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.26 -156.49 7.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.002 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 27' ' ' ARG . 7.4 tp -135.22 125.66 26.67 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.95 109.14 23.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.314 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.23 154.55 49.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.273 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.0 mt -120.79 139.07 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.562 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.03 128.19 27.88 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.764 0.665 . . . . 0.0 110.485 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.67 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.6 tt0 -98.63 124.93 43.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.072 0.463 . . . . 0.0 109.936 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.7 p -85.33 172.46 11.07 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.56 -10.17 24.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.766 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.18 7.92 40.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.296 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.7 m 62.3 25.95 15.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.261 0.553 . . . . 0.0 110.623 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.639 HD11 HG11 ' C' ' 70' ' ' VAL . 73.3 mt -100.21 120.79 40.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.53 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -81.46 120.25 32.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -96.58 113.89 25.49 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.531 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -97.43 107.09 19.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 143.32 50.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.889 0.852 . . . . 0.0 112.861 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -119.44 117.39 28.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.51 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -106.69 144.02 33.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.375 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -81.81 130.26 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -72.59 -17.59 61.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.05 0.452 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -59.21 -45.41 91.17 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -117.16 -12.42 10.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.307 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.94 23.58 77.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -102.07 152.31 21.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.81 101.97 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.215 0.531 . . . . 0.0 110.451 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.41 -38.1 65.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.125 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -126.4 145.52 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.285 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.445 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.6 t0 -158.26 98.18 1.55 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.143 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.606 HD22 ' CG ' ' C' ' 48' ' ' LYS . 42.5 mt -125.34 136.62 53.65 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.84 118.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.696 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.4 mm -109.15 120.41 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.196 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.557 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 40.8 m-85 -82.59 163.24 52.81 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.598 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.02 141.08 96.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.498 2.132 . . . . 0.0 111.745 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t0 59.86 11.81 2.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.419 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.12 -29.38 28.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.727 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 75' ' ' ILE . 18.6 p -148.03 168.7 21.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.411 0.624 . . . . 0.0 110.783 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.17 130.94 36.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.354 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -100.96 118.83 37.75 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.92 168.03 20.71 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.645 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -83.24 157.68 22.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.45 88.88 9.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.56 60.17 7.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.831 1.687 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -114.28 -36.55 4.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.283 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -130.25 81.93 67.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.71 130.36 27.69 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.762 1.641 . . . . 0.0 111.817 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.0 -38.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.819 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.05 -153.25 6.08 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.14 106.59 15.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.1 t -125.8 129.57 72.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.02 154.43 39.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.434 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.83 136.75 59.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.943 0.402 . . . . 0.0 110.44 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.561 HD11 ' SG ' ' A' ' 80' ' ' CYS . 68.1 tp -102.98 121.37 42.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -118.51 132.24 56.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.048 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -82.96 115.21 21.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.302 0.572 . . . . 0.0 109.515 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.97 -37.64 87.94 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.36 -22.85 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.465 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.94 -171.74 20.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.9 m -119.52 13.95 12.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.566 0.222 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.72 ' HD3' HD21 ' A' ' 105' ' ' LEU . 24.0 ttmt -86.55 141.14 29.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.004 0.431 . . . . 0.0 111.085 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -133.77 129.02 36.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.082 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.72 HD21 ' HD3' ' A' ' 103' ' ' LYS . 42.5 mt -115.59 147.57 40.6 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.786 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' CE1' HD22 ' A' ' 33' ' ' LEU . 92.2 m-85 -119.84 135.88 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.564 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.82 155.13 50.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -130.57 137.5 49.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.342 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.2 mmm -73.59 138.83 45.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.32 6.29 32.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.728 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.9 141.07 58.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.06 -26.3 26.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.945 1.763 . . . . 0.0 112.459 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.51 142.62 48.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.33 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.3 p -95.08 9.02 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.495 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.2 -20.36 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.21 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -126.38 -9.67 6.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.839 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.98 -40.64 98.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 110.719 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -69.93 -35.89 74.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.58 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.12 -42.99 88.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.756 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.4 m170 -63.96 -38.67 91.94 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.997 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.95 -46.03 92.36 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.031 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.46 -43.92 95.96 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.23 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.78 -38.23 87.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 120' ' ' HIS . 57.1 t -58.38 -48.29 85.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.232 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.49 -28.84 41.46 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.934 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.38 -38.1 81.05 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.604 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.2 -32.42 33.52 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.2 mt -79.02 -26.12 43.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -110.36 -21.03 12.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.82 67.7 42.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.371 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.11 158.42 56.56 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.984 2.456 . . . . 0.0 112.29 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.217 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.22 148.66 95.88 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.533 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.25 147.29 25.9 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.713 2.275 . . . . 0.0 112.089 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.91 155.87 90.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.74 151.11 69.12 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.059 1.839 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.74 -172.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.134 1.889 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -122.38 155.82 61.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.0 141.36 88.89 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.083 1.855 . . . . 0.0 112.073 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.82 163.45 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.739 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -86.58 138.73 31.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.379 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.78 127.64 46.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.073 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.403 ' N ' HD12 ' B' ' 951' ' ' ILE . 3.0 mp -130.9 123.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.635 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.38 83.57 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.079 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 . . . . . 0 C--O 1.218 -0.578 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.522 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.85 163.84 11.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.519 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.66 143.45 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.519 ' HD2' HG21 ' C' ' 12' ' ' THR . 6.3 m-85 -87.46 122.07 30.72 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.754 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.2 t -106.63 113.3 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.963 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -97.55 120.86 38.69 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.771 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.828 HG22 HD23 ' C' ' 69' ' ' LEU . 76.9 p -82.06 171.23 14.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.595 HD11 ' H ' ' C' ' 71' ' ' LEU . 55.9 mt -64.85 -25.08 67.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.907 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -74.23 -9.27 58.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.86 -10.05 70.47 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -73.19 133.21 43.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . 0.519 HG21 ' HD2' ' C' ' 4' ' ' PHE . 95.7 m -107.3 132.19 53.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.79 111.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.655 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -83.32 127.9 34.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.5 mt -120.41 132.43 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.21 117.52 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.484 HG12 ' HE3' ' C' ' 29' ' ' LYS . 27.5 m -135.72 163.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -103.93 152.04 38.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.86 -35.7 94.3 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.973 1.782 . . . . 0.0 112.148 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.28 -3.11 58.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -61.86 137.57 58.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.961 0.41 . . . . 0.0 110.704 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -78.29 162.87 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.483 HD12 HD13 ' C' ' 50' ' ' LEU . 47.9 mm -64.53 -38.11 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.864 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.36 -42.11 90.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.032 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.06 -40.74 96.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.196 0.522 . . . . 0.0 110.519 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.508 HG21 HD21 ' C' ' 56' ' ' LEU . 61.3 t -63.31 -42.72 97.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.659 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.73 -40.09 91.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.5 90.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.254 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.484 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.89 -38.78 83.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.764 ' CD1' HD21 ' C' ' 43' ' ' LEU . 95.0 mt -66.74 -38.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.434 0.635 . . . . 0.0 110.359 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.39 -46.67 88.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.221 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.62 -31.24 68.13 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.481 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -89.8 -4.33 57.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -147.95 -41.64 0.17 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.45 11.77 28.37 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.309 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.577 HG22 ' HG3' ' C' ' 41' ' ' GLN . 59.5 mt -75.79 121.09 84.39 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.42 154.54 63.42 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.496 1.464 . . . . 0.0 111.495 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.18 -31.19 94.9 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.937 1.758 . . . . 0.0 112.771 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.99 -40.22 94.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.905 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.32 -7.48 57.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.956 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.577 ' HG3' HG22 ' C' ' 36' ' ' ILE . 91.4 mt-30 -87.04 105.98 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.155 0.502 . . . . 0.0 111.536 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -116.51 99.11 6.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.175 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.764 HD21 ' CD1' ' C' ' 30' ' ' ILE . 75.6 mt -86.4 131.18 34.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.25 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.503 HG21 ' HE1' ' A' ' 76' ' ' PHE . 85.5 mt -131.36 127.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.695 0.283 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 67.7 t80 -149.17 150.87 33.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.127 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.82 16.41 9.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.46 -14.36 59.82 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.778 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -113.44 144.34 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.965 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.25 135.08 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.006 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' C' ' 43' ' ' LEU . 52.9 mt -71.64 105.44 3.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.781 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -75.22 139.03 42.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.41 138.55 57.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.41 55.84 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -82.04 172.55 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.4 p -118.26 161.69 19.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.579 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.508 HD21 HG21 ' C' ' 26' ' ' VAL . 84.1 mt -61.69 -40.46 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.983 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -63.85 -23.46 67.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.3 -37.6 86.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.134 0.492 . . . . 0.0 110.184 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.39 13.19 28.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.201 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.77 40.26 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.78 114.63 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.942 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -100.2 -179.6 4.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.845 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.75 146.19 53.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 59.24 17.45 5.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -70.6 132.62 45.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -82.81 128.6 34.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.96 140.24 49.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.852 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.01 117.44 28.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.954 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.828 HD23 HG22 ' C' ' 7' ' ' THR . 57.2 tp -100.43 121.42 41.51 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.009 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.712 HG11 HD11 ' A' ' 56' ' ' LEU . 62.5 t -111.98 132.57 60.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.066 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.595 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.9 mt -109.36 145.66 35.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.093 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 . . . . . 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.623 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.76 163.51 13.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.299 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 pt -143.94 145.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.535 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -92.88 121.53 34.33 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.672 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -104.73 104.63 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.42 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -87.54 126.7 35.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.846 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.807 HG22 HD23 ' D' ' 69' ' ' LEU . 79.2 p -77.52 -171.86 2.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.854 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' D' ' 70' ' ' VAL . 88.8 mt -59.09 -19.88 48.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.673 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 22.2 p -111.15 -176.37 2.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.95 -18.45 57.21 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.76 131.04 38.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.082 0.468 . . . . 0.0 110.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -125.08 136.91 54.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.499 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.39 104.99 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.837 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -83.26 129.07 34.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' D' ' 29' ' ' LYS . 77.0 mt -124.51 131.97 53.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -76.63 116.56 17.42 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.343 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.735 HG12 ' HE3' ' D' ' 29' ' ' LYS . 27.3 m -135.15 161.7 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.65 152.71 40.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.02 -29.62 83.59 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.614 1.543 . . . . 0.0 111.791 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.7 p -80.97 -12.6 59.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.839 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.03 144.72 57.09 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.909 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -85.71 165.35 17.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.21 0.528 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.434 HD12 HD13 ' D' ' 50' ' ' LEU . 47.1 mm -62.79 -38.1 80.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.04 88.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.692 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.63 -41.07 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 110.345 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.523 HG21 HD21 ' D' ' 56' ' ' LEU . 63.2 t -63.4 -42.3 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -61.1 -40.55 94.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 110.202 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.87 89.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.905 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.735 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.1 mttm -59.75 -38.26 81.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.788 ' CD1' HD21 ' D' ' 43' ' ' LEU . 85.6 mt -64.24 -39.92 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' D' ' 35' ' ' GLY . 65.9 tt0 -60.35 -44.78 95.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.25 0.548 . . . . 0.0 110.134 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.48 -41.06 98.59 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.622 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.45 ' HD2' HD21 ' D' ' 15' ' ' LEU . 18.0 mttm -83.52 -14.53 52.08 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -136.36 -50.04 0.68 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 113.37 9.5 17.32 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.565 HD13 ' CD2' ' D' ' 71' ' ' LEU . 59.6 mt -78.08 125.69 84.82 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.59 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.99 159.95 50.87 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 120.917 1.078 . . . . 0.0 109.88 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.49 -40.41 78.82 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.165 1.91 . . . . 0.0 112.864 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.79 -44.37 96.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.65 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.65 -40.16 80.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.893 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.577 ' OE1' HD12 ' D' ' 30' ' ' ILE . 24.1 pt20 -85.57 140.71 30.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.206 0.527 . . . . 0.0 111.383 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . 0.552 HH21 HG11 ' D' ' 70' ' ' VAL . 61.3 mtm180 -130.25 118.96 22.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.788 HD21 ' CD1' ' D' ' 30' ' ' ILE . 74.3 mt -96.22 118.14 32.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.134 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -124.22 127.52 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 68.6 t80 -123.67 128.59 49.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.259 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 64.81 26.75 12.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.502 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.48 13.2 83.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -121.72 127.44 50.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.23 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -62.43 135.37 57.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 0.0 110.476 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' D' ' 43' ' ' LEU . 84.5 mt -80.57 103.87 10.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.154 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.66 143.99 49.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.401 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -67.49 167.07 13.48 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.424 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 18.37 79.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -128.87 148.83 50.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -90.9 165.31 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.523 HD21 HG21 ' D' ' 26' ' ' VAL . 81.2 mt -62.79 -38.39 90.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.394 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -62.54 -25.55 68.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.243 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -36.55 81.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.095 0.474 . . . . 0.0 110.156 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.32 14.42 24.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 56.42 39.27 30.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.19 104.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.01 -175.03 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.344 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -67.53 150.16 49.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.101 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 58.06 30.09 18.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.813 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 31.1 m -81.2 128.01 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 30.8 m -85.76 122.47 29.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.7 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.17 145.82 36.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.45 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -89.91 115.85 27.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.807 HD23 HG22 ' D' ' 7' ' ' THR . 49.8 tp -100.85 118.54 37.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' D' ' 8' ' ' LEU . 96.9 t -116.02 130.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.872 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.565 ' CD2' HD13 ' D' ' 36' ' ' ILE . 48.8 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.674 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.68 112.05 23.86 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.5 mt -65.97 -38.69 89.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.621 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.4 p -148.84 163.48 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.668 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -173.7 122.18 0.34 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.187 0.518 . . . . 0.0 110.855 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.07 156.61 37.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.378 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -72.29 125.04 26.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.081 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -159.13 143.26 15.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.549 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.68 163.11 12.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -96.57 171.9 8.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.239 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.0 mtp -136.95 174.94 10.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -124.33 128.85 49.73 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.524 HD22 ' CE1' ' A' ' 106' ' ' PHE . 36.3 tp -108.15 116.89 32.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.179 0.514 . . . . 0.0 110.193 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.65 111.34 18.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.397 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.22 0.37 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -142.41 20.34 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.856 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.498 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.3 m -120.25 129.27 53.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.769 0.319 . . . . 0.0 110.485 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.0 t -107.95 122.29 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.032 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.6 p -114.47 131.37 23.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.38 147.57 52.99 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.744 1.629 . . . . 0.0 112.996 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -100.78 133.92 44.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -70.73 -12.46 61.57 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.008 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -76.34 68.97 2.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -58.88 134.41 56.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.9 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.11 -150.57 7.15 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.223 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 27' ' ' ARG . 2.7 tp -137.51 126.64 24.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 28' ' ' ALA . 48.8 t -97.65 112.7 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.07 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -134.52 155.0 51.16 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.3 mt -118.61 136.62 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.698 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.75 129.61 32.83 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 123.495 0.497 . . . . 0.0 110.463 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.486 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.4 tt0 -99.24 125.34 44.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 110.301 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.516 HG23 ' CD2' ' A' ' 58' ' ' HIS . 18.9 p -86.23 170.12 12.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.423 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -61.95 -10.56 9.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.296 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.77 0.83 56.13 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.472 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.76 19.93 7.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.255 0.55 . . . . 0.0 110.48 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.712 HD11 HG11 ' C' ' 70' ' ' VAL . 83.4 mt -98.49 123.34 42.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.6 mm -80.85 123.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.516 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.5 m-70 -99.38 114.76 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.978 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -93.16 107.69 19.44 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.4 m -120.65 148.22 44.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.717 0.77 . . . . 0.0 113.036 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -127.83 115.24 18.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.175 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.52 131.74 53.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.932 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -72.11 134.37 45.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.63 -17.42 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.942 0.401 . . . . 0.0 110.428 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -60.03 -45.65 92.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.694 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.0 p -116.37 -16.77 10.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.131 0.491 . . . . 0.0 109.871 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.67 22.15 75.57 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -100.46 152.26 20.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.08 104.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.851 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -82.13 -29.78 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.354 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -126.71 146.29 50.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.408 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.74 ' O ' HD23 ' A' ' 73' ' ' LEU . 68.5 t0 -157.56 101.26 1.83 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.856 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.778 HD22 ' HB3' ' C' ' 48' ' ' LYS . 13.8 mt -130.95 128.88 41.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.427 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.427 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -75.23 124.83 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.606 HG21 ' SG ' ' A' ' 80' ' ' CYS . 24.4 mm -114.0 122.23 67.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.631 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 65.5 m-85 -88.44 162.92 38.17 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.586 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.87 138.54 86.29 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.202 1.934 . . . . 0.0 111.831 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.05 6.2 1.68 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.754 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -71.68 -37.64 70.72 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.683 0.277 . . . . 0.0 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 96' ' ' LEU . 19.7 p -146.81 167.08 24.77 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.732 0.777 . . . . 0.0 111.019 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -128.52 128.94 45.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.324 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -99.04 118.53 36.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -143.64 165.55 27.3 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.913 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -79.53 160.29 26.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.62 90.36 12.45 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.109 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.59 59.75 7.54 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.812 1.675 . . . . 0.0 112.381 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.0 -39.76 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.321 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 p -127.82 75.45 78.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.478 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.04 130.01 30.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.981 1.788 . . . . 0.0 111.474 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.43 -44.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.662 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.38 -148.32 6.53 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -116.1 106.37 13.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.97 127.82 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -123.73 155.09 38.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.692 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 105' ' ' LEU . 13.1 p -129.75 138.37 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.089 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' A' ' 80' ' ' CYS . 67.8 tp -104.78 121.24 43.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -117.79 121.64 41.33 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.172 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.491 ' HE2' HD12 ' A' ' 75' ' ' ILE . 59.1 m-85 -80.68 112.3 17.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.52 -36.21 77.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.695 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.1 -17.71 14.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.397 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -85.89 -13.9 68.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.576 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 53.2 31.46 11.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.09 0.445 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 98' ' ' PHE . 12.1 ttmm -120.75 145.73 47.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.249 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -127.06 127.93 45.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.089 0.471 . . . . 0.0 111.532 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 95' ' ' VAL . 48.9 mt -119.32 149.14 42.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.62 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.524 ' CE1' HD22 ' A' ' 33' ' ' LEU . 91.2 m-85 -123.61 134.96 53.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.558 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.23 155.43 50.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.38 0.61 . . . . 0.0 111.322 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -129.01 136.23 50.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.183 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.5 mtp -81.29 138.4 35.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.227 0.537 . . . . 0.0 111.51 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.91 5.3 49.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.669 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.95 130.96 89.45 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.183 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.6 -24.83 41.29 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.692 1.595 . . . . 0.0 112.686 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.4 143.24 48.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.453 HG22 ' HG2' ' A' ' 92' ' ' ARG . 74.4 p -95.68 11.45 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.02 -20.62 58.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -122.81 9.28 9.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.067 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -62.85 -45.69 91.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.41 -32.82 73.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.415 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.48 -46.69 81.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.41 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.657 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.1 m170 -64.54 -40.81 96.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 109.626 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.1 t -63.1 -44.27 96.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.262 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -69.8 -41.33 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.241 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.54 -42.71 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.378 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.6 t -57.77 -48.26 84.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.917 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.824 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.12 -20.68 63.17 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.549 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 23.3 m-85 -94.41 -18.2 21.77 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.746 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 124' ' ' VAL . 86.3 mt -95.62 -24.64 16.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.096 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -118.72 -12.25 9.71 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.271 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.15 64.71 55.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.122 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.23 152.67 75.78 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.492 1.394 0 C-N-CA 122.245 1.963 . . . . 0.0 111.872 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -129.13 148.6 69.73 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.635 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.46 146.71 27.89 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.606 2.204 . . . . 0.0 112.194 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -73.41 153.03 90.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.45 154.0 65.34 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.938 1.759 . . . . 0.0 112.139 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.65 -170.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.336 2.024 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -126.43 159.02 65.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.197 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.41 139.9 87.79 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.457 2.105 . . . . 0.0 112.331 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.41 163.6 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.604 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -86.44 134.3 33.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -118.72 131.39 56.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -63.95 158.92 21.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.237 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.34 148.82 24.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.114 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -91.37 120.99 32.7 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.285 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.63 110.22 29.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -98.27 121.29 40.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.638 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -82.2 173.83 11.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.526 HD11 ' H ' ' C' ' 71' ' ' LEU . 74.3 mt -61.65 -30.35 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -71.25 -12.15 61.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.13 -13.98 62.87 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.43 131.86 49.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 110.364 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 95.3 m -108.93 131.03 55.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.392 . . . . 0.0 110.374 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.03 114.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.474 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 29.1 m -81.32 129.98 34.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.347 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.61 127.32 48.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -71.3 115.26 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.452 HG12 ' CD ' ' C' ' 29' ' ' LYS . 25.7 m -135.37 163.49 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.634 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.34 152.86 40.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.98 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.35 -37.23 94.8 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.119 1.879 . . . . 0.0 112.229 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -83.84 -4.92 59.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.063 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -59.72 136.97 58.16 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.953 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -77.58 161.75 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.2 mm -63.91 -38.99 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.236 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.13 -42.02 89.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.27 -41.04 98.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.145 0.498 . . . . 0.0 110.619 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 56' ' ' LEU . 54.1 t -63.19 -43.45 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.77 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.63 -39.97 90.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.237 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.452 ' CD ' HG12 ' C' ' 17' ' ' VAL . 67.5 mttm -60.55 -39.68 88.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.637 HG21 HD11 ' C' ' 69' ' ' LEU . 95.7 mt -66.28 -39.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.308 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.57 -40.99 93.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.32 -39.6 92.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.151 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -74.86 -64.39 1.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.712 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.17 170.93 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.219 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.26 21.12 26.31 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.679 HG22 ' HG3' ' C' ' 41' ' ' GLN . 27.3 mm -77.03 117.49 65.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.851 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.77 156.27 57.26 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.299 1.999 . . . . 0.0 111.797 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.07 -39.3 70.6 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.071 1.847 . . . . 0.0 112.526 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.13 -39.59 93.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.681 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.39 -3.51 56.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.114 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.679 ' HG3' HG22 ' C' ' 36' ' ' ILE . 17.7 mt-30 -87.42 68.04 9.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.61 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' C' ' 70' ' ' VAL . 94.0 mtt-85 -85.53 110.72 19.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.55 ' HB2' HD12 ' C' ' 50' ' ' LEU . 25.9 mt -98.78 132.58 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.64 129.62 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 110.525 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.66 151.65 40.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.984 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.88 15.56 6.11 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.34 -14.25 63.0 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.678 ' CG ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -107.2 140.71 39.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.56 133.88 44.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' C' ' 43' ' ' LEU . 48.6 mt -72.22 102.2 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.891 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -75.3 140.12 42.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.83 137.94 57.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.216 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.47 -17.78 52.58 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmp_? -83.49 177.7 8.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.337 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -125.24 163.21 23.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.109 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 26' ' ' VAL . 85.4 mt -61.54 -40.93 96.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.552 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.83 -24.41 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.78 -37.93 86.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.2 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.72 13.88 26.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.509 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.79 39.34 27.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.41 . . . . 0.0 110.264 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.414 HG21 HD22 ' C' ' 56' ' ' LEU . 63.2 mt -85.54 118.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.069 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -106.87 -179.18 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.686 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -61.97 146.14 50.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.935 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.6 15.63 9.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.618 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.8 m -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.545 ' C ' HD12 ' C' ' 67' ' ' LEU . 88.3 m -82.54 129.77 34.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.064 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.545 HD12 ' C ' ' C' ' 66' ' ' THR . 9.9 mp -114.89 144.31 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.127 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -95.83 118.14 31.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.231 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.637 HD11 HG21 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -96.82 123.32 40.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 56' ' ' LEU . 66.4 t -114.49 126.95 72.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.947 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.526 ' H ' HD11 ' C' ' 8' ' ' LEU . 15.7 mt -98.45 -174.25 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.405 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.332 . . . . 0.0 110.527 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -63.21 154.83 30.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.078 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -133.9 160.72 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.321 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.623 ' CD2' HG23 ' D' ' 14' ' ' THR . 12.9 m-30 -101.59 125.71 48.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.615 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.47 HG21 HD12 ' D' ' 15' ' ' LEU . 78.5 t -111.56 107.15 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.898 0.38 . . . . 0.0 111.008 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -85.2 129.23 34.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.679 HG22 HD23 ' D' ' 69' ' ' LEU . 68.5 p -90.18 176.6 6.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 110.961 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.648 HD11 ' H ' ' D' ' 71' ' ' LEU . 90.1 mt -60.65 -37.37 81.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -74.68 -8.22 55.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.75 67.37 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -63.29 126.59 27.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.059 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 92.3 m -96.21 136.88 36.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 0.0 110.611 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -122.3 118.18 54.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.278 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.623 HG23 ' CD2' ' D' ' 4' ' ' PHE . 0.2 OUTLIER -83.41 125.14 31.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.061 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 29' ' ' LYS . 90.5 mt -123.26 113.11 18.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.94 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -65.78 106.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.242 0.544 . . . . 0.0 110.853 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.658 HG12 ' HE3' ' D' ' 29' ' ' LYS . 32.7 m -130.61 163.2 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.639 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -105.76 155.09 38.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.58 -37.24 97.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.174 1.916 . . . . 0.0 111.981 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -83.42 -5.22 59.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.976 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -59.15 138.06 57.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.995 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -79.65 161.35 25.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.944 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -64.02 -38.37 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.755 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.77 -41.59 86.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.817 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.17 -41.4 98.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 110.714 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.406 HG22 HG11 ' D' ' 17' ' ' VAL . 65.9 t -64.19 -42.73 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.1 mtmt -60.52 -39.8 89.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.406 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.63 92.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.511 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.681 ' HB3' HD22 ' D' ' 15' ' ' LEU . 66.8 mttm -59.82 -40.06 87.14 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.62 -39.62 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.338 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.17 -42.42 90.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.678 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -90.69 19.73 5.21 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -122.52 -39.56 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -126.11 -6.99 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.315 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 18.87 76.6 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.675 ' CD1' HD21 ' D' ' 69' ' ' LEU . 70.8 mt -77.05 120.56 82.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 147.84 92.36 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.341 2.027 . . . . 0.0 111.727 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 -41.76 62.97 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.943 1.762 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.11 -32.02 72.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.9 -10.24 58.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.466 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.625 ' HG3' HG22 ' D' ' 36' ' ' ILE . 89.2 mt-30 -88.88 112.97 23.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.601 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -115.74 101.42 8.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' D' ' 27' ' ' LYS . 10.0 mt -94.66 118.48 31.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.2 mt -125.99 123.08 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.116 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -113.42 122.83 48.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.15 30.11 19.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.473 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.46 89.99 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -103.41 119.11 38.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -64.11 138.64 58.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' D' ' 43' ' ' LEU . 49.3 mt -90.5 105.34 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.33 153.32 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.728 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -72.37 161.21 31.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.063 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.89 84.69 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.01 176.98 4.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.707 0.289 . . . . 0.0 110.45 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -126.16 164.42 20.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.406 HD21 HG21 ' D' ' 26' ' ' VAL . 91.1 mt -62.24 -39.79 94.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.743 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -63.27 -29.52 70.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 0.0 110.923 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.78 -32.17 72.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.46 14.19 30.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.215 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 55.83 39.93 30.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.817 0.341 . . . . 0.0 110.542 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.35 105.01 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.817 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.26 -177.04 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.436 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -61.08 148.76 39.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.085 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 56.96 47.7 17.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -104.62 124.45 49.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.318 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.537 ' C ' HD12 ' D' ' 67' ' ' LEU . 94.4 m -74.66 130.73 40.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.537 HD12 ' C ' ' D' ' 66' ' ' THR . 7.9 mp -121.25 145.68 47.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -91.16 111.19 22.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.923 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.679 HD23 HG22 ' D' ' 7' ' ' THR . 64.4 tp -98.28 118.03 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.531 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.3 t -115.84 135.61 55.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.071 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.648 ' H ' HD11 ' D' ' 8' ' ' LEU . 49.0 mt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.528 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -97.05 126.18 42.02 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.332 0.587 . . . . 0.0 109.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 51' ' ' GLN . 86.3 mt -68.24 -38.58 81.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.092 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -145.64 161.45 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.88 179.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.7 122.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.23 158.98 41.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.071 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.75 121.21 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.945 0.402 . . . . 0.0 111.004 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.77 145.0 22.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.27 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.86 153.15 17.28 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -88.2 173.95 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.977 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.5 mtp -136.93 175.47 9.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.9 m -124.23 124.56 42.71 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.473 HD13 ' CG2' ' A' ' 38' ' ' VAL . 25.8 tp -106.35 116.94 32.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.47 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -120.02 110.53 16.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.795 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -90.46 0.47 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 p -140.18 23.09 2.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.608 0.242 . . . . 0.0 110.745 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.0 m -125.06 129.82 51.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.655 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.473 ' CG2' HD13 ' A' ' 33' ' ' LEU . 61.2 t -110.99 122.72 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.3 m -118.74 129.08 25.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.05 146.48 64.75 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.692 1.594 . . . . 0.0 113.183 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.93 136.32 39.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.791 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -71.16 -8.73 55.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.639 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.87 77.32 0.89 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -58.08 134.23 56.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.96 -160.79 9.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.679 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.7 tp -137.41 123.98 20.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -95.48 109.91 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.249 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -131.32 154.98 47.98 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.191 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -120.45 140.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.454 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.77 128.17 26.39 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.827 0.705 . . . . 0.0 110.35 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.75 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.7 tt0 -99.5 124.4 44.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 58' ' ' HIS . 10.7 p -84.63 172.14 11.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.65 -10.56 27.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.93 1.54 55.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.561 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t 70.24 21.05 6.01 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.309 0.576 . . . . 0.0 110.432 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.672 HD11 HG11 ' C' ' 70' ' ' VAL . 75.5 mt -98.76 121.56 40.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.622 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -80.22 121.23 33.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.461 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 52' ' ' THR . 70.2 m-70 -97.65 114.25 26.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.614 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -97.59 107.05 19.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.06 50.29 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.782 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -117.82 116.06 26.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.571 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -105.55 144.95 31.6 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.416 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.41 130.89 35.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.15 -18.69 62.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 110.755 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.1 m -59.41 -45.49 91.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.608 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.4 m -117.06 -11.85 10.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.972 0.415 . . . . 0.0 110.496 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 22.77 78.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.37 149.94 23.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.669 0.271 . . . . 0.0 110.448 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.58 102.19 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.07 -38.76 66.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.836 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -126.37 146.17 50.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.069 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.8 t0 -157.9 100.8 1.76 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.678 HD22 ' CG ' ' C' ' 48' ' ' LYS . 35.0 mt -126.86 135.93 51.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.976 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.2 mt -77.96 120.51 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.225 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.699 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.4 mm -110.5 121.48 63.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.236 0.541 . . . . 0.0 111.153 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.639 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 59.6 m-85 -85.08 163.04 47.38 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.799 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.53 140.21 92.61 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.105 1.87 . . . . 0.0 111.567 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t0 60.08 11.86 2.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.45 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -84.23 -26.26 28.82 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.863 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.699 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.7 p -150.76 168.69 23.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.523 0.678 . . . . 0.0 110.603 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -135.06 131.72 37.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.382 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -103.38 117.34 34.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -142.13 167.52 21.93 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.823 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -82.69 160.25 22.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.945 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -112.64 90.12 14.32 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.014 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.9 60.05 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.904 1.736 . . . . 0.0 112.347 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.52 -39.72 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.514 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.3 t -127.44 85.99 59.6 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.647 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.39 130.62 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.679 1.586 . . . . 0.0 111.671 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 169.29 -40.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.13 -157.9 7.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -104.52 109.23 21.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.21 129.02 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -126.54 153.24 45.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.36 135.34 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.589 HD11 ' SG ' ' A' ' 80' ' ' CYS . 66.2 tp -103.61 119.92 39.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -116.29 131.13 57.03 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.302 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -84.47 114.37 21.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.038 0.447 . . . . 0.0 109.988 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.41 -36.49 82.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.46 -24.01 66.37 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.294 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -137.82 -148.98 5.46 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.7 p -121.08 7.2 10.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.637 0.256 . . . . 0.0 111.014 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HE2' HD21 ' A' ' 105' ' ' LEU . 87.6 tttt -63.19 134.87 56.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -136.48 135.64 38.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.971 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.466 HD21 ' HE2' ' A' ' 103' ' ' LYS . 60.9 mt -119.55 145.01 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.517 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 33' ' ' LEU . 95.7 m-85 -116.36 131.66 56.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.724 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.6 154.84 51.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.237 0.542 . . . . 0.0 110.915 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -128.63 137.08 51.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.306 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.45 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 26.9 tpp -73.88 140.2 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.527 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.73 1.73 19.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 109' ' ' MET . 76.5 mm-40 -73.39 141.07 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.587 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -28.98 22.64 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.886 1.724 . . . . 0.0 112.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -119.1 143.63 47.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.477 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.2 p -97.73 6.01 48.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.021 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -58.2 -21.61 48.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -124.19 -14.18 7.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.046 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.32 -41.24 98.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.646 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.51 -40.35 96.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.75 -41.91 97.92 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.495 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.8 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.2 m170 -63.35 -40.61 97.77 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.49 0.662 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.19 -46.8 88.97 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -65.5 -36.96 85.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.314 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -33.46 67.54 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.275 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.3 t -60.63 -46.71 95.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.146 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.51 -31.96 53.83 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -71.04 -30.56 66.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.349 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -83.75 -29.73 27.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.91 0.386 . . . . 0.0 110.304 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.622 HD23 HG21 ' A' ' 57' ' ' ILE . 67.9 mt -87.75 -23.68 24.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.913 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -108.91 -24.42 11.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.52 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -135.73 67.79 65.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.37 160.27 49.18 Favored 'Trans proline' 0 C--N 1.297 -2.137 0 C-N-CA 122.849 2.366 . . . . 0.0 112.242 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.187 . . . . 0.0 112.228 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.35 151.11 77.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.46 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.19 147.8 26.56 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.181 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.78 152.82 89.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.011 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.67 152.15 64.4 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.392 2.061 . . . . 0.0 112.221 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.85 -174.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.421 2.08 . . . . 0.0 111.964 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -122.44 157.64 58.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.205 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.19 139.49 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 122.457 2.105 . . . . 0.0 111.709 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 165.15 37.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -86.08 138.41 31.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.419 HD13 HG21 ' B' ' 951' ' ' ILE . 3.8 mt . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' C' ' 16' ' ' GLU . 9.6 pt20 -62.1 157.65 18.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -139.41 148.15 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.933 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.79 124.21 40.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.777 0.322 . . . . 0.0 110.986 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.722 HG11 HD12 ' C' ' 69' ' ' LEU . 99.4 t -108.18 114.57 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.646 -0.421 . . . . 0.0 109.99 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -97.31 119.86 36.61 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.342 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.6 p -79.56 171.83 14.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.535 HD11 ' H ' ' C' ' 71' ' ' LEU . 56.9 mt -62.51 -24.85 67.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.171 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -75.57 -10.5 59.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.051 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.56 -14.48 64.16 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.62 133.09 49.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 110.34 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -107.56 132.19 53.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.389 . . . . 0.0 110.759 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.1 112.67 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.466 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.01 132.99 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.666 HD21 ' HG3' ' C' ' 33' ' ' LYS . 29.6 mt -130.96 122.24 26.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' C' ' 2' ' ' GLN . 8.7 pt-20 -66.81 115.17 6.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.1 163.45 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.589 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -107.3 152.7 41.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.634 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -37.16 87.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.922 1.748 . . . . 0.0 112.089 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -80.43 -9.57 59.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -58.51 136.0 57.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -77.61 158.97 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.134 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.497 HD12 HD13 ' C' ' 50' ' ' LEU . 46.8 mm -66.43 -40.98 87.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -59.13 -42.7 91.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.36 -43.97 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.303 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.16 -44.01 97.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -38.63 79.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.061 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.04 94.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.532 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.444 ' HE2' HD22 ' C' ' 15' ' ' LEU . 9.4 mtmm -61.68 -37.48 84.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.139 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.821 ' CD1' HD21 ' C' ' 43' ' ' LEU . 80.8 mt -64.25 -39.2 84.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -59.02 -39.97 83.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.366 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -86.95 7.29 28.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.666 ' HG3' HD21 ' C' ' 15' ' ' LEU . 2.0 mmtt -107.8 -47.62 3.56 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -116.54 -0.76 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.591 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 19.64 79.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.551 HG21 ' HB3' ' C' ' 41' ' ' GLN . 16.8 mm -81.43 119.96 76.96 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.133 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.26 149.3 65.24 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.065 1.843 . . . . 0.0 111.861 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -33.42 77.03 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.429 2.086 . . . . 0.0 112.65 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.05 7.68 39.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.395 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -108.33 -31.12 7.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.753 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.605 ' CB ' HD21 ' C' ' 69' ' ' LEU . 7.8 pt20 -99.22 131.53 45.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.498 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -122.95 115.35 21.77 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.821 HD21 ' CD1' ' C' ' 30' ' ' ILE . 70.0 mt -85.8 129.62 34.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.18 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt -131.87 129.16 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.326 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . 0.566 ' HB2' HD23 ' C' ' 67' ' ' LEU . 92.6 t80 -145.96 150.08 35.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.019 0.438 . . . . 0.0 111.456 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.92 20.12 11.25 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.022 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 84.32 -8.72 66.65 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.673 ' HG2' HD22 ' A' ' 73' ' ' LEU . 8.8 mtpt -107.9 137.22 46.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.972 0.415 . . . . 0.0 111.237 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -74.19 132.99 42.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.838 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.721 HD12 ' CB ' ' C' ' 43' ' ' LEU . 45.1 mt -74.95 98.66 3.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.53 141.23 43.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.819 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.68 142.86 52.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.99 -18.06 57.31 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -87.99 171.19 10.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.883 0.373 . . . . 0.0 110.476 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.8 p -115.46 163.52 15.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.131 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' C' ' 56' ' ' LEU . 77.9 mt -61.41 -40.96 96.32 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 94.7 p -63.79 -22.64 67.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.448 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.78 -37.82 85.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.95 0.405 . . . . 0.0 110.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -98.37 15.47 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.245 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 58.98 41.8 20.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.586 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -88.39 109.99 20.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -95.51 178.37 5.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.453 0.644 . . . . 0.0 111.171 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -61.23 148.3 41.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.746 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 59.25 17.11 5.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.398 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -65.92 138.13 57.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 39.2 m -98.31 122.1 41.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' C' ' 45' ' ' PHE . 3.3 mp -116.57 148.22 41.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.554 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -92.19 133.19 36.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.722 HD12 HG11 ' C' ' 5' ' ' VAL . 1.9 tt -108.26 115.86 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.048 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.5 131.5 47.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.054 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.658 HD21 HD22 ' C' ' 69' ' ' LEU . 39.4 mt -106.1 132.92 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.536 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . 0.513 ' OE1' HG21 ' D' ' 14' ' ' THR . 5.4 pt20 -63.06 160.69 14.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.162 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -138.41 156.42 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.258 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.6 m-30 -96.29 125.37 40.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.709 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.45 107.35 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.913 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 122.78 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.093 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.424 HG23 ' O ' ' D' ' 11' ' ' LYS . 80.4 p -82.3 172.1 13.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.776 HD11 ' H ' ' D' ' 71' ' ' LEU . 88.1 mt -63.22 -26.02 68.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.179 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -86.6 -1.34 57.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.828 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 -8.72 77.83 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . 0.424 ' O ' HG23 ' D' ' 7' ' ' THR . 7.5 tmtm? -68.3 118.34 11.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.896 0.379 . . . . 0.0 110.107 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 74.6 m -90.99 137.38 32.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mt -122.48 119.0 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.116 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.573 HG23 ' CD2' ' D' ' 4' ' ' PHE . 1.1 m -86.47 117.8 25.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.702 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.89 123.39 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.94 113.06 7.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.707 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.6 m -133.05 160.52 42.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.276 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.45 152.98 40.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.926 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.1 -36.86 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 111.661 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -80.06 -9.7 59.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.303 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -57.93 138.43 55.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 47.0 p -81.03 163.11 23.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.174 0.511 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.861 HD12 HD23 ' D' ' 50' ' ' LEU . 43.5 mm -63.54 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.207 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.18 -39.4 86.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.875 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.529 HG21 HD21 ' D' ' 56' ' ' LEU . 52.9 t -63.03 -43.48 99.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.698 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -61.34 -39.38 90.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.053 0.454 . . . . 0.0 109.994 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.38 89.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.125 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.707 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.7 mttm -59.92 -38.91 83.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.6 ' CD1' HD21 ' D' ' 43' ' ' LEU . 80.1 mt -64.89 -39.87 87.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.71 -44.57 96.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.057 0.456 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.83 -13.25 59.95 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.911 -0.493 . . . . 0.0 112.065 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -105.92 -4.01 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -148.48 -37.19 0.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 110.459 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.01 11.8 36.08 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.535 HD13 ' CD2' ' D' ' 71' ' ' LEU . 41.4 mt -82.38 121.02 78.1 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 155.07 42.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.038 1.825 . . . . 0.0 111.745 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.11 -25.27 73.06 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.626 2.217 . . . . 0.0 112.528 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -95.01 7.02 47.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -118.35 9.77 12.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.894 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' D' ' 69' ' ' LEU . 26.8 pt20 -142.05 154.45 44.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . 0.475 ' NE ' HD11 ' D' ' 44' ' ' ILE . 58.0 ttp180 -134.22 129.62 35.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.747 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' D' ' 30' ' ' ILE . 67.0 mt -99.9 115.29 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.054 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.475 HD11 ' NE ' ' D' ' 42' ' ' ARG . 88.5 mt -121.47 117.07 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.326 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -64.71 -47.07 79.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.051 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -176.74 78.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.827 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.91 89.95 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -129.67 125.82 36.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.816 0.341 . . . . 0.0 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -82.71 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.476 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.861 HD23 HD12 ' D' ' 23' ' ' ILE . 7.9 mp -75.36 106.24 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.65 143.81 48.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.037 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.06 156.96 20.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.2 16.58 69.02 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.91 165.8 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 110.49 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -113.15 165.49 12.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.529 HD21 HG21 ' D' ' 26' ' ' VAL . 89.6 mt -61.26 -39.88 92.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.476 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.8 -26.41 68.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.53 -37.95 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.128 0.49 . . . . 0.0 110.186 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -95.03 13.62 24.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.056 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.16 40.81 27.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . 0.833 HD11 HD21 ' D' ' 50' ' ' LEU . 87.0 mt -92.33 114.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -100.43 -169.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.395 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -68.86 151.54 46.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 56.72 37.57 28.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.625 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -86.87 123.58 32.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -80.15 124.3 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.55 132.78 54.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.149 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.71 123.79 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.918 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' D' ' 41' ' ' GLN . 65.9 tp -103.97 111.54 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.666 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.6 t -107.36 132.61 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.776 ' H ' HD11 ' D' ' 8' ' ' LEU . 58.4 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 111.022 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -99.62 126.98 45.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.391 0.615 . . . . 0.0 110.225 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 51' ' ' GLN . 85.6 mt -68.49 -37.34 80.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.072 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.1 p -147.31 161.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.756 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.53 122.68 0.36 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.183 0.515 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -153.72 158.32 40.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.084 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.535 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -74.77 120.92 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.619 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -152.51 145.32 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.112 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.42 152.48 17.83 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.46 171.4 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.413 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 28.6 mtp -132.63 174.47 10.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.0 m -122.7 123.22 40.61 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 37' ' ' THR . 26.9 tp -105.02 116.94 32.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.19 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -120.81 112.25 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.94 -92.45 0.46 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 p -138.35 23.28 2.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.678 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' HD12 ' A' ' 33' ' ' LEU . 88.3 m -125.32 131.73 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 33' ' ' LEU . 74.3 t -111.01 123.73 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.204 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.799 HG22 ' HB3' ' B' ' 947' ' ' PRO . 58.4 p -119.02 135.12 23.66 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.141 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.5 150.38 57.57 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.98 1.787 . . . . 0.0 113.356 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -105.49 140.07 39.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.156 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -76.35 -7.08 54.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -72.76 75.13 1.13 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -55.48 127.96 32.12 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.78 -159.12 9.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.2 tp -139.17 124.46 19.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 28' ' ' ALA . 41.1 t -96.53 109.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.346 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.0 p90 -131.57 154.25 49.03 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.018 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.2 mt -118.42 139.14 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.712 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 128.53 30.76 Favored 'General case' 0 C--O 1.22 -0.478 0 O-C-N 123.89 0.744 . . . . 0.0 110.35 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.757 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.8 tt0 -99.42 125.3 45.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.977 0.417 . . . . 0.0 109.956 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.6 p -85.56 170.39 12.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.384 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -62.79 -10.62 13.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.166 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.5 2.62 54.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.475 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t 69.63 20.62 6.94 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.208 0.528 . . . . 0.0 110.401 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 74.9 mt -97.32 121.97 39.82 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.476 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -81.88 120.06 32.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.7 m-70 -96.9 111.53 23.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.114 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -90.58 108.24 19.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 74.2 m -121.02 145.98 47.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.648 . . . . 0.0 112.627 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -124.39 112.84 17.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.435 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -104.86 135.23 46.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.028 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -74.79 136.69 41.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.874 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -78.9 -17.77 54.98 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.537 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -60.84 -46.64 89.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -117.02 -13.02 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.95 24.94 75.01 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -102.01 144.48 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 0.0 110.673 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.16 105.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.27 -28.11 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.008 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -127.69 144.05 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.196 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.6 p30 -159.49 95.9 1.25 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.87 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.673 HD22 ' HG2' ' C' ' 48' ' ' LYS . 41.3 mt -123.13 138.01 54.77 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.821 0.343 . . . . 0.0 110.727 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 86.1 mt -83.21 116.8 27.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.496 ' HB ' HD22 ' A' ' 128' ' ' LEU . 1.2 mp -105.52 116.65 49.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.957 0.408 . . . . 0.0 111.139 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.585 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 44.7 m-85 -79.69 164.17 54.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.988 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.08 139.68 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.95 1.767 . . . . 0.0 111.041 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.59 11.82 3.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -85.91 -42.2 14.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.481 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.473 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -130.85 148.17 52.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.0 111.364 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -122.02 129.56 52.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.663 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -101.78 118.46 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -144.06 167.94 21.18 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.767 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -94.68 146.25 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.288 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.39 99.58 21.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.221 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.81 60.09 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.741 1.627 . . . . 0.0 112.223 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -114.35 -36.34 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.246 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 p -121.94 74.35 37.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.711 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.02 130.27 26.92 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.103 1.869 . . . . 0.0 111.745 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.98 -43.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.905 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.93 -139.61 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.47 106.38 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.3 127.31 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.82 156.21 35.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 105' ' ' LEU . 10.5 p -131.7 137.52 54.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.473 HD11 ' SG ' ' A' ' 80' ' ' CYS . 60.3 tp -105.69 119.92 40.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -119.61 139.18 52.59 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.991 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -88.78 115.81 26.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.62 -37.19 83.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.526 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.98 -22.86 24.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.176 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.51 -169.28 21.9 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.1 m -124.0 17.96 9.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.771 ' HD3' HD21 ' A' ' 105' ' ' LEU . 30.5 ttmt -89.64 138.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.27 0.557 . . . . 0.0 111.087 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.49 109.25 10.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.771 HD21 ' HD3' ' A' ' 103' ' ' LYS . 50.7 mt -96.0 150.4 20.51 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.45 ' CE1' HD22 ' A' ' 33' ' ' LEU . 88.3 m-85 -123.94 136.48 54.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.258 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.06 155.7 49.33 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.316 0.579 . . . . 0.0 111.118 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -128.32 137.45 51.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.838 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.1 tpp -75.82 123.95 26.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.242 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -16.81 34.72 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.7 127.29 88.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.28 -20.05 43.33 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.94 1.76 . . . . 0.0 112.724 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.54 140.4 47.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.132 0.491 . . . . 0.0 110.317 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.9 p -99.12 10.88 40.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.09 -26.42 49.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.379 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -126.03 -0.69 7.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.805 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.73 -48.56 80.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.77 -40.91 97.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -64.07 -42.67 96.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.807 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.784 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.4 m170 -64.79 -39.65 93.94 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.511 0.672 . . . . 0.0 109.213 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.82 -45.72 92.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.558 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -64.37 -43.47 94.43 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.212 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.25 -38.1 87.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.1 t -58.89 -48.08 87.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.164 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -80.61 -32.51 36.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.04 -38.18 87.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.571 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -80.62 -37.78 30.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.005 0.431 . . . . 0.0 110.258 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 75' ' ' ILE . 77.0 mt -71.53 -34.41 70.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.115 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -100.89 -24.13 14.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.677 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -139.99 69.04 35.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.746 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.83 160.49 49.23 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.916 2.411 . . . . 0.0 112.28 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.649 2.233 . . . . 0.0 112.248 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.67 81.99 68.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.724 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 138.88 83.81 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.808 2.339 . . . . 0.0 112.249 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.04 159.26 71.17 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.84 146.65 77.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.41 -173.96 1.29 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.541 2.161 . . . . 0.0 112.189 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -100.33 153.35 37.8 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.389 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.799 ' HB3' HG22 ' A' ' 39' ' ' THR . 43.2 Cg_endo -68.83 152.04 73.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.491 2.127 . . . . 0.0 112.084 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.43 168.74 25.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.35 132.14 34.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.82 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -113.37 136.04 53.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.079 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.447 -0.61 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.585 -179.23 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -62.45 160.34 13.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -139.31 149.97 22.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.614 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -91.86 119.82 31.99 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.263 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.422 ' CG1' HD12 ' C' ' 69' ' ' LEU . 69.4 t -104.36 108.64 25.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.07 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -92.75 122.31 35.03 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.889 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.0 p -81.56 171.5 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.593 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.645 HD11 ' H ' ' C' ' 71' ' ' LEU . 62.3 mt -65.54 -21.34 66.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.047 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.25 -5.88 58.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.343 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.49 74.68 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -74.16 128.8 36.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.844 0.322 . . . . 0.0 110.236 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.48 132.16 47.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.07 111.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.438 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -81.44 126.99 32.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.71 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' C' ' 29' ' ' LYS . 79.0 mt -120.03 129.82 54.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.66 116.58 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.441 HG12 ' HE2' ' C' ' 29' ' ' LYS . 21.0 m -136.13 165.63 28.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.706 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.405 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.2 mt-10 -110.32 154.14 43.06 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.42 -30.61 91.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.72 1.613 . . . . 0.0 111.965 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.3 m -88.86 -6.5 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.27 144.21 57.31 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.812 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.91 163.86 23.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.3 mm -63.04 -38.56 82.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.786 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -58.96 -40.89 86.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.41 -46.37 90.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.566 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.449 HG21 HD21 ' C' ' 56' ' ' LEU . 74.7 t -60.71 -42.66 92.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.04 -37.04 78.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.33 95.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' C' ' 15' ' ' LEU . 0.9 OUTLIER -59.35 -39.31 82.81 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.228 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' C' ' 43' ' ' LEU . 80.8 mt -65.15 -39.36 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.445 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.12 -43.05 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.43 19.31 6.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.47 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -123.72 -42.88 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.374 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -116.84 -18.95 10.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.575 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.26 10.81 65.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.515 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.402 HD13 ' CD2' ' C' ' 71' ' ' LEU . 52.0 mt -75.04 128.03 85.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.77 154.23 63.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.502 1.468 . . . . 0.0 111.02 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.64 -23.42 65.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.2 1.933 . . . . 0.0 111.968 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.85 -1.69 52.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.013 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -123.31 -31.49 3.55 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.52 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -78.8 132.84 37.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.318 0.58 . . . . 0.0 111.449 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -130.43 126.74 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.397 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' C' ' 30' ' ' ILE . 77.3 mt -103.39 124.71 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.961 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.508 HG21 ' HE1' ' A' ' 76' ' ' PHE . 80.5 mt -129.38 129.08 67.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.293 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -144.39 149.41 36.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.899 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.6 16.72 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.396 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.26 -14.95 59.56 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.702 ' HG2' HD22 ' A' ' 73' ' ' LEU . 9.7 mttt -98.94 141.49 31.64 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.449 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -75.43 127.27 32.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.751 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' C' ' 43' ' ' LEU . 48.3 mt -76.09 89.49 3.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -74.97 171.37 14.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -75.81 169.0 18.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.079 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.42 19.49 77.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -124.53 167.2 14.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.687 0.279 . . . . 0.0 110.585 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -122.71 161.22 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.578 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.449 HD21 HG21 ' C' ' 26' ' ' VAL . 80.6 mt -60.89 -40.51 93.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.8 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.62 -23.0 67.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.561 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.2 -38.06 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.017 0.437 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.438 ' CE2' HD23 ' C' ' 50' ' ' LEU . 71.1 m-85 -97.18 13.2 30.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.151 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 59.05 41.08 21.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.257 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.35 118.4 33.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.912 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -107.07 178.38 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.002 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -59.53 146.59 40.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.807 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 61.49 18.6 9.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 27.5 t -71.6 131.09 42.71 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 93.6 m -83.91 127.89 34.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -116.5 144.1 44.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.201 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -92.33 123.64 35.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.056 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.612 HD22 HD21 ' C' ' 71' ' ' LEU . 1.8 tt -102.8 115.25 30.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.127 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 56' ' ' LEU . 68.4 t -108.96 132.82 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.645 ' H ' HD11 ' C' ' 8' ' ' LEU . 33.3 mt -105.84 135.35 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.29 158.19 12.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.771 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -138.42 151.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.859 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.447 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.0 m-30 -92.69 122.92 35.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.711 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.68 109.95 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.694 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -94.52 122.3 36.95 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.088 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.649 HG22 HD23 ' D' ' 69' ' ' LEU . 77.0 p -82.19 -179.08 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.321 0.581 . . . . 0.0 111.632 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.747 HD11 ' H ' ' D' ' 71' ' ' LEU . 85.0 mt -61.58 -37.06 82.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.825 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.14 -8.99 57.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.262 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.92 -9.12 70.6 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.81 128.0 34.13 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -102.05 130.54 48.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.118 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.41 HG21 HD13 ' D' ' 13' ' ' ILE . 1.3 mt -124.37 113.86 38.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.743 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.447 HG23 ' CD2' ' D' ' 4' ' ' PHE . 10.6 m -80.03 125.78 30.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.757 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.25 118.25 30.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.281 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.19 110.29 2.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.299 0.571 . . . . 0.0 110.715 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.673 HG12 ' HE2' ' D' ' 29' ' ' LYS . 29.3 m -133.81 160.82 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -103.58 155.02 37.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.997 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 -38.37 95.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.124 1.883 . . . . 0.0 111.996 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.7 p -80.0 -8.78 59.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.026 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -58.7 135.74 57.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.979 0.418 . . . . 0.0 110.89 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.14 163.45 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.547 HD12 HD13 ' D' ' 50' ' ' LEU . 50.0 mm -64.23 -37.92 81.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.98 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.66 -43.81 89.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.99 -42.3 98.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 110.754 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.465 HG22 HG11 ' D' ' 17' ' ' VAL . 61.2 t -62.9 -42.38 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.923 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -60.64 -39.56 88.74 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.109 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.03 88.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.673 ' HE2' HG12 ' D' ' 17' ' ' VAL . 62.9 mttp -59.71 -38.98 83.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.813 ' CD1' HD21 ' D' ' 43' ' ' LEU . 87.3 mt -64.77 -40.58 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.931 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.69 -47.0 87.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.28 -15.94 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -103.57 -4.84 23.36 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.59 -37.65 0.2 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.78 10.42 32.82 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.618 HD13 ' CD2' ' D' ' 71' ' ' LEU . 49.9 mt -77.82 127.45 82.01 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.17 155.98 42.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.168 1.245 . . . . 0.0 110.728 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.78 -36.69 83.23 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.063 1.842 . . . . 0.0 112.468 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.14 -39.01 88.43 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.311 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -96.65 23.26 7.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.551 ' HG3' HG22 ' D' ' 36' ' ' ILE . 36.9 mt-30 -118.29 112.32 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 111.712 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -118.64 110.61 17.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.813 HD21 ' CD1' ' D' ' 30' ' ' ILE . 78.0 mt -97.7 117.12 31.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.417 HG23 ' C ' ' D' ' 48' ' ' ARG . 85.1 mt -121.82 126.58 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 85.5 t80 -127.68 130.14 48.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.7 29.13 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 17.16 79.69 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.417 ' C ' HG23 ' D' ' 44' ' ' ILE . 44.2 ttm180 -132.66 127.91 35.89 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.573 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -66.54 148.07 52.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.06 0.457 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.547 HD13 HD12 ' D' ' 23' ' ' ILE . 77.2 mt -90.21 115.36 27.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.882 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -70.01 136.7 50.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -61.31 136.94 58.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.198 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.62 55.72 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -82.25 172.58 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -118.27 163.21 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.89 -39.48 89.42 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.402 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.2 p -63.81 -24.35 67.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.3 . . . . 0.0 110.414 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.95 -37.75 85.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.327 0.584 . . . . 0.0 110.044 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -98.14 14.53 27.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.282 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 m120 56.83 39.94 29.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.829 0.347 . . . . 0.0 110.278 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -90.14 113.75 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.856 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -99.33 -172.25 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.531 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -68.79 150.75 47.49 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.273 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 56.85 41.77 27.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -98.5 127.45 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.559 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.51 ' C ' HD12 ' D' ' 67' ' ' LEU . 90.3 m -78.22 127.53 32.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.51 HD12 ' C ' ' D' ' 66' ' ' THR . 8.5 mp -118.57 138.4 52.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.921 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -89.07 113.96 25.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.649 HD23 HG22 ' D' ' 7' ' ' THR . 48.5 tp -99.46 120.53 39.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.695 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.5 t -112.97 132.75 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.747 ' H ' HD11 ' D' ' 8' ' ' LEU . 24.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.455 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -86.15 112.41 21.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.4 mt -68.32 -37.02 80.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.606 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -147.65 161.7 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.26 122.24 0.29 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 0.0 110.834 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.04 160.07 40.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.696 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.8 mtm-85 -78.66 124.05 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.046 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.75 146.03 20.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.86 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.47 152.12 17.19 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -95.52 161.9 13.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.875 0.369 . . . . 0.0 111.13 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mtm -134.81 170.27 16.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -121.09 135.92 55.08 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.403 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 37' ' ' THR . 29.6 tp -110.97 119.36 38.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.947 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -120.75 112.38 18.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.85 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -106.54 1.81 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.6 p -124.06 20.86 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.292 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.563 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.0 m -124.61 130.32 52.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 110.798 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.561 HG22 HD13 ' A' ' 33' ' ' LEU . 62.1 t -107.71 121.28 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -108.77 131.55 21.71 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.95 145.4 45.08 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.062 1.842 . . . . 0.0 113.35 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.12 120.74 42.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -65.23 -11.32 39.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -72.31 78.84 1.0 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -58.83 140.13 55.55 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.98 -157.3 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.815 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.0 tp -135.31 127.93 30.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.37 111.77 32.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.546 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -136.09 156.29 48.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.231 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.7 mt -122.24 137.7 54.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.873 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -135.06 130.56 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.632 0.583 . . . . 0.0 110.112 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.668 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.4 tt0 -100.7 124.15 45.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.107 0.48 . . . . 0.0 110.085 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.507 HG23 ' CD2' ' A' ' 58' ' ' HIS . 17.7 p -85.34 171.59 11.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.49 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.02 -10.34 21.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.116 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.93 1.09 55.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.282 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t 69.12 21.74 7.14 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.312 0.577 . . . . 0.0 110.252 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.844 HD11 HG11 ' C' ' 70' ' ' VAL . 83.6 mt -98.28 122.72 41.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.439 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.1 mm -81.99 122.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.507 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.0 m-70 -98.17 112.67 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.851 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -92.15 109.29 20.65 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 77.9 m -121.74 145.96 47.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -128.3 117.86 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.53 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -108.68 143.81 37.28 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.348 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -80.98 129.21 34.42 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -71.34 -16.64 62.44 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 m -59.4 -45.35 91.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.429 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.1 m -117.22 -13.27 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 110.182 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.79 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -101.72 152.04 21.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.04 103.86 6.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -77.97 -32.93 51.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -126.68 146.1 50.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.538 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 73' ' ' LEU . 68.2 t0 -157.68 98.73 1.67 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.052 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.702 HD22 ' HG2' ' C' ' 48' ' ' LYS . 28.3 mt -127.64 133.85 49.65 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.501 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -79.09 123.92 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.421 ' HB ' HD22 ' A' ' 128' ' ' LEU . 29.0 mm -112.23 129.5 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 111.103 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.508 ' HE1' HG21 ' C' ' 44' ' ' ILE . 59.3 m-85 -94.14 162.51 26.33 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.436 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.76 140.67 91.56 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.172 1.915 . . . . 0.0 111.658 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 60.71 12.26 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -88.4 -35.24 17.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.977 0.418 . . . . 0.0 110.401 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -135.51 148.36 49.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.179 0.514 . . . . 0.0 111.561 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -122.61 127.68 49.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.455 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -100.57 120.63 40.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -145.37 167.13 23.63 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.792 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -92.14 159.27 15.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.889 0.376 . . . . 0.0 110.217 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 t -120.95 89.83 46.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.382 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.31 60.45 7.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.81 1.674 . . . . 0.0 112.169 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.69 -34.3 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.172 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.5 t -124.91 86.78 56.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.54 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.48 129.91 19.94 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.771 1.647 . . . . 0.0 111.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.98 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.33 -176.77 33.8 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.521 ' NE ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -86.03 110.36 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.42 126.53 72.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -121.95 152.82 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.233 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.9 p -128.04 135.79 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.212 0.529 . . . . 0.0 109.904 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.453 HD11 ' SG ' ' A' ' 80' ' ' CYS . 61.5 tp -104.76 118.22 36.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -115.29 132.47 56.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 111.29 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 54.5 m-85 -86.65 115.56 24.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.58 -37.14 82.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.318 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -108.68 -23.36 11.83 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.362 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -63.86 -33.7 87.94 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.76 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p 74.05 27.89 1.54 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.621 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -139.45 162.11 35.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.491 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -138.69 149.42 45.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.464 . . . . 0.0 111.2 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 95' ' ' VAL . 46.1 mt -125.24 150.82 46.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' A' ' 33' ' ' LEU . 94.1 m-85 -120.3 135.92 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.501 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -137.34 156.38 48.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.191 0.519 . . . . 0.0 111.223 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -133.75 137.17 45.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.826 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttm -74.67 131.73 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.946 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.47 4.31 26.04 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.709 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -71.86 148.73 92.37 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.424 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.89 -27.6 14.29 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.099 1.866 . . . . 0.0 112.967 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -119.51 142.18 48.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.31 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.521 HG22 ' NE ' ' A' ' 92' ' ' ARG . 79.8 p -98.31 8.46 44.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.491 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.58 -22.47 13.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.351 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -123.73 8.11 8.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.579 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -61.16 -49.1 78.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.47 -40.5 95.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.209 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.77 -43.31 99.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.614 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.5 m170 -64.18 -40.13 95.46 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.92 94.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.792 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -65.65 -43.34 89.75 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.245 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.46 -39.33 93.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.887 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.3 t -59.14 -47.78 89.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.233 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.33 -27.88 38.25 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.82 -38.71 80.06 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.55 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -81.18 -33.23 33.16 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.64 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 75' ' ' ILE . 67.5 mt -77.96 -28.63 49.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -104.83 -26.87 12.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.319 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.7 72.84 73.09 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.313 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.411 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.1 Cg_exo -59.77 149.14 84.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.799 2.333 . . . . 0.0 111.573 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 122.175 1.916 . . . . 0.0 112.182 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 -72.08 154.35 92.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.449 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.16 153.88 66.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.829 2.352 . . . . 0.0 112.638 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.37 155.05 94.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.725 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.83 157.32 62.34 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.176 1.917 . . . . 0.0 112.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.74 176.94 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.224 . . . . 0.0 111.622 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.05 157.62 42.99 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.856 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 145.27 99.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.225 1.95 . . . . 0.0 111.788 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -158.07 169.3 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.09 137.86 32.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.185 0.517 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.9 121.49 38.18 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.471 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 63.4 mt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -62.08 156.09 22.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.019 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.97 148.83 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.27 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -90.21 123.86 34.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.443 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.55 114.73 47.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.195 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -103.02 123.07 45.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.644 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.3 p -84.1 172.5 11.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.069 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.54 HD11 ' H ' ' C' ' 71' ' ' LEU . 73.4 mt -64.35 -25.47 68.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -74.28 -8.89 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.22 6.11 66.91 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.25 127.95 34.27 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.788 0.327 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -104.54 131.76 51.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.916 0.389 . . . . 0.0 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 117.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.295 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -83.72 130.14 34.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.447 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' C' ' 33' ' ' LYS . 90.7 mt -123.24 122.95 39.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.775 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -66.13 110.77 3.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.744 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.503 HG12 ' HE3' ' C' ' 29' ' ' LYS . 22.4 m -134.23 163.44 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.447 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -106.09 154.35 39.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.98 -35.37 94.33 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.033 1.822 . . . . 0.0 112.17 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -84.78 -3.83 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.01 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -60.15 136.55 58.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 110.775 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.44 162.19 26.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.54 -38.32 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.12 -43.27 91.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.243 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.43 -41.63 98.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 110.909 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.7 -42.69 96.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.742 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' C' ' 43' ' ' LEU . 58.2 mtmt -60.41 -39.32 86.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -40.26 93.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.379 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.519 ' HB3' HD22 ' C' ' 15' ' ' LEU . 66.6 mttm -60.22 -39.68 87.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.543 HG21 HD11 ' C' ' 69' ' ' LEU . 96.8 mt -66.54 -39.8 84.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.211 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -59.49 -39.63 84.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 0.0 110.284 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.07 -44.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.701 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.617 ' HG3' HD21 ' C' ' 15' ' ' LEU . 19.7 mttt -70.82 -39.7 72.89 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -132.94 152.03 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.67 2.22 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.553 HG22 ' HB2' ' C' ' 41' ' ' GLN . 41.3 mm -117.39 94.91 46.46 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.36 149.62 80.08 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.73 2.287 . . . . 0.0 112.232 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -52.62 -40.06 74.08 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.962 1.774 . . . . 0.0 112.387 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.57 -39.54 94.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.03 31.86 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.706 ' HG3' HD21 ' C' ' 69' ' ' LEU . 12.9 tt0 -136.04 120.42 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.842 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -128.67 115.0 17.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.53 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.501 ' CB ' HD12 ' C' ' 50' ' ' LEU . 27.0 mt -92.89 132.31 37.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.151 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -129.46 128.61 66.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -144.27 151.39 39.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.869 0.366 . . . . 0.0 110.999 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 15.81 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.469 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.64 63.21 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.658 ' CG ' HD22 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -107.72 141.45 39.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.05 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -72.3 132.98 44.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.501 HD12 ' CB ' ' C' ' 43' ' ' LEU . 51.0 mt -77.06 100.29 5.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.681 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.61 144.64 41.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.258 0.552 . . . . 0.0 110.765 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.0 141.01 57.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.338 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.19 54.56 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -84.26 178.53 7.75 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.333 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -126.54 165.59 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.45 HD22 HG21 ' C' ' 61' ' ' ILE . 84.8 mt -62.71 -40.42 97.12 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.668 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.6 -26.67 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.99 -36.94 82.99 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 110.245 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.474 ' CE2' HD23 ' C' ' 50' ' ' LEU . 76.0 m-85 -97.69 13.8 29.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.162 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.33 43.56 28.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.443 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.45 HG21 HD22 ' C' ' 56' ' ' LEU . 57.6 mt -89.74 103.8 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.4 -179.39 5.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -63.28 148.98 46.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.007 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 59.51 44.33 14.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -102.83 127.93 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.432 ' C ' HD12 ' C' ' 67' ' ' LEU . 86.0 m -77.58 127.76 33.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.432 HD12 ' C ' ' C' ' 66' ' ' THR . 7.2 mp -116.29 145.69 42.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -98.19 123.16 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.374 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.747 HD22 HD21 ' C' ' 71' ' ' LEU . 1.7 tt -100.27 126.0 46.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.61 ' N ' HD23 ' C' ' 69' ' ' LEU . 93.9 t -108.75 131.03 60.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.444 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.747 HD21 HD22 ' C' ' 69' ' ' LEU . 33.1 mt -112.17 147.72 35.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.719 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.817 179.26 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -65.67 159.08 25.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.39 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.561 HD13 HD21 ' D' ' 56' ' ' LEU . 15.0 pt -137.9 141.4 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.219 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.594 ' HD2' HG21 ' D' ' 12' ' ' THR . 4.2 m-85 -84.26 123.88 30.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.884 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -110.11 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.818 0.342 . . . . 0.0 110.505 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -92.9 122.28 35.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.807 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -82.86 179.13 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.762 HD11 ' H ' ' D' ' 71' ' ' LEU . 85.0 mt -62.74 -35.85 81.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.27 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 42.8 p -67.42 -11.41 57.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.727 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.1 -9.94 67.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.4 129.6 40.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.594 HG21 ' HD2' ' D' ' 4' ' ' PHE . 98.9 m -101.52 132.18 47.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 110.807 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -127.11 105.79 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.611 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -81.88 127.11 32.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' D' ' 29' ' ' LYS . 86.5 mt -122.04 127.73 50.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.698 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.19 114.6 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.713 HG12 ' HE3' ' D' ' 29' ' ' LYS . 16.4 m -137.07 171.92 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.5 155.24 56.75 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.087 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.9 -39.41 84.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.128 1.886 . . . . 0.0 112.313 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -24.33 63.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.17 136.97 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.49 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -85.49 165.89 16.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.329 0.585 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.51 HD12 HD13 ' D' ' 50' ' ' LEU . 43.8 mm -63.38 -37.66 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.846 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.76 -42.15 88.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.856 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.11 -41.11 97.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.506 HG21 HD11 ' D' ' 56' ' ' LEU . 53.4 t -62.96 -42.97 98.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.878 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.59 -40.41 91.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.162 0.506 . . . . 0.0 110.485 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.713 ' HE3' HG12 ' D' ' 17' ' ' VAL . 64.8 mttm -59.31 -38.67 80.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.825 ' CD1' HD21 ' D' ' 43' ' ' LEU . 96.9 mt -64.5 -38.37 82.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.849 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -59.11 -38.99 80.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.23 -59.43 3.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.802 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.552 ' HD2' HD21 ' D' ' 15' ' ' LEU . 69.4 mttt -63.55 -41.49 98.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.03 142.52 50.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.095 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.97 60.28 3.04 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' D' ' 41' ' ' GLN . 2.9 mt -115.26 122.01 33.93 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.231 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 159.29 49.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.476 1.451 . . . . 0.0 111.649 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.3 -37.32 70.8 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.149 1.899 . . . . 0.0 112.563 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.69 -39.88 93.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.555 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.39 -11.33 54.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.367 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' D' ' 36' ' ' ILE . 91.4 mt-30 -86.6 83.19 7.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.008 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -98.28 98.93 10.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.825 HD21 ' CD1' ' D' ' 30' ' ' ILE . 73.5 mt -86.81 122.64 30.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.443 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.26 126.79 71.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.006 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.444 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.3 t80 -128.61 130.26 47.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.0 28.35 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.95 79.01 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -131.01 129.53 42.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.5 139.16 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.51 HD13 HD12 ' D' ' 23' ' ' ILE . 85.8 mt -82.96 118.68 23.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.11 137.32 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.315 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -66.73 147.54 53.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.179 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.58 -13.68 63.39 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -88.44 149.12 23.85 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -87.66 165.58 15.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.064 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.561 HD21 HD13 ' D' ' 3' ' ' ILE . 5.4 mp -66.72 -36.13 81.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.722 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -62.01 -27.02 68.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.727 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.22 -37.55 85.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.125 0.488 . . . . 0.0 110.285 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -95.74 11.81 32.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 55.26 41.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.14 103.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -90.03 -176.8 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -63.32 152.16 38.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 55.5 40.1 31.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.4 t -90.31 120.44 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.444 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.434 ' C ' HD12 ' D' ' 67' ' ' LEU . 61.6 m -75.42 127.09 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.163 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.434 HD12 ' C ' ' D' ' 66' ' ' THR . 7.1 mp -118.76 145.97 45.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 67.9 m170 -92.97 117.76 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.098 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.703 HD11 HD13 ' D' ' 30' ' ' ILE . 0.4 OUTLIER -97.84 99.46 10.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.371 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' D' ' 8' ' ' LEU . 73.3 t -90.78 135.57 26.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.382 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.762 ' H ' HD11 ' D' ' 8' ' ' LEU . 50.0 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.442 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.718 0.294 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -91.42 111.94 23.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.0 mt -65.75 -37.79 87.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.597 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -150.62 162.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.363 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.16 122.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.0 111.127 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.68 158.28 36.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.919 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -75.53 121.3 22.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.411 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.13 140.9 20.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.026 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.65 151.98 17.14 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -88.6 170.93 10.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 0.0 111.248 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 mtp -135.65 174.21 10.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.757 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -124.71 121.62 35.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 37' ' ' THR . 32.8 tp -102.91 121.78 43.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.904 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -118.83 104.1 10.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.029 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 -82.54 0.8 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -144.8 18.03 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.492 0.187 . . . . 0.0 110.95 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.656 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.2 m -119.99 128.01 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 33' ' ' LEU . 58.1 t -107.84 122.97 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.227 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.8 m -117.12 130.11 24.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.352 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.13 148.89 70.15 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.104 1.869 . . . . 0.0 113.229 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.77 136.04 45.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.91 -7.37 50.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.19 63.61 3.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -51.26 141.18 15.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.302 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.55 -153.37 6.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.369 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.1 tp -137.96 125.58 22.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.43 108.48 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.6 153.44 48.89 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.231 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' CG1' HG12 ' A' ' 24' ' ' VAL . 98.2 mt -119.17 138.55 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.469 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 129.87 31.78 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.806 0.691 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.546 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.9 tt0 -99.94 123.79 44.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.51 . . . . 0.0 110.387 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.0 p -83.62 170.23 14.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.706 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.48 -10.09 10.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.169 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.95 3.06 55.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.64 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 69.53 20.12 7.23 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.325 0.583 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 73.8 mt -96.35 121.66 38.39 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.521 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.3 mm -81.22 120.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.487 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.2 m-70 -97.49 114.49 26.37 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.347 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -99.25 107.23 19.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.798 0.809 . . . . 0.0 112.827 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -118.72 113.53 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.827 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -101.57 126.87 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -73.58 133.26 43.49 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -76.54 -18.45 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.4 m -60.47 -45.36 94.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.033 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -116.47 -16.62 10.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.973 0.416 . . . . 0.0 109.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.34 78.91 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.21 145.02 30.57 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.5 104.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 0.0 109.9 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -80.93 -33.61 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -127.13 142.99 51.38 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.865 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.3 t0 -158.72 95.53 1.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.31 0.381 . . . . 0.0 110.162 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.658 HD22 ' CG ' ' C' ' 48' ' ' LYS . 40.2 mt -124.7 137.25 54.36 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.079 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -79.57 118.4 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.725 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.0 mm -108.06 121.27 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.801 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 49.5 m-85 -84.66 160.5 55.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.153 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.02 144.91 99.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.004 1.803 . . . . 0.0 111.555 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 60.06 12.96 3.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.14 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.84 -25.77 17.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.536 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 75' ' ' ILE . 11.7 p -149.12 166.22 29.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.321 0.582 . . . . 0.0 110.575 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.411 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.9 tt0 -136.89 133.99 36.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.101 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -104.33 118.28 36.24 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -144.77 167.86 21.58 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.532 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -87.73 160.41 18.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.438 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.8 89.15 15.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.212 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.42 60.46 7.86 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.056 1.837 . . . . 0.0 112.111 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -114.02 -37.34 4.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.1 t -126.63 80.11 70.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.609 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.14 129.76 37.03 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.082 1.855 . . . . 0.0 111.186 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.52 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.858 0.724 . . . . 0.0 110.243 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.85 177.16 32.29 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -86.07 114.33 22.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.625 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.06 129.69 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.42 151.48 40.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.875 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.5 p -130.95 134.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.635 HD11 ' SG ' ' A' ' 80' ' ' CYS . 65.5 tp -100.45 120.07 39.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -115.96 131.97 56.79 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.28 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -82.73 111.99 19.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.267 0.556 . . . . 0.0 109.798 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -37.72 84.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.483 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 -20.54 23.14 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.261 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.82 177.42 27.92 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.2 p -114.14 23.36 12.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 153.72 46.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.855 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 157.09 46.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 95' ' ' VAL . 36.7 mt -118.49 156.24 29.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.873 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 91.1 m-85 -124.6 136.38 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -139.17 155.7 47.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.339 0.59 . . . . 0.0 111.247 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -128.99 137.45 51.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.4 tpp -67.8 132.45 47.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -2.89 15.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.0 146.6 97.44 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.231 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.27 -28.9 12.0 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.979 1.786 . . . . 0.0 113.155 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -118.59 144.73 45.92 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.633 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 p -100.49 12.27 37.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.734 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.28 -22.22 64.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.647 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -131.31 -6.63 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.837 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.81 -42.54 99.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.82 -39.8 91.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.0 111.305 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.86 -41.41 95.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.197 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.785 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.0 m170 -61.34 -40.05 92.84 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.552 0.692 . . . . 0.0 109.204 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.25 -44.91 94.87 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.644 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -62.65 -42.69 99.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.058 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -65.27 -35.64 81.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.018 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 120' ' ' HIS . 71.0 t -57.21 -48.02 83.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.021 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.42 -31.08 48.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.561 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.65 -27.18 64.83 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.042 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -92.52 -23.81 18.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.473 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.4 mt -95.24 -17.58 21.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -18.72 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.366 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -134.48 63.1 58.67 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.038 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.52 159.11 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.834 2.356 . . . . 0.0 112.457 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 122.664 2.243 . . . . 0.0 112.139 -179.427 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -92.92 153.1 41.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.21 145.82 31.18 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.565 2.177 . . . . 0.0 112.006 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -80.37 159.69 69.39 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.71 134.76 59.95 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.162 1.908 . . . . 0.0 112.165 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.35 -162.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.269 1.979 . . . . 0.0 112.009 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -128.31 155.18 78.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.679 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.59 145.35 81.74 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.486 2.124 . . . . 0.0 111.704 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -155.55 164.34 38.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.677 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.62 138.55 32.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -124.81 121.71 35.35 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.79 158.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.61 150.47 20.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.118 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -98.43 127.12 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.87 116.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.675 -0.41 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -101.32 121.15 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.596 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -81.58 171.69 14.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.494 HD11 ' H ' ' C' ' 71' ' ' LEU . 71.4 mt -63.34 -25.65 68.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -75.11 -8.55 56.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 6.41 66.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.12 126.27 32.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -103.04 131.06 50.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.902 0.382 . . . . 0.0 110.035 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.23 113.17 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.485 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.85 134.75 35.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.766 0.317 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.798 HD21 ' HG3' ' C' ' 33' ' ' LYS . 68.8 mt -132.66 131.48 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.4 115.37 13.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 0.0 110.686 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.447 HG12 ' CD ' ' C' ' 29' ' ' LYS . 21.3 m -134.64 166.08 29.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.558 ' O ' HD12 ' C' ' 56' ' ' LEU . 95.6 mt-10 -113.29 152.01 44.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.221 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.08 -25.51 78.18 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.953 1.769 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -91.05 -12.07 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.676 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.51 142.3 57.14 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.127 0.489 . . . . 0.0 110.928 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -80.46 166.67 21.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.972 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 1.001 HD12 HD23 ' C' ' 50' ' ' LEU . 33.2 mm -64.03 -35.85 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.739 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -58.6 -41.64 86.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.011 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.26 -41.89 93.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.112 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.575 HG21 HD21 ' C' ' 56' ' ' LEU . 64.3 t -63.76 -48.19 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.998 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.28 -31.48 72.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.115 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.79 95.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.249 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.507 ' HB3' HD22 ' C' ' 15' ' ' LEU . 67.6 mttm -60.66 -39.77 89.56 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.541 HG21 HD11 ' C' ' 69' ' ' LEU . 93.9 mt -66.6 -39.57 84.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.326 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.39 -38.68 81.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.422 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -68.69 -47.95 65.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.798 ' HG3' HD21 ' C' ' 15' ' ' LEU . 3.4 mttm -64.19 -40.89 97.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.58 153.84 51.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.121 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.07 57.71 2.73 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' C' ' 41' ' ' GLN . 39.1 mm -112.0 101.3 51.39 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.79 158.12 58.01 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.117 1.878 . . . . 0.0 112.219 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.15 -32.66 94.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.298 1.999 . . . . 0.0 112.349 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -66.94 -39.13 87.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.044 0.45 . . . . 0.0 109.898 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -103.67 23.37 12.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.686 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.728 ' HB2' HG22 ' C' ' 36' ' ' ILE . 0.8 OUTLIER -130.42 116.36 18.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.809 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -127.21 124.77 39.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -102.09 127.15 49.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.194 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -125.89 126.05 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 0.0 110.222 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -148.76 147.9 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 19.73 11.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.426 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.14 -13.27 60.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 147.96 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.238 0.542 . . . . 0.0 111.34 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -97.57 111.33 23.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.558 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 1.001 HD23 HD12 ' C' ' 23' ' ' ILE . 10.6 mp -64.29 97.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.794 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -76.98 -76.54 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.044 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -178.21 166.54 1.93 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.44 73.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -126.65 177.99 6.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -127.22 164.62 21.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.156 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.575 HD21 HG21 ' C' ' 26' ' ' VAL . 78.6 mt -61.55 -39.93 92.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.412 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.32 -28.55 69.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.62 -26.58 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.99 0.424 . . . . 0.0 110.385 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -104.16 12.0 34.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.291 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.54 38.16 29.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.195 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.41 105.06 13.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.969 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.13 -175.96 5.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.347 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -68.65 148.2 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.965 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 57.84 37.96 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -89.66 133.2 34.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.839 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -91.15 120.75 32.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.145 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.463 HD12 ' N ' ' C' ' 67' ' ' LEU . 5.2 mp -113.59 146.21 40.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -91.26 131.31 36.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.591 HD21 ' HG2' ' C' ' 41' ' ' GLN . 0.7 OUTLIER -106.17 119.13 38.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.299 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.477 ' N ' HD23 ' C' ' 69' ' ' LEU . 95.4 t -104.07 131.42 52.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.494 ' H ' HD11 ' C' ' 8' ' ' LEU . 26.4 mt -109.28 125.93 52.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.133 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 110.708 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -65.23 155.46 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.92 145.84 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -93.65 127.64 39.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.508 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.56 HG11 HD11 ' D' ' 30' ' ' ILE . 85.6 t -109.54 115.41 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.172 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -86.46 116.67 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.583 HG23 ' O ' ' D' ' 11' ' ' LYS . 82.0 p -74.63 171.26 14.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.087 0.47 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -41.43 73.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.391 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -76.31 -6.56 52.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.41 -13.31 59.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . 0.583 ' O ' HG23 ' D' ' 7' ' ' THR . 11.9 tmtt? -55.29 108.6 0.44 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -83.58 136.89 34.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.07 112.46 23.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.004 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.11 127.0 32.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.205 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.431 HD13 ' CB ' ' D' ' 29' ' ' LYS . 85.1 mt -126.06 120.77 31.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.789 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -66.1 108.97 2.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.719 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.4 m -131.57 166.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.94 154.54 41.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.53 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.88 -36.47 95.61 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.029 1.82 . . . . 0.0 111.861 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.0 p -80.54 -7.94 59.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -58.17 135.27 57.03 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.006 0.432 . . . . 0.0 110.748 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.23 162.48 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.79 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.31 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.687 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.55 -41.6 90.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.937 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.15 -41.59 98.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.049 0.452 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.56 -43.17 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.615 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.99 -38.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.157 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.58 90.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.107 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.719 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.8 mttm -60.77 -39.41 88.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.56 HD11 HG11 ' D' ' 5' ' ' VAL . 7.4 mm -64.93 -40.96 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.524 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.42 -40.41 94.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.712 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -65.15 -44.42 88.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.41 ' HD2' HD21 ' D' ' 15' ' ' LEU . 52.6 mttt -74.16 -66.26 0.74 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.375 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -92.25 171.56 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.004 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -91.1 18.84 49.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.552 HG22 ' HB2' ' D' ' 41' ' ' GLN . 30.2 mm -77.39 119.84 79.09 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.583 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.86 160.49 45.95 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.332 2.021 . . . . 0.0 111.478 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.58 -40.4 85.58 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.106 1.87 . . . . 0.0 112.993 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.08 -52.27 50.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.508 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.58 ' OE1' HD21 ' D' ' 43' ' ' LEU . 4.5 tt0 -65.23 112.64 3.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.889 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -118.1 111.2 18.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.311 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.58 HD21 ' OE1' ' D' ' 41' ' ' GLN . 64.3 mt -90.43 120.57 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.472 . . . . 0.0 110.514 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.3 mt -124.96 127.0 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 78.6 t80 -128.24 128.46 44.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.124 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.38 28.52 9.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.21 79.69 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -128.08 128.66 45.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.0 0.429 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.62 137.96 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.499 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' D' ' 59' ' ' TYR . 66.3 mt -84.64 118.87 24.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.261 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.36 137.77 41.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -62.76 137.77 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.471 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -16.87 57.75 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -78.81 178.68 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 110.459 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 80.5 p -125.53 161.87 26.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.114 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.36 -39.95 92.52 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.106 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.03 -27.58 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.424 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.09 -37.02 81.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.189 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.2 m-85 -98.25 15.02 25.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.084 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 54.74 40.45 31.92 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.859 0.361 . . . . 0.0 110.339 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -89.86 101.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -85.3 -175.83 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -64.09 166.67 7.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.032 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 45.72 36.49 2.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -89.61 122.86 33.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.19 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -83.46 125.48 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.135 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.81 162.75 15.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -109.99 120.73 43.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.381 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.493 HD11 HG21 ' D' ' 30' ' ' ILE . 1.3 tt -99.31 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 81.6 t -103.83 132.69 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.227 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.45 HD21 HD22 ' D' ' 69' ' ' LEU . 48.6 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.231 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.55 126.71 35.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.428 0.632 . . . . 0.0 110.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 51' ' ' GLN . 88.7 mt -68.05 -36.08 79.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.809 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 ' CG1' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -148.81 161.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.17 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -174.01 122.43 0.31 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.74 158.14 37.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.989 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.5 mtt180 -75.54 119.54 19.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.76 146.25 25.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.326 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.21 150.71 17.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.88 167.08 12.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 111.454 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.4 mtp -132.92 175.32 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.849 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.8 m -125.65 121.69 34.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 37' ' ' THR . 29.1 tp -104.46 118.08 35.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.393 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -122.74 113.42 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.977 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.12 -86.33 0.48 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 p -146.51 23.78 1.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.612 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.522 ' O ' HD12 ' A' ' 33' ' ' LEU . 87.9 m -126.54 132.59 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 33' ' ' LEU . 63.4 t -110.12 123.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.305 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.499 HG22 ' HB3' ' B' ' 947' ' ' PRO . 42.2 p -118.21 122.42 30.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.115 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.57 148.5 59.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.772 1.648 . . . . 0.0 113.365 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.88 133.06 44.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.845 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -7.63 48.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.33 78.58 1.85 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.11 132.66 33.34 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.634 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.05 -163.92 11.47 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.227 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.4 tp -137.12 120.44 16.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.55 108.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.548 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.0 p90 -130.83 153.42 49.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' CG1' HG12 ' A' ' 24' ' ' VAL . 96.7 mt -119.0 139.69 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.09 128.14 27.67 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 123.83 0.706 . . . . 0.0 110.847 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.648 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.8 tt0 -99.0 125.15 44.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.416 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.495 HG23 ' CD2' ' A' ' 58' ' ' HIS . 10.7 p -83.51 171.47 13.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.682 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.88 -10.04 25.57 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.509 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.05 2.49 55.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.57 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 t 70.23 21.36 5.91 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 121.088 0.47 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.4 mt -99.45 120.65 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.57 HG21 HD23 ' A' ' 128' ' ' LEU . 49.1 mm -79.33 122.43 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.495 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.6 m-70 -98.56 115.44 28.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.58 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -96.09 107.98 20.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 96.9 m -121.38 146.15 47.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.728 0.775 . . . . 0.0 112.462 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -126.51 113.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.902 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -105.27 145.92 30.03 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.05 0.452 . . . . 0.0 110.572 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.13 132.19 34.71 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -71.64 -18.31 62.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.03 0.443 . . . . 0.0 110.852 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -59.55 -44.98 93.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.789 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.55 -10.36 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.66 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.68 22.85 78.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -102.46 147.16 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.8 106.41 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.67 -22.62 25.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.799 ' OD2' HD21 ' A' ' 73' ' ' LEU . 7.3 t0 -128.64 142.78 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.933 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' HD23 ' A' ' 73' ' ' LEU . 66.6 t0 -157.15 107.65 2.28 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.016 0.436 . . . . 0.0 110.193 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.799 HD21 ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -141.86 130.72 22.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.355 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.67 124.26 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.571 ' HB ' HD22 ' A' ' 128' ' ' LEU . 23.6 mm -111.6 119.6 60.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.602 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.38 161.03 68.99 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.332 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.89 142.12 97.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.063 1.842 . . . . 0.0 111.541 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 61.01 12.36 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.374 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -87.66 -37.39 16.79 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 120.584 0.231 . . . . 0.0 110.602 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.516 ' HB3' HD11 ' A' ' 96' ' ' LEU . 72.7 m -131.31 154.92 48.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.252 0.548 . . . . 0.0 111.745 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -126.72 128.21 46.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.113 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -100.39 117.2 34.1 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -143.64 167.34 22.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -83.56 160.53 21.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.551 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.05 89.21 13.43 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.333 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.3 60.23 7.76 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.124 1.882 . . . . 0.0 112.175 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -114.7 -40.52 3.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.409 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.3 t -128.89 79.65 74.16 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.578 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.29 130.32 39.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.301 2.001 . . . . 0.0 111.284 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.83 -36.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.17 -167.12 12.88 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.55 106.64 18.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.913 0.387 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.4 t -124.83 128.35 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.732 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -125.29 151.38 46.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.125 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -125.43 135.92 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.379 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 80' ' ' CYS . 60.1 tp -102.07 112.71 25.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -112.2 143.1 43.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.505 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.87 116.52 28.01 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.25 -37.53 85.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.787 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.77 -22.33 18.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.397 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.03 174.97 26.98 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -111.94 21.44 15.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.661 0.267 . . . . 0.0 110.294 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.99 149.02 39.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.79 152.42 47.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 95' ' ' VAL . 43.5 mt -120.16 154.63 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CE1' HD22 ' A' ' 33' ' ' LEU . 90.8 m-85 -124.46 134.74 52.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 0.0 110.287 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -138.85 155.31 48.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.106 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -129.97 137.27 50.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.7 mmm -72.23 138.0 47.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -1.19 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.292 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -74.1 132.25 79.93 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.09 -25.54 58.43 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.112 1.875 . . . . 0.0 112.585 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 139.59 50.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -94.17 0.89 56.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.056 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -54.28 -21.76 10.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -120.07 -15.65 8.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.71 -40.92 96.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.6 -42.15 98.27 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.166 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.15 -41.47 90.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.727 ' O ' HG23 ' A' ' 124' ' ' VAL . 59.9 m170 -65.28 -39.84 93.09 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.01 -41.99 99.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.666 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -67.56 -40.96 84.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.243 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.64 -38.63 91.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.8 t -58.52 -48.14 86.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.266 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -80.54 -27.21 37.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.33 -38.25 78.08 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.47 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -82.01 -32.25 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.994 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.571 HD22 ' HB ' ' A' ' 75' ' ' ILE . 73.5 mt -79.64 -25.16 41.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.304 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -110.83 -23.44 11.01 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.686 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -137.76 67.84 50.82 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.715 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.41 156.92 60.6 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.626 2.218 . . . . 0.0 112.569 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.127 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.69 89.3 52.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.29 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.33 139.32 73.61 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.475 2.116 . . . . 0.0 112.453 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -80.81 154.35 73.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.71 146.19 83.26 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.929 1.753 . . . . 0.0 112.278 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 163.55 36.91 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.791 2.327 . . . . 0.0 112.396 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.45 160.24 73.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 39' ' ' THR . 41.9 Cg_exo -58.49 146.54 90.24 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.565 2.176 . . . . 0.0 111.864 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -150.29 162.71 39.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -85.96 140.12 30.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.983 0.421 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . 0.782 ' O ' HD13 ' B' ' 951' ' ' ILE . 56.7 t80 -121.91 133.46 54.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.86 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.782 HD13 ' O ' ' B' ' 950' ' ' TYR . 9.1 mm . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.11 163.8 19.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.719 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.531 ' HB ' HD13 ' C' ' 67' ' ' LEU . 14.9 pt -143.65 145.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.261 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -93.59 113.05 25.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.392 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -97.27 115.63 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.628 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -100.67 127.72 46.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.673 HG22 HD23 ' C' ' 69' ' ' LEU . 81.4 p -82.03 175.73 10.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.76 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.576 HD11 ' H ' ' C' ' 71' ' ' LEU . 60.4 mt -62.61 -21.63 65.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -88.35 -4.33 58.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.75 74.9 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -59.36 120.78 9.94 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -101.93 132.2 47.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.5 107.05 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.328 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.06 120.66 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.55 130.99 54.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.606 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.9 115.94 15.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.466 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.479 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.2 m -134.92 165.16 31.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.62 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.489 ' O ' HD12 ' C' ' 56' ' ' LEU . 98.0 mt-10 -108.85 151.57 41.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.77 -25.31 75.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.106 1.871 . . . . 0.0 112.071 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 53.6 m -91.78 -10.27 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.527 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 143.25 57.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -80.76 164.42 22.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.609 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.907 HD12 HD23 ' C' ' 50' ' ' LEU . 41.1 mm -63.27 -37.43 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.827 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.75 -41.59 86.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -61.49 -43.6 98.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 110.523 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.533 HG21 HD21 ' C' ' 56' ' ' LEU . 63.2 t -62.97 -42.47 96.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -60.4 -39.95 89.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.59 90.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.199 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.479 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.99 -39.32 85.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.76 ' CD1' HD21 ' C' ' 43' ' ' LEU . 95.3 mt -65.71 -39.3 84.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.577 0.703 . . . . 0.0 110.32 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.79 -46.12 90.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -77.13 -14.64 59.76 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.665 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -102.09 -3.88 26.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -149.14 -42.48 0.14 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.224 0.535 . . . . 0.0 110.391 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.65 29.25 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.212 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' C' ' 41' ' ' GLN . 52.8 mt -72.08 128.43 89.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.777 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.65 153.27 48.89 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.828 1.685 . . . . 0.0 111.708 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.27 -38.17 61.27 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.066 1.844 . . . . 0.0 112.737 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.7 -39.77 92.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.842 0.353 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -89.44 -2.64 58.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.032 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.624 ' HG3' HG22 ' C' ' 36' ' ' ILE . 92.2 mt-30 -93.79 106.89 18.84 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.693 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.76 HD21 ' CD1' ' C' ' 30' ' ' ILE . 73.6 mt -79.54 133.9 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.837 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.539 HG21 ' HE1' ' A' ' 76' ' ' PHE . 80.5 mt -135.04 129.39 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.345 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 71.1 t80 -151.47 151.72 32.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.36 16.54 10.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.731 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -10.63 67.19 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.649 ' HG2' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -112.68 145.14 40.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.312 0.577 . . . . 0.0 110.84 -178.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -73.63 129.82 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.905 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.907 HD23 HD12 ' C' ' 23' ' ' ILE . 9.2 mp -76.46 94.3 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.829 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.2 150.13 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 111.122 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -60.36 143.08 53.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.402 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.58 -19.35 48.02 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -88.14 169.1 12.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.522 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.9 p -118.17 164.5 15.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.954 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.533 HD21 HG21 ' C' ' 26' ' ' VAL . 80.0 mt -61.01 -41.14 95.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.587 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -64.24 -22.72 67.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.388 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.96 -36.68 82.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.547 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -99.92 15.76 26.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.103 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 57.58 38.72 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.694 HD11 HD21 ' C' ' 50' ' ' LEU . 61.7 mt -83.99 105.29 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.899 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -92.16 -178.89 5.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.409 0.623 . . . . 0.0 111.159 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.46 146.88 52.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.009 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 60.93 15.79 6.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.215 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 33.7 m -69.87 133.63 47.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -87.4 118.49 26.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.723 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' C' ' 3' ' ' ILE . 6.8 mp -107.93 140.98 40.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.997 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -89.82 129.43 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.673 HD23 HG22 ' C' ' 7' ' ' THR . 50.2 tp -107.91 121.25 44.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.19 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 56' ' ' LEU . 90.5 t -108.4 132.3 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.152 0.501 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.576 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.7 mt -106.16 152.14 23.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.559 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.454 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.82 157.04 22.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.351 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.84 148.12 25.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.419 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.0 m-30 -89.11 121.97 31.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.788 HG11 HD11 ' D' ' 30' ' ' ILE . 58.9 t -110.1 105.97 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.554 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -89.12 129.95 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 110.893 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -89.16 175.98 7.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.812 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.7 mt -61.73 -35.44 78.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.913 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -70.46 -11.65 61.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 -12.79 63.0 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.04 127.83 33.13 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -98.82 133.62 42.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 13' ' ' ILE . 1.4 mt -124.23 111.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.429 HG23 ' CD2' ' D' ' 4' ' ' PHE . 17.5 m -82.76 125.91 31.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.86 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.52 125.97 48.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.475 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -69.3 113.87 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.619 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 13.1 m -135.99 170.58 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -120.1 156.39 54.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.254 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.42 -26.64 82.62 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.163 1.909 . . . . 0.0 112.069 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -83.71 -14.26 52.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.563 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.17 144.05 57.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -87.68 166.33 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.41 -39.55 85.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.066 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.52 -42.25 91.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.183 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.29 -39.85 94.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.28 -43.34 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.996 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -61.3 -40.02 92.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.2 91.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.929 0.395 . . . . 0.0 109.998 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.619 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 87.9 mttt -59.86 -38.03 80.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.788 HD11 HG11 ' D' ' 5' ' ' VAL . 5.3 mm -63.92 -39.93 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.156 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.78 -45.59 93.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.289 0.566 . . . . 0.0 110.635 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.2 -33.91 76.84 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.045 -0.409 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -89.95 -6.88 55.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -146.08 -53.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.0 110.456 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.28 20.68 4.68 Favored Glycine 0 CA--C 1.517 0.205 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.567 HD13 HD21 ' D' ' 71' ' ' LEU . 60.4 mt -95.35 114.18 63.26 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.418 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.01 153.82 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.094 1.863 . . . . 0.0 112.215 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.99 -28.85 86.9 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.648 2.232 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -91.46 -4.34 55.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -92.6 -16.87 25.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.551 ' OE1' HD11 ' D' ' 69' ' ' LEU . 15.6 pt20 -137.88 160.55 38.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.305 0.574 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.18 130.93 53.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.561 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.79 119.54 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.823 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -121.23 128.07 75.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.981 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 89.6 t80 -122.61 128.48 50.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.455 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 64.15 25.05 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.67 90.29 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -110.29 126.23 53.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -65.05 135.55 55.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.66 107.69 17.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.112 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -74.79 154.15 38.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.337 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -72.97 162.99 28.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.342 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.43 20.73 77.18 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -122.94 150.79 42.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.66 0.267 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.6 p -96.87 160.44 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.467 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.37 -39.09 92.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.412 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.2 -39.06 93.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.055 0.455 . . . . 0.0 110.361 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -94.42 13.36 24.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 56.69 42.81 26.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 69.0 mt -90.97 104.24 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.097 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.04 179.31 5.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.438 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -60.74 150.65 31.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 58.49 45.42 16.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 85.5 p -101.21 128.89 47.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.988 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.426 ' C ' HD12 ' D' ' 67' ' ' LEU . 87.2 m -81.15 126.05 31.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.582 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.426 HD12 ' C ' ' D' ' 66' ' ' THR . 7.4 mp -117.03 148.27 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.38 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.67 116.32 28.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.441 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.551 HD11 ' OE1' ' D' ' 41' ' ' GLN . 5.2 tt -99.54 104.71 16.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.978 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.621 ' HA ' HD21 ' D' ' 8' ' ' LEU . 94.1 t -100.59 128.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.253 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.812 ' H ' HD11 ' D' ' 8' ' ' LEU . 81.9 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.871 0.367 . . . . 0.0 110.755 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 C--O 1.237 0.42 0 CA-C-O 120.827 0.346 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -90.06 120.54 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.327 0.584 . . . . 0.0 110.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 51' ' ' GLN . 95.1 mt -69.05 -35.28 76.38 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -149.22 161.14 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.984 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.63 122.66 0.35 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.229 0.537 . . . . 0.0 110.814 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.98 158.22 38.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.878 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HA ' HD12 ' A' ' 46' ' ' LEU . 90.7 mtt-85 -76.46 120.5 21.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.538 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.78 148.01 26.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.5 150.64 17.64 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -87.72 165.44 15.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.953 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 26.4 mtp -134.01 175.07 9.8 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.1 m -129.8 126.73 38.79 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.355 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 33' ' ' LEU . 8.4 tt -102.16 125.52 48.88 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.472 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -116.13 103.29 10.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.903 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.16 -83.14 0.74 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -144.02 20.26 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.554 0.216 . . . . 0.0 110.879 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -122.22 129.18 52.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 HD12 ' A' ' 33' ' ' LEU . 57.8 t -100.74 125.47 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.626 HG22 ' HB3' ' B' ' 947' ' ' PRO . 27.3 p -118.72 128.28 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.328 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.99 145.97 51.37 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.779 1.653 . . . . 0.0 112.603 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -108.02 138.2 44.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.878 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -72.6 -5.42 37.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.993 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.2 73.67 0.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.64 134.83 41.46 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.408 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.76 -162.64 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.0 tp -136.67 126.44 25.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 108.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.979 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.6 p90 -133.22 153.5 51.49 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.922 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.414 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.3 mt -119.45 139.48 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.285 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.63 132.49 40.83 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 123.923 0.765 . . . . 0.0 110.147 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.665 ' HB2' HD11 ' A' ' 23' ' ' LEU . 49.5 tt0 -102.68 122.47 44.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.133 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.456 HG23 ' CD2' ' A' ' 58' ' ' HIS . 8.2 p -82.89 171.58 13.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.46 -10.06 22.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.705 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.6 8.17 40.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.47 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m 62.82 23.99 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 110.762 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.598 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 69.7 mt -98.8 120.32 39.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.527 HG21 HD23 ' A' ' 128' ' ' LEU . 51.9 mm -80.1 121.15 32.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.552 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.456 ' CD2' HG23 ' A' ' 52' ' ' THR . 75.3 m-70 -97.67 112.55 24.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.899 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -92.9 107.2 19.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 93.3 m -119.38 143.9 47.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.929 0.871 . . . . 0.0 112.847 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.2 t90 -126.85 113.44 16.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.109 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -103.9 144.32 31.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.631 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -82.83 130.52 35.14 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -71.36 -16.65 62.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.75 0.31 . . . . 0.0 110.755 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.54 -45.87 90.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.442 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.69 -11.77 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.54 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.73 22.45 78.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -102.57 152.0 21.68 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.57 102.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.371 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.88 -38.25 67.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.888 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.48 147.18 49.86 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.392 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.497 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p-10 -158.78 97.74 1.45 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.314 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD22 ' HG2' ' C' ' 48' ' ' LYS . 31.8 mt -124.55 136.78 54.26 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.095 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.56 119.47 30.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.705 HG21 ' SG ' ' A' ' 80' ' ' CYS . 22.5 mm -109.29 120.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 111.05 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.598 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.0 m-85 -85.13 163.03 47.28 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.51 141.48 95.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.171 1.914 . . . . 0.0 111.689 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 61.14 12.42 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -87.42 -25.99 23.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.705 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.3 p -149.98 167.02 27.89 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.452 0.644 . . . . 0.0 110.569 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -137.11 132.52 34.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.189 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -103.38 118.58 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.44 167.9 21.0 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.496 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -87.8 160.37 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.176 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.67 90.82 13.35 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.152 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.21 59.82 7.18 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -115.6 -36.72 4.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.526 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.9 t -127.89 81.72 69.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.288 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.29 130.4 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.898 1.732 . . . . 0.0 111.651 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t 169.1 -44.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.83 -147.83 5.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' HD3' HG22 ' A' ' 114' ' ' THR . 0.1 OUTLIER -118.13 105.73 12.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.188 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.3 t -122.71 126.59 74.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -123.57 152.93 41.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.718 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -130.97 135.36 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.516 HD11 ' SG ' ' A' ' 80' ' ' CYS . 61.2 tp -100.87 121.84 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -116.78 124.85 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.026 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' HE2' HD12 ' A' ' 75' ' ' ILE . 32.3 m-85 -81.4 115.1 20.58 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.01 -37.54 82.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.497 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.72 -23.66 11.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.486 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.51 -24.5 72.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.192 -0.527 . . . . 0.0 111.894 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m 66.89 6.66 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.576 ' HD3' HD21 ' A' ' 105' ' ' LEU . 5.5 ttmm -98.36 150.17 21.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.498 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.6 mtt180 -131.23 136.78 48.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.835 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.576 HD21 ' HD3' ' A' ' 103' ' ' LYS . 40.1 mt -123.29 151.16 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.045 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 97.6 m-85 -123.67 137.52 54.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.41 155.22 47.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 111.4 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -129.82 136.75 49.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.127 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.82 141.26 58.35 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.341 0.591 . . . . 0.0 111.369 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -112.99 -8.2 13.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.169 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.2 135.15 89.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.704 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.94 -23.13 35.0 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.826 1.684 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -116.44 141.1 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.341 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.49 HG22 ' HD3' ' A' ' 92' ' ' ARG . 77.0 p -97.93 17.23 18.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.261 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.4 -21.14 59.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -135.64 17.76 3.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.841 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.63 -48.9 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.199 0.523 . . . . 0.0 111.059 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.63 -33.02 70.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.322 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.22 -44.78 90.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.489 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.748 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.2 m170 -62.01 -41.37 98.0 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.451 0.643 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.3 -44.83 95.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.847 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.5 -42.55 91.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.388 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.01 -37.61 88.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.918 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.0 t -58.78 -47.77 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.272 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -80.08 -28.41 39.14 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.843 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -68.91 -37.74 79.15 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.404 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.72 -33.16 35.45 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.731 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 75' ' ' ILE . 69.5 mt -79.58 -26.89 41.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -108.25 -24.01 11.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.655 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -136.88 69.19 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.797 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.37 157.78 55.87 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.854 2.369 . . . . 0.0 112.55 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.654 2.236 . . . . 0.0 112.211 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -128.95 150.59 75.64 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.634 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.96 147.02 33.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.695 2.263 . . . . 0.0 112.031 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.25 153.64 92.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.21 151.36 76.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.106 1.871 . . . . 0.0 112.253 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.09 -171.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.466 2.11 . . . . 0.0 112.096 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -120.06 155.08 55.87 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.626 ' HB3' HG22 ' A' ' 39' ' ' THR . 22.2 Cg_endo -60.93 141.76 95.55 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.352 2.035 . . . . 0.0 112.115 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.73 165.2 37.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.834 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.64 136.69 32.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.849 0.357 . . . . 0.0 110.41 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -120.62 121.21 37.84 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.64 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -62.26 156.13 22.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.369 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -136.78 157.02 35.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.362 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.619 ' CD2' HG23 ' C' ' 14' ' ' THR . 15.5 m-30 -96.19 122.59 39.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.897 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.3 t -110.43 101.85 13.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.224 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -88.34 124.09 33.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.177 0.513 . . . . 0.0 110.82 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.519 HG21 ' OE2' ' C' ' 34' ' ' GLU . 82.1 p -86.47 172.09 10.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.07 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.524 HD11 ' H ' ' C' ' 71' ' ' LEU . 70.5 mt -65.5 -19.08 65.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -83.95 -5.0 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.057 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.32 80.5 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.17 126.37 30.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.87 0.366 . . . . 0.0 110.218 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -97.6 131.22 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -115.84 116.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.374 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . 0.619 HG23 ' CD2' ' C' ' 4' ' ' PHE . 0.2 OUTLIER -85.15 117.12 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.428 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.65 116.41 27.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.922 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.75 105.99 1.4 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.731 HG12 ' HE3' ' C' ' 29' ' ' LYS . 28.4 m -130.45 162.71 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.497 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -105.88 155.72 37.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -37.79 93.7 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.896 1.731 . . . . 0.0 112.109 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -80.32 -7.55 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.301 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . 0.418 ' HB3' HD12 ' C' ' 56' ' ' LEU . 31.8 t0 -57.21 135.54 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -79.23 163.27 25.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.767 HD12 HD23 ' C' ' 50' ' ' LEU . 40.6 mm -64.54 -38.77 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.102 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.26 -41.48 88.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.995 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.05 -41.4 98.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.799 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.455 HG21 HD21 ' C' ' 56' ' ' LEU . 57.5 t -63.35 -42.98 98.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.417 ' HG2' HD11 ' C' ' 43' ' ' LEU . 55.0 mtmt -60.83 -40.17 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.635 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.83 92.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.104 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.731 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.62 -38.75 82.15 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.752 HD13 HD11 ' C' ' 69' ' ' LEU . 97.1 mt -66.37 -39.78 84.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.752 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -59.54 -46.93 87.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.365 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.21 -16.26 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.986 -0.446 . . . . 0.0 111.897 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -101.18 -5.81 25.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . 0.519 ' OE2' HG21 ' C' ' 7' ' ' THR . 81.5 mt-10 -148.31 -41.96 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.1 0.476 . . . . 0.0 110.476 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.8 8.16 28.43 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.352 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.08 128.78 82.27 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.899 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 160.44 43.66 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.564 1.509 . . . . 0.0 111.683 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.79 -39.16 93.4 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.274 1.982 . . . . 0.0 112.472 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.86 -39.88 93.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.761 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -89.17 -4.43 58.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.06 90.34 7.33 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -101.6 97.18 7.64 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.417 HD11 ' HG2' ' C' ' 27' ' ' LYS . 22.2 mt -88.27 129.47 35.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.594 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.415 HG21 ' HE1' ' A' ' 76' ' ' PHE . 83.7 mt -127.92 129.09 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -151.64 152.83 33.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.75 17.15 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.93 -13.59 60.8 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.675 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.99 146.5 42.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 110.599 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.19 132.18 42.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.045 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.767 HD23 HD12 ' C' ' 23' ' ' ILE . 6.8 mp -67.26 101.47 0.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.35 140.69 44.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.91 143.0 55.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.299 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.56 -16.26 61.34 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -83.44 176.19 9.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.193 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -122.27 161.95 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.817 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.455 HD21 HG21 ' C' ' 26' ' ' VAL . 84.5 mt -61.8 -40.39 95.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.823 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -63.69 -23.98 67.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -62.83 -37.63 87.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 110.149 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -96.46 13.48 27.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.252 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.05 42.42 22.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.41 HG21 HD22 ' C' ' 56' ' ' LEU . 64.9 mt -90.37 109.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.301 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -98.19 -177.99 3.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.213 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.26 146.89 52.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 59.34 42.28 18.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . 0.479 ' O ' HD12 ' C' ' 67' ' ' LEU . 45.7 m -97.55 127.28 43.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.98 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 87.1 m -76.86 126.57 31.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.113 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.479 HD12 ' O ' ' C' ' 65' ' ' SER . 5.7 mp -116.33 149.03 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.084 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.26 117.34 32.44 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.752 HD11 HD13 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -97.21 99.05 10.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.642 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -87.06 130.67 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.524 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.8 mt -110.39 141.23 43.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.162 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.659 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.62 159.61 12.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.956 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.05 151.91 25.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.054 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.432 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.5 m-30 -93.16 121.94 35.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.536 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.2 105.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . 0.458 ' HG3' HG23 ' D' ' 66' ' ' THR . 32.2 mtmt -90.29 133.28 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.717 HG22 HD23 ' D' ' 69' ' ' LEU . 82.0 p -88.87 -174.9 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.592 HD21 ' HA ' ' D' ' 70' ' ' VAL . 88.7 mt -62.34 -38.08 88.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.004 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -72.84 -9.04 58.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.615 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.45 -7.44 75.04 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.61 124.86 21.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -96.09 131.25 42.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mt -123.56 111.54 29.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.552 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.432 HG23 ' CD2' ' D' ' 4' ' ' PHE . 8.3 m -81.49 125.71 30.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.425 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.8 mt -121.21 125.15 46.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.126 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.96 114.8 9.39 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.441 HG12 ' CD ' ' D' ' 29' ' ' LYS . 26.7 m -135.57 163.01 36.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -104.7 153.29 39.36 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.074 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.55 -36.17 97.58 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.948 1.766 . . . . 0.0 112.043 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.46 -0.65 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -62.28 136.63 58.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -76.96 161.81 28.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.26 0.552 . . . . 0.0 110.794 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.59 -38.54 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.27 -42.53 91.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.88 -41.3 97.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.64 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.4 -42.67 97.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.597 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.2 mtmt -60.71 -39.38 88.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.133 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.26 93.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.411 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.441 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.4 mttm -60.06 -39.53 86.32 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.53 -39.66 84.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.297 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.34 -39.78 84.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.335 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.68 -50.3 52.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.711 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.425 ' HD2' HD21 ' D' ' 15' ' ' LEU . 24.6 mttp -66.18 -40.41 90.43 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -128.66 147.63 50.76 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.06 59.32 3.12 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.563 HG23 HD22 ' D' ' 71' ' ' LEU . 31.0 mm -110.31 107.07 58.46 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.8 152.82 54.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.316 2.011 . . . . 0.0 111.747 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.61 -42.4 66.21 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.744 1.629 . . . . 0.0 112.884 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.6 -43.29 99.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -68.3 -38.55 81.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.444 ' HG3' HG22 ' D' ' 36' ' ' ILE . 68.2 mt-30 -58.05 118.03 4.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.013 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . 0.731 ' NE ' HD11 ' D' ' 44' ' ' ILE . 77.9 ttt180 -121.21 106.31 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' D' ' 27' ' ' LYS . 19.8 mt -96.15 115.93 28.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.081 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.731 HD11 ' NE ' ' D' ' 42' ' ' ARG . 83.9 mt -123.27 124.37 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.377 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 85.1 t80 -128.36 130.02 47.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.179 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.62 27.11 11.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.357 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.22 81.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -125.9 127.3 45.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.834 0.349 . . . . 0.0 110.725 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.47 137.0 55.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.47 HD12 ' CB ' ' D' ' 43' ' ' LEU . 77.9 mt -78.68 122.06 25.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.083 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -76.15 136.28 39.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -65.06 130.92 45.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.5 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.67 -15.81 52.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -79.88 -176.99 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.8 p -125.66 163.47 22.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' D' ' 56' ' ' LEU . 85.7 mt -62.22 -40.06 94.86 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.606 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.4 p -64.1 -27.46 69.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.13 -29.72 71.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.123 0.487 . . . . 0.0 110.178 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -101.66 12.41 37.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.403 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.48 40.41 29.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.036 0.446 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 90.0 mt -89.82 107.22 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.673 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.09 177.89 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -59.75 149.79 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 60.01 18.66 7.81 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.631 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.0 m -73.81 129.65 38.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.07 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.647 ' C ' HD12 ' D' ' 67' ' ' LEU . 86.7 m -81.82 130.15 34.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.019 0.437 . . . . 0.0 110.58 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.647 HD12 ' C ' ' D' ' 66' ' ' THR . 9.4 mp -120.63 140.11 52.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -86.49 113.44 22.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.717 HD23 HG22 ' D' ' 7' ' ' THR . 62.8 tp -100.72 115.49 30.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.431 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.592 ' HA ' HD21 ' D' ' 8' ' ' LEU . 78.1 t -114.53 139.38 40.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.74 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.563 HD22 HG23 ' D' ' 36' ' ' ILE . 37.9 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.161 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt . . . . . 0 C--O 1.236 0.353 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -94.16 113.65 25.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.082 0.468 . . . . 0.0 109.792 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' A' ' 57' ' ' ILE . 95.7 mt -67.53 -36.94 81.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' HE3' ' A' ' 123' ' ' LYS . 1.2 p -149.76 162.3 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.868 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.15 122.5 0.39 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.251 0.548 . . . . 0.0 110.934 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.78 158.16 37.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.889 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.06 123.8 25.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.574 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.0 21.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.176 0.512 . . . . 0.0 110.35 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.51 16.94 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -92.11 158.4 16.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 0.0 110.78 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.33 163.32 25.99 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -115.69 129.92 56.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.741 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 37' ' ' THR . 31.5 tp -106.7 120.8 42.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.83 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -122.92 110.99 16.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.328 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.52 -93.61 0.55 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.3 p -137.45 21.27 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.604 0.24 . . . . 0.0 111.036 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.516 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.5 m -125.88 131.55 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.516 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' CG2' HD13 ' A' ' 33' ' ' LEU . 60.3 t -107.64 125.18 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.9 p -113.61 111.53 49.01 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.13 139.75 91.63 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.577 2.185 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -94.87 129.22 41.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -68.41 -10.17 53.42 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.864 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -72.19 82.85 1.01 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.19 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.27 133.59 52.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.193 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.8 -161.07 10.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.315 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.1 tp -138.77 126.98 22.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 t -100.2 110.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -133.13 155.0 50.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.26 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.4 mt -120.05 137.19 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.387 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.12 131.27 36.67 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.586 0.554 . . . . 0.0 110.231 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.471 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.4 tt0 -100.84 125.98 47.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.044 0.45 . . . . 0.0 110.144 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.504 HG23 ' CD2' ' A' ' 58' ' ' HIS . 16.5 p -86.33 172.94 10.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.634 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.37 -10.83 27.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.657 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.34 5.65 46.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.442 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 m 63.55 24.81 14.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.587 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 75.0 mt -100.6 122.78 43.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.511 HG21 HD23 ' A' ' 128' ' ' LEU . 51.0 mm -80.9 122.28 35.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.504 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.8 m-70 -98.36 114.9 27.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.693 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.46 108.39 20.32 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.9 m -121.44 146.92 46.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.753 0.787 . . . . 0.0 112.675 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -125.19 115.02 19.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.064 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -107.45 134.5 50.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.845 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.0 132.5 41.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.557 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -73.88 -18.55 60.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -59.94 -45.95 90.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.049 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -116.48 -16.26 10.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.102 0.477 . . . . 0.0 109.768 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.33 22.89 72.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -101.38 152.2 21.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.827 0.346 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -80.75 107.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.902 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.94 -27.5 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -127.94 144.15 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.183 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.571 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -158.59 99.76 1.6 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.46 179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' C' ' 48' ' ' LYS . 40.5 mt -129.07 133.08 47.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.52 122.6 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.632 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.0 mm -112.39 121.31 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.366 0.603 . . . . 0.0 111.142 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 38.6 m-85 -85.56 163.39 44.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.718 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.51 140.53 93.54 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.246 1.964 . . . . 0.0 111.536 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t0 60.07 12.08 3.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.344 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.48 -26.48 30.2 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.298 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 96' ' ' LEU . 17.7 p -151.18 166.92 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.475 0.655 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -133.58 132.06 40.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.259 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.4 119.45 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -143.86 168.87 18.94 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.742 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -85.7 157.06 20.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.58 89.37 7.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.319 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.18 61.03 7.64 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.965 1.776 . . . . 0.0 112.274 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.82 -39.22 4.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.398 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 p -129.69 73.61 81.38 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.45 130.06 36.75 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.213 1.942 . . . . 0.0 111.297 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.02 -45.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.146 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.88 -156.34 8.71 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.15 105.37 15.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.786 0.327 . . . . 0.0 110.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.63 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.08 152.22 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.405 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.86 134.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.281 0.562 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.3 tp -102.47 117.61 35.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -114.23 122.84 48.0 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.417 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.469 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 37.9 m-85 -78.46 114.1 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.95 -37.95 84.15 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.14 -23.03 12.71 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.376 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -71.42 -20.29 78.19 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.133 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 m 59.75 34.33 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.945 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 162.02 36.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.484 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -134.9 143.31 46.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.911 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 mt -119.81 147.09 45.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.5 m-85 -115.51 132.04 56.75 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.271 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.11 157.43 46.34 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.256 0.551 . . . . 0.0 110.938 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -134.25 141.64 47.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.387 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.0 mmm -74.68 139.09 43.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.062 0.458 . . . . 0.0 110.976 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.81 10.67 10.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.011 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.2 145.07 90.55 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.488 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.47 -39.1 79.08 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.994 1.796 . . . . 0.0 112.577 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -118.89 146.31 45.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.909 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.5 p -97.86 6.94 47.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.722 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -54.02 -20.98 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -126.94 14.77 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.155 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.59 -45.71 91.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.12 -33.06 67.52 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.521 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.6 -43.32 90.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.058 0.456 . . . . 0.0 110.641 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.772 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.3 m170 -65.31 -40.89 94.35 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.645 0.736 . . . . 0.0 109.383 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.6 t -62.32 -45.67 92.18 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.796 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -64.97 -43.34 92.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.322 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HE3' HG23 ' A' ' 24' ' ' VAL . 27.2 mtpp -62.48 -38.73 91.01 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.694 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.8 t -58.95 -47.65 89.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.36 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.23 -30.01 38.5 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.844 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.3 -38.94 85.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.567 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -80.33 -34.22 36.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.668 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.574 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.5 mt -77.52 -26.96 51.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.435 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -108.53 -20.46 13.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.272 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -140.39 68.54 32.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.443 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.41 158.27 56.61 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 C-N-CA 122.949 2.432 . . . . 0.0 112.495 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--N 1.312 -1.356 0 C-N-CA 122.64 2.227 . . . . 0.0 112.321 -179.611 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.83 148.16 98.87 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.61 152.82 38.43 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.587 2.192 . . . . 0.0 111.959 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.91 151.03 90.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.118 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.21 158.75 48.44 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.278 1.985 . . . . 0.0 112.239 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 168.41 23.99 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.706 2.271 . . . . 0.0 111.918 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -105.68 159.86 28.08 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.78 145.97 87.87 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.237 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.87 166.56 33.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -85.15 138.01 32.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.32 125.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.84 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 46.5 mt . . . . . 0 C--N 1.313 -0.984 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -66.97 161.08 25.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.26 149.99 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.133 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.04 126.44 44.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.646 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.75 117.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -100.6 117.89 35.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.467 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.674 HG22 HD23 ' C' ' 69' ' ' LEU . 71.2 p -80.0 171.22 15.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.049 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.525 HD11 ' H ' ' C' ' 71' ' ' LEU . 64.9 mt -63.42 -24.02 67.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.173 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.2 p -75.42 -8.73 57.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.24 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -72.41 132.89 44.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.792 0.33 . . . . 0.0 110.264 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -109.09 131.71 54.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.229 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.25 117.37 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.819 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 135.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.665 HD21 ' CD ' ' C' ' 33' ' ' LYS . 16.0 mt -133.91 126.68 30.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.114 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -70.74 117.35 12.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.653 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 21.3 m -137.18 166.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.538 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.6 mt-10 -112.26 151.52 43.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.02 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.14 -26.37 81.48 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.981 1.788 . . . . 0.0 112.207 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -87.02 -11.51 50.18 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.743 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -62.99 143.49 57.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.615 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -81.67 165.95 20.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.315 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.634 HD12 HD23 ' C' ' 50' ' ' LEU . 42.4 mm -62.44 -39.18 83.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.314 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.48 -41.99 91.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.83 -41.57 97.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.141 0.496 . . . . 0.0 110.876 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.677 HG21 HD21 ' C' ' 56' ' ' LEU . 56.7 t -63.13 -43.35 98.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.702 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.79 -39.71 89.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.43 91.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 0.0 110.519 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.664 ' HB3' HD22 ' C' ' 15' ' ' LEU . 71.9 mttt -60.15 -39.76 87.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.373 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.8 ' CD1' HD21 ' C' ' 43' ' ' LEU . 96.8 mt -66.98 -38.4 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.257 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.28 -42.21 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -63.51 -43.79 96.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.665 ' CD ' HD21 ' C' ' 15' ' ' LEU . 0.0 OUTLIER -69.49 -65.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.225 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.41 155.9 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.854 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.8 57.82 4.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.674 HG22 ' HG3' ' C' ' 41' ' ' GLN . 32.2 mm -110.78 104.69 56.44 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.37 157.57 35.28 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.53 2.154 . . . . 0.0 112.041 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.07 -30.55 90.59 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.249 1.966 . . . . 0.0 112.309 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.83 -40.73 88.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.056 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -87.22 -9.67 54.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.58 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.674 ' HG3' HG22 ' C' ' 36' ' ' ILE . 86.1 mt-30 -81.73 95.84 7.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.334 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -110.36 93.67 4.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' C' ' 30' ' ' ILE . 74.3 mt -80.07 135.14 36.28 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.44 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -135.8 127.33 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -152.0 149.83 29.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.805 0.336 . . . . 0.0 111.211 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.03 15.27 9.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.14 -15.2 60.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.457 ' HE3' HD22 ' A' ' 73' ' ' LEU . 12.1 mtpt -100.9 140.61 34.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.942 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -77.94 118.19 20.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.886 HD21 HD11 ' C' ' 61' ' ' ILE . 8.6 mp -66.56 86.14 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.243 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . 0.437 ' O ' HG21 ' C' ' 23' ' ' ILE . 24.5 pt-20 -74.52 -175.89 2.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.4 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.7 156.5 30.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.15 -152.23 48.17 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 55.36 172.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.519 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -125.99 167.96 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.348 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.677 HD21 HG21 ' C' ' 26' ' ' VAL . 78.8 mt -60.7 -40.74 93.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.563 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -63.78 -24.32 67.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.91 -37.06 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.446 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -96.44 13.78 26.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.997 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.58 40.59 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.886 HD11 HD21 ' C' ' 50' ' ' LEU . 60.9 mt -87.88 108.68 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.754 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.71 179.99 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.82 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.65 145.97 53.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 59.18 17.64 5.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 137.23 57.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -98.07 120.21 38.08 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.685 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.497 HD12 ' N ' ' C' ' 67' ' ' LEU . 4.8 mp -113.6 142.27 46.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.324 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -88.91 130.32 35.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.194 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.674 HD23 HG22 ' C' ' 7' ' ' THR . 59.9 tp -105.88 122.07 45.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.017 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.75 132.67 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.525 ' H ' HD11 ' C' ' 8' ' ' LEU . 27.8 mt -108.49 143.25 37.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.345 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.686 179.806 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . 0.458 HE21 HG21 ' D' ' 14' ' ' THR . 9.8 pt20 -62.88 155.64 26.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.552 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -134.85 154.61 36.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.547 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.578 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.1 m-30 -94.87 125.08 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.397 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.83 99.06 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.383 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -85.18 130.05 34.68 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.73 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.838 HG23 HD23 ' D' ' 69' ' ' LEU . 0.2 OUTLIER -90.51 -175.06 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.709 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.656 HD11 ' H ' ' D' ' 71' ' ' LEU . 73.2 mt -70.85 -26.01 63.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.291 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -78.97 -9.98 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.55 -13.55 64.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.71 132.08 48.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 68.5 m -102.72 130.75 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 110.608 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mm -113.47 117.9 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.489 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.578 HG23 ' CD2' ' D' ' 4' ' ' PHE . 0.5 OUTLIER -88.58 118.75 28.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.598 HD11 HG12 ' D' ' 30' ' ' ILE . 81.1 mt -117.44 116.95 28.17 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.67 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -65.46 105.69 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.674 HG12 ' HE3' ' D' ' 29' ' ' LYS . 17.8 m -129.13 166.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.205 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -115.18 155.91 46.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.03 -24.65 66.76 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.76 1.64 . . . . 0.0 111.707 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.7 p -88.18 -11.82 45.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.822 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.14 141.99 58.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.171 0.51 . . . . 0.0 111.103 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -81.52 164.18 22.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.505 HD12 HD13 ' D' ' 50' ' ' LEU . 48.7 mm -62.86 -42.28 95.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -59.98 -34.56 73.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.353 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -64.76 -41.14 96.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.494 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 -42.38 95.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.456 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.434 ' HG2' HD11 ' D' ' 43' ' ' LEU . 55.6 mtmt -60.56 -40.39 91.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.286 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.22 86.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.674 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.65 -39.5 84.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.607 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.598 HG12 HD11 ' D' ' 15' ' ' LEU . 60.7 mt -67.84 -39.52 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.173 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -58.98 -42.52 90.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.917 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -89.77 17.99 6.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -123.16 -38.01 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -124.85 -8.28 7.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.297 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.71 77.0 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.449 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.549 HD13 ' CD2' ' D' ' 71' ' ' LEU . 44.1 mt -82.04 121.58 79.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.512 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.55 153.61 60.01 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.956 1.771 . . . . 0.0 111.71 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.47 -39.52 73.97 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.112 1.874 . . . . 0.0 111.898 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.21 -39.66 93.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.683 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -83.54 -7.96 59.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.658 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.96 90.83 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.316 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -100.94 111.16 23.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.437 HD21 HD12 ' D' ' 30' ' ' ILE . 35.1 mt -96.67 114.83 26.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.384 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.45 125.14 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 71.0 t80 -144.12 151.29 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.334 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.13 22.91 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.62 16.01 80.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.54 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.4 ' NH1' ' HB1' ' D' ' 46' ' ' ALA . 32.1 ptt-85 -149.29 152.96 36.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 110.794 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.26 139.9 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.505 HD13 HD12 ' D' ' 23' ' ' ILE . 84.8 mt -76.38 127.57 33.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.75 135.54 40.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -67.09 132.16 47.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.211 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.17 -18.19 52.28 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.67 171.49 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.8 164.04 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.723 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.5 p -62.36 -29.15 70.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.4 -35.59 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.081 0.467 . . . . 0.0 110.164 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -96.56 12.58 31.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.304 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 55.18 41.79 31.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 110.14 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -90.39 104.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.638 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.39 -176.1 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -64.58 149.7 48.31 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.446 -0.501 . . . . 0.0 109.935 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 59.14 44.77 15.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 54.3 m -100.32 122.7 43.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.222 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -71.76 128.49 35.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.71 136.64 54.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.75 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -85.64 109.07 18.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.713 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.838 HD23 HG23 ' D' ' 7' ' ' THR . 63.0 tp -96.76 113.4 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.01 134.49 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.035 0.445 . . . . 0.0 110.054 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.656 ' H ' HD11 ' D' ' 8' ' ' LEU . 35.5 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.685 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.233 0.191 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.12 110.96 19.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.223 0.535 . . . . 0.0 109.926 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.8 mt -65.89 -38.46 88.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.22 162.78 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.842 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.6 122.91 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.207 0.527 . . . . 0.0 110.686 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.47 155.4 34.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.765 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.732 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -71.39 121.35 18.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.824 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.25 22.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.106 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.48 152.64 17.34 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -87.13 159.24 18.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.823 0.344 . . . . 0.0 110.737 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.1 mtp -124.81 176.17 6.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -126.01 126.51 44.41 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 37' ' ' THR . 33.4 tp -107.27 122.32 46.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -117.42 106.24 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.923 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.04 -87.27 0.38 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -139.72 23.78 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.687 0.279 . . . . 0.0 111.054 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.704 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.4 m -125.08 125.69 44.18 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.236 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.569 ' CG2' HD13 ' A' ' 33' ' ' LEU . 58.0 t -105.16 124.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.916 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.6 m -123.09 134.26 25.01 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.78 146.89 79.97 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.947 1.765 . . . . 0.0 112.875 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.51 150.82 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -80.73 -6.87 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.808 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -72.79 73.3 1.1 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.86 129.99 43.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.76 -159.58 9.26 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.229 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 27' ' ' ARG . 2.2 tp -140.32 127.75 21.36 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -99.99 110.0 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.556 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.0 p90 -132.42 154.8 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.196 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.1 mt -119.01 138.12 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.397 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -134.66 130.55 36.53 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.666 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.6 tt0 -101.1 124.38 46.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 0.0 109.954 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.481 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.0 p -85.15 172.5 11.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.816 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.48 -10.31 24.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.54 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.51 7.16 42.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.602 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m 63.37 23.86 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 110.603 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -98.63 122.48 41.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.516 HG21 HD23 ' A' ' 128' ' ' LEU . 51.8 mm -81.74 120.65 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.481 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.0 m-70 -97.85 111.24 23.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.973 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -91.0 106.69 18.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 92.7 m -119.03 146.62 44.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.708 0.766 . . . . 0.0 112.752 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.7 t90 -124.94 113.4 17.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.262 -1.336 . . . . 0.0 108.331 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -105.85 135.3 47.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.959 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -76.82 132.7 39.34 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -73.58 -18.68 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -59.88 -46.1 90.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.829 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.1 m -116.46 -15.18 10.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.057 0.456 . . . . 0.0 110.072 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.37 21.51 77.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -101.88 152.74 20.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.242 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.0 t -78.16 107.84 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.54 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -86.59 -28.26 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -129.28 143.8 50.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.191 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.767 ' O ' HD23 ' A' ' 73' ' ' LEU . 43.5 p-10 -157.88 101.96 1.81 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.193 0.521 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 72' ' ' ASP . 5.5 mt -129.7 134.03 47.41 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.24 120.14 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.2 mp -108.16 112.5 40.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -71.2 162.56 71.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.937 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.58 131.43 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.921 1.747 . . . . 0.0 111.668 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.7 t0 63.88 12.22 6.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.404 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -82.13 -35.92 28.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.315 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -128.74 150.62 50.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.301 0.572 . . . . 0.0 111.105 -178.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.567 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.2 tp10 -121.77 129.59 52.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.96 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -107.03 118.08 35.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.43 168.25 20.16 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.579 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -87.39 160.32 18.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.003 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.08 90.66 11.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.119 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.75 60.15 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.984 1.789 . . . . 0.0 112.359 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.84 -39.68 3.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.34 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.6 t -128.29 80.88 71.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.67 130.49 26.52 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.604 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.81 -41.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.02 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.98 -150.92 6.7 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.44 106.23 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.467 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.19 129.35 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.22 154.17 45.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.635 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.69 134.91 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.379 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 81' ' ' GLU . 61.4 tp -104.08 123.19 46.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -122.02 130.98 53.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.129 0.49 . . . . 0.0 110.915 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 61.3 m-85 -84.43 117.83 23.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.97 -31.52 71.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.462 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.73 -21.7 11.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.936 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -80.66 -25.68 55.84 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.961 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.31 8.93 6.0 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.309 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.618 ' HD3' HD21 ' A' ' 105' ' ' LEU . 22.8 ttmt -93.97 143.88 25.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.811 0.339 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -122.83 125.27 45.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.469 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.618 HD21 ' HD3' ' A' ' 103' ' ' LYS . 52.9 mt -114.27 141.88 47.01 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.52 ' CE1' HD22 ' A' ' 33' ' ' LEU . 99.6 m-85 -115.07 134.74 54.91 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -138.01 153.55 49.39 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.276 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -129.03 136.44 50.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.532 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.445 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 29.9 tpp -72.34 134.08 45.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.078 0.466 . . . . 0.0 111.107 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.15 -0.9 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.913 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 109' ' ' MET . 99.3 mt-10 -73.16 133.08 81.62 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.278 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.96 -24.84 39.1 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.9 1.733 . . . . 0.0 112.88 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -111.25 140.8 45.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 p -99.0 12.32 36.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.371 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.92 -20.91 60.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.595 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -126.36 10.87 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.359 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.48 -47.02 83.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.534 . . . . 0.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.31 -31.04 65.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.122 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.64 -45.0 80.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.926 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.671 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.8 m170 -62.81 -41.15 99.17 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.704 0.764 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.55 -44.34 96.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.506 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -65.68 -43.36 89.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.818 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.4 -42.19 99.24 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 120' ' ' HIS . 59.9 t -58.59 -48.8 84.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.912 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.39 -39.16 88.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.298 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -74.39 -22.93 58.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.192 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 m-85 -89.42 -28.25 19.86 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.527 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.516 HD23 HG21 ' A' ' 57' ' ' ILE . 63.1 mt -92.91 -16.72 24.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.062 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -117.16 -17.61 10.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.316 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.52 63.98 18.17 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.798 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.82 153.67 68.39 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 122.522 2.148 . . . . 0.0 112.443 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.313 -1.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.22 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 48.69 70.74 1.9 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.643 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.73 145.73 70.34 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -73.73 159.15 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.298 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.14 154.36 46.31 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.762 2.308 . . . . 0.0 111.998 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.09 -155.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.615 2.21 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -125.39 155.34 71.85 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.01 143.44 90.95 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.473 2.115 . . . . 0.0 111.676 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -156.97 166.99 31.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.77 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.03 135.33 33.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 110.618 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -112.55 123.2 49.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.766 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.444 -0.748 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -67.67 161.15 26.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.503 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.66 143.11 31.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.417 ' HD2' HG21 ' C' ' 12' ' ' THR . 6.4 m-85 -87.5 123.74 32.73 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.42 114.68 47.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.413 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -100.74 121.94 42.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.901 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 79.7 p -83.39 172.49 12.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.597 HD11 ' H ' ' C' ' 71' ' ' LEU . 67.2 mt -62.83 -25.09 68.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.289 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -73.9 -10.04 59.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -11.08 70.52 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.76 132.79 47.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . 0.417 HG21 ' HD2' ' C' ' 4' ' ' PHE . 93.3 m -109.63 132.21 54.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.556 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.65 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.677 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -84.25 130.17 34.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.49 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.6 mt -123.79 130.21 52.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.687 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.42 115.36 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' C' ' 29' ' ' LYS . 22.4 m -135.35 166.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.0 150.7 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.961 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.27 -36.57 86.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.94 1.76 . . . . 0.0 112.069 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -83.31 -9.98 58.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.85 138.52 57.24 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.663 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -79.5 163.81 24.42 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.772 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.974 HD12 HD23 ' C' ' 50' ' ' LEU . 42.0 mm -65.39 -36.7 78.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.857 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.49 -44.15 89.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -62.9 -41.19 99.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 110.814 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.411 HG21 HD21 ' C' ' 56' ' ' LEU . 62.0 t -63.37 -42.86 97.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.48 -39.02 86.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.68 91.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.397 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.515 ' CB ' HD13 ' C' ' 15' ' ' LEU . 67.2 mttm -60.63 -39.19 87.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.71 ' CD1' HD21 ' C' ' 43' ' ' LEU . 96.8 mt -67.63 -39.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.187 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.21 -38.51 80.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.241 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -67.32 -50.86 58.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.649 ' HG3' HD21 ' C' ' 15' ' ' LEU . 22.1 mttt -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.7 151.08 51.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.77 64.23 1.89 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.648 HG22 ' HB2' ' C' ' 41' ' ' GLN . 42.1 mm -117.98 93.11 43.72 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 149.59 70.68 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.744 2.296 . . . . 0.0 112.11 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -51.69 -42.59 55.86 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.112 1.874 . . . . 0.0 112.277 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.2 -38.66 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 110.347 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -95.7 25.39 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.507 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.648 ' HB2' HG22 ' C' ' 36' ' ' ILE . 12.7 tt0 -131.61 119.87 22.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -127.23 106.64 9.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.71 HD21 ' CD1' ' C' ' 30' ' ' ILE . 63.4 mt -85.13 138.51 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.4 mt -134.39 130.23 53.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.599 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 69.0 t80 -156.37 155.88 32.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.55 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.54 14.13 9.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 89.59 -14.04 62.45 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.09 150.18 39.08 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.407 0.622 . . . . 0.0 110.551 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.04 137.66 45.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.509 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.974 HD23 HD12 ' C' ' 23' ' ' ILE . 6.6 mp -74.13 101.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.18 139.43 42.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -61.48 138.81 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -17.68 55.66 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -83.03 175.68 9.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -119.23 162.21 19.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.279 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.411 HD21 HG21 ' C' ' 26' ' ' VAL . 80.9 mt -61.31 -41.26 96.7 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.757 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -63.25 -24.07 67.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.839 0.352 . . . . 0.0 110.684 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.28 -36.92 83.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -98.3 14.47 27.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.272 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 57.69 38.68 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.894 0.378 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.41 HG21 HD22 ' C' ' 56' ' ' LEU . 53.1 mt -83.82 111.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.234 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -98.08 178.51 5.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -60.33 146.09 45.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.957 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 59.76 22.1 10.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . 0.532 ' O ' HD12 ' C' ' 67' ' ' LEU . 17.0 m -74.34 127.03 31.96 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.874 0.368 . . . . 0.0 110.185 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.1 m -80.33 126.43 31.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.532 HD12 ' O ' ' C' ' 65' ' ' SER . 4.5 mp -116.41 152.86 33.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -103.0 126.18 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.152 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.656 HD22 HD21 ' C' ' 71' ' ' LEU . 2.3 tt -103.4 122.27 44.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 56' ' ' LEU . 47.6 t -109.12 132.49 57.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.656 HD21 HD22 ' C' ' 69' ' ' LEU . 29.1 mt -107.25 135.54 48.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.081 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 110.509 -179.906 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -63.35 157.07 23.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.023 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 17.5 pt -138.17 145.17 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.163 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -86.5 126.96 34.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.841 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -112.38 101.18 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -90.67 127.63 36.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.696 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -89.73 -179.21 5.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.688 HD11 ' H ' ' D' ' 71' ' ' LEU . 79.3 mt -64.23 -34.59 78.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -68.21 -12.88 61.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.627 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.18 63.39 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.14 129.96 42.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -102.11 132.35 48.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.458 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.419 HD13 HG21 ' D' ' 13' ' ' ILE . 1.4 mt -126.95 110.4 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.956 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -81.38 130.4 35.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.571 HD21 ' HD2' ' D' ' 33' ' ' LYS . 91.7 mt -125.73 123.73 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.471 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -66.11 112.43 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.073 0.463 . . . . 0.0 110.946 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.517 HG12 ' CD ' ' D' ' 29' ' ' LYS . 20.0 m -136.08 165.57 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.881 -0.512 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . 0.602 ' O ' HD12 ' D' ' 56' ' ' LEU . 96.1 mt-10 -111.27 152.63 43.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.115 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -38.34 86.01 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.826 1.684 . . . . 0.0 112.222 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -66.27 -36.49 83.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.162 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -50.45 140.57 13.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.688 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 31.0 p -87.05 169.46 12.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.108 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.38 -34.73 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.279 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.63 -44.07 89.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.102 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.62 -42.4 99.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.466 HG21 HD21 ' D' ' 56' ' ' LEU . 68.0 t -63.21 -42.97 98.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.462 ' CG ' HD22 ' D' ' 43' ' ' LEU . 56.5 mtmt -60.22 -40.42 90.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.58 94.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.704 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.517 ' CD ' HG12 ' D' ' 17' ' ' VAL . 68.4 mttm -60.81 -39.19 88.02 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.665 0.745 . . . . 0.0 109.089 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' D' ' 43' ' ' LEU . 97.4 mt -63.53 -40.13 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.548 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -59.08 -42.17 89.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.732 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.74 -40.71 93.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.751 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.571 ' HD2' HD21 ' D' ' 15' ' ' LEU . 28.0 mttm -77.32 -62.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.327 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.16 156.4 18.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.375 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.92 55.48 4.26 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.656 HG22 ' HB2' ' D' ' 41' ' ' GLN . 41.9 mm -109.8 99.06 36.7 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.136 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.31 153.13 71.47 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.775 1.65 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.62 -40.32 73.37 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.079 1.853 . . . . 0.0 111.952 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.36 -39.37 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 110.402 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -103.1 35.23 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.656 ' HB2' HG22 ' D' ' 36' ' ' ILE . 12.0 tt0 -136.65 124.22 22.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.937 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -122.16 104.68 9.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.53 HD11 ' CD1' ' D' ' 30' ' ' ILE . 3.5 mp -85.31 115.23 22.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.935 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -126.07 126.11 69.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.435 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.569 ' HB2' HD21 ' D' ' 50' ' ' LEU . 52.1 t80 -63.39 -46.21 87.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.658 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.71 -78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.776 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.26 2.56 57.82 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -145.02 136.81 25.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.126 0.489 . . . . 0.0 110.931 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -78.55 138.07 38.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.378 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' D' ' 45' ' ' PHE . 77.7 mt -74.47 122.96 23.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.96 132.56 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 133.63 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.619 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.41 55.61 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -82.3 147.21 29.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.735 0.302 . . . . 0.0 111.011 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 48.8 p -75.71 162.57 28.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.602 HD12 ' O ' ' D' ' 18' ' ' GLU . 80.5 mt -67.36 -38.27 84.52 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.632 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.09 -25.34 67.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.942 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.31 -37.63 83.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -98.06 15.15 25.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 54.37 39.89 31.31 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.75 91.32 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.779 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -82.11 177.99 8.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.974 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -58.7 151.37 21.16 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 60.09 44.51 12.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -97.29 120.9 38.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.526 ' C ' HD12 ' D' ' 67' ' ' LEU . 84.9 m -75.06 127.27 32.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.526 HD12 ' C ' ' D' ' 66' ' ' THR . 8.2 mp -121.21 126.83 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.194 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.01 120.76 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.95 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.458 HD22 HD21 ' D' ' 71' ' ' LEU . 3.5 tt -100.12 112.22 24.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.978 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' D' ' 8' ' ' LEU . 92.1 t -99.92 132.16 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.688 ' H ' HD11 ' D' ' 8' ' ' LEU . 60.9 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.906 0.384 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.21 127.23 37.61 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.708 0.765 . . . . 0.0 110.206 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 51' ' ' GLN . 84.3 mt -67.12 -37.48 83.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.53 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.495 HG11 HG22 ' A' ' 124' ' ' VAL . 1.4 p -148.62 162.93 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.829 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -173.85 122.03 0.32 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.344 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.78 151.4 27.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.912 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -70.37 123.08 20.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 110.357 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -154.93 145.45 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.0 154.26 16.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -87.1 172.62 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 111.165 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 23.4 mtp -138.79 173.72 11.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -124.89 123.6 40.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.53 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 37' ' ' THR . 25.9 tp -107.61 117.24 33.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -120.97 114.46 21.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.953 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.78 -90.09 0.48 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.1 p -141.66 21.14 2.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.841 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.581 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.8 m -123.05 130.86 53.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 33' ' ' LEU . 96.3 t -109.42 123.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.976 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.821 HG22 ' HB3' ' B' ' 947' ' ' PRO . 59.4 p -118.25 132.77 23.61 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.685 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.57 142.67 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.963 1.775 . . . . 0.0 113.05 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -97.74 145.62 26.17 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.733 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -81.21 -6.86 59.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.132 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -73.35 75.41 1.37 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.61 134.12 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.28 -156.53 7.88 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -138.72 123.01 18.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 28' ' ' ALA . 56.1 t -95.77 108.42 21.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.711 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.4 p90 -131.25 153.88 49.06 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.665 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 24' ' ' VAL . 95.5 mt -117.67 139.83 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.548 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.32 128.67 26.05 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 123.84 0.713 . . . . 0.0 110.854 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.537 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.0 tt0 -98.29 124.22 42.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.308 0.575 . . . . 0.0 110.278 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 58' ' ' HIS . 14.5 p -83.75 171.61 13.01 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.54 -10.05 23.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.549 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -89.22 1.97 54.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.5 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.66 19.18 7.4 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.672 HD11 HG11 ' C' ' 70' ' ' VAL . 72.4 mt -98.95 122.73 42.58 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 mm -79.21 125.06 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.506 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.7 m-70 -101.11 114.87 29.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.108 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -93.31 106.67 18.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.89 145.46 45.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -126.96 111.98 14.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.837 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -102.59 145.24 29.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.627 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -81.7 133.55 35.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -73.96 -17.62 60.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.937 0.399 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.4 m -60.18 -45.3 93.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 m -117.79 -12.97 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.456 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.86 23.24 75.37 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -102.51 151.77 21.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.771 0.32 . . . . 0.0 110.813 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.01 109.03 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.309 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.06 -28.42 21.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.92 145.37 50.98 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.075 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.778 ' O ' HD23 ' A' ' 73' ' ' LEU . 64.4 t0 -158.09 100.44 1.71 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.944 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.778 HD23 ' O ' ' A' ' 72' ' ' ASP . 4.7 mt -131.7 129.24 40.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.441 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -75.29 125.97 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.105 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 74' ' ' ILE . 26.2 mm -115.28 121.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.915 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.474 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 39.3 m-85 -82.79 159.76 62.64 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.274 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.09 142.44 97.06 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.992 1.795 . . . . 0.0 111.324 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 61.27 12.64 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.876 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -93.09 -33.33 14.12 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.635 0.255 . . . . 0.0 110.889 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -139.48 148.42 42.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.5 tp10 -120.89 132.24 54.86 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.403 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -105.82 115.83 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -140.81 168.97 18.53 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.098 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -85.61 162.38 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.316 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.54 88.56 9.42 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.317 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.47 60.95 8.02 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.507 2.138 . . . . 0.0 112.09 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 -41.99 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.451 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.3 t -129.23 80.01 73.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.474 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.23 130.11 38.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.189 1.926 . . . . 0.0 111.219 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t 168.02 -39.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.627 0.58 . . . . 0.0 110.123 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.54 -170.1 11.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.605 ' HG3' HG22 ' A' ' 114' ' ' THR . 1.4 mmt-85 -95.96 107.0 19.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.732 0.301 . . . . 0.0 111.002 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.07 129.42 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -122.66 156.06 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.971 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.75 131.45 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 81' ' ' GLU . 60.7 tp -102.34 123.23 45.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -118.98 137.54 53.44 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.74 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -92.8 112.75 24.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.309 0.576 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.88 -37.92 88.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.828 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.78 -21.63 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.514 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.62 -173.16 20.74 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.8 m -122.52 25.75 8.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.941 0.4 . . . . 0.0 110.299 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 149.43 33.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -134.81 144.86 47.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.463 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -120.2 152.08 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.768 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 31' ' ' MET . 98.1 m-85 -124.03 135.0 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.812 0.339 . . . . 0.0 110.578 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.35 158.7 43.84 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -131.99 135.98 46.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.574 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.1 mmm -72.43 139.91 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.0 110.85 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -101.38 0.29 36.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.339 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -72.19 145.2 88.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.15 -28.35 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.095 1.863 . . . . 0.0 112.728 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.07 143.62 49.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.147 0.499 . . . . 0.0 110.321 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.605 HG22 ' HG3' ' A' ' 92' ' ' ARG . 76.9 p -89.52 -0.16 57.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.268 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.11 -19.22 42.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -117.76 -18.38 9.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.3 -41.03 98.17 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.335 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.23 -40.03 95.19 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.394 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.37 -42.92 95.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.535 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.724 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.5 m170 -65.87 -40.07 91.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.476 0.655 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.91 -43.48 98.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.464 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -66.64 -41.44 88.26 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.524 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -64.59 -41.08 96.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.4 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.2 t -57.29 -46.98 85.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.72 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -62.21 -39.45 92.78 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.463 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.65 -25.59 61.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.019 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -87.62 -26.05 23.25 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.999 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 HG12 ' A' ' 124' ' ' VAL . 88.3 mt -95.44 -16.37 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.467 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -115.34 -22.44 9.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.09 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -135.22 71.76 67.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.935 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.42 147.57 77.15 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.254 1.97 . . . . 0.0 112.365 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.585 0 C-N-CA 122.463 2.109 . . . . 0.0 112.213 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.46 152.43 95.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.69 154.74 49.45 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.811 2.34 . . . . 0.0 112.385 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.72 156.58 35.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.382 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -53.18 138.08 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.839 1.693 . . . . 0.0 112.255 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 172.96 15.3 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -95.66 156.08 37.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.821 ' HB3' HG22 ' A' ' 39' ' ' THR . 34.8 Cg_endo -66.06 151.42 83.86 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.78 166.28 32.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.798 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.36 134.58 34.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -120.21 132.48 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.415 HD13 HG21 ' B' ' 951' ' ' ILE . 2.9 mt . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . 0.733 HE21 HG21 ' C' ' 14' ' ' THR . 14.1 pt20 -58.34 158.21 7.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.654 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.681 HD13 HD21 ' C' ' 56' ' ' LEU . 20.9 pt -139.05 142.27 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.911 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -81.94 127.21 32.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.157 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -114.67 115.84 50.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -96.91 118.6 33.68 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.17 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -75.23 173.73 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.429 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -45.86 -31.56 2.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.533 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 76.9 p -99.96 -179.87 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.56 -19.11 53.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -53.1 129.37 30.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.049 0.452 . . . . 0.0 110.728 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -127.58 134.6 49.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.454 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.533 HD13 ' HG2' ' C' ' 34' ' ' GLU . 0.0 OUTLIER -130.7 122.39 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.517 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . 0.733 HG21 HE21 ' C' ' 2' ' ' GLN . 85.7 m -88.8 131.87 34.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.595 HD13 ' CB ' ' C' ' 29' ' ' LYS . 65.7 mt -119.3 125.1 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' C' ' 2' ' ' GLN . 8.0 pm0 -65.94 109.68 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 111.009 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.652 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.3 m -133.13 163.78 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.487 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -108.07 156.08 38.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.159 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.29 -37.85 96.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.136 1.891 . . . . 0.0 111.87 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -79.72 -7.2 58.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . 0.54 ' HB3' HD13 ' C' ' 56' ' ' LEU . 34.6 t0 -57.6 137.57 56.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.008 0.432 . . . . 0.0 110.899 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -80.75 160.74 24.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.835 HD12 HD23 ' C' ' 50' ' ' LEU . 43.1 mm -63.7 -41.41 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -57.95 -36.63 72.81 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.292 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.0 -41.51 95.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.556 . . . . 0.0 110.8 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.814 HG21 HD11 ' C' ' 56' ' ' LEU . 61.5 t -63.6 -42.63 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.773 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.469 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.8 mtmt -60.76 -39.62 89.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.354 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.92 93.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.652 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.652 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.1 mttm -60.22 -38.86 84.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.77 HD13 HD11 ' C' ' 69' ' ' LEU . 97.2 mt -65.05 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.962 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -59.01 -43.91 91.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.411 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.75 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.833 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -72.09 -75.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . 0.533 ' HG2' HD13 ' C' ' 13' ' ' ILE . 77.1 mm-40 -93.71 151.49 19.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.366 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.46 56.02 4.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.464 HG23 HD22 ' C' ' 71' ' ' LEU . 42.6 mm -106.4 109.97 63.52 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.69 154.36 49.56 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.054 1.836 . . . . 0.0 112.195 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.98 -38.85 80.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.112 1.875 . . . . 0.0 112.235 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -61.52 -39.97 92.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -87.02 -3.18 59.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.476 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.401 ' HG3' HG22 ' C' ' 36' ' ' ILE . 81.2 mt-30 -88.16 67.15 8.76 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.565 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -84.27 109.89 18.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' C' ' 27' ' ' LYS . 23.4 mt -100.32 128.94 46.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.239 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -128.79 128.67 67.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.69 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -147.8 145.42 28.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.435 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 19.84 7.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.099 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 75' ' ' ILE . . . 90.31 -13.15 65.91 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.66 145.99 24.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.27 0.557 . . . . 0.0 111.482 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -95.21 105.33 17.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.835 HD23 HD12 ' C' ' 23' ' ' ILE . 10.2 mp -65.86 88.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.17 -74.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -177.05 169.02 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.46 20.84 77.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.32 171.28 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 110.025 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -126.33 163.69 22.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.8 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.814 HD11 HG21 ' C' ' 26' ' ' VAL . 3.1 mp -57.87 -43.14 85.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.587 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -63.09 -22.35 66.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.951 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.77 -36.56 83.48 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.354 0.597 . . . . 0.0 109.784 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.28 11.29 39.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.454 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 57.7 46.41 17.39 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.298 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' C' ' 56' ' ' LEU . 80.9 mt -92.71 119.84 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.542 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.99 -178.9 3.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.83 147.84 52.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 58.79 45.21 15.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.215 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -98.45 126.36 43.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.075 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 82.3 m -75.62 126.97 32.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.1 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -112.52 145.44 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.12 114.62 26.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.387 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.77 HD11 HD13 ' C' ' 30' ' ' ILE . 1.2 mt -96.17 126.43 41.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.261 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.648 HG11 HD11 ' A' ' 56' ' ' LEU . 58.3 t -116.45 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.464 HD22 HG23 ' C' ' 36' ' ' ILE . 27.4 mt -103.51 149.19 25.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.286 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.498 179.643 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.28 163.52 15.25 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' D' ' 65' ' ' SER . 16.3 pt -141.84 142.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.044 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.64 ' HD2' HG21 ' D' ' 12' ' ' THR . 5.5 m-85 -87.01 126.56 34.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.75 105.36 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -88.57 125.86 34.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.71 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.581 HG22 HD23 ' D' ' 69' ' ' LEU . 73.7 p -78.01 -166.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.883 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' D' ' 70' ' ' VAL . 92.4 mt -59.16 -28.47 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.793 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -102.91 -177.63 3.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.36 57.6 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -53.07 129.85 32.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 110.894 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.64 HG21 ' HD2' ' D' ' 4' ' ' PHE . 98.4 m -123.93 138.14 54.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.029 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.51 HG22 ' HD2' ' D' ' 33' ' ' LYS . 0.9 OUTLIER -122.75 109.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.956 -178.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -85.41 129.91 34.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.438 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.539 HD21 ' HD2' ' D' ' 33' ' ' LYS . 96.1 mt -122.07 134.07 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.44 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.26 117.54 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.732 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.439 HG12 ' HE2' ' D' ' 29' ' ' LYS . 21.7 m -136.94 167.44 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.168 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.23 154.2 45.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.51 -29.6 85.42 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.609 1.539 . . . . 0.0 111.729 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -84.55 -11.87 55.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.609 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.66 142.16 58.14 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.786 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.0 p -83.27 166.91 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.078 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.57 -37.4 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.13 -42.73 91.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.507 HG21 HD21 ' D' ' 56' ' ' LEU . 69.7 t -61.98 -43.78 98.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.806 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.529 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.7 mtmt -61.08 -38.39 86.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.1 94.35 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.105 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.475 ' CB ' HD13 ' D' ' 15' ' ' LEU . 15.3 mttp -59.96 -39.03 84.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.68 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.31 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.8 -39.5 89.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.175 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.79 -45.1 91.23 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.478 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.539 ' HD2' HD21 ' D' ' 15' ' ' LEU . 71.2 mttt -73.48 -40.51 64.06 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -128.16 151.19 49.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.27 62.06 2.23 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.1 103.25 54.71 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.07 154.43 66.52 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.346 1.364 . . . . 0.0 111.954 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -53.61 -25.97 35.39 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.629 2.22 . . . . 0.0 112.517 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.96 13.63 14.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.418 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -145.4 59.97 1.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.376 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.93 147.08 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.24 0.543 . . . . 0.0 111.774 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.8 124.29 31.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.466 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.529 HD11 ' HG2' ' D' ' 27' ' ' LYS . 53.8 mt -105.49 114.25 28.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.57 HG23 ' C ' ' D' ' 48' ' ' ARG . 82.3 mt -121.68 121.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.82 -46.99 79.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -179.04 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.021 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.34 -8.15 79.54 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.57 ' C ' HG23 ' D' ' 44' ' ' ILE . 44.0 ttm180 -129.79 127.89 41.26 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.867 0.365 . . . . 0.0 110.499 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -81.13 153.47 27.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.572 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.57 102.71 14.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.062 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.84 155.62 35.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.56 154.37 41.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.41 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.13 12.67 63.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -127.33 150.78 49.43 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.198 0.523 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.37 163.36 13.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.999 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.507 HD21 HG21 ' D' ' 26' ' ' VAL . 81.3 mt -61.91 -39.31 91.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.709 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.5 -22.51 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.322 . . . . 0.0 110.367 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.46 -38.33 83.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.261 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -99.83 16.86 22.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.86 40.93 28.64 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.337 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . 0.463 HG23 ' OG ' ' D' ' 65' ' ' SER . 78.8 mt -88.22 110.1 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -95.54 178.61 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -59.62 152.23 22.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.539 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 56.82 33.73 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . 0.463 ' OG ' HG23 ' D' ' 61' ' ' ILE . 4.2 t -77.03 120.86 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.937 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 78.1 m -81.63 119.8 24.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.35 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.75 142.76 45.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.075 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -87.69 114.42 24.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.35 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.581 HD23 HG22 ' D' ' 7' ' ' THR . 36.1 tp -102.51 118.14 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.583 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.438 ' HA ' HD21 ' D' ' 8' ' ' LEU . 87.0 t -117.72 128.73 74.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.814 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.69 -178.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -95.87 113.19 24.79 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.479 ' CD1' HD12 ' A' ' 57' ' ' ILE . 96.6 mt -66.04 -39.01 89.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.603 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.3 p -147.5 163.04 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.05 122.38 0.31 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.756 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.31 158.7 40.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.815 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -74.08 124.21 25.85 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.097 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.416 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -157.0 145.28 19.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.336 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.47 154.72 16.47 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -90.26 174.7 7.45 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.17 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.4 mtp -138.76 172.77 12.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -123.12 123.9 41.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 37' ' ' THR . 27.0 tp -105.29 119.81 39.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.329 0.585 . . . . 0.0 110.618 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -121.42 107.62 12.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.571 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.56 -97.06 0.68 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 p -131.06 19.71 4.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.297 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.563 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.1 m -121.76 130.63 53.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.7 t -110.65 124.07 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.81 133.6 22.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.65 148.21 46.78 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.799 1.666 . . . . 0.0 112.959 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -103.63 130.69 51.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.68 -8.18 50.08 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.917 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.63 78.09 1.08 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -58.53 131.08 49.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.237 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.47 -158.56 9.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.84 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.7 tp -137.57 126.51 24.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 28' ' ' ALA . 36.9 t -96.58 113.5 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.066 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -136.41 155.88 49.4 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.062 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' LEU . 90.8 mt -123.89 140.14 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.105 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -140.09 146.14 38.53 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -109.78 128.55 55.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.221 0.534 . . . . 0.0 110.335 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 58' ' ' HIS . 28.5 p -89.68 172.64 8.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.756 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.56 -10.51 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.152 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.15 3.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m 63.12 26.55 15.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.336 0.589 . . . . 0.0 110.335 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.648 HD11 HG11 ' C' ' 70' ' ' VAL . 71.4 mt -103.97 125.47 50.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.479 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.2 mm -83.11 122.92 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.518 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.8 m-70 -100.59 116.03 31.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.713 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -93.25 110.37 21.89 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -124.64 146.99 48.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.162 0.982 . . . . 0.0 112.951 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -124.08 116.37 22.67 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.943 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -108.19 134.31 51.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.061 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.69 131.2 39.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.82 -17.27 61.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.888 0.375 . . . . 0.0 110.464 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -59.53 -46.4 88.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.863 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.6 m -116.49 -15.36 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 109.888 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.18 21.7 77.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -101.36 152.89 20.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.16 104.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.926 0.393 . . . . 0.0 110.424 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.73 -30.98 36.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -127.95 145.65 50.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.819 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.576 ' C ' HD23 ' A' ' 73' ' ' LEU . 42.9 p-10 -158.11 120.21 3.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.612 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.817 HD12 HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -148.1 136.09 21.09 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.17 0.509 . . . . 0.0 110.381 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -81.62 122.88 37.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.574 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.817 HD11 HD12 ' A' ' 73' ' ' LEU . 24.6 mm -114.06 121.23 65.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.279 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 61.9 m-85 -84.78 162.3 50.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.63 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.92 139.56 89.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.368 2.045 . . . . 0.0 111.54 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 59.64 12.02 2.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.229 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -87.17 -25.12 24.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.716 ' SG ' HG21 ' A' ' 75' ' ' ILE . 14.6 p -144.43 169.23 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.35 0.595 . . . . 0.0 110.324 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -137.54 125.25 22.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.809 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.23 118.74 37.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.57 164.71 30.84 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.415 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -79.4 159.84 26.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.018 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.6 t -111.36 90.62 12.28 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.18 60.25 7.72 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.829 1.686 . . . . 0.0 112.509 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -114.24 -38.82 4.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.991 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.06 82.35 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.585 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.16 130.33 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.702 1.602 . . . . 0.0 111.685 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.5 t 169.68 -45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.571 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.72 -154.98 8.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.7 OUTLIER -109.85 106.81 16.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.505 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.65 128.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.08 154.37 41.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.681 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.01 136.12 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.196 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.442 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.7 tp -103.77 120.0 40.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -118.36 136.08 53.95 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.238 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -84.22 114.67 21.98 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.124 0.488 . . . . 0.0 109.833 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.9 -37.88 86.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.706 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.96 -21.92 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.23 -175.38 22.68 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -117.88 15.81 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.675 0.274 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HD3' HD21 ' A' ' 105' ' ' LEU . 10.2 ttmt -93.35 146.0 24.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.87 137.96 40.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.408 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.673 HD21 ' HD3' ' A' ' 103' ' ' LYS . 43.6 mt -119.23 148.21 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.44 133.59 55.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.961 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.72 157.99 45.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.293 0.568 . . . . 0.0 111.188 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -132.07 138.07 48.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.522 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.3 ttm -77.07 131.55 38.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.072 0.463 . . . . 0.0 111.475 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -1.7 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.702 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.25 144.91 98.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.06 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.32 -26.93 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.051 1.834 . . . . 0.0 112.786 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -121.85 144.57 48.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.054 0.454 . . . . 0.0 110.245 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.46 HG22 ' HG2' ' A' ' 92' ' ' ARG . 72.4 p -94.0 9.16 38.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.629 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.88 -22.1 61.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.84 -4.66 12.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.54 -46.95 87.77 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -41.44 99.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.71 -43.23 97.19 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.716 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.9 m170 -64.34 -40.7 96.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.577 0.703 . . . . 0.0 109.111 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.77 -45.07 94.38 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.901 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -68.01 -42.12 81.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.4 -41.88 98.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.513 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 120' ' ' HIS . 56.2 t -59.13 -47.08 91.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.312 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.89 -39.59 93.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.271 0.558 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.87 -36.37 80.15 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.075 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.441 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 23.7 m-85 -80.17 -30.43 38.83 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.955 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 75' ' ' ILE . 80.4 mt -90.02 -17.51 27.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.853 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -116.98 -19.0 9.98 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.372 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.81 69.78 36.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.339 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.21 157.6 59.01 Favored 'Trans proline' 0 C--N 1.296 -2.195 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.539 2.16 . . . . 0.0 112.319 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.69 154.69 81.84 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 145.1 29.19 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.402 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.35 156.47 68.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.018 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.17 137.39 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.017 1.811 . . . . 0.0 111.873 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.08 -170.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.033 1.822 . . . . 0.0 111.848 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -124.95 158.33 63.38 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.257 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.59 144.32 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.588 2.192 . . . . 0.0 112.377 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -155.53 164.43 38.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.72 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -86.16 135.74 33.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.905 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -121.06 122.95 41.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.429 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -69.37 161.84 28.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 pt -140.04 144.77 27.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.367 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.16 126.38 35.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.774 HG11 HD11 ' C' ' 30' ' ' ILE . 96.5 t -112.31 115.27 49.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -103.49 127.22 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.53 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -90.03 173.34 8.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 111.314 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.66 -25.92 68.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.174 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -73.41 -9.39 58.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.77 -7.41 73.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -71.87 130.83 41.99 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 110.198 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -109.84 132.22 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.255 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.4 HD13 HG21 ' C' ' 13' ' ' ILE . 0.0 OUTLIER -132.7 116.55 27.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 -179.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -87.07 131.45 34.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.072 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.626 HD21 ' HG3' ' C' ' 33' ' ' LYS . 92.5 mt -123.38 133.64 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -73.5 115.49 12.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.532 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.463 HG12 ' HE3' ' C' ' 29' ' ' LYS . 22.9 m -135.37 168.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.458 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.19 153.35 45.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.193 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.22 -38.17 93.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.999 1.799 . . . . 0.0 112.345 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -81.73 -8.19 59.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -59.04 139.03 57.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.953 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -80.16 161.78 25.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.491 HD12 HD13 ' C' ' 50' ' ' LEU . 48.8 mm -63.67 -38.53 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.177 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.19 -41.93 89.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.284 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.12 -41.25 98.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.124 0.488 . . . . 0.0 110.548 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.414 HG22 HG11 ' C' ' 17' ' ' VAL . 56.1 t -62.91 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.614 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -60.96 -38.39 85.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.01 91.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.585 ' CB ' HD13 ' C' ' 15' ' ' LEU . 67.3 mttm -60.11 -39.28 85.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.774 HD11 HG11 ' C' ' 5' ' ' VAL . 5.8 mm -64.59 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.471 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -59.69 -40.15 86.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.811 0.338 . . . . 0.0 110.377 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -67.55 -50.94 56.24 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.626 ' HG3' HD21 ' C' ' 15' ' ' LEU . 19.6 mttt -64.93 -40.98 95.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 112.038 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -132.18 146.41 52.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.199 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.04 63.98 2.01 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.589 HG22 ' HB2' ' C' ' 41' ' ' GLN . 3.5 mt -121.71 112.32 32.39 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.16 157.35 57.65 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.777 1.651 . . . . 0.0 111.748 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.8 -38.07 96.6 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.168 1.912 . . . . 0.0 112.188 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.96 -40.92 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.915 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -88.64 -17.68 29.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.658 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.589 ' HB2' HG22 ' C' ' 36' ' ' ILE . 4.8 tt0 -92.03 116.44 28.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.054 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -120.28 114.19 21.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.667 ' CB ' HD12 ' C' ' 50' ' ' LEU . 79.4 mt -92.48 131.86 37.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.295 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -130.75 129.25 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -145.17 152.46 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.899 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.54 20.31 10.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 110.505 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.72 -5.09 76.44 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.668 ' HG2' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -115.11 139.31 50.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.087 0.47 . . . . 0.0 110.736 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.16 131.61 43.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.667 HD12 ' CB ' ' C' ' 43' ' ' LEU . 50.4 mt -69.68 103.7 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.778 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -75.31 138.94 42.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.97 137.04 58.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.69 -17.81 52.01 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -84.28 174.99 9.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -120.62 165.54 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.346 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' C' ' 56' ' ' LEU . 79.3 mt -62.54 -39.88 94.99 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.567 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -64.11 -25.96 68.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.66 -33.55 75.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.437 . . . . 0.0 110.356 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -99.45 13.77 32.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.283 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 56.29 43.93 25.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -91.02 114.76 28.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.45 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -63.7 146.2 54.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.16 44.96 18.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.939 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 38.9 m -99.33 124.93 44.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.47 ' C ' HD12 ' C' ' 67' ' ' LEU . 40.9 m -74.45 130.83 40.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.223 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.47 HD12 ' C ' ' C' ' 66' ' ' THR . 7.5 mp -118.65 155.16 31.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.399 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -105.89 120.65 42.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.503 HD11 HG21 ' C' ' 30' ' ' ILE . 1.8 tt -101.27 114.79 29.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.015 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.574 HG11 HD11 ' A' ' 56' ' ' LEU . 58.8 t -104.25 130.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.76 131.94 38.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.908 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -153.18 166.94 30.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.754 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.611 HG22 ' HB3' ' D' ' 65' ' ' SER . 3.1 pt -144.1 150.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.019 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.0 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.43 111.95 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -95.43 122.04 37.73 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.639 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.713 HG22 HD23 ' D' ' 69' ' ' LEU . 75.3 p -79.77 173.3 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.778 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.4 mt -61.1 -35.34 76.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.158 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -69.17 -12.03 61.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.892 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.4 60.3 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -61.56 130.96 48.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.71 0.291 . . . . 0.0 110.457 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -103.89 133.94 48.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.561 HD12 ' OE2' ' D' ' 34' ' ' GLU . 1.3 mt -126.98 106.67 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.965 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 124.4 27.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.225 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -121.01 132.25 54.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.357 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.81 120.8 21.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.632 HG12 ' CD ' ' D' ' 29' ' ' LYS . 31.4 m -134.56 -177.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.744 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . 0.533 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.6 mt-10 -132.04 152.08 79.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.119 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.75 -27.21 82.9 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.983 1.789 . . . . 0.0 111.977 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.3 p -86.21 -14.05 45.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.34 143.3 57.92 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.593 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -87.43 168.48 13.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.172 0.51 . . . . 0.0 110.854 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.89 -38.31 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.682 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.31 -39.71 87.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -62.29 -40.9 97.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.687 HG21 HD21 ' D' ' 56' ' ' LEU . 58.7 t -63.55 -42.47 96.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.784 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.81 -40.59 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.085 0.469 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.87 91.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.109 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.632 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.37 -38.69 81.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.779 ' CD1' HD21 ' D' ' 43' ' ' LEU . 81.1 mt -64.37 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.167 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -61.13 -43.65 98.55 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.867 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.78 -23.18 61.54 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.079 -0.388 . . . . 0.0 111.904 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.46 3.54 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . 0.679 ' OE2' HG23 ' D' ' 30' ' ' ILE . 43.0 mt-10 -149.22 -46.07 0.14 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.51 20.11 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' D' ' 71' ' ' LEU . 30.2 mt -88.69 119.84 70.08 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.662 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.76 159.35 50.99 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.715 1.61 . . . . 0.0 111.888 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.37 -23.17 36.9 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.498 2.132 . . . . 0.0 112.537 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -93.24 18.17 9.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.886 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -146.14 23.96 1.32 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.728 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.423 ' HB2' HD11 ' D' ' 69' ' ' LEU . 27.5 pt20 -150.12 144.77 25.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.978 0.418 . . . . 0.0 110.987 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -128.28 120.49 27.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.526 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.779 HD21 ' CD1' ' D' ' 30' ' ' ILE . 74.9 mt -96.3 121.38 38.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.36 129.34 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.53 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 74.0 t80 -130.95 133.1 45.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.18 26.47 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.23 79.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -126.09 130.73 51.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -65.21 138.34 58.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' D' ' 43' ' ' LEU . 84.0 mt -84.66 112.0 20.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.491 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.83 152.38 37.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -73.65 164.3 26.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.315 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.14 25.03 75.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -127.23 149.64 49.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -93.41 161.91 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.285 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.687 HD21 HG21 ' D' ' 26' ' ' VAL . 76.9 mt -62.61 -39.55 94.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.733 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.0 p -63.3 -22.84 67.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.429 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.87 -37.97 86.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.036 0.446 . . . . 0.0 110.62 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -96.76 16.31 19.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.43 42.07 25.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -91.51 101.75 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.728 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -94.96 179.84 5.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.478 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -56.32 145.33 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.268 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 59.92 42.44 16.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . 0.611 ' HB3' HG22 ' D' ' 3' ' ' ILE . 28.5 t -95.98 120.81 36.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.595 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.432 ' C ' HD12 ' D' ' 67' ' ' LEU . 25.1 m -76.84 124.99 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.389 . . . . 0.0 110.396 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.432 HD12 ' C ' ' D' ' 66' ' ' THR . 7.9 mp -115.69 136.02 53.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.154 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -84.0 124.02 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.404 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.713 HD23 HG22 ' D' ' 7' ' ' THR . 55.4 tp -104.9 118.37 36.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.701 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.665 ' HA ' HD21 ' D' ' 8' ' ' LEU . 98.0 t -115.43 132.04 65.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.238 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.778 ' H ' HD11 ' D' ' 8' ' ' LEU . 49.9 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.488 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.6 pttm . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.98 128.65 35.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 51' ' ' GLN . 81.7 mt -67.59 -37.26 82.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.853 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -148.67 160.98 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.84 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.47 122.56 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.12 155.17 34.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.649 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -74.08 118.03 16.57 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.358 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.15 26.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.94 150.72 17.12 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -89.32 157.84 18.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.73 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 29.6 mtp -124.24 175.56 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -126.16 122.64 36.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.246 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 37' ' ' THR . 30.5 tp -106.03 122.75 46.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.993 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -118.36 103.75 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.12 -85.18 0.69 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -141.3 18.11 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.534 0.206 . . . . 0.0 110.911 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.674 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.0 m -120.01 126.16 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG2' HD13 ' A' ' 33' ' ' LEU . 61.2 t -105.99 122.75 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.414 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.596 HG23 ' HG3' ' B' ' 947' ' ' PRO . 53.0 m -119.33 122.62 29.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.427 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 147.18 64.48 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.924 1.749 . . . . 0.0 112.905 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.15 139.99 39.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.969 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -72.93 -5.25 37.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -72.47 74.77 1.04 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -52.79 134.27 36.77 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.334 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.65 -165.06 11.3 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.9 tp -135.92 122.55 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG22 ' HD1' ' A' ' 61' ' ' TRP . 53.7 t -97.63 108.36 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.831 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 39.0 p90 -133.14 153.59 51.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.576 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.8 mt -122.04 141.62 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.826 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -141.67 142.63 33.37 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 123.687 0.617 . . . . 0.0 110.18 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.478 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.8 tt0 -106.29 127.6 53.36 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 58' ' ' HIS . 20.9 p -87.3 172.79 9.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.754 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.11 -10.42 22.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.625 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.22 -0.16 56.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 70.04 19.77 6.72 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.574 HD11 HG11 ' C' ' 70' ' ' VAL . 70.4 mt -101.72 126.02 48.5 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 131' ' ' PRO . 49.4 mm -80.78 126.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.501 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -102.42 115.99 31.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.915 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -91.92 108.19 19.75 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.06 140.03 50.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.805 0.812 . . . . 0.0 112.902 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.417 ' HD1' HG22 ' A' ' 47' ' ' VAL . 92.4 t90 -125.46 113.25 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.189 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -106.18 144.7 32.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.817 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -80.62 131.65 35.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.82 -18.63 62.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.952 0.406 . . . . 0.0 110.529 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -59.65 -46.18 89.78 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.45 -11.3 10.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 0.0 110.646 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.08 22.78 78.7 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.51 146.88 27.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.722 0.296 . . . . 0.0 110.657 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.79 102.02 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.036 0.445 . . . . 0.0 110.304 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -73.08 -39.4 65.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.906 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.8 147.13 50.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.522 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p30 -158.54 103.24 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.597 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD22 ' HG2' ' C' ' 48' ' ' LYS . 35.2 mt -126.98 135.7 51.23 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.775 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -77.43 122.22 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' A' ' 80' ' ' CYS . 31.5 mm -111.81 121.08 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.618 . . . . 0.0 111.183 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 42.9 m-85 -82.76 160.98 59.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 142.35 98.64 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.797 1.664 . . . . 0.0 111.441 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 61.84 12.34 4.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.103 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -89.87 -35.79 15.44 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 120.628 0.251 . . . . 0.0 110.678 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.609 ' HB3' HD11 ' A' ' 96' ' ' LEU . 71.4 m -132.48 156.29 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.25 0.548 . . . . 0.0 111.399 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.516 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.4 tt0 -129.31 130.63 46.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.126 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -101.96 117.95 35.89 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.412 ' NZ ' HG11 ' A' ' 95' ' ' VAL . 22.8 pttp -143.49 161.27 38.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.538 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -83.19 160.34 21.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.131 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.5 89.39 15.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.192 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.6 60.21 7.55 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.091 1.86 . . . . 0.0 112.047 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -114.25 -44.27 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.9 t -116.36 99.06 52.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.78 129.73 15.9 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.38 1.386 . . . . 0.0 111.458 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 165.23 -38.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 O-C-N 124.02 0.825 . . . . 0.0 110.372 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.59 -179.69 25.64 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -91.83 113.55 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.88 128.26 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.176 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -119.18 155.75 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.719 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.2 p -133.63 137.74 52.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.4 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 80' ' ' CYS . 63.9 tp -103.68 121.47 43.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -117.89 141.6 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -88.09 117.18 26.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.27 -37.47 85.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.949 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.83 -15.85 19.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.53 176.14 19.96 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.6 p -111.7 15.76 20.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.668 0.27 . . . . 0.0 110.465 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' CE ' HD21 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -95.28 144.56 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.969 0.414 . . . . 0.0 110.77 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.93 140.59 42.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.716 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . 57.9 mt -119.62 152.06 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.5 m-85 -124.28 137.15 54.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.84 154.24 48.41 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.29 0.567 . . . . 0.0 111.216 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -132.43 136.04 46.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.07 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.95 131.68 51.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.121 0.486 . . . . 0.0 111.215 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 -1.67 12.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.483 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.09 149.23 94.56 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.664 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.14 -39.93 64.82 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.002 1.802 . . . . 0.0 112.224 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.57 145.91 48.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.3 p -98.45 18.72 15.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.5 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.49 -22.2 61.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.61 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -123.48 13.85 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.51 91.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.776 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.54 -41.21 84.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.066 0.46 . . . . 0.0 111.128 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.75 -43.35 96.71 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.757 ' O ' HG23 ' A' ' 124' ' ' VAL . 60.8 m170 -63.54 -41.08 98.48 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.517 0.675 . . . . 0.0 109.322 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.23 -42.02 96.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -67.58 -40.14 84.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.2 -37.57 83.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.713 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.3 t -58.51 -47.83 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -80.05 -27.42 39.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.942 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.96 -38.22 82.5 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.53 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -81.62 -34.18 31.05 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.479 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 124' ' ' VAL . 67.3 mt -76.24 -26.69 56.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.917 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -107.45 -24.16 11.92 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.56 74.83 58.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.536 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.8 Cg_exo -59.4 155.63 40.23 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.004 2.469 . . . . 0.0 112.362 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.081 -179.643 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 49.44 67.65 4.26 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.558 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.35 143.95 78.47 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.723 2.282 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.89 160.05 82.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.806 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.52 155.42 62.76 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.765 2.31 . . . . 0.0 112.187 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.35 -169.44 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.608 2.205 . . . . 0.0 111.608 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -110.1 160.4 28.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.596 ' HG3' HG23 ' A' ' 39' ' ' THR . 50.8 Cg_exo -57.14 142.68 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.538 2.159 . . . . 0.0 111.808 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.72 163.93 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.68 138.36 32.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.867 0.365 . . . . 0.0 110.434 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -124.57 119.87 30.32 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.784 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.716 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.14 162.93 18.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.461 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.499 HD13 HD21 ' C' ' 56' ' ' LEU . 16.6 pt -144.35 147.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.962 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -96.43 119.5 35.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.571 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -103.5 103.8 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -87.67 118.54 27.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.803 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.786 HG22 HD23 ' C' ' 69' ' ' LEU . 80.9 p -82.36 171.13 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.431 HD11 ' H ' ' C' ' 71' ' ' LEU . 67.9 mt -64.89 -25.03 67.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.138 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.8 p -73.47 -11.5 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -13.74 63.59 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.56 132.53 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.257 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -101.56 132.02 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.144 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mm -116.3 103.55 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.95 120.31 25.53 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.098 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.771 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.9 mt -122.34 132.76 54.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.32 114.45 16.16 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.574 HG12 ' HE3' ' C' ' 29' ' ' LYS . 26.7 m -136.91 171.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.989 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -116.51 156.33 47.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.237 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.98 -41.23 77.47 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.887 1.724 . . . . 0.0 112.322 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -72.94 -12.25 60.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -59.13 135.76 57.74 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.851 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -77.51 160.54 28.56 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.869 HD12 HD13 ' C' ' 50' ' ' LEU . 47.9 mm -66.17 -37.65 80.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.071 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.44 -42.92 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -62.29 -42.03 99.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 110.074 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.678 HG21 HD11 ' C' ' 56' ' ' LEU . 53.0 t -61.21 -43.58 96.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.428 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -40.1 79.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.187 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.6 94.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.991 0.424 . . . . 0.0 110.339 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.63 ' HB3' HD13 ' C' ' 15' ' ' LEU . 67.0 mttm -59.8 -39.4 84.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.394 0.616 . . . . 0.0 109.386 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.798 ' CD1' HD21 ' C' ' 43' ' ' LEU . 97.3 mt -66.56 -38.86 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.443 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -58.03 -42.36 85.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.447 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.11 -40.89 71.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.456 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.771 ' HG3' HD21 ' C' ' 15' ' ' LEU . 7.0 mmtm -65.63 -40.96 93.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.959 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -138.07 157.27 46.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.45 57.44 3.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 32.6 mm -110.81 104.84 56.68 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 153.49 50.38 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.354 2.036 . . . . 0.0 112.204 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.81 -39.14 78.43 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.822 1.681 . . . . 0.0 112.302 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.83 -39.55 92.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.279 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.08 -9.24 59.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.913 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.55 93.87 7.93 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . 0.428 ' HB2' ' HB ' ' C' ' 70' ' ' VAL . 76.5 mtp85 -108.82 95.81 5.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.798 HD21 ' CD1' ' C' ' 30' ' ' ILE . 81.5 mt -84.55 130.21 34.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.274 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -132.17 127.51 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -141.76 148.82 39.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.948 0.404 . . . . 0.0 111.108 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.64 17.48 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.249 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 89.87 -17.11 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -95.48 133.27 39.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 111.056 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -75.73 130.92 39.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.69 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.869 HD13 HD12 ' C' ' 23' ' ' ILE . 35.5 mt -72.89 129.8 38.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.58 -80.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.479 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.01 -68.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.611 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.12 94.49 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -49.07 162.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.514 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -109.54 178.46 4.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.308 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.678 HD11 HG21 ' C' ' 26' ' ' VAL . 6.6 mp -69.79 -39.61 76.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.825 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.29 -24.96 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.56 -37.4 86.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.451 ' CE2' HD23 ' C' ' 50' ' ' LEU . 85.1 m-85 -98.76 11.98 37.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.113 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 t30 59.33 40.08 21.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.852 0.358 . . . . 0.0 110.365 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -86.24 103.72 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -91.68 179.95 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.512 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -63.19 145.08 56.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.186 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 64.28 13.32 7.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.322 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.0 m -67.02 134.78 52.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 43.6 m -92.49 117.63 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.518 HD12 ' N ' ' C' ' 67' ' ' LEU . 5.8 mp -108.17 139.39 42.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.56 127.91 35.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.28 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.786 HD23 HG22 ' C' ' 7' ' ' THR . 55.7 tp -105.85 121.17 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.722 HG11 HD11 ' A' ' 56' ' ' LEU . 57.6 t -108.87 132.61 56.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.736 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.431 ' H ' HD11 ' C' ' 8' ' ' LEU . 22.4 mt -95.9 133.41 40.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.3 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -64.27 160.68 18.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.599 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -139.17 142.44 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.377 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.633 ' HD2' HG21 ' D' ' 12' ' ' THR . 4.0 m-85 -86.63 122.73 30.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -108.82 107.28 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.382 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -92.0 130.43 37.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.883 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.802 HG22 HD23 ' D' ' 69' ' ' LEU . 61.6 p -89.19 -179.32 5.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.662 HD11 ' H ' ' D' ' 71' ' ' LEU . 80.8 mt -64.36 -37.22 86.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.136 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.39 -12.18 61.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 -12.51 61.36 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.98 131.4 49.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.633 HG21 ' HD2' ' D' ' 4' ' ' PHE . 83.3 m -104.77 133.53 49.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 111.163 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.405 HD13 HG21 ' D' ' 13' ' ' ILE . 0.9 OUTLIER -125.83 108.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.729 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.6 m -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.299 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' D' ' 29' ' ' LYS . 94.6 mt -122.91 126.57 47.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.627 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -68.85 116.39 9.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.849 0.357 . . . . 0.0 111.039 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.564 HG12 ' HE2' ' D' ' 29' ' ' LYS . 20.7 m -139.2 165.57 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -106.28 155.24 38.96 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.027 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.46 -32.77 90.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.102 1.868 . . . . 0.0 112.282 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -87.3 -3.31 59.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -60.06 136.24 57.96 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -80.18 163.41 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.234 0.54 . . . . 0.0 111.021 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.412 HD12 HD13 ' D' ' 50' ' ' LEU . 49.9 mm -63.03 -37.26 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.426 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.39 -42.33 86.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.084 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -62.48 -41.27 98.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.443 . . . . 0.0 110.432 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.572 HG21 HD21 ' D' ' 56' ' ' LEU . 53.2 t -61.47 -43.61 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.67 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.404 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.8 mtmt -61.08 -39.46 89.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.71 97.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.564 ' HE2' HG12 ' D' ' 17' ' ' VAL . 16.2 mttp -59.66 -38.92 82.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.571 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.426 HD12 HD21 ' D' ' 43' ' ' LEU . 59.2 mt -67.04 -38.48 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.842 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -59.12 -39.74 83.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.406 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -70.49 -53.76 14.99 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.485 ' HD2' HD21 ' D' ' 15' ' ' LEU . 28.7 mttp -63.14 -40.95 99.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.094 0.473 . . . . 0.0 111.753 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -128.2 143.45 51.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.793 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.36 61.96 2.69 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' D' ' 41' ' ' GLN . 2.8 mt -114.02 110.11 49.01 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.54 155.07 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.16 1.907 . . . . 0.0 111.691 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.18 -34.49 98.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.216 1.944 . . . . 0.0 113.035 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.17 -47.42 77.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 110.101 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.2 -38.85 88.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.624 ' HG3' HG22 ' D' ' 36' ' ' ILE . 89.3 mt-30 -58.86 115.74 3.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.729 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -119.37 102.89 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.583 ' CB ' HD12 ' D' ' 50' ' ' LEU . 30.9 mt -90.37 118.55 29.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.13 126.06 67.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 86.8 t80 -132.1 132.21 43.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.306 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.97 27.24 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.535 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.06 78.59 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -129.72 129.19 43.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -66.08 140.34 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.621 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.583 HD12 ' CB ' ' D' ' 43' ' ' LEU . 70.8 mt -82.47 114.84 21.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.965 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.51 139.89 42.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.949 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.95 136.81 57.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.39 56.63 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -81.97 170.08 16.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.6 p -113.71 165.44 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.572 HD21 HG21 ' D' ' 26' ' ' VAL . 88.4 mt -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.599 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.8 p -63.54 -26.72 68.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.067 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.27 -29.15 70.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.028 0.442 . . . . 0.0 110.389 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . 0.405 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.0 m-85 -103.08 15.65 28.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.87 38.81 30.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -89.88 115.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -104.93 -174.85 2.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.273 0.559 . . . . 0.0 110.804 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -61.57 144.26 54.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.324 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 60.98 19.78 10.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.826 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -70.1 126.41 29.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 59.4 m -79.06 129.89 34.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.212 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.94 144.45 46.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.074 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -91.67 110.0 21.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.117 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.802 HD23 HG22 ' D' ' 7' ' ' THR . 61.0 tp -96.27 106.68 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.498 ' HA ' HD21 ' D' ' 8' ' ' LEU . 80.1 t -99.83 140.14 19.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.124 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.662 ' H ' HD11 ' D' ' 8' ' ' LEU . 46.1 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.122 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.755 0.312 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.71 113.22 25.44 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.26 0.552 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 57' ' ' ILE . 92.0 mt -66.97 -38.86 86.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.479 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.1 p -149.34 162.75 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.955 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.83 122.81 0.33 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -155.32 158.17 38.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.869 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.564 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.2 122.01 23.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.05 0.452 . . . . 0.0 110.866 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.16 139.93 17.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.12 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.12 154.17 17.68 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -90.41 172.37 8.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.136 0.493 . . . . 0.0 111.435 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.403 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 22.9 mtp -134.74 172.23 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.639 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -122.68 121.88 37.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD13 ' CG2' ' A' ' 38' ' ' VAL . 29.4 tp -104.62 116.85 32.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.312 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.45 117.82 26.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.825 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -84.76 0.35 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 p -149.81 23.41 0.87 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.719 0.295 . . . . 0.0 110.689 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.1 m -125.85 131.34 52.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.431 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.4 t -108.9 122.44 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.639 HG22 ' HB3' ' B' ' 947' ' ' PRO . 67.3 p -114.71 131.25 23.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.223 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.79 148.59 46.62 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.195 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.51 142.61 27.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.817 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -82.46 -8.53 59.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.718 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.9 86.52 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -53.37 137.24 35.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.94 -162.98 10.83 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.047 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.7 tp -140.51 122.04 15.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -94.55 109.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -131.74 153.2 50.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.062 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.6 mt -122.36 140.83 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.365 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -141.57 144.99 34.55 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 123.499 0.5 . . . . 0.0 109.7 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -109.24 127.18 54.05 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.469 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.503 HG23 ' CD2' ' A' ' 58' ' ' HIS . 20.7 p -87.47 172.59 9.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.028 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.38 -10.72 18.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.698 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.49 4.7 48.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.586 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m 63.83 25.32 14.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.485 0.659 . . . . 0.0 110.566 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.722 HD11 HG11 ' C' ' 70' ' ' VAL . 63.4 mt -103.24 125.51 49.94 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.437 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.6 mm -82.38 123.59 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.074 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.9 m-70 -101.23 115.3 30.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.477 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -96.68 107.96 20.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.66 142.92 51.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.41 113.58 24.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.292 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -103.85 135.82 44.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.832 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.44 136.95 38.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.873 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -78.67 -18.65 54.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -60.65 -46.46 90.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.787 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -117.0 -13.3 10.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.22 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.14 75.5 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.8 144.47 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.702 0.287 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.45 102.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.879 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -75.31 -37.15 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.876 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -126.28 144.7 50.7 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.2 t0 -158.81 101.05 1.62 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.509 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 72' ' ' ASP . 47.4 mt -128.12 140.94 51.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.753 0.311 . . . . 0.0 110.451 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.448 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 97.0 mt -82.75 122.85 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.712 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.7 mm -112.91 122.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.067 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -85.16 162.95 47.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.587 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.36 140.25 93.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.138 1.892 . . . . 0.0 111.322 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.76 11.89 2.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.256 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -85.06 -26.24 27.11 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.719 0.295 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 75' ' ' ILE . 15.8 p -147.19 167.2 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.319 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.04 127.74 32.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.222 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.51 117.06 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -142.37 168.17 20.37 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.699 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -87.36 160.27 18.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.194 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.42 89.76 13.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 60.83 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.015 1.81 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -52.16 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.5 t -114.52 98.11 48.32 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.66 130.46 17.08 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.483 1.455 . . . . 0.0 111.668 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.65 -32.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.8 0.688 . . . . 0.0 110.071 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.24 -171.9 20.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.351 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.42 110.1 22.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 110.466 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.97 154.48 38.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.31 133.62 62.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 ' SG ' ' A' ' 80' ' ' CYS . 66.7 tp -101.68 121.58 42.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -119.14 132.46 55.99 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.392 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -83.79 115.12 22.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.22 -37.41 87.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.795 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.24 -23.15 24.83 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.476 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.48 -169.71 19.56 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -120.55 13.79 11.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.554 0.216 . . . . 0.0 110.629 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.725 ' HD3' HD21 ' A' ' 105' ' ' LEU . 19.9 ttmt -86.11 142.81 28.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -136.04 129.3 31.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.156 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.725 HD21 ' HD3' ' A' ' 103' ' ' LYS . 37.9 mt -115.18 150.58 35.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.812 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' A' ' 33' ' ' LEU . 89.6 m-85 -124.22 137.86 54.47 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.124 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.47 156.81 47.21 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.29 0.567 . . . . 0.0 111.123 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -129.01 137.34 51.28 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.276 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.5 mmm -72.81 141.13 48.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -0.93 24.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.68 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.76 147.03 88.77 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.583 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.25 -27.16 13.88 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.163 1.908 . . . . 0.0 112.607 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.01 146.86 47.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.3 p -92.6 4.07 54.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.811 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.12 -21.17 45.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.51 -13.88 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -61.1 -45.58 94.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.296 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.91 -43.36 93.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.258 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.713 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.7 m170 -63.58 -40.62 97.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.62 0.724 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -62.69 -45.04 94.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.855 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.96 -42.37 85.3 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.533 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.65 -42.87 99.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.484 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.2 t -57.57 -47.65 84.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.046 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -64.05 -39.41 94.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.76 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.22 -27.53 62.59 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.175 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.1 m-85 -85.0 -29.03 25.35 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.735 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.53 -12.38 29.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -120.12 -16.65 8.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.794 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -144.23 72.68 16.21 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 57' ' ' ILE . 34.9 Cg_exo -60.81 148.97 90.44 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.931 2.421 . . . . 0.0 111.963 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 C-N-CA 122.308 2.005 . . . . 0.0 111.984 179.85 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -133.73 151.22 76.65 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.96 152.72 36.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.574 2.183 . . . . 0.0 111.661 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -95.13 156.28 38.0 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.186 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.84 140.01 68.36 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.447 2.098 . . . . 0.0 112.144 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.98 172.61 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.37 2.047 . . . . 0.0 112.097 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -93.03 154.33 41.73 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 39' ' ' THR . 36.2 Cg_endo -65.88 150.29 85.86 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.467 2.112 . . . . 0.0 111.908 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.01 163.85 37.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -85.91 139.81 30.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.127 0.489 . . . . 0.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -124.89 128.82 49.25 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.355 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.417 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.8 mp . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.366 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . 0.445 ' OE1' HG21 ' C' ' 14' ' ' THR . 6.5 pt20 -64.48 162.4 15.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.462 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.43 151.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.285 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.546 ' CD1' HG23 ' C' ' 14' ' ' THR . 10.9 m-30 -92.34 114.5 27.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.893 HG11 HD11 ' C' ' 30' ' ' ILE . 80.1 t -104.37 98.85 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.135 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -77.79 116.45 18.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.805 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -73.21 -178.18 2.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.322 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -48.56 -29.21 4.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -101.06 -177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.045 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.38 -12.67 56.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.05 134.66 57.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . 0.432 ' C ' HD13 ' C' ' 13' ' ' ILE . 93.6 m -118.68 133.57 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.432 HD13 ' C ' ' C' ' 12' ' ' THR . 12.8 mm -113.2 110.14 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . 0.546 HG23 ' CD1' ' C' ' 4' ' ' PHE . 3.8 m -83.82 119.01 24.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.603 HD13 ' CB ' ' C' ' 29' ' ' LYS . 73.5 mt -118.31 125.9 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.563 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.5 113.35 9.44 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.487 HG11 HG22 ' C' ' 26' ' ' VAL . 31.1 m -135.35 164.56 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.091 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -107.49 155.56 39.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.741 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.48 -32.76 90.51 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.027 1.818 . . . . 0.0 112.302 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.52 -1.34 57.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.186 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -62.77 138.76 58.6 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -79.15 159.42 27.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.174 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.52 HD12 HD13 ' C' ' 50' ' ' LEU . 43.9 mm -64.12 -40.96 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -58.02 -36.32 72.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.955 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.69 -43.13 94.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.197 0.522 . . . . 0.0 110.904 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.499 HG21 HD21 ' C' ' 56' ' ' LEU . 62.5 t -62.37 -43.08 97.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.802 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -60.75 -38.38 84.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.16 91.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.852 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.603 ' CB ' HD13 ' C' ' 15' ' ' LEU . 5.8 mptt -60.07 -38.74 83.75 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.343 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.893 HD11 HG11 ' C' ' 5' ' ' VAL . 6.9 mm -63.85 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.244 0.545 . . . . 0.0 110.14 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -59.88 -48.77 80.33 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.76 -11.55 59.85 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.082 -0.386 . . . . 0.0 112.026 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -104.87 -8.03 18.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -147.27 -35.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.433 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.81 15.54 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.465 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' C' ' 41' ' ' GLN . 28.5 mt -95.78 115.05 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.69 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.35 153.77 51.49 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.6 2.2 . . . . 0.0 111.294 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.31 -40.12 87.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.649 1.566 . . . . 0.0 111.855 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.95 -41.01 97.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.827 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -88.88 -2.57 58.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.585 ' HG3' HD21 ' C' ' 69' ' ' LEU . 4.7 tt0 -111.88 120.83 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.798 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -122.77 120.54 33.88 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.546 ' CB ' HD12 ' C' ' 50' ' ' LEU . 78.2 mt -99.12 131.47 45.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.199 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.425 HG21 ' HE1' ' A' ' 76' ' ' PHE . 78.5 mt -129.72 129.01 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . 0.541 ' HB2' HD23 ' C' ' 67' ' ' LEU . 75.1 t80 -151.77 153.46 34.34 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.61 15.37 10.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.418 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.69 -12.0 66.85 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.736 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -117.42 146.85 43.18 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.624 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.18 137.14 44.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.014 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.546 HD12 ' CB ' ' C' ' 43' ' ' LEU . 44.1 mt -72.79 103.17 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.741 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -74.6 135.98 42.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -59.95 136.67 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.67 -18.29 37.96 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -89.52 174.44 7.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.2 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -115.67 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.267 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.499 HD21 HG21 ' C' ' 26' ' ' VAL . 82.0 mt -62.7 -40.19 96.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.801 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.05 -25.94 68.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.29 -30.63 71.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' C' ' 50' ' ' LEU . 59.3 m-85 -100.82 12.82 36.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.42 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 56.7 39.66 29.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.378 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.422 HG21 HD22 ' C' ' 56' ' ' LEU . 48.2 mt -83.93 117.77 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -101.98 175.09 5.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.015 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -59.81 145.46 45.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.753 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 59.13 20.81 8.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.405 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 7.9 m -67.93 133.92 49.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -86.75 120.3 27.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.358 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' C' ' 45' ' ' PHE . 3.7 mp -114.19 147.98 38.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -100.27 129.03 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.55 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.585 HD21 ' HG3' ' C' ' 41' ' ' GLN . 0.6 OUTLIER -104.91 121.26 43.34 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 56' ' ' LEU . 57.7 t -107.07 135.41 45.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.545 ' HG ' HD23 ' C' ' 8' ' ' LEU . 31.1 mt -109.32 142.52 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.64 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 179.763 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.89 156.76 16.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.107 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.619 HD13 HD21 ' D' ' 56' ' ' LEU . 16.8 pt -136.79 150.57 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.415 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.8 m-30 -92.51 121.85 34.37 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.999 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.49 103.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.56 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -89.5 128.66 36.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.528 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.763 HG22 HD23 ' D' ' 69' ' ' LEU . 81.6 p -89.24 -177.36 5.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 111.228 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.692 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.1 mt -63.97 -37.58 87.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -70.02 -10.35 58.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.907 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.59 -10.56 66.78 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.91 130.58 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.252 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 131.38 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -121.93 108.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.415 HG23 ' CD2' ' D' ' 4' ' ' PHE . 19.6 m -81.38 129.69 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.553 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.77 HD21 ' HG3' ' D' ' 33' ' ' LYS . 38.2 mt -127.06 123.19 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -65.73 111.79 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.409 0.623 . . . . 0.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.691 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 18.1 m -135.07 164.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.165 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.27 155.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.452 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.88 -33.69 95.4 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.084 1.856 . . . . 0.0 111.89 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -82.9 -5.6 59.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.529 ' OD2' HG23 ' D' ' 26' ' ' VAL . 35.2 t70 -60.96 133.29 55.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 110.717 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -76.34 161.53 28.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.532 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.916 HD12 HD23 ' D' ' 50' ' ' LEU . 44.0 mm -64.44 -40.34 88.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.22 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.57 -40.04 86.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -61.89 -40.36 95.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.194 0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.878 HG21 HD11 ' D' ' 56' ' ' LEU . 54.6 t -62.24 -44.27 98.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.546 ' HG2' HD23 ' D' ' 43' ' ' LEU . 30.8 mtmt -60.35 -40.79 91.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.814 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.3 93.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.502 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.691 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 90.7 mttt -60.0 -39.97 87.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.637 HD11 HD11 ' D' ' 43' ' ' LEU . 96.4 mt -67.35 -40.67 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.581 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.99 -39.62 82.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.734 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.67 8.55 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.77 ' HG3' HD21 ' D' ' 15' ' ' LEU . 0.0 OUTLIER -109.79 -58.12 2.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.865 0.364 . . . . 0.0 110.595 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.11 0.59 25.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.651 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.37 23.78 77.67 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 20.5 mm -84.07 117.78 69.57 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.901 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.08 150.8 76.87 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.244 1.963 . . . . 0.0 112.291 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.25 -19.74 51.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.301 2.001 . . . . 0.0 112.023 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.9 3.44 41.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -124.71 -54.8 1.64 Allowed 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.84 0.352 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.66 114.13 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.286 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -112.3 124.25 52.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.637 HD11 HD11 ' D' ' 30' ' ' ILE . 4.4 mm? -100.48 119.68 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.69 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 84.4 mt -126.88 126.04 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.731 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 84.4 t80 -125.44 131.53 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.085 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.07 26.23 12.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.447 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.73 16.03 80.47 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.28 130.16 53.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.516 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -67.53 131.99 46.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.916 HD23 HD12 ' D' ' 23' ' ' ILE . 8.0 mp -88.72 97.59 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.04 163.36 27.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.868 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -73.45 163.77 27.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.91 71.2 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -131.24 165.53 23.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.104 0.478 . . . . 0.0 110.776 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -116.74 164.34 14.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.878 HD11 HG21 ' D' ' 26' ' ' VAL . 4.6 mp -59.82 -38.65 82.58 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.97 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -62.09 -29.42 70.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.911 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.3 -30.12 71.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.159 0.504 . . . . 0.0 110.066 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -99.43 11.65 38.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 54.98 40.35 31.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.308 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . 0.62 HD11 HD21 ' D' ' 50' ' ' LEU . 81.5 mt -89.81 115.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -103.87 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.443 0.64 . . . . 0.0 110.887 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -60.43 146.92 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.921 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 61.25 19.83 10.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.2 m -74.84 126.98 32.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.924 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.475 ' C ' HD12 ' D' ' 67' ' ' LEU . 62.1 m -77.71 131.26 37.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.465 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.475 HD12 ' C ' ' D' ' 66' ' ' THR . 7.5 mp -118.63 138.78 52.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.95 110.12 20.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.865 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.763 HD23 HG22 ' D' ' 7' ' ' THR . 63.3 tp -98.15 117.56 32.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' D' ' 8' ' ' LEU . 95.5 t -110.28 132.77 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.517 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.692 ' H ' HD11 ' D' ' 8' ' ' LEU . 41.2 mt . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.968 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.16 112.15 24.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.5 mt -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.92 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.64 161.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.984 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 122.6 0.37 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.54 158.47 38.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.2 mtm-85 -75.34 121.76 22.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.056 0.455 . . . . 0.0 110.713 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.85 146.02 22.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.52 152.24 17.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -91.66 164.46 13.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.952 0.406 . . . . 0.0 111.113 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.4 mtp -132.5 175.27 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.797 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.3 m -125.56 124.09 40.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 37' ' ' THR . 36.6 tp -107.27 119.62 39.9 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.323 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.7 113.78 19.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.952 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -87.78 0.57 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -145.1 21.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.566 0.222 . . . . 0.0 110.723 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.663 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.2 m -123.03 130.53 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.536 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.1 t -106.94 123.15 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.872 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.48 128.03 26.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.62 146.71 39.24 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.765 1.643 . . . . 0.0 112.552 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.55 134.56 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.11 -6.96 46.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -73.14 78.21 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -52.79 134.18 36.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.329 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.54 -165.9 11.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.068 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 27' ' ' ARG . 8.6 tp -134.55 125.91 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.78 109.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.3 p90 -134.04 154.21 51.3 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 137.96 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.584 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.96 131.18 36.89 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.648 0.593 . . . . 0.0 110.399 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.569 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.3 tt0 -100.87 124.97 47.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.22 0.534 . . . . 0.0 109.998 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.4 p -84.46 172.23 11.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.696 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.77 -10.0 24.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.653 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.75 7.49 41.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.482 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 m 63.42 24.41 14.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.434 0.635 . . . . 0.0 110.651 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.569 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 73.8 mt -99.98 121.97 42.17 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.542 HG21 HD23 ' A' ' 128' ' ' LEU . 51.5 mm -81.14 121.23 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.6 m-70 -97.59 113.69 25.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.999 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -93.1 108.35 19.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 82.3 m -120.86 145.83 47.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.747 0.784 . . . . 0.0 112.89 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -127.6 115.22 18.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.154 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -106.63 145.98 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.38 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -84.18 130.73 34.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -70.79 -17.51 62.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -59.21 -45.45 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.543 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.5 m -117.07 -11.54 10.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.44 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.15 21.47 79.2 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -102.56 148.33 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.1 t -76.27 106.01 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.13 -29.87 31.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.109 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -127.74 145.11 51.01 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.308 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.7 p-10 -159.18 100.04 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.764 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.736 HD22 ' HB3' ' C' ' 48' ' ' LYS . 39.9 mt -128.27 133.59 48.8 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.65 119.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.126 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.712 HG21 ' SG ' ' A' ' 80' ' ' CYS . 26.3 mm -110.88 120.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.03 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 47.2 m-85 -82.45 163.21 53.27 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.727 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 141.61 94.8 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.162 1.908 . . . . 0.0 111.728 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.95 12.28 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -85.1 -25.14 27.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.555 0.217 . . . . 0.0 110.875 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.7 p -149.26 167.17 26.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.529 0.68 . . . . 0.0 110.695 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.89 130.67 34.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.353 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.07 119.12 38.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.55 167.12 22.84 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.74 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -82.09 160.44 23.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.107 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.04 89.81 12.44 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 59.99 7.64 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.837 1.691 . . . . 0.0 112.246 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -114.65 -36.5 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.129 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 17.2 p -130.44 75.45 79.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.643 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 130.2 34.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.887 1.725 . . . . 0.0 111.558 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t 168.97 -43.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.919 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.05 -147.74 5.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.6 107.24 14.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 110.535 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.19 129.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 111.088 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.49 156.08 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.55 136.81 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.499 HD11 ' SG ' ' A' ' 80' ' ' CYS . 64.7 tp -103.31 122.36 44.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -118.76 130.9 56.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.073 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.28 115.81 21.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.289 0.566 . . . . 0.0 109.714 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.44 -37.54 87.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.579 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 -22.0 23.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.643 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.55 -171.84 19.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.4 m -117.8 12.67 13.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.622 0.248 . . . . 0.0 110.682 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.652 ' HD3' HD21 ' A' ' 105' ' ' LEU . 26.5 ttmt -83.92 141.59 31.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.932 0.396 . . . . 0.0 110.787 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.19 125.97 25.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.652 HD21 ' HD3' ' A' ' 103' ' ' LYS . 38.0 mt -113.53 151.15 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.002 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 33' ' ' LEU . 96.6 m-85 -124.85 137.27 54.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.352 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.67 155.0 51.11 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.298 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -129.97 136.43 49.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.723 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 tpp -70.3 131.19 43.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.76 -4.86 17.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.022 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.15 149.13 94.66 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.559 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' B' ' 942' ' ' PRO . 58.3 Cg_endo -72.43 -27.14 16.27 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.036 1.824 . . . . 0.0 112.922 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.03 142.72 49.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 110.266 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -98.22 13.95 29.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.57 -20.93 59.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -125.62 11.95 7.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.17 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -63.24 -46.57 86.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.698 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -71.84 -34.37 69.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.357 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.08 -46.21 82.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.407 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.6 m170 -63.23 -41.06 99.05 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.606 0.717 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.99 -45.32 94.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.609 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -64.85 -43.77 91.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.214 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.15 -36.74 84.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 120' ' ' HIS . 58.2 t -59.2 -48.26 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.092 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.7 -29.82 40.83 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.952 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -68.61 -36.58 78.86 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.316 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -81.3 -32.82 32.96 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.554 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.632 HD22 ' HB ' ' A' ' 75' ' ' ILE . 80.6 mt -80.32 -25.25 39.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.284 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -110.12 -20.37 12.71 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.641 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.36 69.13 39.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.487 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.98 159.99 50.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 123.038 2.492 . . . . 0.0 112.382 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -72.27 153.54 92.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.618 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 55.5 Cg_endo -68.79 147.22 68.56 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.609 2.206 . . . . 0.0 112.179 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.96 157.5 87.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.0 139.23 84.53 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.551 2.167 . . . . 0.0 111.939 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.88 -172.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.043 1.828 . . . . 0.0 112.059 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -122.46 158.36 56.38 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.433 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.85 141.53 95.9 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.19 162.25 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.636 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -86.91 139.41 30.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.32 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -123.99 124.31 42.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.112 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.773 179.701 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.75 161.6 9.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.955 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 pt -139.73 146.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.092 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.57 124.85 33.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.79 116.02 51.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.84 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -94.92 118.31 31.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.138 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.29 173.08 10.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.251 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.564 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -46.49 -29.03 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.662 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -101.93 -179.1 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.119 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 -17.66 55.43 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -57.2 130.63 47.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.698 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 76.4 m -128.23 135.97 50.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.937 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.541 HD13 ' HG2' ' C' ' 34' ' ' GLU . 0.0 OUTLIER -126.24 121.06 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -88.94 127.6 35.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' C' ' 29' ' ' LYS . 67.4 mt -119.65 135.28 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.594 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -73.82 118.04 16.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.678 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.577 HG12 ' HE3' ' C' ' 29' ' ' LYS . 30.4 m -135.49 167.03 26.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.72 151.23 42.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.87 -35.87 94.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.818 1.679 . . . . 0.0 112.176 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -87.7 -0.99 57.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.115 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -62.81 137.92 58.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.725 0.298 . . . . 0.0 110.878 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -78.87 163.22 25.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.347 0.594 . . . . 0.0 111.342 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' C' ' 50' ' ' LEU . 48.3 mm -62.75 -37.1 78.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.762 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.35 -41.25 84.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.157 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -64.33 -41.07 96.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 110.594 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.586 HG21 HD21 ' C' ' 56' ' ' LEU . 57.7 t -64.16 -47.36 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.02 -32.49 72.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.87 98.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.423 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.633 ' HB3' HD13 ' C' ' 15' ' ' LEU . 66.8 mttm -60.25 -38.72 84.35 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.742 HD13 HD11 ' C' ' 69' ' ' LEU . 90.1 mt -64.42 -39.15 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -57.3 -43.97 83.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.23 -44.73 95.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.27 -78.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.745 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . 0.541 ' HG2' HD13 ' C' ' 13' ' ' ILE . 79.4 mm-40 -89.1 149.14 23.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.72 56.09 4.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.542 HG22 ' HG3' ' C' ' 41' ' ' GLN . 30.9 mt -106.96 121.87 43.44 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.083 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.24 157.84 52.96 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.477 1.451 . . . . 0.0 111.19 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.8 -38.22 94.71 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.793 1.662 . . . . 0.0 112.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -61.59 -43.37 98.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -85.75 -5.95 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.542 ' HG3' HG22 ' C' ' 36' ' ' ILE . 31.4 mt-30 -87.27 74.91 9.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.151 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -88.58 97.51 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.425 ' CB ' HD12 ' C' ' 50' ' ' LEU . 25.7 mt -87.46 132.71 33.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.142 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.21 129.87 63.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.759 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 85.8 t80 -150.17 150.9 32.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.29 15.1 9.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.297 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.41 -13.6 64.85 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.606 ' CG ' HD22 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -111.9 143.27 43.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.181 -178.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.06 132.3 43.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.684 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' C' ' 59' ' ' TYR . 54.6 mt -72.08 98.45 2.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.79 140.43 43.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.523 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -58.81 140.04 55.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.335 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.12 -17.39 54.19 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -82.88 178.11 8.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.842 0.353 . . . . 0.0 110.427 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 58.9 p -125.66 161.56 26.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.948 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.586 HD21 HG21 ' C' ' 26' ' ' VAL . 83.9 mt -61.27 -41.4 96.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.648 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -64.2 -22.74 67.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.803 0.335 . . . . 0.0 110.397 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -62.85 -36.8 84.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.398 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.433 ' CE2' HD23 ' C' ' 50' ' ' LEU . 73.1 m-85 -98.16 13.94 29.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.196 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.86 39.81 23.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.181 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.428 HG21 HD22 ' C' ' 56' ' ' LEU . 65.5 mt -84.56 117.35 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.962 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -104.43 178.36 4.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.17 143.95 47.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.127 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 60.78 21.08 11.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -70.05 127.84 34.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.436 ' C ' HD12 ' C' ' 67' ' ' LEU . 81.4 m -78.81 128.34 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.436 HD12 ' C ' ' C' ' 66' ' ' THR . 9.1 mp -113.18 151.22 31.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.59 116.76 33.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.444 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.742 HD11 HD13 ' C' ' 30' ' ' ILE . 0.9 OUTLIER -96.32 114.34 26.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.259 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 56' ' ' LEU . 96.0 t -108.78 127.21 65.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.73 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.564 ' HG ' HD23 ' C' ' 8' ' ' LEU . 26.4 mt -88.9 146.65 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.671 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.79 162.86 8.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.93 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.97 151.25 23.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.407 ' CD1' HG23 ' D' ' 14' ' ' THR . 11.7 m-30 -91.36 123.25 34.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.756 HG11 HD11 ' D' ' 30' ' ' ILE . 79.2 t -109.38 105.89 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.384 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -91.83 127.19 37.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.37 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.865 HG22 HD23 ' D' ' 69' ' ' LEU . 73.6 p -87.6 179.17 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.424 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.641 HD11 ' H ' ' D' ' 71' ' ' LEU . 80.8 mt -62.3 -36.22 81.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.817 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -68.79 -12.68 61.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.071 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.16 66.0 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.75 133.52 51.2 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -104.34 131.95 51.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.211 0.529 . . . . 0.0 110.507 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -121.02 113.44 39.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.625 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.407 HG23 ' CD1' ' D' ' 4' ' ' PHE . 14.0 m -83.98 124.7 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.118 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.583 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.9 mt -120.05 128.73 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.309 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.15 116.98 12.08 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 110.585 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.435 HG12 ' HD2' ' D' ' 29' ' ' LYS . 24.4 m -135.39 166.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.012 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.06 153.29 47.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 -29.0 85.75 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.641 1.56 . . . . 0.0 111.912 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 60.3 m -87.47 -9.74 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.705 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -64.32 142.37 58.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 45.7 p -82.19 166.12 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.742 ' CD1' HD12 ' D' ' 50' ' ' LEU . 37.0 mm -63.04 -36.58 76.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.773 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.04 90.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.989 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.36 -41.23 98.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.679 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 67.4 t -63.79 -43.35 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.838 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.536 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.54 90.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.286 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.435 ' HD2' HG12 ' D' ' 17' ' ' VAL . 67.2 mttm -60.39 -39.49 87.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.756 HD11 HG11 ' D' ' 5' ' ' VAL . 8.8 mm -64.83 -40.8 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.235 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.447 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.03 -40.81 98.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.583 ' HD2' HD21 ' D' ' 15' ' ' LEU . 45.1 mttt -76.8 -71.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.88 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.45 152.98 19.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 55.97 4.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.643 HG22 ' HG3' ' D' ' 41' ' ' GLN . 32.7 mm -107.23 109.85 63.02 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.88 153.31 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.084 1.856 . . . . 0.0 111.51 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.85 -37.91 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.849 1.7 . . . . 0.0 112.233 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.15 -39.38 89.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -12.5 40.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.643 ' HG3' HG22 ' D' ' 36' ' ' ILE . 20.0 mt-30 -78.99 86.04 4.89 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.875 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . 0.482 ' HD3' HD11 ' D' ' 44' ' ' ILE . 61.4 ttm-85 -97.44 115.27 27.44 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.71 118.1 36.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.482 HD11 ' HD3' ' D' ' 42' ' ' ARG . 83.2 mt -125.09 127.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.474 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' D' ' 67' ' ' LEU . 40.8 t80 -119.1 127.24 53.19 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.46 26.35 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.15 2.71 90.6 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.411 ' C ' HG23 ' D' ' 44' ' ' ILE . 43.3 ttm180 -112.86 121.84 45.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.013 0.407 . . . . 0.0 110.335 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -60.25 142.98 53.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.041 0.448 . . . . 0.0 110.388 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.742 HD12 ' CD1' ' D' ' 23' ' ' ILE . 4.0 mm? -78.09 123.85 27.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.063 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.92 138.67 50.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.69 129.96 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.093 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.91 -14.64 61.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.41 174.15 10.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -117.95 160.87 20.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.61 -39.87 92.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -63.88 -23.9 67.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.308 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -62.13 -37.6 85.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.295 0.569 . . . . 0.0 110.202 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -98.11 13.95 29.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.374 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 55.93 40.09 30.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.273 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -85.47 105.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.68 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -88.99 -172.82 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.434 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.55 149.58 49.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.316 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 57.5 42.39 24.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -89.87 121.43 31.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.965 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.455 ' O ' HD22 ' D' ' 67' ' ' LEU . 67.3 m -71.33 127.57 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.455 HD22 ' O ' ' D' ' 66' ' ' THR . 3.0 mm? -117.41 139.53 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.173 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -88.22 105.35 17.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.865 HD23 HG22 ' D' ' 7' ' ' THR . 67.3 tp -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.475 ' HA ' HD21 ' D' ' 8' ' ' LEU . 98.4 t -108.83 133.46 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.115 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.641 ' H ' HD11 ' D' ' 8' ' ' LEU . 25.7 mt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.427 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.4 pttp . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.895 0.378 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -94.88 128.77 41.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 109.897 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 51' ' ' GLN . 85.7 mt -69.78 -36.31 75.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.435 HG12 ' CG1' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -147.61 160.92 7.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.504 178.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -174.2 122.21 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.41 159.85 40.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.139 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -77.37 117.8 19.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.554 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.99 142.17 22.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.26 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.39 154.15 17.56 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -93.61 176.32 6.41 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.773 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.7 mtp -139.84 172.88 12.15 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.13 124.76 44.64 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 37' ' ' THR . 48.5 tp -105.38 117.08 33.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.015 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -120.42 116.64 25.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.598 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 -85.76 0.36 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.56 22.04 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.576 0.227 . . . . 0.0 110.714 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.583 ' O ' HD12 ' A' ' 33' ' ' LEU . 93.6 m -122.97 130.13 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.888 0.375 . . . . 0.0 110.559 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 33' ' ' LEU . 59.3 t -103.4 122.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.667 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 p -112.55 120.85 40.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.37 141.34 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.029 1.819 . . . . 0.0 112.348 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -98.08 116.27 29.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.46 -15.05 14.94 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.142 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -74.57 73.63 1.97 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.541 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -54.15 140.94 30.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.754 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.26 -156.49 7.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.002 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 27' ' ' ARG . 7.4 tp -135.22 125.66 26.67 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.95 109.14 23.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.314 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.23 154.55 49.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.273 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.0 mt -120.79 139.07 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.562 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.03 128.19 27.88 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.764 0.665 . . . . 0.0 110.485 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.67 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.6 tt0 -98.63 124.93 43.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.072 0.463 . . . . 0.0 109.936 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.7 p -85.33 172.46 11.07 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.56 -10.17 24.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.766 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.18 7.92 40.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.296 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.7 m 62.3 25.95 15.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.261 0.553 . . . . 0.0 110.623 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.639 HD11 HG11 ' C' ' 70' ' ' VAL . 73.3 mt -100.21 120.79 40.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.53 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -81.46 120.25 32.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -96.58 113.89 25.49 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.531 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -97.43 107.09 19.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 143.32 50.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.889 0.852 . . . . 0.0 112.861 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -119.44 117.39 28.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.51 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -106.69 144.02 33.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.375 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -81.81 130.26 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -72.59 -17.59 61.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.05 0.452 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -59.21 -45.41 91.17 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -117.16 -12.42 10.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.307 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.94 23.58 77.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -102.07 152.31 21.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.81 101.97 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.215 0.531 . . . . 0.0 110.451 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.41 -38.1 65.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.125 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -126.4 145.52 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.285 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.445 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.6 t0 -158.26 98.18 1.55 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.143 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.606 HD22 ' CG ' ' C' ' 48' ' ' LYS . 42.5 mt -125.34 136.62 53.65 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.84 118.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.696 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.4 mm -109.15 120.41 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.196 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.557 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 40.8 m-85 -82.59 163.24 52.81 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.598 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.02 141.08 96.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.498 2.132 . . . . 0.0 111.745 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t0 59.86 11.81 2.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.419 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.12 -29.38 28.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.727 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 75' ' ' ILE . 18.6 p -148.03 168.7 21.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.411 0.624 . . . . 0.0 110.783 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.17 130.94 36.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.354 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -100.96 118.83 37.75 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.92 168.03 20.71 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.645 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -83.24 157.68 22.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.45 88.88 9.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.56 60.17 7.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.831 1.687 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -114.28 -36.55 4.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.283 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -130.25 81.93 67.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.71 130.36 27.69 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.762 1.641 . . . . 0.0 111.817 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.0 -38.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.819 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.05 -153.25 6.08 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.14 106.59 15.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.1 t -125.8 129.57 72.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.02 154.43 39.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.434 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.83 136.75 59.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.943 0.402 . . . . 0.0 110.44 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.561 HD11 ' SG ' ' A' ' 80' ' ' CYS . 68.1 tp -102.98 121.37 42.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -118.51 132.24 56.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.048 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -82.96 115.21 21.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.302 0.572 . . . . 0.0 109.515 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.97 -37.64 87.94 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.36 -22.85 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.465 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.94 -171.74 20.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.9 m -119.52 13.95 12.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.566 0.222 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.72 ' HD3' HD21 ' A' ' 105' ' ' LEU . 24.0 ttmt -86.55 141.14 29.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.004 0.431 . . . . 0.0 111.085 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -133.77 129.02 36.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.082 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.72 HD21 ' HD3' ' A' ' 103' ' ' LYS . 42.5 mt -115.59 147.57 40.6 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.786 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' CE1' HD22 ' A' ' 33' ' ' LEU . 92.2 m-85 -119.84 135.88 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.564 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.82 155.13 50.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -130.57 137.5 49.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.342 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.2 mmm -73.59 138.83 45.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.32 6.29 32.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.728 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.9 141.07 58.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.06 -26.3 26.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.945 1.763 . . . . 0.0 112.459 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.51 142.62 48.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.33 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.3 p -95.08 9.02 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.495 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.2 -20.36 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.21 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -126.38 -9.67 6.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.839 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.98 -40.64 98.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 110.719 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -69.93 -35.89 74.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.58 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.12 -42.99 88.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.756 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.4 m170 -63.96 -38.67 91.94 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.997 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.95 -46.03 92.36 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.031 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.46 -43.92 95.96 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.23 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.78 -38.23 87.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 120' ' ' HIS . 57.1 t -58.38 -48.29 85.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.232 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.49 -28.84 41.46 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.934 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.38 -38.1 81.05 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.604 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.2 -32.42 33.52 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.2 mt -79.02 -26.12 43.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -110.36 -21.03 12.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.82 67.7 42.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.371 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.11 158.42 56.56 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.984 2.456 . . . . 0.0 112.29 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.217 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.22 148.66 95.88 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.533 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.25 147.29 25.9 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.713 2.275 . . . . 0.0 112.089 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.91 155.87 90.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.74 151.11 69.12 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.059 1.839 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.74 -172.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.134 1.889 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -122.38 155.82 61.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.0 141.36 88.89 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.083 1.855 . . . . 0.0 112.073 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.82 163.45 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.739 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -86.58 138.73 31.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.379 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.78 127.64 46.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.073 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.403 ' N ' HD12 ' B' ' 951' ' ' ILE . 3.0 mp . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.635 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.85 163.84 11.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.519 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.66 143.45 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.519 ' HD2' HG21 ' C' ' 12' ' ' THR . 6.3 m-85 -87.46 122.07 30.72 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.754 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.2 t -106.63 113.3 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.963 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -97.55 120.86 38.69 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.771 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.828 HG22 HD23 ' C' ' 69' ' ' LEU . 76.9 p -82.06 171.23 14.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.595 HD11 ' H ' ' C' ' 71' ' ' LEU . 55.9 mt -64.85 -25.08 67.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.907 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -74.23 -9.27 58.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.86 -10.05 70.47 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -73.19 133.21 43.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . 0.519 HG21 ' HD2' ' C' ' 4' ' ' PHE . 95.7 m -107.3 132.19 53.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.79 111.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.655 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -83.32 127.9 34.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.5 mt -120.41 132.43 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.21 117.52 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.484 HG12 ' HE3' ' C' ' 29' ' ' LYS . 27.5 m -135.72 163.23 35.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.714 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -103.93 152.04 38.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.86 -35.7 94.3 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.973 1.782 . . . . 0.0 112.148 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.28 -3.11 58.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -61.86 137.57 58.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.961 0.41 . . . . 0.0 110.704 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -78.29 162.87 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.483 HD12 HD13 ' C' ' 50' ' ' LEU . 47.9 mm -64.53 -38.11 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.864 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.36 -42.11 90.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.032 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.06 -40.74 96.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.196 0.522 . . . . 0.0 110.519 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.508 HG21 HD21 ' C' ' 56' ' ' LEU . 61.3 t -63.31 -42.72 97.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.659 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.73 -40.09 91.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.5 90.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.254 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.484 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.89 -38.78 83.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.764 ' CD1' HD21 ' C' ' 43' ' ' LEU . 95.0 mt -66.74 -38.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.434 0.635 . . . . 0.0 110.359 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.39 -46.67 88.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.221 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.62 -31.24 68.13 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.481 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -89.8 -4.33 57.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -147.95 -41.64 0.17 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.45 11.77 28.37 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.309 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.577 HG22 ' HG3' ' C' ' 41' ' ' GLN . 59.5 mt -75.79 121.09 84.39 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.42 154.54 63.42 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.496 1.464 . . . . 0.0 111.495 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.18 -31.19 94.9 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.937 1.758 . . . . 0.0 112.771 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -64.99 -40.22 94.63 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.905 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.32 -7.48 57.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.956 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.577 ' HG3' HG22 ' C' ' 36' ' ' ILE . 91.4 mt-30 -87.04 105.98 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.155 0.502 . . . . 0.0 111.536 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -116.51 99.11 6.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.175 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.764 HD21 ' CD1' ' C' ' 30' ' ' ILE . 75.6 mt -86.4 131.18 34.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.25 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.503 HG21 ' HE1' ' A' ' 76' ' ' PHE . 85.5 mt -131.36 127.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.695 0.283 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 67.7 t80 -149.17 150.87 33.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.127 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.82 16.41 9.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.46 -14.36 59.82 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.778 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -113.44 144.34 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.965 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.25 135.08 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.006 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' C' ' 43' ' ' LEU . 52.9 mt -71.64 105.44 3.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.781 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -75.22 139.03 42.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.41 138.55 57.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.41 55.84 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -82.04 172.55 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.4 p -118.26 161.69 19.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.579 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.508 HD21 HG21 ' C' ' 26' ' ' VAL . 84.1 mt -61.69 -40.46 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.983 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -63.85 -23.46 67.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.3 -37.6 86.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.134 0.492 . . . . 0.0 110.184 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.39 13.19 28.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.201 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.77 40.26 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.78 114.63 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.942 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -100.2 -179.6 4.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.845 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.75 146.19 53.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 59.24 17.45 5.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -70.6 132.62 45.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -82.81 128.6 34.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.96 140.24 49.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.852 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.01 117.44 28.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.954 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.828 HD23 HG22 ' C' ' 7' ' ' THR . 57.2 tp -100.43 121.42 41.51 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.009 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.712 HG11 HD11 ' A' ' 56' ' ' LEU . 62.5 t -111.98 132.57 60.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.066 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.595 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.9 mt -109.36 145.66 35.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.093 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -68.74 142.12 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.623 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.88 -39.55 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 53.85 42.25 31.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.28 179.29 46.61 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.66 -179.26 47.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 p30 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.73 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.76 163.51 13.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.299 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 pt -143.94 145.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.535 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -92.88 121.53 34.33 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.672 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -104.73 104.63 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.42 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -87.54 126.7 35.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.846 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.807 HG22 HD23 ' D' ' 69' ' ' LEU . 79.2 p -77.52 -171.86 2.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.854 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' D' ' 70' ' ' VAL . 88.8 mt -59.09 -19.88 48.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.673 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 22.2 p -111.15 -176.37 2.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.95 -18.45 57.21 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.76 131.04 38.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.082 0.468 . . . . 0.0 110.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -125.08 136.91 54.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.499 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.39 104.99 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.837 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -83.26 129.07 34.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' D' ' 29' ' ' LYS . 77.0 mt -124.51 131.97 53.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -76.63 116.56 17.42 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.343 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.735 HG12 ' HE3' ' D' ' 29' ' ' LYS . 27.3 m -135.15 161.7 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.65 152.71 40.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.02 -29.62 83.59 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.614 1.543 . . . . 0.0 111.791 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.7 p -80.97 -12.6 59.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.839 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.03 144.72 57.09 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.909 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 32.4 p -85.71 165.35 17.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.21 0.528 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.434 HD12 HD13 ' D' ' 50' ' ' LEU . 47.1 mm -62.79 -38.1 80.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.04 88.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.692 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.63 -41.07 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 110.345 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.523 HG21 HD21 ' D' ' 56' ' ' LEU . 63.2 t -63.4 -42.3 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -61.1 -40.55 94.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 110.202 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.87 89.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.905 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.735 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.1 mttm -59.75 -38.26 81.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.788 ' CD1' HD21 ' D' ' 43' ' ' LEU . 85.6 mt -64.24 -39.92 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' D' ' 35' ' ' GLY . 65.9 tt0 -60.35 -44.78 95.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.25 0.548 . . . . 0.0 110.134 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.48 -41.06 98.59 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.622 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.45 ' HD2' HD21 ' D' ' 15' ' ' LEU . 18.0 mttm -83.52 -14.53 52.08 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -136.36 -50.04 0.68 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 113.37 9.5 17.32 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.565 HD13 ' CD2' ' D' ' 71' ' ' LEU . 59.6 mt -78.08 125.69 84.82 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.59 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.99 159.95 50.87 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 120.917 1.078 . . . . 0.0 109.88 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.49 -40.41 78.82 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.165 1.91 . . . . 0.0 112.864 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.79 -44.37 96.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.65 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.65 -40.16 80.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.893 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.577 ' OE1' HD12 ' D' ' 30' ' ' ILE . 24.1 pt20 -85.57 140.71 30.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.206 0.527 . . . . 0.0 111.383 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . 0.552 HH21 HG11 ' D' ' 70' ' ' VAL . 61.3 mtm180 -130.25 118.96 22.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.788 HD21 ' CD1' ' D' ' 30' ' ' ILE . 74.3 mt -96.22 118.14 32.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.134 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 81.5 mt -124.22 127.52 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 68.6 t80 -123.67 128.59 49.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.259 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 64.81 26.75 12.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.502 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.48 13.2 83.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -121.72 127.44 50.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.23 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -62.43 135.37 57.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 0.0 110.476 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' D' ' 43' ' ' LEU . 84.5 mt -80.57 103.87 10.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.154 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.66 143.99 49.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.401 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -67.49 167.07 13.48 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.424 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 18.37 79.22 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -128.87 148.83 50.93 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.2 p -90.9 165.31 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.523 HD21 HG21 ' D' ' 26' ' ' VAL . 81.2 mt -62.79 -38.39 90.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.394 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -62.54 -25.55 68.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.243 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -36.55 81.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.095 0.474 . . . . 0.0 110.156 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.32 14.42 24.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 56.42 39.27 30.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.19 104.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.01 -175.03 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.344 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -67.53 150.16 49.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.101 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 58.06 30.09 18.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.813 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 31.1 m -81.2 128.01 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 30.8 m -85.76 122.47 29.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.7 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.17 145.82 36.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.45 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -89.91 115.85 27.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.807 HD23 HG22 ' D' ' 7' ' ' THR . 49.8 tp -100.85 118.54 37.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' D' ' 8' ' ' LEU . 96.9 t -116.02 130.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.872 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.565 ' CD2' HD13 ' D' ' 36' ' ' ILE . 48.8 mt -103.91 139.78 38.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.674 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -69.85 -174.55 0.77 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.484 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.557 HD23 ' CE ' ' C' ' 48' ' ' LYS . 1.1 mp -64.3 120.13 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.12 0.486 . . . . 0.0 110.649 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -80.45 149.79 29.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.618 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.79 49.88 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.398 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.363 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -84.14 149.93 25.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.105 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.68 112.05 23.86 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.5 mt -65.97 -38.69 89.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.621 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.4 p -148.84 163.48 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.668 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -173.7 122.18 0.34 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.187 0.518 . . . . 0.0 110.855 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.07 156.61 37.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.378 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -72.29 125.04 26.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.081 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -159.13 143.26 15.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.549 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.68 163.11 12.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -96.57 171.9 8.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.239 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.0 mtp -136.95 174.94 10.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -124.33 128.85 49.73 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.524 HD22 ' CE1' ' A' ' 106' ' ' PHE . 36.3 tp -108.15 116.89 32.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.179 0.514 . . . . 0.0 110.193 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.65 111.34 18.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.397 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.22 0.37 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -142.41 20.34 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.856 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.498 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.3 m -120.25 129.27 53.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.769 0.319 . . . . 0.0 110.485 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.0 t -107.95 122.29 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.032 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.6 p -114.47 131.37 23.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.38 147.57 52.99 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.744 1.629 . . . . 0.0 112.996 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -100.78 133.92 44.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -70.73 -12.46 61.57 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.008 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -76.34 68.97 2.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -58.88 134.41 56.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.9 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.11 -150.57 7.15 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.223 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 27' ' ' ARG . 2.7 tp -137.51 126.64 24.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 28' ' ' ALA . 48.8 t -97.65 112.7 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.07 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -134.52 155.0 51.16 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.3 mt -118.61 136.62 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.698 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.75 129.61 32.83 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 123.495 0.497 . . . . 0.0 110.463 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.486 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.4 tt0 -99.24 125.34 44.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 110.301 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.516 HG23 ' CD2' ' A' ' 58' ' ' HIS . 18.9 p -86.23 170.12 12.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.423 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -61.95 -10.56 9.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.296 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.77 0.83 56.13 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.472 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.76 19.93 7.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.255 0.55 . . . . 0.0 110.48 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.712 HD11 HG11 ' C' ' 70' ' ' VAL . 83.4 mt -98.49 123.34 42.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.6 mm -80.85 123.74 37.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.516 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.5 m-70 -99.38 114.76 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.978 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -93.16 107.69 19.44 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.4 m -120.65 148.22 44.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.717 0.77 . . . . 0.0 113.036 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -127.83 115.24 18.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.175 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.52 131.74 53.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.932 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -72.11 134.37 45.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.63 -17.42 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.942 0.401 . . . . 0.0 110.428 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -60.03 -45.65 92.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.694 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.0 p -116.37 -16.77 10.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.131 0.491 . . . . 0.0 109.871 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.67 22.15 75.57 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -100.46 152.26 20.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.08 104.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.851 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -82.13 -29.78 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.354 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -126.71 146.29 50.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.408 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.74 ' O ' HD23 ' A' ' 73' ' ' LEU . 68.5 t0 -157.56 101.26 1.83 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.856 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.778 HD22 ' HB3' ' C' ' 48' ' ' LYS . 13.8 mt -130.95 128.88 41.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.427 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.427 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -75.23 124.83 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.606 HG21 ' SG ' ' A' ' 80' ' ' CYS . 24.4 mm -114.0 122.23 67.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.631 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 65.5 m-85 -88.44 162.92 38.17 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.586 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.87 138.54 86.29 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.202 1.934 . . . . 0.0 111.831 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 62.05 6.2 1.68 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.754 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -71.68 -37.64 70.72 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.683 0.277 . . . . 0.0 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 96' ' ' LEU . 19.7 p -146.81 167.08 24.77 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.732 0.777 . . . . 0.0 111.019 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -128.52 128.94 45.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.324 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -99.04 118.53 36.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -143.64 165.55 27.3 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.913 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -79.53 160.29 26.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.62 90.36 12.45 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.109 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.59 59.75 7.54 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.812 1.675 . . . . 0.0 112.381 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.0 -39.76 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.321 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.5 p -127.82 75.45 78.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.478 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.04 130.01 30.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.981 1.788 . . . . 0.0 111.474 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.43 -44.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.662 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.38 -148.32 6.53 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -116.1 106.37 13.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.97 127.82 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -123.73 155.09 38.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.692 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 105' ' ' LEU . 13.1 p -129.75 138.37 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.089 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' A' ' 80' ' ' CYS . 67.8 tp -104.78 121.24 43.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -117.79 121.64 41.33 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.172 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.491 ' HE2' HD12 ' A' ' 75' ' ' ILE . 59.1 m-85 -80.68 112.3 17.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.52 -36.21 77.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.695 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.1 -17.71 14.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.397 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -85.89 -13.9 68.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.576 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 53.2 31.46 11.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.09 0.445 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 98' ' ' PHE . 12.1 ttmm -120.75 145.73 47.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.249 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -127.06 127.93 45.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.089 0.471 . . . . 0.0 111.532 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 95' ' ' VAL . 48.9 mt -119.32 149.14 42.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.62 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.524 ' CE1' HD22 ' A' ' 33' ' ' LEU . 91.2 m-85 -123.61 134.96 53.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.558 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.23 155.43 50.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.38 0.61 . . . . 0.0 111.322 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -129.01 136.23 50.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.183 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.5 mtp -81.29 138.4 35.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.227 0.537 . . . . 0.0 111.51 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.91 5.3 49.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.669 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.95 130.96 89.45 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.183 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.6 -24.83 41.29 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.692 1.595 . . . . 0.0 112.686 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.4 143.24 48.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.453 HG22 ' HG2' ' A' ' 92' ' ' ARG . 74.4 p -95.68 11.45 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.02 -20.62 58.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.496 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -122.81 9.28 9.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.067 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -62.85 -45.69 91.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.41 -32.82 73.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.415 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.48 -46.69 81.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.41 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.657 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.1 m170 -64.54 -40.81 96.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 109.626 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.1 t -63.1 -44.27 96.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.262 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -69.8 -41.33 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.241 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.54 -42.71 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.378 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.6 t -57.77 -48.26 84.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.917 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.824 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.12 -20.68 63.17 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.549 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 23.3 m-85 -94.41 -18.2 21.77 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.746 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 124' ' ' VAL . 86.3 mt -95.62 -24.64 16.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.096 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -118.72 -12.25 9.71 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.271 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.15 64.71 55.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.122 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.23 152.67 75.78 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.492 1.394 0 C-N-CA 122.245 1.963 . . . . 0.0 111.872 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -129.13 148.6 69.73 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.635 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.46 146.71 27.89 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.606 2.204 . . . . 0.0 112.194 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -73.41 153.03 90.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.45 154.0 65.34 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.938 1.759 . . . . 0.0 112.139 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.65 -170.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.336 2.024 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -126.43 159.02 65.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.197 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.41 139.9 87.79 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.457 2.105 . . . . 0.0 112.331 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.41 163.6 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.604 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -86.44 134.3 33.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -118.72 131.39 56.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.98 132.82 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -76.38 85.07 3.13 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.091 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.754 179.767 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -63.95 158.92 21.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.237 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.34 148.82 24.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.114 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -91.37 120.99 32.7 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.285 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.63 110.22 29.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -98.27 121.29 40.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.638 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -82.2 173.83 11.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.526 HD11 ' H ' ' C' ' 71' ' ' LEU . 74.3 mt -61.65 -30.35 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -71.25 -12.15 61.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.13 -13.98 62.87 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.43 131.86 49.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 110.364 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 95.3 m -108.93 131.03 55.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.924 0.392 . . . . 0.0 110.374 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.03 114.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.474 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 29.1 m -81.32 129.98 34.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.347 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.61 127.32 48.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -71.3 115.26 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.452 HG12 ' CD ' ' C' ' 29' ' ' LYS . 25.7 m -135.37 163.49 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.634 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -106.34 152.86 40.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.98 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.35 -37.23 94.8 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.119 1.879 . . . . 0.0 112.229 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -83.84 -4.92 59.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.063 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -59.72 136.97 58.16 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.953 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -77.58 161.75 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.2 mm -63.91 -38.99 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.236 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.13 -42.02 89.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.27 -41.04 98.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.145 0.498 . . . . 0.0 110.619 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 56' ' ' LEU . 54.1 t -63.19 -43.45 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.77 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.63 -39.97 90.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.237 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.452 ' CD ' HG12 ' C' ' 17' ' ' VAL . 67.5 mttm -60.55 -39.68 88.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.637 HG21 HD11 ' C' ' 69' ' ' LEU . 95.7 mt -66.28 -39.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.308 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.57 -40.99 93.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.32 -39.6 92.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.151 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -74.86 -64.39 1.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.712 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.17 170.93 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.219 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.26 21.12 26.31 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.679 HG22 ' HG3' ' C' ' 41' ' ' GLN . 27.3 mm -77.03 117.49 65.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.851 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.77 156.27 57.26 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.299 1.999 . . . . 0.0 111.797 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.07 -39.3 70.6 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.071 1.847 . . . . 0.0 112.526 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.13 -39.59 93.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.681 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.39 -3.51 56.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.114 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.679 ' HG3' HG22 ' C' ' 36' ' ' ILE . 17.7 mt-30 -87.42 68.04 9.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.61 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' C' ' 70' ' ' VAL . 94.0 mtt-85 -85.53 110.72 19.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.55 ' HB2' HD12 ' C' ' 50' ' ' LEU . 25.9 mt -98.78 132.58 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.815 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.64 129.62 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 110.525 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.66 151.65 40.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.984 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.88 15.56 6.11 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.34 -14.25 63.0 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.678 ' CG ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -107.2 140.71 39.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.56 133.88 44.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' C' ' 43' ' ' LEU . 48.6 mt -72.22 102.2 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.891 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -75.3 140.12 42.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.83 137.94 57.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.216 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.47 -17.78 52.58 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmp_? -83.49 177.7 8.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.337 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -125.24 163.21 23.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.109 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 26' ' ' VAL . 85.4 mt -61.54 -40.93 96.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.552 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.83 -24.41 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.78 -37.93 86.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.2 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -96.72 13.88 26.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.509 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.79 39.34 27.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.41 . . . . 0.0 110.264 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.414 HG21 HD22 ' C' ' 56' ' ' LEU . 63.2 mt -85.54 118.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.069 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -106.87 -179.18 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.686 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -61.97 146.14 50.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.935 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.6 15.63 9.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.618 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.8 m -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.545 ' C ' HD12 ' C' ' 67' ' ' LEU . 88.3 m -82.54 129.77 34.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.064 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.545 HD12 ' C ' ' C' ' 66' ' ' THR . 9.9 mp -114.89 144.31 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.127 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -95.83 118.14 31.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.231 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.637 HD11 HG21 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -96.82 123.32 40.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 56' ' ' LEU . 66.4 t -114.49 126.95 72.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.947 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.526 ' H ' HD11 ' C' ' 8' ' ' LEU . 15.7 mt -98.45 -174.25 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.405 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -129.16 153.06 48.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.332 . . . . 0.0 110.527 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -109.1 142.96 39.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.564 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -100.63 125.71 47.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.55 -170.18 54.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -171.97 53.49 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.632 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -63.21 154.83 30.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.078 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -133.9 160.72 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.321 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.623 ' CD2' HG23 ' D' ' 14' ' ' THR . 12.9 m-30 -101.59 125.71 48.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.615 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.47 HG21 HD12 ' D' ' 15' ' ' LEU . 78.5 t -111.56 107.15 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.898 0.38 . . . . 0.0 111.008 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -85.2 129.23 34.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.679 HG22 HD23 ' D' ' 69' ' ' LEU . 68.5 p -90.18 176.6 6.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 110.961 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.648 HD11 ' H ' ' D' ' 71' ' ' LEU . 90.1 mt -60.65 -37.37 81.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -74.68 -8.22 55.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.75 67.37 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -63.29 126.59 27.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.059 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 92.3 m -96.21 136.88 36.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 0.0 110.611 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -122.3 118.18 54.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.278 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.623 HG23 ' CD2' ' D' ' 4' ' ' PHE . 0.2 OUTLIER -83.41 125.14 31.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.061 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 29' ' ' LYS . 90.5 mt -123.26 113.11 18.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.94 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -65.78 106.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.242 0.544 . . . . 0.0 110.853 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.658 HG12 ' HE3' ' D' ' 29' ' ' LYS . 32.7 m -130.61 163.2 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.639 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -105.76 155.09 38.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.58 -37.24 97.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.174 1.916 . . . . 0.0 111.981 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -83.42 -5.22 59.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.976 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -59.15 138.06 57.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.995 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -79.65 161.35 25.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.944 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -64.02 -38.37 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.755 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.77 -41.59 86.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.817 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.17 -41.4 98.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 110.714 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.406 HG22 HG11 ' D' ' 17' ' ' VAL . 65.9 t -64.19 -42.73 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.1 mtmt -60.52 -39.8 89.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.406 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.63 92.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.511 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.681 ' HB3' HD22 ' D' ' 15' ' ' LEU . 66.8 mttm -59.82 -40.06 87.14 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.62 -39.62 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.338 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.17 -42.42 90.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.678 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -90.69 19.73 5.21 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -122.52 -39.56 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -126.11 -6.99 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.315 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.77 18.87 76.6 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.675 ' CD1' HD21 ' D' ' 69' ' ' LEU . 70.8 mt -77.05 120.56 82.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 147.84 92.36 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.341 2.027 . . . . 0.0 111.727 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 -41.76 62.97 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.943 1.762 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.11 -32.02 72.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.9 -10.24 58.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.466 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.625 ' HG3' HG22 ' D' ' 36' ' ' ILE . 89.2 mt-30 -88.88 112.97 23.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.601 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -115.74 101.42 8.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' D' ' 27' ' ' LYS . 10.0 mt -94.66 118.48 31.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.2 mt -125.99 123.08 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.116 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -113.42 122.83 48.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.15 30.11 19.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.473 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.46 89.99 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -103.41 119.11 38.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -64.11 138.64 58.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' D' ' 43' ' ' LEU . 49.3 mt -90.5 105.34 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.33 153.32 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.728 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -72.37 161.21 31.14 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.063 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.25 0.89 84.69 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.01 176.98 4.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.707 0.289 . . . . 0.0 110.45 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -126.16 164.42 20.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.406 HD21 HG21 ' D' ' 26' ' ' VAL . 91.1 mt -62.24 -39.79 94.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.743 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -63.27 -29.52 70.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 0.0 110.923 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.78 -32.17 72.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.46 14.19 30.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.215 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 55.83 39.93 30.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.817 0.341 . . . . 0.0 110.542 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.35 105.01 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.817 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.26 -177.04 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.436 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -61.08 148.76 39.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.085 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 56.96 47.7 17.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 45.8 m -104.62 124.45 49.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.318 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.537 ' C ' HD12 ' D' ' 67' ' ' LEU . 94.4 m -74.66 130.73 40.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.537 HD12 ' C ' ' D' ' 66' ' ' THR . 7.9 mp -121.25 145.68 47.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -91.16 111.19 22.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.923 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.679 HD23 HG22 ' D' ' 7' ' ' THR . 64.4 tp -98.28 118.03 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.531 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.3 t -115.84 135.61 55.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.071 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.648 ' H ' HD11 ' D' ' 8' ' ' LEU . 49.0 mt -101.77 150.42 23.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.528 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -111.1 140.05 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.249 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mp -98.05 142.32 29.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -107.87 107.14 17.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.346 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.31 -132.67 52.67 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.67 157.99 33.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.083 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -97.05 126.18 42.02 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.332 0.587 . . . . 0.0 109.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 51' ' ' GLN . 86.3 mt -68.24 -38.58 81.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.092 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -145.64 161.45 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.88 179.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.7 122.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.23 158.98 41.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.071 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.75 121.21 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.945 0.402 . . . . 0.0 111.004 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.77 145.0 22.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.27 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.86 153.15 17.28 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -88.2 173.95 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.977 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.5 mtp -136.93 175.47 9.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.9 m -124.23 124.56 42.71 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.473 HD13 ' CG2' ' A' ' 38' ' ' VAL . 25.8 tp -106.35 116.94 32.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.47 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -120.02 110.53 16.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.795 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -90.46 0.47 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 p -140.18 23.09 2.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.608 0.242 . . . . 0.0 110.745 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.0 m -125.06 129.82 51.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.655 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.473 ' CG2' HD13 ' A' ' 33' ' ' LEU . 61.2 t -110.99 122.72 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.3 m -118.74 129.08 25.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.05 146.48 64.75 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.692 1.594 . . . . 0.0 113.183 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.93 136.32 39.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.791 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -71.16 -8.73 55.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.639 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.87 77.32 0.89 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -58.08 134.23 56.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.96 -160.79 9.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.679 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.7 tp -137.41 123.98 20.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -95.48 109.91 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.249 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -131.32 154.98 47.98 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.191 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -120.45 140.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.454 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.77 128.17 26.39 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.827 0.705 . . . . 0.0 110.35 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.75 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.7 tt0 -99.5 124.4 44.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 58' ' ' HIS . 10.7 p -84.63 172.14 11.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.65 -10.56 27.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.93 1.54 55.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.561 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t 70.24 21.05 6.01 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.309 0.576 . . . . 0.0 110.432 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.672 HD11 HG11 ' C' ' 70' ' ' VAL . 75.5 mt -98.76 121.56 40.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.622 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -80.22 121.23 33.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.461 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 52' ' ' THR . 70.2 m-70 -97.65 114.25 26.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.614 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -97.59 107.05 19.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.06 50.29 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.782 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -117.82 116.06 26.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.571 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -105.55 144.95 31.6 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.416 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.41 130.89 35.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.15 -18.69 62.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 110.755 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.1 m -59.41 -45.49 91.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.608 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.4 m -117.06 -11.85 10.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.972 0.415 . . . . 0.0 110.496 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 22.77 78.77 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.37 149.94 23.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.669 0.271 . . . . 0.0 110.448 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.58 102.19 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.07 -38.76 66.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.836 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -126.37 146.17 50.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.069 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.8 t0 -157.9 100.8 1.76 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.678 HD22 ' CG ' ' C' ' 48' ' ' LYS . 35.0 mt -126.86 135.93 51.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.976 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.2 mt -77.96 120.51 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.225 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.699 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.4 mm -110.5 121.48 63.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.236 0.541 . . . . 0.0 111.153 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.639 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 59.6 m-85 -85.08 163.04 47.38 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.799 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.53 140.21 92.61 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.105 1.87 . . . . 0.0 111.567 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t0 60.08 11.86 2.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.45 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -84.23 -26.26 28.82 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.863 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.699 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.7 p -150.76 168.69 23.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.523 0.678 . . . . 0.0 110.603 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -135.06 131.72 37.35 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.382 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -103.38 117.34 34.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -142.13 167.52 21.93 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.823 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -82.69 160.25 22.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.945 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -112.64 90.12 14.32 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.014 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.9 60.05 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.904 1.736 . . . . 0.0 112.347 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.52 -39.72 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.514 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.3 t -127.44 85.99 59.6 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.647 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.39 130.62 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.679 1.586 . . . . 0.0 111.671 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 169.29 -40.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.931 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.13 -157.9 7.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -104.52 109.23 21.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.21 129.02 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -126.54 153.24 45.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.36 135.34 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.589 HD11 ' SG ' ' A' ' 80' ' ' CYS . 66.2 tp -103.61 119.92 39.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -116.29 131.13 57.03 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.302 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -84.47 114.37 21.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.038 0.447 . . . . 0.0 109.988 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.41 -36.49 82.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.46 -24.01 66.37 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.294 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -137.82 -148.98 5.46 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.7 p -121.08 7.2 10.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.637 0.256 . . . . 0.0 111.014 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HE2' HD21 ' A' ' 105' ' ' LEU . 87.6 tttt -63.19 134.87 56.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -136.48 135.64 38.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.971 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.466 HD21 ' HE2' ' A' ' 103' ' ' LYS . 60.9 mt -119.55 145.01 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.517 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 33' ' ' LEU . 95.7 m-85 -116.36 131.66 56.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.724 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.6 154.84 51.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.237 0.542 . . . . 0.0 110.915 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.6 p-90 -128.63 137.08 51.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.306 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.45 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 26.9 tpp -73.88 140.2 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.527 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.73 1.73 19.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 109' ' ' MET . 76.5 mm-40 -73.39 141.07 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.587 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -28.98 22.64 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.886 1.724 . . . . 0.0 112.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -119.1 143.63 47.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.477 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.2 p -97.73 6.01 48.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.021 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -58.2 -21.61 48.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -124.19 -14.18 7.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.046 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.32 -41.24 98.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.646 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.51 -40.35 96.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.75 -41.91 97.92 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.495 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.8 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.2 m170 -63.35 -40.61 97.77 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.49 0.662 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.19 -46.8 88.97 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -65.5 -36.96 85.4 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.314 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -33.46 67.54 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.275 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.3 t -60.63 -46.71 95.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.146 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.51 -31.96 53.83 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -71.04 -30.56 66.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.349 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -83.75 -29.73 27.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.91 0.386 . . . . 0.0 110.304 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.622 HD23 HG21 ' A' ' 57' ' ' ILE . 67.9 mt -87.75 -23.68 24.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.913 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -108.91 -24.42 11.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.52 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -135.73 67.79 65.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.37 160.27 49.18 Favored 'Trans proline' 0 C--N 1.297 -2.137 0 C-N-CA 122.849 2.366 . . . . 0.0 112.242 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.187 . . . . 0.0 112.228 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.35 151.11 77.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.46 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.19 147.8 26.56 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.181 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.78 152.82 89.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.011 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.67 152.15 64.4 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.392 2.061 . . . . 0.0 112.221 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.85 -174.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.421 2.08 . . . . 0.0 111.964 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -122.44 157.64 58.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.205 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.19 139.49 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 122.457 2.105 . . . . 0.0 111.709 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 165.15 37.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -86.08 138.41 31.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.419 HD13 HG21 ' B' ' 951' ' ' ILE . 3.8 mt -131.41 133.28 62.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -76.98 85.28 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.331 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.579 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' C' ' 16' ' ' GLU . 9.6 pt20 -62.1 157.65 18.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -139.41 148.15 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.933 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.79 124.21 40.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.777 0.322 . . . . 0.0 110.986 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.722 HG11 HD12 ' C' ' 69' ' ' LEU . 99.4 t -108.18 114.57 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.646 -0.421 . . . . 0.0 109.99 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -97.31 119.86 36.61 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.342 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.6 p -79.56 171.83 14.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.535 HD11 ' H ' ' C' ' 71' ' ' LEU . 56.9 mt -62.51 -24.85 67.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.171 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -75.57 -10.5 59.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.051 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.56 -14.48 64.16 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.62 133.09 49.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 110.34 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -107.56 132.19 53.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.389 . . . . 0.0 110.759 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.1 112.67 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.466 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.01 132.99 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.666 HD21 ' HG3' ' C' ' 33' ' ' LYS . 29.6 mt -130.96 122.24 26.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' C' ' 2' ' ' GLN . 8.7 pt-20 -66.81 115.17 6.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.1 163.45 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.589 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -107.3 152.7 41.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.634 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -37.16 87.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.922 1.748 . . . . 0.0 112.089 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -80.43 -9.57 59.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -58.51 136.0 57.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 110.986 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -77.61 158.97 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.134 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.497 HD12 HD13 ' C' ' 50' ' ' LEU . 46.8 mm -66.43 -40.98 87.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -59.13 -42.7 91.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.36 -43.97 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.184 0.516 . . . . 0.0 110.303 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.16 -44.01 97.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -38.63 79.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.061 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.04 94.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.532 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.444 ' HE2' HD22 ' C' ' 15' ' ' LEU . 9.4 mtmm -61.68 -37.48 84.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.139 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.821 ' CD1' HD21 ' C' ' 43' ' ' LEU . 80.8 mt -64.25 -39.2 84.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -59.02 -39.97 83.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.366 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -86.95 7.29 28.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.666 ' HG3' HD21 ' C' ' 15' ' ' LEU . 2.0 mmtt -107.8 -47.62 3.56 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -116.54 -0.76 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.591 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 19.64 79.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.551 HG21 ' HB3' ' C' ' 41' ' ' GLN . 16.8 mm -81.43 119.96 76.96 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.133 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.26 149.3 65.24 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.065 1.843 . . . . 0.0 111.861 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -33.42 77.03 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.429 2.086 . . . . 0.0 112.65 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.05 7.68 39.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.395 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -108.33 -31.12 7.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.753 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.605 ' CB ' HD21 ' C' ' 69' ' ' LEU . 7.8 pt20 -99.22 131.53 45.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.498 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -122.95 115.35 21.77 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.821 HD21 ' CD1' ' C' ' 30' ' ' ILE . 70.0 mt -85.8 129.62 34.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.18 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 77.4 mt -131.87 129.16 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.326 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . 0.566 ' HB2' HD23 ' C' ' 67' ' ' LEU . 92.6 t80 -145.96 150.08 35.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.019 0.438 . . . . 0.0 111.456 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.92 20.12 11.25 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.022 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 84.32 -8.72 66.65 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.778 ' HE2' HD22 ' D' ' 73' ' ' LEU . 8.8 mtpt -107.9 137.22 46.29 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.972 0.415 . . . . 0.0 111.237 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -74.19 132.99 42.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.838 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.721 HD12 ' CB ' ' C' ' 43' ' ' LEU . 45.1 mt -74.95 98.66 3.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.53 141.23 43.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.819 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.68 142.86 52.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.99 -18.06 57.31 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -87.99 171.19 10.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.883 0.373 . . . . 0.0 110.476 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.8 p -115.46 163.52 15.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.131 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' C' ' 56' ' ' LEU . 77.9 mt -61.41 -40.96 96.32 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 94.7 p -63.79 -22.64 67.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.448 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.78 -37.82 85.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.95 0.405 . . . . 0.0 110.531 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' D' ' 73' ' ' LEU . 74.2 m-85 -98.37 15.47 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.245 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 58.98 41.8 20.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.586 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -88.39 109.99 20.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -95.51 178.37 5.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.453 0.644 . . . . 0.0 111.171 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -61.23 148.3 41.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.746 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 59.25 17.11 5.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.398 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -65.92 138.13 57.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 39.2 m -98.31 122.1 41.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' C' ' 45' ' ' PHE . 3.3 mp -116.57 148.22 41.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.554 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -92.19 133.19 36.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.722 HD12 HG11 ' C' ' 5' ' ' VAL . 1.9 tt -108.26 115.86 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.048 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.5 131.5 47.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.054 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.658 HD21 HD22 ' C' ' 69' ' ' LEU . 39.4 mt -106.1 132.92 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.536 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.0 145.21 46.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.24 148.87 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.551 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -62.46 -39.44 93.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.44 171.74 43.27 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.34 -40.29 98.42 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.2 p30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.719 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . 0.513 ' OE1' HG21 ' D' ' 14' ' ' THR . 5.4 pt20 -63.06 160.69 14.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.162 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -138.41 156.42 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.258 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.6 m-30 -96.29 125.37 40.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.709 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.45 107.35 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.913 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 122.78 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.093 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.424 HG23 ' O ' ' D' ' 11' ' ' LYS . 80.4 p -82.3 172.1 13.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.776 HD11 ' H ' ' D' ' 71' ' ' LEU . 88.1 mt -63.22 -26.02 68.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.179 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -86.6 -1.34 57.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.828 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 -8.72 77.83 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . 0.424 ' O ' HG23 ' D' ' 7' ' ' THR . 7.5 tmtm? -68.3 118.34 11.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.896 0.379 . . . . 0.0 110.107 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 74.6 m -90.99 137.38 32.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mt -122.48 119.0 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.116 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.573 HG23 ' CD2' ' D' ' 4' ' ' PHE . 1.1 m -86.47 117.8 25.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.702 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.89 123.39 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.94 113.06 7.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.707 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.6 m -133.05 160.52 42.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.276 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -106.45 152.98 40.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.926 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.1 -36.86 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 111.661 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -80.06 -9.7 59.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.303 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -57.93 138.43 55.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 47.0 p -81.03 163.11 23.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.174 0.511 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.861 HD12 HD23 ' D' ' 50' ' ' LEU . 43.5 mm -63.54 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.207 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.18 -39.4 86.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.875 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.529 HG21 HD21 ' D' ' 56' ' ' LEU . 52.9 t -63.03 -43.48 99.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.698 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -61.34 -39.38 90.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.053 0.454 . . . . 0.0 109.994 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.38 89.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.125 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.707 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.7 mttm -59.92 -38.91 83.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.6 ' CD1' HD21 ' D' ' 43' ' ' LEU . 80.1 mt -64.89 -39.87 87.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.71 -44.57 96.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.057 0.456 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.83 -13.25 59.95 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.911 -0.493 . . . . 0.0 112.065 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -105.92 -4.01 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -148.48 -37.19 0.18 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 110.459 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.01 11.8 36.08 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.535 HD13 ' CD2' ' D' ' 71' ' ' LEU . 41.4 mt -82.38 121.02 78.1 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 155.07 42.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.038 1.825 . . . . 0.0 111.745 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.11 -25.27 73.06 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.626 2.217 . . . . 0.0 112.528 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -95.01 7.02 47.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -118.35 9.77 12.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.894 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' D' ' 69' ' ' LEU . 26.8 pt20 -142.05 154.45 44.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . 0.475 ' NE ' HD11 ' D' ' 44' ' ' ILE . 58.0 ttp180 -134.22 129.62 35.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.747 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' D' ' 30' ' ' ILE . 67.0 mt -99.9 115.29 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.054 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.475 HD11 ' NE ' ' D' ' 42' ' ' ARG . 88.5 mt -121.47 117.07 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.326 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -64.71 -47.07 79.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.051 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -176.74 78.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.827 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.91 89.95 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -129.67 125.82 36.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.816 0.341 . . . . 0.0 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -82.71 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.476 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.861 HD23 HD12 ' D' ' 23' ' ' ILE . 7.9 mp -75.36 106.24 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.65 143.81 48.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.037 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.06 156.96 20.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.2 16.58 69.02 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -127.91 165.8 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 110.49 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -113.15 165.49 12.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.529 HD21 HG21 ' D' ' 26' ' ' VAL . 89.6 mt -61.26 -39.88 92.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.476 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.8 -26.41 68.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.53 -37.95 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.128 0.49 . . . . 0.0 110.186 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -95.03 13.62 24.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.056 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.16 40.81 27.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . 0.833 HD11 HD21 ' D' ' 50' ' ' LEU . 87.0 mt -92.33 114.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -100.43 -169.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.395 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -68.86 151.54 46.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 56.72 37.57 28.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.625 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -86.87 123.58 32.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.1 m -80.15 124.3 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.55 132.78 54.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.149 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -77.71 123.79 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.918 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' D' ' 41' ' ' GLN . 65.9 tp -103.97 111.54 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.666 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.6 t -107.36 132.61 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.776 ' H ' HD11 ' D' ' 8' ' ' LEU . 58.4 mt -104.67 136.4 44.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 111.022 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.05 146.61 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.578 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.778 HD22 ' HE2' ' C' ' 48' ' ' LYS . 78.7 mt -95.23 14.59 21.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 120.53 9.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.928 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.71 15.56 79.39 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.528 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -66.91 151.74 47.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.425 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -99.62 126.98 45.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.391 0.615 . . . . 0.0 110.225 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 51' ' ' GLN . 85.6 mt -68.49 -37.34 80.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.072 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.1 p -147.31 161.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.756 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.53 122.68 0.36 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.183 0.515 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -153.72 158.32 40.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.084 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -74.77 120.92 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.619 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -152.51 145.32 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.112 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.42 152.48 17.83 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.46 171.4 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.413 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 28.6 mtp -132.63 174.47 10.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.0 m -122.7 123.22 40.61 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 37' ' ' THR . 26.9 tp -105.02 116.94 32.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.19 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -120.81 112.25 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.94 -92.45 0.46 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 p -138.35 23.28 2.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.678 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' HD12 ' A' ' 33' ' ' LEU . 88.3 m -125.32 131.73 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 33' ' ' LEU . 74.3 t -111.01 123.73 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.204 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.799 HG22 ' HB3' ' B' ' 947' ' ' PRO . 58.4 p -119.02 135.12 23.66 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.141 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.5 150.38 57.57 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.98 1.787 . . . . 0.0 113.356 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -105.49 140.07 39.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.156 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -76.35 -7.08 54.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -72.76 75.13 1.13 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -55.48 127.96 32.12 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.78 -159.12 9.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.2 tp -139.17 124.46 19.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 28' ' ' ALA . 41.1 t -96.53 109.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.346 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.0 p90 -131.57 154.25 49.03 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.018 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.2 mt -118.42 139.14 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.712 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 128.53 30.76 Favored 'General case' 0 C--O 1.22 -0.478 0 O-C-N 123.89 0.744 . . . . 0.0 110.35 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.757 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.8 tt0 -99.42 125.3 45.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.977 0.417 . . . . 0.0 109.956 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.6 p -85.56 170.39 12.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.384 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -62.79 -10.62 13.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.166 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.5 2.62 54.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.475 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t 69.63 20.62 6.94 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.208 0.528 . . . . 0.0 110.401 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 74.9 mt -97.32 121.97 39.82 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.476 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -81.88 120.06 32.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.7 m-70 -96.9 111.53 23.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.114 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -90.58 108.24 19.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 74.2 m -121.02 145.98 47.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.648 . . . . 0.0 112.627 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -124.39 112.84 17.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.435 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -104.86 135.23 46.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.028 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -74.79 136.69 41.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.874 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -78.9 -17.77 54.98 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.537 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -60.84 -46.64 89.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -117.02 -13.02 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.95 24.94 75.01 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -102.01 144.48 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 0.0 110.673 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.16 105.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.27 -28.11 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.008 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -127.69 144.05 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.196 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.6 p30 -159.49 95.9 1.25 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.87 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.673 HD22 ' HG2' ' C' ' 48' ' ' LYS . 41.3 mt -123.13 138.01 54.77 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.821 0.343 . . . . 0.0 110.727 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 86.1 mt -83.21 116.8 27.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.496 ' HB ' HD22 ' A' ' 128' ' ' LEU . 1.2 mp -105.52 116.65 49.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.957 0.408 . . . . 0.0 111.139 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.585 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 44.7 m-85 -79.69 164.17 54.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.988 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.08 139.68 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.95 1.767 . . . . 0.0 111.041 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.59 11.82 3.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -85.91 -42.2 14.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.481 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.473 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -130.85 148.17 52.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.0 111.364 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -122.02 129.56 52.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.663 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -101.78 118.46 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -144.06 167.94 21.18 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.767 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -94.68 146.25 24.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.288 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.39 99.58 21.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.221 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.81 60.09 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.741 1.627 . . . . 0.0 112.223 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -114.35 -36.34 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.246 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 p -121.94 74.35 37.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.711 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.02 130.27 26.92 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.103 1.869 . . . . 0.0 111.745 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.98 -43.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.905 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.93 -139.61 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.47 106.38 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.3 127.31 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.82 156.21 35.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 105' ' ' LEU . 10.5 p -131.7 137.52 54.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.473 HD11 ' SG ' ' A' ' 80' ' ' CYS . 60.3 tp -105.69 119.92 40.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -119.61 139.18 52.59 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.991 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -88.78 115.81 26.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.62 -37.19 83.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.526 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.98 -22.86 24.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.176 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.51 -169.28 21.9 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.1 m -124.0 17.96 9.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.771 ' HD3' HD21 ' A' ' 105' ' ' LEU . 30.5 ttmt -89.64 138.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.27 0.557 . . . . 0.0 111.087 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.49 109.25 10.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.771 HD21 ' HD3' ' A' ' 103' ' ' LYS . 50.7 mt -96.0 150.4 20.51 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.45 ' CE1' HD22 ' A' ' 33' ' ' LEU . 88.3 m-85 -123.94 136.48 54.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.258 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.06 155.7 49.33 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.316 0.579 . . . . 0.0 111.118 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -128.32 137.45 51.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.838 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.1 tpp -75.82 123.95 26.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.242 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -16.81 34.72 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.7 127.29 88.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.28 -20.05 43.33 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.94 1.76 . . . . 0.0 112.724 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.54 140.4 47.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.132 0.491 . . . . 0.0 110.317 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.9 p -99.12 10.88 40.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.09 -26.42 49.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.379 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -126.03 -0.69 7.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.805 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.73 -48.56 80.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.77 -40.91 97.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -64.07 -42.67 96.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.807 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.784 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.4 m170 -64.79 -39.65 93.94 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.511 0.672 . . . . 0.0 109.213 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.82 -45.72 92.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.558 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -64.37 -43.47 94.43 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.212 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.25 -38.1 87.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.1 t -58.89 -48.08 87.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.164 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -80.61 -32.51 36.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.04 -38.18 87.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.571 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -80.62 -37.78 30.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.005 0.431 . . . . 0.0 110.258 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 75' ' ' ILE . 77.0 mt -71.53 -34.41 70.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.115 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -100.89 -24.13 14.42 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.677 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -139.99 69.04 35.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.746 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.83 160.49 49.23 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.916 2.411 . . . . 0.0 112.28 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.649 2.233 . . . . 0.0 112.248 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.67 81.99 68.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.724 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 138.88 83.81 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.808 2.339 . . . . 0.0 112.249 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.04 159.26 71.17 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.188 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.84 146.65 77.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.41 -173.96 1.29 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.541 2.161 . . . . 0.0 112.189 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -100.33 153.35 37.8 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.389 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.799 ' HB3' HG22 ' A' ' 39' ' ' THR . 43.2 Cg_endo -68.83 152.04 73.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.491 2.127 . . . . 0.0 112.084 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.43 168.74 25.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.35 132.14 34.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.82 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -113.37 136.04 53.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.079 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.44 129.93 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.585 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.24 85.89 0.26 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.338 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.054 -0.975 . . . . 0.0 110.49 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -62.45 160.34 13.79 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -139.31 149.97 22.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.614 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -91.86 119.82 31.99 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.263 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.422 ' CG1' HD12 ' C' ' 69' ' ' LEU . 69.4 t -104.36 108.64 25.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.07 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -92.75 122.31 35.03 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.889 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 78.0 p -81.56 171.5 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.593 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.645 HD11 ' H ' ' C' ' 71' ' ' LEU . 62.3 mt -65.54 -21.34 66.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.047 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.25 -5.88 58.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.343 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.49 74.68 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -74.16 128.8 36.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.844 0.322 . . . . 0.0 110.236 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.48 132.16 47.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.07 111.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.438 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -81.44 126.99 32.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.71 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' C' ' 29' ' ' LYS . 79.0 mt -120.03 129.82 54.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.66 116.58 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.441 HG12 ' HE2' ' C' ' 29' ' ' LYS . 21.0 m -136.13 165.63 28.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.706 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.405 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.2 mt-10 -110.32 154.14 43.06 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.42 -30.61 91.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.72 1.613 . . . . 0.0 111.965 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.3 m -88.86 -6.5 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.27 144.21 57.31 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.812 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.91 163.86 23.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.044 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.3 mm -63.04 -38.56 82.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.786 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -58.96 -40.89 86.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.41 -46.37 90.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 110.566 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.449 HG21 HD21 ' C' ' 56' ' ' LEU . 74.7 t -60.71 -42.66 92.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.04 -37.04 78.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.33 95.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' C' ' 15' ' ' LEU . 0.9 OUTLIER -59.35 -39.31 82.81 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.228 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' C' ' 43' ' ' LEU . 80.8 mt -65.15 -39.36 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.445 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.12 -43.05 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.43 19.31 6.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.47 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -123.72 -42.88 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.374 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -116.84 -18.95 10.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.575 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.26 10.81 65.51 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.515 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.402 HD13 ' CD2' ' C' ' 71' ' ' LEU . 52.0 mt -75.04 128.03 85.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.77 154.23 63.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.502 1.468 . . . . 0.0 111.02 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.64 -23.42 65.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.2 1.933 . . . . 0.0 111.968 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.85 -1.69 52.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.013 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -123.31 -31.49 3.55 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.52 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -78.8 132.84 37.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.318 0.58 . . . . 0.0 111.449 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -130.43 126.74 37.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.397 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' C' ' 30' ' ' ILE . 77.3 mt -103.39 124.71 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.961 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.508 HG21 ' HE1' ' A' ' 76' ' ' PHE . 80.5 mt -129.38 129.08 67.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.293 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -144.39 149.41 36.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.899 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.6 16.72 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.396 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.26 -14.95 59.56 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.771 ' HD2' HD22 ' D' ' 73' ' ' LEU . 9.7 mttt -98.94 141.49 31.64 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.449 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -75.43 127.27 32.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.751 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' C' ' 43' ' ' LEU . 48.3 mt -76.09 89.49 3.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -74.97 171.37 14.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -75.81 169.0 18.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.079 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.42 19.49 77.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -124.53 167.2 14.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.687 0.279 . . . . 0.0 110.585 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -122.71 161.22 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.578 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.449 HD21 HG21 ' C' ' 26' ' ' VAL . 80.6 mt -60.89 -40.51 93.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.8 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.62 -23.0 67.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.561 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.2 -38.06 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.017 0.437 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.505 ' CE2' HD13 ' D' ' 73' ' ' LEU . 71.1 m-85 -97.18 13.2 30.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.151 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 59.05 41.08 21.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 0.0 110.257 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.35 118.4 33.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.912 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -107.07 178.38 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.002 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -59.53 146.59 40.01 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.807 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 61.49 18.6 9.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 27.5 t -71.6 131.09 42.71 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 93.6 m -83.91 127.89 34.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -116.5 144.1 44.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.201 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -92.33 123.64 35.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.056 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.612 HD22 HD21 ' C' ' 71' ' ' LEU . 1.8 tt -102.8 115.25 30.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.127 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 56' ' ' LEU . 68.4 t -108.96 132.82 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.645 ' H ' HD11 ' C' ' 8' ' ' LEU . 33.3 mt -105.84 135.35 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -70.8 148.64 47.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.67 152.05 40.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.6 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.64 -39.11 90.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.321 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.1 141.01 42.61 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.07 89.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.343 179.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.29 158.19 12.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.771 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -138.42 151.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.859 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.447 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.0 m-30 -92.69 122.92 35.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.711 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.68 109.95 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.694 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -94.52 122.3 36.95 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.088 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.649 HG22 HD23 ' D' ' 69' ' ' LEU . 77.0 p -82.19 -179.08 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.321 0.581 . . . . 0.0 111.632 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.747 HD11 ' H ' ' D' ' 71' ' ' LEU . 85.0 mt -61.58 -37.06 82.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.825 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.14 -8.99 57.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.262 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.92 -9.12 70.6 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.81 128.0 34.13 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -102.05 130.54 48.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.118 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.41 HG21 HD13 ' D' ' 13' ' ' ILE . 1.3 mt -124.37 113.86 38.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.743 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.447 HG23 ' CD2' ' D' ' 4' ' ' PHE . 10.6 m -80.03 125.78 30.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.757 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.25 118.25 30.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.281 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.19 110.29 2.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.299 0.571 . . . . 0.0 110.715 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.673 HG12 ' HE2' ' D' ' 29' ' ' LYS . 29.3 m -133.81 160.82 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -103.58 155.02 37.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.997 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 -38.37 95.28 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.124 1.883 . . . . 0.0 111.996 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.7 p -80.0 -8.78 59.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.026 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -58.7 135.74 57.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.979 0.418 . . . . 0.0 110.89 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.14 163.45 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.547 HD12 HD13 ' D' ' 50' ' ' LEU . 50.0 mm -64.23 -37.92 81.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.98 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.66 -43.81 89.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.99 -42.3 98.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 110.754 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.465 HG22 HG11 ' D' ' 17' ' ' VAL . 61.2 t -62.9 -42.38 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.923 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -60.64 -39.56 88.74 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.109 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.03 88.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.126 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.673 ' HE2' HG12 ' D' ' 17' ' ' VAL . 62.9 mttp -59.71 -38.98 83.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.813 ' CD1' HD21 ' D' ' 43' ' ' LEU . 87.3 mt -64.77 -40.58 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.931 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.69 -47.0 87.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.28 -15.94 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -103.57 -4.84 23.36 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.59 -37.65 0.2 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.78 10.42 32.82 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.618 HD13 ' CD2' ' D' ' 71' ' ' LEU . 49.9 mt -77.82 127.45 82.01 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.17 155.98 42.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.168 1.245 . . . . 0.0 110.728 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.78 -36.69 83.23 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.063 1.842 . . . . 0.0 112.468 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.14 -39.01 88.43 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.311 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -96.65 23.26 7.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.551 ' HG3' HG22 ' D' ' 36' ' ' ILE . 36.9 mt-30 -118.29 112.32 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 111.712 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -118.64 110.61 17.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.813 HD21 ' CD1' ' D' ' 30' ' ' ILE . 78.0 mt -97.7 117.12 31.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.417 HG23 ' C ' ' D' ' 48' ' ' ARG . 85.1 mt -121.82 126.58 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 85.5 t80 -127.68 130.14 48.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.7 29.13 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.35 17.16 79.69 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.417 ' C ' HG23 ' D' ' 44' ' ' ILE . 44.2 ttm180 -132.66 127.91 35.89 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.573 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -66.54 148.07 52.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.06 0.457 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.547 HD13 HD12 ' D' ' 23' ' ' ILE . 77.2 mt -90.21 115.36 27.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.882 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -70.01 136.7 50.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.725 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -61.31 136.94 58.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.198 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.62 55.72 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -82.25 172.58 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -118.27 163.21 17.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.89 -39.48 89.42 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.402 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.2 p -63.81 -24.35 67.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.3 . . . . 0.0 110.414 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.95 -37.75 85.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.327 0.584 . . . . 0.0 110.044 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -98.14 14.53 27.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.282 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 m120 56.83 39.94 29.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.829 0.347 . . . . 0.0 110.278 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -90.14 113.75 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.856 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -99.33 -172.25 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.531 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -68.79 150.75 47.49 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.273 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 56.85 41.77 27.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 72.5 m -98.5 127.45 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.559 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.51 ' C ' HD12 ' D' ' 67' ' ' LEU . 90.3 m -78.22 127.53 32.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.51 HD12 ' C ' ' D' ' 66' ' ' THR . 8.5 mp -118.57 138.4 52.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.921 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -89.07 113.96 25.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.649 HD23 HG22 ' D' ' 7' ' ' THR . 48.5 tp -99.46 120.53 39.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.695 ' HA ' HD21 ' D' ' 8' ' ' LEU . 90.5 t -112.97 132.75 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.747 ' H ' HD11 ' D' ' 8' ' ' LEU . 24.4 mt -105.0 128.94 53.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.455 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.74 141.2 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 110.947 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.771 HD22 ' HD2' ' C' ' 48' ' ' LYS . 33.0 mt -103.64 16.04 27.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.612 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -58.61 -45.05 90.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.881 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.18 9.67 22.68 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.617 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -84.05 146.65 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -86.15 112.41 21.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.164 0.507 . . . . 0.0 109.817 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.4 mt -68.32 -37.02 80.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.606 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -147.65 161.7 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.26 122.24 0.29 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 0.0 110.834 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.04 160.07 40.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.696 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.8 mtm-85 -78.66 124.05 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.046 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.75 146.03 20.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.86 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.47 152.12 17.19 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -95.52 161.9 13.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.875 0.369 . . . . 0.0 111.13 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mtm -134.81 170.27 16.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -121.09 135.92 55.08 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.403 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 37' ' ' THR . 29.6 tp -110.97 119.36 38.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.947 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -120.75 112.38 18.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.85 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -106.54 1.81 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.6 p -124.06 20.86 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.292 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.563 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.0 m -124.61 130.32 52.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 110.798 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.561 HG22 HD13 ' A' ' 33' ' ' LEU . 62.1 t -107.71 121.28 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.8 p -108.77 131.55 21.71 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.95 145.4 45.08 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.062 1.842 . . . . 0.0 113.35 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.12 120.74 42.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -65.23 -11.32 39.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -72.31 78.84 1.0 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -58.83 140.13 55.55 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.98 -157.3 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.815 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.0 tp -135.31 127.93 30.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.37 111.77 32.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.546 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -136.09 156.29 48.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.231 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.7 mt -122.24 137.7 54.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.873 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -135.06 130.56 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.632 0.583 . . . . 0.0 110.112 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.668 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.4 tt0 -100.7 124.15 45.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.107 0.48 . . . . 0.0 110.085 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.507 HG23 ' CD2' ' A' ' 58' ' ' HIS . 17.7 p -85.34 171.59 11.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.49 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.02 -10.34 21.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.116 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.93 1.09 55.98 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.282 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t 69.12 21.74 7.14 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.312 0.577 . . . . 0.0 110.252 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.844 HD11 HG11 ' C' ' 70' ' ' VAL . 83.6 mt -98.28 122.72 41.79 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.439 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.1 mm -81.99 122.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.507 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.0 m-70 -98.17 112.67 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.851 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -92.15 109.29 20.65 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 77.9 m -121.74 145.96 47.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -128.3 117.86 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.53 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -108.68 143.81 37.28 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.348 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -80.98 129.21 34.42 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -71.34 -16.64 62.44 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 m -59.4 -45.35 91.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.429 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.1 m -117.22 -13.27 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 110.182 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.79 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -101.72 152.04 21.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.04 103.86 6.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -77.97 -32.93 51.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -126.68 146.1 50.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.538 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 73' ' ' LEU . 68.2 t0 -157.68 98.73 1.67 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.052 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.702 HD22 ' HG2' ' C' ' 48' ' ' LYS . 28.3 mt -127.64 133.85 49.65 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.501 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -79.09 123.92 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.421 ' HB ' HD22 ' A' ' 128' ' ' LEU . 29.0 mm -112.23 129.5 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 111.103 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.508 ' HE1' HG21 ' C' ' 44' ' ' ILE . 59.3 m-85 -94.14 162.51 26.33 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.436 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.76 140.67 91.56 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.172 1.915 . . . . 0.0 111.658 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 60.71 12.26 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -88.4 -35.24 17.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.977 0.418 . . . . 0.0 110.401 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -135.51 148.36 49.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.179 0.514 . . . . 0.0 111.561 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -122.61 127.68 49.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.455 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -100.57 120.63 40.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -145.37 167.13 23.63 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.792 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -92.14 159.27 15.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.889 0.376 . . . . 0.0 110.217 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 t -120.95 89.83 46.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.382 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.31 60.45 7.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.81 1.674 . . . . 0.0 112.169 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.69 -34.3 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.172 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.5 t -124.91 86.78 56.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.54 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.48 129.91 19.94 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.771 1.647 . . . . 0.0 111.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.98 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.33 -176.77 33.8 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.521 ' NE ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -86.03 110.36 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.42 126.53 72.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -121.95 152.82 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.233 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.9 p -128.04 135.79 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.212 0.529 . . . . 0.0 109.904 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.453 HD11 ' SG ' ' A' ' 80' ' ' CYS . 61.5 tp -104.76 118.22 36.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -115.29 132.47 56.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 111.29 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 54.5 m-85 -86.65 115.56 24.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.58 -37.14 82.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.318 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -108.68 -23.36 11.83 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.362 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -63.86 -33.7 87.94 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.76 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p 74.05 27.89 1.54 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.621 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -139.45 162.11 35.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.491 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -138.69 149.42 45.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.464 . . . . 0.0 111.2 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 95' ' ' VAL . 46.1 mt -125.24 150.82 46.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' A' ' 33' ' ' LEU . 94.1 m-85 -120.3 135.92 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.501 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -137.34 156.38 48.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.191 0.519 . . . . 0.0 111.223 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -133.75 137.17 45.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.826 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.2 ttm -74.67 131.73 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.946 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.47 4.31 26.04 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.709 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -71.86 148.73 92.37 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.424 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.89 -27.6 14.29 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.099 1.866 . . . . 0.0 112.967 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -119.51 142.18 48.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.31 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.521 HG22 ' NE ' ' A' ' 92' ' ' ARG . 79.8 p -98.31 8.46 44.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.491 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.58 -22.47 13.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.351 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -123.73 8.11 8.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.579 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -61.16 -49.1 78.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.47 -40.5 95.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.209 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.77 -43.31 99.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.614 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.5 m170 -64.18 -40.13 95.46 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.92 94.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.792 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -65.65 -43.34 89.75 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.245 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.46 -39.33 93.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.887 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.3 t -59.14 -47.78 89.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.233 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.33 -27.88 38.25 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.82 -38.71 80.06 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.55 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -81.18 -33.23 33.16 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.64 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 75' ' ' ILE . 67.5 mt -77.96 -28.63 49.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -104.83 -26.87 12.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.319 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.7 72.84 73.09 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.313 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.411 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.1 Cg_exo -59.77 149.14 84.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.799 2.333 . . . . 0.0 111.573 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 122.175 1.916 . . . . 0.0 112.182 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 -72.08 154.35 92.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.449 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.16 153.88 66.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.829 2.352 . . . . 0.0 112.638 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.37 155.05 94.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.725 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.83 157.32 62.34 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.176 1.917 . . . . 0.0 112.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.74 176.94 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.224 . . . . 0.0 111.622 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.05 157.62 42.99 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.856 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.01 145.27 99.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.225 1.95 . . . . 0.0 111.788 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -158.07 169.3 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.09 137.86 32.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.185 0.517 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.9 121.49 38.18 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.471 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 63.4 mt -130.49 125.61 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -75.46 83.76 2.54 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.053 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.608 179.67 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -62.08 156.09 22.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.019 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.97 148.83 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.27 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -90.21 123.86 34.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.443 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.55 114.73 47.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.195 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -103.02 123.07 45.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.644 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.3 p -84.1 172.5 11.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.069 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.54 HD11 ' H ' ' C' ' 71' ' ' LEU . 73.4 mt -64.35 -25.47 68.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -74.28 -8.89 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.22 6.11 66.91 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.25 127.95 34.27 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.788 0.327 . . . . 0.0 110.148 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -104.54 131.76 51.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.916 0.389 . . . . 0.0 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 117.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.295 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -83.72 130.14 34.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.447 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' C' ' 33' ' ' LYS . 90.7 mt -123.24 122.95 39.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.775 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -66.13 110.77 3.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.744 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.503 HG12 ' HE3' ' C' ' 29' ' ' LYS . 22.4 m -134.23 163.44 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.447 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -106.09 154.35 39.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.98 -35.37 94.33 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.033 1.822 . . . . 0.0 112.17 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -84.78 -3.83 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.01 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -60.15 136.55 58.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 110.775 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.44 162.19 26.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.54 -38.32 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.12 -43.27 91.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.243 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.43 -41.63 98.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 110.909 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.7 -42.69 96.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.742 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' C' ' 43' ' ' LEU . 58.2 mtmt -60.41 -39.32 86.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -40.26 93.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.379 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.519 ' HB3' HD22 ' C' ' 15' ' ' LEU . 66.6 mttm -60.22 -39.68 87.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.543 HG21 HD11 ' C' ' 69' ' ' LEU . 96.8 mt -66.54 -39.8 84.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.211 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -59.49 -39.63 84.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 0.0 110.284 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.07 -44.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.701 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.617 ' HG3' HD21 ' C' ' 15' ' ' LEU . 19.7 mttt -70.82 -39.7 72.89 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -132.94 152.03 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.67 2.22 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.553 HG22 ' HB2' ' C' ' 41' ' ' GLN . 41.3 mm -117.39 94.91 46.46 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.36 149.62 80.08 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.73 2.287 . . . . 0.0 112.232 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -52.62 -40.06 74.08 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.962 1.774 . . . . 0.0 112.387 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.57 -39.54 94.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -99.03 31.86 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.706 ' HG3' HD21 ' C' ' 69' ' ' LEU . 12.9 tt0 -136.04 120.42 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.842 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -128.67 115.0 17.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.53 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.501 ' CB ' HD12 ' C' ' 50' ' ' LEU . 27.0 mt -92.89 132.31 37.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.151 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -129.46 128.61 66.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -144.27 151.39 39.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.869 0.366 . . . . 0.0 110.999 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 15.81 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.469 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.64 63.21 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.727 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.1 OUTLIER -107.72 141.45 39.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.05 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -72.3 132.98 44.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.501 HD12 ' CB ' ' C' ' 43' ' ' LEU . 51.0 mt -77.06 100.29 5.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.681 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.61 144.64 41.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.258 0.552 . . . . 0.0 110.765 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.0 141.01 57.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.338 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.19 54.56 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -84.26 178.53 7.75 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.333 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -126.54 165.59 18.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.45 HD22 HG21 ' C' ' 61' ' ' ILE . 84.8 mt -62.71 -40.42 97.12 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.668 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.6 -26.67 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.99 -36.94 82.99 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.084 0.469 . . . . 0.0 110.245 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.5 ' CE2' HD13 ' D' ' 73' ' ' LEU . 76.0 m-85 -97.69 13.8 29.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.162 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.33 43.56 28.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.443 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.45 HG21 HD22 ' C' ' 56' ' ' LEU . 57.6 mt -89.74 103.8 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.4 -179.39 5.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -63.28 148.98 46.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.007 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 59.51 44.33 14.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -102.83 127.93 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.432 ' C ' HD12 ' C' ' 67' ' ' LEU . 86.0 m -77.58 127.76 33.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.432 HD12 ' C ' ' C' ' 66' ' ' THR . 7.2 mp -116.29 145.69 42.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -98.19 123.16 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.374 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.747 HD22 HD21 ' C' ' 71' ' ' LEU . 1.7 tt -100.27 126.0 46.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.61 ' N ' HD23 ' C' ' 69' ' ' LEU . 93.9 t -108.75 131.03 60.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.444 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.747 HD21 HD22 ' C' ' 69' ' ' LEU . 33.1 mt -112.17 147.72 35.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.719 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.04 133.14 52.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.817 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -113.77 145.72 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.608 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -123.21 139.57 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.596 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.99 -173.65 54.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 19.03 79.91 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.522 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -65.67 159.08 25.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.39 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.561 HD13 HD21 ' D' ' 56' ' ' LEU . 15.0 pt -137.9 141.4 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.219 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.594 ' HD2' HG21 ' D' ' 12' ' ' THR . 4.2 m-85 -84.26 123.88 30.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.884 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -110.11 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.818 0.342 . . . . 0.0 110.505 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -92.9 122.28 35.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.807 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -82.86 179.13 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.762 HD11 ' H ' ' D' ' 71' ' ' LEU . 85.0 mt -62.74 -35.85 81.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.27 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 42.8 p -67.42 -11.41 57.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.727 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.1 -9.94 67.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.4 129.6 40.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.594 HG21 ' HD2' ' D' ' 4' ' ' PHE . 98.9 m -101.52 132.18 47.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 110.807 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -127.11 105.79 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.611 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -81.88 127.11 32.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' D' ' 29' ' ' LYS . 86.5 mt -122.04 127.73 50.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.698 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.19 114.6 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.713 HG12 ' HE3' ' D' ' 29' ' ' LYS . 16.4 m -137.07 171.92 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.236 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.5 155.24 56.75 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.087 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.9 -39.41 84.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.128 1.886 . . . . 0.0 112.313 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -24.33 63.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.17 136.97 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.49 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -85.49 165.89 16.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.329 0.585 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.51 HD12 HD13 ' D' ' 50' ' ' LEU . 43.8 mm -63.38 -37.66 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.846 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.76 -42.15 88.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.856 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.11 -41.11 97.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.506 HG21 HD11 ' D' ' 56' ' ' LEU . 53.4 t -62.96 -42.97 98.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.878 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -60.59 -40.41 91.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.162 0.506 . . . . 0.0 110.485 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.713 ' HE3' HG12 ' D' ' 17' ' ' VAL . 64.8 mttm -59.31 -38.67 80.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.825 ' CD1' HD21 ' D' ' 43' ' ' LEU . 96.9 mt -64.5 -38.37 82.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.849 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 tm0? -59.11 -38.99 80.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.23 -59.43 3.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.802 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.552 ' HD2' HD21 ' D' ' 15' ' ' LEU . 69.4 mttt -63.55 -41.49 98.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.03 142.52 50.77 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.095 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.97 60.28 3.04 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' D' ' 41' ' ' GLN . 2.9 mt -115.26 122.01 33.93 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.231 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 159.29 49.32 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.476 1.451 . . . . 0.0 111.649 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.3 -37.32 70.8 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.149 1.899 . . . . 0.0 112.563 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.69 -39.88 93.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.555 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.39 -11.33 54.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.367 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' D' ' 36' ' ' ILE . 91.4 mt-30 -86.6 83.19 7.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.008 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -98.28 98.93 10.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.825 HD21 ' CD1' ' D' ' 30' ' ' ILE . 73.5 mt -86.81 122.64 30.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.443 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.26 126.79 71.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.006 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.444 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.3 t80 -128.61 130.26 47.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.0 28.35 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.95 79.01 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -131.01 129.53 42.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.5 139.16 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.51 HD13 HD12 ' D' ' 23' ' ' ILE . 85.8 mt -82.96 118.68 23.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.11 137.32 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.315 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -66.73 147.54 53.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.179 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.58 -13.68 63.39 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -88.44 149.12 23.85 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.754 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -87.66 165.58 15.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.064 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.561 HD21 HD13 ' D' ' 3' ' ' ILE . 5.4 mp -66.72 -36.13 81.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.722 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.4 p -62.01 -27.02 68.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.727 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.22 -37.55 85.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.125 0.488 . . . . 0.0 110.285 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -95.74 11.81 32.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 55.26 41.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.14 103.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -90.03 -176.8 5.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.208 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -63.32 152.16 38.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 55.5 40.1 31.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.4 t -90.31 120.44 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.444 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.434 ' C ' HD12 ' D' ' 67' ' ' LEU . 61.6 m -75.42 127.09 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.163 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.434 HD12 ' C ' ' D' ' 66' ' ' THR . 7.1 mp -118.76 145.97 45.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 67.9 m170 -92.97 117.76 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.098 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.703 HD11 HD13 ' D' ' 30' ' ' ILE . 0.4 OUTLIER -97.84 99.46 10.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.371 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' D' ' 8' ' ' LEU . 73.3 t -90.78 135.57 26.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.382 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.762 ' H ' HD11 ' D' ' 8' ' ' LEU . 50.0 mt -111.82 161.71 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.442 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -76.33 -173.43 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.727 HD22 ' HE2' ' C' ' 48' ' ' LYS . 83.6 mt -65.42 -13.4 58.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.639 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 11.6 mmm-85 -41.27 120.15 1.34 Allowed 'General case' 0 C--N 1.341 0.229 0 CA-C-O 121.148 0.499 . . . . 0.0 110.388 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.38 7.9 34.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 179.33 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.1 m120 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -82.41 152.15 26.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.461 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -91.42 111.94 23.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.0 mt -65.75 -37.79 87.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.597 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -150.62 162.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.363 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.16 122.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.0 111.127 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.68 158.28 36.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.919 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -75.53 121.3 22.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.411 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.13 140.9 20.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.026 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.65 151.98 17.14 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -88.6 170.93 10.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 0.0 111.248 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 mtp -135.65 174.21 10.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.757 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -124.71 121.62 35.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 37' ' ' THR . 32.8 tp -102.91 121.78 43.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.904 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -118.83 104.1 10.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.029 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.51 -82.54 0.8 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -144.8 18.03 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.492 0.187 . . . . 0.0 110.95 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.656 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.2 m -119.99 128.01 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 33' ' ' LEU . 58.1 t -107.84 122.97 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.227 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.8 m -117.12 130.11 24.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.352 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.13 148.89 70.15 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.104 1.869 . . . . 0.0 113.229 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.77 136.04 45.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.91 -7.37 50.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.19 63.61 3.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -51.26 141.18 15.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.302 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.55 -153.37 6.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.369 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.1 tp -137.96 125.58 22.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.43 108.48 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.6 153.44 48.89 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.231 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' CG1' HG12 ' A' ' 24' ' ' VAL . 98.2 mt -119.17 138.55 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.469 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 129.87 31.78 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.806 0.691 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.546 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.9 tt0 -99.94 123.79 44.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.51 . . . . 0.0 110.387 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.0 p -83.62 170.23 14.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.706 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.48 -10.09 10.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.169 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.95 3.06 55.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.64 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 69.53 20.12 7.23 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.325 0.583 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 73.8 mt -96.35 121.66 38.39 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.521 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.3 mm -81.22 120.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.487 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.2 m-70 -97.49 114.49 26.37 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.347 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -99.25 107.23 19.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.798 0.809 . . . . 0.0 112.827 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -118.72 113.53 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.827 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -101.57 126.87 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -73.58 133.26 43.49 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -76.54 -18.45 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.51 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.4 m -60.47 -45.36 94.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.033 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -116.47 -16.62 10.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.973 0.416 . . . . 0.0 109.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.34 78.91 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.21 145.02 30.57 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.5 104.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 0.0 109.9 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -80.93 -33.61 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -127.13 142.99 51.38 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.865 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.3 t0 -158.72 95.53 1.31 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.31 0.381 . . . . 0.0 110.162 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.658 HD22 ' CG ' ' C' ' 48' ' ' LYS . 40.2 mt -124.7 137.25 54.36 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.079 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -79.57 118.4 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.725 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.0 mm -108.06 121.27 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.801 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 49.5 m-85 -84.66 160.5 55.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.153 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.02 144.91 99.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.004 1.803 . . . . 0.0 111.555 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 60.06 12.96 3.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.14 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.84 -25.77 17.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.536 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 75' ' ' ILE . 11.7 p -149.12 166.22 29.42 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.321 0.582 . . . . 0.0 110.575 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.411 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.9 tt0 -136.89 133.99 36.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.101 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -104.33 118.28 36.24 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -144.77 167.86 21.58 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.532 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -87.73 160.41 18.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.438 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.8 89.15 15.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.212 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.42 60.46 7.86 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.056 1.837 . . . . 0.0 112.111 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -114.02 -37.34 4.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.1 t -126.63 80.11 70.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.609 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.14 129.76 37.03 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.082 1.855 . . . . 0.0 111.186 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.52 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.858 0.724 . . . . 0.0 110.243 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.85 177.16 32.29 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -86.07 114.33 22.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.625 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.06 129.69 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.42 151.48 40.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.875 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.5 p -130.95 134.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.635 HD11 ' SG ' ' A' ' 80' ' ' CYS . 65.5 tp -100.45 120.07 39.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -115.96 131.97 56.79 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.28 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -82.73 111.99 19.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.267 0.556 . . . . 0.0 109.798 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -37.72 84.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.483 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 -20.54 23.14 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.261 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.82 177.42 27.92 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.2 p -114.14 23.36 12.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 153.72 46.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.855 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 157.09 46.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 95' ' ' VAL . 36.7 mt -118.49 156.24 29.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.873 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 91.1 m-85 -124.6 136.38 53.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -139.17 155.7 47.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.339 0.59 . . . . 0.0 111.247 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -128.99 137.45 51.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.4 tpp -67.8 132.45 47.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -2.89 15.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.0 146.6 97.44 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.231 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.27 -28.9 12.0 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.979 1.786 . . . . 0.0 113.155 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -118.59 144.73 45.92 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.633 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 p -100.49 12.27 37.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.734 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.28 -22.22 64.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.647 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -131.31 -6.63 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.837 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.81 -42.54 99.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.82 -39.8 91.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.0 111.305 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.86 -41.41 95.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.197 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.785 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.0 m170 -61.34 -40.05 92.84 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.552 0.692 . . . . 0.0 109.204 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.25 -44.91 94.87 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.644 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -62.65 -42.69 99.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.058 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -65.27 -35.64 81.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.018 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 120' ' ' HIS . 71.0 t -57.21 -48.02 83.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.021 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.42 -31.08 48.02 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.561 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.65 -27.18 64.83 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.042 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -92.52 -23.81 18.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.473 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.4 mt -95.24 -17.58 21.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -18.72 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.366 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -134.48 63.1 58.67 Favored Pre-proline 0 N--CA 1.464 0.234 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.038 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.52 159.11 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.834 2.356 . . . . 0.0 112.457 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 122.664 2.243 . . . . 0.0 112.139 -179.427 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -92.92 153.1 41.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.21 145.82 31.18 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.565 2.177 . . . . 0.0 112.006 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -80.37 159.69 69.39 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.71 134.76 59.95 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.162 1.908 . . . . 0.0 112.165 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.35 -162.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.269 1.979 . . . . 0.0 112.009 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -128.31 155.18 78.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.679 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.59 145.35 81.74 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.486 2.124 . . . . 0.0 111.704 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -155.55 164.34 38.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.677 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.62 138.55 32.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -124.81 121.71 35.35 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 122.98 49.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -79.23 84.13 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.823 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 53.8 p30 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.773 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.79 158.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.61 150.47 20.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.118 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -98.43 127.12 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.87 116.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.675 -0.41 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -101.32 121.15 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.596 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -81.58 171.69 14.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.494 HD11 ' H ' ' C' ' 71' ' ' LEU . 71.4 mt -63.34 -25.65 68.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -75.11 -8.55 56.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 6.41 66.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.12 126.27 32.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.731 0.3 . . . . 0.0 110.3 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -103.04 131.06 50.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.902 0.382 . . . . 0.0 110.035 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.23 113.17 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.485 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.85 134.75 35.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.766 0.317 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.798 HD21 ' HG3' ' C' ' 33' ' ' LYS . 68.8 mt -132.66 131.48 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.4 115.37 13.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 0.0 110.686 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.447 HG12 ' CD ' ' C' ' 29' ' ' LYS . 21.3 m -134.64 166.08 29.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.558 ' O ' HD12 ' C' ' 56' ' ' LEU . 95.6 mt-10 -113.29 152.01 44.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.221 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.08 -25.51 78.18 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.953 1.769 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -91.05 -12.07 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.676 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.51 142.3 57.14 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.127 0.489 . . . . 0.0 110.928 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -80.46 166.67 21.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.972 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 1.001 HD12 HD23 ' C' ' 50' ' ' LEU . 33.2 mm -64.03 -35.85 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.739 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -58.6 -41.64 86.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.011 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.26 -41.89 93.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.112 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.575 HG21 HD21 ' C' ' 56' ' ' LEU . 64.3 t -63.76 -48.19 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.998 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.28 -31.48 72.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.115 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.79 95.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.249 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.507 ' HB3' HD22 ' C' ' 15' ' ' LEU . 67.6 mttm -60.66 -39.77 89.56 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.541 HG21 HD11 ' C' ' 69' ' ' LEU . 93.9 mt -66.6 -39.57 84.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.326 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.39 -38.68 81.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.422 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -68.69 -47.95 65.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.798 ' HG3' HD21 ' C' ' 15' ' ' LEU . 3.4 mttm -64.19 -40.89 97.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.58 153.84 51.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.121 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.07 57.71 2.73 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' C' ' 41' ' ' GLN . 39.1 mm -112.0 101.3 51.39 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.79 158.12 58.01 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.117 1.878 . . . . 0.0 112.219 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.15 -32.66 94.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.298 1.999 . . . . 0.0 112.349 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -66.94 -39.13 87.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.044 0.45 . . . . 0.0 109.898 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -103.67 23.37 12.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.686 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.728 ' HB2' HG22 ' C' ' 36' ' ' ILE . 0.8 OUTLIER -130.42 116.36 18.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.809 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -127.21 124.77 39.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -102.09 127.15 49.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.194 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.6 mt -125.89 126.05 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.944 0.402 . . . . 0.0 110.222 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -148.76 147.9 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 19.73 11.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.426 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.14 -13.27 60.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 147.96 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.238 0.542 . . . . 0.0 111.34 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -97.57 111.33 23.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.558 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 1.001 HD23 HD12 ' C' ' 23' ' ' ILE . 10.6 mp -64.29 97.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.794 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -76.98 -76.54 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.044 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -178.21 166.54 1.93 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.44 73.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -126.65 177.99 6.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.4 p -127.22 164.62 21.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.156 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.575 HD21 HG21 ' C' ' 26' ' ' VAL . 78.6 mt -61.55 -39.93 92.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.412 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.32 -28.55 69.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.62 -26.58 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.99 0.424 . . . . 0.0 110.385 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.403 ' CZ ' HD13 ' D' ' 73' ' ' LEU . 67.2 m-85 -104.16 12.0 34.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.291 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.54 38.16 29.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.195 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.41 105.06 13.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.969 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.13 -175.96 5.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.347 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -68.65 148.2 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.965 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 57.84 37.96 27.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.5 m -89.66 133.2 34.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.839 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -91.15 120.75 32.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.145 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.463 HD12 ' N ' ' C' ' 67' ' ' LEU . 5.2 mp -113.59 146.21 40.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -91.26 131.31 36.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.591 HD21 ' HG2' ' C' ' 41' ' ' GLN . 0.7 OUTLIER -106.17 119.13 38.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.299 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.477 ' N ' HD23 ' C' ' 69' ' ' LEU . 95.4 t -104.07 131.42 52.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.494 ' H ' HD11 ' C' ' 8' ' ' LEU . 26.4 mt -109.28 125.93 52.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.133 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -72.32 151.51 42.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.62 139.18 39.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -66.36 142.75 57.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.24 176.62 54.62 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.03 159.33 27.64 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 57.5 t0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.515 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -65.23 155.46 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.92 145.84 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -93.65 127.64 39.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.508 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.56 HG11 HD11 ' D' ' 30' ' ' ILE . 85.6 t -109.54 115.41 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.172 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -86.46 116.67 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.583 HG23 ' O ' ' D' ' 11' ' ' LYS . 82.0 p -74.63 171.26 14.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.087 0.47 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -41.43 73.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.391 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -76.31 -6.56 52.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.41 -13.31 59.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . 0.583 ' O ' HG23 ' D' ' 7' ' ' THR . 11.9 tmtt? -55.29 108.6 0.44 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -83.58 136.89 34.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.07 112.46 23.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.004 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.11 127.0 32.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.205 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.431 HD13 ' CB ' ' D' ' 29' ' ' LYS . 85.1 mt -126.06 120.77 31.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.789 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -66.1 108.97 2.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.719 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.4 m -131.57 166.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.94 154.54 41.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.53 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.88 -36.47 95.61 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.029 1.82 . . . . 0.0 111.861 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.0 p -80.54 -7.94 59.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -58.17 135.27 57.03 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.006 0.432 . . . . 0.0 110.748 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -78.23 162.48 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.79 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.31 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.687 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.55 -41.6 90.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.937 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.15 -41.59 98.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.049 0.452 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.56 -43.17 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.615 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.99 -38.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.157 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.58 90.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.107 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.719 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.8 mttm -60.77 -39.41 88.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.56 HD11 HG11 ' D' ' 5' ' ' VAL . 7.4 mm -64.93 -40.96 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.524 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.42 -40.41 94.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.712 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -65.15 -44.42 88.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.41 ' HD2' HD21 ' D' ' 15' ' ' LEU . 52.6 mttt -74.16 -66.26 0.74 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.375 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -92.25 171.56 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.004 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -91.1 18.84 49.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.552 HG22 ' HB2' ' D' ' 41' ' ' GLN . 30.2 mm -77.39 119.84 79.09 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.583 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.86 160.49 45.95 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.332 2.021 . . . . 0.0 111.478 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.58 -40.4 85.58 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.106 1.87 . . . . 0.0 112.993 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.08 -52.27 50.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.508 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.905 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.58 ' OE1' HD21 ' D' ' 43' ' ' LEU . 4.5 tt0 -65.23 112.64 3.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.889 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -118.1 111.2 18.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.311 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.58 HD21 ' OE1' ' D' ' 41' ' ' GLN . 64.3 mt -90.43 120.57 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.472 . . . . 0.0 110.514 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 91.3 mt -124.96 127.0 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 78.6 t80 -128.24 128.46 44.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.124 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.38 28.52 9.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.21 79.69 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -128.08 128.66 45.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.0 0.429 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.62 137.96 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.499 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' D' ' 59' ' ' TYR . 66.3 mt -84.64 118.87 24.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.261 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.36 137.77 41.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -62.76 137.77 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.471 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -16.87 57.75 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -78.81 178.68 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 110.459 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 80.5 p -125.53 161.87 26.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.114 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.36 -39.95 92.52 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.106 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.03 -27.58 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.424 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.09 -37.02 81.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.189 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.2 m-85 -98.25 15.02 25.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.084 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 54.74 40.45 31.92 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.859 0.361 . . . . 0.0 110.339 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -89.86 101.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -85.3 -175.83 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -64.09 166.67 7.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.032 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 45.72 36.49 2.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -89.61 122.86 33.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.19 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -83.46 125.48 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.135 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.81 162.75 15.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -109.99 120.73 43.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.381 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.493 HD11 HG21 ' D' ' 30' ' ' ILE . 1.3 tt -99.31 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 81.6 t -103.83 132.69 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.227 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.45 HD21 HD22 ' D' ' 69' ' ' LEU . 48.6 mt -104.78 128.66 53.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.231 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -61.32 152.27 29.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.686 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.456 ' O ' HD23 ' D' ' 73' ' ' LEU . 6.3 tt -120.4 87.86 2.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.709 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 46.45 55.41 7.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.997 0.427 . . . . 0.0 110.682 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.76 -127.25 40.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.924 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.394 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.14 149.18 41.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.468 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.55 126.71 35.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.428 0.632 . . . . 0.0 110.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 51' ' ' GLN . 88.7 mt -68.05 -36.08 79.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.809 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 ' CG1' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -148.81 161.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.17 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -174.01 122.43 0.31 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -155.74 158.14 37.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.989 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.5 mtt180 -75.54 119.54 19.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.76 146.25 25.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.326 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.21 150.71 17.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.88 167.08 12.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 111.454 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.4 mtp -132.92 175.32 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.849 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.8 m -125.65 121.69 34.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 37' ' ' THR . 29.1 tp -104.46 118.08 35.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.393 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -122.74 113.42 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.977 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.12 -86.33 0.48 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 p -146.51 23.78 1.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 110.612 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.522 ' O ' HD12 ' A' ' 33' ' ' LEU . 87.9 m -126.54 132.59 51.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 33' ' ' LEU . 63.4 t -110.12 123.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.305 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.499 HG22 ' HB3' ' B' ' 947' ' ' PRO . 42.2 p -118.21 122.42 30.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.115 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.57 148.5 59.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.772 1.648 . . . . 0.0 113.365 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.88 133.06 44.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.845 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -7.63 48.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.33 78.58 1.85 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -52.11 132.66 33.34 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.634 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.05 -163.92 11.47 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.227 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.4 tp -137.12 120.44 16.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.55 108.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.548 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.0 p90 -130.83 153.42 49.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' CG1' HG12 ' A' ' 24' ' ' VAL . 96.7 mt -119.0 139.69 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.746 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.09 128.14 27.67 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 123.83 0.706 . . . . 0.0 110.847 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.648 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.8 tt0 -99.0 125.15 44.4 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.416 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.495 HG23 ' CD2' ' A' ' 58' ' ' HIS . 10.7 p -83.51 171.47 13.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.682 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.88 -10.04 25.57 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.509 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.05 2.49 55.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.57 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 t 70.23 21.36 5.91 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 121.088 0.47 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.4 mt -99.45 120.65 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.57 HG21 HD23 ' A' ' 128' ' ' LEU . 49.1 mm -79.33 122.43 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.495 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.6 m-70 -98.56 115.44 28.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.58 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -96.09 107.98 20.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 96.9 m -121.38 146.15 47.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.728 0.775 . . . . 0.0 112.462 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -126.51 113.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.902 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -105.27 145.92 30.03 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.05 0.452 . . . . 0.0 110.572 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.13 132.19 34.71 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -71.64 -18.31 62.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.03 0.443 . . . . 0.0 110.852 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -59.55 -44.98 93.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.789 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.55 -10.36 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.66 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.68 22.85 78.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -102.46 147.16 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.8 106.41 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.67 -22.62 25.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.799 ' OD2' HD21 ' A' ' 73' ' ' LEU . 7.3 t0 -128.64 142.78 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.933 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' HD23 ' A' ' 73' ' ' LEU . 66.6 t0 -157.15 107.65 2.28 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.016 0.436 . . . . 0.0 110.193 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.799 HD21 ' OD2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -141.86 130.72 22.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.355 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.67 124.26 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.571 ' HB ' HD22 ' A' ' 128' ' ' LEU . 23.6 mm -111.6 119.6 60.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.602 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.38 161.03 68.99 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.332 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.89 142.12 97.94 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.063 1.842 . . . . 0.0 111.541 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 61.01 12.36 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.374 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -87.66 -37.39 16.79 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 120.584 0.231 . . . . 0.0 110.602 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.516 ' HB3' HD11 ' A' ' 96' ' ' LEU . 72.7 m -131.31 154.92 48.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.252 0.548 . . . . 0.0 111.745 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -126.72 128.21 46.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.113 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -100.39 117.2 34.1 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -143.64 167.34 22.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -83.56 160.53 21.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.551 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.05 89.21 13.43 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.333 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.3 60.23 7.76 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.124 1.882 . . . . 0.0 112.175 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -114.7 -40.52 3.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.409 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.3 t -128.89 79.65 74.16 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.578 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.29 130.32 39.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.301 2.001 . . . . 0.0 111.284 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 t 169.83 -36.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.17 -167.12 12.88 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.55 106.64 18.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.913 0.387 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.4 t -124.83 128.35 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.732 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -125.29 151.38 46.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.125 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -125.43 135.92 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.379 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 80' ' ' CYS . 60.1 tp -102.07 112.71 25.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -112.2 143.1 43.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.505 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.87 116.52 28.01 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.25 -37.53 85.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.787 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.77 -22.33 18.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.397 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.03 174.97 26.98 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -111.94 21.44 15.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.661 0.267 . . . . 0.0 110.294 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.99 149.02 39.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.79 152.42 47.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.479 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 95' ' ' VAL . 43.5 mt -120.16 154.63 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CE1' HD22 ' A' ' 33' ' ' LEU . 90.8 m-85 -124.46 134.74 52.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 0.0 110.287 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -138.85 155.31 48.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.106 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -129.97 137.27 50.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.7 mmm -72.23 138.0 47.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -1.19 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.292 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -74.1 132.25 79.93 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.09 -25.54 58.43 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.112 1.875 . . . . 0.0 112.585 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 139.59 50.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -94.17 0.89 56.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.056 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -54.28 -21.76 10.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -120.07 -15.65 8.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.71 -40.92 96.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.6 -42.15 98.27 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.166 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.15 -41.47 90.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.727 ' O ' HG23 ' A' ' 124' ' ' VAL . 59.9 m170 -65.28 -39.84 93.09 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.01 -41.99 99.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.666 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -67.56 -40.96 84.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.243 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.64 -38.63 91.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.8 t -58.52 -48.14 86.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.266 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -80.54 -27.21 37.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.33 -38.25 78.08 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.47 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -82.01 -32.25 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.994 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.571 HD22 ' HB ' ' A' ' 75' ' ' ILE . 73.5 mt -79.64 -25.16 41.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.304 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -110.83 -23.44 11.01 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.686 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -137.76 67.84 50.82 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.715 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.41 156.92 60.6 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.626 2.218 . . . . 0.0 112.569 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.127 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.69 89.3 52.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.29 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.33 139.32 73.61 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.475 2.116 . . . . 0.0 112.453 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -80.81 154.35 73.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.71 146.19 83.26 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.929 1.753 . . . . 0.0 112.278 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 163.55 36.91 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.791 2.327 . . . . 0.0 112.396 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.45 160.24 73.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 39' ' ' THR . 41.9 Cg_exo -58.49 146.54 90.24 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.565 2.176 . . . . 0.0 111.864 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -150.29 162.71 39.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -85.96 140.12 30.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.983 0.421 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . 0.782 ' O ' HD13 ' B' ' 951' ' ' ILE . 56.7 t80 -121.91 133.46 54.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.86 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.782 HD13 ' O ' ' B' ' 950' ' ' TYR . 9.1 mm -128.57 133.59 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -77.88 85.63 4.13 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.213 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.536 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.11 163.8 19.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.719 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.531 ' HB ' HD13 ' C' ' 67' ' ' LEU . 14.9 pt -143.65 145.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.261 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -93.59 113.05 25.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.392 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -97.27 115.63 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.628 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -100.67 127.72 46.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.673 HG22 HD23 ' C' ' 69' ' ' LEU . 81.4 p -82.03 175.73 10.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.76 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.576 HD11 ' H ' ' C' ' 71' ' ' LEU . 60.4 mt -62.61 -21.63 65.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -88.35 -4.33 58.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.75 74.9 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -59.36 120.78 9.94 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -101.93 132.2 47.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.5 107.05 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.328 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.06 120.66 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.55 130.99 54.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.606 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -74.9 115.94 15.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.466 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.479 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.2 m -134.92 165.16 31.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.62 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.489 ' O ' HD12 ' C' ' 56' ' ' LEU . 98.0 mt-10 -108.85 151.57 41.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.77 -25.31 75.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.106 1.871 . . . . 0.0 112.071 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 53.6 m -91.78 -10.27 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.527 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 143.25 57.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -80.76 164.42 22.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.609 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.907 HD12 HD23 ' C' ' 50' ' ' LEU . 41.1 mm -63.27 -37.43 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.827 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.75 -41.59 86.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -61.49 -43.6 98.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 110.523 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.533 HG21 HD21 ' C' ' 56' ' ' LEU . 63.2 t -62.97 -42.47 96.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -60.4 -39.95 89.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.59 90.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.199 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.479 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.99 -39.32 85.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.76 ' CD1' HD21 ' C' ' 43' ' ' LEU . 95.3 mt -65.71 -39.3 84.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.577 0.703 . . . . 0.0 110.32 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.79 -46.12 90.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -77.13 -14.64 59.76 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.665 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -102.09 -3.88 26.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -149.14 -42.48 0.14 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.224 0.535 . . . . 0.0 110.391 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.65 29.25 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.212 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' C' ' 41' ' ' GLN . 52.8 mt -72.08 128.43 89.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.777 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.65 153.27 48.89 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.828 1.685 . . . . 0.0 111.708 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.27 -38.17 61.27 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.066 1.844 . . . . 0.0 112.737 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.7 -39.77 92.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.842 0.353 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -89.44 -2.64 58.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.032 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.624 ' HG3' HG22 ' C' ' 36' ' ' ILE . 92.2 mt-30 -93.79 106.89 18.84 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.693 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.76 HD21 ' CD1' ' C' ' 30' ' ' ILE . 73.6 mt -79.54 133.9 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.837 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.539 HG21 ' HE1' ' A' ' 76' ' ' PHE . 80.5 mt -135.04 129.39 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.345 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 71.1 t80 -151.47 151.72 32.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.36 16.54 10.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.731 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -10.63 67.19 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.83 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.0 OUTLIER -112.68 145.14 40.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.312 0.577 . . . . 0.0 110.84 -178.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -73.63 129.82 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.905 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.907 HD23 HD12 ' C' ' 23' ' ' ILE . 9.2 mp -76.46 94.3 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.829 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.2 150.13 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 111.122 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -60.36 143.08 53.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.402 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.58 -19.35 48.02 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -88.14 169.1 12.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.522 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 72.9 p -118.17 164.5 15.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.954 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.533 HD21 HG21 ' C' ' 26' ' ' VAL . 80.0 mt -61.01 -41.14 95.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.587 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -64.24 -22.72 67.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.388 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.96 -36.68 82.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.992 0.425 . . . . 0.0 110.547 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.521 ' CE2' HD13 ' D' ' 73' ' ' LEU . 82.5 m-85 -99.92 15.76 26.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.103 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.5 t30 57.58 38.72 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.694 HD11 HD21 ' C' ' 50' ' ' LEU . 61.7 mt -83.99 105.29 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.899 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -92.16 -178.89 5.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.409 0.623 . . . . 0.0 111.159 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.46 146.88 52.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.009 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 60.93 15.79 6.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.215 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 33.7 m -69.87 133.63 47.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -87.4 118.49 26.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.723 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' C' ' 3' ' ' ILE . 6.8 mp -107.93 140.98 40.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.997 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -89.82 129.43 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.673 HD23 HG22 ' C' ' 7' ' ' THR . 50.2 tp -107.91 121.25 44.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.19 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 56' ' ' LEU . 90.5 t -108.4 132.3 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.152 0.501 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.576 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.7 mt -106.16 152.14 23.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.559 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -100.86 126.08 47.44 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.454 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.86 140.04 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.719 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -71.7 134.02 46.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.162 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.66 0.87 88.54 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.54 -165.84 54.51 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.524 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.82 157.04 22.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.351 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.84 148.12 25.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.419 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' D' ' 14' ' ' THR . 15.0 m-30 -89.11 121.97 31.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.788 HG11 HD11 ' D' ' 30' ' ' ILE . 58.9 t -110.1 105.97 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.554 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -89.12 129.95 35.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 110.893 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -89.16 175.98 7.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.812 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.7 mt -61.73 -35.44 78.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.913 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 58.7 p -70.46 -11.65 61.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 -12.79 63.0 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.04 127.83 33.13 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -98.82 133.62 42.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 13' ' ' ILE . 1.4 mt -124.23 111.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.429 HG23 ' CD2' ' D' ' 4' ' ' PHE . 17.5 m -82.76 125.91 31.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.86 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.52 125.97 48.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.475 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -69.3 113.87 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.619 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 13.1 m -135.99 170.58 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -120.1 156.39 54.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.254 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.42 -26.64 82.62 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.163 1.909 . . . . 0.0 112.069 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -83.71 -14.26 52.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.563 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.17 144.05 57.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -87.68 166.33 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.41 -39.55 85.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.066 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.52 -42.25 91.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.183 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -62.29 -39.85 94.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.28 -43.34 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.996 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -61.3 -40.02 92.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.211 0.529 . . . . 0.0 110.604 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.89 -39.2 91.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.929 0.395 . . . . 0.0 109.998 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.619 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 87.9 mttt -59.86 -38.03 80.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.788 HD11 HG11 ' D' ' 5' ' ' VAL . 5.3 mm -63.92 -39.93 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.156 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.78 -45.59 93.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.289 0.566 . . . . 0.0 110.635 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.2 -33.91 76.84 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.045 -0.409 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -89.95 -6.88 55.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -146.08 -53.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.0 110.456 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.28 20.68 4.68 Favored Glycine 0 CA--C 1.517 0.205 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.567 HD13 HD21 ' D' ' 71' ' ' LEU . 60.4 mt -95.35 114.18 63.26 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 120.134 -0.627 . . . . 0.0 110.418 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.01 153.82 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.094 1.863 . . . . 0.0 112.215 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.99 -28.85 86.9 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.648 2.232 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -91.46 -4.34 55.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -92.6 -16.87 25.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.551 ' OE1' HD11 ' D' ' 69' ' ' LEU . 15.6 pt20 -137.88 160.55 38.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.305 0.574 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.18 130.93 53.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.561 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.79 119.54 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.823 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -121.23 128.07 75.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.981 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 89.6 t80 -122.61 128.48 50.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.455 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 64.15 25.05 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.67 90.29 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -110.29 126.23 53.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -65.05 135.55 55.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.66 107.69 17.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.112 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -74.79 154.15 38.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.337 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -72.97 162.99 28.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.342 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.43 20.73 77.18 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -122.94 150.79 42.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.66 0.267 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.6 p -96.87 160.44 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.467 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.37 -39.09 92.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.412 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 95.9 p -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.232 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.2 -39.06 93.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.055 0.455 . . . . 0.0 110.361 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -94.42 13.36 24.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 t30 56.69 42.81 26.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 69.0 mt -90.97 104.24 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.097 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.04 179.31 5.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.438 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -60.74 150.65 31.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.52 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 58.49 45.42 16.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 85.5 p -101.21 128.89 47.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.988 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.426 ' C ' HD12 ' D' ' 67' ' ' LEU . 87.2 m -81.15 126.05 31.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.582 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.426 HD12 ' C ' ' D' ' 66' ' ' THR . 7.4 mp -117.03 148.27 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.38 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.67 116.32 28.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.441 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.551 HD11 ' OE1' ' D' ' 41' ' ' GLN . 5.2 tt -99.54 104.71 16.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.978 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.621 ' HA ' HD21 ' D' ' 8' ' ' LEU . 94.1 t -100.59 128.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.253 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.812 ' H ' HD11 ' D' ' 8' ' ' LEU . 81.9 mt -97.85 136.93 37.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.871 0.367 . . . . 0.0 110.755 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -79.09 154.33 29.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.83 HD22 ' HE2' ' C' ' 48' ' ' LYS . 57.1 mt -98.74 132.19 44.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.058 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -121.46 130.94 53.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.803 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.56 70.16 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -83.27 156.37 23.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.397 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -90.06 120.54 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.327 0.584 . . . . 0.0 110.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 51' ' ' GLN . 95.1 mt -69.05 -35.28 76.38 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -149.22 161.14 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.984 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.63 122.66 0.35 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.229 0.537 . . . . 0.0 110.814 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.98 158.22 38.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.878 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HA ' HD12 ' A' ' 46' ' ' LEU . 90.7 mtt-85 -76.46 120.5 21.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.538 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.78 148.01 26.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.5 150.64 17.64 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -87.72 165.44 15.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.953 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 26.4 mtp -134.01 175.07 9.8 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.1 m -129.8 126.73 38.79 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.355 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 33' ' ' LEU . 8.4 tt -102.16 125.52 48.88 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.472 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -116.13 103.29 10.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.903 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.16 -83.14 0.74 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -144.02 20.26 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.554 0.216 . . . . 0.0 110.879 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -122.22 129.18 52.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 HD12 ' A' ' 33' ' ' LEU . 57.8 t -100.74 125.47 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.626 HG22 ' HB3' ' B' ' 947' ' ' PRO . 27.3 p -118.72 128.28 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.328 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.99 145.97 51.37 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.779 1.653 . . . . 0.0 112.603 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -108.02 138.2 44.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.878 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -72.6 -5.42 37.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.993 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.2 73.67 0.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.64 134.83 41.46 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.408 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.76 -162.64 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.343 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.0 tp -136.67 126.44 25.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 108.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.979 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.6 p90 -133.22 153.5 51.49 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.922 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.414 ' HB ' HG12 ' A' ' 24' ' ' VAL . 96.3 mt -119.45 139.48 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.285 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.63 132.49 40.83 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 123.923 0.765 . . . . 0.0 110.147 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.665 ' HB2' HD11 ' A' ' 23' ' ' LEU . 49.5 tt0 -102.68 122.47 44.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.133 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.456 HG23 ' CD2' ' A' ' 58' ' ' HIS . 8.2 p -82.89 171.58 13.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.46 -10.06 22.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.705 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.6 8.17 40.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.47 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m 62.82 23.99 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 110.762 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.598 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 69.7 mt -98.8 120.32 39.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.527 HG21 HD23 ' A' ' 128' ' ' LEU . 51.9 mm -80.1 121.15 32.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.552 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.456 ' CD2' HG23 ' A' ' 52' ' ' THR . 75.3 m-70 -97.67 112.55 24.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.899 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -92.9 107.2 19.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 93.3 m -119.38 143.9 47.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.929 0.871 . . . . 0.0 112.847 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.2 t90 -126.85 113.44 16.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.109 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -103.9 144.32 31.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.631 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -82.83 130.52 35.14 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -71.36 -16.65 62.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.75 0.31 . . . . 0.0 110.755 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.54 -45.87 90.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.442 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.69 -11.77 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.54 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.73 22.45 78.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -102.57 152.0 21.68 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.57 102.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.371 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.88 -38.25 67.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.888 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.48 147.18 49.86 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.392 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.497 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p-10 -158.78 97.74 1.45 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.314 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD22 ' HG2' ' C' ' 48' ' ' LYS . 31.8 mt -124.55 136.78 54.26 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.095 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.56 119.47 30.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.705 HG21 ' SG ' ' A' ' 80' ' ' CYS . 22.5 mm -109.29 120.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 111.05 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.598 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.0 m-85 -85.13 163.03 47.28 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.51 141.48 95.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.171 1.914 . . . . 0.0 111.689 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 61.14 12.42 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.397 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -87.42 -25.99 23.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.705 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.3 p -149.98 167.02 27.89 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.452 0.644 . . . . 0.0 110.569 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -137.11 132.52 34.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.189 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -103.38 118.58 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.44 167.9 21.0 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.496 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -87.8 160.37 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.176 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.67 90.82 13.35 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.152 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.21 59.82 7.18 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -115.6 -36.72 4.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.526 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.9 t -127.89 81.72 69.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.288 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.29 130.4 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.898 1.732 . . . . 0.0 111.651 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t 169.1 -44.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.83 -147.83 5.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' HD3' HG22 ' A' ' 114' ' ' THR . 0.1 OUTLIER -118.13 105.73 12.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.941 0.4 . . . . 0.0 110.188 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.3 t -122.71 126.59 74.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -123.57 152.93 41.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.718 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -130.97 135.36 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.516 HD11 ' SG ' ' A' ' 80' ' ' CYS . 61.2 tp -100.87 121.84 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -116.78 124.85 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.026 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' HE2' HD12 ' A' ' 75' ' ' ILE . 32.3 m-85 -81.4 115.1 20.58 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.01 -37.54 82.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.497 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.72 -23.66 11.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.486 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.51 -24.5 72.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.192 -0.527 . . . . 0.0 111.894 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m 66.89 6.66 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.576 ' HD3' HD21 ' A' ' 105' ' ' LEU . 5.5 ttmm -98.36 150.17 21.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.498 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.6 mtt180 -131.23 136.78 48.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.835 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.576 HD21 ' HD3' ' A' ' 103' ' ' LYS . 40.1 mt -123.29 151.16 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.045 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 97.6 m-85 -123.67 137.52 54.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.41 155.22 47.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 111.4 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -129.82 136.75 49.94 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.127 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.82 141.26 58.35 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.341 0.591 . . . . 0.0 111.369 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -112.99 -8.2 13.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.169 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.2 135.15 89.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.704 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.94 -23.13 35.0 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.826 1.684 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -116.44 141.1 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.341 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.49 HG22 ' HD3' ' A' ' 92' ' ' ARG . 77.0 p -97.93 17.23 18.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.261 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.4 -21.14 59.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -135.64 17.76 3.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.841 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.63 -48.9 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.199 0.523 . . . . 0.0 111.059 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.63 -33.02 70.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.322 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.22 -44.78 90.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.489 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.748 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.2 m170 -62.01 -41.37 98.0 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.451 0.643 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.3 -44.83 95.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.847 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.5 -42.55 91.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.388 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.01 -37.61 88.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.918 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.0 t -58.78 -47.77 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.272 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -80.08 -28.41 39.14 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.843 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -68.91 -37.74 79.15 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.404 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -80.72 -33.16 35.45 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.731 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 75' ' ' ILE . 69.5 mt -79.58 -26.89 41.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -108.25 -24.01 11.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.655 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -136.88 69.19 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.797 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.37 157.78 55.87 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.854 2.369 . . . . 0.0 112.55 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.654 2.236 . . . . 0.0 112.211 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -128.95 150.59 75.64 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.634 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.96 147.02 33.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.695 2.263 . . . . 0.0 112.031 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.25 153.64 92.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.21 151.36 76.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.106 1.871 . . . . 0.0 112.253 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.09 -171.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.466 2.11 . . . . 0.0 112.096 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -120.06 155.08 55.87 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.626 ' HB3' HG22 ' A' ' 39' ' ' THR . 22.2 Cg_endo -60.93 141.76 95.55 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.352 2.035 . . . . 0.0 112.115 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.73 165.2 37.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.834 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.64 136.69 32.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.849 0.357 . . . . 0.0 110.41 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -120.62 121.21 37.84 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 55.5 mt -131.91 123.65 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -79.21 84.21 5.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.872 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.8 t0 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.452 179.552 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -62.26 156.13 22.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.369 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -136.78 157.02 35.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.362 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.619 ' CD2' HG23 ' C' ' 14' ' ' THR . 15.5 m-30 -96.19 122.59 39.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.897 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.3 t -110.43 101.85 13.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.224 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -88.34 124.09 33.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.177 0.513 . . . . 0.0 110.82 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.519 HG21 ' OE2' ' C' ' 34' ' ' GLU . 82.1 p -86.47 172.09 10.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.07 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.524 HD11 ' H ' ' C' ' 71' ' ' LEU . 70.5 mt -65.5 -19.08 65.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -83.95 -5.0 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.057 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.32 80.5 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.17 126.37 30.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.87 0.366 . . . . 0.0 110.218 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -97.6 131.22 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -115.84 116.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.374 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . 0.619 HG23 ' CD2' ' C' ' 4' ' ' PHE . 0.2 OUTLIER -85.15 117.12 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.428 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.65 116.41 27.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.922 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.75 105.99 1.4 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.731 HG12 ' HE3' ' C' ' 29' ' ' LYS . 28.4 m -130.45 162.71 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.497 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -105.88 155.72 37.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -37.79 93.7 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.896 1.731 . . . . 0.0 112.109 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -80.32 -7.55 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.301 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . 0.418 ' HB3' HD12 ' C' ' 56' ' ' LEU . 31.8 t0 -57.21 135.54 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -79.23 163.27 25.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.767 HD12 HD23 ' C' ' 50' ' ' LEU . 40.6 mm -64.54 -38.77 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.102 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.26 -41.48 88.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.995 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.05 -41.4 98.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.799 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.455 HG21 HD21 ' C' ' 56' ' ' LEU . 57.5 t -63.35 -42.98 98.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.417 ' HG2' HD11 ' C' ' 43' ' ' LEU . 55.0 mtmt -60.83 -40.17 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.635 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.83 92.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.104 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.731 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.2 mttm -59.62 -38.75 82.15 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.752 HD13 HD11 ' C' ' 69' ' ' LEU . 97.1 mt -66.37 -39.78 84.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.752 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -59.54 -46.93 87.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.365 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.21 -16.26 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.986 -0.446 . . . . 0.0 111.897 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -101.18 -5.81 25.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . 0.519 ' OE2' HG21 ' C' ' 7' ' ' THR . 81.5 mt-10 -148.31 -41.96 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.1 0.476 . . . . 0.0 110.476 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.8 8.16 28.43 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.352 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.08 128.78 82.27 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.899 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 160.44 43.66 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.564 1.509 . . . . 0.0 111.683 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.79 -39.16 93.4 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.274 1.982 . . . . 0.0 112.472 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.86 -39.88 93.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.761 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -89.17 -4.43 58.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.06 90.34 7.33 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -101.6 97.18 7.64 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.417 HD11 ' HG2' ' C' ' 27' ' ' LYS . 22.2 mt -88.27 129.47 35.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.594 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.415 HG21 ' HE1' ' A' ' 76' ' ' PHE . 83.7 mt -127.92 129.09 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.851 0.358 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -151.64 152.83 33.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.75 17.15 10.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.93 -13.59 60.8 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.675 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.99 146.5 42.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 110.599 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.19 132.18 42.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.045 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.767 HD23 HD12 ' C' ' 23' ' ' ILE . 6.8 mp -67.26 101.47 0.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.35 140.69 44.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.91 143.0 55.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.299 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.56 -16.26 61.34 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -83.44 176.19 9.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.193 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -122.27 161.95 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.817 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.455 HD21 HG21 ' C' ' 26' ' ' VAL . 84.5 mt -61.8 -40.39 95.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.823 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -63.69 -23.98 67.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -62.83 -37.63 87.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 110.149 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -96.46 13.48 27.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.252 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.05 42.42 22.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.41 HG21 HD22 ' C' ' 56' ' ' LEU . 64.9 mt -90.37 109.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.301 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -98.19 -177.99 3.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.213 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.26 146.89 52.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 59.34 42.28 18.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . 0.479 ' O ' HD12 ' C' ' 67' ' ' LEU . 45.7 m -97.55 127.28 43.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.98 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 87.1 m -76.86 126.57 31.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.113 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.479 HD12 ' O ' ' C' ' 65' ' ' SER . 5.7 mp -116.33 149.03 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.084 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.26 117.34 32.44 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.752 HD11 HD13 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -97.21 99.05 10.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.642 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -87.06 130.67 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.524 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.8 mt -110.39 141.23 43.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.162 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.71 142.43 57.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.0 131.19 38.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -62.68 -39.26 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.571 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.45 172.16 24.92 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.33 163.39 54.13 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.656 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.62 159.61 12.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.956 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.05 151.91 25.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.054 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.432 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.5 m-30 -93.16 121.94 35.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.536 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.2 105.33 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . 0.458 ' HG3' HG23 ' D' ' 66' ' ' THR . 32.2 mtmt -90.29 133.28 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.717 HG22 HD23 ' D' ' 69' ' ' LEU . 82.0 p -88.87 -174.9 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.592 HD21 ' HA ' ' D' ' 70' ' ' VAL . 88.7 mt -62.34 -38.08 88.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.004 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -72.84 -9.04 58.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.615 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.45 -7.44 75.04 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.61 124.86 21.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -96.09 131.25 42.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 110.673 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mt -123.56 111.54 29.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.552 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.432 HG23 ' CD2' ' D' ' 4' ' ' PHE . 8.3 m -81.49 125.71 30.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.425 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.8 mt -121.21 125.15 46.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.126 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.96 114.8 9.39 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.441 HG12 ' CD ' ' D' ' 29' ' ' LYS . 26.7 m -135.57 163.01 36.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -104.7 153.29 39.36 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.074 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.55 -36.17 97.58 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.948 1.766 . . . . 0.0 112.043 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.46 -0.65 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -62.28 136.63 58.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -76.96 161.81 28.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.26 0.552 . . . . 0.0 110.794 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.59 -38.54 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.27 -42.53 91.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.88 -41.3 97.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.64 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.4 -42.67 97.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.597 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.2 mtmt -60.71 -39.38 88.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.133 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.26 93.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.411 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.441 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.4 mttm -60.06 -39.53 86.32 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.53 -39.66 84.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.297 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.34 -39.78 84.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.335 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.68 -50.3 52.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.711 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.425 ' HD2' HD21 ' D' ' 15' ' ' LEU . 24.6 mttp -66.18 -40.41 90.43 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -128.66 147.63 50.76 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.06 59.32 3.12 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.563 HG23 HD22 ' D' ' 71' ' ' LEU . 31.0 mm -110.31 107.07 58.46 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.8 152.82 54.36 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.316 2.011 . . . . 0.0 111.747 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.61 -42.4 66.21 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.744 1.629 . . . . 0.0 112.884 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.6 -43.29 99.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -68.3 -38.55 81.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.444 ' HG3' HG22 ' D' ' 36' ' ' ILE . 68.2 mt-30 -58.05 118.03 4.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.013 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . 0.731 ' NE ' HD11 ' D' ' 44' ' ' ILE . 77.9 ttt180 -121.21 106.31 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' D' ' 27' ' ' LYS . 19.8 mt -96.15 115.93 28.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.081 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.731 HD11 ' NE ' ' D' ' 42' ' ' ARG . 83.9 mt -123.27 124.37 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.377 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 85.1 t80 -128.36 130.02 47.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.179 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.62 27.11 11.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.357 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.22 81.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -125.9 127.3 45.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.834 0.349 . . . . 0.0 110.725 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.47 137.0 55.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.47 HD12 ' CB ' ' D' ' 43' ' ' LEU . 77.9 mt -78.68 122.06 25.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.083 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -76.15 136.28 39.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -65.06 130.92 45.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.5 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.67 -15.81 52.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -79.88 -176.99 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.8 p -125.66 163.47 22.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.786 0.327 . . . . 0.0 110.358 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' D' ' 56' ' ' LEU . 85.7 mt -62.22 -40.06 94.86 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.606 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.4 p -64.1 -27.46 69.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.13 -29.72 71.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.123 0.487 . . . . 0.0 110.178 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -101.66 12.41 37.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.403 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.48 40.41 29.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.036 0.446 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 90.0 mt -89.82 107.22 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.673 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.09 177.89 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -59.75 149.79 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 60.01 18.66 7.81 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.631 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.0 m -73.81 129.65 38.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.07 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.647 ' C ' HD12 ' D' ' 67' ' ' LEU . 86.7 m -81.82 130.15 34.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.019 0.437 . . . . 0.0 110.58 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.647 HD12 ' C ' ' D' ' 66' ' ' THR . 9.4 mp -120.63 140.11 52.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.127 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -86.49 113.44 22.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.128 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.717 HD23 HG22 ' D' ' 7' ' ' THR . 62.8 tp -100.72 115.49 30.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.431 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.592 ' HA ' HD21 ' D' ' 8' ' ' LEU . 78.1 t -114.53 139.38 40.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.74 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.563 HD22 HG23 ' D' ' 36' ' ' ILE . 37.9 mt -102.31 121.09 41.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.161 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.33 146.76 42.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 mt -69.65 139.12 53.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.263 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -118.42 127.65 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.254 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.89 -130.56 50.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.859 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.872 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -72.26 147.13 46.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.975 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -94.16 113.65 25.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.082 0.468 . . . . 0.0 109.792 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' A' ' 57' ' ' ILE . 95.7 mt -67.53 -36.94 81.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' HE3' ' A' ' 123' ' ' LYS . 1.2 p -149.76 162.3 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.868 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.15 122.5 0.39 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.251 0.548 . . . . 0.0 110.934 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.78 158.16 37.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.889 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.06 123.8 25.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.574 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.0 21.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.176 0.512 . . . . 0.0 110.35 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.51 16.94 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -92.11 158.4 16.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.923 0.392 . . . . 0.0 110.78 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.33 163.32 25.99 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -115.69 129.92 56.66 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.741 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 37' ' ' THR . 31.5 tp -106.7 120.8 42.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.83 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -122.92 110.99 16.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.328 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.52 -93.61 0.55 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.3 p -137.45 21.27 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.604 0.24 . . . . 0.0 111.036 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.516 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.5 m -125.88 131.55 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.516 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' CG2' HD13 ' A' ' 33' ' ' LEU . 60.3 t -107.64 125.18 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.9 p -113.61 111.53 49.01 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.13 139.75 91.63 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.577 2.185 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -94.87 129.22 41.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -68.41 -10.17 53.42 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.864 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -72.19 82.85 1.01 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.19 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.27 133.59 52.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.193 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.8 -161.07 10.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.315 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.1 tp -138.77 126.98 22.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 t -100.2 110.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -133.13 155.0 50.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.26 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.4 mt -120.05 137.19 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.387 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.12 131.27 36.67 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.586 0.554 . . . . 0.0 110.231 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.471 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.4 tt0 -100.84 125.98 47.4 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.044 0.45 . . . . 0.0 110.144 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.504 HG23 ' CD2' ' A' ' 58' ' ' HIS . 16.5 p -86.33 172.94 10.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.634 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.37 -10.83 27.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.657 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.34 5.65 46.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.442 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 m 63.55 24.81 14.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.587 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 75.0 mt -100.6 122.78 43.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.511 HG21 HD23 ' A' ' 128' ' ' LEU . 51.0 mm -80.9 122.28 35.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.504 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.8 m-70 -98.36 114.9 27.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.693 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.46 108.39 20.32 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.9 m -121.44 146.92 46.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.753 0.787 . . . . 0.0 112.675 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -125.19 115.02 19.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.131 -1.395 . . . . 0.0 108.064 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -107.45 134.5 50.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.845 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.0 132.5 41.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.557 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -73.88 -18.55 60.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -59.94 -45.95 90.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.049 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -116.48 -16.26 10.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.102 0.477 . . . . 0.0 109.768 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.33 22.89 72.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -101.38 152.2 21.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.827 0.346 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -80.75 107.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.902 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.94 -27.5 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -127.94 144.15 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.183 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.571 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.8 OUTLIER -158.59 99.76 1.6 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.46 179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' C' ' 48' ' ' LYS . 40.5 mt -129.07 133.08 47.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.52 122.6 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.632 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.0 mm -112.39 121.31 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.366 0.603 . . . . 0.0 111.142 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 38.6 m-85 -85.56 163.39 44.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.718 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.51 140.53 93.54 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.246 1.964 . . . . 0.0 111.536 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t0 60.07 12.08 3.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.344 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.48 -26.48 30.2 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.298 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 96' ' ' LEU . 17.7 p -151.18 166.92 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.475 0.655 . . . . 0.0 110.677 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -133.58 132.06 40.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.259 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -103.4 119.45 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -143.86 168.87 18.94 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.742 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -85.7 157.06 20.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.58 89.37 7.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.319 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.18 61.03 7.64 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.965 1.776 . . . . 0.0 112.274 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.82 -39.22 4.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.398 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 p -129.69 73.61 81.38 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.45 130.06 36.75 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.213 1.942 . . . . 0.0 111.297 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.02 -45.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.146 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.88 -156.34 8.71 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.15 105.37 15.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.786 0.327 . . . . 0.0 110.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.63 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.08 152.22 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.405 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.86 134.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.281 0.562 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.3 tp -102.47 117.61 35.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -114.23 122.84 48.0 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.417 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.469 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 37.9 m-85 -78.46 114.1 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.95 -37.95 84.15 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.14 -23.03 12.71 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.376 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -71.42 -20.29 78.19 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.133 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 m 59.75 34.33 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.945 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 162.02 36.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.484 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -134.9 143.31 46.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.911 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 mt -119.81 147.09 45.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.5 m-85 -115.51 132.04 56.75 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.271 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.11 157.43 46.34 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.256 0.551 . . . . 0.0 110.938 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -134.25 141.64 47.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.387 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.0 mmm -74.68 139.09 43.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.062 0.458 . . . . 0.0 110.976 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.81 10.67 10.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.011 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.2 145.07 90.55 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.488 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.47 -39.1 79.08 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.994 1.796 . . . . 0.0 112.577 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -118.89 146.31 45.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.909 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.5 p -97.86 6.94 47.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.722 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -54.02 -20.98 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -126.94 14.77 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.155 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.59 -45.71 91.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.12 -33.06 67.52 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.521 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.6 -43.32 90.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.058 0.456 . . . . 0.0 110.641 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.772 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.3 m170 -65.31 -40.89 94.35 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.645 0.736 . . . . 0.0 109.383 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.6 t -62.32 -45.67 92.18 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.796 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -64.97 -43.34 92.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.322 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HE3' HG23 ' A' ' 24' ' ' VAL . 27.2 mtpp -62.48 -38.73 91.01 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.694 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.8 t -58.95 -47.65 89.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.36 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.23 -30.01 38.5 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.844 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.3 -38.94 85.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.567 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -80.33 -34.22 36.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.668 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.574 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.5 mt -77.52 -26.96 51.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.435 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -108.53 -20.46 13.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.272 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -140.39 68.54 32.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.443 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.41 158.27 56.61 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 C-N-CA 122.949 2.432 . . . . 0.0 112.495 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--N 1.312 -1.356 0 C-N-CA 122.64 2.227 . . . . 0.0 112.321 -179.611 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.83 148.16 98.87 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.61 152.82 38.43 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.587 2.192 . . . . 0.0 111.959 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.91 151.03 90.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.118 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.21 158.75 48.44 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.278 1.985 . . . . 0.0 112.239 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.93 168.41 23.99 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.706 2.271 . . . . 0.0 111.918 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -105.68 159.86 28.08 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.78 145.97 87.87 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.237 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.87 166.56 33.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -85.15 138.01 32.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.32 125.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.84 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.51 127.28 56.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -74.18 84.31 1.85 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.811 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.569 179.672 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -66.97 161.08 25.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.26 149.99 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.133 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.04 126.44 44.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.646 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.75 117.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -100.6 117.89 35.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.467 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.674 HG22 HD23 ' C' ' 69' ' ' LEU . 71.2 p -80.0 171.22 15.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.049 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.525 HD11 ' H ' ' C' ' 71' ' ' LEU . 64.9 mt -63.42 -24.02 67.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.173 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.2 p -75.42 -8.73 57.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.24 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -72.41 132.89 44.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.792 0.33 . . . . 0.0 110.264 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -109.09 131.71 54.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.229 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.25 117.37 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.819 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 135.72 34.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.665 HD21 ' CD ' ' C' ' 33' ' ' LYS . 16.0 mt -133.91 126.68 30.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.114 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -70.74 117.35 12.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.653 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 21.3 m -137.18 166.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.538 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.6 mt-10 -112.26 151.52 43.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.02 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.14 -26.37 81.48 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.981 1.788 . . . . 0.0 112.207 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -87.02 -11.51 50.18 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.743 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -62.99 143.49 57.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.615 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -81.67 165.95 20.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.315 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.634 HD12 HD23 ' C' ' 50' ' ' LEU . 42.4 mm -62.44 -39.18 83.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.314 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.48 -41.99 91.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -61.83 -41.57 97.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.141 0.496 . . . . 0.0 110.876 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.677 HG21 HD21 ' C' ' 56' ' ' LEU . 56.7 t -63.13 -43.35 98.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.702 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.79 -39.71 89.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.43 91.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 0.0 110.519 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.664 ' HB3' HD22 ' C' ' 15' ' ' LEU . 71.9 mttt -60.15 -39.76 87.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.373 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.8 ' CD1' HD21 ' C' ' 43' ' ' LEU . 96.8 mt -66.98 -38.4 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.257 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.28 -42.21 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -63.51 -43.79 96.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.665 ' CD ' HD21 ' C' ' 15' ' ' LEU . 0.0 OUTLIER -69.49 -65.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.225 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.41 155.9 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.854 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.8 57.82 4.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.674 HG22 ' HG3' ' C' ' 41' ' ' GLN . 32.2 mm -110.78 104.69 56.44 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.37 157.57 35.28 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.53 2.154 . . . . 0.0 112.041 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.07 -30.55 90.59 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.249 1.966 . . . . 0.0 112.309 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.83 -40.73 88.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.056 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -87.22 -9.67 54.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.58 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.674 ' HG3' HG22 ' C' ' 36' ' ' ILE . 86.1 mt-30 -81.73 95.84 7.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.334 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -110.36 93.67 4.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' C' ' 30' ' ' ILE . 74.3 mt -80.07 135.14 36.28 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.44 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 86.7 mt -135.8 127.33 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -152.0 149.83 29.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.805 0.336 . . . . 0.0 111.211 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.03 15.27 9.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.14 -15.2 60.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.457 ' HE3' HD22 ' A' ' 73' ' ' LEU . 12.1 mtpt -100.9 140.61 34.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.942 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -77.94 118.19 20.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.886 HD21 HD11 ' C' ' 61' ' ' ILE . 8.6 mp -66.56 86.14 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.243 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . 0.437 ' O ' HG21 ' C' ' 23' ' ' ILE . 24.5 pt-20 -74.52 -175.89 2.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.4 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.7 156.5 30.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.807 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.15 -152.23 48.17 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 55.36 172.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.519 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -125.99 167.96 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.348 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.677 HD21 HG21 ' C' ' 26' ' ' VAL . 78.8 mt -60.7 -40.74 93.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.563 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -63.78 -24.32 67.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.341 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.91 -37.06 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.446 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.793 ' CZ ' HD11 ' D' ' 73' ' ' LEU . 67.0 m-85 -96.44 13.78 26.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.997 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 58.58 40.59 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.886 HD11 HD21 ' C' ' 50' ' ' LEU . 60.9 mt -87.88 108.68 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.754 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -94.71 179.99 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.82 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.65 145.97 53.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 59.18 17.64 5.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 137.23 57.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -98.07 120.21 38.08 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.685 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.497 HD12 ' N ' ' C' ' 67' ' ' LEU . 4.8 mp -113.6 142.27 46.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.324 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -88.91 130.32 35.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.194 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.674 HD23 HG22 ' C' ' 7' ' ' THR . 59.9 tp -105.88 122.07 45.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.017 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.75 132.67 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.525 ' H ' HD11 ' C' ' 8' ' ' LEU . 27.8 mt -108.49 143.25 37.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.345 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -62.82 -39.39 94.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.686 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -108.41 132.11 54.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.539 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -63.32 -39.32 94.24 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.59 174.79 55.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.44 -173.99 54.24 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.648 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . 0.458 HE21 HG21 ' D' ' 14' ' ' THR . 9.8 pt20 -62.88 155.64 26.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.552 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -134.85 154.61 36.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.547 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.578 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.1 m-30 -94.87 125.08 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.397 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.83 99.06 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.383 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -85.18 130.05 34.68 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.73 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.838 HG23 HD23 ' D' ' 69' ' ' LEU . 0.2 OUTLIER -90.51 -175.06 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.709 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.656 HD11 ' H ' ' D' ' 71' ' ' LEU . 73.2 mt -70.85 -26.01 63.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.291 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -78.97 -9.98 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.55 -13.55 64.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.71 132.08 48.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 68.5 m -102.72 130.75 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 110.608 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 mm -113.47 117.9 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.489 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.578 HG23 ' CD2' ' D' ' 4' ' ' PHE . 0.5 OUTLIER -88.58 118.75 28.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.598 HD11 HG12 ' D' ' 30' ' ' ILE . 81.1 mt -117.44 116.95 28.17 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.67 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -65.46 105.69 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.674 HG12 ' HE3' ' D' ' 29' ' ' LYS . 17.8 m -129.13 166.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.205 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -115.18 155.91 46.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.03 -24.65 66.76 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.76 1.64 . . . . 0.0 111.707 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.7 p -88.18 -11.82 45.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.822 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.14 141.99 58.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.171 0.51 . . . . 0.0 111.103 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -81.52 164.18 22.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.505 HD12 HD13 ' D' ' 50' ' ' LEU . 48.7 mm -62.86 -42.28 95.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -59.98 -34.56 73.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.353 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -64.76 -41.14 96.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.494 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 -42.38 95.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.456 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.434 ' HG2' HD11 ' D' ' 43' ' ' LEU . 55.6 mtmt -60.56 -40.39 91.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.286 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.22 86.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.674 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.65 -39.5 84.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.607 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.598 HG12 HD11 ' D' ' 15' ' ' LEU . 60.7 mt -67.84 -39.52 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.173 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -58.98 -42.52 90.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.917 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -89.77 17.99 6.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -123.16 -38.01 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -124.85 -8.28 7.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.297 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.71 77.0 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.449 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.549 HD13 ' CD2' ' D' ' 71' ' ' LEU . 44.1 mt -82.04 121.58 79.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.512 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.55 153.61 60.01 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.956 1.771 . . . . 0.0 111.71 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.47 -39.52 73.97 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.112 1.874 . . . . 0.0 111.898 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.21 -39.66 93.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.683 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -83.54 -7.96 59.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.658 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.96 90.83 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.316 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -100.94 111.16 23.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.437 HD21 HD12 ' D' ' 30' ' ' ILE . 35.1 mt -96.67 114.83 26.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.384 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.45 125.14 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 71.0 t80 -144.12 151.29 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.334 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.13 22.91 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.62 16.01 80.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.54 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.4 ' NH1' ' HB1' ' D' ' 46' ' ' ALA . 32.1 ptt-85 -149.29 152.96 36.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 110.794 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.26 139.9 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.505 HD13 HD12 ' D' ' 23' ' ' ILE . 84.8 mt -76.38 127.57 33.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.75 135.54 40.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -67.09 132.16 47.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.211 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.17 -18.19 52.28 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -79.67 171.49 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 p -111.8 164.04 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.407 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.723 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.5 p -62.36 -29.15 70.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.4 -35.59 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.081 0.467 . . . . 0.0 110.164 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -96.56 12.58 31.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.304 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 55.18 41.79 31.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 110.14 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -90.39 104.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.638 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.39 -176.1 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -64.58 149.7 48.31 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.446 -0.501 . . . . 0.0 109.935 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 59.14 44.77 15.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 54.3 m -100.32 122.7 43.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.222 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -71.76 128.49 35.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.71 136.64 54.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.75 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -85.64 109.07 18.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.713 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.838 HD23 HG23 ' D' ' 7' ' ' THR . 63.0 tp -96.76 113.4 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.01 134.49 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.035 0.445 . . . . 0.0 110.054 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.656 ' H ' HD11 ' D' ' 8' ' ' LEU . 35.5 mt -105.15 143.39 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.685 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -84.42 161.31 20.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.793 HD11 ' CZ ' ' C' ' 59' ' ' TYR . 21.7 mt -65.05 137.86 57.96 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.58 132.24 43.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.96 -129.68 47.81 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.669 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.23 151.2 28.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.12 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.12 110.96 19.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.223 0.535 . . . . 0.0 109.926 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.8 mt -65.89 -38.46 88.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.708 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.22 162.78 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.842 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.6 122.91 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.207 0.527 . . . . 0.0 110.686 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.47 155.4 34.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.765 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.732 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -71.39 121.35 18.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.824 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.25 22.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.106 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.48 152.64 17.34 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -87.13 159.24 18.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.823 0.344 . . . . 0.0 110.737 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.1 mtp -124.81 176.17 6.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -126.01 126.51 44.41 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 37' ' ' THR . 33.4 tp -107.27 122.32 46.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -117.42 106.24 12.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.923 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.04 -87.27 0.38 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -139.72 23.78 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.687 0.279 . . . . 0.0 111.054 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.704 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.4 m -125.08 125.69 44.18 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.236 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.569 ' CG2' HD13 ' A' ' 33' ' ' LEU . 58.0 t -105.16 124.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.916 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.6 m -123.09 134.26 25.01 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.78 146.89 79.97 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.947 1.765 . . . . 0.0 112.875 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.51 150.82 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -80.73 -6.87 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.808 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -72.79 73.3 1.1 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.86 129.99 43.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.76 -159.58 9.26 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.229 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 27' ' ' ARG . 2.2 tp -140.32 127.75 21.36 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -99.99 110.0 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.556 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.0 p90 -132.42 154.8 49.48 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.196 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.1 mt -119.01 138.12 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.397 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -134.66 130.55 36.53 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.666 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.6 tt0 -101.1 124.38 46.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 0.0 109.954 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.481 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.0 p -85.15 172.5 11.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.816 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.48 -10.31 24.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.54 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -91.51 7.16 42.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.602 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m 63.37 23.86 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 110.603 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -98.63 122.48 41.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.516 HG21 HD23 ' A' ' 128' ' ' LEU . 51.8 mm -81.74 120.65 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.481 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.0 m-70 -97.85 111.24 23.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.973 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -91.0 106.69 18.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 92.7 m -119.03 146.62 44.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.708 0.766 . . . . 0.0 112.752 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.7 t90 -124.94 113.4 17.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.262 -1.336 . . . . 0.0 108.331 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -105.85 135.3 47.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.959 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -76.82 132.7 39.34 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -73.58 -18.68 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -59.88 -46.1 90.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.829 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.1 m -116.46 -15.18 10.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.057 0.456 . . . . 0.0 110.072 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.37 21.51 77.45 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -101.88 152.74 20.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.242 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.0 t -78.16 107.84 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.54 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -86.59 -28.26 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -129.28 143.8 50.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.191 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.767 ' O ' HD23 ' A' ' 73' ' ' LEU . 43.5 p-10 -157.88 101.96 1.81 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.193 0.521 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 72' ' ' ASP . 5.5 mt -129.7 134.03 47.41 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.24 120.14 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.2 mp -108.16 112.5 40.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -71.2 162.56 71.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.937 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.58 131.43 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.921 1.747 . . . . 0.0 111.668 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.7 t0 63.88 12.22 6.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.404 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -82.13 -35.92 28.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.315 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -128.74 150.62 50.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.301 0.572 . . . . 0.0 111.105 -178.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.567 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.2 tp10 -121.77 129.59 52.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.96 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -107.03 118.08 35.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.43 168.25 20.16 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.579 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -87.39 160.32 18.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.003 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.08 90.66 11.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.119 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.75 60.15 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.984 1.789 . . . . 0.0 112.359 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.84 -39.68 3.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.34 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.6 t -128.29 80.88 71.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.525 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.67 130.49 26.52 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.604 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 p 168.81 -41.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.02 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.98 -150.92 6.7 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.44 106.23 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 110.467 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.19 129.35 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.22 154.17 45.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.635 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.69 134.91 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.379 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 81' ' ' GLU . 61.4 tp -104.08 123.19 46.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -122.02 130.98 53.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.129 0.49 . . . . 0.0 110.915 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 61.3 m-85 -84.43 117.83 23.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.97 -31.52 71.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.462 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.73 -21.7 11.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.936 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -80.66 -25.68 55.84 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.961 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.31 8.93 6.0 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.309 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.618 ' HD3' HD21 ' A' ' 105' ' ' LEU . 22.8 ttmt -93.97 143.88 25.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.811 0.339 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -122.83 125.27 45.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.469 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.618 HD21 ' HD3' ' A' ' 103' ' ' LYS . 52.9 mt -114.27 141.88 47.01 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.52 ' CE1' HD22 ' A' ' 33' ' ' LEU . 99.6 m-85 -115.07 134.74 54.91 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -138.01 153.55 49.39 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.276 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -129.03 136.44 50.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.532 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.445 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 29.9 tpp -72.34 134.08 45.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.078 0.466 . . . . 0.0 111.107 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.15 -0.9 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.913 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 109' ' ' MET . 99.3 mt-10 -73.16 133.08 81.62 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.278 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.96 -24.84 39.1 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.9 1.733 . . . . 0.0 112.88 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -111.25 140.8 45.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 p -99.0 12.32 36.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.371 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.92 -20.91 60.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.595 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -126.36 10.87 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.359 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.48 -47.02 83.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.534 . . . . 0.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.31 -31.04 65.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.122 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.64 -45.0 80.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.926 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.671 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.8 m170 -62.81 -41.15 99.17 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.704 0.764 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.55 -44.34 96.59 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.506 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -65.68 -43.36 89.52 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.818 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.4 -42.19 99.24 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 120' ' ' HIS . 59.9 t -58.59 -48.8 84.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.912 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.39 -39.16 88.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.298 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -74.39 -22.93 58.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.192 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 m-85 -89.42 -28.25 19.86 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.527 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.516 HD23 HG21 ' A' ' 57' ' ' ILE . 63.1 mt -92.91 -16.72 24.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.062 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -117.16 -17.61 10.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.316 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.52 63.98 18.17 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.798 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.82 153.67 68.39 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 122.522 2.148 . . . . 0.0 112.443 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.313 -1.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.22 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 48.69 70.74 1.9 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.643 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.73 145.73 70.34 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -73.73 159.15 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.298 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.14 154.36 46.31 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.762 2.308 . . . . 0.0 111.998 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.09 -155.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.615 2.21 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -125.39 155.34 71.85 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.01 143.44 90.95 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.473 2.115 . . . . 0.0 111.676 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -156.97 166.99 31.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.77 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -86.03 135.33 33.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 110.618 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -112.55 123.2 49.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.766 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.29 122.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.95 84.94 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.069 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 30.3 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.736 179.776 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -67.67 161.15 26.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.503 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.66 143.11 31.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.417 ' HD2' HG21 ' C' ' 12' ' ' THR . 6.4 m-85 -87.5 123.74 32.73 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.42 114.68 47.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.413 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -100.74 121.94 42.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.901 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 79.7 p -83.39 172.49 12.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.597 HD11 ' H ' ' C' ' 71' ' ' LEU . 67.2 mt -62.83 -25.09 68.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.289 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -73.9 -10.04 59.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -11.08 70.52 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.76 132.79 47.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . 0.417 HG21 ' HD2' ' C' ' 4' ' ' PHE . 93.3 m -109.63 132.21 54.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.556 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.65 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.677 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -84.25 130.17 34.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.49 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.6 mt -123.79 130.21 52.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.687 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.42 115.36 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' C' ' 29' ' ' LYS . 22.4 m -135.35 166.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.0 150.7 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.961 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.27 -36.57 86.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.94 1.76 . . . . 0.0 112.069 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -83.31 -9.98 58.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.85 138.52 57.24 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.663 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -79.5 163.81 24.42 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.772 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.974 HD12 HD23 ' C' ' 50' ' ' LEU . 42.0 mm -65.39 -36.7 78.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.857 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.49 -44.15 89.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -62.9 -41.19 99.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 110.814 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.411 HG21 HD21 ' C' ' 56' ' ' LEU . 62.0 t -63.37 -42.86 97.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.48 -39.02 86.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.68 91.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.397 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.515 ' CB ' HD13 ' C' ' 15' ' ' LEU . 67.2 mttm -60.63 -39.19 87.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.71 ' CD1' HD21 ' C' ' 43' ' ' LEU . 96.8 mt -67.63 -39.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.187 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.21 -38.51 80.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.241 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -67.32 -50.86 58.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.649 ' HG3' HD21 ' C' ' 15' ' ' LEU . 22.1 mttt -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.7 151.08 51.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.77 64.23 1.89 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.648 HG22 ' HB2' ' C' ' 41' ' ' GLN . 42.1 mm -117.98 93.11 43.72 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 149.59 70.68 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.744 2.296 . . . . 0.0 112.11 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -51.69 -42.59 55.86 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.112 1.874 . . . . 0.0 112.277 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.2 -38.66 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 110.347 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -95.7 25.39 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.507 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.648 ' HB2' HG22 ' C' ' 36' ' ' ILE . 12.7 tt0 -131.61 119.87 22.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -127.23 106.64 9.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.71 HD21 ' CD1' ' C' ' 30' ' ' ILE . 63.4 mt -85.13 138.51 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.4 mt -134.39 130.23 53.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.599 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 69.0 t80 -156.37 155.88 32.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.55 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 67.54 14.13 9.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.845 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 89.59 -14.04 62.45 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.613 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.0 OUTLIER -117.09 150.18 39.08 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.407 0.622 . . . . 0.0 110.551 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.04 137.66 45.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.509 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.974 HD23 HD12 ' C' ' 23' ' ' ILE . 6.6 mp -74.13 101.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.18 139.43 42.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -61.48 138.81 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -17.68 55.66 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -83.03 175.68 9.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -119.23 162.21 19.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.279 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.411 HD21 HG21 ' C' ' 26' ' ' VAL . 80.9 mt -61.31 -41.26 96.7 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.757 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.6 p -63.25 -24.07 67.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.839 0.352 . . . . 0.0 110.684 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.28 -36.92 83.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.548 ' CE2' HD13 ' D' ' 73' ' ' LEU . 66.2 m-85 -98.3 14.47 27.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.272 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 57.69 38.68 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.894 0.378 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.41 HG21 HD22 ' C' ' 56' ' ' LEU . 53.1 mt -83.82 111.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.234 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -98.08 178.51 5.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -60.33 146.09 45.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.957 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 59.76 22.1 10.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . 0.532 ' O ' HD12 ' C' ' 67' ' ' LEU . 17.0 m -74.34 127.03 31.96 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.874 0.368 . . . . 0.0 110.185 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 58.1 m -80.33 126.43 31.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.532 HD12 ' O ' ' C' ' 65' ' ' SER . 4.5 mp -116.41 152.86 33.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -103.0 126.18 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.152 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.656 HD22 HD21 ' C' ' 71' ' ' LEU . 2.3 tt -103.4 122.27 44.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 56' ' ' LEU . 47.6 t -109.12 132.49 57.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.656 HD21 HD22 ' C' ' 69' ' ' LEU . 29.1 mt -107.25 135.54 48.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.081 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.631 ' O ' HD22 ' C' ' 73' ' ' LEU . 94.1 mtt-85 -62.18 -39.47 92.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 110.509 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . 0.631 HD22 ' O ' ' C' ' 72' ' ' ARG . 1.5 mm? -126.54 -77.18 0.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.328 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . 0.569 ' O ' HD13 ' C' ' 71' ' ' LEU . 12.8 tpt180 -153.62 -54.91 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.23 -172.06 55.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.72 90.27 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.69 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -63.35 157.07 23.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.023 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 17.5 pt -138.17 145.17 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.163 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -86.5 126.96 34.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.841 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -112.38 101.18 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -90.67 127.63 36.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.696 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -89.73 -179.21 5.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.688 HD11 ' H ' ' D' ' 71' ' ' LEU . 79.3 mt -64.23 -34.59 78.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.0 p -68.21 -12.88 61.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.627 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.18 63.39 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.14 129.96 42.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -102.11 132.35 48.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.458 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.419 HD13 HG21 ' D' ' 13' ' ' ILE . 1.4 mt -126.95 110.4 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.956 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -81.38 130.4 35.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.571 HD21 ' HD2' ' D' ' 33' ' ' LYS . 91.7 mt -125.73 123.73 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.471 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -66.11 112.43 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.073 0.463 . . . . 0.0 110.946 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.517 HG12 ' CD ' ' D' ' 29' ' ' LYS . 20.0 m -136.08 165.57 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.881 -0.512 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . 0.602 ' O ' HD12 ' D' ' 56' ' ' LEU . 96.1 mt-10 -111.27 152.63 43.96 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.115 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -38.34 86.01 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.826 1.684 . . . . 0.0 112.222 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -66.27 -36.49 83.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.162 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -50.45 140.57 13.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.688 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 31.0 p -87.05 169.46 12.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.108 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.38 -34.73 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.279 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.63 -44.07 89.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.102 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.62 -42.4 99.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.466 HG21 HD21 ' D' ' 56' ' ' LEU . 68.0 t -63.21 -42.97 98.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.462 ' CG ' HD22 ' D' ' 43' ' ' LEU . 56.5 mtmt -60.22 -40.42 90.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.58 94.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.704 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.517 ' CD ' HG12 ' D' ' 17' ' ' VAL . 68.4 mttm -60.81 -39.19 88.02 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.665 0.745 . . . . 0.0 109.089 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' D' ' 43' ' ' LEU . 97.4 mt -63.53 -40.13 87.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.548 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -59.08 -42.17 89.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.732 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.74 -40.71 93.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.751 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.571 ' HD2' HD21 ' D' ' 15' ' ' LEU . 28.0 mttm -77.32 -62.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.327 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.16 156.4 18.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.375 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.92 55.48 4.26 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.656 HG22 ' HB2' ' D' ' 41' ' ' GLN . 41.9 mm -109.8 99.06 36.7 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.136 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.31 153.13 71.47 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.775 1.65 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.62 -40.32 73.37 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.079 1.853 . . . . 0.0 111.952 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.36 -39.37 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 110.402 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -103.1 35.23 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.656 ' HB2' HG22 ' D' ' 36' ' ' ILE . 12.0 tt0 -136.65 124.22 22.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.937 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -122.16 104.68 9.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.086 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.53 HD11 ' CD1' ' D' ' 30' ' ' ILE . 3.5 mp -85.31 115.23 22.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.935 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -126.07 126.11 69.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.435 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.569 ' HB2' HD21 ' D' ' 50' ' ' LEU . 52.1 t80 -63.39 -46.21 87.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.658 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.71 -78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.776 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.26 2.56 57.82 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -145.02 136.81 25.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.126 0.489 . . . . 0.0 110.931 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -78.55 138.07 38.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.378 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' D' ' 45' ' ' PHE . 77.7 mt -74.47 122.96 23.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.96 132.56 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 133.63 51.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.619 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.41 55.61 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -82.3 147.21 29.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.735 0.302 . . . . 0.0 111.011 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 48.8 p -75.71 162.57 28.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.602 HD12 ' O ' ' D' ' 18' ' ' GLU . 80.5 mt -67.36 -38.27 84.52 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.632 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.09 -25.34 67.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.942 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.31 -37.63 83.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -98.06 15.15 25.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 54.37 39.89 31.31 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.75 91.32 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.779 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -82.11 177.99 8.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.974 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -58.7 151.37 21.16 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 60.09 44.51 12.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -97.29 120.9 38.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.526 ' C ' HD12 ' D' ' 67' ' ' LEU . 84.9 m -75.06 127.27 32.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.526 HD12 ' C ' ' D' ' 66' ' ' THR . 8.2 mp -121.21 126.83 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.194 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.01 120.76 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.95 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.458 HD22 HD21 ' D' ' 71' ' ' LEU . 3.5 tt -100.12 112.22 24.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.978 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' D' ' 8' ' ' LEU . 92.1 t -99.92 132.16 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.688 ' H ' HD11 ' D' ' 8' ' ' LEU . 60.9 mt -102.4 135.77 43.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -72.4 136.05 45.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.613 HD22 ' HE2' ' C' ' 48' ' ' LYS . 53.3 mt -98.63 6.49 47.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.824 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -54.59 134.15 46.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.06 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.57 -19.82 43.78 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.357 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.185 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.518 179.788 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.72 152.36 43.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.21 127.23 37.61 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.708 0.765 . . . . 0.0 110.206 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 51' ' ' GLN . 84.3 mt -67.12 -37.48 83.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.53 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.495 HG11 HG22 ' A' ' 124' ' ' VAL . 1.4 p -148.62 162.93 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.829 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -173.85 122.03 0.32 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.344 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.78 151.4 27.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.912 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -70.37 123.08 20.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 110.357 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -154.93 145.45 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.0 154.26 16.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -87.1 172.62 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 111.165 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 23.4 mtp -138.79 173.72 11.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -124.89 123.6 40.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.53 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 37' ' ' THR . 25.9 tp -107.61 117.24 33.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -120.97 114.46 21.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.953 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.78 -90.09 0.48 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.1 p -141.66 21.14 2.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.841 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.581 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.8 m -123.05 130.86 53.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 33' ' ' LEU . 96.3 t -109.42 123.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.976 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.821 HG22 ' HB3' ' B' ' 947' ' ' PRO . 59.4 p -118.25 132.77 23.61 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.685 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.57 142.67 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.963 1.775 . . . . 0.0 113.05 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -97.74 145.62 26.17 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.733 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -81.21 -6.86 59.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.132 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -73.35 75.41 1.37 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.61 134.12 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.28 -156.53 7.88 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.568 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -138.72 123.01 18.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 28' ' ' ALA . 56.1 t -95.77 108.42 21.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.711 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.4 p90 -131.25 153.88 49.06 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.665 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 24' ' ' VAL . 95.5 mt -117.67 139.83 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.548 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.32 128.67 26.05 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 123.84 0.713 . . . . 0.0 110.854 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.537 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.0 tt0 -98.29 124.22 42.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.308 0.575 . . . . 0.0 110.278 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 58' ' ' HIS . 14.5 p -83.75 171.61 13.01 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.54 -10.05 23.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.549 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -89.22 1.97 54.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.5 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.66 19.18 7.4 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.672 HD11 HG11 ' C' ' 70' ' ' VAL . 72.4 mt -98.95 122.73 42.58 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 mm -79.21 125.06 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.506 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.7 m-70 -101.11 114.87 29.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.108 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -93.31 106.67 18.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.89 145.46 45.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -126.96 111.98 14.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.837 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -102.59 145.24 29.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.627 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -81.7 133.55 35.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -73.96 -17.62 60.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.937 0.399 . . . . 0.0 110.749 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.4 m -60.18 -45.3 93.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 m -117.79 -12.97 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.456 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.86 23.24 75.37 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -102.51 151.77 21.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.771 0.32 . . . . 0.0 110.813 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.01 109.03 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.309 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.06 -28.42 21.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.92 145.37 50.98 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.075 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.778 ' O ' HD23 ' A' ' 73' ' ' LEU . 64.4 t0 -158.09 100.44 1.71 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.944 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.778 HD23 ' O ' ' A' ' 72' ' ' ASP . 4.7 mt -131.7 129.24 40.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.441 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -75.29 125.97 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.105 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 74' ' ' ILE . 26.2 mm -115.28 121.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.915 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.474 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 39.3 m-85 -82.79 159.76 62.64 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.274 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.09 142.44 97.06 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.992 1.795 . . . . 0.0 111.324 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 61.27 12.64 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.876 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -93.09 -33.33 14.12 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.635 0.255 . . . . 0.0 110.889 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -139.48 148.42 42.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.5 tp10 -120.89 132.24 54.86 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.403 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -105.82 115.83 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -140.81 168.97 18.53 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.098 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -85.61 162.38 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.316 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.54 88.56 9.42 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.317 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.47 60.95 8.02 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.507 2.138 . . . . 0.0 112.09 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 -41.99 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.451 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.3 t -129.23 80.01 73.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.474 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.23 130.11 38.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.189 1.926 . . . . 0.0 111.219 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t 168.02 -39.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.627 0.58 . . . . 0.0 110.123 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.54 -170.1 11.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.605 ' HG3' HG22 ' A' ' 114' ' ' THR . 1.4 mmt-85 -95.96 107.0 19.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.732 0.301 . . . . 0.0 111.002 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.07 129.42 71.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -122.66 156.06 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.971 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.75 131.45 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 81' ' ' GLU . 60.7 tp -102.34 123.23 45.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -118.98 137.54 53.44 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.74 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -92.8 112.75 24.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.309 0.576 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.88 -37.92 88.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.828 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.78 -21.63 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.514 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.62 -173.16 20.74 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.8 m -122.52 25.75 8.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.941 0.4 . . . . 0.0 110.299 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 149.43 33.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -134.81 144.86 47.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.463 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -120.2 152.08 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.768 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 31' ' ' MET . 98.1 m-85 -124.03 135.0 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.812 0.339 . . . . 0.0 110.578 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.35 158.7 43.84 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -131.99 135.98 46.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.574 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.1 mmm -72.43 139.91 48.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.0 110.85 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -101.38 0.29 36.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.339 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -72.19 145.2 88.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.15 -28.35 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.095 1.863 . . . . 0.0 112.728 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.07 143.62 49.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.147 0.499 . . . . 0.0 110.321 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.605 HG22 ' HG3' ' A' ' 92' ' ' ARG . 76.9 p -89.52 -0.16 57.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.268 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.11 -19.22 42.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -117.76 -18.38 9.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.3 -41.03 98.17 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.335 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.23 -40.03 95.19 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.394 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.37 -42.92 95.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.535 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.724 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.5 m170 -65.87 -40.07 91.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.476 0.655 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.91 -43.48 98.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.464 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -66.64 -41.44 88.26 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.524 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -64.59 -41.08 96.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.4 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.2 t -57.29 -46.98 85.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.72 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -62.21 -39.45 92.78 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.463 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.65 -25.59 61.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.019 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -87.62 -26.05 23.25 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.999 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 HG12 ' A' ' 124' ' ' VAL . 88.3 mt -95.44 -16.37 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.467 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -115.34 -22.44 9.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.09 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -135.22 71.76 67.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.935 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.42 147.57 77.15 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.254 1.97 . . . . 0.0 112.365 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.585 0 C-N-CA 122.463 2.109 . . . . 0.0 112.213 179.817 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.46 152.43 95.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.69 154.74 49.45 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.811 2.34 . . . . 0.0 112.385 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.72 156.58 35.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.382 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -53.18 138.08 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.839 1.693 . . . . 0.0 112.255 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 172.96 15.3 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -95.66 156.08 37.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.821 ' HB3' HG22 ' A' ' 39' ' ' THR . 34.8 Cg_endo -66.06 151.42 83.86 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.78 166.28 32.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.798 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -85.36 134.58 34.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -120.21 132.48 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.415 HD13 HG21 ' B' ' 951' ' ' ILE . 2.9 mt -130.18 128.69 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -76.2 85.79 3.03 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.111 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.664 179.921 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.733 HE21 HG21 ' C' ' 14' ' ' THR . 14.1 pt20 -58.34 158.21 7.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.654 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.681 HD13 HD21 ' C' ' 56' ' ' LEU . 20.9 pt -139.05 142.27 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.911 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -81.94 127.21 32.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.157 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -114.67 115.84 50.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -96.91 118.6 33.68 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.17 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -75.23 173.73 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.429 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -45.86 -31.56 2.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.533 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 76.9 p -99.96 -179.87 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.56 -19.11 53.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -53.1 129.37 30.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.049 0.452 . . . . 0.0 110.728 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -127.58 134.6 49.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.454 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.533 HD13 ' HG2' ' C' ' 34' ' ' GLU . 0.0 OUTLIER -130.7 122.39 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.517 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . 0.733 HG21 HE21 ' C' ' 2' ' ' GLN . 85.7 m -88.8 131.87 34.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.595 HD13 ' CB ' ' C' ' 29' ' ' LYS . 65.7 mt -119.3 125.1 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' C' ' 2' ' ' GLN . 8.0 pm0 -65.94 109.68 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 111.009 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.652 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.3 m -133.13 163.78 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.487 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -108.07 156.08 38.94 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.159 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.29 -37.85 96.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.136 1.891 . . . . 0.0 111.87 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -79.72 -7.2 58.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . 0.54 ' HB3' HD13 ' C' ' 56' ' ' LEU . 34.6 t0 -57.6 137.57 56.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.008 0.432 . . . . 0.0 110.899 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -80.75 160.74 24.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.835 HD12 HD23 ' C' ' 50' ' ' LEU . 43.1 mm -63.7 -41.41 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -57.95 -36.63 72.81 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.292 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.0 -41.51 95.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.556 . . . . 0.0 110.8 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.814 HG21 HD11 ' C' ' 56' ' ' LEU . 61.5 t -63.6 -42.63 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.773 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.469 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.8 mtmt -60.76 -39.62 89.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.354 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.92 93.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.652 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.652 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.1 mttm -60.22 -38.86 84.65 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.77 HD13 HD11 ' C' ' 69' ' ' LEU . 97.2 mt -65.05 -38.98 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.962 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -59.01 -43.91 91.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.411 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.75 -43.37 98.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.833 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -72.09 -75.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . 0.533 ' HG2' HD13 ' C' ' 13' ' ' ILE . 77.1 mm-40 -93.71 151.49 19.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.366 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.46 56.02 4.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.464 HG23 HD22 ' C' ' 71' ' ' LEU . 42.6 mm -106.4 109.97 63.52 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.69 154.36 49.56 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.054 1.836 . . . . 0.0 112.195 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.98 -38.85 80.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.112 1.875 . . . . 0.0 112.235 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -61.52 -39.97 92.93 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -87.02 -3.18 59.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.476 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.401 ' HG3' HG22 ' C' ' 36' ' ' ILE . 81.2 mt-30 -88.16 67.15 8.76 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.565 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -84.27 109.89 18.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' C' ' 27' ' ' LYS . 23.4 mt -100.32 128.94 46.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.239 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.4 mt -128.79 128.67 67.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.69 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -147.8 145.42 28.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.435 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 19.84 7.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.099 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 75' ' ' ILE . . . 90.31 -13.15 65.91 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.758 ' HD2' HD23 ' D' ' 73' ' ' LEU . 72.8 mmtt -91.66 145.99 24.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.27 0.557 . . . . 0.0 111.482 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -95.21 105.33 17.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.835 HD23 HD12 ' C' ' 23' ' ' ILE . 10.2 mp -65.86 88.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.17 -74.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -177.05 169.02 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.46 20.84 77.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.32 171.28 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 110.025 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -126.33 163.69 22.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.8 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.814 HD11 HG21 ' C' ' 26' ' ' VAL . 3.1 mp -57.87 -43.14 85.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.587 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -63.09 -22.35 66.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.951 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.77 -36.56 83.48 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.354 0.597 . . . . 0.0 109.784 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.64 ' CE2' HD22 ' D' ' 73' ' ' LEU . 97.2 m-85 -100.28 11.29 39.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.454 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 57.7 46.41 17.39 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.298 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' C' ' 56' ' ' LEU . 80.9 mt -92.71 119.84 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.542 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.99 -178.9 3.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.83 147.84 52.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 58.79 45.21 15.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.215 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 54.7 m -98.45 126.36 43.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.075 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 82.3 m -75.62 126.97 32.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.1 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -112.52 145.44 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.12 114.62 26.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.387 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.77 HD11 HD13 ' C' ' 30' ' ' ILE . 1.2 mt -96.17 126.43 41.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.261 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.648 HG11 HD11 ' A' ' 56' ' ' LEU . 58.3 t -116.45 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.464 HD22 HG23 ' C' ' 36' ' ' ILE . 27.4 mt -103.51 149.19 25.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.286 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -62.16 -39.9 94.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.498 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.0 mt -113.69 147.45 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.613 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -60.66 -40.61 92.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.12 -158.52 53.38 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.68 179.08 47.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 64.2 t0 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.326 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.28 163.52 15.25 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' D' ' 65' ' ' SER . 16.3 pt -141.84 142.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.044 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.64 ' HD2' HG21 ' D' ' 12' ' ' THR . 5.5 m-85 -87.01 126.56 34.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.75 105.36 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -88.57 125.86 34.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.71 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.581 HG22 HD23 ' D' ' 69' ' ' LEU . 73.7 p -78.01 -166.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.883 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' D' ' 70' ' ' VAL . 92.4 mt -59.16 -28.47 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.793 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -102.91 -177.63 3.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.36 57.6 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -53.07 129.85 32.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 110.894 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.64 HG21 ' HD2' ' D' ' 4' ' ' PHE . 98.4 m -123.93 138.14 54.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.029 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.51 HG22 ' HD2' ' D' ' 33' ' ' LYS . 0.9 OUTLIER -122.75 109.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.956 -178.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -85.41 129.91 34.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.438 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.539 HD21 ' HD2' ' D' ' 33' ' ' LYS . 96.1 mt -122.07 134.07 54.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.44 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.26 117.54 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.732 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.439 HG12 ' HE2' ' D' ' 29' ' ' LYS . 21.7 m -136.94 167.44 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.168 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.23 154.2 45.3 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.51 -29.6 85.42 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.609 1.539 . . . . 0.0 111.729 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -84.55 -11.87 55.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.609 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.66 142.16 58.14 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.786 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.0 p -83.27 166.91 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.078 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.57 -37.4 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.001 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.13 -42.73 91.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 110.494 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.507 HG21 HD21 ' D' ' 56' ' ' LEU . 69.7 t -61.98 -43.78 98.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.806 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.529 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.7 mtmt -61.08 -38.39 86.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.1 94.35 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.105 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.475 ' CB ' HD13 ' D' ' 15' ' ' LEU . 15.3 mttp -59.96 -39.03 84.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.68 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.31 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.8 -39.5 89.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.175 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.79 -45.1 91.23 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.478 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.539 ' HD2' HD21 ' D' ' 15' ' ' LEU . 71.2 mttt -73.48 -40.51 64.06 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -128.16 151.19 49.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.27 62.06 2.23 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.1 103.25 54.71 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.07 154.43 66.52 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.346 1.364 . . . . 0.0 111.954 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -53.61 -25.97 35.39 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.629 2.22 . . . . 0.0 112.517 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.96 13.63 14.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.418 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -145.4 59.97 1.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.376 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.93 147.08 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.24 0.543 . . . . 0.0 111.774 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.8 124.29 31.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.466 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.529 HD11 ' HG2' ' D' ' 27' ' ' LYS . 53.8 mt -105.49 114.25 28.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.57 HG23 ' C ' ' D' ' 48' ' ' ARG . 82.3 mt -121.68 121.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -64.82 -46.99 79.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -179.04 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.021 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.34 -8.15 79.54 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.57 ' C ' HG23 ' D' ' 44' ' ' ILE . 44.0 ttm180 -129.79 127.89 41.26 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.867 0.365 . . . . 0.0 110.499 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -81.13 153.47 27.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.572 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.57 102.71 14.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.062 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.84 155.62 35.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.56 154.37 41.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.41 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.13 12.67 63.15 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -127.33 150.78 49.43 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.198 0.523 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -95.37 163.36 13.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.999 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.507 HD21 HG21 ' D' ' 26' ' ' VAL . 81.3 mt -61.91 -39.31 91.57 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.709 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.5 p -63.5 -22.51 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.322 . . . . 0.0 110.367 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.46 -38.33 83.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.261 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -99.83 16.86 22.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.86 40.93 28.64 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.337 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . 0.463 HG23 ' OG ' ' D' ' 65' ' ' SER . 78.8 mt -88.22 110.1 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -95.54 178.61 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -59.62 152.23 22.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.539 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 56.82 33.73 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . 0.463 ' OG ' HG23 ' D' ' 61' ' ' ILE . 4.2 t -77.03 120.86 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.937 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 78.1 m -81.63 119.8 24.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.35 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -112.75 142.76 45.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.075 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -87.69 114.42 24.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.35 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.581 HD23 HG22 ' D' ' 7' ' ' THR . 36.1 tp -102.51 118.14 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.583 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.438 ' HA ' HD21 ' D' ' 8' ' ' LEU . 87.0 t -117.72 128.73 74.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.814 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -99.37 145.71 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.69 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -72.82 148.25 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.432 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.758 HD23 ' HD2' ' C' ' 48' ' ' LYS . 63.0 tp -70.06 127.49 33.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.516 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.2 143.44 52.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -14.47 62.61 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.498 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -71.68 139.76 49.34 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.054 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -95.87 113.19 24.79 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.479 ' CD1' HD12 ' A' ' 57' ' ' ILE . 96.6 mt -66.04 -39.01 89.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.603 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.3 p -147.5 163.04 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.05 122.38 0.31 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.756 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.31 158.7 40.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.815 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -74.08 124.21 25.85 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.097 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.416 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -157.0 145.28 19.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.336 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.47 154.72 16.47 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -90.26 174.7 7.45 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.17 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.4 mtp -138.76 172.77 12.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -123.12 123.9 41.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 37' ' ' THR . 27.0 tp -105.29 119.81 39.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.329 0.585 . . . . 0.0 110.618 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -121.42 107.62 12.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.571 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.56 -97.06 0.68 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 p -131.06 19.71 4.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.297 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.563 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.1 m -121.76 130.63 53.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.7 t -110.65 124.07 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.81 133.6 22.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.65 148.21 46.78 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.799 1.666 . . . . 0.0 112.959 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -103.63 130.69 51.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.68 -8.18 50.08 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.917 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.63 78.09 1.08 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -58.53 131.08 49.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.237 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.47 -158.56 9.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.84 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.7 tp -137.57 126.51 24.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 28' ' ' ALA . 36.9 t -96.58 113.5 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.066 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -136.41 155.88 49.4 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.062 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' LEU . 90.8 mt -123.89 140.14 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.105 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -140.09 146.14 38.53 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -109.78 128.55 55.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.221 0.534 . . . . 0.0 110.335 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 58' ' ' HIS . 28.5 p -89.68 172.64 8.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.756 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.56 -10.51 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.152 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.15 3.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m 63.12 26.55 15.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.336 0.589 . . . . 0.0 110.335 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.648 HD11 HG11 ' C' ' 70' ' ' VAL . 71.4 mt -103.97 125.47 50.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.479 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.2 mm -83.11 122.92 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.518 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.8 m-70 -100.59 116.03 31.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.713 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -93.25 110.37 21.89 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -124.64 146.99 48.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.162 0.982 . . . . 0.0 112.951 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -124.08 116.37 22.67 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.943 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -108.19 134.31 51.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.061 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.69 131.2 39.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.82 -17.27 61.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.888 0.375 . . . . 0.0 110.464 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -59.53 -46.4 88.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.863 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.6 m -116.49 -15.36 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 109.888 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.18 21.7 77.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -101.36 152.89 20.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.16 104.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.926 0.393 . . . . 0.0 110.424 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -80.73 -30.98 36.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -127.95 145.65 50.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.819 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.576 ' C ' HD23 ' A' ' 73' ' ' LEU . 42.9 p-10 -158.11 120.21 3.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.612 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.817 HD12 HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -148.1 136.09 21.09 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.17 0.509 . . . . 0.0 110.381 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -81.62 122.88 37.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.574 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.817 HD11 HD12 ' A' ' 73' ' ' LEU . 24.6 mm -114.06 121.23 65.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.279 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 61.9 m-85 -84.78 162.3 50.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.63 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.92 139.56 89.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.368 2.045 . . . . 0.0 111.54 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 59.64 12.02 2.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.229 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -87.17 -25.12 24.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.716 ' SG ' HG21 ' A' ' 75' ' ' ILE . 14.6 p -144.43 169.23 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.35 0.595 . . . . 0.0 110.324 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -137.54 125.25 22.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.809 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.23 118.74 37.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.57 164.71 30.84 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.415 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -79.4 159.84 26.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.018 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.6 t -111.36 90.62 12.28 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.18 60.25 7.72 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.829 1.686 . . . . 0.0 112.509 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -114.24 -38.82 4.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.991 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.06 82.35 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.585 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.16 130.33 26.89 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.702 1.602 . . . . 0.0 111.685 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.5 t 169.68 -45.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.571 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.72 -154.98 8.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.7 OUTLIER -109.85 106.81 16.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.505 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.5 t -125.65 128.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.08 154.37 41.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.681 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.01 136.12 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.196 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.442 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.7 tp -103.77 120.0 40.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -118.36 136.08 53.95 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.238 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -84.22 114.67 21.98 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.124 0.488 . . . . 0.0 109.833 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.9 -37.88 86.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.706 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.96 -21.92 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.23 -175.38 22.68 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -117.88 15.81 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.675 0.274 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HD3' HD21 ' A' ' 105' ' ' LEU . 10.2 ttmt -93.35 146.0 24.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.87 137.96 40.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.408 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.673 HD21 ' HD3' ' A' ' 103' ' ' LYS . 43.6 mt -119.23 148.21 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.44 133.59 55.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.961 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.72 157.99 45.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.293 0.568 . . . . 0.0 111.188 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -132.07 138.07 48.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.522 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.3 ttm -77.07 131.55 38.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.072 0.463 . . . . 0.0 111.475 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -1.7 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.702 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.25 144.91 98.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.06 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.32 -26.93 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.051 1.834 . . . . 0.0 112.786 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -121.85 144.57 48.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.054 0.454 . . . . 0.0 110.245 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.46 HG22 ' HG2' ' A' ' 92' ' ' ARG . 72.4 p -94.0 9.16 38.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.629 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.88 -22.1 61.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.84 -4.66 12.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.54 -46.95 87.77 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -41.44 99.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.71 -43.23 97.19 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.716 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.9 m170 -64.34 -40.7 96.41 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.577 0.703 . . . . 0.0 109.111 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.77 -45.07 94.38 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.901 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -68.01 -42.12 81.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.4 -41.88 98.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.513 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 120' ' ' HIS . 56.2 t -59.13 -47.08 91.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.312 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.89 -39.59 93.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.271 0.558 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.87 -36.37 80.15 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.075 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.441 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 23.7 m-85 -80.17 -30.43 38.83 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.955 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 75' ' ' ILE . 80.4 mt -90.02 -17.51 27.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.853 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -116.98 -19.0 9.98 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.372 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.81 69.78 36.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.339 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.21 157.6 59.01 Favored 'Trans proline' 0 C--N 1.296 -2.195 0 C-N-CA 122.797 2.331 . . . . 0.0 112.688 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.539 2.16 . . . . 0.0 112.319 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.69 154.69 81.84 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 145.1 29.19 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.402 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.35 156.47 68.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.018 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.17 137.39 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.017 1.811 . . . . 0.0 111.873 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.08 -170.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.033 1.822 . . . . 0.0 111.848 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -124.95 158.33 63.38 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.257 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.59 144.32 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.588 2.192 . . . . 0.0 112.377 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -155.53 164.43 38.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.72 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -86.16 135.74 33.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.905 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -121.06 122.95 41.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.429 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.33 124.1 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -68.92 83.4 0.31 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.807 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.515 179.506 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -69.37 161.84 28.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 pt -140.04 144.77 27.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.367 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.16 126.38 35.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.774 HG11 HD11 ' C' ' 30' ' ' ILE . 96.5 t -112.31 115.27 49.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -103.49 127.22 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.53 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -90.03 173.34 8.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 111.314 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.66 -25.92 68.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.174 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -73.41 -9.39 58.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.77 -7.41 73.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -71.87 130.83 41.99 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 110.198 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -109.84 132.22 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.255 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.4 HD13 HG21 ' C' ' 13' ' ' ILE . 0.0 OUTLIER -132.7 116.55 27.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 -179.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -87.07 131.45 34.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.072 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.626 HD21 ' HG3' ' C' ' 33' ' ' LYS . 92.5 mt -123.38 133.64 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -73.5 115.49 12.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.532 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.463 HG12 ' HE3' ' C' ' 29' ' ' LYS . 22.9 m -135.37 168.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.458 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.19 153.35 45.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.193 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.22 -38.17 93.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.999 1.799 . . . . 0.0 112.345 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -81.73 -8.19 59.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -59.04 139.03 57.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.974 0.416 . . . . 0.0 110.953 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -80.16 161.78 25.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.491 HD12 HD13 ' C' ' 50' ' ' LEU . 48.8 mm -63.67 -38.53 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.177 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.19 -41.93 89.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.284 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.12 -41.25 98.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.124 0.488 . . . . 0.0 110.548 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.414 HG22 HG11 ' C' ' 17' ' ' VAL . 56.1 t -62.91 -42.88 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.614 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -60.96 -38.39 85.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.01 91.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.585 ' CB ' HD13 ' C' ' 15' ' ' LEU . 67.3 mttm -60.11 -39.28 85.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.774 HD11 HG11 ' C' ' 5' ' ' VAL . 5.8 mm -64.59 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.471 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -59.69 -40.15 86.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.811 0.338 . . . . 0.0 110.377 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -67.55 -50.94 56.24 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.626 ' HG3' HD21 ' C' ' 15' ' ' LEU . 19.6 mttt -64.93 -40.98 95.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 112.038 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -132.18 146.41 52.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.199 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.04 63.98 2.01 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.589 HG22 ' HB2' ' C' ' 41' ' ' GLN . 3.5 mt -121.71 112.32 32.39 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.16 157.35 57.65 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.777 1.651 . . . . 0.0 111.748 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.8 -38.07 96.6 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.168 1.912 . . . . 0.0 112.188 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.96 -40.92 97.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.915 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -88.64 -17.68 29.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.658 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.589 ' HB2' HG22 ' C' ' 36' ' ' ILE . 4.8 tt0 -92.03 116.44 28.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.054 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -120.28 114.19 21.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.667 ' CB ' HD12 ' C' ' 50' ' ' LEU . 79.4 mt -92.48 131.86 37.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.295 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -130.75 129.25 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -145.17 152.46 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.899 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.54 20.31 10.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 110.505 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.72 -5.09 76.44 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.668 ' HG2' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -115.11 139.31 50.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.087 0.47 . . . . 0.0 110.736 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.16 131.61 43.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.667 HD12 ' CB ' ' C' ' 43' ' ' LEU . 50.4 mt -69.68 103.7 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.778 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -75.31 138.94 42.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.97 137.04 58.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.69 -17.81 52.01 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -84.28 174.99 9.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -120.62 165.54 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.346 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' C' ' 56' ' ' LEU . 79.3 mt -62.54 -39.88 94.99 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.567 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -64.11 -25.96 68.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.66 -33.55 75.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.437 . . . . 0.0 110.356 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' D' ' 73' ' ' LEU . 65.1 m-85 -99.45 13.77 32.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.283 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 56.29 43.93 25.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -91.02 114.76 28.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.45 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -63.7 146.2 54.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.16 44.96 18.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.939 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 38.9 m -99.33 124.93 44.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.243 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.47 ' C ' HD12 ' C' ' 67' ' ' LEU . 40.9 m -74.45 130.83 40.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.223 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.47 HD12 ' C ' ' C' ' 66' ' ' THR . 7.5 mp -118.65 155.16 31.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.399 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -105.89 120.65 42.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.503 HD11 HG21 ' C' ' 30' ' ' ILE . 1.8 tt -101.27 114.79 29.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.015 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.574 HG11 HD11 ' A' ' 56' ' ' LEU . 58.8 t -104.25 130.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.76 131.94 38.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -80.45 132.12 35.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.62 137.96 44.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -62.6 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.24 -166.56 52.72 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.9 -39.93 97.63 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.58 179.827 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -153.18 166.94 30.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.754 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.611 HG22 ' HB3' ' D' ' 65' ' ' SER . 3.1 pt -144.1 150.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.019 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.0 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.43 111.95 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -95.43 122.04 37.73 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.639 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.713 HG22 HD23 ' D' ' 69' ' ' LEU . 75.3 p -79.77 173.3 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.778 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.4 mt -61.1 -35.34 76.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.158 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -69.17 -12.03 61.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.892 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.4 60.3 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -61.56 130.96 48.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.71 0.291 . . . . 0.0 110.457 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -103.89 133.94 48.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.561 HD12 ' OE2' ' D' ' 34' ' ' GLU . 1.3 mt -126.98 106.67 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.965 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 124.4 27.86 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.225 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -121.01 132.25 54.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.357 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.81 120.8 21.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.632 HG12 ' CD ' ' D' ' 29' ' ' LYS . 31.4 m -134.56 -177.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.744 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . 0.533 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.6 mt-10 -132.04 152.08 79.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.119 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.75 -27.21 82.9 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.983 1.789 . . . . 0.0 111.977 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.3 p -86.21 -14.05 45.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.34 143.3 57.92 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.593 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p -87.43 168.48 13.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.172 0.51 . . . . 0.0 110.854 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.89 -38.31 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.682 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.31 -39.71 87.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.86 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -62.29 -40.9 97.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.687 HG21 HD21 ' D' ' 56' ' ' LEU . 58.7 t -63.55 -42.47 96.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.784 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.81 -40.59 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.085 0.469 . . . . 0.0 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.87 91.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.109 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.632 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.37 -38.69 81.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.779 ' CD1' HD21 ' D' ' 43' ' ' LEU . 81.1 mt -64.37 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.167 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -61.13 -43.65 98.55 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.867 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.78 -23.18 61.54 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.079 -0.388 . . . . 0.0 111.904 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.46 3.54 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . 0.679 ' OE2' HG23 ' D' ' 30' ' ' ILE . 43.0 mt-10 -149.22 -46.07 0.14 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.51 20.11 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' D' ' 71' ' ' LEU . 30.2 mt -88.69 119.84 70.08 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.662 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.76 159.35 50.99 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.715 1.61 . . . . 0.0 111.888 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.37 -23.17 36.9 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.498 2.132 . . . . 0.0 112.537 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -93.24 18.17 9.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.886 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -146.14 23.96 1.32 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.728 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.423 ' HB2' HD11 ' D' ' 69' ' ' LEU . 27.5 pt20 -150.12 144.77 25.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.978 0.418 . . . . 0.0 110.987 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -128.28 120.49 27.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.526 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.779 HD21 ' CD1' ' D' ' 30' ' ' ILE . 74.9 mt -96.3 121.38 38.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.36 129.34 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.53 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 74.0 t80 -130.95 133.1 45.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.18 26.47 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.23 79.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -126.09 130.73 51.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.528 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -65.21 138.34 58.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' D' ' 43' ' ' LEU . 84.0 mt -84.66 112.0 20.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.491 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.83 152.38 37.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -73.65 164.3 26.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.315 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.14 25.03 75.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -127.23 149.64 49.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -93.41 161.91 14.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.285 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.687 HD21 HG21 ' D' ' 26' ' ' VAL . 76.9 mt -62.61 -39.55 94.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.733 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.0 p -63.3 -22.84 67.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.429 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.87 -37.97 86.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.036 0.446 . . . . 0.0 110.62 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -96.76 16.31 19.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.43 42.07 25.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.392 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -91.51 101.75 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.728 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -94.96 179.84 5.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.478 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -56.32 145.33 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.268 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 59.92 42.44 16.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . 0.611 ' HB3' HG22 ' D' ' 3' ' ' ILE . 28.5 t -95.98 120.81 36.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.595 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.432 ' C ' HD12 ' D' ' 67' ' ' LEU . 25.1 m -76.84 124.99 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.389 . . . . 0.0 110.396 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.432 HD12 ' C ' ' D' ' 66' ' ' THR . 7.9 mp -115.69 136.02 53.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.154 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -84.0 124.02 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.404 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.713 HD23 HG22 ' D' ' 7' ' ' THR . 55.4 tp -104.9 118.37 36.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.701 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.665 ' HA ' HD21 ' D' ' 8' ' ' LEU . 98.0 t -115.43 132.04 65.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.238 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.778 ' H ' HD11 ' D' ' 8' ' ' LEU . 49.9 mt -104.55 152.84 21.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.488 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.88 -40.35 95.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' C' ' 59' ' ' TYR . 88.0 mt -121.62 144.64 48.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -97.38 -158.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.043 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.54 93.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.725 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -69.34 166.31 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.599 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -88.98 128.65 35.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 51' ' ' GLN . 81.7 mt -67.59 -37.26 82.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.853 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -148.67 160.98 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.84 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.47 122.56 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.12 155.17 34.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.649 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -74.08 118.03 16.57 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.358 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.15 26.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.94 150.72 17.12 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -89.32 157.84 18.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.73 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 29.6 mtp -124.24 175.56 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -126.16 122.64 36.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.246 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 37' ' ' THR . 30.5 tp -106.03 122.75 46.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.993 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -118.36 103.75 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.942 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.12 -85.18 0.69 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -141.3 18.11 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.534 0.206 . . . . 0.0 110.911 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.674 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.0 m -120.01 126.16 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG2' HD13 ' A' ' 33' ' ' LEU . 61.2 t -105.99 122.75 59.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.414 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.596 HG23 ' HG3' ' B' ' 947' ' ' PRO . 53.0 m -119.33 122.62 29.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.427 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 147.18 64.48 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.924 1.749 . . . . 0.0 112.905 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.15 139.99 39.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.969 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -72.93 -5.25 37.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -72.47 74.77 1.04 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -52.79 134.27 36.77 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.334 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.65 -165.06 11.3 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 27' ' ' ARG . 9.9 tp -135.92 122.55 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG22 ' HD1' ' A' ' 61' ' ' TRP . 53.7 t -97.63 108.36 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.831 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 39.0 p90 -133.14 153.59 51.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.576 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.8 mt -122.04 141.62 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.826 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -141.67 142.63 33.37 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 123.687 0.617 . . . . 0.0 110.18 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.478 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.8 tt0 -106.29 127.6 53.36 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 58' ' ' HIS . 20.9 p -87.3 172.79 9.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.754 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.11 -10.42 22.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.625 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.22 -0.16 56.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t 70.04 19.77 6.72 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.574 HD11 HG11 ' C' ' 70' ' ' VAL . 70.4 mt -101.72 126.02 48.5 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 131' ' ' PRO . 49.4 mm -80.78 126.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.501 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -102.42 115.99 31.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.915 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -91.92 108.19 19.75 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.7 m -118.06 140.03 50.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.805 0.812 . . . . 0.0 112.902 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.417 ' HD1' HG22 ' A' ' 47' ' ' VAL . 92.4 t90 -125.46 113.25 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.189 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -106.18 144.7 32.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.817 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -80.62 131.65 35.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.82 -18.63 62.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.952 0.406 . . . . 0.0 110.529 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -59.65 -46.18 89.78 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -117.45 -11.3 10.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 0.0 110.646 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.08 22.78 78.7 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.51 146.88 27.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.722 0.296 . . . . 0.0 110.657 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.79 102.02 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.036 0.445 . . . . 0.0 110.304 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -73.08 -39.4 65.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.906 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.8 147.13 50.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.522 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p30 -158.54 103.24 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.597 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD22 ' HG2' ' C' ' 48' ' ' LYS . 35.2 mt -126.98 135.7 51.23 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.775 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -77.43 122.22 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' A' ' 80' ' ' CYS . 31.5 mm -111.81 121.08 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.618 . . . . 0.0 111.183 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 42.9 m-85 -82.76 160.98 59.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 142.35 98.64 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.797 1.664 . . . . 0.0 111.441 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 61.84 12.34 4.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.103 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -89.87 -35.79 15.44 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 120.628 0.251 . . . . 0.0 110.678 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.609 ' HB3' HD11 ' A' ' 96' ' ' LEU . 71.4 m -132.48 156.29 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.25 0.548 . . . . 0.0 111.399 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.516 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.4 tt0 -129.31 130.63 46.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.126 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -101.96 117.95 35.89 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.412 ' NZ ' HG11 ' A' ' 95' ' ' VAL . 22.8 pttp -143.49 161.27 38.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.538 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -83.19 160.34 21.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.131 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.5 89.39 15.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.192 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.6 60.21 7.55 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.091 1.86 . . . . 0.0 112.047 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -114.25 -44.27 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.9 t -116.36 99.06 52.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.78 129.73 15.9 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.38 1.386 . . . . 0.0 111.458 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 165.23 -38.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 O-C-N 124.02 0.825 . . . . 0.0 110.372 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.59 -179.69 25.64 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -91.83 113.55 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.88 128.26 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.176 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -119.18 155.75 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.719 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.2 p -133.63 137.74 52.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.4 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 80' ' ' CYS . 63.9 tp -103.68 121.47 43.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -117.89 141.6 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -88.09 117.18 26.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.27 -37.47 85.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.949 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.83 -15.85 19.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.53 176.14 19.96 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.6 p -111.7 15.76 20.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.668 0.27 . . . . 0.0 110.465 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' CE ' HD21 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -95.28 144.56 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.969 0.414 . . . . 0.0 110.77 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.93 140.59 42.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.716 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . 57.9 mt -119.62 152.06 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.5 m-85 -124.28 137.15 54.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.84 154.24 48.41 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.29 0.567 . . . . 0.0 111.216 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -132.43 136.04 46.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.07 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.95 131.68 51.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.121 0.486 . . . . 0.0 111.215 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 -1.67 12.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.483 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.09 149.23 94.56 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.664 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.14 -39.93 64.82 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.002 1.802 . . . . 0.0 112.224 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.57 145.91 48.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.3 p -98.45 18.72 15.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.5 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.49 -22.2 61.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.61 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -123.48 13.85 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.51 91.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.776 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.54 -41.21 84.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.066 0.46 . . . . 0.0 111.128 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.75 -43.35 96.71 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.757 ' O ' HG23 ' A' ' 124' ' ' VAL . 60.8 m170 -63.54 -41.08 98.48 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.517 0.675 . . . . 0.0 109.322 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.23 -42.02 96.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -67.58 -40.14 84.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.2 -37.57 83.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.713 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.3 t -58.51 -47.83 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -80.05 -27.42 39.41 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.942 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.96 -38.22 82.5 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.53 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -81.62 -34.18 31.05 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.479 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 124' ' ' VAL . 67.3 mt -76.24 -26.69 56.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.917 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -107.45 -24.16 11.92 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.56 74.83 58.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.536 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.8 Cg_exo -59.4 155.63 40.23 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.004 2.469 . . . . 0.0 112.362 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.081 -179.643 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 49.44 67.65 4.26 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.558 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.35 143.95 78.47 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.723 2.282 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.89 160.05 82.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.806 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.52 155.42 62.76 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.765 2.31 . . . . 0.0 112.187 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.35 -169.44 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.608 2.205 . . . . 0.0 111.608 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -110.1 160.4 28.36 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.596 ' HG3' HG23 ' A' ' 39' ' ' THR . 50.8 Cg_exo -57.14 142.68 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.538 2.159 . . . . 0.0 111.808 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.72 163.93 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.68 138.36 32.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.867 0.365 . . . . 0.0 110.434 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -124.57 119.87 30.32 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.784 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 49.8 mt -131.8 119.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -69.57 84.2 0.43 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.308 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 62.1 t0 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.537 179.685 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.14 162.93 18.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.461 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.499 HD13 HD21 ' C' ' 56' ' ' LEU . 16.6 pt -144.35 147.98 18.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.962 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -96.43 119.5 35.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.571 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -103.5 103.8 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -87.67 118.54 27.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.803 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.786 HG22 HD23 ' C' ' 69' ' ' LEU . 80.9 p -82.36 171.13 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.431 HD11 ' H ' ' C' ' 71' ' ' LEU . 67.9 mt -64.89 -25.03 67.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.138 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.8 p -73.47 -11.5 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -13.74 63.59 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.56 132.53 44.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.257 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -101.56 132.02 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.144 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mm -116.3 103.55 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.95 120.31 25.53 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.098 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.771 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.9 mt -122.34 132.76 54.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.32 114.45 16.16 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.574 HG12 ' HE3' ' C' ' 29' ' ' LYS . 26.7 m -136.91 171.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.989 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -116.51 156.33 47.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.237 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.98 -41.23 77.47 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.887 1.724 . . . . 0.0 112.322 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -72.94 -12.25 60.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -59.13 135.76 57.74 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.851 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -77.51 160.54 28.56 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.869 HD12 HD13 ' C' ' 50' ' ' LEU . 47.9 mm -66.17 -37.65 80.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.071 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.44 -42.92 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -62.29 -42.03 99.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 110.074 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.678 HG21 HD11 ' C' ' 56' ' ' LEU . 53.0 t -61.21 -43.58 96.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.428 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -40.1 79.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.187 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.6 94.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.991 0.424 . . . . 0.0 110.339 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.63 ' HB3' HD13 ' C' ' 15' ' ' LEU . 67.0 mttm -59.8 -39.4 84.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.394 0.616 . . . . 0.0 109.386 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.798 ' CD1' HD21 ' C' ' 43' ' ' LEU . 97.3 mt -66.56 -38.86 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.443 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -58.03 -42.36 85.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.447 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.11 -40.89 71.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.456 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.771 ' HG3' HD21 ' C' ' 15' ' ' LEU . 7.0 mmtm -65.63 -40.96 93.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.959 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -138.07 157.27 46.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.45 57.44 3.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 32.6 mm -110.81 104.84 56.68 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 153.49 50.38 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.354 2.036 . . . . 0.0 112.204 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.81 -39.14 78.43 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.822 1.681 . . . . 0.0 112.302 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.83 -39.55 92.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.279 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -83.08 -9.24 59.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.913 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.55 93.87 7.93 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . 0.428 ' HB2' ' HB ' ' C' ' 70' ' ' VAL . 76.5 mtp85 -108.82 95.81 5.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.798 HD21 ' CD1' ' C' ' 30' ' ' ILE . 81.5 mt -84.55 130.21 34.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.274 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 82.0 mt -132.17 127.51 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -141.76 148.82 39.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.948 0.404 . . . . 0.0 111.108 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.64 17.48 5.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.249 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 74' ' ' ILE . . . 89.87 -17.11 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.552 ' HE2' HD22 ' D' ' 73' ' ' LEU . 17.8 mtpt -95.48 133.27 39.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 111.056 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -75.73 130.92 39.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.69 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.869 HD13 HD12 ' C' ' 23' ' ' ILE . 35.5 mt -72.89 129.8 38.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.58 -80.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.479 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.01 -68.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 110.611 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.12 94.49 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -49.07 162.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.514 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -109.54 178.46 4.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.308 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.678 HD11 HG21 ' C' ' 26' ' ' VAL . 6.6 mp -69.79 -39.61 76.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.825 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.29 -24.96 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.56 -37.4 86.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.469 ' CE2' HD13 ' D' ' 73' ' ' LEU . 85.1 m-85 -98.76 11.98 37.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.113 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 t30 59.33 40.08 21.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.852 0.358 . . . . 0.0 110.365 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -86.24 103.72 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -91.68 179.95 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.512 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -63.19 145.08 56.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.186 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 64.28 13.32 7.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.322 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 34.0 m -67.02 134.78 52.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 43.6 m -92.49 117.63 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.518 HD12 ' N ' ' C' ' 67' ' ' LEU . 5.8 mp -108.17 139.39 42.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.56 127.91 35.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.28 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.786 HD23 HG22 ' C' ' 7' ' ' THR . 55.7 tp -105.85 121.17 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.722 HG11 HD11 ' A' ' 56' ' ' LEU . 57.6 t -108.87 132.61 56.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.736 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.431 ' H ' HD11 ' C' ' 8' ' ' LEU . 22.4 mt -95.9 133.41 40.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.3 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -86.98 130.49 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 85.2 mt -107.43 143.79 35.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.332 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -112.08 144.33 41.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.447 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.65 -170.67 52.1 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.58 18.57 79.73 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.623 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -64.27 160.68 18.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.599 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -139.17 142.44 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.377 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.633 ' HD2' HG21 ' D' ' 12' ' ' THR . 4.0 m-85 -86.63 122.73 30.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -108.82 107.28 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.382 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -92.0 130.43 37.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.883 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.802 HG22 HD23 ' D' ' 69' ' ' LEU . 61.6 p -89.19 -179.32 5.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.662 HD11 ' H ' ' D' ' 71' ' ' LEU . 80.8 mt -64.36 -37.22 86.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.136 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.39 -12.18 61.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.56 -12.51 61.36 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.98 131.4 49.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.633 HG21 ' HD2' ' D' ' 4' ' ' PHE . 83.3 m -104.77 133.53 49.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 111.163 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.405 HD13 HG21 ' D' ' 13' ' ' ILE . 0.9 OUTLIER -125.83 108.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.729 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.6 m -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.299 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' D' ' 29' ' ' LYS . 94.6 mt -122.91 126.57 47.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.627 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -68.85 116.39 9.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.849 0.357 . . . . 0.0 111.039 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.564 HG12 ' HE2' ' D' ' 29' ' ' LYS . 20.7 m -139.2 165.57 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -106.28 155.24 38.96 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.027 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.46 -32.77 90.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.102 1.868 . . . . 0.0 112.282 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -87.3 -3.31 59.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -60.06 136.24 57.96 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -80.18 163.41 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.234 0.54 . . . . 0.0 111.021 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.412 HD12 HD13 ' D' ' 50' ' ' LEU . 49.9 mm -63.03 -37.26 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.426 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.39 -42.33 86.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.084 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -62.48 -41.27 98.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.443 . . . . 0.0 110.432 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.572 HG21 HD21 ' D' ' 56' ' ' LEU . 53.2 t -61.47 -43.61 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.67 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.404 ' HG2' HD11 ' D' ' 43' ' ' LEU . 57.8 mtmt -61.08 -39.46 89.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.71 97.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.564 ' HE2' HG12 ' D' ' 17' ' ' VAL . 16.2 mttp -59.66 -38.92 82.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.571 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.426 HD12 HD21 ' D' ' 43' ' ' LEU . 59.2 mt -67.04 -38.48 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.842 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -59.12 -39.74 83.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.406 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -70.49 -53.76 14.99 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.485 ' HD2' HD21 ' D' ' 15' ' ' LEU . 28.7 mttp -63.14 -40.95 99.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.094 0.473 . . . . 0.0 111.753 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -128.2 143.45 51.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.793 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.36 61.96 2.69 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' D' ' 41' ' ' GLN . 2.8 mt -114.02 110.11 49.01 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.54 155.07 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.16 1.907 . . . . 0.0 111.691 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.18 -34.49 98.41 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.216 1.944 . . . . 0.0 113.035 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -65.17 -47.42 77.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 110.101 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.2 -38.85 88.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.624 ' HG3' HG22 ' D' ' 36' ' ' ILE . 89.3 mt-30 -58.86 115.74 3.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.729 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -119.37 102.89 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.583 ' CB ' HD12 ' D' ' 50' ' ' LEU . 30.9 mt -90.37 118.55 29.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.13 126.06 67.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 86.8 t80 -132.1 132.21 43.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.306 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.97 27.24 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.535 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 17.06 78.59 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -129.72 129.19 43.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -66.08 140.34 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.621 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.583 HD12 ' CB ' ' D' ' 43' ' ' LEU . 70.8 mt -82.47 114.84 21.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.965 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.51 139.89 42.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.949 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.95 136.81 57.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.39 56.63 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -81.97 170.08 16.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 44.6 p -113.71 165.44 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.572 HD21 HG21 ' D' ' 26' ' ' VAL . 88.4 mt -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.599 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.8 p -63.54 -26.72 68.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.067 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.27 -29.15 70.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.028 0.442 . . . . 0.0 110.389 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . 0.405 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.0 m-85 -103.08 15.65 28.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.87 38.81 30.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.5 mt -89.88 115.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -104.93 -174.85 2.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.273 0.559 . . . . 0.0 110.804 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -61.57 144.26 54.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.324 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 60.98 19.78 10.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.826 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -70.1 126.41 29.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 59.4 m -79.06 129.89 34.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.212 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.94 144.45 46.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.074 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -91.67 110.0 21.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.117 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.802 HD23 HG22 ' D' ' 7' ' ' THR . 61.0 tp -96.27 106.68 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.498 ' HA ' HD21 ' D' ' 8' ' ' LEU . 80.1 t -99.83 140.14 19.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.124 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.662 ' H ' HD11 ' D' ' 8' ' ' LEU . 46.1 mt -115.04 140.48 49.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.122 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -63.23 143.74 57.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.552 HD22 ' HE2' ' C' ' 48' ' ' LYS . 3.1 tt -65.33 107.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.301 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 53.08 35.25 19.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.139 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.77 79.81 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -70.45 146.87 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.178 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.71 113.22 25.44 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.26 0.552 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 57' ' ' ILE . 92.0 mt -66.97 -38.86 86.86 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.479 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' HB ' ' A' ' 49' ' ' ILE . 1.1 p -149.34 162.75 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.955 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.83 122.81 0.33 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -155.32 158.17 38.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.869 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.564 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -75.2 122.01 23.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.05 0.452 . . . . 0.0 110.866 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.16 139.93 17.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.12 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.12 154.17 17.68 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -90.41 172.37 8.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.136 0.493 . . . . 0.0 111.435 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.403 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 22.9 mtp -134.74 172.23 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.639 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -122.68 121.88 37.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD13 ' CG2' ' A' ' 38' ' ' VAL . 29.4 tp -104.62 116.85 32.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.312 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.45 117.82 26.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.825 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -84.76 0.35 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 p -149.81 23.41 0.87 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.719 0.295 . . . . 0.0 110.689 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.1 m -125.85 131.34 52.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.431 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.4 t -108.9 122.44 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.639 HG22 ' HB3' ' B' ' 947' ' ' PRO . 67.3 p -114.71 131.25 23.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.223 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.79 148.59 46.62 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.932 1.754 . . . . 0.0 113.195 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.51 142.61 27.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.817 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -82.46 -8.53 59.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.718 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.9 86.52 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -53.37 137.24 35.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.94 -162.98 10.83 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.047 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.7 tp -140.51 122.04 15.13 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.0 t -94.55 109.49 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -131.74 153.2 50.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.062 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.6 mt -122.36 140.83 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.365 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -141.57 144.99 34.55 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 123.499 0.5 . . . . 0.0 109.7 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -109.24 127.18 54.05 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.469 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.503 HG23 ' CD2' ' A' ' 58' ' ' HIS . 20.7 p -87.47 172.59 9.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.028 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.38 -10.72 18.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.698 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.49 4.7 48.31 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.586 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m 63.83 25.32 14.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.485 0.659 . . . . 0.0 110.566 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.722 HD11 HG11 ' C' ' 70' ' ' VAL . 63.4 mt -103.24 125.51 49.94 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.437 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.6 mm -82.38 123.59 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.074 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.9 m-70 -101.23 115.3 30.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.477 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -96.68 107.96 20.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.66 142.92 51.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.41 113.58 24.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.292 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -103.85 135.82 44.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.832 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.44 136.95 38.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.873 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -78.67 -18.65 54.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -60.65 -46.46 90.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.787 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -117.0 -13.3 10.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.22 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.14 75.5 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.8 144.47 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.702 0.287 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.45 102.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.879 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -75.31 -37.15 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.876 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -126.28 144.7 50.7 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.2 t0 -158.81 101.05 1.62 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.509 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 72' ' ' ASP . 47.4 mt -128.12 140.94 51.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.753 0.311 . . . . 0.0 110.451 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.448 ' O ' ' HA2' ' C' ' 47' ' ' GLY . 97.0 mt -82.75 122.85 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.712 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.7 mm -112.91 122.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.067 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -85.16 162.95 47.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.587 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.36 140.25 93.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.138 1.892 . . . . 0.0 111.322 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.76 11.89 2.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.256 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -85.06 -26.24 27.11 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.719 0.295 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 75' ' ' ILE . 15.8 p -147.19 167.2 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.319 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.04 127.74 32.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.222 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.51 117.06 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -142.37 168.17 20.37 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.699 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -87.36 160.27 18.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.194 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.42 89.76 13.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 60.83 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.015 1.81 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.12 -52.16 2.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.5 t -114.52 98.11 48.32 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.66 130.46 17.08 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.483 1.455 . . . . 0.0 111.668 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.65 -32.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.8 0.688 . . . . 0.0 110.071 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.24 -171.9 20.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.351 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.42 110.1 22.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 110.466 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.97 154.48 38.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.31 133.62 62.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 ' SG ' ' A' ' 80' ' ' CYS . 66.7 tp -101.68 121.58 42.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -119.14 132.46 55.99 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.392 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -83.79 115.12 22.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.22 -37.41 87.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.795 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.24 -23.15 24.83 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.476 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.48 -169.71 19.56 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -120.55 13.79 11.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.554 0.216 . . . . 0.0 110.629 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.725 ' HD3' HD21 ' A' ' 105' ' ' LEU . 19.9 ttmt -86.11 142.81 28.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -136.04 129.3 31.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.156 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.725 HD21 ' HD3' ' A' ' 103' ' ' LYS . 37.9 mt -115.18 150.58 35.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.812 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' A' ' 33' ' ' LEU . 89.6 m-85 -124.22 137.86 54.47 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.124 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.47 156.81 47.21 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.29 0.567 . . . . 0.0 111.123 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -129.01 137.34 51.28 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.276 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.5 mmm -72.81 141.13 48.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -0.93 24.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.68 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.76 147.03 88.77 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.583 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.25 -27.16 13.88 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.163 1.908 . . . . 0.0 112.607 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.01 146.86 47.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.3 p -92.6 4.07 54.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.811 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.12 -21.17 45.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.51 -13.88 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -61.1 -45.58 94.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.296 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.91 -43.36 93.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.258 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.713 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.7 m170 -63.58 -40.62 97.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.62 0.724 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -62.69 -45.04 94.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.855 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.96 -42.37 85.3 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.533 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.65 -42.87 99.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.484 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.2 t -57.57 -47.65 84.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.046 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -64.05 -39.41 94.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.76 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.22 -27.53 62.59 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.175 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.1 m-85 -85.0 -29.03 25.35 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.735 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.53 -12.38 29.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -120.12 -16.65 8.52 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.794 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -144.23 72.68 16.21 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 57' ' ' ILE . 34.9 Cg_exo -60.81 148.97 90.44 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.931 2.421 . . . . 0.0 111.963 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 C-N-CA 122.308 2.005 . . . . 0.0 111.984 179.85 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -133.73 151.22 76.65 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.96 152.72 36.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.574 2.183 . . . . 0.0 111.661 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -95.13 156.28 38.0 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.186 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.84 140.01 68.36 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.447 2.098 . . . . 0.0 112.144 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.98 172.61 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.37 2.047 . . . . 0.0 112.097 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -93.03 154.33 41.73 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 39' ' ' THR . 36.2 Cg_endo -65.88 150.29 85.86 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.467 2.112 . . . . 0.0 111.908 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.01 163.85 37.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -85.91 139.81 30.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.127 0.489 . . . . 0.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -124.89 128.82 49.25 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.355 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.417 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.8 mp -130.42 127.68 62.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.366 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -75.65 83.45 2.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.942 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.829 179.419 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.445 ' OE1' HG21 ' C' ' 14' ' ' THR . 6.5 pt20 -64.48 162.4 15.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.462 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.43 151.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.285 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.546 ' CD1' HG23 ' C' ' 14' ' ' THR . 10.9 m-30 -92.34 114.5 27.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.893 HG11 HD11 ' C' ' 30' ' ' ILE . 80.1 t -104.37 98.85 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.135 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -77.79 116.45 18.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.805 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -73.21 -178.18 2.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.322 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -48.56 -29.21 4.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -101.06 -177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.045 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.38 -12.67 56.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -59.05 134.66 57.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . 0.432 ' C ' HD13 ' C' ' 13' ' ' ILE . 93.6 m -118.68 133.57 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.432 HD13 ' C ' ' C' ' 12' ' ' THR . 12.8 mm -113.2 110.14 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . 0.546 HG23 ' CD1' ' C' ' 4' ' ' PHE . 3.8 m -83.82 119.01 24.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.603 HD13 ' CB ' ' C' ' 29' ' ' LYS . 73.5 mt -118.31 125.9 51.01 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.563 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.5 113.35 9.44 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.487 HG11 HG22 ' C' ' 26' ' ' VAL . 31.1 m -135.35 164.56 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.091 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -107.49 155.56 39.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.741 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.48 -32.76 90.51 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.027 1.818 . . . . 0.0 112.302 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.52 -1.34 57.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.186 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -62.77 138.76 58.6 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -79.15 159.42 27.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.174 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.52 HD12 HD13 ' C' ' 50' ' ' LEU . 43.9 mm -64.12 -40.96 90.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -58.02 -36.32 72.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.955 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.69 -43.13 94.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.197 0.522 . . . . 0.0 110.904 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.499 HG21 HD21 ' C' ' 56' ' ' LEU . 62.5 t -62.37 -43.08 97.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.802 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -60.75 -38.38 84.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.16 91.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.852 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.603 ' CB ' HD13 ' C' ' 15' ' ' LEU . 5.8 mptt -60.07 -38.74 83.75 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.343 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.893 HD11 HG11 ' C' ' 5' ' ' VAL . 6.9 mm -63.85 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.244 0.545 . . . . 0.0 110.14 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -59.88 -48.77 80.33 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.76 -11.55 59.85 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.082 -0.386 . . . . 0.0 112.026 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -104.87 -8.03 18.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -147.27 -35.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.433 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.81 15.54 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.465 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' C' ' 41' ' ' GLN . 28.5 mt -95.78 115.05 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.69 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.35 153.77 51.49 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.6 2.2 . . . . 0.0 111.294 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.31 -40.12 87.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.649 1.566 . . . . 0.0 111.855 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.95 -41.01 97.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.827 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -88.88 -2.57 58.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.585 ' HG3' HD21 ' C' ' 69' ' ' LEU . 4.7 tt0 -111.88 120.83 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.798 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -122.77 120.54 33.88 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.546 ' CB ' HD12 ' C' ' 50' ' ' LEU . 78.2 mt -99.12 131.47 45.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.199 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.425 HG21 ' HE1' ' A' ' 76' ' ' PHE . 78.5 mt -129.72 129.01 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . 0.541 ' HB2' HD23 ' C' ' 67' ' ' LEU . 75.1 t80 -151.77 153.46 34.34 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.61 15.37 10.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.418 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 88.69 -12.0 66.85 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.802 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.0 OUTLIER -117.42 146.85 43.18 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.624 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -73.18 137.14 44.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.014 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.546 HD12 ' CB ' ' C' ' 43' ' ' LEU . 44.1 mt -72.79 103.17 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.741 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -74.6 135.98 42.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -59.95 136.67 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.67 -18.29 37.96 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -89.52 174.44 7.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.2 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -115.67 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.267 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.499 HD21 HG21 ' C' ' 26' ' ' VAL . 82.0 mt -62.7 -40.19 96.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.801 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -64.05 -25.94 68.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -63.29 -30.63 71.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' C' ' 50' ' ' LEU . 59.3 m-85 -100.82 12.82 36.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.42 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 56.7 39.66 29.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.378 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.422 HG21 HD22 ' C' ' 56' ' ' LEU . 48.2 mt -83.93 117.77 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -101.98 175.09 5.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.015 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -59.81 145.46 45.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.753 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 59.13 20.81 8.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.405 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 7.9 m -67.93 133.92 49.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -86.75 120.3 27.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.358 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' C' ' 45' ' ' PHE . 3.7 mp -114.19 147.98 38.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.364 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -100.27 129.03 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.55 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.585 HD21 ' HG3' ' C' ' 41' ' ' GLN . 0.6 OUTLIER -104.91 121.26 43.34 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 56' ' ' LEU . 57.7 t -107.07 135.41 45.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.545 ' HG ' HD23 ' C' ' 8' ' ' LEU . 31.1 mt -109.32 142.52 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.64 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.17 -40.62 98.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 tp -124.34 128.99 49.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.76 144.31 49.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.23 147.52 18.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.46 -130.56 50.44 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.521 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.89 156.76 16.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.107 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.619 HD13 HD21 ' D' ' 56' ' ' LEU . 16.8 pt -136.79 150.57 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.415 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.8 m-30 -92.51 121.85 34.37 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.999 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.49 103.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.56 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -89.5 128.66 36.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.528 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.763 HG22 HD23 ' D' ' 69' ' ' LEU . 81.6 p -89.24 -177.36 5.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 111.228 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.692 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.1 mt -63.97 -37.58 87.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -70.02 -10.35 58.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.907 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.59 -10.56 66.78 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.91 130.58 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.252 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 131.38 48.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -121.93 108.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.415 HG23 ' CD2' ' D' ' 4' ' ' PHE . 19.6 m -81.38 129.69 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.553 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.77 HD21 ' HG3' ' D' ' 33' ' ' LYS . 38.2 mt -127.06 123.19 36.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -65.73 111.79 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.409 0.623 . . . . 0.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.691 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 18.1 m -135.07 164.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.165 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.27 155.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.452 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.88 -33.69 95.4 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.084 1.856 . . . . 0.0 111.89 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -82.9 -5.6 59.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.529 ' OD2' HG23 ' D' ' 26' ' ' VAL . 35.2 t70 -60.96 133.29 55.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 110.717 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -76.34 161.53 28.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.532 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.916 HD12 HD23 ' D' ' 50' ' ' LEU . 44.0 mm -64.44 -40.34 88.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.22 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.57 -40.04 86.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -61.89 -40.36 95.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.194 0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.878 HG21 HD11 ' D' ' 56' ' ' LEU . 54.6 t -62.24 -44.27 98.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.546 ' HG2' HD23 ' D' ' 43' ' ' LEU . 30.8 mtmt -60.35 -40.79 91.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.814 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.3 93.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.02 0.438 . . . . 0.0 110.502 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.691 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 90.7 mttt -60.0 -39.97 87.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.637 HD11 HD11 ' D' ' 43' ' ' LEU . 96.4 mt -67.35 -40.67 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.581 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.99 -39.62 82.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.734 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.67 8.55 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.77 ' HG3' HD21 ' D' ' 15' ' ' LEU . 0.0 OUTLIER -109.79 -58.12 2.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.865 0.364 . . . . 0.0 110.595 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.11 0.59 25.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.651 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.37 23.78 77.67 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 20.5 mm -84.07 117.78 69.57 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.901 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.08 150.8 76.87 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.244 1.963 . . . . 0.0 112.291 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.25 -19.74 51.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.301 2.001 . . . . 0.0 112.023 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -85.9 3.44 41.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -124.71 -54.8 1.64 Allowed 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.84 0.352 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.66 114.13 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.286 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -112.3 124.25 52.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.637 HD11 HD11 ' D' ' 30' ' ' ILE . 4.4 mm? -100.48 119.68 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.69 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 84.4 mt -126.88 126.04 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.731 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 84.4 t80 -125.44 131.53 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.085 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.07 26.23 12.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.447 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.73 16.03 80.47 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.28 130.16 53.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.516 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -67.53 131.99 46.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.916 HD23 HD12 ' D' ' 23' ' ' ILE . 8.0 mp -88.72 97.59 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.04 163.36 27.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.868 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -73.45 163.77 27.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.91 71.2 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -131.24 165.53 23.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.104 0.478 . . . . 0.0 110.776 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -116.74 164.34 14.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.228 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.878 HD11 HG21 ' D' ' 26' ' ' VAL . 4.6 mp -59.82 -38.65 82.58 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.97 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -62.09 -29.42 70.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.911 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.3 -30.12 71.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.159 0.504 . . . . 0.0 110.066 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -99.43 11.65 38.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 54.98 40.35 31.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.308 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . 0.62 HD11 HD21 ' D' ' 50' ' ' LEU . 81.5 mt -89.81 115.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -103.87 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.443 0.64 . . . . 0.0 110.887 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -60.43 146.92 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.921 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 61.25 19.83 10.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.2 m -74.84 126.98 32.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.924 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.475 ' C ' HD12 ' D' ' 67' ' ' LEU . 62.1 m -77.71 131.26 37.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.465 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.475 HD12 ' C ' ' D' ' 66' ' ' THR . 7.5 mp -118.63 138.78 52.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -87.95 110.12 20.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.865 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.763 HD23 HG22 ' D' ' 7' ' ' THR . 63.3 tp -98.15 117.56 32.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' D' ' 8' ' ' LEU . 95.5 t -110.28 132.77 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.517 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.692 ' H ' HD11 ' D' ' 8' ' ' LEU . 41.2 mt -106.48 136.07 46.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.968 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . 0.619 ' O ' HD23 ' D' ' 73' ' ' LEU . 81.0 mtp180 -62.92 -41.37 99.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.561 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.802 HD22 ' HE2' ' C' ' 48' ' ' LYS . 51.5 mt -132.87 144.28 50.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.232 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.4 117.48 8.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.028 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.98 79.21 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m120 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.28 155.33 22.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.158 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.16 112.15 24.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.5 mt -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.92 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.64 161.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.984 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 122.6 0.37 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.54 158.47 38.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.2 mtm-85 -75.34 121.76 22.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.056 0.455 . . . . 0.0 110.713 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.85 146.02 22.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.52 152.24 17.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -91.66 164.46 13.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.952 0.406 . . . . 0.0 111.113 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.4 mtp -132.5 175.27 9.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.797 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.3 m -125.56 124.09 40.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 37' ' ' THR . 36.6 tp -107.27 119.62 39.9 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.323 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.7 113.78 19.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.952 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -87.78 0.57 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -145.1 21.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.566 0.222 . . . . 0.0 110.723 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.663 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.2 m -123.03 130.53 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.536 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.1 t -106.94 123.15 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.872 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.5 p -114.48 128.03 26.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.62 146.71 39.24 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.765 1.643 . . . . 0.0 112.552 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.55 134.56 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.11 -6.96 46.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -73.14 78.21 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -52.79 134.18 36.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.329 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.54 -165.9 11.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.068 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 27' ' ' ARG . 8.6 tp -134.55 125.91 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.78 109.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.3 p90 -134.04 154.21 51.3 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 137.96 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.584 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.96 131.18 36.89 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.648 0.593 . . . . 0.0 110.399 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.569 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.3 tt0 -100.87 124.97 47.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.22 0.534 . . . . 0.0 109.998 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.4 p -84.46 172.23 11.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.696 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.77 -10.0 24.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.653 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.75 7.49 41.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.482 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 m 63.42 24.41 14.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.434 0.635 . . . . 0.0 110.651 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.569 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 73.8 mt -99.98 121.97 42.17 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.542 HG21 HD23 ' A' ' 128' ' ' LEU . 51.5 mm -81.14 121.23 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.6 m-70 -97.59 113.69 25.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.999 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -93.1 108.35 19.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 82.3 m -120.86 145.83 47.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.747 0.784 . . . . 0.0 112.89 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -127.6 115.22 18.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.154 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -106.63 145.98 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.38 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -84.18 130.73 34.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -70.79 -17.51 62.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.9 0.381 . . . . 0.0 110.633 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -59.21 -45.45 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.543 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.5 m -117.07 -11.54 10.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.44 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.15 21.47 79.2 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -102.56 148.33 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.1 t -76.27 106.01 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.13 -29.87 31.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.109 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -127.74 145.11 51.01 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.308 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.7 p-10 -159.18 100.04 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.764 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.736 HD22 ' HB3' ' C' ' 48' ' ' LYS . 39.9 mt -128.27 133.59 48.8 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.65 119.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.126 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.712 HG21 ' SG ' ' A' ' 80' ' ' CYS . 26.3 mm -110.88 120.09 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.03 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 47.2 m-85 -82.45 163.21 53.27 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.727 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 141.61 94.8 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.162 1.908 . . . . 0.0 111.728 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.95 12.28 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -85.1 -25.14 27.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.555 0.217 . . . . 0.0 110.875 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.7 p -149.26 167.17 26.78 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.529 0.68 . . . . 0.0 110.695 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.89 130.67 34.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.353 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.07 119.12 38.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -142.55 167.12 22.84 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.74 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -82.09 160.44 23.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.107 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.04 89.81 12.44 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.83 59.99 7.64 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.837 1.691 . . . . 0.0 112.246 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -114.65 -36.5 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.129 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 17.2 p -130.44 75.45 79.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.643 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 130.2 34.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.887 1.725 . . . . 0.0 111.558 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t 168.97 -43.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.919 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.05 -147.74 5.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.6 107.24 14.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 110.535 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.19 129.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 111.088 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.49 156.08 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.55 136.81 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.499 HD11 ' SG ' ' A' ' 80' ' ' CYS . 64.7 tp -103.31 122.36 44.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -118.76 130.9 56.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.073 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.28 115.81 21.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.289 0.566 . . . . 0.0 109.714 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.44 -37.54 87.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.579 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 -22.0 23.49 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.643 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.55 -171.84 19.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.4 m -117.8 12.67 13.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.622 0.248 . . . . 0.0 110.682 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.652 ' HD3' HD21 ' A' ' 105' ' ' LEU . 26.5 ttmt -83.92 141.59 31.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.932 0.396 . . . . 0.0 110.787 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.19 125.97 25.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.652 HD21 ' HD3' ' A' ' 103' ' ' LYS . 38.0 mt -113.53 151.15 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.002 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 33' ' ' LEU . 96.6 m-85 -124.85 137.27 54.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.352 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.67 155.0 51.11 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.298 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -129.97 136.43 49.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.723 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 tpp -70.3 131.19 43.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.76 -4.86 17.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.022 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.15 149.13 94.66 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.559 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' B' ' 942' ' ' PRO . 58.3 Cg_endo -72.43 -27.14 16.27 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.036 1.824 . . . . 0.0 112.922 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.03 142.72 49.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.028 0.442 . . . . 0.0 110.266 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -98.22 13.95 29.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.57 -20.93 59.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -125.62 11.95 7.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.17 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -63.24 -46.57 86.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.698 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -71.84 -34.37 69.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.357 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.08 -46.21 82.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.407 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.6 m170 -63.23 -41.06 99.05 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.606 0.717 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.9 t -61.99 -45.32 94.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.609 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -64.85 -43.77 91.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.214 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.15 -36.74 84.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 120' ' ' HIS . 58.2 t -59.2 -48.26 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.092 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.7 -29.82 40.83 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.952 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -68.61 -36.58 78.86 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.316 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -81.3 -32.82 32.96 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.554 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.632 HD22 ' HB ' ' A' ' 75' ' ' ILE . 80.6 mt -80.32 -25.25 39.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.284 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -110.12 -20.37 12.71 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.641 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.36 69.13 39.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.487 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.98 159.99 50.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 123.038 2.492 . . . . 0.0 112.382 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -72.27 153.54 92.24 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.618 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 55.5 Cg_endo -68.79 147.22 68.56 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.609 2.206 . . . . 0.0 112.179 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.96 157.5 87.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.0 139.23 84.53 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.551 2.167 . . . . 0.0 111.939 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.88 -172.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.043 1.828 . . . . 0.0 112.059 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -122.46 158.36 56.38 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.433 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.85 141.53 95.9 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.19 162.25 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.636 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -86.91 139.41 30.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.32 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -123.99 124.31 42.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.112 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.06 123.94 51.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.773 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -82.02 84.05 7.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.61 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.4 t0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.776 179.723 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.75 161.6 9.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.955 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 pt -139.73 146.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.092 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.57 124.85 33.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.79 116.02 51.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.84 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -94.92 118.31 31.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.138 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.29 173.08 10.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.251 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.564 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -46.49 -29.03 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.662 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -101.93 -179.1 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.119 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 -17.66 55.43 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -57.2 130.63 47.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.698 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 76.4 m -128.23 135.97 50.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.937 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.541 HD13 ' HG2' ' C' ' 34' ' ' GLU . 0.0 OUTLIER -126.24 121.06 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -88.94 127.6 35.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' C' ' 29' ' ' LYS . 67.4 mt -119.65 135.28 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.594 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -73.82 118.04 16.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.678 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.577 HG12 ' HE3' ' C' ' 29' ' ' LYS . 30.4 m -135.49 167.03 26.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.72 151.23 42.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.87 -35.87 94.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.818 1.679 . . . . 0.0 112.176 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -87.7 -0.99 57.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.115 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -62.81 137.92 58.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.725 0.298 . . . . 0.0 110.878 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -78.87 163.22 25.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.347 0.594 . . . . 0.0 111.342 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' C' ' 50' ' ' LEU . 48.3 mm -62.75 -37.1 78.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.762 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.35 -41.25 84.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.157 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -64.33 -41.07 96.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 110.594 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.586 HG21 HD21 ' C' ' 56' ' ' LEU . 57.7 t -64.16 -47.36 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.02 -32.49 72.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.87 98.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.423 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.633 ' HB3' HD13 ' C' ' 15' ' ' LEU . 66.8 mttm -60.25 -38.72 84.35 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.742 HD13 HD11 ' C' ' 69' ' ' LEU . 90.1 mt -64.42 -39.15 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -57.3 -43.97 83.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.23 -44.73 95.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.27 -78.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.745 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . 0.541 ' HG2' HD13 ' C' ' 13' ' ' ILE . 79.4 mm-40 -89.1 149.14 23.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.72 56.09 4.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.542 HG22 ' HG3' ' C' ' 41' ' ' GLN . 30.9 mt -106.96 121.87 43.44 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.083 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.24 157.84 52.96 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.477 1.451 . . . . 0.0 111.19 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.8 -38.22 94.71 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.793 1.662 . . . . 0.0 112.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -61.59 -43.37 98.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -85.75 -5.95 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.542 ' HG3' HG22 ' C' ' 36' ' ' ILE . 31.4 mt-30 -87.27 74.91 9.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.151 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -88.58 97.51 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.425 ' CB ' HD12 ' C' ' 50' ' ' LEU . 25.7 mt -87.46 132.71 33.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.142 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.21 129.87 63.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.759 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 85.8 t80 -150.17 150.9 32.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.29 15.1 9.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.297 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.41 -13.6 64.85 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.797 ' HE2' HD22 ' D' ' 73' ' ' LEU . 0.1 OUTLIER -111.9 143.27 43.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.181 -178.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.06 132.3 43.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.684 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' C' ' 59' ' ' TYR . 54.6 mt -72.08 98.45 2.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.79 140.43 43.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.523 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -58.81 140.04 55.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.335 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.12 -17.39 54.19 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -82.88 178.11 8.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.842 0.353 . . . . 0.0 110.427 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 58.9 p -125.66 161.56 26.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.948 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.586 HD21 HG21 ' C' ' 26' ' ' VAL . 83.9 mt -61.27 -41.4 96.86 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.648 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -64.2 -22.74 67.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.803 0.335 . . . . 0.0 110.397 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -62.85 -36.8 84.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.398 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.433 ' CE2' HD23 ' C' ' 50' ' ' LEU . 73.1 m-85 -98.16 13.94 29.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.196 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.86 39.81 23.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.181 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.428 HG21 HD22 ' C' ' 56' ' ' LEU . 65.5 mt -84.56 117.35 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.962 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -104.43 178.36 4.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.17 143.95 47.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.127 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 60.78 21.08 11.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -70.05 127.84 34.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.436 ' C ' HD12 ' C' ' 67' ' ' LEU . 81.4 m -78.81 128.34 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.436 HD12 ' C ' ' C' ' 66' ' ' THR . 9.1 mp -113.18 151.22 31.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.59 116.76 33.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.444 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.742 HD11 HD13 ' C' ' 30' ' ' ILE . 0.9 OUTLIER -96.32 114.34 26.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.259 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 56' ' ' LEU . 96.0 t -108.78 127.21 65.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.73 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.564 ' HG ' HD23 ' C' ' 8' ' ' LEU . 26.4 mt -88.9 146.65 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.671 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -104.91 125.93 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 66.0 tp -107.88 121.88 45.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -62.97 -38.93 93.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.602 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.34 -130.87 49.32 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.45 176.99 54.5 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.47 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.79 162.86 8.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.93 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -138.97 151.25 23.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.407 ' CD1' HG23 ' D' ' 14' ' ' THR . 11.7 m-30 -91.36 123.25 34.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.756 HG11 HD11 ' D' ' 30' ' ' ILE . 79.2 t -109.38 105.89 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.384 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -91.83 127.19 37.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.37 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.865 HG22 HD23 ' D' ' 69' ' ' LEU . 73.6 p -87.6 179.17 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.424 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.641 HD11 ' H ' ' D' ' 71' ' ' LEU . 80.8 mt -62.3 -36.22 81.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.817 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -68.79 -12.68 61.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.071 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.16 66.0 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.75 133.52 51.2 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -104.34 131.95 51.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.211 0.529 . . . . 0.0 110.507 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -121.02 113.44 39.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.625 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.407 HG23 ' CD1' ' D' ' 4' ' ' PHE . 14.0 m -83.98 124.7 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.118 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.583 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.9 mt -120.05 128.73 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.309 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.15 116.98 12.08 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 110.585 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.435 HG12 ' HD2' ' D' ' 29' ' ' LYS . 24.4 m -135.39 166.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.012 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.06 153.29 47.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.1 -29.0 85.75 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.641 1.56 . . . . 0.0 111.912 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 60.3 m -87.47 -9.74 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.705 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -64.32 142.37 58.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 45.7 p -82.19 166.12 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.742 ' CD1' HD12 ' D' ' 50' ' ' LEU . 37.0 mm -63.04 -36.58 76.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.773 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.04 90.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.989 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.36 -41.23 98.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.679 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 67.4 t -63.79 -43.35 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.838 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.536 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.54 90.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.286 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.435 ' HD2' HG12 ' D' ' 17' ' ' VAL . 67.2 mttm -60.39 -39.49 87.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.756 HD11 HG11 ' D' ' 5' ' ' VAL . 8.8 mm -64.83 -40.8 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.235 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.447 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.03 -40.81 98.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.583 ' HD2' HD21 ' D' ' 15' ' ' LEU . 45.1 mttt -76.8 -71.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.88 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.45 152.98 19.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 55.97 4.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.643 HG22 ' HG3' ' D' ' 41' ' ' GLN . 32.7 mm -107.23 109.85 63.02 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.88 153.31 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.084 1.856 . . . . 0.0 111.51 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.85 -37.91 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.849 1.7 . . . . 0.0 112.233 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.15 -39.38 89.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.547 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -12.5 40.76 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.643 ' HG3' HG22 ' D' ' 36' ' ' ILE . 20.0 mt-30 -78.99 86.04 4.89 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.875 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . 0.482 ' HD3' HD11 ' D' ' 44' ' ' ILE . 61.4 ttm-85 -97.44 115.27 27.44 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.71 118.1 36.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.482 HD11 ' HD3' ' D' ' 42' ' ' ARG . 83.2 mt -125.09 127.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.474 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' D' ' 67' ' ' LEU . 40.8 t80 -119.1 127.24 53.19 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.46 26.35 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.15 2.71 90.6 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.411 ' C ' HG23 ' D' ' 44' ' ' ILE . 43.3 ttm180 -112.86 121.84 45.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.013 0.407 . . . . 0.0 110.335 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -60.25 142.98 53.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.041 0.448 . . . . 0.0 110.388 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.742 HD12 ' CD1' ' D' ' 23' ' ' ILE . 4.0 mm? -78.09 123.85 27.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.063 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.92 138.67 50.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.69 129.96 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.093 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.91 -14.64 61.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.41 174.15 10.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -117.95 160.87 20.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.61 -39.87 92.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.8 p -63.88 -23.9 67.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.308 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -62.13 -37.6 85.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.295 0.569 . . . . 0.0 110.202 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -98.11 13.95 29.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.374 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 55.93 40.09 30.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.273 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -85.47 105.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.68 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -88.99 -172.82 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.434 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.55 149.58 49.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.316 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 57.5 42.39 24.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -89.87 121.43 31.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.965 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.455 ' O ' HD22 ' D' ' 67' ' ' LEU . 67.3 m -71.33 127.57 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.455 HD22 ' O ' ' D' ' 66' ' ' THR . 3.0 mm? -117.41 139.53 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.173 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -88.22 105.35 17.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.865 HD23 HG22 ' D' ' 7' ' ' THR . 67.3 tp -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.475 ' HA ' HD21 ' D' ' 8' ' ' LEU . 98.4 t -108.83 133.46 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.115 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.641 ' H ' HD11 ' D' ' 8' ' ' LEU . 25.7 mt -96.13 129.58 43.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.427 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -74.18 142.51 45.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.797 HD22 ' HE2' ' C' ' 48' ' ' LYS . 47.2 mt -92.0 4.85 52.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.907 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 58.55 26.7 14.69 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.615 0.245 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.84 19.49 75.2 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.79 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -69.36 153.91 42.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -94.88 128.77 41.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 109.897 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 51' ' ' GLN . 85.7 mt -69.78 -36.31 75.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.435 HG12 ' CG1' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -147.61 160.92 7.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.504 178.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -174.2 122.21 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.41 159.85 40.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.139 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -77.37 117.8 19.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.554 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.99 142.17 22.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.26 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.39 154.15 17.56 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -93.61 176.32 6.41 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.773 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.7 mtp -139.84 172.88 12.15 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.13 124.76 44.64 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 37' ' ' THR . 48.5 tp -105.38 117.08 33.1 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.015 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -120.42 116.64 25.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.598 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 -85.76 0.36 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.56 22.04 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.576 0.227 . . . . 0.0 110.714 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.583 ' O ' HD12 ' A' ' 33' ' ' LEU . 93.6 m -122.97 130.13 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.888 0.375 . . . . 0.0 110.559 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 33' ' ' LEU . 59.3 t -103.4 122.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.667 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 p -112.55 120.85 40.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.37 141.34 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.029 1.819 . . . . 0.0 112.348 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -98.08 116.27 29.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.46 -15.05 14.94 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.142 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -74.57 73.63 1.97 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.541 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -54.15 140.94 30.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.754 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.26 -156.49 7.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.002 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 27' ' ' ARG . 7.4 tp -135.22 125.66 26.67 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.95 109.14 23.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.314 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -132.23 154.55 49.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.273 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.0 mt -120.79 139.07 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.562 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.03 128.19 27.88 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.764 0.665 . . . . 0.0 110.485 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.67 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.6 tt0 -98.63 124.93 43.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.072 0.463 . . . . 0.0 109.936 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.7 p -85.33 172.46 11.07 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.56 -10.17 24.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.766 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.18 7.92 40.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.296 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.7 m 62.3 25.95 15.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.261 0.553 . . . . 0.0 110.623 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.639 HD11 HG11 ' C' ' 70' ' ' VAL . 73.3 mt -100.21 120.79 40.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.53 HG21 HD23 ' A' ' 128' ' ' LEU . 51.1 mm -81.46 120.25 32.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -96.58 113.89 25.49 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.531 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -97.43 107.09 19.53 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 143.32 50.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.889 0.852 . . . . 0.0 112.861 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -119.44 117.39 28.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.51 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -106.69 144.02 33.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.375 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -81.81 130.26 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -72.59 -17.59 61.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.05 0.452 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -59.21 -45.41 91.17 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -117.16 -12.42 10.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.307 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.94 23.58 77.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -102.07 152.31 21.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.81 101.97 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.215 0.531 . . . . 0.0 110.451 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.41 -38.1 65.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.125 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -126.4 145.52 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.285 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.445 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.6 t0 -158.26 98.18 1.55 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.143 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.606 HD22 ' CG ' ' C' ' 48' ' ' LYS . 42.5 mt -125.34 136.62 53.65 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.84 118.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.696 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.4 mm -109.15 120.41 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.196 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.557 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 40.8 m-85 -82.59 163.24 52.81 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.598 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.02 141.08 96.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.498 2.132 . . . . 0.0 111.745 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.8 t0 59.86 11.81 2.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.419 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.12 -29.38 28.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.727 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 75' ' ' ILE . 18.6 p -148.03 168.7 21.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.411 0.624 . . . . 0.0 110.783 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.17 130.94 36.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.354 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -100.96 118.83 37.75 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.92 168.03 20.71 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.645 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -83.24 157.68 22.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.45 88.88 9.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.56 60.17 7.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.831 1.687 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -114.28 -36.55 4.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.283 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -130.25 81.93 67.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.71 130.36 27.69 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.762 1.641 . . . . 0.0 111.817 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.0 -38.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.819 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.05 -153.25 6.08 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.14 106.59 15.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.1 t -125.8 129.57 72.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.02 154.43 39.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.434 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.83 136.75 59.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.943 0.402 . . . . 0.0 110.44 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.561 HD11 ' SG ' ' A' ' 80' ' ' CYS . 68.1 tp -102.98 121.37 42.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -118.51 132.24 56.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.048 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -82.96 115.21 21.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.302 0.572 . . . . 0.0 109.515 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.97 -37.64 87.94 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.36 -22.85 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.465 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -108.94 -171.74 20.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.9 m -119.52 13.95 12.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.566 0.222 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.72 ' HD3' HD21 ' A' ' 105' ' ' LEU . 24.0 ttmt -86.55 141.14 29.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.004 0.431 . . . . 0.0 111.085 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -133.77 129.02 36.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.082 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.72 HD21 ' HD3' ' A' ' 103' ' ' LYS . 42.5 mt -115.59 147.57 40.6 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.786 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' CE1' HD22 ' A' ' 33' ' ' LEU . 92.2 m-85 -119.84 135.88 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.564 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.82 155.13 50.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -130.57 137.5 49.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.342 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.2 mmm -73.59 138.83 45.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.32 6.29 32.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.728 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.9 141.07 58.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.06 -26.3 26.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.945 1.763 . . . . 0.0 112.459 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.51 142.62 48.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.33 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.3 p -95.08 9.02 41.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.495 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.2 -20.36 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.21 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -126.38 -9.67 6.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.839 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.98 -40.64 98.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 110.719 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -69.93 -35.89 74.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.58 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.12 -42.99 88.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.756 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.4 m170 -63.96 -38.67 91.94 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.997 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.95 -46.03 92.36 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.031 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.46 -43.92 95.96 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.23 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.78 -38.23 87.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 120' ' ' HIS . 57.1 t -58.38 -48.29 85.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.232 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.49 -28.84 41.46 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.934 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.38 -38.1 81.05 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.604 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.2 -32.42 33.52 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.2 mt -79.02 -26.12 43.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -110.36 -21.03 12.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.578 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.82 67.7 42.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.371 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.11 158.42 56.56 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.984 2.456 . . . . 0.0 112.29 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.217 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.22 148.66 95.88 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.533 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.25 147.29 25.9 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.713 2.275 . . . . 0.0 112.089 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.91 155.87 90.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.74 151.11 69.12 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.059 1.839 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.74 -172.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.134 1.889 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -122.38 155.82 61.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.0 141.36 88.89 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.083 1.855 . . . . 0.0 112.073 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.82 163.45 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.739 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -86.58 138.73 31.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.379 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.78 127.64 46.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.073 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.403 ' N ' HD12 ' B' ' 951' ' ' ILE . 3.0 mp -130.9 123.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.635 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.38 83.57 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.079 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 . . . . . 0 C--O 1.218 -0.578 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.522 179.591 . . . . . . . . 0 0 . 1 stop_ save_